All DT CAPITAL All
All VB live
live NNS births
births JJR >
> CC or
or JJ =
= CD 23
23 NNS weeks
weeks IN at
at DT the
the NNP CAPITAL University
University IN of
of NNP CAPITAL Vermont
Vermont IN in
in CD 1995
1995 NN (
( NN n
n JJ =
= CD 2395
2395 NN )
) VBD were
were RB retrospectively
retrospectively VBN analyzed
analyzed IN for
for NN delivery
delivery NN route
route , ,
, NN indication
indication IN for
for NN cesarean
cesarean , ,
, JJ gestational
gestational NN age
age , ,
, NN parity
parity , ,
, CC and
and NN practice
practice NN group
group NN (
( TO to
to VB reflect
reflect NN risk
risk NN status
status NN )

The DT CAPITAL The
The NN total
total NN cesarean
cesarean NN rate
rate VBD was
was CD 14.4
14.4 NN %
% NN (
( CD 344
344 IN of
of CD 2395
2395 NN )
) , ,
, CC and
and DT the
the JJ primary
primary NN rate
rate VBD was
was CD 11.4
11.4 NN %
% NN (
( CD 244
244 IN of
of CD 2144
2144 NN )

Abnormal JJ CAPITAL Abnormal
Abnormal NN presentation
presentation VBD was
was DT the
the RBS most
most JJ common
common NN indication
indication NN (
( CD 25.6
25.6 NN %
% , ,
, CD 88
88 IN of
of CD 344
344 NN )

The DT CAPITAL The
The `` ``
`` VBN corrected
corrected '' ''
'' NN cesarean
cesarean NN rate
rate NN (
( JJ maternal-fetal
maternal-fetal NN medicine
medicine CC and
and VBN transported
transported NNS patients
patients VBN excluded
excluded NN )
) VBD was
was CD 12.4
12.4 NN %
% NN (
( CD 273
273 IN of
of CD 2194
2194 NN )
) , ,
, CC and
and DT the
the `` ``
`` VBN corrected
corrected '' ''
'' JJ primary
primary NN rate
rate VBD was
was CD 9.6
9.6 NN %
% NN (
( CD 190
190 IN of
of CD 1975
1975 NN )

Furthermore RB CAPITAL Furthermore
Furthermore , ,
, WRB when
when DT all
all NNS deliveries
deliveries VBD were
were VBN analyzed
analyzed , ,
, RB regardless
regardless IN of
of NN risk
risk NN status
status CC but
but JJ limited
limited TO to
to JJ gestational
gestational NN age
age JJR >
> CC or
or JJ =
= CD 36
36 NNS weeks
weeks , ,
, DT the
the NNS rates
rates VBD did
did RB not
not NN change
change NN (
( CD 12.6
12.6 NN %
% , ,
, CD 280
280 IN of
of CD 2214
2214 : ;
; JJ primary
primary CD 9.2
9.2 NN %
% , ,
, CD 183
183 IN of
of CD 1994
1994 NN )

Arrest NN CAPITAL Arrest
Arrest IN of
of NN dilation
dilation VBD was
was DT the
the RBS most
most JJ common
common NN indication
indication IN in
in DT both
both `` ``
`` VBN corrected
corrected '' ''
'' NNS subgroups
subgroups NN (
( CD 23.4
23.4 CC and
and CD 24.6
24.6 NN %
% , ,
, RB respectively
respectively NN )

Cesarean NNP CAPITAL Cesarean
Cesarean NNS rates
rates IN at
at JJ tertiary
tertiary NN care
care NNS hospitals
hospitals MD should
should VB be
be VBN compared
compared IN with
with NNS rates
rates IN at
at NN community
community NNS hospitals
hospitals RB only
only IN after
after VBG correcting
correcting IN for
for JJ dissimilar
dissimilar NN patient
patient NNS groups
groups CC or
or JJ gestational
gestational NN age

In IN CAPITAL In
In DT the
the JJ third
third NN trimester
trimester , ,
, DT the
the JJ amniotic
amniotic NN fluid
fluid NN index
index NN (
( NNP CAPITAL AFI
AFI NN )
) MD may
may VB be
be VBN affected
affected IN by
by JJ maternal
maternal NN fluid
fluid NN status

As IN CAPITAL As
As DT the
the JJ ambient
ambient NN temperature
temperature NNS increases
increases , ,
, RB there
there VBZ is
is DT an
an NN increase
increase IN in
in JJ insensible
insensible NN fluid
fluid NN loss
loss CC and
and DT the
the NN potential
potential IN for
for NN dehydration

We PRP CAPITAL We
We VB hypothesize
hypothesize IN that
that IN as
as NN temperature
temperature NNS increases
increases RB there
there MD would
would VB be
be DT a
a JJ concomitant
concomitant NN decrease
decrease IN in
in NNP CAPITAL AFI

From IN CAPITAL From
From NNP CAPITAL June
June CD 11
11 TO to
to NNP CAPITAL August
August CD 16
16 , ,
, CD 1993
1993 , ,
, IN during
during DT a
a NN period
period IN of
of JJ unusual
unusual JJ high
high NN heat
heat , ,
, CD 42
42 NNS women
women IN with
with NN singleton
singleton NNS pregnancies
pregnancies IN between
between CD 27
27 CC and
and CD 40
40 NNS weeks
weeks '' '
' NN gestation
gestation VBG undergoing
undergoing NN serial
serial JJ antenatal
antenatal NN testing
testing VBD had
had NNP CAPITAL AFI
AFI NNS determinations
determinations VBN recorded
recorded IN at
at JJS least
least RB weekly

The DT CAPITAL The
The RB daily
daily JJ high
high JJ ambient
ambient NN temperature
temperature IN in
in PRP$ our
our JJ urban
urban NN area
area VBD was
was RB subsequently
subsequently VBN obtained

A DT CAPITAL A
A CD 2-
2- , ,
, CD 3-
3- , ,
, CC and
and JJ 4-day
4-day VB mean
mean NN temperature
temperature RB prior
prior TO to
to DT the
the NN test
test NN date
date VBD was
was VBN compared
compared TO to
to NNP CAPITAL AFI
AFI VBG using
using DT a
a JJ CAPITAL Spearman-rank
Spearman-rank NN CAPITAL Correlation

The DT CAPITAL The
The RB daily
daily JJ high
high NN temperature
temperature VBD ranged
ranged IN from
from CD 71
71 TO to
to CD 104
104 NNS degrees
degrees NN CAPITAL F
F CC and
and NNP CAPITAL AFI
AFI NNS values
values VBD ranged
ranged IN from
from CD 1.7
1.7 TO to
to CD 24.7
24.7 NN cm
cm IN during
during DT the
the NN study
study NN period

There EX CAPITAL There
There VBD was
was DT a
a JJ significant
significant NN correlation
correlation IN between
between DT the
the CD 2-
2- , ,
, CD 3-
3- , ,
, CC and
and JJ 4-day
4-day VB mean
mean NN temperature
temperature CC and
and NNP CAPITAL AFI
AFI , ,
, IN with
with DT the
the JJ 4-day
4-day VB mean
mean VBG being
being DT the
the RBS most
most JJ significant
significant NN (
( NN r
r JJ =
= CD 0.31
0.31 , ,
, NN p
p CC &
& # #
# CD 60
60 : ;
; CD 0.001
0.001 NN )

Fluctuations NNS CAPITAL Fluctuations
Fluctuations IN in
in JJ ambient
ambient NN temperature
temperature VBP are
are RB inversely
inversely VBD correlated
correlated TO to
to NNS changes
changes IN in
in NNP CAPITAL AFI

This DT CAPITAL This
This NN relationship
relationship MD should
should VB be
be VBN taken
taken IN into
into NN account
account WRB when
when VBG interpreting
interpreting DT the
the NNP CAPITAL AFI
AFI IN as
as DT a
a NN measure
measure IN of
of JJ fetal
fetal NN well-being

This DT CAPITAL This
This NN study
study VBN tested
tested DT the
the NN hypothesis
hypothesis IN that
that TO to
to VB reduce
reduce DT the
the NN rate
rate IN of
of JJ macrosomic
macrosomic NNS infants
infants IN in
in JJ gestational
gestational NN diabetes
diabetes NNS cases
cases , ,
, JJ good
good JJ glycemic
glycemic NN control
control MD should
should VB be
be VBN initiated
initiated IN before
before CD 34
34 VBN completed
completed JJ gestational
gestational NNS weeks

The DT CAPITAL The
The NN study
study NN population
population VBN included
included CD 84
84 NNS women
women IN with
with JJ gestational
gestational NN diabetes
diabetes , ,
, VBN ascertained
ascertained IN by
by JJ universal
universal NN screening
screening IN of
of DT all
all NNS women
women VBG attending
attending DT the
the JJ antenatal
antenatal NN clinic
clinic IN of
of DT the
the NNP CAPITAL Hadassah
Hadassah NNP CAPITAL Medical
Medical NNP CAPITAL Center
Center , ,
, IN over
over DT a
a JJ 2-year
2-year NN period

The DT CAPITAL The
The CD 60
60 NNS women
women NN (
( CD 71
71 NN %
% NN )
) , ,
, WP who
who VBN initiated
initiated NN treatment
treatment IN before
before CD 34
34 VBN completed
completed NNS weeks
weeks , ,
, VBN composed
composed DT the
the `` ``
`` RB early
early '' ''
'' NN group

The DT CAPITAL The
The CD 24
24 NNS women
women NN (
( CD 29
29 NN %
% NN )
) , ,
, WP who
who VBN initiated
initiated NN treatment
treatment IN after
after DT the
the JJ 34th
34th NN week
week , ,
, VBN composed
composed DT the
the `` ``
`` RB late
late '' ''
'' NN group

All DT CAPITAL All
All NNS patients
patients VBD were
were VBN managed
managed IN by
by DT an
an VBN intensified
intensified NN protocol
protocol , ,
, VBG including
including JJ stringent
stringent JJ glycemic
glycemic NN control

In IN CAPITAL In
In DT the
the `` ``
`` RB early
early '' ''
'' CC and
and `` ``
`` RB late
late '' ''
'' NNS groups
groups , ,
, VB mean
mean JJ gestational
gestational NN age
age IN at
at DT the
the VBG beginning
beginning IN of
of NN treatment
treatment VBD was
was CD 30.0
30.0 CC +/-
+/- CD 3.8
3.8 CC and
and CD 36.2
36.2 CC +/-
+/- CD 1.2
1.2 NNS weeks
weeks , ,
, CC and
and NN duration
duration IN of
of NN treatment
treatment VBD was
was CD 9.6
9.6 CC +/-
+/- CD 4.1
4.1 CC and
and CD 3.7
3.7 CC +/-
+/- CD 1.8
1.8 NNS weeks
weeks , ,
, RB respectively

Maternal JJ CAPITAL Maternal
Maternal NNS characteristics
characteristics VBD were
were JJ similar
similar IN in
in DT the
the CD two
two NNS groups

The DT CAPITAL The
The NN rate
rate IN of
of JJ macrosomic
macrosomic CC and
and JJ large-for-gestational-age
large-for-gestational-age NNS infants
infants VBD were
were CD 5
5 CC and
and CD 11
11 NN %
% , ,
, RB respectively
respectively , ,
, IN in
in DT the
the RB early
early NN group
group IN as
as VBN compared
compared TO to
to CD 25
25 CC and
and CD 29
29 NN %
% IN in
in DT the
the `` ``
`` RB late
late '' ''
'' NN group
group NN (
( NN p
p CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )

No DT CAPITAL No
No JJ significant
significant NNS differences
differences VBD were
were VBN found
found IN between
between DT the
the CD two
two NNS groups
groups IN in
in DT the
the NN mode
mode IN of
of NN delivery
delivery CC or
or NNP CAPITAL Apgar
Apgar NNS scores

We PRP CAPITAL We
We VBP conclude
conclude IN that
that TO to
to VB reduce
reduce DT the
the NN rate
rate IN of
of JJ macrosomic
macrosomic NNS infants
infants IN in
in JJ gestational
gestational NN diabetes
diabetes NNS cases
cases , ,
, JJ good
good JJ glycemic
glycemic NN control
control MD should
should VB be
be VBN initiated
initiated IN before
before CD 34
34 VBN completed
completed JJ gestational
gestational NNS weeks

Our PRP$ CAPITAL Our
Our NN aim
aim VBD was
was TO to
to VB investigate
investigate DT the
the NN contribution
contribution IN of
of JJ certain
certain RB antenatally
antenatally JJ detectable
detectable NNS markers
markers VBG leading
leading TO to
to DT the
the NN diagnosis
diagnosis IN of
of JJ trisomic
trisomic NNS fetuses
fetuses PRP we
we VBN observed
observed IN over
over DT a
a NN period
period IN of
of CD 6
6 NNS years

In IN CAPITAL In
In PRP$ our
our NN study
study , ,
, PRP we
we RB specifically
specifically VBN analyzed
analyzed DT the
the NN role
role VBN played
played IN by
by VBN advanced
advanced JJ maternal
maternal NN age
age CC and
and RB sonographically
sonographically VBN discovered
discovered NNS abnormalities
abnormalities IN in
in DT the
the NN detection
detection IN of
of JJ autosomal
autosomal NNS trisomies

All DT CAPITAL All
All RB together
together , ,
, CD 27
27 NNS fetuses
fetuses VBD had
had DT this
this NN disorder
disorder , ,
, VBG representing
representing CD 28.7
28.7 NN %
% NN (
( CD 27
27 IN of
of CD 94
94 NN )
) IN of
of DT all
all JJ cytogenetic
cytogenetic NNS aberrations
aberrations VBN detected
detected IN at
at PRP$ our
our NN center
center IN over
over DT the
the JJ same
same NN period

Down NN CAPITAL Down
Down NN syndrome
syndrome NN (
( CD 12
12 NNS cases
cases NN )
) CC and
and NNP CAPITAL Edward
Edward NN syndrome
syndrome NN (
( CD 11
11 NNS cases
cases NN )
) VBD were
were DT the
the RBS most
most JJ common
common NNS trisomies
trisomies , ,
, IN while
while CD 4
4 NNS cases
cases IN of
of NN CAPITAL Patau
Patau NN syndrome
syndrome VBD were
were RB also
also VBN diagnosed

The DT CAPITAL The
The RBS most
most JJ common
common NN indication
indication VBG leading
leading TO to
to NN diagnosis
diagnosis VBD was
was JJ abnormal
abnormal NN ultrasound
ultrasound NN finding
finding NN (
( CD 48.2
48.2 NN %
% NN )
) , ,
, VBN followed
followed IN by
by VBN advanced
advanced JJ maternal
maternal NN age
age NN (
( CD 44.4
44.4 NN %
% NN )

However RB CAPITAL However
However , ,
, CD 63
63 NN %
% IN of
of DT the
the JJ trisomic
trisomic NNS fetuses
fetuses VBD belonged
belonged TO to
to NNS mothers
mothers JJ aged
aged CD 35
35 NNS years
years CC and
and IN above

Down NN CAPITAL Down
Down NN syndrome
syndrome NNS fetuses
fetuses NN (
( CD 41.7
41.7 NN %
% NN )
) VBD had
had RB prenatally
prenatally VBN detected
detected JJ sonographic
sonographic NNS anomalies
anomalies , ,
, CD 63.6
63.6 NN %
% IN for
for NNP CAPITAL Edward
Edward NN syndrome
syndrome , ,
, CC and
and DT all
all NNS fetuses
fetuses IN with
with NN CAPITAL Patau
Patau NN syndrome
syndrome NN (
( CD 4
4 IN of
of CD 4
4 NN )
) VBD showed
showed JJ abnormal
abnormal JJ sonographic
sonographic NNS signs

Trisomy NNP CAPITAL Trisomy
Trisomy CD 21
21 VBN presented
presented IN with
with DT the
the VBG following
following NNS features
features : :
: NNS hydramnios
hydramnios , ,
, NN complex
complex NNS malformations
malformations , ,
, NN pyelectasis
pyelectasis , ,
, CC and
and JJ duodenal
duodenal NN atresia

Trisomy NNP CAPITAL Trisomy
Trisomy CD 18
18 NNS fetuses
fetuses VBD showed
showed NNS hydramnios
hydramnios , ,
, JJ intrauterine
intrauterine NN growth
growth NN retardation
retardation , ,
, NN microcephaly
microcephaly , ,
, NN spina
spina NN bifida
bifida , ,
, CC and
and JJ nonimmune
nonimmune NNS hydrops
hydrops NN fetalis

Signs NNS CAPITAL Signs
Signs VBN observed
observed IN in
in NNS fetuses
fetuses IN with
with NN trisomy
trisomy CD 13
13 VBD were
were : :
: NN hydrocephalus
hydrocephalus , ,
, JJ intrauterine
intrauterine NN growth
growth NN retardation
retardation , ,
, NNS oligoanhydramnios
oligoanhydramnios , ,
, NN complex
complex NNS malformations
malformations , ,
, JJ severe
severe JJ fetal
fetal NN bradycardia
bradycardia CC and
and NN hydronephrosis

The DT CAPITAL The
The NN objective
objective IN of
of DT this
this NN study
study VBD was
was TO to
to VB determine
determine IN if
if DT the
the NN rate
rate IN of
of NN preeclampsia
preeclampsia VBZ is
is VBN increased
increased IN in
in NN triplet
triplet IN as
as VBN compared
compared TO to
to NN twin
twin NNS gestations

Fifty-three CD CAPITAL Fifty-three
Fifty-three NN triplet
triplet NNS pregnancies
pregnancies IN between
between CD 1986
1986 CC and
and CD 1993
1993 IN at
at DT CAPITAL The
The NNP CAPITAL New
New NNP CAPITAL York
York NNP CAPITAL Hospital-Cornell
Hospital-Cornell NNP CAPITAL Medical
Medical NNP CAPITAL Center
Center VBD were
were VBN reviewed

These DT CAPITAL These
These VBD were
were VBN matched
matched IN for
for JJ maternal
maternal NN age
age , ,
, NN parity
parity , ,
, CC and
and NN race
race TO to
to NN twin
twin NNS gestations
gestations NN (
( NN CAPITAL N
N JJ =
= CD 53
53 NN )
) IN from
from DT the
the JJ same
same NN population

Severe JJ CAPITAL Severe
Severe NN preeclampsia
preeclampsia VBD was
was VBN defined
defined IN by
by NN standard
standard NNS criteria

Student NN CAPITAL Student
Student POS 's
's NN t-test
t-test , ,
, NNP CAPITAL Fisher
Fisher JJ exact
exact NN test
test , ,
, CC and
and JJ CAPITAL Chi-square
Chi-square VBD were
were VBN used
used IN for
for JJ statistical
statistical NN analysis

The DT CAPITAL The
The NN rate
rate IN of
of JJ severe
severe NN preeclampsia
preeclampsia VBD was
was VBN increased
increased RB significantly
significantly IN in
in DT the
the NN triplet
triplet NN group
group CD 12
12 IN of
of CD 53
53 NN (
( CD 22.6
22.6 NN %
% NN )
) IN as
as VBN compared
compared IN with
with DT the
the NN twin
twin NN group
group CD 3
3 IN of
of CD 53
53 NN (
( CD 5.7
5.7 NN %
% NN )
) NN (
( NN CAPITAL OR
OR JJ =
= CD 4.9
4.9 , ,
, CD 95
95 NN %
% NN CAPITAL CI
CI CD 1.2-23.5
1.2-23.5 , ,
, NN p
p JJ =
= CD 0.02
0.02 NN )

The DT CAPITAL The
The NN rate
rate IN of
of RB overall
overall NN preeclampsia
preeclampsia VBD was
was RB not
not RB significantly
significantly JJ different
different IN in
in DT the
the NN triplet
triplet CD 18
18 IN of
of CD 53
53 NN (
( CD 33.96
33.96 NN %
% NN )
) CC or
or NN twin
twin CD 12
12 IN of
of CD 53
53 NN (
( CD 22.6
22.6 NN %
% NN )
) NNS groups

In IN CAPITAL In
In DT this
this NN retrospective
retrospective , ,
, JJ case-controlled
case-controlled NN study
study , ,
, DT the
the NN rate
rate IN of
of JJ severe
severe NN pre-eclampsia
pre-eclampsia VBD was
was RB significantly
significantly VBN increased
increased IN in
in NN triplet
triplet NNS gestations
gestations IN as
as VBN compared
compared TO to
to NNS twins
twins IN although
although DT the
the RB overall
overall NN rate
rate IN of
of NN preeclampsia
preeclampsia VBD was
was RB not

This DT CAPITAL This
This NN information
information MD may
may VB be
be JJ useful
useful IN in
in NN counseling
counseling NNS patients
patients IN with
with JJ high
high NN order
order JJ multifetal
multifetal NNS gestations

We PRP CAPITAL We
We VBN conducted
conducted DT a
a NN survey
survey CC and
and NN audit
audit IN of
of JJ thermal
thermal NN equipment
equipment NN use
use IN in
in RB very
very JJ low-birth-weight
low-birth-weight NNS infants
infants IN in
in CD five
five NNP CAPITAL Ohio
Ohio JJ neonatal
neonatal JJ intensive
intensive NN care
care NNS units
units NN (
( NNS CAPITAL NICUs
NICUs NN )
) TO to
to NN document
document JJ regional
regional NN practice

The DT CAPITAL The
The NN survey
survey VBD indicated
indicated DT a
a NN variety
variety IN of
of JJ thermal
thermal NN care
care NNS styles

Two CD CAPITAL Two
Two NNS CAPITAL NICUs
NICUs VBN preferred
preferred TO to
to VB admit
admit NNS infants
infants TO to
to NNS incubators
incubators , ,
, DT the
the JJ other
other CD three
three VBG favoring
favoring JJ radiant
radiant NNS warmers

These DT CAPITAL These
These CD three
three NNS CAPITAL NICUs
NICUs VBN moved
moved NNS infants
infants IN from
from JJ radiant
radiant NNS warmers
warmers IN into
into NNS incubators
incubators IN at
at RB significantly
significantly JJ different
different VB mean
mean NNS ages

The DT CAPITAL The
The NN audit
audit VBN demonstrated
demonstrated JJ inconsistent
inconsistent NN use
use IN of
of NN plastic
plastic NNS covers
covers , ,
, VBG warming
warming NNS mattresses
mattresses , ,
, CC and
and VBN added
added NN humidity
humidity IN under
under JJ radiant
radiant NNS warmers
warmers , ,
, CC and
and NNS discrepancies
discrepancies IN between
between NN survey
survey NNS responses
responses CC and
and JJ actual
actual NN use
use IN within
within NNS CAPITAL NICUs

Inter-NICU NNP CAPITAL Inter-NICU
Inter-NICU NN variability
variability IN of
of JJ thermal
thermal NN equipment
equipment NN use
use MD may
may VB complicate
complicate NN fluid
fluid NN management

This DT CAPITAL This
This NN report
report VBZ describes
describes DT a
a JJ full-term
full-term JJ newborn
newborn IN with
with JJ massive
massive JJ fetomaternal
fetomaternal NN hemorrhage

Fetal JJ CAPITAL Fetal
Fetal NNS movements
movements VBD were
were VBN decreased
decreased CD 48
48 NN hr
hr RB prior
prior TO to
to NN delivery

On IN CAPITAL On
On DT the
the NN day
day IN of
of NN delivery
delivery , ,
, PRP they
they VBD were
were JJ absent

The DT CAPITAL The
The NN nonstress
nonstress NN test
test VBD was
was JJ abnormal
abnormal IN with
with JJ low
low JJ biophysical
biophysical NN profile
profile CC and
and VBN decreased
decreased NN beat-to-beat
beat-to-beat NN variability

The DT CAPITAL The
The NN infant
infant VBN presented
presented IN with
with JJ extreme
extreme NN pallor
pallor , ,
, NN hypotonia
hypotonia , ,
, RB hepatosplenomegaly
hepatosplenomegaly , ,
, CC and
and NNS ascites

The DT CAPITAL The
The JJ initial
initial NN hemoglobin
hemoglobin VBD was
was CD 2.2
2.2 NN g/dL
g/dL , ,
, DT the
the NNP CAPITAL Kleihauer-Betke
Kleihauer-Betke VB stain
stain VBD was
was CD 27.6
27.6 NN %
% NN (
( JJS highest
highest NN level
level RB ever
ever VBN reported
reported NN )

Right RB CAPITAL Right
Right JJ temporal
temporal CC and
and NN cerebellar
cerebellar NNS hemorrhages
hemorrhages VBD were
were JJ present

Sequelae NNP CAPITAL Sequelae
Sequelae VB include
include JJ severe
severe JJ developmental
developmental NN delay
delay CC and
and JJ asymmetric
asymmetric RB double
double NN hemiplegia

Omphalocele-Exstrophy-Imperforate JJ CAPITAL Omphalocele-Exstrophy-Imperforate
Omphalocele-Exstrophy-Imperforate JJ anus-Spinal
anus-Spinal NNS defects
defects NN (
( NNS CAPITAL OEIS
OEIS NN complex
complex NN )
) , ,
, DT a
a NN combination
combination IN of
of NN omphalocele
omphalocele , ,
, NN exstrophy
exstrophy IN of
of DT the
the NN bladder
bladder , ,
, DT an
an NN imperforate
imperforate NN anus
anus CC and
and JJ spinal
spinal NNS defects
defects , ,
, VBZ arises
arises IN from
from DT a
a JJ single
single JJ localized
localized NN defect
defect IN in
in DT the
the RB early
early NN development
development IN of
of DT the
the NN mesoderm
mesoderm IN that
that MD will
will RB later
later VB contribute
contribute TO to
to JJ infraumbilical
infraumbilical NN mesenchyme
mesenchyme , ,
, JJ cloacal
cloacal NN septum
septum , ,
, CC and
and NN caudal
caudal NNS vertebrae

In IN CAPITAL In
In DT this
this NN report
report , ,
, PRP we
we NN document
document DT the
the JJ perinatal
perinatal NNS features
features IN of
of CD two
two NNS cases
cases IN of
of NNS CAPITAL OEIS
OEIS NN complex
complex VBN associated
associated IN with
with NNS meningomyeloceles
meningomyeloceles CC and
and JJ severe
severe JJR lower
lower NN limb
limb NNS defects
defects , ,
, CC and
and VB discuss
discuss DT the
the JJ prenatal
prenatal NN diagnosis
diagnosis , ,
, NN inheritance
inheritance , ,
, CC and
and JJ differential
differential NN diagnosis
diagnosis IN of
of DT this
this NN association
association IN of
of NNS malformations

Although IN CAPITAL Although
Although JJ long-term
long-term NN survival
survival MD can
can VB be
be VBN achieved
achieved IN by
by JJ successful
successful JJ corrective
corrective NN surgery
surgery , ,
, DT the
the VBN associated
associated JJ structural
structural NNS defects
defects JJ such
such IN as
as JJ large
large NN meningomyelocele
meningomyelocele CC and
and JJ severe
severe NN limb
limb NN aplasia
aplasia CC or
or NN hypoplasia
hypoplasia , ,
, IN as
as VBN seen
seen IN in
in PRP$ our
our NN patient
patient , ,
, MD can
can NN influence
influence DT the
the NN patient
patient POS 's
's NN quality
quality IN of
of NN life
life . .

We PRP CAPITAL We
We MD would
would IN like
like TO to
to VB emphasize
emphasize IN that
that DT an
an JJ accurate
accurate JJ prenatal
prenatal NN diagnosis
diagnosis IN of
of NNS CAPITAL OEIS
OEIS NN complex
complex CC and
and VBN associated
associated NNS malformations
malformations VBZ is
is JJ important
important IN for
for DT the
the VBN detailed
detailed NN counseling
counseling IN of
of DT the
the NN family
family IN as
as RB well
well IN as
as JJ appropriate
appropriate JJ perinatal
perinatal NN management
management IN by
by DT the
the NNS obstetricians
obstetricians , ,
, JJ pediatric
pediatric NNS surgeons
surgeons , ,
, NNS urologists
urologists , ,
, NNS neurosurgeons
neurosurgeons , ,
, CC and
and NNS neonatologists

Nonimmune JJ CAPITAL Nonimmune
Nonimmune NNS hydrops
hydrops NNS fetails
fetails VBN diagnosed
diagnosed IN at
at CD 21
21 NNS weeks
weeks '' '
' NN gestation
gestation IN with
with JJ profound
profound NNS ascites
ascites , ,
, NN hydrothorax
hydrothorax , ,
, CC and
and JJ pericardial
pericardial NN effusion
effusion VBN receded
receded RB gradually
gradually IN with
with NN regression
regression IN of
of DT a
a NN subchorial
subchorial JJ placental
placental NNS lucencies
lucencies RB immediately
immediately IN below
below DT the
the JJ umbilical
umbilical NN cord
cord NN insertion

Careful JJ CAPITAL Careful
Careful NN inspection
inspection IN of
of DT the
the VBN delivered
delivered NN placenta
placenta VBD revealed
revealed IN that
that RB there
there VBD was
was DT a
a JJ yellowish
yellowish NN lesion
lesion IN of
of JJ fibrin
fibrin NNS deposits
deposits IN below
below DT the
the NN cord
cord NN insertion
insertion NN site
site , ,
, WDT which
which VBD resulted
resulted IN from
from DT the
the NN absorption
absorption IN of
of NN hematoma

A DT CAPITAL A
A NN subchorial
subchorial JJ placental
placental NN hematoma
hematoma , ,
, WDT which
which VBN detected
detected IN as
as DT a
a NN subchorial
subchorial JJ placental
placental NNS lucencies
lucencies IN by
by NN ultrasonography
ultrasonography , ,
, MD can
can VB be
be DT a
a NN cause
cause IN of
of JJ reversible
reversible JJ nonimmune
nonimmune NNS hydrops
hydrops NN fetalis

The DT CAPITAL The
The JJ mitochondrial
mitochondrial NNS diseases
diseases VBP are
are JJ uncommon
uncommon NN multisystem
multisystem NNS disorders
disorders VBN characterized
characterized IN by
by DT the
the NN presence
presence IN of
of RB functionally
functionally CC and/or
and/or RB structurally
structurally JJ abnormal
abnormal NN mitochondria

As IN CAPITAL As
As RB there
there VB have
have VBN been
been JJ few
few NNS reports
reports IN of
of DT the
the JJ obstetrical
obstetrical NN care
care IN of
of VBN affected
affected NNS patients
patients , ,
, PRP we
we NN wish
wish TO to
to NN document
document CD two
two NNS pregnancies
pregnancies IN in
in DT a
a NN woman
woman IN with
with DT a
a JJ CAPITAL Chronic
Chronic JJ CAPITAL Progressive
Progressive JJ CAPITAL External
External NNP CAPITAL Ophthalmoplegia
Ophthalmoplegia NN (
( JJ CAPITAL Kearns-Sayre-like
Kearns-Sayre-like NN syndrome
syndrome NN )

Both DT CAPITAL Both
Both NNS pregnancies
pregnancies VBD were
were VBN complicated
complicated IN by
by NN preterm
preterm NN labor
labor CC and
and NN hypertension

CONTEXT NN CAPITAL CONTEXT
CONTEXT : :
: CD CAPITAL Four
Four JJ genetic
genetic NNS loci
loci VB have
have VBN been
been VBN identified
identified IN as
as VBG contributing
contributing TO to
to NN CAPITAL Alzheimer
Alzheimer NN disease
disease NN (
( NN CAPITAL AD
AD NN )
) , ,
, VBG including
including DT the
the NN amyloid
amyloid NN precursor
precursor NN protein
protein NN gene
gene , ,
, DT the
the NN presenilin
presenilin CD 1
1 NN gene
gene , ,
, DT the
the NN presenilin
presenilin CD 2
2 NN gene
gene , ,
, CC and
and DT the
the NN apolipoprotein
apolipoprotein NN CAPITAL E
E NN gene
gene , ,
, CC but
but VB do
do RB not
not NN account
account IN for
for DT all
all DT the
the JJ genetic
genetic NN risk
risk IN for
for NN CAPITAL AD

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB identify
identify JJ additional
additional JJ genetic
genetic NN risk
risk NNS factors
factors IN for
for NN late-onset
late-onset NN CAPITAL AD

DESIGN NN CAPITAL DESIGN
DESIGN : :
: DT CAPITAL A
A JJ complete
complete JJ genomic
genomic NN screen
screen VBD was
was VBN performed
performed NN (
( NN CAPITAL N=280
N=280 NNS markers
markers NN )

Critical JJ CAPITAL Critical
Critical NNS values
values IN for
for JJ chromosomal
chromosomal JJ regional
regional NN follow-up
follow-up VBD were
were DT a
a NN CAPITAL P
P NN value
value IN of
of CD .05
.05 CC or
or JJR less
less IN for
for VBN affected
affected JJ relative
relative NN pair
pair NN analysis
analysis CC or
or NN sibpair
sibpair NN analysis
analysis , ,
, DT a
a JJ parametric
parametric NN lod
lod NN score
score IN of
of CD 1.0
1.0 CC or
or JJR greater
greater , ,
, CC or
or DT both

Regional NNP CAPITAL Regional
Regional NN follow-up
follow-up VBN included
included NN analysis
analysis IN of
of JJ additional
additional NNS markers
markers CC and
and DT a
a JJ second
second NNS data
data NN set

SETTING VBG CAPITAL SETTING
SETTING : :
: NNP CAPITAL Clinic
Clinic NNS populations
populations IN in
in DT the
the JJ continental
continental NNP CAPITAL United
United NNPS CAPITAL States

PATIENTS NNS CAPITAL PATIENTS
PATIENTS : :
: JJR >
> IN CAPITAL From
From DT a
a NN series
series IN of
of JJ multiplex
multiplex NNS families
families VBN affected
affected IN with
with NN late-onset
late-onset NN (
( JJR >
> CC or
or CD =60
=60 NNS years
years NN )
) NN CAPITAL AD
AD VBN ascertained
ascertained IN during
during DT the
the JJ last
last CD 14
14 NNS years
years NN (
( NNP CAPITAL National
National NNP CAPITAL Insititute
Insititute IN of
of JJ CAPITAL Neurological
Neurological NNS CAPITAL Disorders
Disorders CC and
and NNP CAPITAL Stroke-Alzheimer
Stroke-Alzheimer POS 's
's NN CAPITAL Disease
Disease CC and
and VBN CAPITAL Related
Related NNS CAPITAL Disorders
Disorders NNP CAPITAL Association
Association JJ diagnostic
diagnostic NNS criteria
criteria NN )
) CC and
and IN for
for WDT which
which NN CAPITAL DNA
DNA VBZ has
has VBN been
been VBN obtained
obtained , ,
, DT a
a NN subset
subset IN of
of CD 16
16 NNS families
families NN (
( CD 135
135 NN total
total NN family
family NNS members
members , ,
, CD 52
52 IN of
of WP whom
whom VBD were
were NNS patients
patients IN with
with NN CAPITAL AD
AD NN )
) VBD was
was VBN used
used IN for
for DT the
the JJ genomic
genomic NN screen

A DT CAPITAL A
A JJ second
second NN subset
subset IN of
of CD 38
38 NNS families
families NN (
( CD 216
216 NN total
total NN family
family NNS members
members , ,
, CD 89
89 IN of
of WP whom
whom VBD were
were NNS patients
patients IN with
with NN CAPITAL AD
AD NN )
) VBD was
was VBN used
used IN for
for DT the
the NN follow-up
follow-up NN analysis

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: NN CAPITAL Linkage
Linkage NN analysis
analysis NNS results
results VBN generated
generated VBG using
using DT both
both JJ genetic
genetic JJ model-dependent
model-dependent NN (
( NN lod
lod NN score
score NN )
) CC and
and JJ model-independent
model-independent NNS methods

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: CD CAPITAL Fifteen
Fifteen JJ chromosomal
chromosomal NNS regions
regions VBN warranted
warranted JJ initial
initial NN follow-up

Follow-up JJ CAPITAL Follow-up
Follow-up NNS analyses
analyses VBD revealed
revealed CD 4
4 NNS regions
regions IN of
of VBN continued
continued NN interest
interest IN on
on NNS chromosomes
chromosomes CD 4
4 , ,
, CD 6
6 , ,
, CD 12
12 , ,
, CC and
and CD 20
20 , ,
, IN with
with DT the
the JJS strongest
strongest NNS results
results VBN observed
observed NN forchromosome
forchromosome CD 12

Peak JJ CAPITAL Peak
Peak JJ 2-point
2-point RB affecteds-only
affecteds-only NN lod
lod NNS scores
scores NN (
( NN n=54
n=54 NN )
) VBD were
were CD 1.3
1.3 , ,
, CD 1.6
1.6 , ,
, CD 2.7
2.7 , ,
, CC and
and CD 2.2
2.2 CC and
and VBN affected
affected JJ relative
relative NNS pairs
pairs NN CAPITAL P
P NNS values
values NN (
( NN n=54
n=54 NN )
) VBD were
were NN .04
.04 , ,
, CD .03
.03 , ,
, NN .14
.14 , ,
, CC and
and NN .04
.04 IN for
for NN CAPITAL D12S373
D12S373 , ,
, NN CAPITAL D12S1057
D12S1057 , ,
, NN CAPITAL D12S1042
D12S1042 , ,
, CC and
and NN CAPITAL D12S390
D12S390 , ,
, RB respectively

Sibpair NNP CAPITAL Sibpair
Sibpair NN analysis
analysis NN (
( NN n=54
n=54 NN )
) VBD resulted
resulted IN in
in NN maximum
maximum NN lod
lod NNS scores
scores NN (
( NNS CAPITAL MLSs
MLSs NN )
) IN of
of CD 1.5
1.5 , ,
, CD 2.6
2.6 , ,
, CD 3.2
3.2 , ,
, CC and
and CD 2.3
2.3 IN for
for DT these
these NNS markers
markers , ,
, IN with
with DT a
a NN peak
peak NN multipoint
multipoint NN CAPITAL MLS
MLS IN of
of CD 3.5

A DT CAPITAL A
A FW priori
priori NN stratification
stratification IN by
by NN CAPITAL APOE
APOE NN genotype
genotype VBN identified
identified CD 27
27 NNS families
families IN that
that VBD had
had IN at
at JJS least
least CD 1
1 NN member
member IN with
with NN CAPITAL AD
AD WP$ whose
whose NN genotype
genotype VBD did
did RB not
not VB contain
contain DT an
an NN CAPITAL APOE*4
APOE*4 NN allele

Analysis NN CAPITAL Analysis
Analysis IN of
of DT these
these CD 27
27 NNS families
families VBD resulted
resulted IN in
in NNS CAPITAL MLSs
MLSs IN of
of CD 1.0
1.0 , ,
, CD 2.4
2.4 , ,
, CD 3.7
3.7 , ,
, CC and
and CD 3.3
3.3 CC and
and DT a
a NN peak
peak NN multipoint
multipoint NN CAPITAL MLS
MLS IN of
of CD 3.9

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL A
A JJ complete
complete JJ genomic
genomic NN screen
screen IN in
in NNS families
families VBN affected
affected IN with
with NN late-onset
late-onset NN CAPITAL AD
AD VBN identified
identified CD 4
4 NNS regions
regions IN of
of NN interest
interest IN after
after NN follow-up

Chromosome NN CAPITAL Chromosome
Chromosome CD 12
12 VBD gave
gave DT the
the JJS strongest
strongest CC and
and RBS most
most JJ consistent
consistent NNS results
results IN with
with DT a
a NN peak
peak NN multipoint
multipoint NN CAPITAL MLS
MLS IN of
of CD 3.5
3.5 , ,
, VBG suggesting
suggesting IN that
that DT this
this NN region
region VBZ contains
contains DT a
a JJ new
new NN susceptibility
susceptibility NN gene
gene IN for
for NN CAPITAL AD

Additional JJ CAPITAL Additional
Additional NNS analyses
analyses VBP are
are JJ necessary
necessary TO to
to VB identify
identify DT the
the NN chromosome
chromosome CD 12
12 NN susceptibility
susceptibility NN gene
gene IN for
for NN CAPITAL AD
AD CC and
and TO to
to VB follow
follow RB up
up DT the
the NNS regions
regions IN of
of NN interest
interest IN on
on NNS chromosomes
chromosomes CD 4
4 , ,
, CD 6
6 , ,
, CC and
and CD 20

CONTEXT NN CAPITAL CONTEXT
CONTEXT : :
: DT CAPITAL A
A NN mutation
mutation IN in
in DT the
the NN CAPITAL BRCA1
BRCA1 NN gene
gene MD may
may VB confer
confer JJ substantial
substantial NN risk
risk IN for
for NN breast
breast CC and/or
and/or JJ ovarian
ovarian NN cancer

However RB CAPITAL However
However , ,
, NN knowledge
knowledge VBG regarding
regarding DT all
all JJ possible
possible NNS mutations
mutations CC and
and DT the
the NN relationship
relationship IN between
between NN risk
risk NNS factors
factors CC and
and NNS mutations
mutations VBZ is
is JJ incomplete

OBJECTIVES NNS CAPITAL OBJECTIVES
OBJECTIVES : :
: TO CAPITAL To
To VB identify
identify NN CAPITAL BRCA1
BRCA1 NNS mutations
mutations CC and
and TO to
to VB determine
determine NNS factors
factors IN that
that RB best
best VB predict
predict NN presence
presence IN of
of DT a
a JJ deleterious
deleterious NN CAPITAL BRCA1
BRCA1 NN mutation
mutation IN in
in NNS patients
patients IN with
with NN breast
breast CC and/or
and/or JJ ovarian
ovarian NN cancer

DESIGN NN CAPITAL DESIGN
DESIGN : :
: DT CAPITAL A
A JJ complete
complete NN sequence
sequence NN analysis
analysis IN of
of DT the
the NN CAPITAL BRCA1
BRCA1 VBG coding
coding NN sequence
sequence CC and
and VBG flanking
flanking JJ intronic
intronic NNS regions
regions VBD was
was VBN performed
performed IN in
in CD 798
798 NNS women
women IN in
in DT a
a JJ collaborative
collaborative NN effort
effort VBG involving
involving NNS institutions
institutions IN from
from DT the
the NNP CAPITAL United
United NNPS CAPITAL States
States , ,
, NNP CAPITAL Italy
Italy , ,
, NNP CAPITAL Germany
Germany , ,
, NNP CAPITAL Finland
Finland , ,
, CC and
and NNP CAPITAL Switzerland

PARTICIPANTS NNS CAPITAL PARTICIPANTS
PARTICIPANTS : :
: NNS CAPITAL Institutions
Institutions VBN selected
selected CD 798
798 NNS persons
persons VBG representing
representing NNS families
families NN (
( CD 1
1 NN person
person IN for
for DT each
each NN family
family NN )
) NN thought
thought TO to
to VB be
be IN at
at JJ elevated
elevated DT a
a FW priori
priori NN risk
risk IN of
of NN CAPITAL BRCA1
BRCA1 NN mutation
mutation JJ due
due TO to
to NN potential
potential NN risk
risk NNS factors
factors , ,
, JJ such
such IN as
as JJ multiple
multiple NNS cases
cases IN of
of NN breast
breast NN cancer
cancer , ,
, RB early
early NN age
age IN of
of NN breast
breast NN cancer
cancer NN diagnosis
diagnosis , ,
, CC and
and NNS cases
cases IN of
of JJ ovarian
ovarian NN cancer

No DT CAPITAL No
No NN participant
participant VBD was
was IN from
from DT a
a NN family
family IN in
in WDT which
which JJ genetic
genetic NNS markers
markers VBD showed
showed NN linkage
linkage TO to
to DT the
the NN CAPITAL BRCA1
BRCA1 NN locus

MAJOR NN CAPITAL MAJOR
MAJOR NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: NN CAPITAL Sequence
Sequence NNS variants
variants VBN detected
detected IN in
in DT this
this NN sample
sample VBP are
are VBN presented
presented IN along
along IN with
with NNS analyses
analyses VBN designed
designed TO to
to VB determine
determine JJ predictive
predictive NNS characteristics
characteristics IN of
of DT those
those NN testing
testing JJ positive
positive IN for
for NN CAPITAL BRCA1
BRCA1 NNS mutations

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: IN CAPITAL In
In CD 102
102 NNS women
women NN (
( CD 12.8
12.8 NN %
% NN )
) , ,
, RB clearly
clearly JJ deleterious
deleterious NNS mutations
mutations VBD were
were VBN detected

Fifty CD CAPITAL Fifty
Fifty JJ new
new JJ genetic
genetic NNS alterations
alterations VBD were
were VBN found
found VBG including
including CD 24
24 JJ deleterious
deleterious NNS mutations
mutations , ,
, CD 24
24 NNS variants
variants IN of
of JJ unknown
unknown NN significance
significance , ,
, CC and
and CD 2
2 JJ rare
rare NNS polymorphisms

In IN CAPITAL In
In DT a
a NN subset
subset IN of
of CD 71
71 NNP CAPITAL Ashkenazi
Ashkenazi JJ CAPITAL Jewish
Jewish NNS women
women , ,
, RB only
only CD 2
2 JJ distinct
distinct JJ deleterious
deleterious NNS mutations
mutations VBD were
were VBN found
found : :
: NN 185delAG
185delAG IN in
in CD 17
17 NNS cases
cases CC and
and NN 5382insC
5382insC IN in
in CD 7
7 NNS cases

A DT CAPITAL A
A NN bias
bias IN in
in RB prior
prior NNS reports
reports IN for
for NNS mutations
mutations IN in
in NN exon
exon CD 11
11 VBD was
was VBD revealed

Characteristics NNS CAPITAL Characteristics
Characteristics IN of
of DT a
a NN patient
patient POS 's
's JJ specific
specific NN diagnosis
diagnosis NN (
( JJ unilateral
unilateral CC or
or JJ bilateral
bilateral NN breast
breast NN cancer
cancer , ,
, IN with
with CC or
or IN without
without JJ ovarian
ovarian NN cancer
cancer NN )
) , ,
, RB early
early NN age
age IN at
at NN diagnosis
diagnosis , ,
, NNP CAPITAL Ashkenazi
Ashkenazi JJ CAPITAL Jewish
Jewish NN ethnicity
ethnicity , ,
, CC and
and NN family
family NN history
history IN of
of NN cancer
cancer VBD were
were RB positively
positively VBN associated
associated IN with
with DT the
the NN probability
probability IN of
of PRP$ her
her VBG carrying
carrying DT a
a JJ deleterious
deleterious NN CAPITAL BRCA1
BRCA1 NN mutation

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: VBG CAPITAL Using
Using JJ logistic
logistic NN regression
regression NN analysis
analysis , ,
, PRP we
we VB provide
provide DT a
a NN method
method IN for
for VBG evaluating
evaluating DT the
the NN probability
probability IN of
of DT a
a NN woman
woman POS 's
's VBG carrying
carrying DT a
a JJ deleterious
deleterious NN CAPITAL BRCA1
BRCA1 NN mutation
mutation IN for
for DT a
a JJ wide
wide NN range
range IN of
of NNS cases
cases , ,
, WDT which
which MD can
can VB be
be DT an
an JJ important
important NN tool
tool IN for
for NNS clinicians
clinicians IN as
as PRP they
they VB incorporate
incorporate JJ genetic
genetic NN susceptibility
susceptibility NN testing
testing IN into
into PRP$ their
their JJ medical
medical NN practice

CONTEXT NN CAPITAL CONTEXT
CONTEXT : :
: RB CAPITAL Approximately
Approximately CD 9
9 NN %
% IN of
of NN prostate
prostate NN cancer
cancer NNS cases
cases VB have
have VBN been
been VBN estimated
estimated TO to
to NN result
result IN from
from NN inheritance
inheritance IN of
of VBN mutated
mutated NN prostate
prostate NN cancer
cancer NN susceptibility
susceptibility NNS genes

Few JJ CAPITAL Few
Few NNS data
data VB exist
exist IN as
as TO to
to IN whether
whether RB there
there VBP are
are JJ clinical
clinical NNS differences
differences IN between
between NN prostate
prostate NNS cancers
cancers IN that
that VBP are
are VBN inherited
inherited CC and
and DT those
those IN that
that VB occur
occur IN in
in DT the
the JJ general
general NN population

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB investigate
investigate JJ phenotypic
phenotypic NNS characteristics
characteristics IN of
of NNS families
families RB potentially
potentially VBN linked
linked TO to
to DT the
the JJ hereditary
hereditary NN prostate
prostate NN cancer
cancer CD 1
1 NN (
( NN CAPITAL HPC1
HPC1 NN )
) NN locus
locus IN on
on NN chromosome
chromosome NN 1q24-25

DESIGN NN CAPITAL DESIGN
DESIGN : :
: JJ CAPITAL Retrospective
Retrospective NN case
case NN study
study IN in
in WDT which
which JJ clinical
clinical NNS data
data VBD were
were VBN extracted
extracted IN from
from JJ medical
medical CC and
and JJ pathological
pathological NNS records

FAMILIES NNS CAPITAL FAMILIES
FAMILIES : :
: DT CAPITAL A
A NN total
total IN of
of CD 74
74 NNP CAPITAL North
North NNP CAPITAL American
American NNS families
families IN with
with JJ hereditary
hereditary NN prostate
prostate NN cancer

Prostate NN CAPITAL Prostate
Prostate NN cancer
cancer NNS cases
cases IN from
from DT the
the NNP CAPITAL National
National NN CAPITAL Cancer
Cancer NNS CAPITAL Data
Data NN CAPITAL Base
Base VBD were
were VBN used
used IN as
as DT a
a NN reference
reference NN population
population IN for
for NN comparison

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: DT CAPITAL The
The NNS families
families VBD were
were VBN divided
divided IN into
into CD 2
2 NNS groups
groups : :
: DT either
either RB potentially
potentially VBN linked
linked NN (
( CD 33
33 NNS families
families IN with
with CD 133
133 NNS men
men IN with
with NN prostate
prostate NN cancer
cancer NN )
) , ,
, CC and
and RB thus
thus RB likely
likely TO to
to VB be
be VBG carrying
carrying DT an
an JJ altered
altered NN CAPITAL HPC1
HPC1 NN gene
gene , ,
, CC or
or RB potentially
potentially JJ unlinked
unlinked NN (
( CD 41
41 NNS families
families IN with
with CD 172
172 NNS men
men IN with
with NN prostate
prostate NN cancer
cancer NN )
) , ,
, IN on
on DT the
the NN basis
basis IN of
of NN haplotype
haplotype NN analysis
analysis IN in
in DT the
the NN region
region IN of
of NN CAPITAL HPC1

The DT CAPITAL The
The NN age
age IN at
at NN diagnosis
diagnosis IN of
of NN prostate
prostate NN cancer
cancer , ,
, NN serum
serum JJ prostate-specific
prostate-specific NN antigen
antigen NNS levels
levels , ,
, JJ digital
digital JJ rectal
rectal NN examination
examination NN status
status , ,
, NN stage
stage , ,
, NN grade
grade , ,
, JJ primary
primary NN treatment
treatment IN of
of NN prostate
prostate NNS cancers
cancers , ,
, CC and
and NN occurrence
occurrence IN of
of JJ other
other NNS cancers
cancers VBD were
were VBN compared
compared IN between
between DT the
the NNS groups

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The VB mean
mean NN age
age IN at
at NN diagnosis
diagnosis IN of
of NN prostate
prostate NN cancer
cancer IN for
for NNS men
men IN in
in RB potentially
potentially VBN linked
linked NNS families
families VBD was
was RB significantly
significantly JJR lower
lower IN than
than IN for
for NNS men
men IN in
in RB potentially
potentially JJ unlinked
unlinked NNS families
families NN (
( CD 63.7
63.7 CC vs
vs CD 65.9
65.9 NNS years
years , ,
, RB respectively
respectively , ,
, NN CAPITAL P=.01
P=.01 : ;
; VB mean
mean NN age
age IN at
at NN diagnosis
diagnosis IN in
in DT the
the NN reference
reference NN population
population VBD was
was CD 71.6
71.6 NNS years
years NN )

Higher-grade JJ CAPITAL Higher-grade
Higher-grade NNS cancers
cancers NN (
( NN grade
grade CD 3
3 NN )
) VBD were
were RBR more
more JJ common
common IN in
in RB potentially
potentially VBN linked
linked NNS families
families , ,
, CC and
and NN advanced-stage
advanced-stage NN disease
disease VBD was
was VBN found
found IN in
in CD 41
41 NN %
% IN of
of DT the
the NN case
case NNS patients
patients IN in
in RB potentially
potentially VBN linked
linked NNS families
families VBN compared
compared IN with
with CD 31
31 NN %
% IN in
in DT both
both DT the
the RB potentially
potentially JJ unlinked
unlinked NNS families
families CC and
and DT the
the NN reference
reference NNS groups
groups NN (
( NN CAPITAL P=.03
P=.03 IN for
for DT the
the JJ latter
latter NN comparison
comparison NN )

In IN CAPITAL In
In DT the
the JJ other
other JJ clinical
clinical NNS parameters
parameters , ,
, PRP we
we VBN found
found DT no
no JJ significant
significant NNS differences
differences IN between
between DT the
the NNS groups

A DT CAPITAL A
A JJ modest
modest NN excess
excess IN of
of NN breast
breast NN cancer
cancer CC and
and NN colon
colon NN cancer
cancer VBD was
was VBN found
found IN in
in RB potentially
potentially VBN linked
linked NNS families
families IN in
in NN comparison
comparison IN with
with RB potentially
potentially JJ unlinked
unlinked NNS families
families , ,
, CC but
but DT this
this NN difference
difference VBD was
was RB not
not RB statistically
statistically JJ significant

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NNS CAPITAL Families
Families IN that
that VB provide
provide NN evidence
evidence IN for
for NN segregation
segregation IN of
of DT an
an JJ altered
altered NN CAPITAL HPC1
HPC1 NN gene
gene VBP are
are VBN characterized
characterized IN by
by JJ multiple
multiple NNS cases
cases IN of
of NN prostate
prostate NN cancer
cancer IN that
that , ,
, IN in
in RBS most
most NNS respects
respects , ,
, VBP are
are JJ indistinguishable
indistinguishable IN from
from JJ nonhereditary
nonhereditary NNS cases

However RB CAPITAL However
However , ,
, CD 3
3 NNS characteristics
characteristics VBD were
were VBN observed
observed : :
: JJR younger
younger NN age
age IN at
at NN diagnosis
diagnosis , ,
, JJ higher-grade
higher-grade NNS tumors
tumors , ,
, CC and
and RBR more
more NN advanced-stage
advanced-stage NN disease

Our PRP$ CAPITAL Our
Our NN study
study NNS shows
shows IN that
that DT a
a JJ significant
significant NN fraction
fraction IN of
of JJ hereditary
hereditary NN prostate
prostate NNS cancers
cancers VBP are
are VBN diagnosed
diagnosed IN in
in VBN advanced
advanced NNS stages
stages , ,
, VBG emphasizing
emphasizing DT the
the JJ clinical
clinical NN importance
importance IN of
of RB early
early NN detection
detection IN in
in NNS men
men RB potentially
potentially VBG carrying
carrying NN prostate
prostate NN cancer
cancer NN susceptibility
susceptibility NNS genes

These DT CAPITAL These
These NNS findings
findings NN support
support DT the
the JJ current
current NNS recommendations
recommendations TO to
to NN screen
screen NNS men
men IN with
with DT a
a JJ positive
positive NN family
family NN history
history IN of
of NN prostate
prostate NN cancer
cancer VBG beginning
beginning IN at
at NN age
age CD 40
40 NNS years

CONTEXT NN CAPITAL CONTEXT
CONTEXT : :
: NN CAPITAL Susceptibility
Susceptibility TO to
to JJ multiple
multiple NN sclerosis
sclerosis NN (
( NN CAPITAL MS
MS NN )
) VBZ involves
involves DT a
a RB genetically
genetically NN complex
complex JJ autoimmune
autoimmune NN component

However RB CAPITAL However
However , ,
, IN except
except IN for
for NNS genes
genes IN in
in DT the
the NN CAPITAL HLA
HLA NN system
system , ,
, JJ specific
specific NN susceptibility
susceptibility NNS loci
loci VBP are
are JJ unknown
unknown CC or
or JJ unconfirmed

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB investigate
investigate JJ several
several NNS loci
loci VBG spanning
spanning CD 3
3 NN candidate
candidate NNS regions
regions IN for
for DT a
a NN role
role IN in
in JJ multiple
multiple NN sclerosis
sclerosis NN (
( NN CAPITAL MS
MS NN )
) NN susceptibility
susceptibility IN in
in CD 2
2 JJ ethnic
ethnic NNS groups
groups VBG using
using DT both
both NN single-locus
single-locus CC and
and NN haplotype
haplotype NNS analyses

The DT CAPITAL The
The CD 3
3 NNS regions
regions VB include
include NN CAPITAL HLA
HLA IN on
on NN chromosome
chromosome NN 6p21.3
6p21.3 , ,
, NN CAPITAL APOE
APOE IN on
on NN chromosome
chromosome NN 19ql
19ql CD 3.2
3.2 , ,
, CC and
and NN CAPITAL MBP
MBP NN (
( JJ myelin
myelin JJ basic
basic NN protein
protein NN )
) IN on
on NN chromosome
chromosome NN 18q23

DESIGN NN CAPITAL DESIGN
DESIGN : :
: JJ CAPITAL Case-control
Case-control NN association
association NN testing

SUBJECTS NNS CAPITAL SUBJECTS
SUBJECTS : :
: DT CAPITAL A
A NN total
total IN of
of CD 120
120 JJ CAPITAL Caucasian
Caucasian NNS patients
patients IN with
with NN CAPITAL MS
MS CC and
and CD 107
107 JJ unrelated
unrelated NN control
control NNS individuals
individuals IN from
from NNP CAPITAL California
California , ,
, CC and
and CD 32
32 NNS patients
patients CC and
and CD 32
32 JJ unrelated
unrelated NN control
control NNS individuals
individuals IN from
from NNP CAPITAL Beijing
Beijing , ,
, NNP CAPITAL China

All DT CAPITAL All
All NNS patients
patients IN with
with NN CAPITAL MS
MS VBD were
were VBN diagnosed
diagnosed IN as
as VBG having
having RB clinically
clinically JJ definite
definite NN disease
disease VBG according
according TO to
to VBN published
published NNS criteria

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: NN CAPITAL Chi2
Chi2 VBG CAPITAL Testing
Testing IN of
of NNS loci
loci CC and
and JJ individual
individual NNS alleles
alleles CC and
and NNS haplotypes

Haplotype NN CAPITAL Haplotype
Haplotype NNS frequencies
frequencies VBD were
were VBN estimated
estimated IN with
with NN standard
standard NN maximum
maximum NN likelihood
likelihood NNS methods

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The NN CAPITAL HLA
HLA NN effect
effect VBZ is
is JJ due
due TO to
to DT the
the NN class
class NNP CAPITAL II
II NN CAPITAL DR2
DR2 NN haplotype
haplotype , ,
, NN CAPITAL DRB1*1501-DQA1*0102-DRB1*0602
DRB1*1501-DQA1*0102-DRB1*0602 : ;
; NNS contributions
contributions TO to
to NN CAPITAL MS
MS NN susceptibility
susceptibility IN from
from JJ additional
additional NN CAPITAL DRB1-DQB1
DRB1-DQB1 NNS alleles
alleles CC or
or JJ other
other NN CAPITAL HLA
HLA NN region
region NNS loci
loci VBD were
were RB not
not VBN observed

Variation NN CAPITAL Variation
Variation IN within
within DT the
the NN CAPITAL MBP
MBP NN locus
locus IN on
on NN chromosome
chromosome NN 18q23
18q23 VBD showed
showed DT no
no NN effect
effect IN in
in NN CAPITAL MS

The DT CAPITAL The
The NN distribution
distribution IN of
of NNS haplotypes
haplotypes IN from
from CD 5
5 NNS loci
loci IN within
within DT the
the NN chromosome
chromosome NN 19q13.2
19q13.2 NN region
region , ,
, VBG including
including NN CAPITAL D19S178
D19S178 , ,
, NN CAPITAL D19S574
D19S574 , ,
, NN CAPITAL APOE
APOE , ,
, NN CAPITAL APOC2
APOC2 , ,
, CC and
and NN CAPITAL D19S219
D19S219 , ,
, VBN differed
differed IN between
between NN patient
patient CC and
and NN control
control NNS samples

D19S574 NN CAPITAL D19S574
D19S574 VBD showed
showed DT a
a JJ significant
significant NN effect
effect NN (
( NN CAPITAL P=.015
P=.015 NN )
) IN in
in JJ CAPITAL Caucasian
Caucasian NNS patients
patients IN with
with NN CAPITAL MS
MS JJ due
due TO to
to DT the
the VBN increased
increased NN frequency
frequency IN of
of DT a
a JJ single
single NN allele
allele NN (
( NN CAPITAL P=.002
P=.002 NN )

The DT CAPITAL The
The NN CAPITAL APOE
APOE NN variation
variation , ,
, JJ prominent
prominent IN in
in JJ other
other JJ neurological
neurological NNS diseases
diseases , ,
, VBD showed
showed DT no
no NN influence
influence IN on
on NN CAPITAL MS
MS NN susceptibility
susceptibility , ,
, IN despite
despite PRP$ its
its NN location
location IN within
within DT the
the NN chromosome
chromosome NN 19q13.2
19q13.2 NN region

Interaction NN CAPITAL Interaction
Interaction NNS effects
effects IN between
between NN CAPITAL DR2
DR2 CC and
and NN chromosome
chromosome NN 19q13.2
19q13.2 CC or
or NN CAPITAL MBP
MBP IN in
in NN CAPITAL MS
MS NN susceptibility
susceptibility VBD were
were RB not
not JJ apparent

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL The
The JJ significant
significant NN chromosome
chromosome NN 19q13.2
19q13.2 NN single-locus
single-locus CC and
and NN multilocus
multilocus NN haplotype
haplotype NNS associations
associations IN with
with NN CAPITAL MS
MS IN in
in JJ CAPITAL Caucasian
Caucasian CC and
and JJ CAPITAL Chinese
Chinese NN patient
patient NNS samples
samples VBP indicate
indicate DT an
an NN effect
effect IN from
from DT a
a RB nearby
nearby NN disease
disease NN susceptibility
susceptibility NN locus

These DT CAPITAL These
These JJ initial
initial NNS observations
observations VBP are
are DT an
an VBG encouraging
encouraging NN step
step IN toward
toward DT the
the NN description
description IN of
of JJ non-HLA
non-HLA JJ genetic
genetic NN susceptibility
susceptibility TO to
to NN CAPITAL MS

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL CONTEXT
CONTEXT : :
: EX CAPITAL There
There VBZ is
is DT a
a JJ substantial
substantial NN risk
risk IN of
of DT a
a JJ second
second NN cancer
cancer IN for
for NNS persons
persons IN with
with JJ hereditary
hereditary NN retinoblastoma
retinoblastoma , ,
, WDT which
which VBZ is
is VBN enhanced
enhanced IN by
by NN radiotherapy

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB examine
examine JJ long-term
long-term NN risk
risk IN of
of JJ new
new JJ primary
primary NNS cancers
cancers IN in
in NNS survivors
survivors IN of
of NN childhood
childhood NN retinoblastoma
retinoblastoma CC and
and VB quantify
quantify DT the
the NN role
role IN of
of NN radiotherapy
radiotherapy IN in
in NN sarcoma
sarcoma NN development

DESIGN NN CAPITAL DESIGN
DESIGN : :
: NN CAPITAL Cohort
Cohort NN incidence
incidence NN study
study IN of
of NNS patients
patients IN with
with NN retinoblastoma
retinoblastoma VBN followed
followed IN for
for DT a
a NN median
median IN of
of CD 20
20 NNS years
years , ,
, CC and
and JJ nested
nested JJ case-control
case-control NN study
study IN of
of DT a
a NN radiation
radiation NN dose-response
dose-response NN relationship
relationship IN for
for NN bone
bone CC and
and JJ soft
soft NN tissue
tissue NNS sarcomas

SETTING/PARTICIPANTS NN CAPITAL SETTING/PARTICIPANTS
SETTING/PARTICIPANTS : :
: DT CAPITAL A
A NN total
total IN of
of CD 1604
1604 NNS patients
patients IN with
with NN retinoblastoma
retinoblastoma WP who
who VBD survived
survived IN at
at JJS least
least CD 1
1 NN year
year IN after
after NN diagnosis
diagnosis , ,
, VBN identified
identified IN from
from NN hospital
hospital NNS records
records IN in
in NNP CAPITAL Massachusetts
Massachusetts CC and
and NNP CAPITAL New
New NNP CAPITAL York
York IN during
during CD 1914
1914 TO to
to CD 1984

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NN CAPITAL Incidence
Incidence IN of
of JJ subsequent
subsequent NNS cancers
cancers VBD was
was RB statistically
statistically RB significantly
significantly JJ elevated
elevated RB only
only IN in
in DT the
the CD 961
961 NNS patients
patients IN with
with JJ hereditary
hereditary NN retinoblastoma
retinoblastoma , ,
, IN in
in WP whom
whom CD 190
190 NNS cancers
cancers VBD were
were VBN diagnosed
diagnosed , ,
, CC vs
vs CD 6.3
6.3 VBN expected
expected IN in
in DT the
the JJ general
general NN population
population NN (
( JJ relative
relative NN risk
risk NN (
( NN CAPITAL RR
RR NN )
) , ,
, CD 30
30 NN (
( CD 95
95 NN %
% NN confidence
confidence NN interval
interval , ,
, CD 26-47
26-47 NN )
) NN )

Cumulative JJ CAPITAL Cumulative
Cumulative NN incidence
incidence NN (
( NN +/-SE
+/-SE NN )
) IN of
of DT a
a JJ second
second NN cancer
cancer IN at
at CD 50
50 NNS years
years IN after
after NN diagnosis
diagnosis VBD was
was CD 51.0
51.0 NN %
% NN (
( NN +/-6.2
+/-6.2 NN %
% NN )
) IN for
for JJ hereditary
hereditary NN retinoblastoma
retinoblastoma , ,
, CC and
and CD 5.0
5.0 NN %
% NN (
( NN +/-3.0
+/-3.0 NN %
% NN )
) IN for
for JJ nonhereditary
nonhereditary NN retinoblastoma

All DT CAPITAL All
All CD 114
114 NNS sarcomas
sarcomas IN of
of JJ diverse
diverse JJ histologic
histologic NNS types
types VBD occurred
occurred IN in
in NNS patients
patients IN with
with JJ hereditary
hereditary NN retinoblastoma

For IN CAPITAL For
For JJ soft
soft NN tissue
tissue NNS sarcomas
sarcomas , ,
, DT the
the SYM CAPITAL RRs
RRs VBD showed
showed DT a
a JJ stepwise
stepwise NN increase
increase IN at
at DT all
all NN dose
dose NNS categories
categories , ,
, CC and
and VBD were
were RB statistically
statistically JJ significant
significant IN at
at CD 10
10 TO to
to CD 29.9
29.9 NN CAPITAL Gy
Gy CC and
and CD 30
30 TO to
to CD 59.9
59.9 NN CAPITAL Gy

A DT CAPITAL A
A NN radiation
radiation NN risk
risk IN for
for DT all
all NNS sarcomas
sarcomas VBN combined
combined VBD was
was JJ evident
evident IN at
at NNS doses
doses IN above
above CD 5
5 NN CAPITAL Gy
Gy , ,
, VBG rising
rising TO to
to RB 10.7-fold
10.7-fold IN at
at NNS doses
doses IN of
of CD 60
60 NN CAPITAL Gy
Gy CC or
or JJR greater
greater NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD .05
.05 NN )

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: JJ CAPITAL Genetic
Genetic NN predisposition
predisposition VBZ has
has DT a
a JJ substantial
substantial NN impact
impact IN on
on NN risk
risk IN of
of JJ subsequent
subsequent NNS cancers
cancers IN in
in NN retinoblastoma
retinoblastoma NNS patients
patients , ,
, WDT which
which VBZ is
is RB further
further VBN increased
increased IN by
by NN radiation
radiation NN treatment

A DT CAPITAL A
A NN radiation
radiation NN dose-response
dose-response NN relationship
relationship VBZ is
is VBN demonstrated
demonstrated IN for
for DT all
all NNS sarcomas
sarcomas CC and
and , ,
, IN for
for DT the
the RB first
first NN time
time IN in
in NNS humans
humans , ,
, IN for
for JJ soft
soft NN tissue
tissue NNS sarcomas

Retinoblastoma NN CAPITAL Retinoblastoma
Retinoblastoma NNS patients
patients MD should
should VB be
be VBN examined
examined IN for
for JJ new
new NNS cancers
cancers CC and
and VBN followed
followed IN into
into RB later
later NN life
life TO to
to VB determine
determine IN whether
whether PRP$ their
their JJ extraordinary
extraordinary NN cancer
cancer NN risk
risk VBZ extends
extends TO to
to JJ common
common NNS cancers
cancers IN of
of NN adulthood

The DT CAPITAL The
The NN objective
objective IN of
of DT this
this NN study
study VBD was
was TO to
to VB determine
determine DT the
the NN rate
rate IN of
of JJ recent
recent NN cocaine
cocaine NN use
use IN among
among DT a
a JJ metropolitan
metropolitan NN population
population IN of
of RB predominantly
predominantly JJ CAPITAL Hispanic
Hispanic CC and
and JJ CAPITAL African-American
African-American NNS women
women IN with
with NN preterm
preterm JJ premature
premature NN rupture
rupture IN of
of DT the
the NNS membranes
membranes NN (
( NN CAPITAL PROM
PROM NN )
) CC and
and TO to
to VB ascertain
ascertain DT the
the NN impact
impact IN of
of NN cocaine
cocaine IN on
on DT the
the NN latency
latency NN period
period IN between
between NN rupture
rupture IN of
of NNS membranes
membranes CC and
and NN delivery

Urine NN CAPITAL Urine
Urine NN toxicology
toxicology NNS screens
screens VBD were
were RB prospectively
prospectively VBN obtained
obtained IN on
on CD 147
147 NNS women
women IN with
with NN preterm
preterm NN CAPITAL PROM

The DT CAPITAL The
The NN urine
urine NN screen
screen VBD did
did RB not
not NN influence
influence NN management
management NNS decisions

All DT CAPITAL All
All NNS women
women VBD were
were RB expectantly
expectantly VBN managed
managed IN without
without NNS tocolytics
tocolytics IN until
until CD 37
37 NNS weeks
weeks '' '
' NN gestation
gestation IN unless
unless PRP they
they VBN developed
developed JJ clinical
clinical NN chorioamnionitis
chorioamnionitis , ,
, CC or
or VBG nonreassuring
nonreassuring JJ fetal
fetal NN heart
heart NN rate
rate VBG tracing
tracing CC or
or JJ biophysical
biophysical NN profile

Demographic JJ CAPITAL Demographic
Demographic NN information
information , ,
, NNS hours
hours IN from
from NN rupture
rupture IN of
of NNS membranes
membranes TO to
to NN delivery
delivery , ,
, JJ gestational
gestational NN age
age , ,
, CC and
and NN birth
birth NN weight
weight IN at
at NN delivery
delivery VBD were
were VBN compared
compared VBG using
using NNP CAPITAL Fisher
Fisher POS 's
's JJ exact
exact , ,
, NNP CAPITAL Mann-Whitney
Mann-Whitney NNP CAPITAL U
U , ,
, CC and
and NN randomization
randomization NNS tests
tests WRB where
where JJ appropriate

The DT CAPITAL The
The NN rate
rate IN of
of JJ positive
positive NN urine
urine NN drug
drug NNS screens
screens IN for
for NN cocaine
cocaine VBD was
was CD 8.2
8.2 NN %

Women NNS CAPITAL Women
Women IN in
in DT the
the NN cocaine
cocaine JJ positive
positive NN group
group VBD were
were IN of
of JJR higher
higher NN parity
parity NN (
( CD 3
3 , ,
, NN (
( CD 0-7
0-7 NN )
) CC vs.
vs. CD 1
1 , ,
, NN (
( CD 0-6
0-6 NN )
) , ,
, NN p
p JJ =
= CD 0.001
0.001 NN )
) CC and
and VBD tended
tended TO to
to VB be
be JJR older
older NN (
( CD 27
27 , ,
, NN (
( CD 23-42
23-42 NN )
) CC vs.
vs. CD 25
25 , ,
, NN (
( CD 14-40
14-40 NN )
) NN )

There EX CAPITAL There
There VBD was
was DT a
a JJR higher
higher NN rate
rate IN of
of JJ recent
recent NN cocaine
cocaine NN use
use IN among
among JJ CAPITAL African-American
African-American NNS women
women NN (
( CD 20.4
20.4 NN %
% NN )
) IN as
as VBN compared
compared TO to
to NNS non-African-Americans
non-African-Americans NN (
( CD 1.2
1.2 NN %
% , ,
, NN p
p JJ =
= CD 0.0001
0.0001 NN )

Cocaine-positive JJ CAPITAL Cocaine-positive
Cocaine-positive NNS women
women VBN presented
presented IN at
at DT an
an RB earlier
earlier JJ gestational
gestational NN age
age NN (
( CD 32
32 NNS weeks
weeks '' '
' , ,
, NN (
( CD 24-34
24-34 NN )
) CC vs.
vs. CD 33
33 NNS weeks
weeks '' '
' , ,
, NN (
( CD 23-36
23-36 NN )
) , ,
, NN p
p JJ =
= CD 0.02
0.02 NN )
) CC and
and VBD had
had DT a
a RB significantly
significantly RB longer
longer NN membrane
membrane NN rupture
rupture TO to
to NN delivery
delivery NN interval
interval IN than
than NNS women
women IN with
with DT a
a JJ negative
negative NN urine
urine NN drug
drug NN screen
screen NN (
( CD 174
174 NN hr
hr , ,
, NN (
( CD 6-475
6-475 NN )
) CC vs.
vs. CD 33
33 NNS hours
hours NN (
( CD 1-833
1-833 NN )
) , ,
, NN p
p JJ =
= CD 0.01
0.01 NN )

There EX CAPITAL There
There VBD was
was DT no
no JJ significant
significant NN difference
difference IN in
in DT the
the NN reason
reason IN for
for NN delivery
delivery IN between
between DT the
the CD two
two NNS groups
groups IN of
of NNS patients

Recent JJ CAPITAL Recent
Recent NN cocaine
cocaine NN use
use IN among
among NNS women
women IN with
with NN preterm
preterm NN CAPITAL PROM
PROM VBZ is
is JJ common
common IN in
in RB only
only DT some
some NNS segments
segments IN of
of DT an
an JJ urban
urban NN population

Women NNS CAPITAL Women
Women IN with
with JJ recent
recent NN cocaine
cocaine NN use
use JJ present
present IN with
with VBN ruptured
ruptured NNS membranes
membranes IN at
at DT an
an RB earlier
earlier JJ gestational
gestational NN age
age CC and
and MD may
may RB actually
actually VB have
have DT a
a RB longer
longer NN latency
latency NN period
period IN than
than NNS women
women WP who
who VB do
do RB not
not NN use
use NN cocaine

The DT CAPITAL The
The NN objective
objective IN of
of DT this
this NN article
article VBZ is
is TO to
to VB explore
explore NNS attitudes
attitudes IN of
of DT an
an NN inner-city
inner-city , ,
, JJ pregnant
pregnant NN cohort
cohort IN about
about JJ general
general CC and
and JJ CAPITAL HIV-related
HIV-related JJ prenatal
prenatal NN care

Responses NNS CAPITAL Responses
Responses TO to
to DT an
an NN interview
interview IN at
at JJ initial
initial JJ prenatal
prenatal NN care
care NN enrollment
enrollment VBD were
were VBN compared
compared VBG using
using JJ CAPITAL Chi-square
Chi-square CC and
and NNP CAPITAL Fisher
Fisher POS 's
's JJ exact
exact NNS tests

Of IN CAPITAL Of
Of CD 75
75 NNS women
women , ,
, NN drug
drug NNS users
users NN (
( CD 51
51 NN %
% NN )
) VBD were
were RBR more
more RB likely
likely TO to
to VB say
say IN that
that PRP they
they MD would
would VB defer
defer VBG initiating
initiating JJ prenatal
prenatal NN care
care NN (
( NN CAPITAL P
P JJ =
= CD 0.03
0.03 NN )
) CC and
and TO to
to VB minimize
minimize DT the
the NN risk
risk IN of
of NN drug
drug CC or
or NN alcohol
alcohol NN use
use TO to
to DT the
the NN fetus
fetus NN (
( NN CAPITAL P
P JJ =
= CD 0.04
0.04 NN )

Most JJS CAPITAL Most
Most NN (
( CD 85
85 NN %
% NN )
) VBN viewed
viewed NN pregnancy
pregnancy IN as
as JJ inappropriate
inappropriate IN for
for NN CAPITAL HIV
HIV JJ infected
infected NNS women
women CC and
and RB primarily
primarily NN drug
drug NNS users
users NN (
( NN CAPITAL P
P JJ =
= CD 0.06
0.06 NN )
) MD would
would VB abort
abort IN if
if NN CAPITAL HIV
HIV JJ infected

Over IN CAPITAL Over
Over NN half
half NN thought
thought NN CAPITAL HIV
HIV NN transmission
transmission VBD occurred
occurred RBS most
most NNS times
times CC or
or RB always

Only RB CAPITAL Only
Only CD 20
20 NN %
% VBD had
had VBN heard
heard IN of
of DT a
a NN drug
drug TO to
to VB reduce
reduce DT this
this NN risk
risk , ,
, CC but
but CD 95
95 NN %
% MD would
would VB take
take JJ such
such DT a
a NN therapy

These DT CAPITAL These
These NN inner-city
inner-city , ,
, JJ pregnant
pregnant NNS women
women VBN disapproved
disapproved IN of
of NN pregnancy
pregnancy IN if
if NN CAPITAL HIV
HIV JJ infected
infected CC and
and NN thought
thought DT the
the NN risk
risk IN of
of NN transmission
transmission VBD was
was JJ high

They PRP CAPITAL They
They VBD knew
knew RB little
little IN of
of WRB how
how TO to
to VB reduce
reduce DT this
this NN risk
risk CC but
but RB nearly
nearly DT all
all MD would
would VB accept
accept DT a
a NN drug
drug TO to
to VB prevent
prevent NN transmission

The DT CAPITAL The
The NN association
association IN of
of NN parvovirus
parvovirus NN CAPITAL B19
B19 NN infection
infection CC and
and NNS hydrops
hydrops NN fetalis
fetalis VBZ is
is RB well
well VBN known

However RB CAPITAL However
However , ,
, DT the
the NN association
association IN of
of NN parvovirus
parvovirus CC and
and JJ fetal
fetal JJ pleural
pleural CC or
or JJ pericardial
pericardial NNS effusions
effusions VBZ has
has RB not
not VBN been
been VBN reported

We PRP CAPITAL We
We JJ present
present CD five
five NNS cases
cases IN of
of VBN isolated
isolated JJ pleural
pleural CC or
or JJ pericardial
pericardial NN effusion
effusion IN with
with VBN documented
documented JJ maternal
maternal NN parvovirus
parvovirus NN infection
infection IN in
in CD four
four IN of
of DT these
these NNS pregnancies

In IN CAPITAL In
In DT the
the NN absence
absence IN of
of JJ structural
structural CC or
or JJ karyotypic
karyotypic NNS abnormalities
abnormalities , ,
, JJ spontaneous
spontaneous NN resolution
resolution IN of
of DT the
the NN effusion
effusion VBZ portends
portends IN for
for DT a
a JJ successful
successful NN pregnancy
pregnancy NN outcome

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: JJ CAPITAL Cochlear
Cochlear NN implantation
implantation VBZ is
is RB nowadays
nowadays DT a
a JJ reliable
reliable CC and
and JJ well-accepted
well-accepted NN method
method IN of
of NN auditory
auditory NN rehabilitation
rehabilitation IN in
in VBN selected
selected NNS adults
adults CC and
and NNS children

METHODS NNS CAPITAL METHODS
METHODS : :
: PRP CAPITAL We
We JJ present
present NN rehabilitation
rehabilitation NNS data
data IN on
on CD 21
21 JJ adult
adult NNS patients
patients VBN provided
provided IN with
with DT the
the NN CAPITAL Nucleus
Nucleus NN CAPITAL CI22
CI22 NN CAPITAL M
M NN cochlear
cochlear VB implant
implant VBG using
using DT the
the VB CAPITAL SPEAK
SPEAK NN strategy

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NNS CAPITAL Results
Results IN of
of RB first
first NN tune-up
tune-up NN show
show DT an
an JJ open
open NN set
set NN speech
speech VBG understanding
understanding IN in
in RB approximately
approximately CD 50
50 NN %
% IN of
of NNS patients

Long-term JJ CAPITAL Long-term
Long-term NNS results
results RB also
also VB reveal
reveal RB further
further NN improvement
improvement IN in
in NNS patients
patients WP who
who VBD had
had DT no
no JJ open
open NN set
set NN speech
speech VBG understanding

Our PRP$ CAPITAL Our
Our NNS data
data VB seem
seem TO to
to VBP indicate
indicate JJ similar
similar NNS results
results IN in
in NN comparison
comparison TO to
to JJ other
other NNS groups
groups VBG using
using DT the
the NN CAPITAL CIS
CIS NN strategy

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: IN CAPITAL In
In NNS adults
adults , ,
, JJ open
open NN set
set NN speech
speech VBG understanding
understanding MD can
can VB be
be VBN achieved
achieved RB even
even IN at
at DT the
the RB first
first NN tune-up

Results NNS CAPITAL Results
Results IN of
of RB early
early NN rehabilitation
rehabilitation VB seem
seem TO to
to VB be
be VBN influenced
influenced IN by
by NN duration
duration CC and
and NN etiology
etiology IN of
of NN deafness
deafness , ,
, NN experience
experience IN with
with NN hearing
hearing NNS aids
aids , ,
, CC and
and JJ other
other NNS factors

Adverse JJ CAPITAL Adverse
Adverse NN drug
drug NNS effects
effects VBP are
are NN manifold
manifold CC and
and JJ heterogenous

Many JJ CAPITAL Many
Many NNS situations
situations MD may
may VB hamper
hamper DT the
the NN signalling
signalling NN (
( NN i.e
i.e . .
. DT the
the NN detection
detection IN of
of RB early
early VBG warning
warning NNS signs
signs NN )
) IN of
of JJ adverse
adverse NNS effects
effects CC and
and JJ new
new NNS signals
signals RB often
often VB differ
differ IN from
from JJ previous
previous NNS experiences

Signals NNS CAPITAL Signals
Signals VB have
have JJ qualitative
qualitative CC and
and JJ quantitative
quantitative NNS aspects

Different JJ CAPITAL Different
Different NNS categories
categories IN of
of JJ adverse
adverse NNS effects
effects NN need
need JJ different
different NNS methods
methods IN for
for NN detection

Current JJ CAPITAL Current
Current NN pharmacovigilance
pharmacovigilance VBZ is
is RB predominantly
predominantly VBN based
based IN on
on JJ spontaneous
spontaneous VBG reporting
reporting CC and
and VBZ is
is RB mainly
mainly JJ helpful
helpful IN in
in VBG detecting
detecting NN type
type NN CAPITAL B
B NNS effects
effects NN (
( DT those
those NNS effects
effects IN that
that VBP are
are RB often
often JJ allergic
allergic CC or
or JJ idiosyncratic
idiosyncratic NNS reactions
reactions , ,
, RB characteristically
characteristically VBG occurring
occurring IN in
in RB only
only DT a
a NN minority
minority IN of
of NNS patients
patients CC and
and RB usually
usually JJ unrelated
unrelated TO to
to NN dosage
dosage CC and
and IN that
that VBP are
are JJ serious
serious , ,
, JJ unexpected
unexpected CC and
and JJ unpredictable
unpredictable NN )
) CC and
and JJ unusual
unusual NN type
type DT CAPITAL A
A NNS effects
effects NN (
( DT those
those NNS effects
effects IN that
that VBP are
are JJ related
related TO to
to DT the
the JJ pharmacological
pharmacological NNS effects
effects IN of
of DT the
the NN drug
drug CC and
and VBP are
are JJ dosage-related
dosage-related NN )

Examples NNS CAPITAL Examples
Examples IN of
of JJ other
other NNS sources
sources IN of
of NNS signals
signals VBP are
are NN prescription
prescription NN event
event VBG monitoring
monitoring , ,
, JJ large
large VBN automated
automated NNS data
data NNS resources
resources IN on
on NN morbidity
morbidity CC and
and NN drug
drug NN use
use NN (
( VBG including
including NN record
record NN linkage
linkage NN )
) , ,
, JJ case-control
case-control NN surveillance
surveillance CC and
and NN follow-up
follow-up NNS studies

Type NN CAPITAL Type
Type NN CAPITAL C
C NNS effects
effects NN (
( DT those
those NNS effects
effects JJ related
related TO to
to DT an
an VBN increased
increased NN frequency
frequency IN of
of JJ 'spontaneous
'spontaneous '' '
' NN disease
disease NN )
) VBP are
are JJ difficult
difficult TO to
to NN study
study , ,
, RB however
however , ,
, CC and
and VB continue
continue TO to
to VB pose
pose DT a
a JJ pharmacoepidemiological
pharmacoepidemiological NN challenge

Seven CD CAPITAL Seven
Seven JJ basic
basic NNS considerations
considerations MD can
can VB be
be VBN identified
identified IN that
that VB determine
determine DT the
the NN evidence
evidence VBN contained
contained IN in
in DT a
a NN signal
signal : :
: JJ quantitative
quantitative NN strength
strength IN of
of DT the
the NN association
association , ,
, NN consistency
consistency IN of
of DT the
the NNS data
data , ,
, NN exposure
exposure NN response
response NN relationship
relationship , ,
, JJ biological
biological NN plausibility
plausibility , ,
, JJ experimental
experimental NNS findings
findings , ,
, JJ possible
possible NNS analogies
analogies CC and
and DT the
the NN nature
nature CC and
and NN quality
quality IN of
of DT the
the NNS data

A DT CAPITAL A
A NN proposal
proposal VBZ is
is VBN made
made IN for
for DT a
a NN standard
standard NN signal
signal NN management
management NN procedure
procedure IN at
at NN pharmacovigilance
pharmacovigilance NNS centres
centres , ,
, VBG including
including DT the
the VBG following
following NNS steps
steps : :
: NN signal
signal NN delineation
delineation , ,
, NN literature
literature NN search
search , ,
, JJ preliminary
preliminary NN inventory
inventory IN of
of NNS data
data , ,
, NN collection
collection IN of
of JJ additional
additional NN information
information , ,
, NN consultation
consultation IN with
with DT the
the NNP CAPITAL World
World NNP CAPITAL Health
Health NNP CAPITAL Organization
Organization NNP CAPITAL Centre
Centre IN for
for NNP CAPITAL International
International NN CAPITAL Drug
Drug NN CAPITAL Monitoring
Monitoring CC and
and DT the
the JJ relevant
relevant NN drug
drug NNS companies
companies , ,
, VBN aggregated
aggregated NNS data
data NN assessment
assessment CC and
and DT a
a NN report
report IN in
in VBG writing

A DT CAPITAL A
A RB better
better VBG understanding
understanding IN of
of DT the
the NNS conditions
conditions CC and
and NNS mechanisms
mechanisms VBN involved
involved IN in
in DT the
the NN detection
detection IN of
of JJ adverse
adverse NN drug
drug NNS effects
effects MD may
may RB further
further VB improve
improve NNS strategies
strategies IN for
for NN pharmacovigilance

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To NN study
study DT the
the NN safety
safety CC and
and NN efficacy
efficacy IN of
of NN methylphenidate
methylphenidate IN in
in NNS children
children IN with
with DT the
the JJ dual
dual NN diagnosis
diagnosis IN of
of NN epilepsy
epilepsy CC and
and NN attention
attention NN deficit
deficit NN hyperactivity
hyperactivity NN disorder
disorder NN (
( NN CAPITAL ADHD
ADHD NN )

STUDY NN CAPITAL STUDY
STUDY NN CAPITAL DESIGN
DESIGN : :
: CD CAPITAL Thirty
Thirty NNS children
children , ,
, JJ aged
aged CD 6.4
6.4 TO to
to CD 16.4
16.4 NNS years
years , ,
, IN with
with NN epilepsy
epilepsy CC and
and NN CAPITAL ADHD
ADHD VBD were
were VBN studied
studied IN during
during DT a
a JJ 4-month
4-month NN period

During IN CAPITAL During
During DT the
the JJ initial
initial CD 2
2 NNS months
months IN of
of DT the
the NN study
study , ,
, DT the
the NNS children
children VBD were
were VBN treated
treated IN with
with JJ antiepileptic
antiepileptic NNS drugs
drugs NN (
( NNS CAPITAL AEDs
AEDs NN )
) RB only
only , ,
, CC and
and IN for
for DT the
the VBG remaining
remaining CD 2
2 NNS months
months , ,
, NN methylphenidate
methylphenidate VBD was
was VBN added
added IN at
at DT a
a NN morning
morning NN dose
dose IN of
of CD 0.3
0.3 NN mg/kg

They PRP CAPITAL They
They VBD underwent
underwent JJ neurologic
neurologic NN assessment
assessment , ,
, NN brain
brain VBN computed
computed NN tomography
tomography , ,
, NNP CAPITAL IQ
IQ NN testing
testing , ,
, CC and
and NN assessment
assessment IN with
with DT the
the NN CAPITAL Childhood
Childhood NN CAPITAL Behavior
Behavior NNP CAPITAL Checklist
Checklist IN at
at NN baseline
baseline IN before
before NN methylphenidate
methylphenidate NN therapy

Electroencephalography NN CAPITAL Electroencephalography
Electroencephalography , ,
, NN CAPITAL AED
AED NNS determinations
determinations , ,
, CC and
and DT the
the NN continuous-performance
continuous-performance NN task
task NN (
( NNP CAPITAL CPT
CPT NN )
) NN test
test VBD were
were VBN done
done IN at
at NN baseline
baseline CC and
and IN after
after CD 2
2 NNS months
months IN of
of NN methylphenidate
methylphenidate NN therapy

A DT CAPITAL A
A JJ double-blind
double-blind , ,
, NN crossover
crossover NN design
design VBD was
was VBN used
used TO to
to VB compare
compare DT the
the NNS effects
effects IN of
of NN methylphenidate
methylphenidate CC versus
versus NN placebo
placebo IN on
on DT an
an NN electroencephalogram
electroencephalogram , ,
, NN CAPITAL AED
AED NNS levels
levels , ,
, CC and
and DT the
the NNP CAPITAL CPT

On IN CAPITAL On
On DT the
the CD 2
2 NNS days
days IN of
of NN testing
testing , ,
, DT the
the NN child
child VBN received
received NNS CAPITAL AEDs
AEDs CC and
and DT a
a NN capsule
capsule VBG containing
containing DT either
either NN placebo
placebo CC or
or NN methylphenidate

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NN CAPITAL None
None IN of
of DT the
the CD 25
25 NNS children
children IN of
of DT this
this NN sample
sample WP who
who VBD were
were NN seizure
seizure JJ free
free VBD had
had NNS attacks
attacks IN while
while VBG taking
taking NN methylphenidate

Of IN CAPITAL Of
Of DT the
the CD 5
5 NNS children
children IN with
with NNS seizures
seizures , ,
, CD 3
3 VBD had
had DT an
an NN increase
increase IN in
in NNS attacks
attacks , ,
, IN whereas
whereas DT the
the JJ other
other CD 2
2 VBD showed
showed DT no
no NN change
change CC or
or DT a
a NN reduction

There EX CAPITAL There
There VBD were
were DT no
no JJ significant
significant NNS changes
changes IN in
in NN CAPITAL AED
AED NNS levels
levels CC or
or JJ electroencephalographic
electroencephalographic NNS findings

Methylphenidate NNP CAPITAL Methylphenidate
Methylphenidate VBN benefited
benefited CD 70
70 NN %
% IN of
of NNS children
children VBG according
according TO to
to JJ parental
parental NN report
report : ;
; NN methylphenidate
methylphenidate RB also
also VBN enhanced
enhanced NN performance
performance IN on
on DT the
the NNP CAPITAL CPT

Side NN CAPITAL Side
Side NNS effects
effects IN of
of NN methylphenidate
methylphenidate VBD were
were JJ mild
mild CC and
and JJ transient

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: NNP CAPITAL Methylphenidate
Methylphenidate VBZ is
is JJ effective
effective IN in
in VBG treating
treating NNS children
children IN with
with NN epilepsy
epilepsy CC and
and NN CAPITAL ADHD
ADHD CC and
and JJ safe
safe IN in
in NNS children
children WP who
who VBP are
are NN seizure
seizure JJ free

Caution NN CAPITAL Caution
Caution VBZ is
is VBN warranted
warranted IN for
for DT those
those RB still
still VBG having
having NNS seizures
seizures IN while
while VBG receiving
receiving NN CAPITAL AED
AED NN therapy

The DT CAPITAL The
The JJ temporal
temporal NNS properties
properties IN of
of JJ semantic
semantic CC and
and JJ phonological
phonological NNS processes
processes IN in
in NN speech
speech NN production
production VBD were
were VBN investigated
investigated IN in
in DT a
a JJ new
new JJ experimental
experimental NN paradigm
paradigm VBG using
using JJ movement-related
movement-related NN brain
brain NNS potentials

The DT CAPITAL The
The JJ main
main JJ experimental
experimental NN task
task VBD was
was NN picture
picture VBG naming

In IN CAPITAL In
In NN addition
addition , ,
, DT a
a NN 2-choice
2-choice NN reaction
reaction NN go/no-go
go/no-go NN procedure
procedure VBD was
was VBN included
included , ,
, VBG involving
involving DT a
a JJ semantic
semantic CC and
and DT a
a JJ phonological
phonological NN categorization
categorization IN of
of DT the
the NN picture
picture NN name

Lateralized VBN CAPITAL Lateralized
Lateralized NN readiness
readiness NNS potentials
potentials NN (
( NNS CAPITAL LRPs
LRPs NN )
) VBD were
were VBN derived
derived TO to
to NN test
test IN whether
whether JJ semantic
semantic CC and
and JJ phonological
phonological NN information
information VBN activated
activated NN motor
motor NNS processes
processes IN at
at JJ separate
separate NNS moments
moments IN in
in NN time

An DT CAPITAL An
An NN CAPITAL LRP
LRP VBD was
was RB only
only VBN observed
observed IN on
on JJ no-go
no-go NNS trials
trials WRB when
when DT the
the JJ semantic
semantic NN (
( RB not
not DT the
the JJ phonological
phonological NN )
) NN decision
decision VBN determined
determined DT the
the NN response
response NN hand

Varying JJ CAPITAL Varying
Varying DT the
the NN position
position IN of
of DT the
the JJ critical
critical NN phoneme
phoneme IN in
in DT the
the NN picture
picture NN name
name VBD did
did RB not
not VB affect
affect DT the
the NN onset
onset IN of
of DT the
the NN CAPITAL LRP
LRP CC but
but RB rather
rather VBN influenced
influenced WRB when
when DT the
the NN CAPITAL LRP
LRP VBD began
began TO to
to VB differ
differ IN on
on VB go
go CC and
and JJ no-go
no-go NNS trials
trials CC and
and VBN allowed
allowed DT the
the NN duration
duration IN of
of JJ phonological
phonological VBG encoding
encoding IN of
of DT a
a NN word
word TO to
to VB be
be VBN estimated

These DT CAPITAL These
These NNS results
results VB provide
provide JJ electrophysiological
electrophysiological NN evidence
evidence IN for
for RB early
early JJ semantic
semantic NN activation
activation CC and
and RB later
later JJ phonological
phonological VBG encoding

The DT CAPITAL The
The NNS effects
effects IN of
of NN alanine
alanine CC and
and NN glycine
glycine NN substitution
substitution IN for
for NN tryptophan
tryptophan IN upon
upon DT the
the NNS species
species NN heterogeneity
heterogeneity IN of
of NN gramicidin
gramicidin DT CAPITAL A
A NNS analogs
analogs VBN incorporated
incorporated IN into
into NN CAPITAL SDS
SDS NNS micelles
micelles VB have
have VBN been
been VBN investigated

The DT CAPITAL The
The JJ sequential
sequential NN replacement
replacement IN of
of DT the
the CD four
four NN tryptophan
tryptophan NNS residues
residues IN in
in NN gramicidin
gramicidin DT CAPITAL A
A IN at
at NNS positions
positions CD 15
15 , ,
, CD 13
13 , ,
, CD 11
11 , ,
, CC and
and CD 9
9 IN with
with NN glycine
glycine VBD showed
showed IN that
that RB there
there VBD was
was DT no
no JJ detectable
detectable NN effect
effect IN at
at NN position
position CD 15
15 CC but
but VBG increasing
increasing NN heterogeneity
heterogeneity IN of
of NNS species
species IN in
in DT the
the NNS micelles
micelles VBG proceeding
proceeding IN toward
toward DT the
the NN interior
interior IN of
of DT the
the NN micelle
micelle IN at
at NN position
position CD 9

The DT CAPITAL The
The NN replacement
replacement IN of
of NN tryptophan
tryptophan IN at
at NNS positions
positions CD 15
15 CC and
and CD 9
9 IN with
with NN alanine
alanine VBD was
was VBN found
found TO to
to VB produce
produce RBR more
more NNS species
species NN heterogeneity
heterogeneity IN than
than VBN found
found IN with
with NN glycine
glycine NN substitution
substitution IN at
at DT the
the JJ same
same NNS positions

An DT CAPITAL An
An NN increase
increase IN in
in DT the
the NN CAPITAL SDS
SDS NN concentration
concentration VBZ reduces
reduces DT the
the NN number
number IN of
of JJ different
different NNS species
species JJ present
present IN in
in NNS micelles

With IN CAPITAL With
With DT the
the NN CAPITAL Gly-11
Gly-11 , ,
, NN CAPITAL Gly-13
Gly-13 , ,
, CC and
and NN CAPITAL Gly-15
Gly-15 NNS analogs
analogs , ,
, DT the
the NN increase
increase IN in
in NN CAPITAL SDS
SDS NN concentration
concentration NNS results
results IN in
in DT the
the NN formation
formation IN of
of DT a
a JJ single
single NNS species
species : ;
; RB however
however , ,
, IN for
for DT the
the NN CAPITAL Gly-9
Gly-9 , ,
, NN CAPITAL Ala-9
Ala-9 , ,
, CC and
and NN CAPITAL Ala-15
Ala-15 NNS analogs
analogs , ,
, NN heterogeneity
heterogeneity NNS remains

Molecular JJ CAPITAL Molecular
Molecular NNS dynamics
dynamics IN in
in NN torsion-angle
torsion-angle NN space
space VBD was
was VBN applied
applied TO to
to JJ nuclear
nuclear JJ magnetic
magnetic NN resonance
resonance NN structure
structure NN calculation
calculation VBG using
using JJ nuclear
nuclear NNP CAPITAL Overhauser
Overhauser JJ effect-derived
effect-derived NNS distances
distances CC and
and JJ CAPITAL J-coupling-constant-derived
J-coupling-constant-derived JJ dihedral
dihedral NN angle
angle NNS restraints

Compared VBN CAPITAL Compared
Compared TO to
to CD two
two JJ other
other RB commonly
commonly VBN used
used NNS algorithms
algorithms , ,
, JJ molecular
molecular NNS dynamics
dynamics IN in
in JJ CAPITAL Cartesian
Cartesian NN space
space CC and
and NN metric-matrix
metric-matrix NN geometry
geometry VBN combined
combined IN with
with JJ CAPITAL Cartesian
Cartesian JJ molecular
molecular NNS dynamics
dynamics , ,
, DT the
the NN method
method NNS shows
shows VBN increased
increased JJ computational
computational NN efficiency
efficiency CC and
and NN success
success NN rate
rate IN for
for JJ large
large NNS proteins
proteins , ,
, CC and
and PRP it
it NNS shows
shows DT a
a RB dramatically
dramatically VBN increased
increased NN radius
radius IN of
of NN convergence
convergence IN for
for NN CAPITAL DNA

The DT CAPITAL The
The NN torsion-angle
torsion-angle JJ molecular
molecular NNS dynamics
dynamics NN algorithm
algorithm NNS starts
starts IN from
from DT an
an VBN extended
extended NN strand
strand NN conformation
conformation CC and
and NNS proceeds
proceeds IN in
in CD four
four NNS stages
stages : :
: JJ high-temperature
high-temperature NN torsion-angle
torsion-angle JJ molecular
molecular NNS dynamics
dynamics , ,
, NN slow-cooling
slow-cooling NN torsion-angle
torsion-angle JJ molecular
molecular NNS dynamics
dynamics , ,
, JJ CAPITAL Cartesian
Cartesian JJ molecular
molecular NNS dynamics
dynamics , ,
, CC and
and NN minimization

Tests NNS CAPITAL Tests
Tests VBD were
were VBD carried
carried IN out
out VBG using
using JJ experimental
experimental NN CAPITAL NMR
NMR NNS data
data IN for
for NN protein
protein NN CAPITAL G
G , ,
, NN interleukin-8
interleukin-8 , ,
, NN villin
villin NN 14T
14T , ,
, CC and
and DT a
a CD 12
12 NN base-pair
base-pair NN duplex
duplex IN of
of NN CAPITAL DNA
DNA , ,
, CC and
and JJ simulated
simulated NN CAPITAL NMR
NMR NNS data
data IN for
for JJ bovine
bovine JJ pancreatic
pancreatic NN trypsin
trypsin NN inhibitor

For IN CAPITAL For
For NN villin
villin NN 14T
14T , ,
, DT a
a NN monomer
monomer VBG consisting
consisting IN of
of CD 126
126 NNS residues
residues , ,
, NN structure
structure NN determination
determination IN by
by NN torsion-angle
torsion-angle JJ molecular
molecular NNS dynamics
dynamics VBZ has
has DT a
a NN success
success NN rate
rate IN of
of CD 85
85 NN %
% , ,
, DT a
a RBR more
more IN than
than RB twofold
twofold NN improvement
improvement IN over
over JJ other
other NNS methods

In IN CAPITAL In
In DT the
the NN case
case IN of
of DT the
the CD 12
12 NN base-pair
base-pair NN CAPITAL DNA
DNA NN duplex
duplex , ,
, NN torsion-angle
torsion-angle JJ molecular
molecular NNS dynamics
dynamics VBD had
had DT a
a NN success
success NN rate
rate IN of
of CD 52
52 NN %
% IN while
while JJ CAPITAL Cartesian
Cartesian JJ molecular
molecular NNS dynamics
dynamics CC and
and NN metric-matrix
metric-matrix NN distance
distance NN geometry
geometry RB always
always VBD failed

The DT CAPITAL The
The NN wavelet-transform
wavelet-transform NN method
method VBZ is
is VBN used
used TO to
to VB quantify
quantify DT the
the JJ magnetic
magnetic NN resonance
resonance NN spectroscopy
spectroscopy NN (
( NNP CAPITAL MRS
MRS NN )
) NNS parameters
parameters : :
: NN chemical
chemical NN shift
shift , ,
, JJ apparent
apparent NN relaxation
relaxation NN time
time NN CAPITAL T2
T2 , ,
, NN resonance
resonance NN amplitude
amplitude , ,
, CC and
and NN phase

Wavelet NNP CAPITAL Wavelet
Wavelet NN transformation
transformation VBZ is
is DT a
a NN time-frequency
time-frequency NN representation
representation WDT which
which VBZ separates
separates DT each
each NN component
component IN from
from DT the
the SYM CAPITAL FID
FID , ,
, RB then
then RB successively
successively VBZ quantifies
quantifies PRP it
it CC and
and NNS subtracts
subtracts PRP it
it IN from
from DT the
the JJ raw
raw NN signal

Two CD CAPITAL Two
Two JJ iterative
iterative NNS procedures
procedures VB have
have VBN been
been VBN developed

They PRP CAPITAL They
They VB have
have VBN been
been VBN combined
combined IN with
with DT a
a JJ nonlinear
nonlinear NN regression
regression NN analysis
analysis NN method
method CC and
and VBN tested
tested IN on
on DT both
both JJ simulated
simulated CC and
and RB real
real NNS sets
sets IN of
of JJ biomedical
biomedical NNP CAPITAL MRS
MRS NNS data
data VBN selected
selected IN with
with NN respect
respect TO to
to DT the
the JJ main
main NNS problems
problems RB usually
usually VBN encountered
encountered IN in
in VBG quantifying
quantifying JJ biomedical
biomedical NNP CAPITAL MRS
MRS , ,
, RB specifically
specifically `` ``
`` NN chemical
chemical NN noise
noise , ,
, '' ''
'' VBG resulting
resulting IN from
from VBG overlapping
overlapping NNS resonances
resonances , ,
, CC and
and NN baseline
baseline NN distortion

The DT CAPITAL The
The NNS results
results VBP indicate
indicate IN that
that DT the
the NN wavelet-transform
wavelet-transform NN method
method MD can
can VB provide
provide JJ efficient
efficient CC and
and JJ accurate
accurate NN quantification
quantification IN of
of NNP CAPITAL MRS
MRS NNS data

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: JJ CAPITAL Antiplatelet
Antiplatelet NN therapy
therapy IN with
with NN aspirin
aspirin CC and
and JJ systematic
systematic NN anticoagulation
anticoagulation IN with
with NN warfarin
warfarin VB reduce
reduce JJ cardiovascular
cardiovascular NN morbidity
morbidity CC and
and NN mortality
mortality IN after
after JJ myocardial
myocardial NN infarction
infarction WRB when
when VBN given
given RB alone

In IN CAPITAL In
In DT the
the NNP CAPITAL Coumadin
Coumadin NN CAPITAL Aspirin
Aspirin NN CAPITAL Reinfarction
Reinfarction NN CAPITAL Study
Study NN (
( NNS CAPITAL CARS
CARS NN )
) , ,
, PRP we
we VBN aimed
aimed TO to
to VB find
find IN out
out IN whether
whether DT a
a NN combination
combination IN of
of JJ low-dose
low-dose NN warfarin
warfarin CC and
and JJ low-dose
low-dose NN aspirin
aspirin MD would
would VB give
give JJ superior
superior NNS results
results TO to
to NN standard
standard NN aspirin
aspirin NN monotherapy
monotherapy IN without
without JJ excessive
excessive VBG bleeding
bleeding NN risk

METHODS NNS CAPITAL METHODS
METHODS : :
: PRP CAPITAL We
We VBN used
used DT a
a VBN randomised
randomised JJ double-blind
double-blind NN study
study NN design

At IN CAPITAL At
At CD 293
293 NNS sites
sites , ,
, PRP we
we RB randomly
randomly VBN assigned
assigned CD 8803
8803 NNS patients
patients WP who
who VBD had
had VBD had
had JJ myocardial
myocardial NN infarction
infarction , ,
, NN treatment
treatment IN with
with CD 160
160 NN mg
mg NN aspirin
aspirin , ,
, CD 3
3 NN mg
mg NN warfarin
warfarin IN with
with CD 80
80 NN mg
mg NN aspirin
aspirin , ,
, CC or
or CD 1
1 NN mg
mg NN warfarin
warfarin IN with
with CD 80
80 NN mg
mg NN aspirin

Patients NNS CAPITAL Patients
Patients VBD took
took DT a
a JJ single
single NN tablet
tablet RB daily
daily , ,
, CC and
and VBD attended
attended IN for
for NN prothrombin
prothrombin NN time
time NN (
( NN CAPITAL PT
PT NN )
) NNS measurements
measurements IN at
at NNS weeks
weeks CD 1
1 , ,
, CD 2
2 , ,
, CD 3
3 , ,
, CD 4
4 , ,
, CD 6
6 , ,
, CC and
and CD 12
12 , ,
, CC and
and RB then
then DT every
every CD 3
3 NNS months

Patients NNS CAPITAL Patients
Patients VBD were
were VBN followed
followed RB up
up IN for
for DT a
a NN maximum
maximum IN of
of CD 33
33 NNS months
months NN (
( NN median
median CD 14
14 NNS months
months NN )

FINDINGS NNS CAPITAL FINDINGS
FINDINGS : :
: DT CAPITAL The
The JJ primary
primary NN event
event VBD was
was RB first
first NN occurrence
occurrence IN of
of NN reinfarction
reinfarction , ,
, JJ non-fatal
non-fatal JJ ischaemic
ischaemic NN stroke
stroke , ,
, CC or
or JJ cardiovascular
cardiovascular NN death

1-year JJ 1-year
1-year JJ life-table
life-table NNS estimates
estimates IN for
for DT the
the JJ primary
primary NN event
event VBD were
were CD 8.6
8.6 NN %
% NN (
( CD 95
95 NN %
% NN CAPITAL CI
CI CD 7.6-9.6
7.6-9.6 NN )
) IN for
for CD 160
160 NN mg
mg NN aspirin
aspirin , ,
, CD 8.4
8.4 NN %
% NN (
( CD 7.4-9.4
7.4-9.4 NN )
) IN for
for CD 3
3 NN mg
mg NN warfarin
warfarin IN with
with CD 80
80 NN mg
mg NN aspirin
aspirin , ,
, CC and
and CD 8.8
8.8 NN %
% NN (
( CD 7.6-10
7.6-10 NN )
) IN for
for CD 1
1 NN mg
mg NN warfarin
warfarin IN with
with CD 80
80 NN mg
mg NN aspirin

Primary JJ CAPITAL Primary
Primary NNS comparisons
comparisons VBD were
were VBN done
done IN with
with DT all
all NN follow-up
follow-up NNS data

The DT CAPITAL The
The JJ relative
relative NN risk
risk IN of
of DT the
the JJ primary
primary NN event
event IN for
for DT the
the CD 160
160 NN mg
mg NN aspirin
aspirin NN group
group VBN compared
compared IN with
with DT the
the CD 3
3 NN mg
mg NN warfarin
warfarin IN with
with CD 80
80 NN mg
mg NN aspirin
aspirin NN group
group VBD was
was CD 0.95
0.95 NN (
( CD 0.81-1.12
0.81-1.12 , ,
, NN p
p JJ =
= CD 0.57
0.57 NN )

For IN CAPITAL For
For JJ spontaneous
spontaneous JJ major
major NN haemorrhage
haemorrhage NN (
( RB not
not NN procedure
procedure JJ related
related NN )
) , ,
, JJ 1-year
1-year JJ life-table
life-table NNS estimates
estimates VBD were
were CD 0.74
0.74 NN %
% NN (
( CD 0.43-1.1
0.43-1.1 NN )
) IN in
in DT the
the CD 160
160 NN mg
mg NN aspirin
aspirin NN group
group CC and
and CD 1.4
1.4 NN %
% NN (
( CD 0.94-1.8
0.94-1.8 NN )
) IN in
in DT the
the CD 3
3 NN mg
mg NN warfarin
warfarin IN with
with CD 80
80 NN mg
mg NN aspirin
aspirin NN group
group NN (
( NN p
p JJ =
= CD 0.014
0.014 NN log
log NN rank
rank IN on
on NN follow-up
follow-up NN )

For IN CAPITAL For
For DT the
the CD 3382
3382 NNS patients
patients VBN assigned
assigned CD 3
3 NN mg
mg NN warfarin
warfarin IN with
with CD 80
80 NN mg
mg NN aspirin
aspirin , ,
, DT the
the NN CAPITAL INR
INR NNS results
results VBD were
were : :
: IN at
at NN week
week CD 1
1 NN (
( NN n
n JJ =
= CD 2985
2985 NN )
) NN median
median CD 1.51
1.51 NN (
( NN CAPITAL IQR
IQR CD 1.23-2.13
1.23-2.13 NN )
) : ;
; IN at
at NN week
week CD 4
4 NN (
( NN n
n JJ =
= CD 2701
2701 NN )
) CD 1.27
1.27 NN (
( CD 1.13-1.64
1.13-1.64 NN )
) : ;
; IN at
at NN month
month CD 6
6 NN (
( NN n
n JJ =
= CD 2145
2145 NN )
) CD 1.19
1.19 NN (
( CD 1.08-1.44
1.08-1.44 NN )

INTERPRETATION NN CAPITAL INTERPRETATION
INTERPRETATION : :
: JJ CAPITAL Low
Low , ,
, JJ fixed-dose
fixed-dose NN warfarin
warfarin NN (
( CD 1
1 NN mg
mg CC or
or CD 3
3 NN mg
mg NN )
) VBN combined
combined IN with
with JJ low-dose
low-dose NN aspirin
aspirin NN (
( CD 80
80 NN mg
mg NN )
) IN in
in NNS patients
patients WP who
who VB have
have VBD had
had JJ myocardial
myocardial NN infarction
infarction VBZ does
does RB not
not VB provide
provide JJ clinical
clinical NN benefit
benefit IN beyond
beyond IN that
that JJ achievable
achievable IN with
with CD 160
160 NN mg
mg NN aspirin
aspirin NN monotherapy

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: EX CAPITAL There
There VBZ is
is JJ serological
serological NN evidence
evidence IN for
for DT an
an NN association
association IN between
between NN CAPITAL Chlamydia
Chlamydia FW pneumoniae
pneumoniae CC and
and JJ coronary
coronary NN heart
heart NN disease

We PRP CAPITAL We
We VBN investigated
investigated DT the
the NN hypothesis
hypothesis IN that
that DT an
an JJ antichlamydial
antichlamydial NN macrolide
macrolide JJ antibiotic
antibiotic , ,
, NN roxithromycin
roxithromycin , ,
, MD can
can VB prevent
prevent CC or
or VB reduce
reduce JJ recurrent
recurrent JJ major
major JJ ischaemic
ischaemic NNS events
events IN in
in NNS patients
patients IN with
with JJ unstable
unstable NN angina

METHODS NNS CAPITAL METHODS
METHODS : :
: DT CAPITAL The
The NN effect
effect IN of
of NN roxithromycin
roxithromycin VBD was
was VBN assessed
assessed IN in
in DT a
a JJ double-blind
double-blind , ,
, VBN randomised
randomised , ,
, JJ prospective
prospective , ,
, JJ multicentre
multicentre , ,
, NN parallel-group
parallel-group , ,
, JJ placebo-controlled
placebo-controlled NN pilot
pilot NN study
study IN of
of CD 202
202 NNS patients
patients IN with
with JJ unstable
unstable NN angina
angina CC or
or JJ non-Q-wave
non-Q-wave JJ myocardial
myocardial NN infarction

Patients NNS CAPITAL Patients
Patients VBD were
were RB randomly
randomly VBN assigned
assigned DT either
either NN roxithromycin
roxithromycin CD 150
150 NN mg
mg RB orally
orally RB twice
twice DT a
a NN day
day NN (
( NN n
n JJ =
= CD 102
102 NN )
) CC or
or NN placebo
placebo RB orally
orally RB twice
twice DT a
a NN day
day NN (
( NN n
n JJ =
= CD 100
100 NN )

The DT CAPITAL The
The NN treatment
treatment VBD was
was IN for
for CD 30
30 NNS days

Patients NNS CAPITAL Patients
Patients VBD were
were VBN followed
followed RB up
up IN for
for CD 6
6 NNS months

We PRP CAPITAL We
We NN report
report DT the
the JJ primary
primary JJ clinical
clinical NNS endpoints
endpoints NN (
( JJ cardiac
cardiac JJ ischaemic
ischaemic NN death
death , ,
, JJ myocardial
myocardial NN infarction
infarction , ,
, CC and
and JJ severe
severe JJ recurrent
recurrent NN ischaemia
ischaemia NN )
) , ,
, VBN assessed
assessed IN at
at NN day
day CD 31
31 , ,
, IN in
in CD 202
202 NNS patients
patients IN on
on DT an
an NN intention-to-treat
intention-to-treat NN basis

FINDINGS NNS CAPITAL FINDINGS
FINDINGS : :
: DT CAPITAL A
A RB statistically
statistically JJ significant
significant NN reduction
reduction IN in
in DT the
the JJ primary
primary JJ composite
composite RB triple
triple NN endpoint
endpoint NNS rates
rates VBD was
was VBN observed
observed IN in
in DT the
the NN roxithromycin
roxithromycin NN group
group : :
: NN p
p JJ =
= CD 0.032

The DT CAPITAL The
The NN rate
rate IN of
of JJ severe
severe JJ recurrent
recurrent NN ischaemia
ischaemia , ,
, JJ myocardial
myocardial NN infarction
infarction , ,
, CC and
and JJ ischaemic
ischaemic NN death
death VBD was
was CD 5.4
5.4 NN %
% , ,
, CD 2.2
2.2 NN %
% , ,
, CC and
and CD 2.2
2.2 NN %
% IN in
in DT the
the NN placebo
placebo NN group
group CC and
and CD 1.1
1.1 NN %
% , ,
, CD 0
0 NN %
% , ,
, CC and
and CD 0
0 NN %
% , ,
, IN in
in DT the
the NN roxithromycin
roxithromycin NN group
group , ,
, RB respectively

No DT CAPITAL No
No JJ major
major JJ drug-related
drug-related JJ adverse
adverse NNS effects
effects VBD were
were VBN observed

INTERPRETATION NN CAPITAL INTERPRETATION
INTERPRETATION : :
: JJ CAPITAL Antichlamydial
Antichlamydial NNS antibiotics
antibiotics MD may
may VB be
be JJ useful
useful IN in
in JJ therapeutic
therapeutic NN intervention
intervention IN in
in NN addition
addition TO to
to NN standard
standard NN medication
medication IN in
in NNS patients
patients IN with
with NN coronary-artery
coronary-artery NN disease

Large-scale JJ CAPITAL Large-scale
Large-scale NNS trials
trials VBP are
are VBN needed
needed TO to
to VB confirm
confirm DT these
these JJ preliminary
preliminary NNS observations

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: NN CAPITAL Stage
Stage NN CAPITAL Ib
Ib CC and
and NN CAPITAL IIa
IIa JJ cervical
cervical NN carcinoma
carcinoma MD can
can VB be
be VBN cured
cured IN by
by NN radical
radical NN surgery
surgery CC or
or NN radiotherapy

These DT CAPITAL These
These CD two
two NNS procedures
procedures VBP are
are RB equally
equally JJ effective
effective , ,
, CC but
but VB differ
differ IN in
in VBN associated
associated NN morbidity
morbidity CC and
and NN type
type IN of
of NNS complications

In IN CAPITAL In
In DT this
this JJ prospective
prospective VBN randomised
randomised NN trial
trial IN of
of NN radiotherapy
radiotherapy CC versus
versus NN surgery
surgery , ,
, PRP$ our
our NN aim
aim VBD was
was TO to
to VB assess
assess DT the
the JJ 5-year
5-year NN survival
survival CC and
and DT the
the NN rate
rate CC and
and NN pattern
pattern IN of
of NNS complications
complications CC and
and NNS recurrences
recurrences VBN associated
associated IN with
with DT each
each NN treatment

METHODS NNS CAPITAL METHODS
METHODS : :
: IN CAPITAL Between
Between NNP CAPITAL September
September , ,
, CD 1986
1986 , ,
, CC and
and NNP CAPITAL December
December , ,
, CD 1991
1991 , ,
, CD 469
469 NNS women
women IN with
with RB newly
newly VBN diagnosed
diagnosed NN stage
stage NN CAPITAL Ib
Ib CC and
and NN CAPITAL IIa
IIa JJ cervical
cervical NN carcinoma
carcinoma VBD were
were VBN referred
referred TO to
to PRP$ our
our NN institute

343 CD 343
343 NN eligible
eligible NNS patients
patients VBD were
were VBN randomised
randomised : :
: CD 172
172 TO to
to NN surgery
surgery CC and
and CD 171
171 TO to
to NN radical
radical NN radiotherapy

Adjuvant JJ CAPITAL Adjuvant
Adjuvant NN radiotherapy
radiotherapy VBD was
was VBN delivered
delivered IN after
after NN surgery
surgery IN for
for NNS women
women IN with
with JJ surgical
surgical NN stage
stage NN pT2b
pT2b CC or
or JJR greater
greater , ,
, JJR less
less IN than
than CD 3
3 NN mm
mm IN of
of JJ safe
safe JJ cervical
cervical NN stroma
stroma , ,
, JJ cut-through
cut-through , ,
, CC or
or JJ positive
positive NNS nodes

The DT CAPITAL The
The JJ primary
primary NN outcome
outcome NNS measures
measures VBD were
were JJ 5-year
5-year NN survival
survival CC and
and DT the
the NN rate
rate IN of
of NNS complications

The DT CAPITAL The
The NN analysis
analysis IN of
of NN survival
survival CC and
and NN recurrence
recurrence VBD was
was IN by
by NN intention
intention TO to
to NN treat
treat CC and
and NN analysis
analysis IN of
of NNS complications
complications VBD was
was IN by
by NN treatment
treatment VBN delivered

FINDINGS NNS CAPITAL FINDINGS
FINDINGS : :
: CD 170
170 NNS patients
patients IN in
in DT the
the NN surgery
surgery NN group
group CC and
and CD 167
167 IN in
in DT the
the NN radiotherapy
radiotherapy NN group
group VBD were
were VBN included
included IN in
in DT the
the NN intention-to-treat
intention-to-treat NN analysis
analysis : ;
; VBN scheduled
scheduled NN treatment
treatment VBD was
was VBN delivered
delivered TO to
to CD 169
169 CC and
and CD 158
158 NNS women
women , ,
, RB respectively
respectively , ,
, CD 62
62 IN of
of CD 114
114 NNS women
women IN with
with JJ cervical
cervical NNS diameters
diameters IN of
of CD 4
4 NN cm
cm CC or
or JJR smaller
smaller CC and
and CD 46
46 IN of
of CD 55
55 IN with
with NNS diameters
diameters JJR larger
larger IN than
than CD 4
4 NN cm
cm VBN received
received JJ adjuvant
adjuvant NN therapy

After IN CAPITAL After
After DT a
a NN median
median NN follow-up
follow-up IN of
of CD 87
87 NN (
( NN range
range JJ 57-120
57-120 NN )
) NNS months
months , ,
, JJ 5-year
5-year RB overall
overall CC and
and JJ disease-free
disease-free NN survival
survival VBD were
were JJ identical
identical IN in
in DT the
the NN surgery
surgery CC and
and NN radiotherapy
radiotherapy NNS groups
groups NN (
( CD 83
83 NN %
% CC and
and CD 74
74 NN %
% , ,
, RB respectively
respectively , ,
, IN for
for DT both
both NNS groups
groups NN )
) , ,
, CD 86
86 NNS women
women VBN developed
developed JJ recurrent
recurrent NN disease
disease : :
: CD 42
42 NN (
( CD 25
25 NN %
% NN )
) IN in
in DT the
the NN surgery
surgery NN group
group CC and
and CD 44
44 NN (
( CD 26
26 NN %
% NN )
) IN in
in DT the
the NN radiotherapy
radiotherapy NN group

Significant JJ CAPITAL Significant
Significant NNS factors
factors IN for
for NN survival
survival IN in
in JJ univariate
univariate CC and
and JJ multivariate
multivariate NNS analyses
analyses VBD were
were : :
: JJ cervical
cervical NN diameter
diameter , ,
, JJ positive
positive NN lymphangiography
lymphangiography , ,
, CC and
and JJ adeno-carcinomatous
adeno-carcinomatous NN histotype

48 CD 48
48 NN (
( CD 28
28 NN %
% NN )
) NN surgery-group
surgery-group NNS patients
patients VBD had
had JJ severe
severe NN morbidity
morbidity VBN compared
compared IN with
with CD 19
19 NN (
( CD 12
12 NN %
% NN )
) NN radiotherapy-group
radiotherapy-group NNS patients
patients NN (
( NN p
p JJ =
= CD 0.0004
0.0004 NN )

INTERPRETATION NN CAPITAL INTERPRETATION
INTERPRETATION : :
: EX CAPITAL There
There VBZ is
is DT no
no NN treatment
treatment IN of
of NN choice
choice IN for
for JJ early-stage
early-stage JJ cervical
cervical NN carcinoma
carcinoma IN in
in NNS terms
terms IN of
of RB overall
overall CC or
or JJ disease-free
disease-free NN survival

The DT CAPITAL The
The NN combination
combination IN of
of NN surgery
surgery CC and
and NN radiotherapy
radiotherapy VBZ has
has DT the
the JJS worst
worst NN morbidity
morbidity , ,
, RB especially
especially NN urological
urological NNS complications

The DT CAPITAL The
The NN optimum
optimum NN therapy
therapy IN for
for DT each
each NN patient
patient MD should
should VB take
take NN account
account IN of
of JJ clinical
clinical NNS factors
factors JJ such
such IN as
as JJ menopausal
menopausal NN status
status , ,
, NN age
age , ,
, JJ medical
medical NN illness
illness , ,
, JJ histological
histological NN type
type , ,
, CC and
and JJ cervical
cervical NN diameter
diameter TO to
to NN yield
yield DT the
the RB best
best NN cure
cure IN with
with NN minimum
minimum NNS complications

Today NN CAPITAL Today
Today POS 's
's NN technology
technology NNS links
links NN health
health NN care
care NNS providers
providers CC and
and NNS patients
patients IN across
across NN town
town , ,
, IN in
in DT the
the IN next
next NN state
state CC or
or RB even
even DT another
another NN country

Nursing NNP CAPITAL Nursing
Nursing IN across
across NN state
state NNS lines
lines VBZ poses
poses NNS complications
complications : :
: JJ state-bound
state-bound JJ regulatory
regulatory CC and
and NN licensure
licensure NNS issues

This DT CAPITAL This
This NN article
article VBZ discusses
discusses JJ many
many IN of
of DT the
the JJ nutritional
nutritional NNS topics
topics JJ important
important TO to
to DT the
the NN intensivist

Nutritional NNP CAPITAL Nutritional
Nutritional NN assessment
assessment , ,
, NN substrate
substrate NN immunonutrition
immunonutrition , ,
, CC and
and NN disease
disease JJ specific
specific NNS issues
issues VBP are
are VBN presented

Early RB CAPITAL Early
Early NN introduction
introduction IN of
of NN enteral
enteral VBZ feeds
feeds CC and
and DT the
the NN use
use IN of
of JJ nutritional
nutritional NN modulation
modulation VBP are
are VBN emphasized

PROBLEM NN CAPITAL PROBLEM
PROBLEM : :
: TO CAPITAL To
To VB compare
compare DT the
the NN expression
expression IN by
by NNS CAPITAL T-lymphocytes
T-lymphocytes IN of
of DT an
an JJ immunomodulatory
immunomodulatory NN protein
protein VBN known
known IN as
as JJ progesterone-induced
progesterone-induced VBG blocking
blocking NN factor
factor NN (
( NN CAPITAL PIBF
PIBF NN )
) IN in
in NN conception
conception CC versus
versus JJ non-conception
non-conception NNS cycles
cycles RB even
even WRB when
when RB there
there VBZ has
has VBN been
been JJ definite
definite NN fertilization
fertilization CC and
and NN embryo
embryo NN formation

METHOD NN CAPITAL METHOD
METHOD : :
: NN CAPITAL PIBF
PIBF NN expression
expression IN on
on NN CAPITAL T
T NNS lymphocytes
lymphocytes VBD was
was VBN measured
measured VBG using
using DT an
an JJ immunohistochemical
immunohistochemical NN method
method IN with
with DT a
a JJ CAPITAL PIBF-specific
PIBF-specific JJ polyclonal
polyclonal NN antibody

These DT CAPITAL These
These NNS levels
levels VBD were
were VBN determined
determined IN in
in NNS patients
patients VBG undergoing
undergoing CD three
three NNS types
types IN of
of NN therapy
therapy : :
: JJ non-in
non-in NN vitro
vitro NN fertilization
fertilization NN (
( NN CAPITAL IVF
IVF NN )
) , ,
, NN CAPITAL IVF-embryo
IVF-embryo NN transfer
transfer NN (
( NNP CAPITAL ET
ET NN )
) , ,
, CC and
and JJ frozen
frozen NNP CAPITAL ET

Sera NNP CAPITAL Sera
Sera VBD were
were VBN drawn
drawn CD 12
12 NNS days
days IN from
from NN ovulation
ovulation IN in
in JJ non-IVF
non-IVF NNS cycles
cycles CC or
or CD 9
9 NNS days
days IN after
after NNP CAPITAL ET
ET CC and
and VBD were
were VBN assayed
assayed IN for
for NN CAPITAL PIBF
PIBF CC and
and NN beta
beta JJ human
human JJ chorionic
chorionic NN gondotropin

Comparison NN CAPITAL Comparison
Comparison IN of
of DT the
the NN frequency
frequency IN of
of NN lymphocyte
lymphocyte NN expression
expression IN of
of NN CAPITAL PIBF
PIBF IN in
in JJ pregnant
pregnant CC versus
versus JJ non-pregnant
non-pregnant NNS women
women VBD were
were VBN made

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NN CAPITAL PIBF
PIBF VBD was
was VBN detected
detected IN in
in CD 29.5
29.5 NN %
% IN of
of JJ non-pregnant
non-pregnant NNS women
women CC and
and CD 52.5
52.5 NN %
% IN of
of JJ pregnant
pregnant NNS women

There EX CAPITAL There
There VBD were
were DT no
no NNS differences
differences IN in
in NN CAPITAL PIBF
PIBF NNS levels
levels IN by
by NN therapy
therapy VBN used
used IN in
in JJ non-pregnant
non-pregnant NNS cases
cases CC or
or IN in
in DT the
the JJ pregnant
pregnant NN group

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: DT CAPITAL These
These NNS data
data VBP are
are JJ consistent
consistent IN with
with DT the
the NN hypothesis
hypothesis IN that
that JJ maternal
maternal NN expression
expression IN of
of NN CAPITAL PIBF
PIBF IN in
in NNS CAPITAL T-lymphocytes
T-lymphocytes RB soon
soon IN after
after NN trophoblast
trophoblast NN invasion
invasion MD may
may VB depend
depend IN on
on JJ successful
successful NN implantation

Many JJ CAPITAL Many
Many NN amino
amino NNS acids
acids VB contain
contain DT an
an JJ asymmetric
asymmetric NN centre
centre , ,
, VBG occurring
occurring IN as
as JJ laevorotatory
laevorotatory , ,
, NN CAPITAL L
L , ,
, CC or
or JJ dextrorotatory
dextrorotatory , ,
, NN CAPITAL D
D , ,
, NNS compounds

It PRP CAPITAL It
It VBZ is
is RB generally
generally VBN assumed
assumed IN that
that JJ abiotic
abiotic NN synthesis
synthesis IN of
of NN amino
amino NNS acids
acids IN on
on DT the
the RB early
early NNP CAPITAL Earth
Earth VBD resulted
resulted IN in
in JJ racemic
racemic NNS mixtures
mixtures NN (
( NN CAPITAL L-
L- CC and
and NNS CAPITAL D-enantiomers
D-enantiomers IN in
in JJ equal
equal NN abundance
abundance NN )

But CC CAPITAL But
But DT the
the NN origin
origin IN of
of NN life
life VBN required
required , ,
, VBG owing
owing TO to
to JJ conformational
conformational NNS constraints
constraints , ,
, DT the
the RB almost
almost JJ exclusive
exclusive NN selection
selection IN of
of DT either
either NN CAPITAL L-
L- CC or
or NNS CAPITAL D-enantiomers
D-enantiomers , ,
, CC and
and DT the
the NN question
question IN of
of WRB why
why VBG living
living NNS systems
systems IN on
on DT the
the NNP CAPITAL Earth
Earth VBP consist
consist IN of
of NNS CAPITAL L-enantiomers
L-enantiomers RB rather
rather IN than
than NNS CAPITAL D-enantiomers
D-enantiomers VBZ is
is JJ unresolved

A DT CAPITAL A
A JJ substantial
substantial NN fraction
fraction IN of
of DT the
the JJ organic
organic NNS compounds
compounds IN on
on DT the
the RB early
early NNP CAPITAL Earth
Earth MD may
may VB have
have VBN been
been VBN derived
derived IN from
from NN comet
comet CC and
and NN meteorite
meteorite NNS impacts

It PRP CAPITAL It
It VBZ has
has VBN been
been VBN reported
reported RB previously
previously IN that
that NN amino
amino NNS acids
acids IN in
in DT the
the NNP CAPITAL Murchison
Murchison NN meteorite
meteorite NN exhibit
exhibit DT an
an NN excess
excess IN of
of NNS CAPITAL L-enantiomers
L-enantiomers , ,
, VBG raising
raising DT the
the NN possibility
possibility IN that
that DT a
a JJ similar
similar NN excess
excess VBD was
was JJ present
present IN in
in DT the
the JJ initial
initial NN inventory
inventory IN of
of JJ organic
organic NNS compounds
compounds IN on
on DT the
the NNP CAPITAL Earth

The DT CAPITAL The
The JJ stable
stable NN carbon
carbon NN isotope
isotope NNS compositions
compositions IN of
of JJ individual
individual NN amino
amino NNS acids
acids IN in
in NNP CAPITAL Murchison
Murchison NN support
support DT an
an JJ extraterrestrial
extraterrestrial NN origin
origin : --
-- RB rather
rather IN than
than DT a
a NN terrestrial
terrestrial NN overprint
overprint IN of
of JJ biological
biological NN amino
amino JJ acids-although
acids-although NNS reservations
reservations VB have
have VBD persisted

Here RB CAPITAL Here
Here PRP we
we NN show
show IN that
that JJ individual
individual JJ amino-acid
amino-acid NNS enantiomers
enantiomers IN from
from NNP CAPITAL Murchison
Murchison VBP are
are JJ enriched
enriched IN in
in NN 15N
15N JJ relative
relative TO to
to PRP$ their
their NN terrestrial
terrestrial NNS counterparts
counterparts , ,
, RB so
so VBG confirming
confirming DT an
an JJ extraterrestrial
extraterrestrial NN source
source IN for
for DT an
an NN CAPITAL L-enantiomer
L-enantiomer NN excess
excess IN in
in DT the
the NNP CAPITAL Solar
Solar NNP CAPITAL System
System IN that
that MD may
may VB predate
predate DT the
the NN origin
origin IN of
of NN life
life IN on
on DT the
the NNP CAPITAL Earth

Home NN CAPITAL Home
Home NN care
care NNS workers
workers NN face
face DT an
an VBG increasing
increasing NN risk
risk IN for
for NN workplace
workplace NN violence

A DT CAPITAL A
A JJ proactive
proactive JJ preventive
preventive NN approach
approach VBZ is
is VBN presented
presented IN that
that VBZ suggests
suggests NNS strategies
strategies TO to
to NN use
use IN during
during DT the
the NN previsit
previsit NN phase
phase , ,
, DT the
the NN visit
visit NN experience
experience , ,
, CC and
and IN on
on DT an
an JJ ongoing
ongoing NN basis

The DT CAPITAL The
The NN miracidia
miracidia IN of
of NN CAPITAL Fasciola
Fasciola NN hepatica
hepatica CC and
and FW CAPITAL Trichobilharzia
Trichobilharzia NN ocellata
ocellata NN approach
approach PRP$ their
their NN host
host NNS snails
snails NNP CAPITAL Lymnaea
Lymnaea NN truncatula
truncatula CC and
and NNP CAPITAL L.
L. NN stagnalis
stagnalis IN by
by VBG increasing
increasing PRP$ their
their NN rate
rate IN of
of NN change
change IN of
of NN direction
direction NN (
( NN CAPITAL RCD
RCD NN )
) IN in
in VBG increasing
increasing NNS gradients
gradients IN of
of JJ snail-conditioned
snail-conditioned NN water
water NN (
( NN CAPITAL SCW
SCW NN )
) , ,
, CC and
and PRP they
they VB perform
perform DT a
a NN turnback
turnback VBG swimming
swimming IN in
in VBG decreasing
decreasing NNS gradients

Both DT CAPITAL Both
Both VBG hostfinding
hostfinding NNS responses
responses IN in
in DT both
both NNS species
species VBD were
were VBN induced
induced IN by
by NNS glycoconjugates
glycoconjugates IN with
with DT a
a JJ molecular
molecular NN weight
weight IN of
of JJR >
> CD 30
30 NN kDa
kDa IN that
that VBD were
were JJ sensitive
sensitive TO to
to NN hydrolysis
hydrolysis IN with
with NN pronase
pronase NN CAPITAL E
E CC and
and NN oxidation
oxidation IN with
with NN CAPITAL NaIO4

Alkaline NN CAPITAL Alkaline
Alkaline NN cleavage
cleavage VBD revealed
revealed IN that
that PRP they
they VBN contained
contained NNS carbohydrates
carbohydrates VBN linked
linked RB CAPITAL O-glycosidically
O-glycosidically IN via
via NN serine
serine CC and
and NN CAPITAL N-acetylgalactosamine

Miracidia NNP CAPITAL Miracidia
Miracidia RB clearly
clearly VBN preferred
preferred NN CAPITAL SCW
SCW IN from
from PRP$ their
their JJ specific
specific NN host
host NN snail
snail CC versus
versus JJ other
other JJ sympatric
sympatric NN snail
snail NNS species
species CC and
and VBD did
did RB not
not NN respond
respond TO to
to NN water
water VBN conditioned
conditioned IN with
with NN fish
fish , ,
, NNS tadpoles
tadpoles , ,
, CC or
or NNS leeches

Differences NNS CAPITAL Differences
Differences IN in
in DT the
the NN chemical
chemical NNS characteristics
characteristics IN of
of NN CAPITAL SCW
SCW IN from
from DT the
the JJ intermediate
intermediate NNS hosts
hosts NNP CAPITAL L.
L. NN truncatula
truncatula CC and
and NNP CAPITAL L.
L. NN stagnalis
stagnalis MD could
could VB be
be VBN shown
shown IN by
by NN sodium
sodium NN dodecyl
dodecyl JJ sulfate-polyacrylamide
sulfate-polyacrylamide NN gel
gel NN electrophoresis
electrophoresis , ,
, NN blotting
blotting , ,
, CC and
and JJ subsequent
subsequent NN carbohydrate
carbohydrate NN detection

The DT CAPITAL The
The RB first
first NN step
step IN of
of NN purification
purification IN of
of DT the
the JJ effective
effective NN signaling
signaling NN CAPITAL SCW
SCW NNS components
components IN from
from DT both
both NN snail
snail NNS species
species VBD was
was VBN achieved
achieved IN by
by NN ion-exchange
ion-exchange NN chromatography

Black NNP CAPITAL Black
Black NNS patients
patients IN with
with NN colon
colon NN cancer
cancer IN in
in DT the
the NN CAPITAL Black/White
Black/White NN CAPITAL Cancer
Cancer NN CAPITAL Survival
Survival NN CAPITAL Study
Study VBD were
were VBN found
found TO to
to VB have
have DT a
a JJR poorer
poorer NN survival
survival IN than
than JJ white
white NNS patients

More RBR CAPITAL More
More NN advanced-stage
advanced-stage NN disease
disease IN at
at NN diagnosis
diagnosis VBD was
was DT the
the JJ primary
primary NN determinant
determinant , ,
, NN accounting
accounting IN for
for CD 60
60 NN %
% IN of
of DT the
the NN excess
excess NN mortality

After IN CAPITAL After
After VBG adjusting
adjusting IN for
for NN stage
stage , ,
, NNS factors
factors JJ such
such IN as
as NN poverty
poverty , ,
, JJ other
other JJ socioeconomic
socioeconomic NNS conditions
conditions , ,
, CC and
and NN treatment
treatment VBD did
did RB not
not RB further
further VB explain
explain DT the
the VBG remaining
remaining NN survival
survival NN deficit

This DT CAPITAL This
This NN study
study VBN examined
examined DT the
the NN aggressiveness
aggressiveness IN of
of NN colon
colon NNS tumors
tumors IN in
in NNS blacks
blacks CC and
and NNS whites
whites TO to
to VB explore
explore PRP$ its
its NN role
role IN in
in DT the
the JJ racial
racial NN survival
survival NNS differences

Tumor NN CAPITAL Tumor
Tumor NNS characteristics
characteristics IN of
of CD 703
703 NNS cases
cases IN of
of RB newly
newly VBN diagnosed
diagnosed JJ invasive
invasive NN colon
colon NN adenocarcinoma
adenocarcinoma VBD were
were RB centrally
centrally VBN evaluated
evaluated IN by
by DT a
a JJ gastrointestinal
gastrointestinal NN pathologist
pathologist , ,
, VBN blinded
blinded IN in
in NN regard
regard TO to
to DT the
the NN age
age , ,
, NN race
race , ,
, CC and
and NN sex
sex IN of
of DT the
the NNS patients

Blacks NNPS CAPITAL Blacks
Blacks VBD were
were JJR less
less RB likely
likely TO to
to VB have
have RB poorly
poorly VBN differentiated
differentiated NN (
( NN grade
grade CD 3
3 NN )
) NNS tumors
tumors NN (
( NNS odds
odds NN ratio
ratio NN (
( NN CAPITAL OR
OR NN )
) , ,
, CD 0.44
0.44 : ;
; CD 95
95 NN %
% NN confidence
confidence NN interval
interval , ,
, CD 0.22-0.88
0.22-0.88 NN )
) CC and
and JJ lymphoid
lymphoid NN reaction
reaction NN (
( NN CAPITAL OR
OR , ,
, CD 0.49
0.49 : ;
; CD 95
95 NN %
% NN confidence
confidence NN interval
interval , ,
, CD 0.26-0.90
0.26-0.90 NN )
) WRB when
when VBN compared
compared IN with
with NNS whites

These DT CAPITAL These
These NN black/white
black/white NN (
( NN CAPITAL B/W
B/W NN )
) NNS differences
differences VBD remained
remained RB statistically
statistically JJ significant
significant IN after
after VBG adjusting
adjusting IN for
for NN age
age , ,
, NN sex
sex , ,
, JJ metropolitan
metropolitan NN area
area , ,
, NN summary
summary NN stage
stage , ,
, JJ socioeconomic
socioeconomic NN status
status , ,
, NN body
body NN mass
mass NN index
index , ,
, CC and
and NN health
health NN care
care NN access
access CC and
and NN utilization

In IN CAPITAL In
In NN addition
addition , ,
, NNS blacks
blacks VBD were
were JJR less
less RB likely
likely TO to
to VB have
have JJ high-grade
high-grade NN (
( NN grade
grade CD 3
3 NN )
) JJ nuclear
nuclear NN atypia
atypia , ,
, JJ mitotic
mitotic NN activity
activity , ,
, CC and
and NN tubule
tubule NN formation
formation , ,
, IN although
although DT these
these NNS CAPITAL ORs
ORs VBD did
did RB not
not NN reach
reach DT a
a JJ statistical
statistical NN significance
significance NN level
level IN of
of CD 0.05

Similar JJ CAPITAL Similar
Similar NN CAPITAL B/W
B/W NNS differences
differences VBD were
were VBN observed
observed IN for
for NNS patients
patients IN with
with VBN advanced
advanced NN disease
disease CC but
but RB not
not IN with
with RB early
early NN stage

Comparison NN CAPITAL Comparison
Comparison IN by
by JJ anatomical
anatomical NN subsite
subsite VBD showed
showed IN that
that NNS blacks
blacks VBD had
had RB statistically
statistically RB significantly
significantly RB better
better VBN differentiated
differentiated NNS tumors
tumors IN for
for NNS cancers
cancers IN of
of DT the
the JJ proximal
proximal CC and
and NN transverse
transverse NN colon
colon CC but
but RB not
not IN for
for DT the
the JJ distal

No DT CAPITAL No
No JJ racial
racial NNS differences
differences VBD were
were VBN found
found IN for
for NN blood
blood NN vessel
vessel CC and
and JJ lymphatic
lymphatic NN invasion
invasion , ,
, NN necrosis
necrosis , ,
, NN fibrosis
fibrosis , ,
, CC and
and JJ mucinous
mucinous NN type
type IN of
of NN histology

The DT CAPITAL The
The NNS findings
findings , ,
, RB therefore
therefore , ,
, VBP are
are DT the
the JJ opposite
opposite IN of
of DT those
those VBN hypothesized

After IN CAPITAL After
After VBG adjusting
adjusting IN for
for NN stage
stage , ,
, RBR more
more JJ aggressive
aggressive NN tumor
tumor NNS characteristics
characteristics VB do
do RB not
not VB explain
explain DT the
the JJ adverse
adverse NN survival
survival JJ differential
differential IN in
in NNS blacks

This DT CAPITAL This
This VBZ suggests
suggests IN that
that RB there
there MD may
may VB be
be JJ racial
racial NNS differences
differences IN in
in JJ environmental
environmental NN exposure
exposure , ,
, CC and
and IN that
that DT the
the NN intensity
intensity CC and
and NN mode
mode IN of
of NN delivery
delivery IN of
of NN carcinogen
carcinogen NN insult
insult IN as
as RB well
well IN as
as NN host
host NN susceptibility
susceptibility MD may
may VB differ
differ IN by
by NN race
race CC and
and JJ anatomical
anatomical NN subsite

Future JJ CAPITAL Future
Future NNS studies
studies MD should
should VB explore
explore DT the
the NN CAPITAL B/W
B/W NNS differences
differences IN in
in NN tumor
tumor NN biology
biology VBG using
using JJ molecular
molecular NNS markers
markers IN that
that VB precede
precede DT the
the JJ conventional
conventional JJ histological
histological NNS parameters
parameters VBN evaluated
evaluated RB here

A DT CAPITAL A
A JJ new
new NN method
method VBZ is
is VBN described
described IN for
for NN detection
detection IN of
of NNS mutations
mutations IN in
in DT the
the JJ lysosomal
lysosomal NN alpha-glucosidase
alpha-glucosidase NN gene
gene NN (
( NN CAPITAL GAA
GAA NN )
) VBG leading
leading TO to
to NN CAPITAL Glycogen
Glycogen NNP CAPITAL Storage
Storage NN CAPITAL Disease
Disease NN type
type NNP CAPITAL II
II NN (
( CD CAPITAL GSDII
GSDII NN )

A DT CAPITAL A
A NN key
key NN feature
feature IN of
of DT the
the NN method
method VBZ is
is NN isolation
isolation CC and
and NN reverse
reverse NN transcription
transcription IN of
of NN mRNA
mRNA VBN followed
followed IN by
by NN CAPITAL PCR
PCR NN amplification
amplification IN of
of JJ lysosomal
lysosomal NN alpha-glucosidase
alpha-glucosidase NN cDNA
cDNA IN with
with JJ CAPITAL M13-extended
M13-extended NNS primers

Dye VB CAPITAL Dye
Dye VBN labeled
labeled NNS primers
primers VBP are
are VBN used
used IN for
for NN cycle
cycle NN sequencing
sequencing CC and
and DT an
an NN CAPITAL ABI
ABI NN CAPITAL PRISM
PRISM CD 377
377 NN CAPITAL DNA
DNA NN sequencing
sequencing NN system
system IN for
for NN analysis

The DT CAPITAL The
The NN method
method VBZ is
is JJ rapid
rapid CC and
and JJ complementary
complementary TO to
to DT the
the VBN automated
automated NN sequencing
sequencing IN of
of DT all
all DT the
the CD 19
19 , ,
, NN CAPITAL PCR
PCR VBN amplified
amplified , ,
, VBG coding
coding NNS exons
exons IN of
of DT the
the NN CAPITAL GAA
GAA NN gene

The DT CAPITAL The
The NNS advantages
advantages CC and
and NNS pitfalls
pitfalls IN of
of DT this
this JJ new
new NN method
method VBP are
are VBN discussed
discussed IN in
in DT the
the NN light
light IN of
of DT the
the NNS results
results VBN obtained
obtained IN with
with DT an
an JJ infantile
infantile CD CAPITAL GSDII
GSDII NN patient

A DT CAPITAL A
A JJ new
new NN splice
splice NN site
site NN mutation
mutation IN in
in DT the
the NN CAPITAL GAA
GAA NN gene
gene IN of
of DT this
this NN patient
patient VBD was
was VBN identified
identified , ,
, NN CAPITAL IVS16
IVS16 NN (
( NN +2T
+2T : --
-- JJR >
> NN CAPITAL C
C NN )
) , ,
, VBG resulting
resulting IN in
in DT the
the NN deletion
deletion IN of
of CD 16
16 NN base
base NNS pairs
pairs IN of
of NN exon
exon CD 16

The DT CAPITAL The
The NN presence
presence IN of
of JJ clinical
clinical JJ autonomic
autonomic NN dysfunction
dysfunction IN in
in NNS patients
patients IN with
with JJ neurologic
neurologic NNS diseases
diseases , ,
, JJ such
such IN as
as JJ multiple
multiple NN sclerosis
sclerosis , ,
, NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease
disease , ,
, CC and
and JJ cerebrovascular
cerebrovascular NN accident
accident , ,
, VBZ has
has VB become
become RB increasingly
increasingly VBN recognized
recognized IN in
in DT the
the IN past
past NN decade

Very RB CAPITAL Very
Very JJ few
few JJ autonomic
autonomic NNS tests
tests VB have
have VBN been
been VBN done
done IN on
on JJ pediatric
pediatric NNS patients
patients RB thus
thus RB far

The DT CAPITAL The
The NN purpose
purpose IN of
of DT this
this NN study
study VBD was
was TO to
to VB investigate
investigate DT the
the JJ autonomic
autonomic NN function
function IN in
in NNS patients
patients IN with
with JJ cerebral
cerebral NN palsy
palsy VBG using
using CD two
two JJ noninvasive
noninvasive NNS tests
tests : :
: JJ sympathetic
sympathetic NN skin
skin NN response
response NN (
( NN CAPITAL SSR
SSR NN )
) CC and
and NN CAPITAL R-R
R-R NN interval
interval NN variation
variation NN (
( NN CAPITAL RRIV
RRIV NN )

Twenty-four CD CAPITAL Twenty-four
Twenty-four NNS patients
patients IN with
with JJ cerebral
cerebral NN palsy
palsy CC and
and CD 24
24 NN control
control NNS subjects
subjects IN between
between DT the
the NNS ages
ages IN of
of CD 4
4 CC and
and CD 12
12 NN yr
yr VBD were
were VBN enrolled
enrolled IN in
in DT this
this NN study

There EX CAPITAL There
There VBD was
was DT no
no JJ significant
significant NN difference
difference IN of
of VB mean
mean NN latency
latency , ,
, NN amplitude
amplitude , ,
, CC or
or NN amplitude
amplitude NN ratio
ratio IN of
of NN CAPITAL SSR
SSR IN between
between DT the
the CD two
two NNS groups
groups IN under
under JJ electric
electric NN stimulus
stimulus , ,
, JJ startling
startling NN stimulus
stimulus , ,
, CC and
and RB deep
deep NN breathing
breathing NNS conditions

No DT CAPITAL No
No JJ significant
significant NN difference
difference IN in
in NN frequency
frequency IN of
of JJ absent
absent NN response
response CC and
and JJ asymmetric
asymmetric NN response
response VBD was
was RB also
also VBN noted

Mean NN CAPITAL Mean
Mean NN heart
heart NN rate
rate IN under
under VBN relaxed
relaxed VBG sitting
sitting NN condition
condition VBD was
was RB significantly
significantly JJR higher
higher IN in
in DT the
the NN study
study NN group

Significant JJ CAPITAL Significant
Significant JJ negative
negative NN correlation
correlation IN between
between NN heart
heart NN rate
rate CC and
and NN age
age VBD was
was VBN noted
noted IN in
in DT the
the NN control
control NN group
group CC but
but VBD was
was RB not
not JJ present
present IN in
in DT the
the NN study
study NN group

Also RB CAPITAL Also
Also , ,
, RB there
there VBD was
was DT no
no JJ statistical
statistical NN difference
difference IN of
of VB mean
mean NN CAPITAL RRIV
RRIV IN between
between DT the
the CD two
two NNS groups

No DT CAPITAL No
No NN objective
objective NN evidence
evidence IN of
of JJ autonomic
autonomic NN disturbance
disturbance IN in
in NNS patients
patients IN with
with JJ cerebral
cerebral NN palsy
palsy VBD was
was VBN found
found IN in
in DT this
this NN study

A DT CAPITAL A
A NNS two-credits
two-credits IN per
per NN semester
semester JJ clinical
clinical NN medicine
medicine NN course
course VBD was
was VBN established
established IN in
in DT the
the NNP CAPITAL Department
Department IN of
of JJ CAPITAL Physical
Physical NN CAPITAL Medicine
Medicine CC and
and NNP CAPITAL Rehabilitation
Rehabilitation NN (
( NN CAPITAL PM
PM CC &
& # #
# CD 38
38 : ;
; NN CAPITAL R
R NN )
) IN in
in NN cooperation
cooperation IN with
with DT the
the NNP CAPITAL Johns
Johns NNP CAPITAL Hopkins
Hopkins NNP CAPITAL University
University JJ undergraduate
undergraduate JJ CAPITAL Human
Human NN CAPITAL Biology
Biology NN faculty
faculty TO to
to JJ present
present DT the
the NN variety
variety IN of
of NN inpatient
inpatient NN consultation
consultation NNS personnel
personnel , ,
, NNS units
units , ,
, NN patient
patient JJ diagnostic
diagnostic NNS groups
groups , ,
, CC and
and JJ functional
functional NNS problems

College NNP CAPITAL College
College NNS students
students VB spend
spend CD 4
4 NN hr
hr RB weekly
weekly IN on
on DT the
the NN CAPITAL PM
PM CC &
& # #
# CD 38
38 : ;
; NN CAPITAL R
R NN consultation
consultation NN service
service IN as
as NN team
team NNS members
members IN under
under NN resident
resident NN supervision

The DT CAPITAL The
The NN curriculum
curriculum VBZ emphasizes
emphasizes NN student
student VBG understanding
understanding IN of
of DT the
the NNS roles
roles IN of
of NN rehabilitation
rehabilitation NN team
team NNS members

Objectives NNS CAPITAL Objectives
Objectives VB include
include NN demonstration
demonstration IN of
of VBG working
working NN knowledge
knowledge IN of
of DT the
the NNP CAPITAL Biopsychosocial
Biopsychosocial NNP CAPITAL Model
Model , ,
, DT the
the NNP CAPITAL World
World NNP CAPITAL Health
Health NNP CAPITAL Organization
Organization NNP CAPITAL Model
Model IN of
of NN disablement
disablement CC and
and JJ interdisciplinary
interdisciplinary NN rehabilitation
rehabilitation NN intervention

The DT CAPITAL The
The NN course
course VBZ includes
includes NNS simulations
simulations IN of
of JJ physical
physical NNS impairments
impairments , ,
, NNS demonstrations
demonstrations IN of
of JJ adaptive
adaptive NN equipment
equipment , ,
, JJ interactive
interactive NN chart
chart NNS reviews
reviews , ,
, NNS readings
readings , ,
, CC and
and NN audio
audio VBZ lectures

A DT CAPITAL A
A NN retrospective
retrospective JJ sequential
sequential NN review
review VBD was
was VBN made
made IN of
of DT the
the JJ last
last CD 100
100 JJ physical
physical NN medicine
medicine CC and
and NN rehabilitation
rehabilitation NNS consultations
consultations IN with
with NN student
student NN attendance

The DT CAPITAL The
The NNS results
results VB confirm
confirm NN student
student NN exposure
exposure TO to
to JJ many
many NN ward
ward NNS settings
settings NN (
( NN surgery
surgery , ,
, CD 30
30 NN %
% : ;
; NN neurology/neurosurgery
neurology/neurosurgery , ,
, CD 28
28 NN %
% : ;
; NN medicine
medicine , ,
, CD 24
24 NN %
% : ;
; JJ intensive
intensive NN care
care , ,
, CD 15
15 NN %
% : ;
; NN oncology
oncology , ,
, CD 2
2 NN %
% : ;
; CC and
and NN psychiatry
psychiatry , ,
, CD 1
1 NN %
% NN )
) , ,
, NN patient
patient NN complexity
complexity NN (
( VBG averaging
averaging CD 10
10 NNS problems
problems NN )
) , ,
, CC and
and JJ multiple
multiple NN CAPITAL ICD-9
ICD-9 NN diagnosis
diagnosis NNS categories
categories NN (
( JJ circulatory
circulatory , ,
, CD 36
36 NN %
% : ;
; JJ neurologic
neurologic , ,
, CD 22
22 NN %
% : ;
; JJ musculoskeletal
musculoskeletal , ,
, CD 17
17 NN %
% : ;
; NNS neoplasms
neoplasms , ,
, CD 10
10 NN %
% : ;
; NN injury
injury , ,
, CD 5
5 NN %
% : ;
; NN endocrine
endocrine , ,
, CD 4
4 NN %
% : ;
; NNS infections
infections , ,
, CD 3
3 NN %
% : ;
; CC and
and NNS others
others , ,
, CD 3
3 NN %
% NN )

The DT CAPITAL The
The NN rehabilitation
rehabilitation NN consultation
consultation NN service
service VBZ is
is RB particularly
particularly JJ effective
effective IN as
as DT an
an NN introduction
introduction TO to
to JJ hospital-based
hospital-based JJ medical
medical NN practice
practice JJ due
due TO to
to DT the
the JJ diagnostic
diagnostic NN variety
variety IN of
of DT the
the NNS patients
patients , ,
, DT the
the JJ functional
functional NN approach
approach IN of
of NN rehabilitation
rehabilitation , ,
, CC and
and NN student
student NN exposure
exposure TO to
to JJ multiple
multiple NN hospital
hospital NNS settings

The DT CAPITAL The
The NNP CAPITAL Biopsychosocial
Biopsychosocial NNP CAPITAL Model
Model IN of
of JJ medical
medical NN practice
practice VBZ is
is VBN demonstrated
demonstrated IN through
through JJ multiple
multiple JJ interdisciplinary
interdisciplinary NNS perspectives
perspectives IN of
of NNS needs
needs CC and
and NNS interventions
interventions IN for
for NNS patients
patients IN with
with JJ obvious
obvious JJ functional
functional NNS deficits

This DT CAPITAL This
This NN process
process VBZ develops
develops DT a
a JJ rudimentary
rudimentary VBG understanding
understanding IN of
of DT the
the NN effect
effect IN of
of NN illness
illness IN on
on DT the
the NN person
person CC and
and DT the
the NN variety
variety IN of
of RB medically
medically JJ effective
effective JJ therapeutic
therapeutic NNS modalities

This DT CAPITAL This
This NN study
study VBZ is
is VBN designed
designed TO to
to VB investigate
investigate DT the
the JJ immediate
immediate NN effectiveness
effectiveness IN of
of NN electrotherapy
electrotherapy IN on
on JJ myofascial
myofascial NN trigger
trigger NNS points
points IN of
of JJ upper
upper NN trapezius
trapezius NN muscle

Sixty CD CAPITAL Sixty
Sixty NNS patients
patients NN (
( CD 25
25 NNS males
males CC and
and CD 35
35 NNS females
females NN )
) WP who
who VBD had
had JJ myofascial
myofascial NN trigger
trigger NNS points
points IN in
in CD one
one NN side
side IN of
of DT the
the JJ upper
upper NN trapezius
trapezius NNS muscles
muscles VBD were
were VBN studied

The DT CAPITAL The
The VBN involved
involved JJ upper
upper NN trapezius
trapezius NNS muscles
muscles VBD were
were VBN treated
treated IN with
with CD three
three JJ different
different NNS methods
methods VBG according
according TO to
to DT a
a JJ random
random NN assignment
assignment : :
: NN group
group DT CAPITAL A
A NNS muscles
muscles NN (
( NN n
n JJ =
= CD 18
18 NN )
) VBD were
were VBN given
given NN placebo
placebo NN treatment
treatment NN (
( NN control
control NN group
group NN )
) : ;
; NN group
group NN CAPITAL B
B NNS muscles
muscles NN (
( NN n
n JJ =
= CD 20
20 NN )
) VBD were
were VBN treated
treated IN with
with JJ electrical
electrical NN nerve
nerve NN stimulation
stimulation NN (
( NN CAPITAL ENS
ENS NN )
) NN therapy
therapy : ;
; CC and
and NN group
group NN CAPITAL C
C NNS muscles
muscles NN (
( NN n
n JJ =
= CD 22
22 NN )
) VBD were
were VBN given
given JJ electrical
electrical NN muscle
muscle NN stimulation
stimulation NN (
( NNP CAPITAL EMS
EMS NN )
) NN therapy

The DT CAPITAL The
The NN effectiveness
effectiveness IN of
of NN treatment
treatment VBD was
was VBN assessed
assessed IN by
by VBG conducting
conducting CD three
three NNS measurements
measurements IN on
on DT each
each NN muscle
muscle IN before
before CC and
and RB immediately
immediately IN after
after NN treatment
treatment : :
: JJ subjective
subjective NN pain
pain NN intensity
intensity NN (
( NN (
( NN CAPITAL PI
PI NN )
) IN with
with DT a
a JJ visual
visual NN analog
analog NN scale
scale NN )
) , ,
, NN pressure
pressure NN pain
pain NN threshold
threshold NN (
( NN (
( NN CAPITAL PT
PT NN )
) IN with
with NN algometry
algometry NN )
) , ,
, CC and
and NN range
range IN of
of NN motion
motion NN (
( NN (
( NN CAPITAL ROM
ROM NN )
) IN with
with DT a
a NN goniometer
goniometer NN )
) IN of
of JJ upper
upper NN trapezius
trapezius NN muscle
muscle NN (
( JJ lateral
lateral VBG bending
bending IN of
of JJ cervical
cervical NN spine
spine TO to
to DT the
the JJ opposite
opposite NN side
side NN )

When WRB CAPITAL When
When DT the
the NN effectiveness
effectiveness IN of
of NN treatment
treatment VBD was
was VBN compared
compared IN with
with IN that
that IN of
of DT the
the NN placebo
placebo NN group
group NN (
( NN group
group DT CAPITAL A
A NN )
) , ,
, RB there
there VBD was
was JJ significant
significant NN improvement
improvement IN in
in NN CAPITAL PI
PI CC and
and NN CAPITAL PT
PT IN in
in NN group
group NN CAPITAL B
B NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.01
0.01 NN )
) CC but
but RB not
not IN in
in NN group
group NN CAPITAL C
C NN (
( NN CAPITAL P
P JJR >
> CD 0.05
0.05 NN )

The DT CAPITAL The
The NN improvement
improvement IN of
of NN CAPITAL ROM
ROM VBD was
was RB significantly
significantly RBR more
more IN in
in NN group
group NN CAPITAL C
C NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.01
0.01 NN )
) IN as
as VBN compared
compared IN with
with IN that
that IN in
in NN group
group DT CAPITAL A
A CC or
or NN group
group NN CAPITAL B

When WRB CAPITAL When
When DT each
each NN group
group VBD was
was VBN divided
divided IN into
into CD two
two JJ additional
additional NNS subgroups
subgroups VBN based
based IN on
on DT the
the JJ initial
initial NN CAPITAL PI
PI , ,
, PRP it
it VBD was
was VBN found
found IN that
that NN CAPITAL ENS
ENS MD could
could VB reduce
reduce NN CAPITAL PI
PI CC and
and NN increase
increase NN CAPITAL PT
PT RB significantly
significantly NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) , ,
, CC but
but VBD did
did RB not
not RB significantly
significantly NN (
( NN CAPITAL P
P JJR >
> CD 0.05
0.05 NN )
) VB improve
improve NN CAPITAL ROM
ROM , ,
, IN as
as VBN compared
compared IN with
with DT the
the NN placebo
placebo NN group
group IN for
for DT both
both NNS subgroups

EMS NNP CAPITAL EMS
EMS MD could
could RB significantly
significantly NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) VB improve
improve NN CAPITAL ROM
ROM , ,
, CC but
but RB not
not NN CAPITAL PT
PT , ,
, RB better
better IN than
than DT the
the NN placebo
placebo NNS groups
groups , ,
, IN for
for DT either
either NN subgroup

It PRP CAPITAL It
It MD could
could VB reduce
reduce NN CAPITAL PI
PI RB significantly
significantly RBR more
more NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) IN than
than NN placebo
placebo NNS controls
controls RB only
only IN for
for DT the
the NN subgroup
subgroup IN with
with JJ mild
mild TO to
to JJ moderate
moderate NN pain
pain , ,
, CC but
but RB not
not IN with
with JJ severe
severe NN pain

For IN CAPITAL For
For NN pain
pain NN relief
relief , ,
, NN CAPITAL ENS
ENS VBD was
was RB significantly
significantly RB better
better NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) IN than
than NNP CAPITAL EMS
EMS : ;
; CC but
but IN for
for DT the
the NN improvement
improvement IN of
of NN CAPITAL ROM
ROM , ,
, NNP CAPITAL EMS
EMS VBD was
was RB significantly
significantly RB better
better NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) IN than
than NN CAPITAL ENS

It PRP CAPITAL It
It VBZ is
is VBD concluded
concluded IN that
that NN CAPITAL ENS
ENS VBZ is
is RBR more
more JJ effective
effective IN for
for JJ immediate
immediate NN relief
relief IN of
of JJ myofascial
myofascial NN trigger
trigger NN point
point NN pain
pain IN than
than NNP CAPITAL EMS
EMS , ,
, CC and
and NNP CAPITAL EMS
EMS VBZ has
has DT a
a RB better
better NN effect
effect IN on
on JJ immediate
immediate NN release
release IN of
of NN muscle
muscle NN tightness
tightness IN than
than NN CAPITAL ENS

Because IN CAPITAL Because
Because NN activity
activity CC and
and JJ regular
regular NN exercise
exercise VBP are
are JJ important
important NNS factors
factors TO to
to VB maintain
maintain JJ general
general JJ good
good NN health
health IN in
in JJ senior
senior NNS citizens
citizens , ,
, PRP we
we VBN investigated
investigated IN whether
whether JJ senior
senior NN dancing
dancing VBZ has
has DT any
any NN effect
effect IN on
on JJ peripheral
peripheral CC or
or NN lumbar
lumbar NN bone
bone NN density

We PRP CAPITAL We
We VBN performed
performed DT a
a JJ prospective
prospective NN study
study IN over
over NN a12-mo
a12-mo NN period
period IN on
on NN bone
bone NN density
density IN at
at DT a
a JJ spinal
spinal CC and
and JJ peripheral
peripheral VBG measuring
measuring NN site
site IN in
in CD 28
28 NN female
female JJ senior
senior NNS members
members NN (
( VB mean
mean NN age
age : :
: CD 67
67 CC +/-
+/- CD 2
2 NN yr
yr NN )
) IN of
of DT a
a NN dancing
dancing NN group
group IN in
in NNP CAPITAL Vienna

Lumbar NNP CAPITAL Lumbar
Lumbar NN bone
bone NN mineral
mineral NN density
density VBD was
was VBN assessed
assessed IN by
by JJ quantitative
quantitative VBN computed
computed NN tomography
tomography NN (
( NN qCT
qCT NN )
) CC and
and JJ radial
radial NN bone
bone NN density
density IN by
by JJ single
single NN photon
photon NN absorptiometry
absorptiometry IN of
of DT the
the JJ distal
distal NN forearm

The DT CAPITAL The
The VB mean
mean NN training
training NN time
time IN per
per NN week
week VBD was
was CD 3.2
3.2 CC +/-
+/- CD 0.8
0.8 NN h.
h. IN CAPITAL In
In DT the
the JJ entire
entire NN group
group IN of
of NN female
female NNS dancers
dancers , ,
, DT no
no JJ significant
significant NNS effects
effects IN of
of NN dancing
dancing IN on
on JJ radial
radial CC or
or NN lumbar
lumbar NN bone
bone NN density
density MD could
could VB be
be VBN observed

Linear JJ CAPITAL Linear
Linear NN regression
regression NN analysis
analysis VBD showed
showed IN that
that DT the
the JJR lower
lower DT the
the NN qCT
qCT IN at
at DT the
the VBG beginning
beginning IN of
of DT the
the NN observation
observation NN period
period , ,
, DT the
the JJR higher
higher VBD was
was DT the
the NN percentage
percentage NN increase
increase IN of
of JJ spinal
spinal NN qCT
qCT IN in
in DT the
the JJ entire
entire NN group
group IN during
during CD 12
12 NN mo
mo IN of
of NN dancing
dancing NN (
( NN r
r JJ =
= CD 0.52
0.52 , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.0001
0.0001 NN )

For IN CAPITAL For
For JJ additional
additional NN evaluation
evaluation , ,
, NNS females
females VBD were
were VBN divided
divided IN into
into CD two
two NNS subgroups
subgroups , ,
, JJ osteoporotic
osteoporotic CC or
or JJ nonosteoporotic
nonosteoporotic , ,
, VBN based
based IN on
on NNPS x-rays
x-rays CC and
and NN lumbar
lumbar NN bone
bone NN mineral
mineral NN density
density NN (
( NN CAPITAL BMD
BMD NN )
) IN as
as VBN measured
measured IN by
by NN qCT

The DT CAPITAL The
The NN group
group VBN classified
classified IN as
as NNS dancers
dancers IN with
with NN osteoporosis
osteoporosis NN (
( NN group
group PRP CAPITAL I
I NN )
) VBD showed
showed DT a
a JJ significant
significant NN increase
increase IN in
in NN lumbar
lumbar NN bone
bone NN density
density , ,
, IN whereas
whereas IN in
in DT the
the NN group
group IN of
of NNS dancers
dancers IN without
without NNS signs
signs IN of
of NN osteoporosis
osteoporosis NN (
( NN group
group NNP CAPITAL II
II NN )
) , ,
, NN CAPITAL BMD
BMD VBD remained
remained JJ unchanged

Additionally RB CAPITAL Additionally
Additionally , ,
, JJ radial
radial NN bone
bone NN density
density VBD did
did RB not
not NN show
show DT any
any NNS changes
changes IN in
in DT either
either NN group

Group NNP CAPITAL Group
Group PRP CAPITAL I
I VBD showed
showed DT a
a JJ significant
significant NN correlation
correlation IN between
between JJ basal
basal JJ spinal
spinal NN CAPITAL BMD
BMD CC and
and DT the
the NN percentage
percentage NN change
change IN of
of NN CAPITAL BMD
BMD IN during
during DT the
the NN observation
observation NN period
period NN (
( NN r
r JJ =
= CD 0.7
0.7 , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.001
0.001 NN )

Changes NNS CAPITAL Changes
Changes IN of
of DT the
the JJ biochemical
biochemical NNS parameters
parameters VBD were
were VBN observed
observed IN in
in DT the
the JJ bone-specific
bone-specific NN isoenzyme
isoenzyme IN of
of NN alkaline
alkaline NN phosphatase
phosphatase , ,
, DT a
a NN marker
marker IN of
of JJ osteoblastic
osteoblastic NN activity
activity , ,
, IN in
in NN group
group PRP CAPITAL I
I VBG giving
giving JJ additional
additional NN evidence
evidence IN of
of VBN increased
increased NN bone
bone NN formation

OBJECTIVES NNS CAPITAL OBJECTIVES
OBJECTIVES : :
: TO CAPITAL To
To NN estimate
estimate DT the
the NN prevalence
prevalence IN of
of NN CAPITAL Chlamydia
Chlamydia NN trachomatis
trachomatis IN in
in JJ asymptomatic
asymptomatic NNS women
women VBG attending
attending JJ general
general NN practice
practice : :
: TO to
to VB assess
assess DT the
the NN potential
potential IN of
of DT the
the NN ligase
ligase NN chain
chain NN reaction
reaction IN as
as DT a
a NN screening
screening NN tool
tool : ;
; CC and
and TO to
to VB evaluate
evaluate JJ selective
selective NN screening
screening NNS criteria

DESIGN NN CAPITAL DESIGN
DESIGN : :
: NN CAPITAL Cross
Cross JJ sectional
sectional NN survey

SETTING VBG CAPITAL SETTING
SETTING : :
: CD CAPITAL Four
Four JJ general
general NNS practices
practices IN in
in RB northeast
northeast NNP CAPITAL London

SUBJECTS NNS CAPITAL SUBJECTS
SUBJECTS : :
: CD 890
890 NNS women
women JJ aged
aged CD 18-35
18-35 NNS years
years VBG attending
attending JJ general
general NN practice
practice IN for
for DT a
a JJ cervical
cervical NN smear
smear CC or
or DT a
a `` ``
`` JJ young
young RB well
well NN woman
woman '' ''
'' NN check
check IN between
between NNP CAPITAL October
October CD 1994
1994 CC and
and NNP CAPITAL January
January CD 1996

The DT CAPITAL The
The NNS women
women VBD were
were VBN tested
tested IN for
for NN CAPITAL C
C NN trachomatis
trachomatis IN with
with VBN confirmed
confirmed NN enzyme
enzyme NN immunoassay
immunoassay NN (
( JJ endocervical
endocervical NNS specimens
specimens NN )
) CC and
and NN ligase
ligase NN chain
chain NN reaction
reaction NN assay
assay IN on
on NN urine
urine NNS specimens

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: NN CAPITAL Prevalence
Prevalence IN of
of NN CAPITAL C
C NN trachomatis
trachomatis NN infection
infection IN in
in NNS women
women JJ aged
aged CD 18-35
18-35 IN on
on DT the
the NN basis
basis IN of
of DT each
each NN test
test : ;
; NN sensitivity
sensitivity CC and
and NN specificity
specificity IN of
of DT both
both NNS tests
tests IN in
in DT this
this NN population

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NN CAPITAL Prevalence
Prevalence IN of
of VBN confirmed
confirmed NN infection
infection VBD was
was CD 2.6
2.6 NN %
% NN (
( CD 95
95 NN %
% NN confidence
confidence NN interval
interval CD 1.6
1.6 NN %
% TO to
to CD 3.6
3.6 NN %
% NN )
) IN in
in DT all
all NNS women

Prevalence NN CAPITAL Prevalence
Prevalence IN on
on DT the
the NN basis
basis IN of
of NN enzyme
enzyme NN immunoassay
immunoassay VBD was
was CD 1.6
1.6 NN %
% NN (
( CD 0.8
0.8 NN %
% TO to
to CD 2.7
2.7 NN %
% NN )
) , ,
, IN with
with DT a
a NN sensitivity
sensitivity IN of
of CD 60
60 NN %
% CC and
and DT a
a NN specificity
specificity IN of
of CD 100
100 NN %

Prevalence NN CAPITAL Prevalence
Prevalence IN on
on DT the
the NN basis
basis IN of
of NN ligase
ligase NN chain
chain NN reaction
reaction VBD was
was CD 2.5
2.5 NN %
% NN (
( CD 1.5
1.5 NN %
% TO to
to CD 3.9
3.9 NN %
% NN )
) , ,
, IN with
with CD 90
90 NN %
% NN sensitivity
sensitivity CC and
and CD 99.8
99.8 NN %
% NN specificity

Screening VBG CAPITAL Screening
Screening DT all
all NNS women
women JJ aged
aged CC &
& # #
# CD 60
60 : ;
; CC or
or JJ =
= CD 25
25 CC and
and DT all
all NNS women
women WP who
who VBD had
had VBD had
had CD two
two CC or
or RBR more
more NNS partners
partners IN in
in DT the
the IN past
past NN year
year MD would
would VB have
have VBN detected
detected CD 87
87 NN %
% NN (
( CD 20/23
20/23 NN )
) IN of
of NNS infections

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: NN CAPITAL Ligase
Ligase NN chain
chain NN reaction
reaction IN on
on NN urine
urine NNS samples
samples VBZ performs
performs IN at
at JJS least
least IN as
as RB well
well IN as
as NN enzyme
enzyme NN immunoassay
immunoassay IN on
on JJ cervical
cervical NNS specimens
specimens IN in
in DT this
this JJ low
low NN prevalence
prevalence NN population

It PRP CAPITAL It
It NNS offers
offers NN potential
potential IN as
as DT a
a JJ non-invasive
non-invasive NN screening
screening NN tool

A DT CAPITAL A
A JJ simple
simple JJ selective
selective NN screening
screening NN strategy
strategy MD might
might VB be
be JJ appropriate
appropriate CC and
and MD would
would VB be
be JJ able
able TO to
to VB detect
detect RBS most
most NNS cases
cases IN of
of NN infection

However RB CAPITAL However
However , ,
, DT a
a JJ rigorous
rigorous JJ economic
economic NN evaluation
evaluation IN of
of JJ possible
possible NN screening
screening NNS strategies
strategies VBZ is
is VBN needed
needed RB first

Recently RB CAPITAL Recently
Recently , ,
, JJ many
many NNS advances
advances VB have
have VBN been
been VBN made
made IN in
in DT the
the NN study
study IN of
of JJ sexual
sexual NN differentiation
differentiation , ,
, VBG including
including DT the
the NNS discoveries
discoveries IN of
of DT the
the NN gene
gene IN for
for antim1/4llerian
antim1/4llerian NN hormone
hormone IN as
as RB well
well IN as
as DT the
the NN gene
gene IN for
for PRP$ its
its NN receptor

However RB CAPITAL However
However , ,
, DT the
the NN etiology
etiology IN of
of DT the
the JJ clinical
clinical NN syndrome
syndrome IN of
of m1/4llerian
m1/4llerian NN agenesis
agenesis NNS remains
remains JJ elusive

We PRP CAPITAL We
We VB hypothesize
hypothesize IN that
that VBG activating
activating NNS mutations
mutations IN of
of DT either
either DT the
the antim1/4llerian
antim1/4llerian NN hormone
hormone NN gene
gene CC or
or PRP$ its
its NN receptor
receptor NN gene
gene MD may
may NN cause
cause m1/4llerian
m1/4llerian NN duct
duct NN regression
regression IN in
in DT a
a JJ genetic
genetic NN female
female IN during
during NN embryogenesis

This DT CAPITAL This
This JJ clinical
clinical NN commentary
commentary VBZ discusses
discusses DT the
the JJ current
current NN management
management IN of
of DT the
the NN syndrome
syndrome VBG including
including DT the
the NNP CAPITAL Abbe-McIndoe
Abbe-McIndoe NN procedure
procedure , ,
, DT the
the RBS most
most RB commonly
commonly VBN used
used NN method
method IN of
of JJ surgical
surgical NN correction
correction , ,
, CC and
and DT the
the NNP CAPITAL Frank
Frank JJ vaginal
vaginal NN dilation
dilation NN method
method , ,
, DT the
the RBS most
most JJ common
common JJ nonsurgical
nonsurgical NN method
method IN of
of NN correction

OBJECTIVES NNS CAPITAL OBJECTIVES
OBJECTIVES : :
: NN CAPITAL Obesity
Obesity VBZ is
is DT an
an JJ important
important JJ clinical
clinical NN problem
problem , ,
, CC and
and DT the
the NN use
use IN of
of NN dexfenfluramine
dexfenfluramine NN hydrochloride
hydrochloride IN for
for NN weight
weight NN reduction
reduction VBZ has
has VBN been
been RB widely
widely VBN publicized
publicized IN since
since PRP$ its
its NN approval
approval IN by
by DT the
the NNP CAPITAL Food
Food CC and
and NN CAPITAL Drug
Drug NN CAPITAL Administration

However RB CAPITAL However
However , ,
, NN animal
animal CC and
and JJ human
human NNS studies
studies VB have
have VBN demonstrated
demonstrated JJ toxic
toxic NNS effects
effects IN of
of NNS fenfluramines
fenfluramines IN that
that NNS clinicians
clinicians MD should
should VB be
be JJ aware
aware IN of
of WRB when
when VBG considering
considering VBG prescribing
prescribing DT the
the NNS drugs

Our PRP$ CAPITAL Our
Our NN purpose
purpose VBD was
was TO to
to RB systematically
systematically NN review
review NNS data
data IN on
on NN brain
brain NN serotonin
serotonin NN neurotoxicity
neurotoxicity IN in
in NNS animals
animals VBN treated
treated IN with
with NNS fenfluramines
fenfluramines CC and
and DT the
the NN evidence
evidence VBG linking
linking NNS fenfluramines
fenfluramines TO to
to JJ primary
primary JJ pulmonary
pulmonary NN hypertension
hypertension NN (
( NN CAPITAL PPH
PPH NN )

DATA NNP CAPITAL DATA
DATA NNS CAPITAL SOURCES
SOURCES : :
: JJ CAPITAL Archival
Archival NNS articles
articles CC and
and NNS reviews
reviews VBN identified
identified IN through
through DT a
a NN computerized
computerized NN search
search IN of
of NN CAPITAL MEDLINE
MEDLINE IN from
from CD 1966
1966 TO to
to NNP CAPITAL April
April CD 1997
1997 VBG using
using `` ``
`` NN fenfluramine
fenfluramine NN (
( NNS s
s NN )
) , ,
, '' ''
'' `` ``
`` NN serotonin
serotonin , ,
, '' ''
'' `` ``
`` NN neurotoxicity
neurotoxicity , ,
, '' ''
'' `` ``
`` NN behavior
behavior , ,
, '' ''
'' `` ``
`` NNS anorexigens
anorexigens , ,
, '' ''
'' `` ``
`` NN weight
weight NN loss
loss , ,
, '' ''
'' CC and
and `` ``
`` JJ primary
primary JJ pulmonary
pulmonary NN hypertension
hypertension '' ''
'' IN as
as NN index
index NNS terms

STUDY NN CAPITAL STUDY
STUDY NN CAPITAL SELECTION
SELECTION : :
: NNS CAPITAL Reports
Reports VBG dealing
dealing IN with
with JJ long-term
long-term NNS effects
effects IN of
of NNS fenfluramines
fenfluramines IN on
on NN brain
brain NN serotonin
serotonin NNS neurons
neurons , ,
, NN body
body NN weight
weight , ,
, CC and
and JJ pulmonary
pulmonary NN function
function IN in
in NNS animals
animals CC and
and NNS humans

DATA NNP CAPITAL DATA
DATA NN CAPITAL EXTRACTION
EXTRACTION : :
: NNS CAPITAL Reports
Reports VBD were
were VBN reviewed
reviewed IN by
by NNS individuals
individuals IN with
with NN expertise
expertise IN in
in NN serotonin
serotonin NN neurobiology
neurobiology , ,
, NN neurotoxicity
neurotoxicity , ,
, NN neuropsychiatry
neuropsychiatry , ,
, CC and
and JJ pulmonary
pulmonary NN medicine
medicine CC and
and VBN evaluated
evaluated IN for
for NN appropriateness
appropriateness IN for
for NN inclusion
inclusion IN in
in DT this
this NN review

DATA NNP CAPITAL DATA
DATA NN CAPITAL SYNTHESIS
SYNTHESIS : :
: NNS CAPITAL Fenfluramines
Fenfluramines NN cause
cause JJ dose-related
dose-related , ,
, JJ long-lasting
long-lasting NNS reductions
reductions IN in
in NN serotonin
serotonin IN axonal
axonal NNS markers
markers IN in
in DT all
all DT the
the NN animal
animal NNS species
species VBN tested
tested CC and
and IN with
with DT all
all DT the
the NNS routes
routes IN of
of NN drug
drug NN administration
administration VBN used

Doses NNS CAPITAL Doses
Doses IN of
of NNS fenfluramines
fenfluramines IN that
that VB produce
produce NNS signs
signs IN of
of NN brain
brain NN serotonin
serotonin NN neurotoxicity
neurotoxicity IN in
in NNS animals
animals VBP are
are IN on
on DT the
the JJ same
same NN order
order IN as
as DT those
those VBN used
used TO to
to NN treat
treat NNS humans
humans IN for
for NN weight
weight NN loss
loss WRB when
when CD one
one VBZ takes
takes IN into
into NN account
account VBN known
known NNS relations
relations IN between
between NN body
body NN mass
mass CC and
and NN drug
drug NN clearance

However RB CAPITAL However
However , ,
, DT no
no JJ human
human NNS studies
studies VB have
have VBN been
been VBN conducted
conducted , ,
, CC and
and DT the
the JJ pathological
pathological CC and
and JJ clinical
clinical NN potential
potential IN for
for NN neurotoxicity
neurotoxicity IN in
in NNS humans
humans VBZ is
is JJ unknown

Appetite NN CAPITAL Appetite
Appetite JJ suppressants-most
suppressants-most RB commonly
commonly NNS fenfluramines
fenfluramines NN -increase
-increase DT the
the NN risk
risk IN of
of VBG developing
developing NN CAPITAL PPH
PPH NN (
( NNS odds
odds NN ratio
ratio , ,
, CD 6.3
6.3 NN )
) , ,
, RB particularly
particularly WRB when
when VBN used
used IN for
for RBR more
more IN than
than CD 3
3 NNS months
months NN (
( NNS odds
odds NN ratio
ratio , ,
, JJR >
> CD 20
20 NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NN CAPITAL Fenfluramine
Fenfluramine CC and
and NN dexfenfluramine
dexfenfluramine VB have
have VBN been
been VBN demonstrated
demonstrated TO to
to NN damage
damage NN brain
brain NN serotonin
serotonin NNS neurons
neurons IN in
in NN animal
animal NNS studies

It PRP CAPITAL It
It VBZ is
is RB not
not VBN known
known IN if
if JJ such
such NN damage
damage VBZ occurs
occurs IN in
in NNS humans
humans CC or
or IN if
if RB there
there VBP are
are JJ clinical
clinical NNS consequences

Use NN CAPITAL Use
Use IN of
of NNS fenfluramines
fenfluramines VBZ is
is VBN associated
associated IN with
with DT an
an VBN increased
increased NN risk
risk IN of
of NN CAPITAL PPH

Future JJ CAPITAL Future
Future NNS studies
studies MD should
should NN address
address DT the
the JJ long-term
long-term NNS consequences
consequences IN of
of JJ prolonged
prolonged NN use
use IN of
of NNS fenfluramines

Moxonidine NN CAPITAL Moxonidine
Moxonidine NN (
( NNP CAPITAL Physiotens-Solvay
Physiotens-Solvay NN )
) VBD was
was VBN introduced
introduced JJ last
last NN year
year IN as
as DT the
the RB first
first IN of
of DT a
a JJ new
new NN class
class IN of
of JJ centrally-acting
centrally-acting JJ antihypertensive
antihypertensive NNS agents
agents , ,
, DT the
the JJ selective
selective NN imidazoline
imidazoline NN receptor
receptor NNS agonists

The DT CAPITAL The
The NN manufacturer
manufacturer NNS claims
claims IN that
that NN moxonidine
moxonidine `` ``
`` RB accurately
accurately NNS targets
targets NN imidazoline
imidazoline NNS receptors
receptors IN at
at DT the
the JJ cardiovascular
cardiovascular NN control
control NN centre
centre IN in
in DT the
the NN brainstem
brainstem '' ''
'' CC and
and VBZ is
is `` ``
`` IN as
as JJ effective
effective IN as
as JJ current
current NN first-line
first-line NNS therapies
therapies IN for
for JJ essential
essential NN hypertension
hypertension `` ``

Other JJ CAPITAL Other
Other NNS claims
claims VB suggest
suggest IN that
that PRP it
it NNS causes
causes JJR fewer
fewer JJ unwanted
unwanted NNS effects
effects IN than
than JJR older
older JJ centrally-acting
centrally-acting JJ antihypertensive
antihypertensive NNS drugs
drugs JJ such
such IN as
as NN clonidine
clonidine CC and
and NN methyldopa

Is VBZ CAPITAL Is
Is NN moxonidine
moxonidine DT a
a JJ useful
useful NN addition
addition TO to
to DT the
the VBG growing
growing NN number
number IN of
of NNS antihypertensives
antihypertensives IN on
on DT the
the NN market
market . ?

This DT CAPITAL This
This NN article
article VBZ discusses
discusses JJ dental
dental NN anxiety
anxiety CC and
and NN phobia

The DT CAPITAL The
The NN author
author NNS presents
presents NN background
background NN information
information , ,
, VBG including
including NN incidence
incidence CC and
and NN etiology

A DT CAPITAL A
A NN discussion
discussion IN of
of JJ evaluative
evaluative NNS techniques
techniques IN for
for VBG assessing
assessing NN anxiety
anxiety NNS levels
levels VBZ follows

Examination NN CAPITAL Examination
Examination CC and
and NN treatment
treatment VBG planning
planning VBP are
are VBN considered
considered IN in
in NN relation
relation TO to
to DT this
this NN patient
patient POS 's
's JJ special
special NNS needs

The DT CAPITAL The
The NN article
article NNS stresses
stresses JJ behavioral
behavioral NN treatment
treatment NNS modalities
modalities IN that
that VB eliminate
eliminate DT the
the VBG debilitating
debilitating NN phobia

In IN CAPITAL In
In VBG closing
closing , ,
, DT the
the NN author
author NNS presents
presents JJ practical
practical NN information
information VBG regarding
regarding NN prevention
prevention IN of
of JJ dental
dental NN phobia
phobia CC and
and DT the
the NNS merits
merits IN of
of VBG incorporating
incorporating DT this
this NN type
type IN of
of NN patient
patient IN into
into DT a
a JJ dental
dental NN practice

In IN CAPITAL In
In NN order
order TO to
to VB evaluate
evaluate DT the
the NN applicability
applicability IN of
of JJ anthelminthic
anthelminthic NN treatment
treatment IN of
of JJ wild
wild NNS foxes
foxes NN (
( NNP CAPITAL Vulpes
Vulpes NNS vulpes
vulpes NN )
) TO to
to NN limit
limit PRP$ their
their NN infection
infection IN with
with NN CAPITAL Echinococcus
Echinococcus NNS multilocularis
multilocularis , ,
, NN bait
bait NNS pellets
pellets , ,
, DT each
each VBG containing
containing CD 50
50 NN mg
mg NN praziquantel
praziquantel , ,
, VBD were
were RB repeatedly
repeatedly VBN distributed
distributed IN in
in DT an
an NN area
area IN of
of CD 566
566 NN km2
km2 WRB where
where JJ many
many NNS foxes
foxes VBP are
are JJ infected
infected , ,
, IN in
in JJ southern
southern NNP CAPITAL Germany

After IN CAPITAL After
After CD six
six VBG baiting
baiting NNS campaigns
campaigns NN (
( CD 15-20
15-20 NN baits/km2
baits/km2 NN )
) IN over
over DT a
a NN period
period IN of
of CD 14
14 NNS months
months , ,
, DT the
the NN prevalence
prevalence IN of
of DT the
the NN cestode
cestode IN in
in NNS foxes
foxes , ,
, RB initially
initially CD 32
32 NN %
% , ,
, VBD had
had VBN fallen
fallen TO to
to CD 4
4 NN %

The DT CAPITAL The
The NN effect
effect VBD was
was RBS most
most JJ pronounced
pronounced IN in
in DT the
the JJ central
central NN part
part IN of
of DT the
the VBN treated
treated NN area
area , ,
, WRB where
where DT no
no JJ positive
positive NN fox
fox VBD was
was VBN found
found IN in
in DT the
the CD 2
2 NNS months
months IN before
before DT the
the NN end
end IN of
of DT the
the NN trial

The DT CAPITAL The
The NN study
study VBD was
was VBN controlled
controlled IN for
for JJ other
other NNS factors
factors IN that
that MD could
could NN influence
influence DT the
the NN parasite
parasite POS 's
's NN prevalence
prevalence , ,
, JJ such
such IN as
as DT the
the NN availability
availability IN of
of JJ intermediate
intermediate NNS hosts

While IN CAPITAL While
While DT the
the NN potential
potential IN of
of DT this
this VBG baiting
baiting NN method
method TO to
to VB remove
remove NN CAPITAL E

multilocularis NNS multilocularis
multilocularis IN from
from JJ wild
wild NNS hosts
hosts VBZ has
has VBN been
been VBN demonstrated
demonstrated , ,
, DT the
the NN question
question IN of
of PRP$ its
its JJ long-term
long-term NN efficacy
efficacy CC and
and JJ other
other JJ unresolved
unresolved NNS problems
problems VB have
have TO to
to VB be
be VBD addressed
addressed IN by
by JJ consecutive
consecutive NNS studies
studies IN before
before JJ routine
routine NN application
application MD can
can VB be
be VBN recommended

In IN CAPITAL In
In NNS patients
patients IN with
with JJ chronic
chronic JJ myeloid
myeloid NN leukemia
leukemia NN (
( NN CAPITAL CML
CML NN )
) , ,
, DT the
the JJ neoplastic
neoplastic NN (
( JJ CAPITAL BCR-ABL+
BCR-ABL+ NN )
) NN progenitor
progenitor NNS cells
cells VBP are
are VBN characterized
characterized IN by
by DT an
an VBN increased
increased JJ proliferative
proliferative NN activity

Whether IN CAPITAL Whether
Whether DT these
these NNS cells
cells VBP are
are RB also
also JJ resistant
resistant TO to
to NN apoptosis
apoptosis CC and
and IN if
if RB so
so , ,
, IN under
under WDT what
what NNS conditions
conditions NNS remains
remains JJ controversial

We PRP CAPITAL We
We RB now
now NN show
show IN that
that RB highly
highly VBN purified
purified NNS populations
populations IN of
of RB very
very JJ primitive
primitive JJ neoplastic
neoplastic NN progenitor
progenitor NNS cells
cells VBN obtained
obtained RB directly
directly IN from
from NN CAPITAL CML
CML NNS patients
patients VB survive
survive CC and
and VB proliferate
proliferate IN in
in NN vitro
vitro IN for
for JJ several
several NNS weeks
weeks IN in
in DT the
the NN absence
absence IN of
of DT any
any VBN added
added NN growth
growth NNS factors
factors NN (
( IN except
except NN insulin
insulin NN )

In IN CAPITAL In
In NN contrast
contrast , ,
, VBN purified
purified JJ primary
primary JJ normal
normal NNS progenitors
progenitors VBN maintained
maintained IN under
under DT the
the JJ same
same NNS conditions
conditions VB die
die RB rapidly

Nevertheless RB CAPITAL Nevertheless
Nevertheless , ,
, DT both
both JJ primary
primary NN CAPITAL CML
CML NNS cells
cells CC and
and JJ CAPITAL BCR-ABL+
BCR-ABL+ NN CAPITAL BAF3
BAF3 NNS cells
cells NN show
show DT the
the JJ same
same JJ dose-dependent
dose-dependent NN sensitivity
sensitivity TO to
to NN CAPITAL TNF-alpha
TNF-alpha CC or
or JJ ceramide-induced
ceramide-induced NN apoptosis
apoptosis IN as
as PRP$ their
their JJ respective
respective JJ normal
normal NNS counterparts

In IN CAPITAL In
In NN fact
fact , ,
, NN time
time NN course
course NNS studies
studies VBN demonstrated
demonstrated DT an
an RB even
even RBR faster
faster NN onset
onset IN of
of NN apoptosis
apoptosis IN in
in JJ ceramide-treated
ceramide-treated JJ CAPITAL BCR-ABL+
BCR-ABL+ NN CAPITAL BAF3
BAF3 NNS cells
cells IN as
as VBN compared
compared TO to
to JJ normal
normal NNS controls

BCR-ABL+ JJ CAPITAL BCR-ABL+
BCR-ABL+ NNS cells
cells VBN treated
treated IN with
with NN ceramide
ceramide RB also
also VBD showed
showed DT a
a JJ rapid
rapid CC and
and JJ sequential
sequential NN increase
increase IN in
in DT the
the NN tyrosine
tyrosine NN phosphorylation
phosphorylation IN of
of NN p210
p210 NN (
( NN CAPITAL BCR-ABL
BCR-ABL NN )
) , ,
, NN p46-56SHC
p46-56SHC CC and
and NN p120Cbl

These DT CAPITAL These
These NNS findings
findings VB suggest
suggest NN growth
growth NN factor
factor NN deprivation
deprivation CC and
and NN treatment
treatment IN with
with NN CAPITAL TNF-alpha
TNF-alpha CC or
or NN ceramide
ceramide NN trigger
trigger JJ different
different JJ initial
initial NNS events
events DT both
both IN of
of WDT which
which MD can
can NN lead
lead TO to
to NN apoptosis
apoptosis IN in
in JJ factor-dependent
factor-dependent JJ hematopoietic
hematopoietic NNS cells

However RB CAPITAL However
However , ,
, IN in
in DT the
the RB first
first NN case
case , ,
, NN activation
activation IN of
of NN apoptosis
apoptosis VBZ is
is VBN blocked
blocked IN by
by DT the
the JJ basal
basal NN activity
activity IN of
of NN p210
p210 NN (
( NN CAPITAL BCR-ABL
BCR-ABL NN )
) , ,
, IN whereas
whereas IN in
in DT the
the JJ second
second , ,
, DT the
the NN presence
presence IN of
of NN p210
p210 NN (
( NN CAPITAL BCR-ABL
BCR-ABL NN )
) VBZ appears
appears TO to
to VB accelerate
accelerate DT the
the NN onset
onset IN of
of NN apoptosis
apoptosis IN by
by DT a
a NN mechanism
mechanism IN that
that MD may
may VB involve
involve DT an
an NN activation
activation IN of
of PRP$ its
its NN kinase
kinase NN function

Clinically RB CAPITAL Clinically
Clinically , ,
, DT the
the NN hallmark
hallmark IN of
of DT the
the JJ human
human JJ amnesic
amnesic NN syndrome
syndrome VBZ is
is DT an
an JJ impaired
impaired NN ability
ability TO to
to RB consciously
consciously NN recollect
recollect CC or
or VB remember
remember RB daily
daily NNS events

If IN CAPITAL If
If DT the
the JJ medial
medial NN region
region IN of
of DT the
the JJ temporal
temporal NNS lobes
lobes , ,
, VBG including
including DT the
the NN hippocampus
hippocampus CC and
and JJ related
related NNS structures
structures , ,
, VBZ is
is JJ critical
critical IN for
for VBG establishing
establishing DT these
these JJ new
new NNS memories
memories , ,
, RB then
then DT this
this NN brain
brain NN region
region MD should
should VB be
be JJ active
active WRB whenever
whenever NNS events
events VBP are
are JJ experienced
experienced , ,
, RB regardless
regardless IN of
of IN whether
whether NNS subjects
subjects VBP are
are VBD asked
asked RB explicitly
explicitly TO to
to VB learn
learn CC and
and VB remember

Here RB CAPITAL Here
Here PRP we
we NN show
show IN that
that DT the
the JJ medial
medial JJ temporal
temporal NN region
region VBZ is
is JJ active
active IN during
during VBG encoding
encoding CC and
and IN that
that DT the
the NN hemisphere
hemisphere VBN activated
activated CC and
and DT the
the NN amount
amount IN of
of NN activation
activation VB depend
depend IN on
on DT the
the NN type
type IN of
of NN stimulus
stimulus VBN presented
presented NN (
( NNS objects
objects CC or
or NNS words
words NN )
) , ,
, IN whether
whether DT the
the NN stimulus
stimulus MD can
can VB be
be VBN encoded
encoded IN for
for VBG meaning
meaning NN (
( RB real
real NNS objects
objects CC and
and NNS words
words CC versus
versus NN nonsense
nonsense NNS objects
objects CC and
and NNS words
words NN )
) , ,
, CC and
and NN task
task NN experience
experience NN (
( RB first
first CC versus
versus DT the
the JJ second
second NN time
time DT a
a NN task
task VBZ is
is VBN performed
performed NN )

These DT CAPITAL These
These NNS findings
findings VB demonstrate
demonstrate IN that
that DT the
the JJ medial
medial JJ temporal
temporal NN lobe
lobe NN memory
memory NN system
system VBZ is
is VBN engaged
engaged RB automatically
automatically WRB when
when PRP we
we VB attend
attend TO to
to DT a
a JJ perceptual
perceptual NN event
event CC and
and IN that
that DT the
the NN location
location CC and
and NN amount
amount IN of
of NN activation
activation VB depend
depend IN on
on NN stimulus
stimulus NNS characteristics
characteristics NN (
( JJ physical
physical NN form
form , ,
, VBG meaning
meaning NN )
) CC and
and NN experience

The DT CAPITAL The
The NN involvement
involvement IN of
of NNS structures
structures IN in
in DT the
the JJ medial
medial JJ temporal
temporal NN lobe
lobe IN during
during DT the
the VBG encoding
encoding IN of
of JJ visual
visual NNS associations
associations VBD was
was VBN studied
studied IN with
with JJ functional
functional JJ magnetic
magnetic NN resonance
resonance NN imaging

In IN CAPITAL In
In CD 11
11 IN out
out IN of
of CD 12
12 JJ normal
normal JJ healthy
healthy NNS volunteers
volunteers DT this
this NN task
task VBD resulted
resulted IN in
in NN activation
activation IN in
in NN posterior
posterior NNS portions
portions IN of
of DT the
the NN parahippocampal
parahippocampal NN region
region , ,
, RB close
close TO to
to DT the
the NN collateral
collateral NN sulcus

In IN CAPITAL In
In CD seven
seven NNS subjects
subjects NN activation
activation VBD was
was VBN encountered
encountered IN in
in DT the
the NN hippocampal
hippocampal NN formation

The DT CAPITAL The
The JJ visual
visual NN association
association NN task
task IN as
as VBN adapted
adapted IN for
for DT this
this NN study
study MD may
may VB provide
provide DT a
a JJ sensitive
sensitive NN measure
measure TO to
to NN study
study NN anterograde
anterograde NN amnesia
amnesia JJ prevalent
prevalent IN in
in NN CAPITAL Alzheimer
Alzheimer POS 's
's NN disease

Therefore RB CAPITAL Therefore
Therefore , ,
, DT the
the JJ present
present NN paradigm
paradigm VBZ enables
enables DT the
the NN study
study IN of
of JJ individual
individual NNS changes
changes IN in
in VBG learning
learning CC and
and NN memory
memory NNS capacities
capacities IN over
over NN time

Altered JJ CAPITAL Altered
Altered NN calcium
calcium NN (
( NN CAPITAL Ca2+
Ca2+ NN )
) NN homeostasis
homeostasis VBZ is
is NN thought
thought TO to
to NN play
play DT a
a NN key
key NN role
role IN in
in VBG aging
aging CC and
and NN neuropathology
neuropathology VBG resulting
resulting IN in
in NN memory
memory NNS deficits

Several JJ CAPITAL Several
Several NNS forms
forms IN of
of NN hippocampal
hippocampal JJ synaptic
synaptic NN plasticity
plasticity VBP are
are JJ dependent
dependent IN on
on NN CAPITAL Ca2+
Ca2+ , ,
, VBG providing
providing DT a
a NN potential
potential NN link
link IN between
between JJ altered
altered NN CAPITAL Ca2+
Ca2+ NN homeostasis
homeostasis CC and
and NN memory
memory NNS deficits
deficits VBN associated
associated IN with
with VBG aging

The DT CAPITAL The
The JJ current
current NN study
study NNS reviews
reviews NN evidence
evidence IN for
for NN CAPITAL Ca2+
Ca2+ NN dysregulation
dysregulation IN during
during VBG aging
aging WDT which
which MD could
could NN interact
interact IN with
with NN CAPITAL Ca
Ca NN (
( JJ 2+
2+ NN )
) JJ -dependent
-dependent JJ synaptic
synaptic NN plasticity

The DT CAPITAL The
The NNS authors
authors VB suggest
suggest IN that
that NNS changes
changes IN in
in NN CAPITAL Ca2+
Ca2+ NN regulation
regulation MD could
could VBP adjust
adjust DT the
the NNS thresholds
thresholds IN for
for JJ synaptic
synaptic NN modification
modification , ,
, VBG favoring
favoring NNS processes
processes IN for
for NN depression
depression IN of
of JJ synaptic
synaptic NN strength
strength IN during
during VBG aging

Transiently RB CAPITAL Transiently
Transiently VBN evolked
evolked JJ otoacoustic
otoacoustic NNS emissions
emissions NN (
( NN CAPITAL TEOAE
TEOAE NN )
) VB have
have VBN been
been VBN reported
reported IN in
in JJ several
several NNS studies
studies IN as
as JJ absent
absent IN in
in DT a
a JJ small
small NN minority
minority IN of
of JJ normal
normal NNS ears

Other JJ CAPITAL Other
Other NNS studies
studies VB have
have VBN reported
reported NNS CAPITAL TEOAEs
TEOAEs IN in
in DT all
all JJ normal
normal NNS ears

Differences NNS CAPITAL Differences
Differences IN between
between NNS studies
studies MD may
may VB arise
arise RB directly
directly IN from
from NNS criteria
criteria IN for
for NN CAPITAL TEOAE
TEOAE NN identification
identification , ,
, NNS criteria
criteria IN for
for NN selection
selection IN of
of NNS normals
normals , ,
, CC or
or RB statistically
statistically JJ due
due TO to
to JJ limited
limited NN sample
sample NNS sizes

In IN CAPITAL In
In NN order
order TO to
to VB understand
understand CC and
and NN model
model NN cochlear
cochlear NNS processes
processes VBN involved
involved IN in
in NN CAPITAL TEOAE
TEOAE NN generation
generation , ,
, PRP it
it NNS needs
needs TO to
to VB be
be VBN known
known IN whether
whether DT the
the NN presence
presence IN of
of JJ normal
normal NN hearing
hearing NNS leads
leads RB automatically
automatically TO to
to NN generation
generation IN of
of NNS CAPITAL TEOAEs

The DT CAPITAL The
The JJ present
present NN study
study NN set
set IN out
out TO to
to VB establish
establish IN in
in DT a
a JJ large
large NN sample
sample IN if
if DT any
any NNS ears
ears MD could
could VB be
be VBN found
found IN that
that VBD lacked
lacked NNS CAPITAL TEOAEs
TEOAEs IN despite
despite JJ normal
normal NN hearing
hearing NN threshold
threshold NNS levels
levels NN (
( NN CAPITAL HTL
HTL NN )

A DT CAPITAL A
A NN total
total IN of
of CD 397
397 NNS ears
ears IN from
from RB highly
highly JJ cooperative
cooperative JJ adult
adult NNS subjects
subjects VBD were
were VBN examined
examined IN under
under NN laboratory
laboratory NNS conditions

Using VBG CAPITAL Using
Using NN cross
cross NN correlation
correlation IN between
between VB replicate
replicate JJ nonlinear
nonlinear NNS waveforms
waveforms IN as
as DT the
the NN criterion
criterion , ,
, NNS CAPITAL TEOAEs
TEOAEs VBD were
were JJ present
present IN in
in CD 99.2
99.2 NN %
% IN of
of DT the
the NN sample
sample NN (
( JJR lower
lower NN CAPITAL CI
CI CD 98.1
98.1 NN %
% NN )

However RB CAPITAL However
However , ,
, JJ careful
careful JJ visual
visual NN assessment
assessment IN of
of DT the
the VBN recorded
recorded NNS waveforms
waveforms IN for
for DT the
the VBG remaining
remaining NNS ears
ears VBD did
did RB not
not RB unequivocally
unequivocally NN show
show NN absence
absence IN of
of NN CAPITAL TEOAE
TEOAE NNS characteristics
characteristics IN in
in DT any
any NN ear
ear IN with
with JJ normal
normal NNS CAPITAL HTLs

While IN CAPITAL While
While NN CAPITAL TEOAE
TEOAE NN strength
strength VBZ varies
varies RB widely
widely IN among
among NNS ears
ears , ,
, DT no
no JJ clear
clear NN evidence
evidence VBD was
was VBN found
found TO to
to NN show
show IN that
that NNS CAPITAL TEOAEs
TEOAEs MD can
can VB be
be JJ absent
absent WRB when
when NNS CAPITAL HTLs
HTLs VBP are
are JJ normal

In IN CAPITAL In
In NN addition
addition TO to
to DT a
a RB long
long NN form
form IN of
of CD 591
591 NN amino
amino NNS acids
acids NN (
( NN aa
aa NN )
) , ,
, CD two
two JJ other
other NNS forms
forms IN of
of NN CAPITAL PRL
PRL NN receptor
receptor NN (
( NN CAPITAL PRLR
PRLR NN )
) , ,
, VBG differing
differing IN in
in DT the
the NN length
length IN of
of PRP$ their
their JJ cytoplasmic
cytoplasmic NNS domains
domains , ,
, VB have
have VBN been
been VBN identified
identified IN in
in DT the
the NN rat

The DT CAPITAL The
The NN CAPITAL Nb2
Nb2 NN form
form , ,
, VBG lacking
lacking CD 198
198 NN aa
aa IN in
in DT the
the JJ cytoplasmic
cytoplasmic NN domain
domain , ,
, VBZ is
is JJ able
able TO to
to VB transmit
transmit DT a
a JJ lactogenic
lactogenic NN signal
signal JJ similar
similar TO to
to DT the
the RB long
long NN form
form , ,
, IN whereas
whereas DT the
the RB short
short NN form
form IN of
of CD 291
291 NN aa
aa VBZ is
is JJ inactive

The DT CAPITAL The
The NN ability
ability IN of
of NN CAPITAL PRL
PRL TO to
to VB activate
activate DT the
the NN promoter
promoter IN of
of DT the
the NN beta-casein
beta-casein NN gene
gene CC or
or DT the
the JJ lactogenic
lactogenic NN hormone
hormone JJ responsive
responsive NN element
element VBN fused
fused TO to
to DT the
the NN luciferase
luciferase NN reporter
reporter VBD was
was VBN assessed
assessed IN in
in JJ CAPITAL Chinese
Chinese NN hamster
hamster NN ovary
ovary NNS cells
cells CC or
or CD 293
293 NNS fibroblasts
fibroblasts RB transiently
transiently VBN transfected
transfected IN with
with NN CAPITAL PRLR
PRLR NNS cDNAs

The DT CAPITAL The
The NN function
function IN of
of DT the
the RB short
short NN form
form VBD was
was VBN examined
examined IN after
after NN cotransfection
cotransfection IN of
of DT both
both DT the
the RB long
long CC and
and RB short
short NNS forms

These DT CAPITAL These
These NNS results
results RB clearly
clearly NN show
show IN that
that DT the
the RB short
short NN form
form NNS acts
acts IN as
as DT a
a JJ dominant
dominant JJ negative
negative NN inhibitor
inhibitor IN through
through DT the
the NN formation
formation IN of
of JJ inactive
inactive NNS heterodimers
heterodimers , ,
, VBG resulting
resulting IN in
in DT an
an NN inhibition
inhibition IN of
of NN CAPITAL Janus
Janus NN kinase
kinase CD 2
2 NN (
( NN CAPITAL JAK2
JAK2 NN )
) NN activation

The DT CAPITAL The
The JJ present
present NN study
study RB also
also VBZ investigates
investigates DT the
the JJ possible
possible NN participation
participation IN of
of JJ cytoplasmic
cytoplasmic NNS receptors
receptors IN in
in DT the
the NN signal
signal NN transduction
transduction NN pathway
pathway , ,
, VBG using
using NN cotransfection
cotransfection NNS experiments
experiments CC and
and DT a
a JJ new
new NN approach
approach IN that
that RB selectively
selectively VBZ determines
determines DT the
the NN contribution
contribution IN of
of JJ cytoplasmic
cytoplasmic NNS receptors
receptors IN in
in DT the
the NN process
process IN of
of NN signal
signal NN transduction

We PRP CAPITAL We
We VBN cotransfected
cotransfected JJ CAPITAL Chinese
Chinese NN hamster
hamster NN ovary
ovary NNS cells
cells IN with
with CD two
two NN cDNA
cDNA NNS constructs
constructs : :
: DT a
a JJ cytoplasmic
cytoplasmic NN (
( JJ soluble
soluble NN )
) NN form
form IN of
of DT the
the NN receptor
receptor IN with
with DT a
a VBN deleted
deleted NN signal
signal NN peptide
peptide NN (
( NN delta-19
delta-19 NN )
) , ,
, WDT which
which VBZ is
is JJ unable
unable TO to
to NN bind
bind NN CAPITAL PRL
PRL , ,
, CC and
and DT a
a RB functionally
functionally JJ inactive
inactive NN receptor
receptor NN mutant
mutant NN (
( VBG lacking
lacking NN box
box CD 1
1 NN )
) , ,
, WDT which
which VBZ is
is VBN anchored
anchored IN in
in DT the
the NN plasma
plasma NN membrane
membrane CC and
and JJ able
able TO to
to NN bind
bind NN CAPITAL PRL

This DT CAPITAL This
This NN approach
approach VBZ has
has VBN allowed
allowed PRP us
us TO to
to NN show
show IN that
that NN delta-19
delta-19 , ,
, VBG lacking
lacking NN expression
expression IN at
at DT the
the NN plasma
plasma NN membrane
membrane , ,
, MD can
can VB transduce
transduce DT the
the JJ hormonal
hormonal NN message
message , ,
, IN at
at JJS least
least TO to
to DT a
a JJ limited
limited NN extent
extent NN (
( RB up
up TO to
to CD 30
30 NN %
% IN of
of JJ wild
wild NN type
type NN efficiency
efficiency NN )
) , ,
, VBG providing
providing IN that
that NN association/activation
association/activation VBZ occurs
occurs IN with
with DT a
a NN CAPITAL PRL-PRLR
PRL-PRLR NN complex
complex VBN initiated
initiated IN at
at DT the
the NN cell
cell NN surface
surface NN level
level : ;
; NN box
box CD 1
1 IN of
of DT the
the JJ cytoplasmic
cytoplasmic NN form
form VBZ is
is JJ necessary
necessary TO to
to NN rescue
rescue DT this
this JJ partial
partial JJ transcriptional
transcriptional NN activity
activity IN of
of DT the
the JJ inactive
inactive NN mutant

This DT CAPITAL This
This JJ partial
partial NN recovery
recovery VBZ is
is RB also
also NN parallel
parallel TO to
to DT the
the JJ partial
partial NN activation
activation IN of
of NN CAPITAL JAK2
JAK2 , ,
, VBG indicating
indicating IN that
that DT the
the NN signal
signal NN transduction
transduction NN pathway
pathway VBN implicated
implicated NN CAPITAL JAK2

Our PRP$ CAPITAL Our
Our NNS results
results VB provide
provide NN evidence
evidence IN that
that NN heterodimerization
heterodimerization IN of
of NNS receptors
receptors MD can
can VB be
be VBN implicated
implicated DT either
either IN in
in DT the
the JJ positive
positive CC or
or IN in
in JJ negative
negative NN activation
activation IN of
of NN gene
gene NN transcription

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: JJ CAPITAL Inadequate
Inadequate JJ dietary
dietary NN intake
intake IN of
of NN calcium
calcium CC and
and NN vitamin
vitamin NN CAPITAL D
D MD may
may VB contribute
contribute TO to
to DT the
the JJ high
high NN prevalence
prevalence IN of
of NN osteoporosis
osteoporosis IN among
among JJR older
older NNS persons

METHODS NNS CAPITAL METHODS
METHODS : :
: PRP CAPITAL We
We VBN studied
studied DT the
the NNS effects
effects IN of
of CD three
three NNS years
years IN of
of JJ dietary
dietary NN supplementation
supplementation IN with
with NN calcium
calcium CC and
and NN vitamin
vitamin NN CAPITAL D
D IN on
on NN bone
bone NN mineral
mineral NN density
density , ,
, JJ biochemical
biochemical NNS measures
measures IN of
of NN bone
bone NN metabolism
metabolism , ,
, CC and
and DT the
the NN incidence
incidence IN of
of JJ nonvertebral
nonvertebral NNS fractures
fractures IN in
in CD 176
176 NNS men
men CC and
and CD 213
213 NNS women
women CD 65
65 NNS years
years IN of
of NN age
age CC or
or JJR older
older WP who
who VBD were
were VBG living
living IN at
at NN home

They PRP CAPITAL They
They VBN received
received DT either
either CD 500
500 NN mg
mg IN of
of NN calcium
calcium CC plus
plus CD 700
700 NN CAPITAL IU
IU IN of
of NN vitamin
vitamin NN CAPITAL D3
D3 NN (
( NN cholecalciferol
cholecalciferol NN )
) IN per
per NN day
day CC or
or NN placebo

Bone NN CAPITAL Bone
Bone NN mineral
mineral NN density
density VBD was
was VBN measured
measured IN by
by NN dual-energy
dual-energy NN x-ray
x-ray NN absorptiometry
absorptiometry , ,
, NN blood
blood CC and
and NN urine
urine VBD were
were VBN analyzed
analyzed DT every
every CD six
six NNS months
months , ,
, CC and
and NNS cases
cases IN of
of JJ nonvertebral
nonvertebral NN fracture
fracture VBD were
were VBN ascertained
ascertained IN by
by NNS means
means IN of
of NNS interviews
interviews CC and
and VBN verified
verified IN with
with NN use
use IN of
of NN hospital
hospital NNS records

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The VB mean
mean NN (
( NN +/-SD
+/-SD NN )
) NNS changes
changes IN in
in NN bone
bone NN mineral
mineral NN density
density IN in
in DT the
the JJ calcium-vitamin
calcium-vitamin NN CAPITAL D
D CC and
and NN placebo
placebo NNS groups
groups VBD were
were IN as
as VBZ follows
follows : :
: JJ femoral
femoral NN neck
neck , ,
, NN +0.50+/-4.80
+0.50+/-4.80 CC and
and CD -0.70+/-5.03
-0.70+/-5.03 NN percent
percent , ,
, RB respectively
respectively NN (
( NN CAPITAL P=0.02
P=0.02 NN )
) : ;
; NN spine
spine , ,
, CD +2.12+/-4.06
+2.12+/-4.06 CC and
and CD +1.22+/-4.25
+1.22+/-4.25 NN percent
percent NN (
( NN CAPITAL P=0.04
P=0.04 NN )
) : ;
; CC and
and NN total
total NN body
body , ,
, NN +0.06+/-1.83
+0.06+/-1.83 CC and
and CD -1.09+/-1.71
-1.09+/-1.71 NN percent
percent NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.001
0.001 NN )

The DT CAPITAL The
The NN difference
difference IN between
between DT the
the JJ calcium-vitamin
calcium-vitamin NN CAPITAL D
D CC and
and NN placebo
placebo NNS groups
groups VBD was
was JJ significant
significant IN at
at DT all
all JJ skeletal
skeletal NNS sites
sites IN after
after CD one
one NN year
year , ,
, CC but
but PRP it
it VBD was
was JJ significant
significant RB only
only IN for
for NN total-body
total-body NN bone
bone NN mineral
mineral NN density
density IN in
in DT the
the JJ second
second CC and
and JJ third
third NNS years

Of IN CAPITAL Of
Of CD 37
37 NNS subjects
subjects WP who
who VBD had
had JJ nonvertebral
nonvertebral NNS fractures
fractures , ,
, CD 26
26 VBD were
were IN in
in DT the
the NN placebo
placebo NN group
group CC and
and CD 11
11 VBD were
were IN in
in DT the
the JJ calcium-vitamin
calcium-vitamin NN CAPITAL D
D NN group
group NN (
( NN CAPITAL P=0.02
P=0.02 NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: IN CAPITAL In
In NNS men
men CC and
and NNS women
women CD 65
65 NNS years
years IN of
of NN age
age CC or
or JJR older
older WP who
who VBP are
are VBG living
living IN in
in DT the
the NN community
community , ,
, JJ dietary
dietary NN supplementation
supplementation IN with
with NN calcium
calcium CC and
and NN vitamin
vitamin NN CAPITAL D
D RB moderately
moderately VBN reduced
reduced NN bone
bone NN loss
loss VBN measured
measured IN in
in DT the
the JJ femoral
femoral NN neck
neck , ,
, NN spine
spine , ,
, CC and
and NN total
total NN body
body IN over
over DT the
the JJ three-year
three-year NN study
study NN period
period CC and
and VBN reduced
reduced DT the
the NN incidence
incidence IN of
of JJ nonvertebral
nonvertebral NNS fractures

The DT CAPITAL The
The NN sterilization
sterilization CC and
and VBN contaminated
contaminated NN waste
waste NN disposal
disposal NNS practices
practices IN in
in DT all
all CD 14
14 JJ dental
dental NNS clinics
clinics VBN operated
operated IN by
by DT the
the NNP CAPITAL Southern
Southern NNP CAPITAL Sydney
Sydney NN CAPITAL Area
Area NNP CAPITAL Health
Health NNP CAPITAL Service
Service VBD were
were VBN surveyed

All DT CAPITAL All
All IN of
of DT the
the NNS clinics
clinics VBN used
used NNS autoclaves
autoclaves IN for
for NN sterilization

All DT CAPITAL All
All NN hand
hand NNS instruments
instruments , ,
, NNS handpieces
handpieces CC and
and IN triplex
triplex NNS syringes
syringes VBD were
were VBN autoclaved
autoclaved IN between
between NNS patients

Chemical NNP CAPITAL Chemical
Chemical NN disinfection
disinfection NNS solutions
solutions VBD were
were VBN used
used IN in
in CD 12
12 IN of
of DT the
the CD 14
14 JJ dental
dental NNS clinics
clinics , ,
, RB mainly
mainly IN for
for NN surface
surface NN decontamination

Five CD CAPITAL Five
Five JJ dental
dental NNS clinics
clinics VBD had
had JJ separate
separate NN storage
storage NNS areas
areas IN for
for VBN contaminated
contaminated NN waste
waste WDT which
which VBN compiled
compiled IN with
with VBN contaminated
contaminated NN waste
waste NN separation
separation CC and
and NN disposal
disposal NNS guidelines

The DT CAPITAL The
The NN practice
practice IN of
of VBG recapping
recapping NNS needles
needles IN with
with NNS fingers
fingers CC and
and DT some
some JJ inadequate
inadequate VBG washing
washing NNS facilities
facilities VBP are
are NNS areas
areas IN that
that VB require
require JJ particular
particular NN attention

Safety NN CAPITAL Safety
Safety CC and
and NN efficacy
efficacy VBP are
are JJ crucial
crucial CC but
but JJ separate
separate NNS issues
issues IN for
for NN vitamin
vitamin CC and
and NN mineral
mineral NNS supplements

Misinterpretation NNP CAPITAL Misinterpretation
Misinterpretation IN of
of `` ``
`` JJ safe
safe CC and
and JJ adequate
adequate '' ''
'' TO to
to VB mean
mean `` ``
`` NN safety
safety NN limit
limit '' ''
'' MD would
would VB impose
impose NNS restrictions
restrictions IN on
on NN vitamin
vitamin CC and
and NN mineral
mineral NN intakes
intakes IN that
that VBP are
are RB not
not VBN needed
needed TO to
to VB ensure
ensure NN safety

Substantial JJ CAPITAL Substantial
Substantial NN evidence
evidence VBZ indicates
indicates IN that
that NN intakes
intakes JJR greater
greater IN than
than DT the
the VBN recommended
recommended JJ dietary
dietary NNS allowances
allowances NN (
( NNS CAPITAL RDAs
RDAs NN )
) IN of
of JJ certain
certain NNS vitamins
vitamins CC and
and NNS minerals
minerals JJ such
such IN as
as NN calcium
calcium , ,
, NN folic
folic NN acid
acid , ,
, NN vitamin
vitamin NN CAPITAL E
E , ,
, NN selenium
selenium , ,
, CC and
and NN chromium
chromium VB reduce
reduce DT the
the NN risk
risk IN of
of JJ certain
certain NNS diseases
diseases IN for
for DT some
some NNS people

Limitation NN CAPITAL Limitation
Limitation IN of
of NN intakes
intakes TO to
to DT the
the NNS CAPITAL RDAs
RDAs MD would
would VB preclude
preclude NNS reductions
reductions IN in
in NN disease
disease NN risk
risk IN from
from DT these
these NNS nutrients

The DT CAPITAL The
The NN margin
margin IN of
of NN safety
safety IN between
between DT the
the JJ usual
usual JJ dietary
dietary NN intake
intake CC and
and DT the
the NN intake
intake IN that
that MD would
would VB produce
produce JJ adverse
adverse NNS effects
effects VBZ varies
varies RB greatly
greatly IN among
among DT the
the JJ different
different NNS nutrients

Very RB CAPITAL Very
Very JJ high
high NN intakes
intakes IN of
of NNS vitamins
vitamins DT CAPITAL A
A CC and
and NN CAPITAL D
D , ,
, NN niacin
niacin , ,
, NN pyridoxine
pyridoxine , ,
, CC and
and NN selenium
selenium VB have
have VBN produced
produced JJ adverse
adverse NNS effects

Many JJ CAPITAL Many
Many RB widely
widely VBN discussed
discussed JJ putative
putative JJ adverse
adverse NNS effects
effects IN of
of NN vitamin
vitamin NN CAPITAL C
C , ,
, NN vitamin
vitamin NN CAPITAL E
E , ,
, CC and
and JJ trivalent
trivalent NN chromium
chromium VB have
have RB little
little JJ factual
factual NN basis

There EX CAPITAL There
There VBZ is
is DT no
no NN evidence
evidence IN of
of JJ adverse
adverse NNS effects
effects IN from
from NN beta-carotene
beta-carotene NNS supplements
supplements IN except
except IN in
in JJ current
current JJ heavy
heavy NNS smokers

The DT CAPITAL The
The NN mutator
mutator NN hypothesis
hypothesis IN of
of NN tumorigenesis
tumorigenesis VBZ suggests
suggests IN that
that NN loss
loss IN of
of JJ chromosomal
chromosomal NN stability
stability CC or
or NN maintenance
maintenance NNS functions
functions NNS results
results IN in
in JJ elevated
elevated NN mutation
mutation NNS rates
rates , ,
, VBG leading
leading TO to
to DT the
the NN accumulation
accumulation IN of
of DT the
the JJ numerous
numerous NNS mutations
mutations VBN required
required IN for
for JJ multistep
multistep NN carcinogenesis

The DT CAPITAL The
The JJ human
human NN CAPITAL DNA
DNA NN mismatch
mismatch NN repair
repair NN (
( NN CAPITAL MMR
MMR NN )
) NNS genes
genes VBP are
are RB highly
highly VBN conserved
conserved NNS homologues
homologues IN of
of DT the
the FW CAPITAL Escherichia
Escherichia NN coli
coli NN CAPITAL MutHLS
MutHLS NN system
system , ,
, WDT which
which VB contribute
contribute TO to
to JJ genomic
genomic NN stability
stability IN by
by NN surveillance
surveillance CC and
and NN repair
repair IN of
of NN replication
replication NN misincorporation
misincorporation NNS errors
errors CC and
and JJ exogenous
exogenous NN CAPITAL DNA
DNA NN damage

Mutations NNS CAPITAL Mutations
Mutations IN in
in CD one
one IN of
of DT these
these NN CAPITAL MMR
MMR NNS genes
genes , ,
, NN hMSH2
hMSH2 , ,
, NN account
account IN for
for IN about
about NN half
half IN of
of DT all
all NNS cases
cases IN of
of RB genetically
genetically VBN linked
linked JJ hereditary
hereditary JJ non-polyposis
non-polyposis JJ colorectal
colorectal NN cancer

Loss NN CAPITAL Loss
Loss IN of
of NN function
function IN of
of NN p53
p53 VBZ has
has RB also
also VBN been
been VBN proposed
proposed TO to
to NN increase
increase JJ cellular
cellular NN hypermutability
hypermutability , ,
, RB thereby
thereby VBG accelerating
accelerating NN carcinogenesis
carcinogenesis , ,
, IN although
although DT a
a JJ clear
clear NN role
role IN for
for NN p53
p53 IN in
in JJ genomic
genomic NN instability
instability NNS remains
remains JJ controversial

p53 NN p53
p53 VBZ is
is VBN mutated
mutated RB frequently
frequently IN in
in DT a
a JJ wide
wide NN range
range IN of
of JJ human
human NNS cancers
cancers , ,
, VBG including
including JJ colonic
colonic NNS tumours

Both DT CAPITAL Both
Both NN CAPITAL Msh2-
Msh2- CC and
and JJ p53-targeted
p53-targeted NN knockout
knockout NNS mice
mice VBP are
are JJ viable
viable CC and
and JJ susceptible
susceptible TO to
to NN cancer

Here RB CAPITAL Here
Here PRP we
we VB demonstrate
demonstrate IN that
that VBN combined
combined NN CAPITAL Msh2
Msh2 CC and
and NN p53
p53 NN ablation
ablation NN (
( NN CAPITAL Msh2-/-p53-/-
Msh2-/-p53-/- NN )
) NNS results
results IN in
in JJ developmental
developmental NN arrest
arrest IN of
of DT all
all NN female
female NNS embryos
embryos IN at
at CD 9.5
9.5 NNS days

In IN CAPITAL In
In NN contrast
contrast , ,
, NN male
male NN CAPITAL Msh2-/-p53-/-
Msh2-/-p53-/- NNS mice
mice VBP are
are JJ viable
viable , ,
, CC but
but VB succumb
succumb TO to
to NNS tumours
tumours RB significantly
significantly RB earlier
earlier NN (
( NN t1-2
t1-2 VBZ is
is CD 73
73 NNS days
days NN )
) IN than
than DT either
either NN CAPITAL Msh2-/-
Msh2-/- CC or
or JJ p53-/-
p53-/- NNS littermates

Furthermore RB CAPITAL Furthermore
Furthermore , ,
, DT the
the NN frequency
frequency IN of
of NN microsatellite
microsatellite NN instability
instability NN (
( NNP CAPITAL MSI
MSI NN )
) IN in
in NNS tumours
tumours IN from
from NN CAPITAL Msh2-/-p53-/-
Msh2-/-p53-/- NNS mice
mice VBZ is
is RB not
not RB significantly
significantly JJ different
different IN than
than IN in
in NN CAPITAL Msh2-/-
Msh2-/- NNS mice

Synergism NN CAPITAL Synergism
Synergism IN in
in NN tumorigenesis
tumorigenesis CC and
and JJ independent
independent NN segregation
segregation IN of
of DT the
the NNP CAPITAL MSI
MSI NN phenotype
phenotype VB suggest
suggest IN that
that NN CAPITAL Msh2
Msh2 CC and
and NN p53
p53 VBP are
are RB not
not RB genetically
genetically JJ epistatic

Our PRP$ CAPITAL Our
Our NNS data
data NN (
( NNP CAPITAL Reddy
Reddy FW et
et NNP al
al . .
. , ,
, NN CAPITAL Radiat

Res NNP CAPITAL Res

141 CD 141
141 , ,
, CD 252-258
252-258 , ,
, CD 1995
1995 NN )
) IN on
on DT the
the NNS kinetics
kinetics IN of
of DT the
the NN repair
repair IN of
of RB potentially
potentially JJ lethal
lethal NN damage
damage IN in
in NN log-phase
log-phase JJ CAPITAL Chinese
Chinese NN hamster
hamster NN CAPITAL V79
V79 NNS cells
cells VBP are
are VBN used
used TO to
to NN test
test DT some
some NNS predictions
predictions WDT which
which VB arise
arise IN from
from DT the
the JJ different
different NNS assumptions
assumptions IN of
of DT the
the NN repair-misrepair
repair-misrepair NN (
( NN CAPITAL RMR
RMR NN )
) NN (
( NN CAPITAL C

A DT CAPITAL A

Tobias NNP CAPITAL Tobias
Tobias , ,
, NN CAPITAL Radiat

Res NNP CAPITAL Res

104 CD 104
104 , ,
, NN CAPITAL S77-S95
S77-S95 , ,
, CD 1985
1985 NN )
) , ,
, RB lethal-potentially
lethal-potentially JJ lethal
lethal NN (
( NNP CAPITAL LPL
LPL NN )
) NN (
( NNP CAPITAL S.
S. NN CAPITAL B

Curtis NNP CAPITAL Curtis
Curtis , ,
, NN CAPITAL Radiat

Res NNP CAPITAL Res

106 CD 106
106 , ,
, CD 252-270
252-270 , ,
, CD 1986
1986 NN )
) CC and
and NN double-strand
double-strand NN break
break NN (
( NN CAPITAL DSB
DSB NN )
) NN (
( NN CAPITAL J

Y NN CAPITAL Y

Ostashevsky NNP CAPITAL Ostashevsky
Ostashevsky , ,
, NN CAPITAL Radiat

Res NNP CAPITAL Res

118 CD 118
118 , ,
, CD 437-466
437-466 , ,
, CD 1989
1989 NN )
) NNS models

The DT CAPITAL The
The NNP CAPITAL LPL
LPL NN model
model VBZ defines
defines DT the
the NN time
time JJ available
available IN for
for NN repair
repair IN of
of NN CAPITAL PLD
PLD NN (
( NN t
t NN (
( NN rep
rep NN )
) NN )
) IN as
as DT the
the NN time
time VBN taken
taken TO to
to NN reach
reach JJ maximal
maximal NN survival
survival IN in
in DT a
a JJ delayed-plating
delayed-plating NN recovery
recovery NN experiment

Those DT CAPITAL Those
Those NNS data
data NN show
show IN that
that IN after
after DT this
this NN time
time VBZ has
has VBN elapsed
elapsed , ,
, NN contrary
contrary TO to
to DT the
the NN expectation
expectation IN of
of DT the
the NNP CAPITAL LPL
LPL NN model
model , ,
, NN survival
survival MD can
can VB be
be VBN increased
increased IN by
by VBG changing
changing DT the
the NN medium
medium VBN used
used IN for
for VBN delayed
delayed VBG plating
plating IN from
from JJ fresh
fresh NN growth
growth NN medium
medium TO to
to VBN conditioned
conditioned NN medium

According VBG CAPITAL According
According TO to
to DT the
the NN CAPITAL RMR
RMR NN model
model , ,
, DT all
all RB potentially
potentially JJ lethal
lethal NNS lesions
lesions MD should
should RB also
also VB be
be VBN committed
committed IN by
by IN that
that NN time
time CC and
and VB be
be JJ unavailable
unavailable IN for
for NN repair
repair IN in
in DT the
the JJ new
new NN medium

Only RB CAPITAL Only
Only DT the
the NN CAPITAL DSB
DSB NN model
model RB correctly
correctly VBN predicted
predicted IN that
that NN CAPITAL PLD
PLD NN (
( JJ =
= NNS CAPITAL DSBs
DSBs NN )
) MD would
would RB still
still VB be
be JJ available
available IN for
for NN repair
repair IN after
after IN that
that NN time

Second JJ CAPITAL Second
Second , ,
, NNS data
data IN for
for NN split-dose
split-dose NN recovery
recovery VBP are
are VBN used
used TO to
to VB predict
predict DT the
the NN first-order
first-order NNS kinetics
kinetics NN time
time JJ constant
constant IN for
for NN CAPITAL DSB
DSB NN repair
repair NN (
( IN tau
tau NN (
( NN CAPITAL DSBR
DSBR NN )
) NN )
) VBG using
using DT the
the NN CAPITAL DSB
DSB NN model
model NN (
( CD 24
24 CC +/-
+/- CD 1.5
1.5 NN min
min NN )

This DT CAPITAL This
This NN value
value VBZ is
is RB nearly
nearly JJ identical
identical TO to
to DT the
the NN value
value IN of
of CD 27
27 CC +/-
+/- CD 1
1 NN min
min VBN determined
determined IN from
from DT the
the NNS data
data VBN obtained
obtained IN by
by NNP CAPITAL Cheong
Cheong FW et
et NNP al
al . .
. VBG using
using JJ pulsed-field
pulsed-field NN gel
gel NN electrophoresis
electrophoresis NN (
( NN CAPITAL PFGE
PFGE NN )
) NN (
( NN CAPITAL Mutat

Res NNP CAPITAL Res

274 CD 274
274 , ,
, CD 111-122
111-122 , ,
, CD 1992
1992 NN )

The DT CAPITAL The
The NN value
value VBN based
based IN on
on NN CAPITAL PFGE
PFGE VBZ is
is VBN used
used TO to
to VB calculate
calculate DT the
the NN value
value IN of
of NN t
t NN (
( NN rep
rep NN )
) VBN predicted
predicted IN by
by DT the
the NN CAPITAL DSB
DSB NN model
model NN (
( CD 2.6
2.6 CC +/-
+/- CD 0.1
0.1 NN h
h NN )
) , ,
, WDT which
which VBZ agrees
agrees IN with
with DT the
the NN value
value VBN determined
determined RB experimentally
experimentally IN as
as DT the
the NN time
time WRB when
when VBG changing
changing DT the
the JJ delayed-plating
delayed-plating NN medium
medium IN from
from NN growth
growth NN medium
medium TO to
to VBN conditioned
conditioned NN medium
medium DT no
no RB longer
longer VBZ gives
gives DT the
the JJ full
full NN recovery
recovery VBN seen
seen IN with
with VBN delayed
delayed VBG plating
plating IN in
in VBN conditioned
conditioned NN medium
medium NN (
( CD 2.5
2.5 NN h
h NN )

However RB CAPITAL However
However , ,
, DT some
some NN recovery
recovery VBD was
was VBN seen
seen IN for
for DT a
a NN change
change IN in
in DT the
the NN medium
medium NN (
( NN growth
growth NN medium
medium TO to
to VBN conditioned
conditioned NN medium
medium NN )
) RB up
up TO to
to CD 5-6
5-6 NN h
h NN postirradiation

Reanalysis NNP CAPITAL Reanalysis
Reanalysis IN of
of DT the
the JJ original
original NNS data
data IN on
on NN CAPITAL DSB
DSB NN repair
repair NNS shows
shows IN that
that PRP they
they VBP are
are JJ consistent
consistent IN with
with CD two
two NN first-order
first-order NN repair
repair NNS rates
rates NN (
( CD 18
18 CC +/-
+/- CD 7
7 NN min
min CC and
and IN about
about CD 52
52 NN min
min NN )

These DT CAPITAL These
These NNS results
results VBP are
are JJ consistent
consistent IN with
with CD two
two NNS pools
pools IN of
of NNS CAPITAL DSBs
DSBs NN (
( CC or
or NNS cells
cells NN )
) , ,
, DT each
each IN with
with PRP$ their
their JJ own
own NN t
t NN (
( NN rep
rep NN )

The DT CAPITAL The
The RB early
early NN t
t NN (
( NN rep
rep NN )
) , ,
, VBN associated
associated IN with
with IN tau
tau NN (
( RB fast
fast NN )
) , ,
, VBZ is
is VBN predicted
predicted TO to
to VB be
be CD 1.7
1.7 CC +/-
+/- CD 0.7
0.7 NN h
h , ,
, CC and
and DT the
the RB late
late NN t
t NN (
( NN rep
rep NN )
) , ,
, VBN associated
associated IN with
with IN tau
tau NN (
( JJ slow
slow NN )
) , ,
, VBZ is
is VBN predicted
predicted TO to
to VB be
be IN about
about CD 5
5 NN h.
h. DT CAPITAL Both
Both NNS values
values VBP are
are IN in
in JJ excellent
excellent NN agreement
agreement IN with
with DT the
the NNS times
times IN at
at WDT which
which VBG changing
changing IN from
from NN growth
growth NN medium
medium TO to
to VBN conditioned
conditioned NN medium
medium DT no
no RB longer
longer VBZ gives
gives DT the
the JJ full
full NN recovery
recovery VBN seen
seen IN in
in VBN conditioned
conditioned NN medium
medium RB only
only NN (
( DT the
the RB early
early NN t
t NN (
( NN rep
rep NN )
) NN )
) , ,
, CC and
and DT the
the NN time
time WRB when
when VBG changing
changing IN from
from NN growth
growth NN medium
medium TO to
to VBN conditioned
conditioned NN medium
medium VBZ produces
produces DT no
no RB further
further NN increase
increase IN in
in NN survival
survival NN (
( DT the
the RB late
late NN t
t NN (
( NN rep
rep NN )
) NN )
) , ,
, RB respectively

It PRP CAPITAL It
It VBZ is
is VBN noted
noted IN that
that NNS attempts
attempts TO to
to NN correlate
correlate NN radiosensitivity
radiosensitivity IN with
with DT the
the NNS rates
rates IN of
of NN CAPITAL DSB
DSB NN repair
repair , ,
, RB rather
rather IN than
than VBG using
using DT an
an JJ explicit
explicit NN model
model JJ such
such IN as
as DT the
the NN CAPITAL DSB
DSB NN model
model , ,
, VBP are
are JJ unlikely
unlikely TO to
to VB be
be JJ productive
productive IN since
since NN survival
survival VBZ depends
depends IN on
on DT both
both IN tau
tau NN (
( NN CAPITAL DSBR
DSBR NN )
) CC and
and NN t
t NN (
( NN rep
rep NN )
) NN (
( IN as
as VBN defined
defined IN in
in DT the
the NN CAPITAL DSB
DSB NN model
model NN )
) CC and
and DT the
the JJ latter
latter MD may
may VB be
be DT the
the RBR more
more JJ important
important NN determinant
determinant IN of
of NN radiosensitivity
radiosensitivity NN (
( IN as
as PRP it
it VBZ appears
appears TO to
to VB be
be IN for
for NN ataxia
ataxia NN telangiectasia
telangiectasia NNS cells
cells VBN compared
compared TO to
to JJ normal
normal NNS fibroblasts
fibroblasts CC and
and IN for
for NNS irs
irs VBN compared
compared TO to
to NN CAPITAL V79
V79 NNS cells
cells NN )

CONTEXT NN CAPITAL CONTEXT
CONTEXT : :
: NNS CAPITAL Adolescents
Adolescents '' '
' NNS concerns
concerns IN about
about NN privacy
privacy IN in
in JJ clinical
clinical NNS settings
settings NN decrease
decrease PRP$ their
their NN willingness
willingness TO to
to VB seek
seek NN health
health NN care
care IN for
for JJ sensitive
sensitive NNS problems
problems CC and
and MD may
may VB inhibit
inhibit PRP$ their
their NN communication
communication IN with
with NNS physicians

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB investigate
investigate DT the
the NN influence
influence IN of
of NNS physicians
physicians '' '
' NNS assurances
assurances IN of
of NN confidentiality
confidentiality IN on
on NNS adolescents
adolescents '' '
' NN willingness
willingness TO to
to VB disclose
disclose NN information
information CC and
and VB seek
seek NN future
future NN health
health NN care

DESIGN NN CAPITAL DESIGN
DESIGN : :
: VBN CAPITAL Randomized
Randomized VBN controlled
controlled NN trial

SETTING VBG CAPITAL SETTING
SETTING : :
: CD CAPITAL Three
Three JJ suburban
suburban NN public
public JJ high
high NNS schools
schools IN in
in NNP CAPITAL California

PARTICIPANTS NNS CAPITAL PARTICIPANTS
PARTICIPANTS : :
: DT CAPITAL The
The CD 562
562 VBG participating
participating NNS adolescents
adolescents VBN represented
represented CD 92
92 NN %
% IN of
of NNS students
students IN in
in JJ mandatory
mandatory NNS classes

INTERVENTION NN CAPITAL INTERVENTION
INTERVENTION : :
: IN CAPITAL After
After JJ random
random NN assignment
assignment TO to
to CD 1
1 IN of
of CD 3
3 NNS groups
groups , ,
, DT the
the NNS adolescents
adolescents VBD listened
listened TO to
to DT a
a JJ standardized
standardized NN audiotape
audiotape NN depiction
depiction IN of
of DT an
an NN office
office NN visit
visit IN during
during WDT which
which PRP they
they VBN heard
heard DT a
a NN physician
physician WP who
who VBN assured
assured JJ unconditional
unconditional NN confidentiality
confidentiality , ,
, DT a
a NN physician
physician WP who
who VBN assured
assured JJ conditional
conditional NN confidentiality
confidentiality , ,
, CC or
or DT a
a NN physician
physician WP who
who VBD did
did RB not
not NN mention
mention NN confidentiality

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: NNS CAPITAL Adolescents
Adolescents '' '
' NN willingness
willingness TO to
to VB disclose
disclose JJ general
general NN information
information , ,
, NN willingness
willingness TO to
to VB disclose
disclose NN information
information IN about
about JJ sensitive
sensitive NNS topics
topics , ,
, VBN intended
intended NN honesty
honesty , ,
, CC and
and NN likelihood
likelihood IN of
of NN return
return NNS visits
visits TO to
to DT the
the NN physician
physician VBN depicted
depicted IN in
in DT the
the NN scenario
scenario VBD were
were VBN assessed
assessed IN by
by JJ anonymous
anonymous VBN written
written NN questionnaire

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NNP CAPITAL Assurances
Assurances IN of
of NN confidentiality
confidentiality VBN increased
increased DT the
the NN number
number IN of
of NNS adolescents
adolescents JJ willing
willing TO to
to VB disclose
disclose JJ sensitive
sensitive NN information
information IN about
about NN sexuality
sexuality , ,
, NN substance
substance NN use
use , ,
, CC and
and JJ mental
mental NN health
health IN from
from CD 39
39 NN %
% NN (
( CD 68/175
68/175 NN )
) TO to
to CD 46.5
46.5 NN %
% NN (
( CD 178/383
178/383 NN )
) NN (
( NN beta=.10
beta=.10 , ,
, NN CAPITAL P=.02
P=.02 NN )
) CC and
and VBN increased
increased DT the
the NN number
number JJ willing
willing TO to
to VB seek
seek NN future
future NN health
health NN care
care IN from
from CD 53
53 NN %
% NN (
( CD 93/175
93/175 NN )
) TO to
to CD 67
67 NN %
% NN (
( CD 259/386
259/386 NN )
) NN (
( NN beta=.17
beta=.17 , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD .001
.001 NN )

When WRB CAPITAL When
When VBG comparing
comparing DT the
the JJ unconditional
unconditional IN with
with DT the
the JJ conditional
conditional NNS groups
groups , ,
, NNS assurances
assurances IN of
of JJ unconditional
unconditional NN confidentiality
confidentiality VBN increased
increased DT the
the NN number
number IN of
of NNS adolescents
adolescents JJ willing
willing TO to
to NN return
return IN for
for DT a
a NN future
future NN visit
visit IN by
by CD 10
10 NN percentage
percentage NNS points
points , ,
, IN from
from CD 62
62 NN %
% NN (
( CD 122/196
122/196 NN )
) TO to
to CD 72
72 NN %
% NN (
( CD 137/190
137/190 NN )
) NN (
( NN beta=.14
beta=.14 , ,
, NN CAPITAL P=.001
P=.001 NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NNS CAPITAL Adolescents
Adolescents VBP are
are RBR more
more JJ willing
willing TO to
to VBP communicate
communicate IN with
with CC and
and VB seek
seek NN health
health NN care
care IN from
from NNS physicians
physicians WP who
who VB assure
assure NN confidentiality

Further RB CAPITAL Further
Further NN investigation
investigation VBZ is
is VBN needed
needed TO to
to VB identify
identify DT a
a NN confidentiality
confidentiality NN assurance
assurance NN statement
statement IN that
that VBZ explains
explains DT the
the JJ legal
legal CC and
and JJ ethical
ethical NNS limitations
limitations IN of
of NN confidentiality
confidentiality IN without
without VBG decreasing
decreasing NNS adolescents
adolescents '' '
' NN likelihood
likelihood IN of
of VBG seeking
seeking NN future
future NN health
health NN care
care IN for
for JJ routine
routine CC and
and JJ nonreportable
nonreportable JJ sensitive
sensitive NN health
health NNS concerns

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: NNP CAPITAL Diabetic
Diabetic NN foot
foot NNS infections
infections NN cause
cause JJ substantial
substantial NN morbidity
morbidity CC and
and NN mortality

Neutrophil NN CAPITAL Neutrophil
Neutrophil NN superoxide
superoxide NN generation
generation , ,
, DT a
a JJ crucial
crucial NN part
part IN of
of NN neutrophil
neutrophil JJ bactericidal
bactericidal NN activity
activity , ,
, VBZ is
is JJ impaired
impaired IN in
in NN diabetes

Granulocyte-colony NN CAPITAL Granulocyte-colony
Granulocyte-colony VBG stimulating
stimulating NN factor
factor NN (
( NN CAPITAL G-CSF
G-CSF NN )
) NNS increases
increases DT the
the NN release
release IN of
of NNS neutrophils
neutrophils IN from
from DT the
the NN bone
bone NN marrow
marrow CC and
and VBZ improves
improves NN neutrophil
neutrophil NN function

We PRP CAPITAL We
We VBN assessed
assessed NN CAPITAL G-CSF
G-CSF IN as
as JJ adjuvant
adjuvant NN therapy
therapy IN for
for DT the
the NN treatment
treatment IN of
of JJ severe
severe NN foot
foot NNS infections
infections IN in
in JJ diabetic
diabetic NNS patients

METHODS NNS CAPITAL METHODS
METHODS : :
: CD 40
40 JJ diabetic
diabetic NNS patients
patients IN with
with NN foot
foot NNS infections
infections VBD were
were VBN enrolled
enrolled IN in
in DT a
a JJ double-blind
double-blind JJ placebo-controlled
placebo-controlled NN study

On IN CAPITAL On
On NN admission
admission , ,
, NNS patients
patients VBD were
were RB randomly
randomly VBN assigned
assigned NN CAPITAL G-CSF
G-CSF NN (
( NN filgrastim
filgrastim NN )
) NN therapy
therapy NN (
( NN n
n JJ =
= CD 20
20 NN )
) CC or
or NN placebo
placebo NN (
( NN n
n JJ =
= CD 20
20 NN )
) IN for
for CD 7
7 NNS days

Both DT CAPITAL Both
Both NNS groups
groups VBN received
received JJ similar
similar JJ antibiotic
antibiotic CC and
and NN insulin
insulin NN treatment

Neutrophils NNS CAPITAL Neutrophils
Neutrophils IN from
from DT the
the JJ peripheral
peripheral NN blood
blood IN of
of DT these
these NNS participants
participants CC and
and IN from
from JJ healthy
healthy NNS controls
controls VBD were
were VBN stimulated
stimulated IN with
with VBN opsonised
opsonised NN zymosan
zymosan , ,
, CC and
and NN superoxide
superoxide NN production
production VBD was
was VBN measured
measured IN by
by DT a
a JJ spectrophotometric
spectrophotometric NN assay
assay NN (
( NN reduction
reduction IN of
of NN ferricytochrome
ferricytochrome NN CAPITAL C
C NN )

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNS CAPITAL FINDINGS
FINDINGS : :
: NN CAPITAL G-CSF
G-CSF NN therapy
therapy VBD was
was VBN associated
associated IN with
with RB earlier
earlier NN eradication
eradication IN of
of NNS pathogens
pathogens IN from
from DT the
the JJ infected
infected NN ulcer
ulcer NN (
( NN median
median CD 4
4 NN (
( NN range
range CD 2-10
2-10 NN )
) CC vs
vs CD 8
8 NN (
( CD 2-79
2-79 NN )
) NNS days
days IN in
in DT the
the NN placebo
placebo NN group
group : ;
; NN p
p JJ =
= CD 0.02
0.02 NN )
) , ,
, JJR quicker
quicker NN resolution
resolution IN of
of NNS cellulitis
cellulitis JJR <
< NN (
( CD 7
7 NN (
( CD 5-20
5-20 NN )
) CC vs
vs CD 12
12 NN (
( NN 5-93
5-93 NN )
) NNS days
days : ;
; NN p
p JJ =
= CD 0.03
0.03 NN )
) , ,
, JJR shorter
shorter NN hospital
hospital NN stay
stay NN (
( CD 10
10 NN (
( CD 7-31
7-31 NN )
) CC vs
vs CD 17.5
17.5 NN (
( CD 9-100
9-100 NN )
) NNS days
days : ;
; NN p
p JJ =
= CD 0.02
0.02 NN )
) , ,
, CC and
and DT a
a JJR shorter
shorter NN duration
duration IN of
of JJ intravenous
intravenous JJ antibiotic
antibiotic NN treatment
treatment NN (
( CD 8.5
8.5 NN (
( CD 5-30
5-30 NN )
) CC vs
vs CD 14.5
14.5 NN (
( CD 8-63
8-63 NN )
) NNS days
days : ;
; NN p
p JJ =
= CD 0.02
0.02 NN )

No DT CAPITAL No
No JJ CAPITAL G-CSF-treated
G-CSF-treated NN patient
patient VBN needed
needed NN surgery
surgery , ,
, IN whereas
whereas CD two
two NN placebo
placebo NNS recipients
recipients VBD underwent
underwent TO to
to NN amputation
amputation CC and
and CD two
two VBD had
had JJ extensive
extensive NN debridement
debridement IN under
under NN anaesthesia

After IN CAPITAL After
After CD 7
7 NNS days
days '' '
' NN treatment
treatment , ,
, NN neutrophil
neutrophil NN superoxide
superoxide NN production
production VBD was
was RB significantly
significantly JJR higher
higher IN in
in DT the
the NN CAPITAL G-CSF
G-CSF NN group
group IN than
than IN in
in DT the
the NN placebo
placebo NN group
group NN (
( CD 16.1
16.1 NN (
( CD 4.2-24.2
4.2-24.2 NN )
) CC vs
vs CD 7.3
7.3 NN (
( CD 2.1-11.5
2.1-11.5 NN )
) NN nmol
nmol IN per
per CD 10
10 NN (
( CD 6
6 NN )
) NNS neutrophils
neutrophils IN in
in CD 30
30 NN min
min : ;
; NN p
p CC &
& # #
# CD 60
60 : ;
; CD 0.0001
0.0001 NN )

G-CSF NN CAPITAL G-CSF
G-CSF NN therapy
therapy VBD was
was RB generally
generally RB well
well VBN tolerated

INTERPRETATION NN CAPITAL INTERPRETATION
INTERPRETATION : :
: NN CAPITAL G-CSF
G-CSF NN treatment
treatment VBD was
was VBN associated
associated IN with
with VBN improved
improved JJ clinical
clinical NN outcome
outcome IN of
of NN foot
foot NN infection
infection IN in
in JJ diabetic
diabetic NNS patients

This DT CAPITAL This
This NN improvement
improvement MD may
may VB be
be JJ related
related TO to
to DT an
an NN increase
increase IN in
in NN neutrophil
neutrophil NN superoxide
superoxide NN production

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: VBN CAPITAL Accelerated
Accelerated NN infusion
infusion IN of
of RB alteplase
alteplase NN (
( NN tissue
tissue NN plasminogen
plasminogen NN activator
activator NN )
) IN over
over DT a
a NN period
period IN of
of CD 90
90 NNS minutes
minutes VBZ induces
induces RBR more
more JJ rapid
rapid NN lysis
lysis IN of
of NN coronary-artery
coronary-artery NN thrombi
thrombi IN than
than DT a
a JJ 3-hour
3-hour NN infusion

With IN CAPITAL With
With CD two
two NN bolus
bolus NNS doses
doses IN of
of RB alteplase
alteplase , ,
, RB further
further VBG shortening
shortening DT the
the NN duration
duration IN of
of NN administration
administration , ,
, JJ complete
complete NN reperfusion
reperfusion VBD was
was VBN achieved
achieved IN in
in RBR more
more IN than
than CD 85
85 NN percent
percent IN of
of DT the
the NNS patients
patients IN in
in JJ initial
initial JJ angiographic
angiographic NNS studies

We PRP CAPITAL We
We VBN tested
tested DT the
the NN hypothesis
hypothesis IN that
that JJ double-bolus
double-bolus RB alteplase
alteplase VBZ is
is IN at
at JJS least
least IN as
as JJ effective
effective IN as
as VBN accelerated
accelerated NN infusion

METHODS NNS CAPITAL METHODS
METHODS : :
: IN CAPITAL In
In CD 398
398 NNS hospitals
hospitals , ,
, CD 7169
7169 NNS patients
patients IN with
with JJ acute
acute JJ myocardial
myocardial NN infarction
infarction VBD were
were RB randomly
randomly VBN assigned
assigned TO to
to JJ weight-adjusted
weight-adjusted , ,
, VBN accelerated
accelerated NN infusion
infusion IN of
of CD 100
100 NN mg
mg IN of
of RB alteplase
alteplase CC or
or TO to
to DT a
a NN bolus
bolus IN of
of CD 50
50 NN mg
mg IN of
of RB alteplase
alteplase IN over
over DT a
a NN period
period IN of
of CD 1
1 TO to
to CD 3
3 NNS minutes
minutes VBN followed
followed CD 30
30 NNS minutes
minutes RB later
later IN by
by DT a
a JJ second
second NN bolus
bolus IN of
of CD 50
50 NN mg
mg NN (
( CC or
or CD 40
40 NN mg
mg IN for
for NNS patients
patients WP who
who VBD weighed
weighed JJR less
less IN than
than CD 60
60 NN kg
kg NN )

The DT CAPITAL The
The JJ primary
primary NN end
end NN point
point VBD was
was NN death
death IN from
from DT any
any NN cause
cause IN at
at CD 30
30 NNS days

The DT CAPITAL The
The NN trial
trial VBD was
was VBD stopped
stopped RB prematurely
prematurely IN because
because IN of
of NN concern
concern IN about
about DT the
the NN safety
safety IN of
of DT the
the JJ double-bolus
double-bolus NN injection

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: JJ CAPITAL Thirty-day
Thirty-day NN mortality
mortality VBD was
was JJR higher
higher IN in
in DT the
the JJ double-bolus
double-bolus NN group
group IN than
than IN in
in DT the
the NN accelerated-infusion
accelerated-infusion NN group
group : :
: CD 7.98
7.98 NN percent
percent IN as
as VBN compared
compared IN with
with CD 7.53
7.53 NN percent

The DT CAPITAL The
The JJ absolute
absolute NN difference
difference VBD was
was CD 0.44
0.44 NN percent
percent , ,
, IN with
with DT a
a JJ one-sided
one-sided CD 95
95 NN percent
percent JJ upper
upper NN boundary
boundary IN of
of CD 1.49
1.49 NN percent
percent , ,
, WDT which
which VBN exceeded
exceeded DT the
the VBD prespecified
prespecified JJ upper
upper NN limit
limit IN of
of CD 0.40
0.40 NN percent
percent TO to
to VBP indicate
indicate JJ equivalence
equivalence IN in
in JJ 30-day
30-day NN mortality
mortality IN between
between DT the
the CD two
two NNS regimens

The DT CAPITAL The
The JJ respective
respective NNS rates
rates IN of
of DT any
any NN stroke
stroke CC and
and IN of
of JJ hemorrhagic
hemorrhagic NN stroke
stroke VBD were
were CD 1.92
1.92 CC and
and CD 1.12
1.12 NN percent
percent IN after
after JJ double-bolus
double-bolus RB alteplase
alteplase , ,
, IN as
as VBN compared
compared IN with
with CD 1.53
1.53 CC and
and CD 0.81
0.81 NN percent
percent IN after
after DT an
an VBN accelerated
accelerated NN infusion
infusion IN of
of RB alteplase
alteplase NN (
( NN CAPITAL P=0.24
P=0.24 CC and
and NN CAPITAL P=0.23
P=0.23 , ,
, RB respectively
respectively NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: JJ CAPITAL Double-bolus
Double-bolus RB alteplase
alteplase VBD was
was RB not
not VBN shown
shown TO to
to VB be
be JJ equivalent
equivalent , ,
, VBG according
according TO to
to DT the
the VBD prespecified
prespecified NNS criteria
criteria , ,
, TO to
to VBN accelerated
accelerated NN infusion
infusion IN with
with NN regard
regard TO to
to JJ 30-day
30-day NN mortality

There EX CAPITAL There
There VBD was
was RB also
also DT a
a RB slightly
slightly JJR higher
higher NN rate
rate IN of
of JJ intracranial
intracranial NN hemorrhage
hemorrhage IN with
with DT the
the JJ double-bolus
double-bolus NN method

Therefore RB CAPITAL Therefore
Therefore , ,
, VBN accelerated
accelerated NN infusion
infusion IN of
of RB alteplase
alteplase IN over
over DT a
a NN period
period IN of
of CD 90
90 NNS minutes
minutes NNS remains
remains DT the
the VBN preferred
preferred NNS regimen

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: NN CAPITAL Fenfluramine
Fenfluramine CC and
and NN phentermine
phentermine VB have
have VBN been
been RB individually
individually VBN approved
approved IN as
as NN anorectic
anorectic NNS agents
agents IN by
by DT the
the NNP CAPITAL Food
Food CC and
and NN CAPITAL Drug
Drug NN CAPITAL Administration
Administration NN (
( NNP CAPITAL FDA
FDA NN )

When WRB CAPITAL When
When VBN used
used IN in
in NN combination
combination DT the
the NNS drugs
drugs MD may
may VB be
be RB just
just IN as
as JJ effective
effective IN as
as DT either
either NN drug
drug RB alone
alone , ,
, IN with
with DT the
the VBN added
added NNS advantages
advantages IN of
of DT the
the NN need
need IN for
for JJR lower
lower NNS doses
doses IN of
of DT each
each NN agent
agent CC and
and RB perhaps
perhaps JJR fewer
fewer NN side
side NNS effects

Although IN CAPITAL Although
Although DT the
the NN combination
combination VBZ has
has RB not
not VBN been
been VBN approved
approved IN by
by DT the
the NNP CAPITAL FDA
FDA , ,
, IN in
in CD 1996
1996 DT the
the NN total
total NN number
number IN of
of NNS prescriptions
prescriptions IN in
in DT the
the NNP CAPITAL United
United NNPS CAPITAL States
States IN for
for NN fenfluramine
fenfluramine CC and
and NN phentermine
phentermine VBN exceeded
exceeded CD 18
18 CD million

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNS CAPITAL METHODS
METHODS : :
: PRP CAPITAL We
We VBN identified
identified JJ valvular
valvular NN heart
heart NN diseasein
diseasein CD 24
24 NNS women
women VBN treated
treated IN with
with NN fenfluramine-phentermine
fenfluramine-phentermine WP who
who VBD had
had DT no
no NN history
history IN of
of JJ cardiac
cardiac NN disease

The DT CAPITAL The
The NNS women
women VBN presented
presented IN with
with JJ cardiovascular
cardiovascular NNS symptoms
symptoms CC or
or DT a
a NN heart
heart NN murmur

As IN CAPITAL As
As VBG increasing
increasing NNS numbers
numbers IN of
of DT these
these NNS patients
patients IN with
with JJ similar
similar JJ clinical
clinical NNS features
features VBD were
were VBN identified
identified , ,
, RB there
there VBD appeared
appeared TO to
to VB be
be DT an
an NN association
association IN between
between DT these
these NNS features
features CC and
and NN fenfluramine-phentermine
fenfluramine-phentermine NN therapy

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: CD CAPITAL Twenty-four
Twenty-four NNS women
women NN (
( VB mean
mean NN (
( NN +/-SD
+/-SD NN )
) NN age
age , ,
, CD 44+/-8
44+/-8 NNS years
years NN )
) VBD were
were VBN evaluated
evaluated CD 12.3+/-7.1
12.3+/-7.1 NNS months
months IN after
after DT the
the NN initiation
initiation IN of
of NN fenfluramine-phentermine
fenfluramine-phentermine NN therapy

Echocardiography NN CAPITAL Echocardiography
Echocardiography VBN demonstrated
demonstrated JJ unusual
unusual JJ valvular
valvular NN morphology
morphology CC and
and NN regurgitation
regurgitation IN in
in DT all
all NNS patients

Both DT CAPITAL Both
Both JJ right-sided
right-sided CC and
and JJ left-sided
left-sided NN heart
heart NNS valves
valves VBD were
were VBN involved

Eight CD CAPITAL Eight
Eight NNS women
women RB also
also VBD had
had RB newly
newly VBN documented
documented JJ pulmonary
pulmonary NN hypertension

To TO CAPITAL To
To NN date
date , ,
, JJ cardiac
cardiac JJ surgical
surgical NN intervention
intervention VBZ has
has VBN been
been VBN required
required IN in
in CD five
five NNS patients

The DT CAPITAL The
The NN heart
heart NNS valves
valves VBD had
had DT a
a VBG glistening
glistening JJ white
white NN appearance

Histopathological JJ CAPITAL Histopathological
Histopathological NNS findings
findings VBN included
included JJ plaque-like
plaque-like NN encasement
encasement IN of
of DT the
the NNS leaflets
leaflets CC and
and JJ chordal
chordal NNS structures
structures IN with
with JJ intact
intact NN valve
valve NN architecture

The DT CAPITAL The
The JJ histopathological
histopathological NNS features
features VBD were
were JJ identical
identical TO to
to DT those
those VBN seen
seen IN in
in NN carcinoid
carcinoid CC or
or JJ ergotamine-induced
ergotamine-induced NN valve
valve NN disease

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL These
These NNS cases
cases VB arouse
arouse NN concern
concern IN that
that NN fenfluramine-phentermine
fenfluramine-phentermine NN therapy
therapy MD may
may VB be
be VBN associated
associated IN with
with JJ valvular
valvular NN heart
heart NN disease

Candidates NNS CAPITAL Candidates
Candidates IN for
for NN fenfluramine-phentermine
fenfluramine-phentermine NN therapy
therapy MD should
should VB be
be VBN informed
informed IN about
about JJ serious
serious NN potential
potential JJ adverse
adverse NNS effects
effects , ,
, VBG including
including JJ pulmonary
pulmonary NN hypertension
hypertension CC and
and JJ valvular
valvular NN heart
heart NN disease

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL Between
Between CD 1987
1987 CC and
and CD 1992
1992 , ,
, DT all
all NNS patients
patients VBG presenting
presenting TO to
to DT the
the JJ senior
senior NN author
author IN with
with DT a
a JJ symptomatic
symptomatic VBD failed
failed NN silicone
silicone VB implant
implant NN arthroplasty
arthroplasty JJ refractory
refractory TO to
to JJ conservative
conservative NN treatment
treatment VBD were
were VBN converted
converted TO to
to DT a
a NN metatarsophalangeal
metatarsophalangeal NN joint
joint NN arthrodesis

Internal JJ CAPITAL Internal
Internal NN fixation
fixation VBD was
was VBN achieved
achieved IN with
with DT either
either JJ dual
dual JJ intrameduilary
intrameduilary VBN threaded
threaded NNP CAPITAL Steinmann
Steinmann NNS pins
pins CC or
or DT an
an RB obliquely
obliquely VBN placed
placed JJ CAPITAL AO
AO NN compression
compression VB screw
screw CC and
and DT a
a CD three-
three- CC or
or JJ four-hole
four-hole NN one-third
one-third JJ tubular
tubular NN dorsal
dorsal NN neutralization
neutralization NN plate

Bone NN CAPITAL Bone
Bone VBG grafting
grafting VBD was
was VBN used
used TO to
to VB maintain
maintain NN hallux
hallux NN length

Successful JJ CAPITAL Successful
Successful NN arthrodesis
arthrodesis VBD was
was VBN achieved
achieved IN in
in DT all
all CD five
five NNS feet
feet IN in
in NNS patients
patients IN with
with JJ rheumatoid
rheumatoid NN arthritis

Subjectively RB CAPITAL Subjectively
Subjectively , ,
, NNS patients
patients VBN improved
improved IN from
from DT an
an NN average
average IN of
of CD 0.69
0.69 IN before
before NN arthrodesis
arthrodesis TO to
to CD 4.89
4.89 IN after
after NN arthrodesis

The DT CAPITAL The
The NN average
average VBG walking
walking NN tolerance
tolerance VBN improved
improved IN from
from CD 1.11
1.11 TO to
to CD 4.80
4.80 , ,
, CC and
and DT the
the RB overall
overall NN level
level IN of
of NN satisfaction
satisfaction VBN improved
improved IN from
from CD 0.0
0.0 TO to
to CD 4.79

The DT CAPITAL The
The NN patient
patient POS 's
's NN ability
ability TO to
to NN wear
wear NNS shoes
shoes VBN improved
improved IN from
from CD 0.87
0.87 TO to
to CD 3.1

Successful JJ CAPITAL Successful
Successful NN arthrodesis
arthrodesis VBZ produces
produces DT a
a NN foot
foot IN that
that VBZ is
is RBR more
more JJ functional
functional CC and
and JJ durable
durable IN than
than JJ excisional
excisional NN arthroplasty

Subjectively RB CAPITAL Subjectively
Subjectively , ,
, DT these
these NNS patients
patients VBN stated
stated IN that
that PRP$ their
their NN level
level IN of
of NN pain
pain , ,
, VBG walking
walking NN tolerance
tolerance , ,
, CC and
and RB overall
overall NN satisfaction
satisfaction VBN improved
improved RB significantly
significantly IN after
after DT the
the NN arthrodesis

Clinically RB CAPITAL Clinically
Clinically , ,
, RB there
there VBD was
was DT no
no NN evidence
evidence IN of
of NN transfer
transfer NNS lesions
lesions , ,
, NN tenderness
tenderness , ,
, CC or
or NN hallux
hallux NN subluxation

Hallux NNP CAPITAL Hallux
Hallux NN length
length VBD was
was RB well
well VBN maintained
maintained IN after
after NN surgery
surgery IN with
with NN bone
bone VBG grafting
grafting , ,
, CC but
but PRP it
it VBD was
was RBR more
more JJ difficult
difficult TO to
to VB obtain
obtain DT the
the NN alignment
alignment NNS goals

The DT CAPITAL The
The NN average
average JJ postoperative
postoperative NN metatarsophalangeal
metatarsophalangeal NN dorsiflexion
dorsiflexion NN angle
angle VBD was
was CD 15.6
15.6 NNS degrees
degrees CC and
and DT the
the RB first
first NN metatarsophalangeal
metatarsophalangeal NN angle
angle VBD was
was CD 3.1
3.1 NNS degrees

Despite IN CAPITAL Despite
Despite DT this
this , ,
, NN patient
patient NN satisfaction
satisfaction VBD was
was JJ high

Arthrodesis FW CAPITAL Arthrodesis
Arthrodesis IN of
of DT the
the RB first
first NN metatarsophalangeal
metatarsophalangeal NN joint
joint VBG using
using DT a
a NN bone
bone NN graft
graft TO to
to NN salvage
salvage VBD failed
failed NN silicone
silicone VB implant
implant NN arthroplasty
arthroplasty VBZ produces
produces JJ acceptable
acceptable JJ subjective
subjective CC and
and JJ radiographic
radiographic NNS results

Although IN CAPITAL Although
Although RB technically
technically VBG demanding
demanding , ,
, PRP it
it VBZ provides
provides JJ long-term
long-term NN stability
stability TO to
to DT the
the NN hallux
hallux , ,
, VBZ restores
restores VBG weightbearing
weightbearing , ,
, CC and
and VBZ allows
allows IN for
for NN maintenance
maintenance IN of
of DT a
a JJ propulsive
propulsive NN gait

We PRP CAPITAL We
We VB recommend
recommend DT this
this NN procedure
procedure RB instead
instead IN of
of DT an
an JJ excisional
excisional NN arthroplasty
arthroplasty TO to
to VB maintain
maintain JJ high
high NN level
level IN of
of NN function
function CC and
and RB overall
overall NN patient
patient NN satisfaction

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To NN estimate
estimate DT the
the NN crude
crude NN incidence
incidence NNS rates
rates IN of
of JJ cerebrovascular
cerebrovascular NNS accidents
accidents IN among
among DT the
the JJ black
black NNS residents
residents IN of
of NNP CAPITAL Harare

DESIGN NN CAPITAL DESIGN
DESIGN : :
: JJ CAPITAL Prospective
Prospective JJ community-based
community-based NN study

SETTING VBG CAPITAL SETTING
SETTING : :
: NNP CAPITAL Black
Black NNS residents
residents IN of
of NNP CAPITAL Harare
Harare , ,
, NNP CAPITAL Zimbabwe

PARTICIPANTS NNS CAPITAL PARTICIPANTS
PARTICIPANTS : :
: CD CAPITAL Two
Two CD hundred
hundred CC and
and CD seventy-three
seventy-three NN 'first-ever
'first-ever '' '
' NNS strokes
strokes RB prospectively
prospectively VBN identified
identified IN over
over DT a
a JJ 12-month
12-month NN period

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NN CAPITAL STUDY
STUDY NNS CAPITAL FACTORS
FACTORS : :
: JJ CAPITAL Cerebrovascular
Cerebrovascular NN accident
accident JJ first-week
first-week NN fatality
fatality NN rate
rate : ;
; NN age-
age- CC and
and JJ sex-related
sex-related NN incidence

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The NN crude
crude NN incidence
incidence NN rate
rate VBD was
was VBN estimated
estimated TO to
to VB be
be CD 30.7
30.7 IN per
per CD 100000
100000 NN (
( CD 95
95 NN %
% NN confidence
confidence NN interval
interval CD 27.1-34.4
27.1-34.4 NN )
) CC and
and DT the
the VBN standardised
standardised NN rate
rate VBD was
was CD 68
68 IN per
per CD 100000

Fifty-one CD CAPITAL Fifty-one
Fifty-one IN per
per NN cent
cent IN of
of NN stroke
stroke NNS victims
victims VBD were
were IN below
below DT the
the NN age
age IN of
of CD 54
54 NNS years

Thirty-five CD CAPITAL Thirty-five
Thirty-five IN per
per NN cent
cent IN of
of NNS patients
patients VBD died
died IN within
within CD 1
1 NN week
week IN of
of DT the
the NN stroke

Overall RB CAPITAL Overall
Overall , ,
, DT the
the JJ age-specific
age-specific NNS rates
rates IN for
for DT both
both NNS sexes
sexes VBD rose
rose IN with
with NN age
age , ,
, IN with
with DT the
the NNS rates
rates IN for
for NNS women
women VBG being
being JJR higher
higher IN at
at DT all
all NN age
age NN strata
strata IN except
except IN for
for DT the
the NN group
group CD 45-54
45-54 NNS years

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: IN CAPITAL With
With DT a
a VBN standardised
standardised NN rate
rate IN of
of CD 68
68 IN per
per CD 100000
100000 CC and
and DT a
a JJ first-week
first-week NN mortality
mortality NN rate
rate IN of
of CD 35
35 NN %
% , ,
, NN stroke
stroke MD must
must RB now
now VB be
be VBN considered
considered DT an
an JJ important
important NN cause
cause IN of
of NN morbidity
morbidity CC and
and NN mortality
mortality IN in
in DT the
the NN population

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB explore
explore DT the
the JJ long-term
long-term NN effect
effect IN of
of NN calcium
calcium NN supplementation
supplementation IN during
during NN pregnancy
pregnancy IN on
on DT the
the NN offspring
offspring POS 's
's NN blood
blood NN pressure
pressure IN during
during NN childhood

DESIGN NN CAPITAL DESIGN
DESIGN : :
: VB CAPITAL Follow
Follow RB up
up IN of
of DT a
a NN population
population VBN enrolled
enrolled IN in
in DT a
a RB double
double JJ blind
blind , ,
, VBN randomised
randomised , ,
, NN placebo
placebo VBN controlled
controlled NN trial

SETTING VBG CAPITAL SETTING
SETTING : :
: JJ CAPITAL Perinatal
Perinatal NN research
research NN unit
unit , ,
, NNP CAPITAL World
World NNP CAPITAL Health
Health NNP CAPITAL Organisation
Organisation POS 's
's JJ collaborative
collaborative NN research
research NN centre

SUBJECTS NNS CAPITAL SUBJECTS
SUBJECTS : :
: CD 591
591 NNS children
children IN at
at DT a
a VB mean
mean NN age
age IN of
of CD 7
7 NNS years
years WP$ whose
whose NNS mothers
mothers VBD were
were RB randomly
randomly VBN assigned
assigned IN during
during NN pregnancy
pregnancy TO to
to VB receive
receive CD 2
2 NN g/day
g/day IN of
of JJ elemental
elemental NN calcium
calcium NN (
( NN n
n JJ =
= CD 298
298 NN )
) CC or
or NN placebo
placebo NN (
( NN n
n JJ =
= CD 293
293 NN )

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: NN CAPITAL Mean
Mean NN blood
blood NN pressure
pressure CC and
and NN rate
rate IN of
of JJ high
high NN blood
blood NN pressure
pressure IN of
of NNS children

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: RB CAPITAL Overall
Overall , ,
, JJ systolic
systolic NN blood
blood NN pressure
pressure VBD was
was JJR lower
lower IN in
in DT the
the NN calcium
calcium NN group
group NN (
( VB mean
mean NN difference
difference CD -1.4
-1.4 NN mm
mm NN CAPITAL Hg
Hg : ;
; CD 95
95 NN %
% NN confidence
confidence NN interval
interval CD -3.2
-3.2 TO to
to CD 0.5
0.5 NN )
) IN than
than IN in
in DT the
the NN placebo
placebo NN group

The DT CAPITAL The
The NN effect
effect VBD was
was VBN found
found RB predominantly
predominantly IN among
among NNS children
children WP$ whose
whose NN body
body NN mass
mass NN index
index IN at
at NN assessment
assessment VBD was
was IN above
above DT the
the NN median
median IN for
for DT this
this NN population
population NN (
( VB mean
mean NN difference
difference IN in
in JJ systolic
systolic NN blood
blood NN pressure
pressure CD -5.8
-5.8 NN mm
mm NN CAPITAL Hg
Hg NN (
( CD -9.8
-9.8 NN mm
mm NN CAPITAL Hg
Hg TO to
to CD -1.7
-1.7 NN mm
mm NN CAPITAL Hg
Hg NN )
) IN for
for NNS children
children IN with
with DT an
an NN index
index JJR >
> CD 17.5
17.5 CC and
and CD -3.2
-3.2 NN mm
mm NN CAPITAL Hg
Hg NN (
( CD -6.3
-6.3 NN mm
mm NN CAPITAL Hg
Hg TO to
to CD -0.1
-0.1 NN mm
mm NN CAPITAL Hg
Hg NN )
) IN for
for DT those
those IN with
with DT an
an NN index
index IN of
of JJR >
> CD 15.7
15.7 TO to
to CD 17.5
17.5 NN )

The DT CAPITAL The
The NN risk
risk IN of
of JJ high
high JJ systolic
systolic NN blood
blood NN pressure
pressure VBD was
was RB also
also JJR lower
lower IN in
in DT the
the NN calcium
calcium NN group
group IN than
than IN in
in DT the
the NN placebo
placebo NN group
group NN (
( JJ relative
relative NN risk
risk CD 0.59
0.59 : ;
; CD 0.39
0.39 TO to
to CD 0.90
0.90 NN )
) CC and
and RB particularly
particularly IN among
among NNS children
children IN in
in DT the
the JJS highest
highest JJ fourth
fourth IN of
of NN body
body NN mass
mass NN index
index NN (
( CD 0.43
0.43 : ;
; CD 0.26
0.26 TO to
to CD 0.71
0.71 NN )

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: NN CAPITAL Calcium
Calcium NN supplementation
supplementation IN during
during NN pregnancy
pregnancy VBZ is
is VBN associated
associated IN with
with JJR lower
lower JJ systolic
systolic NN blood
blood NN pressure
pressure IN in
in DT the
the NN offspring
offspring , ,
, RB particularly
particularly IN among
among JJ overweight
overweight NNS children

The DT CAPITAL The
The RB fast
fast NN reaction
reaction IN of
of NN peroxynitrite
peroxynitrite IN with
with NN CAPITAL CO2
CO2 CC and
and DT the
the JJ high
high NN concentration
concentration IN of
of VBN dissolved
dissolved NN CAPITAL CO2
CO2 IN in
in FW vivo
vivo NN (
( MD ca

1 CD 1
1 NN mM
mM NN )
) VB suggest
suggest IN that
that NN CAPITAL CO2
CO2 VBZ modulates
modulates RBS most
most IN of
of DT the
the NNS reactions
reactions IN of
of NN peroxynitrite
peroxynitrite IN in
in JJ biological
biological NNS systems

The DT CAPITAL The
The NN addition
addition IN of
of NN peroxynitrite
peroxynitrite TO to
to NN CAPITAL CO2
CO2 VBZ produces
produces IN of
of DT the
the NN adduct
adduct NN CAPITAL ONOO-CO2-
ONOO-CO2- NN (
( CD 1
1 NN )

The DT CAPITAL The
The NN production
production IN of
of CD 1
1 RB greatly
greatly VBZ accelerates
accelerates DT the
the NN decomposition
decomposition IN of
of NN peroxynitrite
peroxynitrite TO to
to VB give
give VB nitrate

We PRP CAPITAL We
We RB now
now NN show
show IN that
that DT the
the NN formation
formation IN of
of CD 1
1 VBZ is
is VBN followed
followed IN by
by NN reformation
reformation IN of
of NN CAPITAL CO2
CO2 NN (
( RB rather
rather IN than
than DT another
another NN carbonate
carbonate NNS species
species JJ such
such IN as
as NN CAPITAL CO3
CO3 JJ =
= CC or
or JJ CAPITAL HCO3-
HCO3- NN )

To TO CAPITAL To
To NN show
show DT this
this , ,
, PRP it
it VBZ is
is JJ necessary
necessary TO to
to NN study
study NNS systems
systems IN with
with VBG limiting
limiting NNS concentrations
concentrations IN of
of NN CAPITAL CO2

( NN (
( WRB CAPITAL When
When NN CAPITAL CO2
CO2 VBZ is
is JJ present
present IN in
in NN excess
excess , ,
, PRP$ its
its NN concentration
concentration NNS remains
remains RB nearly
nearly JJ constant
constant IN during
during DT the
the NN decomposition
decomposition IN of
of NN peroxynitrite
peroxynitrite , ,
, CC and
and DT the
the VBG recycling
recycling IN of
of NN CAPITAL CO2
CO2 , ,
, IN although
although PRP it
it VBZ occurs
occurs , ,
, MD can
can RB not
not VB be
be VBN detected
detected RB kinetically
kinetically NN )

We PRP CAPITAL We
We VB find
find IN that
that NN CAPITAL CO2
CO2 VBZ is
is DT a
a JJ true
true NN catalyst
catalyst IN of
of DT the
the NN decomposition
decomposition IN of
of NN peroxynitrite
peroxynitrite , ,
, CC and
and DT this
this JJ fundamental
fundamental NN insight
insight IN into
into PRP$ its
its NN action
action MD must
must VB be
be VBN rationalized
rationalized IN by
by DT any
any IN in
in FW vivo
vivo CC or
or IN in
in NN vitro
vitro NN reaction
reaction NN mechanism
mechanism IN that
that VBZ is
is VBN proposed

When WRB CAPITAL When
When DT the
the NN concentration
concentration IN of
of NN CAPITAL CO2
CO2 VBZ is
is JJR lower
lower IN than
than IN that
that IN of
of NN peroxynitrite
peroxynitrite , ,
, DT the
the NN reformation
reformation IN of
of NN CAPITAL CO2
CO2 VBZ amplifies
amplifies DT the
the NN fraction
fraction IN of
of NN peroxynitrite
peroxynitrite IN that
that VBZ reacts
reacts IN with
with NN CAPITAL CO2

Even RB CAPITAL Even
Even JJ low
low NNS concentrations
concentrations IN of
of NN CAPITAL CO2
CO2 IN that
that NN result
result IN from
from DT the
the NN dissolution
dissolution IN of
of JJ ambient
ambient NN CAPITAL CO2
CO2 MD can
can VB have
have JJ pronounced
pronounced JJ catalytic
catalytic NNS effects

These DT CAPITAL These
These NNS effects
effects MD can
can NN cause
cause NNS deviations
deviations IN from
from VBN predicted
predicted JJ kinetic
kinetic NN behavior
behavior IN in
in NNS studies
studies IN of
of NN peroxynitrite
peroxynitrite IN in
in JJ noncarbonate
noncarbonate NNS buffers
buffers IN in
in NN vitro
vitro , ,
, CC and
and IN since
since CD 1
1 CC and
and JJ other
other NNS intermediates
intermediates VBN derived
derived IN from
from PRP it
it VBP are
are NNS oxidants
oxidants CC and/or
and/or VBG nitrating
nitrating NNS agents
agents , ,
, DT some
some IN of
of DT the
the NNS reactions
reactions VBN attributed
attributed TO to
to NN peroxynitrite
peroxynitrite MD may
may VB depend
depend IN on
on DT the
the NN availability
availability IN of
of NN CAPITAL CO2

A DT CAPITAL A
A JJ prospective
prospective , ,
, VBN randomized
randomized , ,
, JJ placebo-controlled
placebo-controlled , ,
, JJ double-blind
double-blind , ,
, NN parallel-group
parallel-group , ,
, JJ 6-month
6-month NN study
study VBN assessed
assessed DT the
the NN efficacy
efficacy CC and
and NN safety
safety IN of
of NN ropinirole
ropinirole , ,
, DT a
a NN nonergoline
nonergoline NN CAPITAL D2-dopamine
D2-dopamine NN agonist
agonist , ,
, IN in
in NNS patients
patients IN with
with RB early
early NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease
disease NN (
( NN n
n JJ =
= CD 241
241 : ;
; NNP CAPITAL Hoehn
Hoehn CC &
& # #
# CD 38
38 : ;
; NN CAPITAL Yahr
Yahr NNS stages
stages PRP CAPITAL I
I TO to
to NNP CAPITAL III
III NN )
) IN with
with JJ limited
limited CC or
or DT no
no RB prior
prior JJ dopaminergic
dopaminergic NN therapy

Patients NNS CAPITAL Patients
Patients NN (
( VB mean
mean NN age
age , ,
, CD 62.8
62.8 NNS years
years NN )
) , ,
, VBN stratified
stratified IN by
by JJ concomitant
concomitant NN use
use IN of
of NN selegiline
selegiline , ,
, VBD were
were VBN randomized
randomized TO to
to NN ropinirole
ropinirole NN (
( NN n
n JJ =
= CD 116
116 NN )
) CC or
or NN placebo
placebo NN (
( NN n
n JJ =
= CD 125
125 NN )

The DT CAPITAL The
The VBG starting
starting NN dose
dose IN of
of NN ropinirole
ropinirole VBD was
was CD 0.25
0.25 NN mg
mg NN tid
tid IN with
with NN titration
titration TO to
to IN at
at JJS least
least CD 1.5
1.5 NN mg
mg NN tid
tid NN (
( NN maximum
maximum NN dose
dose , ,
, CD 8
8 NN mg
mg NN tid
tid NN )

Primary JJ CAPITAL Primary
Primary NN efficacy
efficacy NN endpoint
endpoint VBD was
was DT the
the NN percentage
percentage NN improvement
improvement IN in
in JJ CAPITAL Unified
Unified NNP CAPITAL Parkinson
Parkinson POS 's
's NN CAPITAL Disease
Disease NNP CAPITAL Rating
Rating NNP CAPITAL Scale
Scale NN (
( NNS CAPITAL UPDRS
UPDRS NN )
) NN motor
motor NN score

Ropinirole-treated JJ CAPITAL Ropinirole-treated
Ropinirole-treated NNS patients
patients VBD had
had DT a
a RB significantly
significantly JJR greater
greater NN percentage
percentage NN improvement
improvement IN in
in NNS CAPITAL UPDRS
UPDRS NN motor
motor NN score
score IN than
than NNS patients
patients WP who
who VBN received
received NN placebo
placebo NN (
( CD +24
+24 NN %
% CC vs
vs CD -3
-3 NN %
% : ;
; NN p
p CC &
& # #
# CD 60
60 : ;
; CD 0.001
0.001 NN )

Ropinirole NNP CAPITAL Ropinirole
Ropinirole VBD was
was RB well
well VBN tolerated
tolerated CC and
and NN patient
patient NNS withdrawals
withdrawals VBD were
were JJ infrequent

Most JJS CAPITAL Most
Most JJ adverse
adverse NNS experiences
experiences VBD were
were JJ related
related TO to
to JJ peripheral
peripheral JJ dopaminergic
dopaminergic NN activity

Ropinirole NNP CAPITAL Ropinirole
Ropinirole NN monotherapy
monotherapy VBZ is
is DT an
an JJ effective
effective CC and
and JJ well-tolerated
well-tolerated JJ therapeutic
therapeutic NN option
option IN for
for NN treatment
treatment IN of
of RB early
early NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease

Starfish NNP CAPITAL Starfish
Starfish NNS oocytes
oocytes MD can
can VB be
be VBN fertilized
fertilized IN after
after JJ germinal
germinal NN vesicle
vesicle NN breakdown
breakdown NN (
( NN CAPITAL GVBD
GVBD NN )
) CC and
and JJ artificial
artificial NN parthenogenesis
parthenogenesis MD can
can VB be
be VBN induced
induced IN by
by VBG activating
activating DT the
the NNS oocytes
oocytes IN after
after NN CAPITAL GVBD
GVBD NN (
( JJ post-GVBD
post-GVBD NN activation
activation NN )

In IN CAPITAL In
In DT the
the JJ present
present NN study
study , ,
, NNS parthenogenotes
parthenogenotes VBD were
were VBN obtained
obtained IN by
by DT the
the NN activation
activation IN of
of JJ immature
immature NNS oocytes
oocytes IN with
with NN caffeine
caffeine IN before
before NN treatment
treatment IN with
with NN 1-methyladenine
1-methyladenine NN (
( NN 1-MeAde
1-MeAde NN )
) TO to
to VB induce
induce NN oocyte
oocyte NN maturation

Most JJS CAPITAL Most
Most IN of
of DT the
the JJ caffeine-treated
caffeine-treated NNS eggs
eggs VBN developed
developed IN as
as NNS tetraploids
tetraploids , ,
, IN as
as NNS parthenogenotes
parthenogenotes VBN produced
produced IN by
by DT the
the JJ post-GVBD
post-GVBD NN activation

The DT CAPITAL The
The NNS parthengenotes
parthengenotes VBD were
were VBN derived
derived RB only
only IN from
from NNS eggs
eggs IN that
that VBD failed
failed TO to
to VB extrude
extrude JJ polar
polar NNS bodies
bodies , ,
, RB mostly
mostly IN from
from NNS eggs
eggs VBG failing
failing TO to
to VB extrude
extrude DT a
a JJ second
second JJ polar
polar NN body

Eggs NNP CAPITAL Eggs
Eggs VBN derived
derived IN from
from JJ immature
immature NNS oocytes
oocytes VBN activated
activated IN by
by NN CAPITAL A23187
A23187 , ,
, VBN treated
treated IN with
with NN 1-MeAde
1-MeAde CC and
and JJ post-treated
post-treated IN with
with NN cytochalasin
cytochalasin NN CAPITAL B
B VBD failed
failed TO to
to VB extrude
extrude JJ polar
polar NNS bodies
bodies , ,
, CC and
and RB eventually
eventually VBN developed
developed IN into
into JJ parthenogenetic
parthenogenetic NNS embryos

These DT CAPITAL These
These NNS results
results VBP indicate
indicate IN that
that DT the
the JJ present
present NN parthenogenesis
parthenogenesis NN mechanism
mechanism NNS shares
shares DT the
the JJ same
same NNS characteristics
characteristics IN as
as IN that
that VBN achieved
achieved IN by
by JJ post-GVBD
post-GVBD NN activation
activation IN in
in DT the
the NN suppression
suppression IN of
of JJ polar
polar NN body
body NN formation
formation IN as
as DT a
a NN key
key NNS means
means IN for
for JJ successful
successful NN starfish
starfish NN parthenogenesis

We PRP CAPITAL We
We VBN hypothesized
hypothesized IN that
that NN fluoride
fluoride RB partly
partly NNS acts
acts IN by
by VBG changing
changing DT the
the NNS levels
levels IN of
of VBG circulating
circulating JJ calcium-regulating
calcium-regulating NNS hormones
hormones CC and
and JJ skeletal
skeletal NN growth
growth NNS factors

The DT CAPITAL The
The NNS effects
effects IN of
of JJ oral
oral NN fluoride
fluoride IN on
on CD 24
24 NN female
female , ,
, JJ CAPITAL Dutch-Belted
Dutch-Belted , ,
, JJ young
young JJ adult
adult NNS rabbits
rabbits VBD were
were VBN studied

The DT CAPITAL The
The NNS rabbits
rabbits VBD were
were VBN divided
divided IN into
into CD two
two NN study
study NNS groups
groups , ,
, CD one
one NN control
control CC and
and DT the
the JJ other
other VBG receiving
receiving IN about
about CD 16
16 NN mg
mg NN fluoride/rabbit/day
fluoride/rabbit/day IN in
in PRP$ their
their NN drinking
drinking NN water

After IN CAPITAL After
After CD 6
6 NNS months
months IN of
of NN fluoride
fluoride NN dosing
dosing , ,
, DT all
all NNS rabbits
rabbits VBD were
were VBN euthanized
euthanized CC and
and NN bone
bone CC and
and NN blood
blood NNS samples
samples VBD were
were VBN taken
taken IN for
for NNS analyses

Fluoride NN CAPITAL Fluoride
Fluoride NN treatment
treatment VBN increased
increased NN serum
serum CC and
and NN bone
bone NN fluoride
fluoride NNS levels
levels IN by
by IN over
over DT an
an NN order
order IN of
of NN magnitude
magnitude NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.001
0.001 NN )
) , ,
, CC but
but VBD did
did RB not
not VB affect
affect NN body
body NN weight
weight CC or
or DT the
the VBG following
following NN serum
serum JJ biochemical
biochemical NNS variables
variables : :
: NN urea
urea , ,
, NN creatinine
creatinine , ,
, NN phosphorus
phosphorus , ,
, NN total
total NN protein
protein , ,
, NN albumin
albumin , ,
, NN bilirubin
bilirubin , ,
, NN CAPITAL SGOT
SGOT , ,
, CC or
or NN total
total NN alkaline
alkaline NN phosphatase

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> DT CAPITAL No
No JJ skeletal
skeletal NN fluorosis
fluorosis CC or
or NN osteomalacia
osteomalacia VBD was
was VBN observed
observed RB histologically
histologically , ,
, CC nor
nor VBD did
did NN fluoride
fluoride VB affect
affect NN serum
serum NN CAPITAL PTH
PTH CC or
or NN CAPITAL Vitamin
Vitamin NN CAPITAL D
D NNS metabolites
metabolites NN (
( NN CAPITAL P
P JJR >
> CD 0.4
0.4 NN )

BAP NN CAPITAL BAP
BAP VBD was
was VBN increased
increased CD 37
37 NN %
% NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) IN by
by NN fluoride
fluoride : ;
; NN serum
serum NN CAPITAL TRAP
TRAP VBD was
was VBN increased
increased CD 42
42 NN %
% NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) : ;
; NN serum
serum NN CAPITAL IGF-1
IGF-1 VBD was
was VBN increased
increased CD 40
40 NN %
% NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )

Fluoride NN CAPITAL Fluoride
Fluoride VBN increased
increased DT the
the NN vertebral
vertebral NN CAPITAL BV/TV
BV/TV IN by
by CD 35
35 NN %
% NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) CC and
and JJ tibial
tibial JJ ash
ash NN weight
weight IN by
by CD 10
10 NN %
% NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )

However RB CAPITAL However
However , ,
, DT the
the NNS increases
increases IN in
in NN bone
bone NN mass
mass CC and
and NN bone
bone NN formation
formation VBD were
were RB not
not VBN reflected
reflected IN in
in VBN improved
improved NN bone
bone NN strength

Fluoride NN CAPITAL Fluoride
Fluoride VBN decreased
decreased NN bone
bone NN strength
strength IN by
by IN about
about CD 19
19 NN %
% IN in
in DT the
the NN CAPITAL L5
L5 NN vertebra
vertebra NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.01
0.01 NN )
) CC and
and CD 25
25 NN %
% IN in
in DT the
the JJ femoral
femoral NN neck
neck NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0

05 NN 05
05 NN )

X-ray NN CAPITAL X-ray
X-ray NN diffraction
diffraction VBD showed
showed JJ altered
altered NN mineral
mineral NN crystal
crystal NN thickness
thickness IN in
in JJ fluoride-treated
fluoride-treated NNS bones
bones NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.001
0.001 NN )
) , ,
, CC and
and RB there
there VBD was
was DT a
a JJ negative
negative NN association
association IN between
between NN crystal
crystal NN width
width CC and
and NN fracture
fracture NN stress
stress IN of
of DT the
the NN femur
femur NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.02
0.02 NN )

In IN CAPITAL In
In NN conclusion
conclusion , ,
, NN fluoride
fluoride POS 's
's NNS effects
effects IN on
on NN bone
bone NN mass
mass CC and
and NN bone
bone NN turnover
turnover VBD were
were RB not
not VBN mediated
mediated IN by
by NN CAPITAL PTH

IGF-1 NN CAPITAL IGF-1
IGF-1 VBD was
was VBN increased
increased IN by
by NN fluoride
fluoride CC and
and VBD was
was VBN associated
associated IN with
with VBN increased
increased NN bone
bone NN turnover
turnover , ,
, CC but
but VBD was
was RB not
not VBD correlated
correlated IN with
with NN bone
bone NN formation
formation NNS markers

High-dose JJ CAPITAL High-dose
High-dose NN fluoride
fluoride NN treatment
treatment VBD did
did RB not
not VB improve
improve , ,
, CC but
but VBN decreased
decreased , ,
, NN bone
bone NN strength
strength IN in
in NNS rabbits
rabbits , ,
, RB even
even IN in
in DT the
the NN absence
absence IN of
of JJ impaired
impaired NN mineralization

PURPOSE NN CAPITAL PURPOSE
PURPOSE : :
: TO CAPITAL To
To VB determine
determine DT the
the NN effect
effect IN of
of JJ various
various NNS methods
methods IN of
of VBG managing
managing DT the
the NN posterior
posterior NN capsule
capsule CC and
and JJ anterior
anterior JJ vitreous
vitreous IN on
on DT the
the NN rate
rate IN of
of NN posterior
posterior NN capsule
capsule NN opacification
opacification IN in
in JJ pediatric
pediatric NNS eyes
eyes VBN implanted
implanted IN with
with NN posterior
posterior NN chamber
chamber JJ intraocular
intraocular NNS lenses
lenses NN (
( NN CAPITAL PC
PC NNS CAPITAL IOLs
IOLs NN )

SETTING VBG CAPITAL SETTING
SETTING : :
: NNP CAPITAL Cullen
Cullen NNP CAPITAL Eye
Eye NNP CAPITAL Institute
Institute , ,
, NNP CAPITAL Baylor
Baylor NNP CAPITAL College
College IN of
of NN CAPITAL Medicine
Medicine , ,
, NNP CAPITAL Houston
Houston , ,
, NNP CAPITAL Texas
Texas , ,
, NNP CAPITAL USA

METHODS NNS CAPITAL METHODS
METHODS : :
: PRP CAPITAL We
We VBN reviewed
reviewed DT the
the NNS charts
charts IN of
of CD 20
20 NNS eyes
eyes IN of
of CD 15
15 NNS children
children NN (
( JJ aged
aged CD 1.5
1.5 TO to
to CD 2
2 NNS years
years NN )
) WP who
who VBD had
had JJ primary
primary NN cataract
cataract NN surgery
surgery IN with
with NN CAPITAL PC
PC NNP CAPITAL IOL
IOL NN implantation
implantation IN during
during DT the
the IN past
past CD 5
5 NNS years

The DT CAPITAL The
The NN posterior
posterior NN capsule
capsule CC and
and JJ anterior
anterior JJ vitreous
vitreous VBD were
were VBN managed
managed IN in
in DT a
a NN variety
variety IN of
of NNS ways
ways : :
: IN CAPITAL In
In CD 5
5 NNS eyes
eyes , ,
, DT the
the NN posterior
posterior NN capsule
capsule VBD was
was RB left
left JJ intact
intact : ;
; IN in
in CD 15
15 NNS eyes
eyes , ,
, DT a
a NN posterior
posterior JJ continuous
continuous NN curvilinear
curvilinear NN capsulorhexis
capsulorhexis NN (
( NN CAPITAL PCCC
PCCC NN )
) VBD was
was VBN performed
performed : -
- CD 6
6 IN with
with CC and
and CD 9
9 IN without
without JJ anterior
anterior NN vitrectomy
vitrectomy : ;
; IN in
in CD 8
8 NNS eyes
eyes , ,
, NN posterior
posterior JJ optic
optic NN capture
capture VBD was
was VBN performed
performed : -
- CD 3
3 IN with
with CC and
and CD 5
5 IN without
without NN vitrectomy

The DT CAPITAL The
The NN follow-up
follow-up VBD ranged
ranged IN from
from CD 1
1 TO to
to CD 4.5
4.5 NNS years
years NN (
( VB mean
mean CD 2
2 NNS years
years NN )

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: RB CAPITAL Visually
Visually JJ significant
significant JJ secondary
secondary NN cataract
cataract VBN developed
developed IN in
in DT the
the CD five
five NNS eyes
eyes IN with
with JJ intact
intact NN posterior
posterior NNS capsules
capsules CC and
and IN in
in DT the
the CD four
four NNS eyes
eyes IN that
that VBD had
had NN CAPITAL PCCC
PCCC IN without
without NN vitrectomy
vitrectomy CC and
and IN without
without NN posterior
posterior JJ optic
optic NN capture
capture NN (
( NN i.e
i.e . .
. , ,
, DT the
the JJ optic
optic VBD was
was RB left
left IN in
in DT the
the JJ capsular
capsular NN bag
bag NN )

The DT CAPITAL The
The JJ optical
optical NN axis
axis VBD remained
remained JJ clear
clear IN in
in DT the
the CD six
six NNS eyes
eyes IN that
that VBD had
had NN CAPITAL PC
PC NNP CAPITAL IOL
IOL NN implantation
implantation IN with
with NN vitrectomy
vitrectomy NN (
( IN with
with CC or
or IN without
without NN posterior
posterior JJ optic
optic NN capture
capture NN )

Initially RB CAPITAL Initially
Initially , ,
, DT all
all NNS eyes
eyes IN that
that VBD had
had JJ optic
optic NN capture
capture IN without
without NN vitrectomy
vitrectomy RB also
also VBD remained
remained JJ clear
clear , ,
, CC but
but IN after
after CD 6
6 NNS months
months , ,
, CD four
four IN of
of CD five
five VBN developed
developed NN opacification

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: IN CAPITAL In
In DT this
this NN series
series , ,
, NN CAPITAL PCCC
PCCC IN with
with JJ anterior
anterior NN vitrectomy
vitrectomy VBD was
was DT the
the RB only
only JJ effective
effective NN method
method IN of
of VBG preventing
preventing CC or
or VBG delaying
delaying JJ secondary
secondary NN cataract
cataract NN formation
formation IN in
in NNS infants
infants CC and
and NNS children

Evidence NN CAPITAL Evidence
Evidence IN for
for DT the
the NN presence
presence IN of
of DT a
a NN serotonin1A
serotonin1A NN (
( NN 5-HT1A
5-HT1A NN )
) NN receptor
receptor NN subtype
subtype IN in
in DT the
the NN salmonid
salmonid NN fish
fish NN brain
brain VBZ has
has RB recently
recently VBN been
been VBN presented

In IN CAPITAL In
In DT the
the JJ present
present NN study
study DT the
the JJ potent
potent NN 5-HT1A
5-HT1A NN receptor
receptor NN agonist
agonist , ,
, NN 8-hydroxy-2-
8-hydroxy-2- NN (
( NN di-n-propylamino
di-n-propylamino NN )
) NN -tetralin
-tetralin NN (
( NN 8-OH-DPAT
8-OH-DPAT NN )
) VBD was
was VBN tested
tested IN for
for PRP$ its
its NN effect
effect IN on
on NN plasma
plasma NN cortisol
cortisol NNS concentrations
concentrations IN in
in NN rainbow
rainbow NNS trout
trout NN (
( NNP CAPITAL Oncorhynchus
Oncorhynchus NN mykiss
mykiss NN )

Blood NN CAPITAL Blood
Blood VBD was
was VBN sampled
sampled CC and
and NN 8-OH-DPAT
8-OH-DPAT VBN administered
administered IN through
through DT a
a NN catheter
catheter IN in
in DT the
the NN dorsal
dorsal NN aorta

Thirty CD CAPITAL Thirty
Thirty NNS minutes
minutes IN after
after DT the
the NN injection
injection IN of
of CD 40
40 NN microg
microg IN of
of NN 8-OH-DPAT/kg
8-OH-DPAT/kg , ,
, NN plasma
plasma NN cortisol
cortisol NNS levels
levels VBD had
had VBN increased
increased IN from
from CD 12
12 TO to
to CD 149
149 NN ng/ml
ng/ml , ,
, NN whereupon
whereupon PRP they
they VBD fell
fell , ,
, VBG reaching
reaching NN baseline
baseline NNS levels
levels IN after
after CD 4
4 NN h.
h. DT CAPITAL The
The NN effect
effect IN of
of CD 1-40
1-40 NN microg
microg NN 8-OH-DPAT/kg
8-OH-DPAT/kg IN on
on NN plasma
plasma NN cortisol
cortisol NNS concentrations
concentrations VBD was
was JJ dose-dependent

The DT CAPITAL The
The NNS results
results VBZ lends
lends RB further
further NN support
support TO to
to DT the
the NN hypothesis
hypothesis IN that
that DT the
the NN brain
brain JJ serotonergic
serotonergic NN system
system NNS plays
plays DT a
a NN key
key NN role
role IN in
in VBG integrating
integrating JJ autonomic
autonomic , ,
, JJ behavioral
behavioral CC and
and NN neuroendocrine
neuroendocrine NNS stress-responses
stress-responses IN in
in NN fish
fish IN as
as RB well
well IN as
as NNS mammals
mammals , ,
, VBG suggesting
suggesting IN that
that RB not
not RB only
only DT the
the JJ structural
structural CC and
and JJ biochemical
biochemical NN organization
organization , ,
, CC but
but RB also
also DT the
the NN function
function IN of
of DT the
the JJ serotonergic
serotonergic NN system
system VBZ has
has VBN been
been VBN conserved
conserved IN during
during NN vertebrate
vertebrate NN evolution

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB assess
assess DT the
the VBG medicalising
medicalising NN effect
effect IN of
of VBG prescribing
prescribing NNS antibiotics
antibiotics IN for
for JJ sore
sore NN throat

SETTING VBG CAPITAL SETTING
SETTING : :
: CD 11
11 JJ general
general NNS practices
practices IN in
in NNP CAPITAL England

DESIGN NN CAPITAL DESIGN
DESIGN : :
: VBN CAPITAL Randomised
Randomised NN trial
trial IN of
of CD three
three NNS approaches
approaches TO to
to JJ sore
sore NN throat
throat : :
: DT a
a CD 10
10 NN day
day NN prescription
prescription IN of
of NNS antibiotics
antibiotics , ,
, DT no
no NNS antibiotics
antibiotics , ,
, CC or
or DT a
a VBN delayed
delayed NN prescription
prescription IN if
if DT the
the JJ sore
sore NN throat
throat VBD had
had RB not
not VBD started
started TO to
to VB settle
settle IN after
after CD three
three NNS days

PATIENTS NNS CAPITAL PATIENTS
PATIENTS : :
: CD 716
716 NNS patients
patients JJ aged
aged CD 4
4 CC and
and IN over
over IN with
with JJ sore
sore NN throat
throat CC and
and DT an
an JJ abnormal
abnormal JJ physical
physical NN sign
sign : :
: CD 84
84 NN %
% VBD had
had NN tonsillitis
tonsillitis CC or
or NN pharyngitis

OUTCOME NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: NN CAPITAL Number
Number CC and
and NN rate
rate IN of
of NNS patients
patients VBG making
making DT a
a RB first
first NN return
return IN with
with JJ sore
sore NN throat
throat , ,
, NN pharyngitis
pharyngitis , ,
, CC or
or NN tonsillitis

Early RB CAPITAL Early
Early NNS returns
returns NN (
( IN within
within CD two
two NNS weeks
weeks NN )
) CC and
and NNS complications
complications NN (
( NN otitis
otitis NNS media
media , ,
, NN sinusitis
sinusitis , ,
, NN quinsy
quinsy NN )

Outcomes NNS CAPITAL Outcomes
Outcomes VBD were
were VBN documented
documented IN in
in CD 675
675 NNS subjects
subjects NN (
( CD 94
94 NN %
% NN )

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NN CAPITAL Mean
Mean VB follow
follow RB up
up NN time
time VBD was
was JJ similar
similar NN (
( JJ antibiotic
antibiotic NN group
group CD 1.07
1.07 NNS years
years , ,
, JJ other
other CD two
two NNS groups
groups CD 1.03
1.03 NNS years
years NN )

More RBR CAPITAL More
More IN of
of DT those
those RB initially
initially VBN prescribed
prescribed NNS antibiotics
antibiotics RB initially
initially VBN returned
returned TO to
to DT the
the NN surgery
surgery IN with
with JJ sore
sore NN throat
throat NN (
( CD 38
38 NN %
% LS v
v CD 27
27 NN %
% , ,
, VBN adjusted
adjusted NN hazard
hazard NN ratio
ratio IN for
for NN return
return CD 1.39
1.39 NN %
% , ,
, CD 95
95 NN %
% NN confidence
confidence NN interval
interval CD 1.03
1.03 TO to
to CD 1.89
1.89 NN )

Antibiotics NNS CAPITAL Antibiotics
Antibiotics VBN prescribed
prescribed IN for
for JJ sore
sore NN throat
throat IN during
during DT the
the JJ previous
previous NN year
year VBD had
had DT an
an JJ additional
additional NN effect
effect NN (
( NN hazard
hazard NN ratio
ratio CD 1.69
1.69 , ,
, CD 1.20
1.20 TO to
to CD 2.37
2.37 NN )

Longer JJR CAPITAL Longer
Longer NN duration
duration IN of
of NN illness
illness NN (
( JJR >
> CD 5
5 NNS days
days NN )
) VBD was
was VBN associated
associated IN with
with VBN increased
increased NN return
return IN within
within CD six
six NNS weeks
weeks NN (
( NN hazard
hazard NN ratio
ratio CD 2.90
2.90 , ,
, CD 1.70
1.70 TO to
to CD 4.92
4.92 NN )

Prior RB CAPITAL Prior
Prior NN attendance
attendance IN with
with JJ upper
upper JJ respiratory
respiratory NNS conditions
conditions VBD was
was RB also
also VBN associated
associated IN with
with VBN increased
increased NN reattendance

There EX CAPITAL There
There VBD was
was DT no
no NN difference
difference IN between
between NNS groups
groups IN in
in RB early
early NN return
return NN (
( CD 13/238
13/238 NN (
( CD 5.5
5.5 NN %
% NN )
) LS v
v CD 27/437
27/437 NN (
( CD 6
6 NN %
% NN )
) NN )
) , ,
, CC or
or NNS complications
complications NN (
( CD 2/236
2/236 NN (
( CD 0.8
0.8 NN %
% NN )
) LS v
v CD 3/434
3/434 NN (
( CD 0.7
0.7 NN %
% NN )
) NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NNS CAPITAL Complications
Complications CC and
and RB early
early NN return
return VBG resulting
resulting IN from
from DT no
no CC or
or VBN delayed
delayed VBG prescribing
prescribing IN of
of NNS antibiotics
antibiotics IN for
for JJ sore
sore NN throat
throat VBP are
are JJ rare

Both DT CAPITAL Both
Both JJ current
current CC and
and JJ previous
previous VBG prescribing
prescribing IN for
for JJ sore
sore NN throat
throat NN increase
increase NN reattendance

To TO CAPITAL To
To VB avoid
avoid VBG medicalising
medicalising DT a
a NN self
self VBG limiting
limiting NN illness
illness NNS doctors
doctors MD should
should VB avoid
avoid NNS antibiotics
antibiotics CC or
or NN offer
offer DT a
a VBN delayed
delayed NN prescription
prescription IN for
for RBS most
most NNS patients
patients IN with
with JJ sore
sore NN throat

This DT CAPITAL This
This NN study
study VBD was
was VBN designed
designed TO to
to VB determine
determine CC and
and VB compare
compare DT the
the NN dose-response
dose-response NNS characteristics
characteristics , ,
, NN speed
speed IN of
of NN onset
onset , ,
, CC and
and JJ relative
relative NN potency
potency IN of
of JJ single-dose
single-dose JJ epidural
epidural NN fentanyl
fentanyl NN (
( NN CAPITAL F
F NN )
) CC and
and NN sufentanil
sufentanil NN (
( NN CAPITAL S
S NN )
) IN for
for JJ postoperative
postoperative NN pain
pain NN relief

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> CD CAPITAL Eighty
Eighty NNS women
women VBG undergoing
undergoing NN cesarean
cesarean NN section
section NN (
( NN CAPITAL C/S
C/S NN )
) IN with
with JJ epidural
epidural CD 2
2 NN %
% NN lidocaine
lidocaine IN with
with NN epinephrine
epinephrine NN (
( CD 1
1 : :
: CD 200
200 , ,
, CD 000
000 NN )
) VBD were
were RB randomly
randomly VBN assigned
assigned TO to
to VB receive
receive JJ double-blind
double-blind JJ epidural
epidural NN administration
administration IN of
of NN CAPITAL F
F NN (
( CD 25
25 , ,
, CD 50
50 , ,
, CD 100
100 , ,
, CC or
or CD 200
200 NN microg
microg NN )
) CC or
or NN CAPITAL S
S NN (
( CD 5
5 , ,
, CD 10
10 , ,
, CD 20
20 , ,
, CC or
or CD 30
30 NN microg
microg NN )
) NN (
( NN n
n JJ =
= CD 10
10 IN per
per NN group
group NN )
) IN upon
upon NN complaint
complaint IN of
of NN pain
pain RB postoperatively

Visual JJ CAPITAL Visual
Visual NN analog
analog NNS scales
scales NN (
( NNP CAPITAL VAS
VAS , ,
, CD 0-100
0-100 NN mm
mm NN )
) VBD were
were VBN used
used TO to
to VB assess
assess NN pain
pain CC and
and NN sedation
sedation IN at
at NN baseline
baseline : ;
; IN at
at CD 3
3 , ,
, CD 6
6 , ,
, CD 9
9 , ,
, CD 12
12 , ,
, CD 15
15 , ,
, CD 20
20 , ,
, CD 25
25 , ,
, CD 30
30 , ,
, CD 45
45 , ,
, CC and
and CD 60
60 NN min
min : ;
; CC and
and DT every
every CD 30
30 NN min
min IN until
until RB further
further NN analgesia
analgesia VBD was
was VBN requested

The DT CAPITAL The
The NN study
study VBD was
was VBN terminated
terminated IN at
at CD 30
30 NN min
min IN if
if JJ satisfactory
satisfactory NN analgesia
analgesia VBD was
was RB not
not VBN achieved

Side NN CAPITAL Side
Side NNS effects
effects VBD were
were VBN recorded

A DT CAPITAL A
A NN dose-response
dose-response VBD was
was VBN demonstrated
demonstrated IN for
for DT both
both NNS opioids

F NN CAPITAL F
F CD 25
25 NN microg
microg CC and
and NN CAPITAL S
S CD 5
5 NN microg
microg VBD were
were JJ ineffective
ineffective , ,
, IN with
with RB significantly
significantly JJR fewer
fewer NNS women
women VBG achieving
achieving NNP CAPITAL VAS
VAS NNS scores
scores CC &
& # #
# CD 60
60 : ;
; CD 10
10 NN mm
mm NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 VBN compared
compared IN with
with NN CAPITAL F
F CD 100
100 CC or
or CD 200
200 NN microg
microg CC and
and NN CAPITAL S
S CD 20
20 CC or
or CD 30
30 NN microg
microg NN )

F NN CAPITAL F
F CD 100
100 CC and
and CD 200
200 NN microg
microg CC and
and NN CAPITAL S
S CD 20
20 CC and
and CD 30
30 NN microg
microg DT all
all VBN achieved
achieved NNP CAPITAL VAS
VAS NNS scores
scores CC &
& # #
# CD 60
60 : ;
; CD 10
10 NN mm
mm IN in
in DT all
all NNS women
women IN with
with DT no
no NNS differences
differences IN in
in NN time
time TO to
to CD 50
50 NN %
% NN reduction
reduction IN in
in NNP CAPITAL VAS
VAS NN (
( VB mean
mean CD 11-16
11-16 NN min
min NN )
) CC and
and DT no
no NNS differences
differences IN in
in NN duration
duration IN of
of NN analgesia
analgesia NN (
( VB mean
mean CD 117-138
117-138 NN min
min NN )

The DT CAPITAL The
The CD 50
50 NN %
% CC and
and CD 95
95 NN %
% JJ effective
effective NN dose
dose NNS values
values IN for
for DT each
each NN opioid
opioid TO to
to VB achieve
achieve DT a
a NNP CAPITAL VAS
VAS NN score
score CC &
& # #
# CD 60
60 : ;
; CD 10
10 NN mm
mm VBD were
were NN CAPITAL F
F CD 33
33 NN microg
microg CC and
and CD 92
92 NN microg
microg CC and
and NN CAPITAL S
S CD 6.7
6.7 NN microg
microg CC and
and CD 17.5
17.5 NN microg

There EX CAPITAL There
There VBD were
were DT no
no NNS differences
differences IN among
among NNS groups
groups IN in
in NN sedation
sedation NNS scores
scores CC or
or NN side
side NNS effects

Our PRP$ CAPITAL Our
Our NNS data
data VB suggest
suggest IN that
that DT the
the JJ relative
relative JJ analgesic
analgesic NN potency
potency IN of
of JJ epidural
epidural NN CAPITAL S
S : :
: NN CAPITAL F
F VBZ is
is RB approximately
approximately CD 5
5 CC and
and IN that
that RB there
there VBP are
are DT no
no NNS differences
differences IN between
between DT the
the NNS opioids
opioids IN in
in DT the
the NN onset
onset , ,
, NN duration
duration , ,
, CC and
and NN effectiveness
effectiveness IN of
of NN analgesia
analgesia WRB when
when JJ equianalgesic
equianalgesic NNS doses
doses VBP are
are VBN administered
administered RB postoperatively
postoperatively IN after
after NN lidocaine
lidocaine NN anesthesia
anesthesia IN for
for NN CAPITAL C/S

We PRP CAPITAL We
We VBP describe
describe CD 2
2 NNS cases
cases IN in
in WDT which
which JJ intraoperative
intraoperative NN transesophageal
transesophageal NN echocardiography
echocardiography VBN detected
detected NNS complications
complications JJ related
related TO to
to DT the
the JJ proximal
proximal JJ coronary
coronary NNS arteries
arteries IN during
during NN homograft
homograft JJ aortic
aortic NN valve
valve CC and
and NN root
root NN replacement

In IN CAPITAL In
In DT both
both NNS cases
cases , ,
, JJ cardiopulmonary
cardiopulmonary NN bypass
bypass MD could
could RB not
not VB be
be VBN discontinued
discontinued IN despite
despite DT the
the NN use
use IN of
of JJ large
large NNS doses
doses IN of
of JJ inotropic
inotropic NNS drugs

Transesophageal NN CAPITAL Transesophageal
Transesophageal NN echocardiography
echocardiography VBN demonstrated
demonstrated VBG aliasing
aliasing IN on
on NN color
color NN flow
flow NN mapping
mapping IN in
in DT the
the RB left
left JJ main
main JJ coronary
coronary NN artery
artery IN in
in CD 1
1 NN case
case CC and
and JJ proximal
proximal RB right
right JJ coronary
coronary NN artery
artery IN in
in DT the
the JJ other
other , ,
, IN along
along IN with
with RB severely
severely JJ depressed
depressed RB left
left JJ ventricular
ventricular JJ anterior
anterior NN wall
wall CC and
and RB right
right JJ ventricular
ventricular NN function
function , ,
, RB respectively

Coronary JJ CAPITAL Coronary
Coronary NN artery
artery NN bypass
bypass VBG grafting
grafting VBD was
was VBN performed
performed IN in
in DT both
both NNS cases
cases , ,
, CC and
and DT the
the NN outcome
outcome VBD was
was JJ successful

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Granulocyte
Granulocyte JJ colony-stimulating
colony-stimulating NN factor
factor NN (
( NN CAPITAL G-CSF
G-CSF NN )
) VBZ has
has VBN been
been VBN used
used TO to
to VB improve
improve NN granulocyte
granulocyte NN count
count IN in
in JJ chronic
chronic NN neutropenia
neutropenia CC and
and NN myelodysplasia
myelodysplasia , ,
, TO to
to VB minimize
minimize DT the
the NN incidence
incidence CC and
and NN duration
duration IN of
of NN neutropenia
neutropenia IN during
during JJ conventional
conventional NN chemotherapy
chemotherapy , ,
, CC and
and TO to
to VB mobilize
mobilize JJ peripheral
peripheral NN blood
blood NN stem
stem NNS cells
cells RB prior
prior TO to
to NN leukapheresis
leukapheresis IN for
for NN use
use IN in
in JJ autologous
autologous CC and
and JJ allogeneic
allogeneic NN marrow
marrow NN transplantation

The DT CAPITAL The
The RBS most
most JJ common
common NN toxicity
toxicity VBZ is
is NN bone
bone NN pain
pain , ,
, CC and
and JJ other
other NNS reactions
reactions JJ such
such IN as
as NN inflammation
inflammation IN at
at DT the
the NN site
site IN of
of NN injection
injection VB have
have RB also
also VBD occurred

In IN CAPITAL In
In NNS patients
patients IN with
with JJ chronic
chronic NN neutropenia
neutropenia , ,
, NN splenomegaly
splenomegaly VBZ has
has VBN been
been VBN described
described IN with
with JJ long-term
long-term NN use
use , ,
, CC and
and JJ extramedullary
extramedullary NN hematopoiesis
hematopoiesis VBZ has
has RB also
also VBN been
been VBN reported

However RB CAPITAL However
However , ,
, RB thus
thus RB far
far , ,
, DT no
no JJ life-threatening
life-threatening NN sequelae
sequelae IN of
of DT these
these NNS effects
effects VBP are
are VBN found
found IN in
in DT the
the NN literature

We PRP CAPITAL We
We RB now
now VBP describe
describe DT a
a NN case
case IN of
of JJ spontaneous
spontaneous JJ splenic
splenic NN rupture
rupture CD four
four NNS days
days VBG following
following DT a
a JJ six-day
six-day NN course
course IN of
of NN CAPITAL G-CSF
G-CSF NN therapy
therapy IN in
in DT an
an JJ allogeneic
allogeneic NN donor
donor IN of
of JJ peripheral
peripheral NN blood
blood NN stem
stem NNS cells

Evidence-based JJ CAPITAL Evidence-based
Evidence-based NN medicine
medicine NN (
( NN CAPITAL EBM
EBM NN )
) NNS aids
aids JJ clinical
clinical NN decision
decision VBG making
making IN in
in DT all
all NNS fields
fields IN of
of NN medicine
medicine , ,
, VBG including
including JJ primary
primary NN care

General NNP CAPITAL General
General NN practice
practice VBZ is
is VBN characterized
characterized IN by
by JJ particular
particular NN emphasis
emphasis IN on
on DT the
the JJ doctor-patient
doctor-patient NN relationship
relationship CC and
and IN on
on JJ biomedical
biomedical , ,
, JJ personal
personal CC and
and JJ contextual
contextual NNS perspectives
perspectives IN in
in NN diagnosis

Most JJS CAPITAL Most
Most NN evidence
evidence JJ available
available TO to
to JJ general
general NNS practitioners
practitioners NN (
( NNS CAPITAL GPs
GPs NN )
) NNS addresses
addresses RB only
only DT the
the JJ bio-medical
bio-medical NN perspective
perspective CC and
and VBZ is
is RB often
often RB not
not RB directly
directly JJ applicable
applicable TO to
to JJ primary
primary NN care
care , ,
, IN as
as PRP it
it VBZ derives
derives IN from
from JJ secondary
secondary CC or
or JJ tertiary
tertiary NN care

Emphasis NN CAPITAL Emphasis
Emphasis IN on
on DT the
the JJ biomedical
biomedical NN domain
domain CC and
and DT the
the VBN randomized
randomized VBN controlled
controlled NN trial
trial NN (
( NN CAPITAL RCT
RCT NN )
) RB alone
alone VBZ reflects
reflects DT a
a JJ reductionist
reductionist NN approach
approach IN that
that VBZ fails
fails TO to
to VB do
do NN justice
justice TO to
to DT the
the NN philosophy
philosophy IN of
of JJ general
general NN practice

The DT CAPITAL The
The NN art
art IN of
of NN medicine
medicine VBZ is
is VBN founded
founded IN on
on NN context
context , ,
, NN anecdote
anecdote , ,
, NN patient
patient NNS stories
stories IN of
of NN illness
illness CC and
and JJ personal
personal NN experience
experience , ,
, CC and
and PRP we
we MD should
should VB continue
continue TO to
to VB blend
blend DT this
this IN with
with JJ good
good NN quality
quality CC and
and JJ appropriate
appropriate NN research
research NNS findings
findings IN in
in NN patient
patient NN care

Abdominal JJ CAPITAL Abdominal
Abdominal NN tuberculosis
tuberculosis VBZ is
is RB not
not JJ uncommon
uncommon IN in
in DT the
the NNP CAPITAL UK
UK , ,
, RB especially
especially IN in
in JJ CAPITAL Asian
Asian NNS immigrants

It PRP CAPITAL It
It VBZ resembles
resembles NN CAPITAL Crohn
Crohn POS 's
's NN disease
disease RB clinically
clinically CC and
and RB radiologically
radiologically , ,
, CC and
and PRP it
it MD may
may VB be
be JJ difficult
difficult TO to
to VB differentiate
differentiate IN between
between PRP them
them , ,
, RB even
even IN at
at NN laparotomy
laparotomy CC or
or NN histology

The DT CAPITAL The
The NN distinction
distinction VBZ is
is JJ important
important , ,
, RB however
however , ,
, IN for
for JJ proper
proper NN management
management IN of
of DT the
the CD two
two NNS conditions

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> DT CAPITAL Every
Every NN effort
effort MD must
must VB be
be VBN made
made TO to
to VB exclude
exclude JJ abdominal
abdominal NN tuberculosis
tuberculosis IN before
before DT the
the NN patient
patient VBZ is
is VBN diagnosed
diagnosed IN as
as VBG having
having NN CAPITAL Crohn
Crohn POS 's
's NN disease
disease CC and
and VBZ is
is VBN treated
treated IN with
with NNS steroids

PURPOSE NN CAPITAL PURPOSE
PURPOSE : :
: DT CAPITAL The
The NNP CAPITAL American
American JJ CAPITAL Urological
Urological NNP CAPITAL Association
Association VBN convened
convened DT the
the JJ CAPITAL Female
Female NN CAPITAL Stress
Stress JJ CAPITAL Urinary
Urinary NN CAPITAL Incontinence
Incontinence JJ CAPITAL Clinical
Clinical NNS CAPITAL Guidelines
Guidelines NN CAPITAL Panel
Panel TO to
to VB analyze
analyze DT the
the NN literature
literature VBG regarding
regarding JJ surgical
surgical NNS procedures
procedures IN for
for VBG treating
treating NN stress
stress JJ urinary
urinary NN incontinence
incontinence IN in
in DT the
the RB otherwise
otherwise JJ healthy
healthy NN female
female NN subject
subject CC and
and TO to
to VB make
make NN practice
practice NNS recommendations
recommendations VBN based
based IN on
on DT the
the NN treatment
treatment NNS outcomes
outcomes NNS data

MATERIALS NNS CAPITAL MATERIALS
MATERIALS CC CAPITAL AND
AND NNS CAPITAL METHODS
METHODS : :
: DT CAPITAL The
The NN panel
panel VBD searched
searched DT the
the NN CAPITAL MEDLINE
MEDLINE NNS data
data NN base
base IN for
for DT all
all NNS articles
articles IN through
through CD 1993
1993 IN on
on JJ surgical
surgical NN treatment
treatment IN of
of NN female
female NN stress
stress JJ urinary
urinary NN incontinence

Outcomes NNS CAPITAL Outcomes
Outcomes NNS data
data VBD were
were VBN extracted
extracted IN from
from NNS articles
articles VBN accepted
accepted IN after
after NN panel
panel NN review

The DT CAPITAL The
The NNS data
data VBD were
were RB then
then JJ meta-analyzed
meta-analyzed TO to
to VB produce
produce NN outcome
outcome NNS estimates
estimates IN for
for NN alternative
alternative JJ surgical
surgical NNS procedures

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The NNS data
data VBP indicate
indicate IN that
that IN after
after CD 48
48 NNS months
months NN retropubic
retropubic NNS suspensions
suspensions CC and
and NNS slings
slings VB appear
appear TO to
to VB be
be RBR more
more JJ efficacious
efficacious IN than
than JJ transvaginal
transvaginal NNS suspensions
suspensions , ,
, CC and
and RB also
also RBR more
more JJ efficacious
efficacious IN than
than JJ anterior
anterior NNS repairs

The DT CAPITAL The
The NN literature
literature VBZ suggests
suggests JJR higher
higher NN complication
complication NNS rates
rates WRB when
when JJ synthetic
synthetic NNS materials
materials VBP are
are VBN used
used IN for
for NNS slings

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL The
The NN panel
panel VBN found
found JJ sufficient
sufficient JJ acceptable
acceptable JJ long-term
long-term NNS outcomes
outcomes NNS data
data NN (
( RB longer
longer IN than
than CD 48
48 NNS months
months NN )
) TO to
to VBP conclude
conclude IN that
that JJ surgical
surgical NN treatment
treatment IN of
of NN female
female NN stress
stress JJ urinary
urinary NN incontinence
incontinence VBZ is
is JJ effective
effective , ,
, NN offering
offering DT a
a JJ long-term
long-term NN cure
cure IN in
in DT a
a JJ significant
significant NN percentage
percentage IN of
of NNS women

The DT CAPITAL The
The NN evidence
evidence NNS supports
supports NN surgery
surgery IN as
as JJ initial
initial NN therapy
therapy CC and
and IN as
as DT a
a JJ secondary
secondary NN form
form IN of
of NN therapy
therapy IN after
after NN failure
failure IN of
of JJ other
other NNS treatments
treatments IN for
for NN stress
stress JJ urinary
urinary NN incontinence

Retropubic JJ CAPITAL Retropubic
Retropubic NNS suspensions
suspensions CC and
and NNS slings
slings VBP are
are DT the
the RBS most
most JJ efficacious
efficacious NNS procedures
procedures IN for
for JJ long-term
long-term NN success
success NN (
( VBN based
based IN on
on NN cure/dry
cure/dry NNS rates
rates NN )

However RB CAPITAL However
However , ,
, IN in
in DT the
the NN panel
panel POS 's
's NN opinion
opinion NN retropubic
retropubic NNS suspensions
suspensions CC and
and NN sling
sling NNS procedures
procedures VBP are
are VBN associated
associated IN with
with RB slightly
slightly JJR higher
higher NN complication
complication NNS rates
rates , ,
, VBG including
including RB longer
longer NN convalescence
convalescence CC and
and JJ postoperative
postoperative VBG voiding
voiding NN dysfunction

A DT CAPITAL A
A JJ 55-year-old
55-year-old NN lady
lady VBD underwent
underwent NN repeat
repeat JJ aortic
aortic NN valve
valve NN replacement
replacement VBG using
using DT a
a NN 16-mm
16-mm NNS CAPITAL Carbomedics
Carbomedics NN prosthesis

She PRP CAPITAL She
She VBN made
made DT an
an JJ uneventful
uneventful JJ postoperative
postoperative NN recovery
recovery CC and
and RB now
now NNS leads
leads DT an
an JJ unrestricted
unrestricted NN life

Doppler NNP CAPITAL Doppler
Doppler NN echocardiography
echocardiography VBZ reveals
reveals DT a
a NN 21-mm
21-mm NN CAPITAL Hg
Hg NN gradient
gradient IN across
across DT the
the NN valve
valve IN at
at NN rest

This DT CAPITAL This
This VBD did
did RB not
not NN increase
increase IN with
with DT an
an NN infusion
infusion IN of
of CD 30
30 NN mcg/kg
mcg/kg IN per
per NN min
min IN of
of NN dobutamine
dobutamine , ,
, WDT which
which VBD resulted
resulted IN in
in DT an
an NN increase
increase IN in
in DT the
the JJ cardiac
cardiac NN output
output IN from
from CD 1.96
1.96 TO to
to CD 5.46
5.46 NN l/min

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: IN CAPITAL For
For RBR more
more IN than
than CD 30
30 NNS years
years PRP it
it VBZ has
has VBN been
been VBN known
known IN that
that JJ gastric
gastric NN acid
acid NN secretion
secretion VBZ is
is RB inversely
inversely JJ related
related TO to
to DT the
the NN extent
extent CC and
and NN severity
severity IN of
of NN corpal
corpal NN gastritis

We PRP CAPITAL We
We RB therefore
therefore VBN evaluated
evaluated DT the
the NN effect
effect IN of
of NN cure
cure IN of
of NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN infection
infection IN on
on JJ basal
basal CC and
and JJ pentagastrin-stimulated
pentagastrin-stimulated NN acid
acid NN secretion

METHODS NNS CAPITAL METHODS
METHODS : :
: JJ CAPITAL Basal
Basal NN acid
acid NN output
output NN (
( NNP CAPITAL BAO
BAO NN )
) CC and
and JJ maximal
maximal NN acid
acid NN output
output NN (
( NNP CAPITAL MAO
MAO NN )
) VBD were
were VBN assessed
assessed IN in
in CD 11
11 NNP CAPITAL H.
H. JJ pylori-infected
pylori-infected JJ dyspeptic
dyspeptic NNS patients
patients NN (
( CD 8
8 NNS women
women CC and
and CD 3
3 NNS men
men : ;
; VB mean
mean NN age
age , ,
, CD 28
28 NNS years
years NN )
) IN before
before CC and
and IN after
after JJ successful
successful JJ anti-H

pylori NN pylori
pylori NN therapy

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The NN gastritis
gastritis NN index
index VBD was
was RB significantly
significantly JJR lower
lower IN after
after NN therapy
therapy CC and
and VBD was
was VBN associated
associated IN with
with DT an
an NN increase
increase IN in
in DT both
both NNP CAPITAL BAO
BAO CC and
and NNP CAPITAL MAO
MAO IN after
after NN cure
cure IN of
of DT the
the NNP CAPITAL H.
H. NN pylori
pylori NN infection
infection NN (
( NNP CAPITAL BAO
BAO IN from
from CD 0.3
0.3 NN mmol/h
mmol/h CC and
and NNP CAPITAL MAO
MAO IN from
from CD 4.8
4.8 NN mmol/h
mmol/h TO to
to CD 19
19 NN mmol/
mmol/ NN h
h NN )

Basal JJ CAPITAL Basal
Basal CC and
and VBN stimulated
stimulated NN acid
acid NNS concentrations
concentrations RB also
also VBN increased
increased NN (
( CD 29.1
29.1 CC +/-
+/- CD 36.6
36.6 TO to
to CD 54
54 CC +/-
+/- CD 31
31 NN mmol/l
mmol/l CC and
and CD 72.5
72.5 CC +/-
+/- CD 46
46 TO to
to CD 120.1
120.1 CC +/-
+/- CD 30
30 NN mmol/l
mmol/l , ,
, RB respectively
respectively , ,
, IN for
for JJ basal
basal CC and
and VBN stimulated
stimulated NN acid
acid NNS concentrations
concentrations : ;
; NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 IN for
for NN peak
peak CC and
and NNP CAPITAL MAO
MAO , ,
, NN CAPITAL P
P JJ =
= CD 0.07
0.07 IN for
for NNP CAPITAL BAO
BAO NN )

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: JJ CAPITAL Gastric
Gastric NN acid
acid NN secretion
secretion VBN increased
increased IN into
into DT the
the JJ normal
normal NN range
range IN after
after JJ successful
successful NN treatment
treatment IN of
of NNP CAPITAL H.
H. NN pylori
pylori NN infection
infection , ,
, VBG suggesting
suggesting IN that
that JJ gastric
gastric NN function
function MD can
can VB recover
recover TO to
to JJ normal
normal CC or
or RB almost
almost JJ normal
normal IN after
after NN cure
cure IN of
of NNP CAPITAL H.
H. NN pylori
pylori NN infection

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: NNS CAPITAL Reports
Reports VB suggest
suggest IN that
that RB there
there VBZ is
is DT an
an VBN increased
increased NN incidence
incidence IN of
of NN preeclampsia
preeclampsia IN after
after DT a
a RB previously
previously JJ normal
normal NN pregnancy
pregnancy IN if
if RB there
there VBZ is
is DT a
a NN change
change IN in
in NN paternity

We PRP CAPITAL We
We VB hypothesize
hypothesize IN that
that RB there
there VBZ is
is DT a
a JJR higher
higher NN incidence
incidence IN of
of NN preeclampsia
preeclampsia NN (
( JJ proteinuric
proteinuric NN hypertension
hypertension NN )
) IN in
in NNS women
women VBG conceiving
conceiving IN by
by JJ intrauterine
intrauterine NN insemination
insemination IN with
with NN donor
donor NN sperm
sperm CC versus
versus JJ intrauterine
intrauterine NN insemination
insemination IN with
with NN partner
partner NN sperm

STUDY NN CAPITAL STUDY
STUDY NN CAPITAL DESIGN
DESIGN : :
: DT CAPITAL This
This VBD was
was DT a
a NN retrospective
retrospective NN cohort
cohort NN study

In IN CAPITAL In
In NNS women
women IN with
with JJ primary
primary NN infertility
infertility DT all
all NNS pregnancies
pregnancies VBN achieved
achieved IN by
by DT either
either NN partner
partner CC or
or NN donor
donor JJ intrauterine
intrauterine NN insemination
insemination VBD carried
carried TO to
to NN birth
birth IN of
of DT a
a NN fetus
fetus NN (
( JJR >
> CD 20
20 NNS weeks
weeks NN )
) VBD were
were VBN identified

The DT CAPITAL The
The JJ medical
medical NNS records
records VBD were
were VBN examined
examined IN for
for DT the
the JJ maternal
maternal CC and
and NN pregnancy
pregnancy NN outcome
outcome NNS data

The DT CAPITAL The
The JJ relative
relative NN risk
risk CC and
and CD 95
95 NN %
% NN confidence
confidence NN interval
interval VBD were
were VBN calculated
calculated IN for
for DT the
the NN risk
risk IN of
of NN preeclampsia

The DT CAPITAL The
The NN baseline
baseline NNS data
data VBD were
were VBN compared
compared IN with
with NN t
t NNS tests
tests , ,
, NN chi
chi CD 2
2 NN analysis
analysis CC and
and NNP CAPITAL Fisher
Fisher POS 's
's JJ exact
exact NN test
test WRB where
where JJ appropriate

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: CD CAPITAL Forty-four
Forty-four NNS patients
patients IN in
in DT the
the NN partner
partner JJ intrauterine
intrauterine NN insemination
insemination NN group
group CC and
and CD 37
37 IN in
in DT the
the NN donor
donor NN insemination
insemination NN group
group VBD were
were VBN identified
identified IN as
as VBG having
having JJ primary
primary NN infertility

Three CD CAPITAL Three
Three NNS cases
cases IN of
of JJ mild
mild NN preeclampsia
preeclampsia VBD were
were VBN found
found IN in
in DT the
the NN partner
partner NN insemination
insemination NN program
program CC and
and CD nine
nine NNS cases
cases IN of
of NN preeclampsia
preeclampsia NN (
( CD five
five JJ severe
severe , ,
, CD four
four JJ mild
mild NN )
) IN in
in DT the
the NN donor
donor NN insemination
insemination NN program
program NN (
( JJ relative
relative NN risk
risk CD 1.85
1.85 , ,
, CD 95
95 NN %
% NN confidence
confidence NN interval
interval CD 1.20
1.20 TO to
to CD 2.85
2.85 NN )
) . .

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: EX CAPITAL There
There VBZ is
is DT a
a JJR higher
higher NN incidence
incidence IN of
of NN preeclampsia
preeclampsia IN in
in NNS women
women VBG conceiving
conceiving IN by
by JJ intrauterine
intrauterine NN insemination
insemination IN with
with VBN washed
washed NN donor
donor NN sperm
sperm VBN compared
compared IN with
with JJ intrauterine
intrauterine NN insemination
insemination IN with
with VBN washed
washed NN partner
partner NN sperm
sperm . .

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: EX CAPITAL There
There VBZ is
is DT a
a JJR higher
higher NN incidence
incidence IN of
of NN preeclampsia
preeclampsia IN in
in NNS women
women VBG conceiving
conceiving IN by
by JJ intrauterine
intrauterine NN insemination
insemination IN with
with VBN washed
washed NN donor
donor NN sperm
sperm VBN compared
compared IN with
with JJ intrauterine
intrauterine NN insemination
insemination IN with
with VBN washed
washed NN partner
partner NN sperm
sperm . .

This DT CAPITAL This
This NNS supports
supports , ,
, RB indirectly
indirectly , ,
, DT an
an JJ immunologic
immunologic NN basis
basis IN for
for NN preeclampsia

The DT CAPITAL The
The JJ antigenic
antigenic NN factor
factor MD would
would VB appear
appear TO to
to VB be
be JJ located
located IN on
on DT the
the NN sperm
sperm IN as
as VBN opposed
opposed TO to
to DT the
the JJ seminal
seminal NN fluid
fluid PRP itself

After IN CAPITAL After
After DT a
a JJ rapid
rapid NN examination
examination IN of
of DT a
a JJ few
few JJ basic
basic NNS concepts
concepts VBG concerning
concerning JJ cellular
cellular VBG aging
aging CC and
and VBN programmed
programmed NN cell
cell NN death
death , ,
, DT the
the VBG aging
aging IN of
of DT the
the NNS tissues
tissues CC and
and NNS organs
organs , ,
, DT the
the NNS authors
authors VB discuss
discuss DT the
the NN principal
principal NNS theories
theories IN on
on NN senescence

They PRP CAPITAL They
They VB underline
underline IN that
that PRP it
it VBZ is
is JJ necessary
necessary TO to
to VB agree
agree IN in
in VBG considering
considering DT the
the JJ various
various JJ genetic
genetic CC and
and JJ epigenetic
epigenetic , ,
, JJ endogenous
endogenous CC and
and JJ exogenous
exogenous NNS mechanisms
mechanisms IN that
that NN lead
lead TO to
to DT the
the NN complex
complex VBG aging
aging NN phenomenon
phenomenon JJ multiple
multiple CC and
and VBN interrelated

In IN CAPITAL In
In JJ particular
particular PRP they
they NN stress
stress DT the
the NN hypothesis
hypothesis IN that
that NN senescence
senescence MD can
can VB be
be JJ due
due TO to
to DT a
a NN sum
sum IN of
of JJ molecular
molecular NNS damages
damages VBN caused
caused IN by
by JJ free
free NNS radicals
radicals , ,
, CC and
and TO to
to DT the
the NN loss
loss IN of
of JJ telomeric
telomeric NN CAPITAL DNA

Radical NNP CAPITAL Radical
Radical NNS reactions
reactions MD can
can NN cause
cause NNS mutations
mutations , ,
, NN inactivation
inactivation CC or
or DT a
a NN decrease
decrease IN in
in DT the
the NN turnover
turnover IN of
of JJ mitochondrial
mitochondrial NN CAPITAL DNA
DNA WDT which
which VBZ is
is RBR more
more JJ vulnerable
vulnerable IN than
than DT the
the JJ nuclear
nuclear NN genoma
genoma TO to
to DT the
the NN attack
attack IN of
of JJ mutagenic
mutagenic NNS agents
agents , ,
, VBG acting
acting RB also
also IN as
as DT a
a JJ continuous
continuous NN source
source IN of
of JJ initial
initial CC and/or
and/or VBG promoting
promoting NNS factors
factors IN of
of DT the
the JJ carcinogenetic
carcinogenetic NN process

The DT CAPITAL The
The JJ somatic
somatic NNS cells
cells VB become
become JJ senescent
senescent IN because
because IN during
during NN cell
cell NN division
division , ,
, PRP they
they VB lose
lose DT the
the NNS mechanisms
mechanisms IN for
for DT the
the VBG lengthening
lengthening IN of
of DT the
the NN telomere

The DT CAPITAL The
The NN telomerase
telomerase VBZ prevents
prevents DT the
the VBG shortening
shortening IN of
of NNS telomeres
telomeres IN in
in JJ neoplastic
neoplastic NNS cells
cells CC and
and RB therefore
therefore VBZ renders
renders PRP them
them JJ immortal

Paradoxically RB CAPITAL Paradoxically
Paradoxically DT the
the NN protection
protection IN of
of DT the
the NN telomere
telomere VBZ is
is RB exactly
exactly WDT what
what MD must
must VB be
be VBN avoided
avoided IN in
in DT the
the NN case
case IN of
of NN tumor
tumor NNS cells

Recently RB CAPITAL Recently
Recently DT the
the NN demonstration
demonstration IN that
that NN telomerase
telomerase VBZ is
is RB not
not RB always
always VBN involved
involved IN in
in DT the
the NN restoration
restoration IN of
of NN telomere
telomere NN length
length NNS shows
shows DT the
the NN complexity
complexity IN of
of DT the
the NNS problems
problems VBN connected
connected TO to
to DT the
the NN cause
cause IN of
of NN senescence

Chromosomally RB CAPITAL Chromosomally
Chromosomally VBN integrated
integrated JJ retroviral
retroviral NN switch
switch NN (
( NN CAPITAL S
S NN )
) NNS substrates
substrates VB have
have VBN been
been VBN developed
developed TO to
to VB reveal
reveal NN switch
switch JJ recombinase-like
recombinase-like NNS activities
activities NN (
( NN CAPITAL SRLA
SRLA NN )
) IN in
in JJ pre-B
pre-B CC and
and JJ mature
mature NN CAPITAL B
B NN cell
cell NNS lines

Switch VB CAPITAL Switch
Switch NN substrate
substrate NNS retrovectors
retrovectors NN (
( NN CAPITAL SSR
SSR NN )
) VB contain
contain DT a
a JJ long-terminal
long-terminal JJ repeat-driven
repeat-driven NN neomycin
neomycin NN (
( NN CAPITAL Neo
Neo NN )
) NN gene
gene IN for
for JJ proviral
proviral JJ chromosomal
chromosomal NN maintenance
maintenance NN (
( JJ pre-
pre- CC and
and JJ post-S
post-S NN recombination
recombination NN )
) CC and
and DT a
a NN CAPITAL CMV
CMV JJ promoter-driven
promoter-driven , ,
, JJ chimeric
chimeric NN hygromycin-thymidine
hygromycin-thymidine NN kinase
kinase NN (
( NN CAPITAL Hytk
Hytk NN )
) NN gene
gene NN (
( VBN flanked
flanked IN by
by NN CAPITAL S
S NN mu
mu CC and
and NN CAPITAL S
S NN gamma
gamma NN 2b
2b NN recombination
recombination NNS targets
targets NN )
) TO to
to JJ select
select IN for
for NN (
( NN ganciclovir
ganciclovir NN )
) CC and
and IN against
against NN (
( NN hygromycin
hygromycin NN CAPITAL B
B NN )
) NN CAPITAL S
S NN region
region NN recombination

The DT CAPITAL The
The NNS retro-substrates
retro-substrates '' '
' JJ strong
strong , ,
, JJ constitutive
constitutive NNS promoters
promoters VB ensure
ensure IN that
that NNS variations
variations IN in
in JJ cellular
cellular NN switch
switch NN recombinase
recombinase NNS activities
activities VBP are
are JJ independent
independent IN of
of NN CAPITAL S
S NN region
region NN accessibility
accessibility NN control

By IN CAPITAL By
By RB initially
initially VBG selecting
selecting IN for
for JJ proviral
proviral NNS integrants
integrants IN in
in NN hygromycin
hygromycin VBN followed
followed IN by
by VBG shifting
shifting IN into
into NN neomycin
neomycin CC +
+ NN ganciclovir
ganciclovir TO to
to JJ select
select IN for
for NN CAPITAL S
S JJ sequence-mediated
sequence-mediated NNS deletions
deletions , ,
, NN switch
switch NNS recombinations
recombinations MD can
can VB be
be RB specifically
specifically VBN forestalled
forestalled IN in
in NN CAPITAL B
B NN cell
cell NNS lines
lines IN whilst
whilst RBS most
most JJ switch-incompetent
switch-incompetent NNS cells
cells VB do
do RB not
not VB survive
survive JJ secondary
secondary NN selection

A DT CAPITAL A
A JJ qualitative
qualitative , ,
, JJ direct
direct NN CAPITAL PCR
PCR NN assay
assay VBZ reveals
reveals IN that
that NN CAPITAL SSR
SSR NNS recombinations
recombinations VBP are
are JJ stochastic
stochastic IN in
in NN CAPITAL B
B NN cell
cell NNS lines
lines VBG generating
generating DT a
a NN product
product NN array
array JJ akin
akin TO to
to JJ natural
natural NN CAPITAL GH
GH NN class
class NN switching

A DT CAPITAL A
A JJ semi-quantitative
semi-quantitative NN CAPITAL DC-PCR
DC-PCR NN assay
assay VBZ detects
detects DT a
a JJ significant
significant NN recombinase
recombinase NN activity
activity RB only
only IN in
in DT a
a JJ restricted
restricted NN set
set IN of
of RB late
late NN stage
stage JJ pre-B
pre-B CC and
and JJ mature
mature NN CAPITAL B
B NN cell
cell NNS lines

BCL1B1 NN CAPITAL BCL1B1
BCL1B1 JJ mature
mature NN CAPITAL B
B NNS cells
cells VB have
have DT the
the JJS highest
highest NN level
level IN of
of NN recombinase
recombinase NN activity
activity IN with
with CD 25
25 NN %
% CC or
or RBR more
more IN of
of JJ proviral
proviral NNS integrants
integrants VBG accumulating
accumulating NN CAPITAL S
S NN mu/S
mu/S NN gamma
gamma NN 2b
2b NN substrate
substrate NNS recombinations
recombinations IN within
within CD 10-14
10-14 NN cell
cell NNS generations

The DT CAPITAL The
The NN CAPITAL SSR
SSR NN recombinase
recombinase NN assay
assay MD can
can VB be
be VBN performed
performed IN in
in DT a
a JJ transient
transient NN fashion
fashion WRB wherein
wherein JJ extensive
extensive , ,
, NN CAPITAL B
B JJ cell-specific
cell-specific NN recombination
recombination MD can
can VB be
be VBN visualized
visualized IN within
within RB only
only DT a
a JJ few
few NN cell
cell NNS divisions
divisions NN post
post JJ proviral
proviral NN integration

We PRP CAPITAL We
We VBP propose
propose IN that
that NN switch
switch NN recombinase
recombinase NN activity
activity VBZ becomes
becomes VBN activated
activated IN during
during NN CAPITAL B
B NN cell
cell NN ontogeny
ontogeny JJ independent
independent IN of
of CC or
or RB prior
prior TO to
to DT the
the NN acquisition
acquisition IN of
of NN CAPITAL CH
CH NN locus
locus NN accessibility
accessibility CC and
and IN that
that JJ endogenous
endogenous NN CAPITAL S
S NN segment
segment VBG targeting
targeting TO to
to JJ pre-existing
pre-existing NN recombinase
recombinase VBZ requires
requires DT a
a NN level
level IN of
of NN accessibility
accessibility IN beyond
beyond JJ transcriptional
transcriptional NN activation

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB determine
determine DT the
the NN prevalence
prevalence IN of
of JJ illicit
illicit NN drug
drug NN abuse
abuse CC and
and NN alcohol
alcohol NN use
use IN in
in DT an
an NN obstetric
obstetric NN population
population VBN based
based IN in
in DT an
an JJ urban
urban NN maternity
maternity NN hospital

SETTING VBG CAPITAL SETTING
SETTING : :
: DT CAPITAL A
A JJ collaborative
collaborative NN study
study IN between
between DT the
the NNP CAPITAL Rotunda
Rotunda NN CAPITAL Hospital
Hospital , ,
, NNP CAPITAL Dublin
Dublin CC and
and DT the
the JJ CAPITAL Irish
Irish NNP CAPITAL National
National NN CAPITAL Drug
Drug NNP CAPITAL Advisory
Advisory CC &
& # #
# CD 38
38 : ;
; NN CAPITAL Treatment
Treatment NNP CAPITAL Centre

DESIGN NN CAPITAL DESIGN
DESIGN : :
: DT CAPITAL A
A JJ prospective
prospective NN study
study VBG consisting
consisting IN of
of JJ anonymous
anonymous , ,
, JJ unlinked
unlinked NN urine
urine NN testing
testing IN of
of CD 504
504 IN 'first
'first NN visit
visit '' '
' JJ antenatal
antenatal NNS patients
patients CC and
and DT a
a JJ separate
separate NN group
group IN of
of CD 515
515 NNS patients
patients CD six
six NNS weeks
weeks IN after
after NN delivery

METHODS NNS CAPITAL METHODS
METHODS CC &
& # #
# CD 38
38 : ;
; NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: JJ CAPITAL Toxicological
Toxicological NN screening
screening VBG using
using JJ enzyme-linked
enzyme-linked NN immunoassay
immunoassay NNS techniques
techniques , ,
, IN with
with DT all
all JJ positive
positive NNS samples
samples VBG being
being VBN reanalysed

Drug NN CAPITAL Drug
Drug NNS histories
histories VBD were
were VBN taken
taken CC and
and NNS samples
samples VBD were
were VBN tested
tested IN for
for NN alcohol
alcohol CC and
and CD six
six IN of
of DT the
the RBS most
most RB commonly
commonly JJ abused
abused NNS drugs

The DT CAPITAL The
The JJ pre-
pre- CC and
and JJ postnatal
postnatal NN prevalence
prevalence IN of
of NN abuse
abuse VBD was
was VBN matched
matched IN with
with JJ demographic
demographic NNS data

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The NN prevalence
prevalence IN of
of NN chemical
chemical NN substance
substance NN misuse
misuse IN in
in DT the
the JJ antenatal
antenatal NN population
population VBD was
was CD 2.8
2.8 NN %
% CC and
and CD 5.6
5.6 NN %
% IN in
in DT the
the JJ postnatal
postnatal NN population

Substances NNS CAPITAL Substances
Substances VBN identified
identified VBN included
included NNS benzodiazepines
benzodiazepines , ,
, NN cannabis
cannabis , ,
, NNS amphetamines
amphetamines , ,
, NNS opiates
opiates CC and
and NN cocaine

Less RBR CAPITAL Less
Less IN than
than CD 2
2 NN %
% IN of
of NNS samples
samples VBN tested
tested JJ positive
positive IN for
for NN alcohol

None NN CAPITAL None
None IN of
of DT the
the NNS women
women VBG yielding
yielding JJ positive
positive NNS samples
samples VBD had
had VBN been
been JJ pre-identified
pre-identified IN on
on DT the
the NN basis
basis IN of
of NN history

A DT CAPITAL A
A JJ significant
significant NN proportion
proportion IN of
of DT the
the NNS women
women VBD were
were IN in
in DT the
the JJ high
high NN risk
risk NNS categories
categories IN with
with NN regard
regard TO to
to NN age
age CC and
and JJ socio-economic
socio-economic NN status

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: DT CAPITAL The
The NN prevalence
prevalence IN of
of NN drug
drug NN misuse
misuse RB antenatally
antenatally VBD was
was RB nearly
nearly CD 3
3 NN %
% CC and
and RB postnatally
postnatally RB almost
almost CD 6
6 NN %

Substance NN CAPITAL Substance
Substance NNS abusers
abusers IN in
in NN pregnancy
pregnancy VBP are
are RBR more
more RB likely
likely TO to
to VB be
be JJ single
single , ,
, JJ unemployed
unemployed , ,
, CC and
and TO to
to VB have
have VBD had
had DT a
a JJ previous
previous NN pregnancy

Schizophrenic JJ CAPITAL Schizophrenic
Schizophrenic NNS illnesses
illnesses VB occur
occur IN with
with RB approximately
approximately DT the
the JJ same
same NN incidence
incidence IN in
in DT all
all JJ human
human NNS populations
populations IN with
with DT a
a JJ characteristic
characteristic NN distribution
distribution NN (
( RB slightly
slightly RB earlier
earlier IN in
in NNS males
males NN )
) IN of
of NNS ages
ages IN of
of NN onset

Given VBN CAPITAL Given
Given IN that
that DT the
the NN predisposition
predisposition NN (
( WDT which
which RB presumably
presumably VBZ is
is JJ genetic
genetic NN )
) VBZ is
is VBN associated
associated IN with
with DT a
a JJ procreative
procreative NN disadvantage
disadvantage WRB why
why VB do
do JJ such
such NNS illnesses
illnesses VB persist
persist . ?
? RB CAPITAL Here
Here PRP it
it VBZ is
is VBN suggested
suggested IN that
that DT these
these NNS conditions
conditions VBP are
are DT a
a NN manifestation
manifestation IN of
of JJ genetic
genetic NN diversity
diversity IN in
in DT the
the NN evolution
evolution IN of
of DT the
the RB specifically
specifically JJ human
human JJ characteristic
characteristic IN of
of NN language
language , ,
, DT an
an NN innovation
innovation IN that
that VBZ has
has VBD occurred
occurred IN by
by DT a
a NN process
process IN of
of JJ progressive
progressive JJ hemispheric
hemispheric NN specialization-the
specialization-the NN establishment
establishment IN of
of NN dominance
dominance IN for
for DT some
some JJ critical
critical NN component
component IN of
of NN language
language IN in
in CD one
one CC or
or DT the
the JJ other
other NN hemisphere

Individuals NNS CAPITAL Individuals
Individuals WP who
who VB develop
develop JJ schizophrenic
schizophrenic NNS symptoms
symptoms NN show
show JJR lesser
lesser JJ anatomical
anatomical CC and
and JJ functional
functional NNS asymmetries
asymmetries IN than
than DT the
the NN population
population IN as
as DT a
a JJ whole
whole : ;
; JJ such
such NNS symptoms
symptoms MD may
may VB reflect
reflect NN 'dominance
'dominance NN failure
failure '' '
' IN for
for NN language

Cloacal JJ CAPITAL Cloacal
Cloacal NNS anomalies
anomalies VBP are
are RB extremely
extremely JJ rare
rare CC and
and VB have
have JJ variable
variable NNS presentations

Prenatal JJ CAPITAL Prenatal
Prenatal NN diagnosis
diagnosis MD can
can VB be
be JJ difficult
difficult RB especially
especially IN if
if PRP they
they JJ present
present IN in
in RB late
late NN gestation

Here RB CAPITAL Here
Here PRP we
we JJ present
present CD two
two NNS cases
cases VBN diagnosed
diagnosed IN in
in DT the
the RB late
late JJ third
third NN trimester
trimester CC and
and NN review
review DT the
the NN literature
literature VBG regarding
regarding JJ prenatal
prenatal NN diagnosis
diagnosis IN of
of JJ cloacal
cloacal NNS anomalies

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB determine
determine IN whether
whether NNS patients
patients IN with
with JJ myocardial
myocardial NN amyloidosis
amyloidosis JJ due
due DT either
either TO to
to NNP CAPITAL AL
AL NN (
( JJ primary
primary NN )
) NN amyloid
amyloid CC or
or JJ familial
familial NN amyloid
amyloid VB have
have VBG distinguishing
distinguishing JJ echocardiographic
echocardiographic CC or
or JJ electrocardiographic
electrocardiographic NNS features
features : ;
; CC and
and TO to
to VB compare
compare DT the
the NN prevalence
prevalence IN of
of NN heart
heart NN failure
failure CC and
and NN survival
survival IN in
in DT the
the CD two
two NNS types
types IN of
of NN amyloidosis
amyloidosis IN in
in NN relation
relation TO to
to JJ echocardiographic
echocardiographic NNS findings

DESIGN NN CAPITAL DESIGN
DESIGN : :
: VBN CAPITAL Blinded
Blinded NN group
group NN comparison
comparison IN of
of RB randomly
randomly VBN selected
selected NNS cases
cases IN of
of JJ cardiac
cardiac NN amyloidosis

SETTING VBG CAPITAL SETTING
SETTING : :
: NNP CAPITAL International
International NN referral
referral NN centre
centre IN for
for NN amyloid
amyloid NN research
research CC and
and NN treatment

PATIENTS NNS CAPITAL PATIENTS
PATIENTS : :
: CD 36
36 NNS patients
patients IN with
with JJ cardiac
cardiac NN amyloid
amyloid NN heart
heart NN disease
disease , ,
, IN of
of WP whom
whom CD 12
12 VBD had
had JJ familial
familial CC and
and CD 24
24 VBD had
had JJ primary
primary NNP CAPITAL AL
AL NN amyloidosis

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: JJ CAPITAL Familial
Familial CC and
and NNP CAPITAL AL
AL NNS echocardiograms
echocardiograms VBD were
were RB morphologically
morphologically JJ indistinguishable
indistinguishable , ,
, IN with
with JJ similar
similar RB left
left JJ ventricular
ventricular NN wall
wall NN thickness
thickness , ,
, VB mean
mean NN (
( NN CAPITAL SD
SD NN )
) CD 15.4
15.4 NN (
( CD 2.3
2.3 NN )
) NN nu
nu CD 15.8
15.8 NN (
( CD 2.5
2.5 NN )
) NN mm
mm , ,
, RB respectively
respectively : ;
; RB right
right JJ ventricular
ventricular NN wall
wall NN thickness
thickness VBD was
was RB also
also JJ similar
similar IN between
between NN amyloid
amyloid NNS types
types : :
: CD 9.6
9.6 NN (
( CD 2.8
2.8 NN )
) NN nu
nu CD 9.7
9.7 NN (
( CD 6.5
6.5 NN )
) NN mm
mm , ,
, RB respectively

Doppler NNP CAPITAL Doppler
Doppler NNS indices
indices IN of
of RB left
left CC and
and RB right
right JJ ventricular
ventricular NN function
function , ,
, RB left
left JJ ventricular
ventricular NN volume
volume , ,
, CC and
and NN ejection
ejection NN fraction
fraction VBD were
were RB also
also JJ similar

Low JJ CAPITAL Low
Low NN voltage
voltage NNS electrocardiograms
electrocardiograms NN (
( CC &
& # #
# CD 60
60 : ;
; CD 0.5
0.5 NN mV
mV NN )
) VBD were
were RBR more
more JJ common
common IN in
in DT the
the NNP CAPITAL AL
AL NN (
( CD 16/24
16/24 , ,
, CD 67
67 NN %
% NN )
) IN than
than IN in
in DT the
the JJ familial
familial NN group
group NN (
( CD 4/12
4/12 , ,
, CD 25
25 NN %
% NN )
) , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05

The DT CAPITAL The
The CD one
one NN year
year NN survival
survival IN for
for JJ familial
familial CC and
and NNP CAPITAL AL
AL NNS forms
forms VBD was
was CD 92
92 NN %
% NN (
( CD 11/12
11/12 NN )
) NN nu
nu CD 38
38 NN %
% NN (
( CD 6/24
6/24 NN )
) , ,
, RB respectively
respectively , ,
, IN with
with RB virtually
virtually DT all
all NNS deaths
deaths JJ due
due TO to
to JJ cardiac
cardiac NNS causes

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: IN CAPITAL Although
Although JJ cardiac
cardiac NN involvement
involvement VBZ is
is RB echocardiographically
echocardiographically JJ indistinguishable
indistinguishable , ,
, JJ cardiac
cardiac NN mortality
mortality VBZ is
is RB very
very JJ different
different IN between
between DT the
the CD two
two NNS forms
forms IN of
of NN amyloidosis

Preservation NN CAPITAL Preservation
Preservation IN of
of JJ electrocardiographic
electrocardiographic NN voltage
voltage IN in
in JJ familial
familial NN amyloidosis
amyloidosis VBZ suggests
suggests IN that
that DT the
the JJ particular
particular JJ biochemical
biochemical NNS characteristics
characteristics IN of
of JJ distinct
distinct NNS types
types IN of
of NN amyloid
amyloid NN fibril
fibril VB have
have JJ different
different JJ pathological
pathological NNS effects
effects IN on
on DT the
the NN myocardium

This DT CAPITAL This
This NN distinction
distinction VBZ becomes
becomes JJ critical
critical IN in
in DT the
the NN evaluation
evaluation , ,
, NN treatment
treatment , ,
, CC and
and NN management
management IN of
of NNS patients
patients WP who
who VB have
have DT a
a NN diagnosis
diagnosis IN within
within DT the
the NN spectrum
spectrum IN of
of DT the
the NN protein
protein NN deposition
deposition NNS diseases

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB examine
examine DT the
the NN relationship
relationship IN between
between NN plasma
plasma NN plasminogen
plasminogen NN activator
activator NN inhibitor
inhibitor CD 1
1 NN (
( NN CAPITAL PAI-1
PAI-1 NN )
) NN activity
activity CC and
and NN CAPITAL PAI-1
PAI-1 NN gene
gene NN (
( NN 4G/5G
4G/5G NN )
) NN polymorphism
polymorphism CC and
and JJ diabetic
diabetic NN retinopathy
retinopathy IN in
in NNP CAPITAL Pima
Pima NNPS CAPITAL Indians
Indians IN with
with NN type
type CD 2
2 NN diabetes

RESEARCH NN CAPITAL RESEARCH
RESEARCH NN CAPITAL DESIGN
DESIGN CC CAPITAL AND
AND NNS CAPITAL METHODS
METHODS : :
: PRP CAPITAL We
We VBN studied
studied CD 171
171 NNP CAPITAL Pima
Pima NNPS CAPITAL Indians
Indians IN with
with NN type
type CD 2
2 NN diabetes
diabetes IN between
between DT the
the NNS ages
ages IN of
of CD 30-70
30-70 NNS years
years IN in
in DT a
a JJ population-based
population-based JJ epidemiological
epidemiological NN survey

Plasma NN CAPITAL Plasma
Plasma NN CAPITAL PAI-1
PAI-1 NN activity
activity VBD was
was VBN measured
measured IN by
by DT a
a JJ spectrophotometric
spectrophotometric NN assay
assay CC and
and NN CAPITAL PAI-1
PAI-1 NN 4G/5G
4G/5G NN promoter
promoter NN genotype
genotype IN by
by DT the
the NN polymerase
polymerase NN chain
chain NN reaction
reaction NN (
( NN CAPITAL PCR
PCR NN )
) VBG using
using JJ allele-specific
allele-specific NNS primers

Retinopathy NNP CAPITAL Retinopathy
Retinopathy VBD was
was VBN assessed
assessed IN by
by NN ophthalmoscopy
ophthalmoscopy IN after
after NN pupillary
pupillary NN dilation
dilation CC and
and VBN classified
classified IN as
as DT any
any NN retinopathy
retinopathy CC or
or IN as
as JJ nonproliferative
nonproliferative CC and
and JJ proliferative

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NNP CAPITAL Retinopathy
Retinopathy VBD was
was JJ present
present IN in
in CD 70
70 NN (
( CD 41
41 NN %
% NN )
) NNS subjects
subjects , ,
, CC and
and CD 4
4 NN (
( CD 2.3
2.3 NN %
% NN )
) NNS subjects
subjects VBD had
had JJ proliferative
proliferative NN retinopathy

Plasma NN CAPITAL Plasma
Plasma NN CAPITAL PAI-1
PAI-1 NN activity
activity VBD was
was RB not
not RB significantly
significantly JJ different
different IN among
among NNS subjects
subjects IN with
with CC and
and IN without
without NN retinopathy
retinopathy NN (
( CD 17.1
17.1 CC +/-
+/- CC vs.
vs. CD 19.7
19.7 CC +/-
+/- CD 9.1
9.1 JJ arbitrary
arbitrary NNS units
units NN (
( NN CAPITAL AU
AU NN )
) NN /ml
/ml , ,
, NN CAPITAL P
P JJ =
= CD 0.09
0.09 NN )

PAI-1 NN CAPITAL PAI-1
PAI-1 NN activity
activity VBD was
was RB negatively
negatively VBD correlated
correlated IN with
with NN duration
duration IN of
of NN diabetes
diabetes NN (
( NNS rs
rs JJ =
= CD -0.18
-0.18 , ,
, NN CAPITAL P
P JJ =
= CD 0.02
0.02 NN )

In IN CAPITAL In
In DT a
a JJ logistic
logistic NN regression
regression NN analysis
analysis VBN controlled
controlled IN for
for NN age
age , ,
, NN sex
sex , ,
, NN CAPITAL BMI
BMI , ,
, CC and
and NN duration
duration IN of
of NN diabetes
diabetes , ,
, DT any
any NN retinopathy
retinopathy VBD was
was RB significantly
significantly VBN associated
associated IN with
with VBG fasting
fasting NN plasma
plasma NN glucose
glucose NNS concentrations
concentrations NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD 0.05
0.05 NN )
) , ,
, JJ 2-h
2-h NN postload
postload NN glucose
glucose NN (
( NN CAPITAL P
P JJ =
= CD 0.02
0.02 NN )
) , ,
, CC and
and NN CAPITAL HbA1c
HbA1c NN (
( NN CAPITAL P
P JJ =
= CD 0.008
0.008 NN )
) , ,
, CC but
but RB not
not IN with
with NN CAPITAL PAI-1
PAI-1 NN activity
activity NN (
( NN CAPITAL P
P JJ =
= CD 0.48
0.48 NN )

The DT CAPITAL The
The NN prevalence
prevalence IN of
of NN retinopathy
retinopathy IN in
in DT the
the CD three
three NN genotype
genotype NNS groups
groups VBN differed
differed RB significantly
significantly NN (
( NN 4G/4G
4G/4G , ,
, NN 4G/5G
4G/5G , ,
, CC and
and NN 5G/5G
5G/5G VBD were
were CD 44
44 , ,
, CD 49
49 , ,
, CC and
and CD 24
24 NN %
% , ,
, RB respectively
respectively : ;
; NN chi
chi CD 2
2 JJ =
= CD 8.22
8.22 , ,
, NN df
df JJ =
= CD 2
2 , ,
, NN CAPITAL P
P JJ =
= CD 0.016
0.016 NN )
) CC and
and VBD remained
remained JJ significant
significant IN after
after VBG controlling
controlling IN for
for NN age
age , ,
, NN sex
sex , ,
, NN CAPITAL BMI
BMI , ,
, NN duration
duration IN of
of NN diabetes
diabetes , ,
, VBN glycated
glycated NN hemoglobin
hemoglobin , ,
, CC and
and NN urine
urine NN albumin-to-creatine
albumin-to-creatine NN ratio
ratio IN in
in DT a
a JJ logistic
logistic NN regression
regression NN analysis

The DT CAPITAL The
The NNS odds
odds NNS ratios
ratios IN for
for NN retinopathy
retinopathy IN in
in NNS subjects
subjects IN with
with NN 4G/4G
4G/4G CC and
and NN 4G/5G
4G/5G , ,
, VBN compared
compared IN with
with DT the
the NN 5G/5G
5G/5G NN genotype
genotype , ,
, VBD were
were CD 2.0
2.0 CC and
and CD 3.1
3.1 , ,
, RB respectively

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: IN CAPITAL Although
Although JJ diabetic
diabetic NN retinopathy
retinopathy IN in
in NNP CAPITAL Pima
Pima NNPS CAPITAL Indians
Indians IN with
with NN type
type CD 2
2 NN diabetes
diabetes VBZ is
is RB not
not VBN associated
associated IN with
with NN CAPITAL PAI-1
PAI-1 NN activity
activity , ,
, NNS subjects
subjects IN with
with DT the
the NN 4G/4G
4G/4G CC and
and NN 4G/5G
4G/5G NN genotype
genotype VBD had
had DT a
a JJR higher
higher NN prevalence
prevalence IN of
of NN retinopathy
retinopathy VBN compared
compared IN with
with NN 5G/5G
5G/5G NN CAPITAL PAI-1genotype

These DT CAPITAL These
These JJ preliminary
preliminary NNS findings
findings VBP indicate
indicate IN that
that IN in
in NNP CAPITAL Pima
Pima NNPS CAPITAL Indians
Indians IN with
with NN type
type CD 2
2 NN diabetes
diabetes , ,
, NN presence
presence IN of
of DT the
the NN 4G
4G NN allele
allele IN of
of DT the
the NN CAPITAL PAI-1
PAI-1 NN gene
gene VBD was
was VBN associated
associated IN with
with DT a
a JJR higher
higher NN risk
risk IN of
of JJ diabetic
diabetic NN retinopathy

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: JJ CAPITAL Diagnostic
Diagnostic NN peritoneal
peritoneal NN lavage
lavage NN (
( NNP CAPITAL DPL
DPL NN )
) VBZ is
is VBN used
used TO to
to VB diagnose
diagnose JJ intra-abdominal
intra-abdominal NN injury
injury IN in
in NNS patients
patients IN with
with NN stab
stab NNS wounds
wounds CC and
and JJ blunt
blunt NN trauma

Because IN CAPITAL Because
Because NN exploratory
exploratory NN celiotomy
celiotomy VBZ is
is RB routinely
routinely VBN performed
performed IN on
on NNS patients
patients IN with
with NN gunshot
gunshot NNS wounds
wounds TO to
to DT the
the NN abdomen
abdomen , ,
, NNP CAPITAL DPL
DPL VBZ is
is RB rarely
rarely VBN employed

However RB CAPITAL However
However , ,
, JJ several
several NNS studies
studies VB have
have VBD questioned
questioned JJ routine
routine NN exploration
exploration CC and
and VB have
have VBN drawn
drawn NN attention
attention TO to
to DT the
the VBN associated
associated NN morbidity
morbidity IN of
of JJ negative
negative NN celiotomy

Diagnostic JJ CAPITAL Diagnostic
Diagnostic NN peritoneal
peritoneal NN lavage
lavage VBZ is
is DT an
an RB easily
easily VBN performed
performed CC and
and JJ inexpensive
inexpensive NN test
test IN that
that MD may
may VB be
be JJ useful
useful IN in
in DT this
this NN situation

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB evaluate
evaluate DT the
the NN performance
performance IN of
of NNP CAPITAL DPL
DPL IN in
in DT the
the NN diagnosis
diagnosis IN of
of JJ intra-abdominal
intra-abdominal NN injury
injury IN in
in RB hemodynamically
hemodynamically JJ stable
stable NNS patients
patients IN with
with NN gunshot
gunshot NNS wounds
wounds TO to
to DT the
the NN abdomen

DESIGN NN CAPITAL DESIGN
DESIGN : :
: DT CAPITAL A
A JJ prospective
prospective JJ clinical
clinical NN trial

SETTING VBG CAPITAL SETTING
SETTING : :
: CD CAPITAL Two
Two JJ urban
urban NN trauma
trauma NNS centers

PATIENTS NNS CAPITAL PATIENTS
PATIENTS : :
: NNS CAPITAL Patients
Patients IN with
with NN gunshot
gunshot NNS wounds
wounds TO to
to DT the
the NN abdomen
abdomen CC and
and DT a
a JJ systolic
systolic NN blood
blood NN pressure
pressure IN of
of IN at
at JJS least
least CD 90
90 NN mm
mm NN CAPITAL Hg

INTERVENTIONS NNS CAPITAL INTERVENTIONS
INTERVENTIONS : :
: JJ CAPITAL Clinical
Clinical NN predication
predication IN of
of JJ intra-abdominal
intra-abdominal NN injury
injury IN in
in DT the
the NN emergency
emergency NN department
department CC and
and NNP CAPITAL DPL
DPL VBN performed
performed IN in
in DT the
the VBG operating
operating NN room
room IN before
before DT the
the NN initiation
initiation IN of
of NN celiotomy

Injuries NNS CAPITAL Injuries
Injuries VBN found
found IN during
during DT the
the NN celiotomy
celiotomy VBD were
were VBN recorded

MAIN NN CAPITAL MAIN
MAIN NN CAPITAL OUTCOME
OUTCOME NNS CAPITAL MEASURES
MEASURES : :
: DT CAPITAL The
The NNS results
results IN of
of DT the
the JJ clinical
clinical NN evaluation
evaluation CC and
and NNP CAPITAL DPL
DPL VBD were
were VBN compared
compared IN with
with DT the
the NNS findings
findings IN of
of DT the
the NN celiotomy

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: CD CAPITAL Forty-four
Forty-four NNS patients
patients VBD were
were VBN enrolled
enrolled IN into
into DT the
the NN study

Intra-abdominal JJ CAPITAL Intra-abdominal
Intra-abdominal NN injury
injury VBD was
was JJ present
present IN in
in CD 32
32 NN (
( CD 73
73 NN %
% NN )
) IN of
of DT these
these NNS patients

The DT CAPITAL The
The JJ senior
senior NN surgery
surgery NN resident
resident RB correctly
correctly VBN predicted
predicted DT the
the NN presence
presence IN of
of JJ intra-abdominal
intra-abdominal NN injury
injury IN in
in CD 36
36 NN (
( CD 82
82 NN %
% NN )
) IN of
of DT the
the NNS patients
patients NN (
( NN sensitivity
sensitivity JJ =
= CD 90.0
90.0 NN %
% , ,
, NN specificity
specificity JJ =
= CD 58.3
58.3 NN %
% , ,
, JJ positive
positive JJ predictive
predictive NN value
value JJ =
= CD 85.3
85.3 NN %
% , ,
, JJ negative
negative JJ predictive
predictive NN value
value JJ =
= CD 63.6
63.6 NN %
% , ,
, NN phi
phi JJ =
= CD 0.52
0.52 , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD .01
.01 NN )
) IN in
in DT the
the NN emergency
emergency NN department
department IN before
before NNP CAPITAL DPL
DPL CC and
and NN celiotomy
celiotomy VBD were
were VBN performed

Diagnostic JJ CAPITAL Diagnostic
Diagnostic NN peritoneal
peritoneal NN lavage
lavage RB correctly
correctly VBN identified
identified DT the
the NN presence
presence CC or
or NN absence
absence IN of
of JJ intra-abdominal
intra-abdominal NN injury
injury IN in
in CD 40
40 NN (
( CD 91
91 NN %
% NN )
) IN of
of DT the
the NNS patients
patients NN (
( JJ positive
positive JJ predictive
predictive NN value
value JJ =
= NN 96.7
96.7 NN %
% , ,
, JJ negative
negative JJ predictive
predictive NN value
value JJ =
= CD 78.6
78.6 NN %
% , ,
, NN phi
phi JJ =
= CD 0.79
0.79 , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD .01
.01 NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: JJ CAPITAL Clinical
Clinical NN judgment
judgment VBZ is
is RB highly
highly JJ accurate
accurate IN in
in VBG separating
separating NNS patients
patients IN with
with JJ tangential
tangential NN gunshot
gunshot NNS wounds
wounds TO to
to DT the
the NN abdomen
abdomen IN from
from DT those
those IN with
with JJ intra-abdominal
intra-abdominal NN injury
injury CC but
but MD may
may VB miss
miss NNS patients
patients IN with
with JJ intra-abdominal
intra-abdominal NN hemorrhage

Diagnostic JJ CAPITAL Diagnostic
Diagnostic NN peritoneal
peritoneal NN lavage
lavage VBZ is
is RB highly
highly JJ predictive
predictive IN of
of DT the
the NN presence
presence IN of
of JJ intra-abdominal
intra-abdominal NN injury

The DT CAPITAL The
The NN return
return IN of
of JJ gross
gross NN blood
blood IN on
on NN aspiration
aspiration CC or
or DT a
a NN lavage
lavage JJ red
red NN blood
blood NN cell
cell NN count
count JJR greater
greater IN than
than CD 10
10 NN x
x CD 10
10 NN (
( CD 9
9 NN )
) NN /L
/L MD should
should JJ prompt
prompt DT an
an JJ urgent
urgent NN celiotomy

Missed VBN CAPITAL Missed
Missed NNS injuries
injuries VBP are
are JJ rare
rare CC and
and RBS most
most RB likely
likely TO to
to VB be
be NN bowel
bowel NNS perforations

Diagnostic JJ CAPITAL Diagnostic
Diagnostic NN peritoneal
peritoneal NN lavage
lavage VBZ is
is DT an
an NN objective
objective NN test
test IN that
that MD may
may VBP augment
augment JJ clinical
clinical NN judgment
judgment IN in
in VBG selecting
selecting RB hemodynamically
hemodynamically JJ stable
stable NNS patients
patients IN with
with NN potential
potential JJ tangential
tangential NN gunshot
gunshot NNS wounds
wounds IN for
for NN observation
observation CC and
and VBZ is
is RB especially
especially JJ useful
useful IN in
in VBG identifying
identifying JJ intra-abdominal
intra-abdominal NN hemorrhage

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: TO CAPITAL To
To VB evaluate
evaluate DT the
the NN frequency
frequency IN of
of NNP CAPITAL Blastocystis
Blastocystis NNS hominis
hominis NN parasitation
parasitation CC and
and TO to
to VB ascertain
ascertain PRP$ its
its NN role
role IN as
as DT an
an JJ intestinal
intestinal DT a
a JJ prospective
prospective NN study
study IN during
during CD 18
18 NNS months
months NN pathogen
pathogen VBZ has
has VBN been
been VBD carried
carried IN out

SUBJECTS NNS CAPITAL SUBJECTS
SUBJECTS CC CAPITAL AND
AND NNS CAPITAL METHODS
METHODS : :
: DT CAPITAL The
The NN study
study VBN included
included CD 2
2 , ,
, CD 039
039 NNS patients
patients , ,
, WDT which
which VBD were
were VBN classified
classified IN in
in CD three
three NNS groups
groups NN (
( JJ asymptomatic
asymptomatic NN (
( NN group
group DT CAPITAL A
A NN )
) , ,
, IN with
with NN suspicion
suspicion IN of
of NN parasitosis
parasitosis NN (
( NN group
group NN CAPITAL B
B NN )
) , ,
, IN with
with NN diarrhoea
diarrhoea NN (
( NN group
group NN CAPITAL C
C NN )
) NN )

In IN CAPITAL In
In DT all
all NNS cases
cases DT a
a JJ coproparasitological
coproparasitological NN study
study VBD was
was VBN performed

In IN CAPITAL In
In DT the
the NN group
group NN CAPITAL C
C DT the
the NN presence
presence IN of
of JJ non-parasitic
non-parasitic NNS enteropathogens
enteropathogens VBD was
was RB also
also VBN investigated

In IN CAPITAL In
In NNS patients
patients IN with
with NN CAPITAL B

hominis NNS hominis
hominis IN in
in DT the
the NN absence
absence IN of
of JJ other
other NNS pathogens
pathogens JJ clinical
clinical CC and
and JJ epidemiological
epidemiological NNS characteristics
characteristics VBD were
were VBN evaluated

Also RB CAPITAL Also
Also , ,
, PRP$ its
its VBD was
was VBN determined
determined DT the
the NN morphology
morphology CC and
and NN quantification
quantification IN of
of NNS parasites

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NNS CAPITAL Parasites
Parasites VBD were
were VBN identified
identified IN in
in CD 26.2
26.2 NN %
% IN of
of NN population

B NN CAPITAL B

hominis NNS hominis
hominis VBD was
was VBN identified
identified IN in
in CD 336
336 NNS patients
patients NN (
( CD 16.5
16.5 NN %
% NN )

The DT CAPITAL The
The NN frequency
frequency IN of
of NN parasitation
parasitation VBD was
was JJ superior
superior IN in
in NNS adults
adults NN (
( NN p
p CC &
& # #
# CD 60
60 : ;
; CD 0.0001
0.0001 NN )
) , ,
, IN with
with DT a
a JJ slight
slight NN predominance
predominance IN in
in DT the
the NN female
female NN sex

The DT CAPITAL The
The NN rate
rate IN of
of JJ asymptomatic
asymptomatic NNS carriers
carriers VBD was
was CD 3.3
3.3 NN %

In IN CAPITAL In
In CD 21
21 NNS patients
patients NN CAPITAL B

hominis NNS hominis
hominis NN (
( NN group
group NN CAPITAL C
C NN )
) VBD was
was VBN observed
observed IN in
in NN absence
absence IN of
of JJ other
other NNS enteropathogens

Statistical JJ CAPITAL Statistical
Statistical JJ significant
significant NN association
association VBD was
was VBN found
found IN between
between NN CAPITAL B

hominis NNS hominis
hominis , ,
, IN in
in NN absence
absence IN of
of JJ other
other NNS pathogens
pathogens CC and
and DT the
the NN presence
presence IN of
of JJ clinical
clinical NNS manifestations
manifestations NN (
( NN p
p CC &
& # #
# CD 60
60 : ;
; CD 0.0001
0.0001 NN )
) , ,
, DT the
the RBS most
most JJ common
common IN of
of WDT which
which VBD were
were NN diarrhoea
diarrhoea CC and
and JJ abdominal
abdominal NN pain

We PRP CAPITAL We
We VBD did
did RB not
not VB find
find DT a
a RB statistically
statistically JJ significant
significant NN association
association IN between
between DT the
the NN number
number IN of
of NN CAPITAL B

hominis NNS hominis
hominis JJ present
present CC and
and NN stool
stool NNS characteristics

The DT CAPITAL The
The NN vacuolar
vacuolar NN form
form VBD was
was DT the
the JJ predominant
predominant JJ morphological
morphological NN type

The DT CAPITAL The
The NN ameboid
ameboid NN form
form VBD was
was VBN observed
observed RB only
only IN in
in NN diarrhoeal
diarrhoeal NNS stools

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NN CAPITAL B

hominis NNS hominis
hominis VBZ is
is DT the
the RBS most
most JJ frequent
frequent NN parasite
parasite VBN found
found IN in
in JJ faecal
faecal JJ parasitological
parasitological NN investigation

In IN CAPITAL In
In NN absence
absence IN of
of JJ other
other NNS causes
causes , ,
, NN CAPITAL B

hominis NNS hominis
hominis MD must
must VB be
be VBN considered
considered IN as
as DT a
a NN pathogen

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL BACKGROUND
BACKGROUND : :
: DT CAPITAL The
The NN cause
cause IN of
of JJ severe
severe VBN acquired
acquired NN hyperammonemia
hyperammonemia , ,
, DT an
an JJ uncommon
uncommon CC but
but RB often
often JJ fatal
fatal NN complication
complication IN of
of NN organ
organ NN transplantation
transplantation CC and
and NN chemotherapy
chemotherapy IN for
for NN cancer
cancer , ,
, VBZ is
is JJ obscure

< JJR <
< NN /TO_SEES
/TO_SEES JJR >
> NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To NN test
test DT the
the NN hypothesis
hypothesis IN that
that NN liver
liver NN glutamine
glutamine NN synthetase
synthetase NN deficiency
deficiency MD may
may VB explain
explain NN hyperammonemia
hyperammonemia IN in
in NNS patients
patients WP who
who VB have
have VBD had
had NN organ
organ NN transplantation
transplantation CC or
or VBP are
are VBG receiving
receiving NN chemotherapy

DESIGN NN CAPITAL DESIGN
DESIGN : :
: NN CAPITAL Case
Case NN report

PATIENTS NNS CAPITAL PATIENTS
PATIENTS : :
: CD CAPITAL Two
Two NNS patients
patients WP who
who VBD had
had JJ fatal
fatal NN hyperammonemia
hyperammonemia IN after
after JJ orthotopic
orthotopic NN lung
lung NN transplantation
transplantation . .

MEASUREMENTS NNS CAPITAL MEASUREMENTS
MEASUREMENTS : :
: NN CAPITAL Liver
Liver NN tissue
tissue VBD was
was VBN analyzed
analyzed TO to
to VB determine
determine DT the
the NNS activities
activities IN of
of CD two
two NN urea
urea NN cycle
cycle NNS enzymes
enzymes CC and
and NN glutamine
glutamine NN synthetase

Western NNP CAPITAL Western
Western NN blot
blot NNS assays
assays IN for
for JJ hepatic
hepatic NN glutamine
glutamine NN synthetase
synthetase VBD were
were VBN performed
performed TO to
to VB determine
determine IN whether
whether NN glutamine
glutamine NN synthetase
synthetase NN deficiency
deficiency VBD resulted
resulted IN from
from VBN reduced
reduced NN enzyme
enzyme NNS levels

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NNS CAPITAL Activities
Activities IN of
of NN carbamoyl
carbamoyl NN phosphate
phosphate NN synthetase
synthetase PRP CAPITAL I
I CC and
and NN ornithine
ornithine NN carbamoyltransferase
carbamoyltransferase IN in
in DT the
the NN liver
liver VBD were
were JJ normal

The DT CAPITAL The
The NN activity
activity IN of
of JJ hepatic
hepatic NN glutamine
glutamine NN synthetase
synthetase VBD was
was RB markedly
markedly VBN reduced
reduced NN (
( IN in
in NN patient
patient CD 1
1 , ,
, CD 12
12 NN %
% IN of
of DT the
the VB mean
mean NN value
value IN in
in NNS controls
controls : ;
; IN in
in NN patient
patient CD 2
2 , ,
, CD 28
28 NN %
% IN of
of DT the
the VB mean
mean NN value
value IN in
in NNS controls
controls NN )
) , ,
, CC and
and DT a
a JJ concomitant
concomitant NN reduction
reduction IN in
in DT the
the NN amount
amount IN of
of NN glutamine
glutamine NN synthetase
synthetase NN protein
protein VBD was
was VBN observed

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL CONCLUSION
CONCLUSION : :
: NN CAPITAL Hyperammonemia
Hyperammonemia IN after
after NN transplantation
transplantation VBD was
was VBN associated
associated IN with
with JJ hepatic
hepatic NN glutamine
glutamine NN synthetase
synthetase NN deficiency
deficiency IN in
in CD two
two NNS patients
patients , ,
, CC but
but DT the
the JJ causal
causal NN relation
relation IN between
between DT these
these CD two
two NNS conditions
conditions MD must
must VB be
be RB further
further VBN studied

Postnatal JJ CAPITAL Postnatal
Postnatal NN growth
growth VBD was
was RB prospectively
prospectively VBN measured
measured IN from
from NN birth
birth TO to
to CD 1
1 NN y
y IN in
in CD 54
54 NN term
term NNS infants
infants VBN born
born JJ small
small IN for
for JJ gestational
gestational NN age
age NN (
( NNP CAPITAL SGA
SGA NN )
) , ,
, NN fed
fed DT either
either NN breast
breast NN milk
milk CC or
or DT a
a NN standard
standard NN term
term NN infant
infant NN formula

Breastfeeding VBG CAPITAL Breastfeeding
Breastfeeding VBD was
was VBN associated
associated IN with
with DT a
a CD 0.36
0.36 CC and
and CD 0.64
0.64 NN standard
standard NN deviation
deviation NN (
( NN CAPITAL SD
SD NN )
) NN increase
increase IN in
in NN weight
weight IN at
at CD 2
2 NNS weeks
weeks CC and
and CD 3
3 NNS months
months IN of
of NN age
age , ,
, RB respectively
respectively , ,
, WDT which
which VBD persisted
persisted IN beyond
beyond DT the
the VBG breastfeeding
breastfeeding NN period
period NN (
( CD 0.64
0.64 NN CAPITAL SD
SD IN at
at CD 1
1 NN y
y NN )

Breastfed VBN CAPITAL Breastfed
Breastfed NNS infants
infants RB also
also VBD showed
showed JJR greater
greater NN catch-up
catch-up NN growth
growth IN in
in NN head
head NN circumference
circumference NN (
( NN CAPITAL SD
SD NN score
score NN (
( NN CAPITAL SDS
SDS NN )
) CD 0.53
0.53 JJR higher
higher IN at
at CD 3
3 NNS months
months NN )
) , ,
, CC and
and JJR greater
greater NN body
body NN length
length NN gain
gain NN (
( NN CAPITAL SDS
SDS CD 0.68
0.68 JJR higher
higher IN at
at CD 6
6 NNS months
months NN )

This DT CAPITAL This
This VBN increased
increased NN growth
growth VBD was
was JJ independent
independent IN of
of RB potentially
potentially VBG confounding
confounding NN obstetric
obstetric , ,
, JJ social
social CC and
and JJ demographic
demographic NNS factors

Our PRP$ CAPITAL Our
Our NNS findings
findings VB suggest
suggest IN that
that VBG breastfeeding
breastfeeding MD may
may VB promote
promote RBR faster
faster NN growth
growth IN in
in NNS infants
infants VBN compromised
compromised IN by
by JJ poor
poor NN growth
growth IN in
in NN utero

SGA NNP CAPITAL SGA
SGA NNS infants
infants MD may
may VB be
be VBN programmed
programmed IN for
for DT a
a NN number
number IN of
of JJ adverse
adverse NNS outcomes
outcomes : ;
; DT the
the NN possibility
possibility IN that
that JJ such
such NNS events
events VBP are
are JJ altered
altered IN by
by NN choice
choice IN of
of JJ postnatal
postnatal NN diet
diet VBZ is
is DT a
a NN key
key NN issue
issue IN for
for NN future
future NN research

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: JJ CAPITAL Few
Few NNS studies
studies VB have
have VBN explored
explored DT the
the NN health
health NNS practices
practices IN of
of JJ critical
critical NN care
care NNS nurses

Critical JJ CAPITAL Critical
Critical NN care
care NNS nurses
nurses RB routinely
routinely VB teach
teach NNS patients
patients IN about
about VBG using
using JJ healthy
healthy NNS practices
practices JJ such
such IN as
as JJ low-fat
low-fat NNS diets
diets , ,
, NN exercise
exercise , ,
, CC and
and JJ routine
routine NN screening
screening NNS examinations

However RB CAPITAL However
However , ,
, PRP it
it MD may
may VB be
be RB even
even RBR more
more JJ important
important IN that
that DT the
the NNS nurses
nurses PRP themselves
themselves VB have
have DT a
a JJ healthy
healthy NN lifestyle
lifestyle , ,
, RB thus
thus VBG serving
serving IN as
as NN role
role NNS models
models IN for
for NNS patients

Nurses NNS CAPITAL Nurses
Nurses VBP are
are VBG selling
selling DT a
a NN product
product , ,
, CC and
and IN that
that NN product
product VBZ is
is NN health

The DT CAPITAL The
The RB best
best NNS salespersons
salespersons VBP are
are DT those
those WP who
who VBP are
are RB genuinely
genuinely VBN committed
committed TO to
to PRP$ their
their NN product
product CC and
and NN model
model PRP$ its
its NNS benefits

Therefore RB CAPITAL Therefore
Therefore , ,
, JJ critical
critical NN care
care NNS nurses
nurses '' '
' JJ healthful
healthful NNS practices
practices MD can
can VB have
have DT a
a JJ profound
profound NN effect
effect IN on
on PRP$ their
their NNS patients

OBJECTIVES NNS CAPITAL OBJECTIVES
OBJECTIVES : :
: DT CAPITAL The
The NN purpose
purpose IN of
of DT this
this JJ descriptive
descriptive NN exploratory
exploratory NN study
study VBD was
was TO to
to VB examine
examine JJ critical
critical NN care
care NNS nurses
nurses '' '
' NNS responses
responses TO to
to CD three
three NNS questions
questions IN about
about NN health
health NNS practices
practices IN in
in PRP$ their
their RB daily
daily NNS lives
lives : :
: NN (
( CD 1
1 NN )
) WDT CAPITAL What
What VBP are
are JJ critical
critical NN care
care NNS nurses
nurses VBG doing
doing RB currently
currently TO to
to NN stay
stay JJ healthy
healthy . ?
? NN (
( CD 2
2 NN )
) VB CAPITAL Do
Do PRP they
they VB anticipate
anticipate VBG making
making DT any
any NNS changes
changes IN in
in PRP$ their
their NN lifestyle
lifestyle IN in
in DT the
the NN future
future . ?
? NN (
( CD 3
3 NN )
) MD CAPITAL Would
Would PRP they
they VB recommend
recommend PRP$ their
their NN lifestyle
lifestyle TO to
to PRP$ their
their NNS patients
patients . ?
? NNS CAPITAL METHODS
METHODS : :
: CD CAPITAL One
One CD hundred
hundred CD twenty-seven
twenty-seven JJ critical
critical NN care
care NNS nurses
nurses VBG attending
attending DT a
a JJ midwestern
midwestern JJ critical
critical NN care
care NN conference
conference VBN completed
completed DT a
a JJ two-part
two-part NN questionnaire
questionnaire VBN designed
designed TO to
to VB produce
produce DT a
a NN health
health NN profile

In IN CAPITAL In
In DT a
a NN man-on-the-street
man-on-the-street NN approach
approach , ,
, CD 23
23 NNS nurses
nurses VBD participated
participated IN in
in DT an
an NN interview
interview IN via
via NN video
video NN camera

Descriptive JJ CAPITAL Descriptive
Descriptive NNS statistics
statistics VBD were
were VBN used
used TO to
to VB analyze
analyze DT the
the NNS data
data VBN retrieved
retrieved IN from
from DT the
the NNS questionnaires

Interviews NNS CAPITAL Interviews
Interviews VBD were
were VBN transcribed
transcribed JJ verbatim
verbatim CC and
and VBN analyzed
analyzed IN for
for NNS themes
themes IN with
with DT a
a JJ constant
constant JJ comparative
comparative NN method

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: RBR CAPITAL More
More IN than
than CD 70
70 NN %
% IN of
of DT the
the JJ critical
critical NN care
care NNS nurses
nurses WP who
who VBD responded
responded VB engage
engage IN in
in NN exercise
exercise CC and
and VB follow
follow DT a
a JJ healthy
healthy , ,
, JJ low-fat
low-fat NN diet

Seventy-one CD CAPITAL Seventy-one
Seventy-one NN percent
percent VBD said
said IN that
that PRP they
they VB anticipate
anticipate VBG making
making DT a
a NN change
change IN in
in PRP$ their
their NN lifestyle
lifestyle IN in
in DT the
the NN future
future , ,
, CC and
and CD 70
70 NN %
% VBD said
said IN that
that PRP they
they MD would
would VB recommend
recommend PRP$ their
their NN lifestyle
lifestyle TO to
to PRP$ their
their NNS patients

Five CD CAPITAL Five
Five NNS themes
themes VBD emerged
emerged IN from
from DT the
the JJ videotaped
videotaped NNS interviews
interviews : :
: NN (
( CD 1
1 NN )
) JJ CAPITAL Heart-healthy
Heart-healthy NNS practices
practices VBD predominated
predominated DT the
the NNS responses

( NN (
( CD 2
2 NN )
) VBG CAPITAL Incorporating
Incorporating DT a
a JJ healthy
healthy NN lifestyle
lifestyle VBD was
was JJ easy
easy IN for
for DT some
some CC and
and DT a
a NN struggle
struggle IN for
for NNS others

( NN (
( CD 3
3 NN )
) JJ CAPITAL Critical
Critical NN care
care NNS nurses
nurses RB readily
readily VBN listed
listed NNS barriers
barriers TO to
to JJ healthy
healthy VBG living

( NN (
( CD 4
4 NN )
) DT CAPITAL The
The NNS nurses
nurses VBD had
had DT a
a JJ positive
positive NN attitude
attitude IN about
about PRP$ their
their JJ healthy
healthy NNS lifestyles
lifestyles CC and
and VBD felt
felt JJ optimistic
optimistic IN about
about VBG being
being NN role
role NNS models
models IN for
for PRP$ their
their NNS patients

( NN (
( CD 5
5 NN )
) JJ CAPITAL Future
Future NNS plans
plans VBD were
were DT either
either JJ singular
singular IN in
in NN focus
focus CC or
or JJ limited
limited TO to
to NN maintenance
maintenance IN of
of JJ current
current NN health
health NNS habits

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL The
The NN majority
majority IN of
of DT the
the NNS nurses
nurses VBN reported
reported VBG practicing
practicing DT a
a JJ healthy
healthy NN lifestyle
lifestyle CC and
and NN thought
thought IN that
that PRP they
they VBD were
were JJ good
good NN role
role NNS models
models IN for
for NNS patients

Cytochrome NN CAPITAL Cytochrome
Cytochrome NN CAPITAL P450
P450 NN 1A1
1A1 NN (
( NN CAPITAL CYP1A1
CYP1A1 NN )
) CC and
and NN glutathione
glutathione NN CAPITAL S-transferase
S-transferase NN CAPITAL M1
M1 NN (
( NN CAPITAL GSTM1
GSTM1 NN )
) JJ genetic
genetic NNS polymorphisms
polymorphisms VBP are
are VBN involved
involved IN in
in DT the
the NN activation
activation CC and
and NN detoxification
detoxification IN of
of NN chemical
chemical NNS carcinogens
carcinogens VBN found
found IN in
in NN tobacco
tobacco NN smoke
smoke : ;
; RB thus
thus PRP they
they MD may
may NN influence
influence NN host
host NN susceptibility
susceptibility TO to
to NN lung
lung NN cancer

In IN CAPITAL In
In DT this
this NN study
study IN at
at NNP CAPITAL Massachusetts
Massachusetts NNP CAPITAL General
General NN CAPITAL Hospital
Hospital NN (
( NNP CAPITAL Boston
Boston , ,
, NNP CAPITAL MA
MA , ,
, NNP CAPITAL USA
USA NN )
) IN of
of CD 416
416 NNS cases
cases CC and
and CD 446
446 NNS controls
controls NN (
( RB mostly
mostly NNP CAPITAL White
White NN )
) PRP we
we VBN evaluated
evaluated DT the
the NN association
association IN between
between DT the
the NN CAPITAL CYP1A1
CYP1A1 NN CAPITAL MspI
MspI CC and
and NN CAPITAL GSTM1
GSTM1 NNS polymorphisms
polymorphisms CC and
and NN lung
lung NN cancer
cancer NN risk
risk , ,
, CC and
and PRP$ their
their NN interaction
interaction IN with
with NN cigarette
cigarette NN smoke

The DT CAPITAL The
The NN CAPITAL CYP1A1
CYP1A1 NN CAPITAL MspI
MspI JJ heterozygous
heterozygous NN genotype
genotype VBD was
was JJ present
present IN in
in CD 18
18 NN percent
percent IN of
of NNS cases
cases CC and
and CD 16
16 NN percent
percent IN of
of NNS controls
controls , ,
, CC and
and CD one
one NN percent
percent IN of
of NNS cases
cases CC and
and NNS controls
controls VBD were
were NN CAPITAL CYP1A1
CYP1A1 NN CAPITAL MspI
MspI JJ homozygous
homozygous NN variant

The DT CAPITAL The
The NN CAPITAL GSTM1
GSTM1 JJ null
null NN genotype
genotype VBD was
was VBN detected
detected IN in
in CD 54
54 NN percent
percent IN of
of NNS cases
cases CC and
and CD 52
52 NN percent
percent IN of
of NNS controls

After IN CAPITAL After
After VBG adjusting
adjusting IN for
for NN age
age , ,
, NN gender
gender , ,
, NNS pack-years
pack-years IN of
of NN smoking
smoking , ,
, CC and
and NNS years
years IN since
since VBG quitting
quitting NN smoking
smoking , ,
, IN while
while DT neither
neither DT the
the NN CAPITAL CYP1A1
CYP1A1 NN CAPITAL MspI
MspI JJ heterozygous
heterozygous NN genotype
genotype RB alone
alone CC nor
nor DT the
the NN CAPITAL GSTM1
GSTM1 JJ null
null NN genotype
genotype RB alone
alone VBD were
were VBN associated
associated IN with
with DT a
a JJ significant
significant NN increase
increase IN in
in NN lung
lung NN cancer
cancer NN risk
risk , ,
, VBG having
having DT both
both JJ genetic
genetic NNS traits
traits VBD was
was VBN associated
associated IN with
with DT a
a RB twofold
twofold NN increase
increase IN in
in NN risk
risk NN (
( CD 95
95 NN percent
percent NN confidence
confidence NN interval
interval NN (
( NN CAPITAL CI
CI NN )
) JJ =
= CD 1.0-3.4
1.0-3.4 NN )

Our PRP$ CAPITAL Our
Our NNS data
data VBD did
did RB not
not VB provide
provide RB enough
enough NN evidence
evidence IN for
for DT a
a JJ substantial
substantial NN modification
modification IN of
of DT the
the NN effect
effect IN of
of NNS pack-years
pack-years IN on
on NN lung
lung NN cancer
cancer NN risk
risk IN by
by DT the
the NN CAPITAL CYP1A1
CYP1A1 NN CAPITAL MspI
MspI CC and
and NN CAPITAL GSTM1
GSTM1 NNS genotypes

However RB CAPITAL However
However , ,
, NNS limitations
limitations IN of
of PRP$ our
our NN study
study VB preclude
preclude DT a
a NN conclusion
conclusion IN about
about DT this
this NN potential
potential NN interaction

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: JJ CAPITAL Thrombolytic
Thrombolytic NN treatment
treatment VBZ has
has VBN been
been VBN shown
shown TO to
to VB accelerate
accelerate NN resolution
resolution IN of
of JJ major
major JJ pulmonary
pulmonary NN embolism
embolism CC and
and NN lead
lead TO to
to DT a
a JJ rapid
rapid NN improvement
improvement IN of
of JJ right-side
right-side NNS hemodynamics

However RB CAPITAL However
However , ,
, DT the
the NN association
association IN between
between DT these
these JJ favorable
favorable NNS effects
effects CC and
and DT the
the JJ clinical
clinical NN outcome
outcome IN of
of NNS patients
patients WP who
who VB have
have DT no
no JJ severe
severe JJ hemodynamic
hemodynamic NN compromise
compromise IN at
at NN presentation
presentation NNS remains
remains JJ unknown

METHODS NNS CAPITAL METHODS
METHODS CC CAPITAL AND
AND NNS CAPITAL RESULTS
RESULTS : :
: DT CAPITAL The
The JJ present
present NN multicenter
multicenter NN registry
registry VBN included
included CD 719
719 JJ consecutive
consecutive NNS patients
patients IN with
with JJ major
major JJ pulmonary
pulmonary NN embolism
embolism VBG according
according TO to
to JJ clinical
clinical , ,
, JJ echocardiographic
echocardiographic , ,
, JJ scintigraphic
scintigraphic , ,
, CC and
and JJ cardiac
cardiac NN catheterization
catheterization NNS criteria

Symptom NN CAPITAL Symptom
Symptom NN onset
onset VBD was
was JJ acute
acute NN (
( CC &
& # #
# CD 60
60 : ;
; CD 48
48 NNS hours
hours NN )
) IN in
in CD 63
63 NN %
% IN of
of NNS patients

All DT CAPITAL All
All NNS patients
patients VBD were
were RB hemodynamically
hemodynamically JJ stable
stable NN (
( FW ie
ie , ,
, IN without
without NN evidence
evidence IN of
of JJ cardiogenic
cardiogenic NN shock
shock NN )
) IN at
at NN presentation

treatment NN treatment
treatment NN (
( IN within
within CD 24
24 NNS hours
hours IN of
of NN diagnosis
diagnosis NN )
) VBD was
was VBN given
given TO to
to CD 169
169 NNS patients
patients NN (
( CD 23.5
23.5 NN %
% NN )
) , ,
, IN whereas
whereas DT the
the VBG remaining
remaining CD 550
550 NNS patients
patients VBD were
were RB initially
initially VBN treated
treated IN with
with NN heparin
heparin RB alone

Overall RB CAPITAL Overall
Overall JJ 30-day
30-day NN mortality
mortality VBD was
was RB significantly
significantly JJR lower
lower IN in
in DT the
the NNS patients
patients WP who
who VBN received
received JJ thrombolytic
thrombolytic NNS agents
agents NN (
( CD 4.7
4.7 CC versus
versus CD 11.1
11.1 NN %
% , ,
, NN CAPITAL P=.016
P=.016 NN )

Clinical JJ CAPITAL Clinical
Clinical NNS factors
factors VBN associated
associated IN with
with DT a
a JJR higher
higher NN death
death NN rate
rate VBD were
were NN syncope
syncope NN (
( NN CAPITAL P=.012
P=.012 NN )
) , ,
, JJ arterial
arterial NN hypotension
hypotension NN (
( NN CAPITAL P=.021
P=.021 NN )
) , ,
, NN history
history IN of
of JJ congestive
congestive NN heart
heart NN failure
failure NN (
( NN CAPITAL P=.013
P=.013 NN )
) , ,
, CC and
and JJ chronic
chronic JJ pulmonary
pulmonary NN disease
disease NN (
( NN CAPITAL P=.032
P=.032 NN )

However RB CAPITAL However
However , ,
, RB only
only JJ primary
primary NN thrombolysis
thrombolysis VBD was
was VBN found
found IN by
by JJ multivariate
multivariate NN analysis
analysis TO to
to VB be
be DT an
an JJ independent
independent NN predictor
predictor IN of
of NN survival
survival NN (
( NNS odds
odds NN ratio
ratio IN for
for JJ in-hospital
in-hospital NN death
death , ,
, CD 0.46
0.46 : ;
; CD 95
95 NN %
% NN confidence
confidence NN interval
interval , ,
, CD 0.21
0.21 TO to
to CD 1.00
1.00 NN )

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNS CAPITAL Patients
Patients WP who
who VBD underwent
underwent RB early
early JJ thrombolytic
thrombolytic NN treatment
treatment VBD had
had DT a
a VBN reduced
reduced NN rate
rate IN of
of JJ recurrent
recurrent JJ pulmonary
pulmonary NN embolism
embolism NN (
( CD 7.7
7.7 CC versus
versus CD 18.7
18.7 NN %
% , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD .001
.001 NN )
) CC but
but RB also
also DT a
a JJR higher
higher NN frequency
frequency IN of
of JJ major
major VBG bleeding
bleeding NNS episodes
episodes NN (
( CD 21.9
21.9 NN %
% CC versus
versus CD 7.8
7.8 NN %
% , ,
, NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD .001
.001 NN )

Cerebral JJ CAPITAL Cerebral
Cerebral VBG bleeding
bleeding VBD occurred
occurred IN in
in CD 2
2 NNS patients
patients IN in
in DT each
each NN treatment
treatment NN group
group , ,
, CC and
and CD 1
1 NN patient
patient IN in
in DT each
each NN group
group VBD died
died IN of
of DT a
a VBG bleeding
bleeding NN complication

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL The
The NNS results
results IN of
of PRP$ our
our NN study
study VB suggest
suggest IN that
that NN thrombolysis
thrombolysis MD may
may RB favorably
favorably VB affect
affect DT the
the JJ clinical
clinical NN outcome
outcome IN of
of RB hemodynamically
hemodynamically JJ stable
stable NNS patients
patients IN with
with JJ major
major JJ pulmonary
pulmonary NN embolism

A DT CAPITAL A
A JJ 66-year-old
66-year-old NN male
male NN engineer
engineer VBN diagnosed
diagnosed IN with
with JJ malignant
malignant JJ pleural
pleural NN mesothelioma
mesothelioma CD 4
4 NNS years
years RB previously
previously VBD had
had NN thoracotomy
thoracotomy , ,
, NN radiotherapy
radiotherapy , ,
, CC and
and NN chemotherapy

He PRP CAPITAL He
He VBD was
was VBN followed
followed RB regularly
regularly IN with
with NN chest
chest VBN computed
computed NN tomography
tomography NN (
( NN CAPITAL CT
CT NN )
) VB scan
scan CC and
and VBD had
had VBN been
been JJ asymptomatic

During IN CAPITAL During
During CD one
one IN of
of PRP$ his
his JJ physical
physical NNS examinations
examinations , ,
, JJ routine
routine NN sigmoidoscopy
sigmoidoscopy VBD showed
showed JJ incidental
incidental JJ colonic
colonic NNS polyps
polyps WDT which
which VBD were
were VBN biopsied

Subsequently RB CAPITAL Subsequently
Subsequently , ,
, NN recurrence
recurrence IN of
of JJ pleural
pleural NN mesothelioma
mesothelioma CC and
and NN peritoneal
peritoneal NN involvement
involvement IN by
by NN mesothelioma
mesothelioma VBD was
was VBN documented

Two CD CAPITAL Two
Two IN of
of DT the
the NNS polyps
polyps VBD showed
showed JJ metastatic
metastatic JJ malignant
malignant NN mesothelioma
mesothelioma IN in
in DT the
the NN lamina
lamina NN propia
propia WDT which
which RB strongly
strongly VBD resembled
resembled NN adenocarcinoma
adenocarcinoma RB histologically
histologically VBG causing
causing NN difficulty
difficulty IN in
in VBG making
making JJ definitive
definitive NN diagnosis

Review NN CAPITAL Review
Review IN of
of DT the
the NN literature
literature VBN disclosed
disclosed DT no
no RB previously
previously VBN documented
documented JJ similar
similar NN occurrence

This DT CAPITAL This
This NN case
case NNS shows
shows DT the
the NN importance
importance IN of
of JJ clinical
clinical NN history
history CC and
and NN ancillary
ancillary NN laboratory
laboratory NNS procedures
procedures JJ such
such IN as
as NN immunohistochemistry
immunohistochemistry CC and
and NN electron
electron NN microscopy
microscopy TO to
to VB avoid
avoid JJ diagnostic
diagnostic NNS pitfalls

The DT CAPITAL The
The NNS authors
authors NN report
report DT the
the JJ postoperative
postoperative JJ magnetic
magnetic NN resonance
resonance NN (
( NN CAPITAL MR
MR NN )
) NN imaging
imaging NNS findings
findings IN in
in CD 36
36 NNS patients
patients IN with
with VBN advanced
advanced NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease
disease WP who
who VBD underwent
underwent JJ unilateral
unilateral JJ microelectrode-guided
microelectrode-guided JJ posteroventral
posteroventral NN pallidotomy

The DT CAPITAL The
The NNS lesions
lesions VBD were
were VBN placed
placed IN within
within CD 1
1 NN mm
mm IN of
of DT the
the JJ ventral
ventral NN border
border IN of
of DT the
the NN globus
globus NN pallidus
pallidus NN internus
internus NN (
( SYM CAPITAL GPi
GPi NN )
) TO to
to VB include
include JJ pallidothalamic
pallidothalamic NN outflow
outflow NNS pathways

Sequential JJ CAPITAL Sequential
Sequential NN CAPITAL MR
MR NNS studies
studies VBD were
were VBN obtained
obtained IN within
within CD 1
1 TO to
to CD 3
3 NNS days
days RB postoperatively
postoperatively CC and
and IN at
at JJ 6-month
6-month NN follow-up
follow-up NN examination

Thirty-four CD CAPITAL Thirty-four
Thirty-four NN (
( CD 94
94 NN %
% NN )
) IN of
of DT the
the CD 36
36 NNS patients
patients VBN enjoyed
enjoyed JJ sustained
sustained JJ moderate
moderate CC or
or JJ marked
marked NN improvement
improvement IN of
of PRP$ their
their NN parkinsonian
parkinsonian NNS symptoms
symptoms CD 6
6 NNS months
months RB postoperatively

Transient JJ CAPITAL Transient
Transient NN side
side NNS effects
effects VBD occurred
occurred IN in
in CD five
five NNS patients
patients NN (
( CD 14
14 NN %
% NN )
) , ,
, CC but
but RB there
there VBD were
were DT no
no JJ persistent
persistent NNS complications

The DT CAPITAL The
The NN pallidal
pallidal NN radiofrequency
radiofrequency NNS lesions
lesions VBD were
were VB prolate
prolate NN spheroid
spheroid VBN shaped
shaped CC and
and VBD were
were VBN composed
composed IN of
of CD three
three JJ concentric
concentric NNS zones
zones IN in
in DT the
the RB early
early JJ postoperative
postoperative NNS studies

The DT CAPITAL The
The VB mean
mean NN volume
volume IN of
of DT the
the JJ middle
middle NN zone
zone , ,
, VBG corresponding
corresponding TO to
to DT the
the NN area
area IN of
of JJ hemorrhagic
hemorrhagic NN coagulation
coagulation NN necrosis
necrosis , ,
, VBD was
was CD 44.4
44.4 CC +/-
+/- CD 17.6
17.6 NN mm3
mm3 : ;
; DT the
the VB mean
mean NN lesion
lesion NN volume
volume IN as
as VBN defined
defined IN by
by DT the
the JJ outer
outer NN zone
zone , ,
, VBG corresponding
corresponding TO to
to JJ perilesional
perilesional NN edema
edema , ,
, VBD was
was CD 262.2
262.2 CC +/-
+/- CD 111.6
111.6 NN mm3

Additional JJ CAPITAL Additional
Additional NN edema
edema VBG spreading
spreading TO to
to DT the
the JJ internal
internal NN capsule
capsule VBD was
was VBN noted
noted IN in
in CD 32
32 IN of
of CD 34
34 NNS cases
cases CC and
and TO to
to DT the
the JJ optic
optic NN tract
tract IN in
in CD 11
11 IN of
of CD 34
34 NNS cases

In IN CAPITAL In
In CD two
two NNS patients
patients JJ small
small JJ ischemic
ischemic NNS infarctions
infarctions VBG involving
involving DT the
the NN corona
corona NN radiata
radiata VBD were
were VBN found
found , ,
, CC and
and IN in
in CD one
one DT a
a JJ venous
venous NN infarction
infarction VBD was
was VBN detected

Ischemic JJ CAPITAL Ischemic
Ischemic NN infarction
infarction VBD resulted
resulted IN in
in JJ mild
mild JJ transient
transient NNP CAPITAL Broca
Broca POS 's
's NN aphasia
aphasia IN in
in CD one
one NN patient
patient , ,
, CC but
but RB there
there VBD was
was DT no
no JJ detectable
detectable JJ neurological
neurological NN deficit
deficit IN in
in DT the
the JJ other
other CD two

The DT CAPITAL The
The VB mean
mean NN volume
volume IN of
of NN late-phase
late-phase NN (
( CD 6
6 NNS months
months NN )
) NNS lesions
lesions VBD was
was CD 22
22 CC +/-
+/- CD 28.8
28.8 NN mm3

In IN CAPITAL In
In CD three
three NNS patients
patients DT no
no NN lesion
lesion VBD was
was VBN identified
identified IN despite
despite JJ sustained
sustained JJ clinical
clinical NN improvement

The DT CAPITAL The
The NN lesion
lesion VBD was
was JJ located
located IN in
in DT the
the JJ posteroventral
posteroventral SYM CAPITAL GPi
GPi IN in
in DT all
all NNS cases
cases IN except
except IN in
in CD one
one NN patient
patient IN in
in WP whom
whom PRP it
it VBD was
was VBN confined
confined TO to
to DT the
the NN CAPITAL GP
GP NN externus
externus NN (
( SYM CAPITAL GPe
GPe NN )

This DT CAPITAL This
This JJ 49-year-old
49-year-old NN woman
woman VBD did
did RB not
not NN experience
experience JJ sustained
sustained NN benefit

The DT CAPITAL The
The NNS authors
authors VBN found
found DT no
no JJ consistent
consistent NNS correlations
correlations IN between
between NN lesion
lesion NN size
size CC and
and NN location
location CC and
and JJ clinical
clinical NN outcome
outcome IN as
as VBN measured
measured IN by
by DT a
a JJ global
global NN outcome
outcome NN score
score , ,
, DT the
the JJ CAPITAL Unified
Unified NNP CAPITAL Parkinson
Parkinson POS 's
's NN CAPITAL Disease
Disease NNP CAPITAL Rating
Rating NNP CAPITAL Scale
Scale NN motor
motor , ,
, NNS activities
activities IN of
of RB daily
daily VBG living
living , ,
, CC and
and NN bradykinesia
bradykinesia `` ``
`` IN off
off '' ''
'' NNS scores
scores CC or
or NN rating
rating IN of
of NNS dyskinesias

Lesioning VBG CAPITAL Lesioning
Lesioning IN of
of NN pallidal
pallidal CC and
and JJ subpallidal
subpallidal NNS pathways
pathways MD may
may VB contribute
contribute TO to
to DT the
the JJ sustained
sustained JJ clinical
clinical NN benefit
benefit IN in
in DT this
this NN series

Magnetic JJ CAPITAL Magnetic
Magnetic NN resonance
resonance NN imaging
imaging NN analysis
analysis VBD showed
showed IN that
that JJ intraoperative
intraoperative NN microelectrode
microelectrode VBG recording
recording VBN facilitated
facilitated JJ accurate
accurate NN placement
placement IN of
of DT the
the NN lesion
lesion IN in
in DT this
this JJ critical
critical NN area

A DT CAPITAL A
A RB commercially
commercially JJ available
available NN health
health NN food
food NN product
product IN of
of JJ cold-pressed
cold-pressed NN hemp
hemp NN seed
seed NN oil
oil VBN ingested
ingested IN by
by CD one
one NN volunteer
volunteer RB twice
twice DT a
a NN day
day IN for
for CD 4
4 CD 1/2
1/2 NNS days
days NN (
( CD 135
135 NN mL
mL NN total
total NN )

Urine NN CAPITAL Urine
Urine NNS specimens
specimens VBN collected
collected IN from
from DT the
the NN volunteer
volunteer VBD were
were VBN subjected
subjected TO to
to NN standard
standard NN workplace
workplace NN urine
urine NN drug
drug NN testing
testing NNS procedures
procedures , ,
, CC and
and DT the
the VBG following
following NNS concentrations
concentrations IN of
of JJ 11-nor-delta9-
11-nor-delta9- NN tetrahydrocannabinol
tetrahydrocannabinol JJ carboxylic
carboxylic NN acid
acid NN (
( NN 9-THCA
9-THCA NN )
) VBD were
were VBN detected
detected : :
: CD 41
41 NN ng/mL
ng/mL NN 9-THCA
9-THCA IN at
at CD 45
45 NN h
h , ,
, CD 49
49 NN ng/mL
ng/mL IN at
at CD 69
69 NN h
h , ,
, CC and
and CD 55
55 NN ng/mL
ng/mL IN at
at CD 93
93 NN h.
h. NN CAPITAL Ingestion
Ingestion VBD was
was VBN discontinued
discontinued IN after
after CD 93
93 NN h
h , ,
, CC and
and DT the
the VBG following
following NNS concentrations
concentrations VBD were
were VBN detected
detected : :
: CD 68
68 NN ng/mL
ng/mL IN at
at CD 108
108 NN h
h , ,
, CD 57
57 NN ng/mL
ng/mL IN at
at CD 117
117 NN h
h , ,
, CD 31
31 NN ng/mL
ng/mL IN at
at CD 126
126 NN h
h , ,
, CC and
and CD 20
20 NN ng/mL
ng/mL IN at
at CD 142
142 NN h.
h. DT CAPITAL The
The RB first
first NN specimen
specimen IN that
that VBN tested
tested JJ negative
negative NN (
( CD 50
50 NN ng/mL
ng/mL JJ initial
initial NN immunoassay
immunoassay NN test
test , ,
, CD 15
15 NN ng/mL
ng/mL JJ confirmatory
confirmatory NN gas
gas NN chromatographic-mass
chromatographic-mass JJ spectrometric
spectrometric NN test
test NN )
) VBD was
was IN at
at CD 146
146 NN h
h , ,
, WDT which
which VBD was
was CD 53
53 NN h
h IN after
after DT the
the JJ last
last NN hemp
hemp NN seed
seed NN oil
oil NN ingestion

Four CD CAPITAL Four
Four JJ subsequent
subsequent NNS specimens
specimens VBN taken
taken TO to
to CD 177
177 NN h
h VBD were
were RB also
also JJ negative

This DT CAPITAL This
This NN study
study VBZ indicates
indicates IN that
that DT a
a NN workplace
workplace NN urine
urine NN drug
drug NN test
test JJ positive
positive IN for
for NNS cannabinoids
cannabinoids MD may
may VB arise
arise IN from
from DT the
the NN consumption
consumption IN of
of RB commercially
commercially JJ available
available JJ cold-pressed
cold-pressed NN hemp
hemp NN seed
seed NN oil

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: PRP CAPITAL We
We VBN determined
determined DT the
the NN sensitivity
sensitivity CC and
and NN specificity
specificity IN of
of JJ neonatal
neonatal NN brain-stem
brain-stem NN auditory
auditory VBN evoked
evoked NNS potentials
potentials NN (
( NN CAPITAL BAEP
BAEP NN )
) IN as
as NNS markers
markers IN for
for JJ subsequent
subsequent NN hearing
hearing NN impairment
impairment CC and
and IN for
for JJ developmental
developmental NNS problems
problems VBN found
found RB later
later IN in
in NN infancy
infancy CC and
and NN childhood

METHODS NNS CAPITAL METHODS
METHODS : :
: NN CAPITAL BAEP
BAEP NNS studies
studies VBD were
were VBN performed
performed IN before
before NN discharge
discharge IN in
in NNS infants
infants VBN treated
treated IN with
with JJ extracorporeal
extracorporeal NN membrane
membrane NN oxygenation
oxygenation NN (
( NN CAPITAL ECMO
ECMO NN )
) , ,
, CC and
and CD two
two JJ specific
specific NNS abnormalities
abnormalities VBD were
were VBN analyzed
analyzed : :
: JJ elevated
elevated NN threshold
threshold CC and
and VBN delayed
delayed JJ central
central NN auditory
auditory NN conduction

Behavioral JJ CAPITAL Behavioral
Behavioral NN audiometry
audiometry VBD was
was VBN repeated
repeated IN during
during JJ periodic
periodic NN follow-up
follow-up IN until
until JJ reliable
reliable NNS responses
responses VBD were
were VBN obtained
obtained IN for
for DT all
all NNS frequencies
frequencies , ,
, CC and
and JJ standardized
standardized JJ developmental
developmental NN testing
testing VBD was
was RB also
also VBN conducted

The DT CAPITAL The
The NN sensitivity
sensitivity CC and
and NN specificity
specificity IN of
of DT an
an JJ elevated
elevated NN threshold
threshold IN on
on DT the
the JJ neonatal
neonatal NN CAPITAL BAEP
BAEP IN for
for VBG detecting
detecting JJ subsequent
subsequent NN hearing
hearing NN loss
loss , ,
, CC and
and DT the
the NN relationship
relationship IN of
of DT any
any JJ neonatal
neonatal NN CAPITAL BAEP
BAEP NN abnormality
abnormality TO to
to NN language
language CC or
or JJ developmental
developmental NNS disorders
disorders IN in
in NN infancy
infancy , ,
, VBD were
were VBN calculated

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: NN CAPITAL Test
Test NNS results
results IN for
for CD 46
46 JJ CAPITAL ECMO-treated
ECMO-treated NNS infants
infants NN (
( CD 57.5
57.5 NN %
% NN )
) VBD were
were JJ normal
normal , ,
, CC and
and DT those
those IN for
for CD 34
34 NNS infants
infants NN (
( CD 42.5
42.5 NN %
% NN )
) VBD were
were JJ abnormal
abnormal , ,
, IN with
with DT either
either JJ elevated
elevated NN wave
wave NN CAPITAL V
V NN threshold
threshold , ,
, JJ prolonged
prolonged NN wave
wave NN CAPITAL I-V
I-V NN interval
interval , ,
, CC or
or DT both
both IN on
on JJ neonatal
neonatal NN CAPITAL BAEP
BAEP NNS recordings

Most JJS CAPITAL Most
Most RB significantly
significantly , ,
, CD 7
7 NN (
( CD 58
58 NN %
% NN )
) IN of
of DT the
the CD 12
12 NNS children
children IN with
with JJ subsequent
subsequent NN sensorineural
sensorineural NN hearing
hearing NN loss
loss VBD had
had RB left
left DT the
the NN hospital
hospital IN after
after VBG showing
showing JJ normal
normal NNS results
results IN on
on NN threshold
threshold NNS tests

There EX CAPITAL There
There VBD was
was DT no
no JJ significant
significant NN difference
difference IN in
in DT the
the NN frequency
frequency IN of
of NN hearing
hearing NN loss
loss IN between
between NNS subjects
subjects IN with
with JJ abnormal
abnormal NN (
( NN 5/21
5/21 , ,
, CC or
or CD 24
24 NN %
% NN )
) CC and
and DT those
those IN with
with JJ normal
normal NN CAPITAL BAEP
BAEP NNS thresholds
thresholds NN (
( CD 7/59
7/59 , ,
, CC or
or CD 12
12 NN %
% : ;
; NNP CAPITAL Fisher
Fisher JJ CAPITAL Exact
Exact NN CAPITAL Test
Test , ,
, NN p
p JJ =
= CD 0.28
0.28 NN )

Therefore RB CAPITAL Therefore
Therefore DT the
the NN sensitivity
sensitivity IN of
of JJ neonatal
neonatal NN CAPITAL BAEP
BAEP NN testing
testing IN for
for VBG predicting
predicting JJ subsequent
subsequent NN hearing
hearing NN loss
loss VBD was
was RB only
only CD 42
42 NN %

Neonatal JJ CAPITAL Neonatal
Neonatal NN CAPITAL BAEP
BAEP NN specificity
specificity IN for
for VBG excluding
excluding JJ subsequent
subsequent NN hearing
hearing NN loss
loss VBD was
was CD 76
76 NN %

In IN CAPITAL In
In NN contrast
contrast , ,
, IN on
on NN language
language NN development
development NN testing
testing , ,
, CD 19
19 NNS children
children VBN demonstrated
demonstrated JJ receptive
receptive NN language
language NN delay

Of IN CAPITAL Of
Of DT these
these NNS children
children , ,
, CD 12
12 NN (
( CD 63
63 NN %
% NN )
) VBD had
had JJ abnormal
abnormal JJ neonatal
neonatal NN CAPITAL BAEP
BAEP NNS recordings
recordings CC and
and CD 7
7 NN (
( CD 37
37 NN %
% NN )
) VBD had
had DT a
a JJ normal
normal NN CAPITAL BAEP
BAEP NN threshold
threshold , ,
, JJ normal
normal JJ central
central NN auditory
auditory NN conduction
conduction NN test
test NNS results
results , ,
, CC or
or DT both
both NN (
( NN p
p JJ =
= CD 0.04
0.04 NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: JJ CAPITAL Neonatal
Neonatal NN CAPITAL BAEP
BAEP NN threshold
threshold NNS recordings
recordings VBD were
were IN of
of JJ limited
limited NN value
value IN for
for VBG predicting
predicting JJ subsequent
subsequent NN hearing
hearing NN loss
loss JJ common
common IN in
in NN CAPITAL ECMO
ECMO JJ -treated
-treated NNS survivors

However RB CAPITAL However
However , ,
, DT an
an JJ abnormal
abnormal JJ neonatal
neonatal NN CAPITAL BAEP
BAEP RB significantly
significantly VBN increased
increased DT the
the NN probability
probability IN of
of NN finding
finding DT a
a JJ receptive
receptive NN language
language NN delay
delay IN during
during RB early
early NN childhood
childhood , ,
, RB even
even IN in
in DT those
those IN with
with RB subsequently
subsequently JJ normal
normal NN audiometry
audiometry NNS findings

Because IN CAPITAL Because
Because JJ neonatal
neonatal NN CAPITAL ECMO
ECMO VBZ is
is VBN associated
associated IN with
with DT a
a JJ high
high NN risk
risk IN of
of NN hearing
hearing CC and
and JJ receptive
receptive NN language
language NNS disorders
disorders , ,
, NNS parents
parents MD should
should VB be
be VBN counseled
counseled IN that
that JJ audiologic
audiologic CC and
and JJ developmental
developmental NN follow-up
follow-up NNS evaluations
evaluations IN in
in VBG surviving
surviving NNS children
children VBP are
are JJ essential
essential RB regardless
regardless IN of
of DT the
the NNS results
results IN of
of JJ neonatal
neonatal NN CAPITAL BAEP
BAEP NN testing

The DT CAPITAL The
The NNP CAPITAL Federated
Federated NNP CAPITAL Council
Council IN of
of JJ CAPITAL Internal
Internal NN CAPITAL Medicine
Medicine VBZ has
has VBN developed
developed DT a
a NN resource
resource NN guide
guide TO to
to NN help
help JJ internal
internal NN medicine
medicine NN residency
residency NNS programs
programs VB produce
produce NNS internists
internists WP who
who VBP are
are JJ prepared
prepared IN for
for NN today
today POS 's
's NN practice
practice IN of
of JJ internal
internal NN medicine
medicine CC and
and DT the
the NNS challenges
challenges IN of
of NN practice
practice IN in
in DT the
the NN future

The DT CAPITAL The
The NN guide
guide VBZ situates
situates JJ general
general JJ internal
internal NN medicine
medicine IN as
as DT the
the JJ primary
primary NN care
care NN profession
profession IN that
that VBZ focuses
focuses IN on
on JJ preventive
preventive , ,
, JJ short-term
short-term , ,
, CC and
and JJ long-term
long-term NN care
care IN of
of JJ adult
adult NNS patients

It PRP CAPITAL It
It VBZ assumes
assumes IN that
that DT a
a JJ single
single NN pathway
pathway VBZ is
is JJ sufficient
sufficient IN for
for VBG educating
educating JJ general
general NNS internists
internists CC and
and JJ subspecialty-bound
subspecialty-bound NNS trainees

It PRP CAPITAL It
It VBZ identifies
identifies DT the
the VBG learning
learning NNS experiences
experiences IN that
that MD should
should VB be
be NN part
part IN of
of JJ general
general JJ internal
internal NN medicine
medicine NN residency
residency NN training
training , ,
, NNS lists
lists DT the
the JJ clinical
clinical NNS competencies
competencies IN that
that VBP are
are JJ important
important IN for
for JJ primary
primary NN care
care NN practice
practice , ,
, CC and
and VBZ describes
describes DT the
the NN role
role IN of
of DT the
the JJ integrative
integrative NNS disciplines
disciplines IN that
that MD should
should VB inform
inform DT the
the NN care
care IN of
of DT every
every NN patient

It PRP CAPITAL It
It RB also
also VBZ describes
describes DT a
a NN process
process IN that
that NN program
program NNS directors
directors CC and
and JJ local
local NN program
program NNS committees
committees MD can
can NN use
use TO to
to VB develop
develop JJ competency-based
competency-based NN curricula

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: NNP CAPITAL Darier
Darier NN disease
disease VBZ is
is DT an
an JJ uncommon
uncommon NN genodermatosis
genodermatosis VBN characterized
characterized IN by
by DT the
the JJ symmetrical
symmetrical NN eruption
eruption IN of
of JJ keratotic
keratotic JJ reddish-brown
reddish-brown NNS papules
papules VBG occurring
occurring IN in
in DT the
the JJ seborrheic
seborrheic NNS areas
areas IN of
of DT the
the NN body

A DT CAPITAL A
A JJ unilateral
unilateral , ,
, CC or
or JJ localized
localized , ,
, NN variant
variant VBZ has
has VBN been
been VBN identified

We PRP CAPITAL We
We NN report
report CD 4
4 JJ new
new NNS cases
cases IN of
of JJ localized
localized NNP CAPITAL Darier
Darier NN disease
disease CC and
and NN review
review DT the
the NN CAPITAL English-language
English-language NN literature

The DT CAPITAL The
The NNS implications
implications IN of
of DT these
these NNS cases
cases IN on
on NN future
future JJ genetic
genetic NNS studies
studies VBP are
are RB also
also VBN discussed

OBSERVATIONS NNS CAPITAL OBSERVATIONS
OBSERVATIONS : :
: JJ CAPITAL Localized
Localized NNP CAPITAL Darier
Darier NN disease
disease VBD occurred
occurred IN with
with JJ equal
equal NN frequency
frequency IN in
in NNS males
males CC and
and NNS females

The DT CAPITAL The
The NN average
average NN age
age IN at
at NN onset
onset VBD was
was CD 27
27 NNS years

The DT CAPITAL The
The RBS most
most JJ frequent
frequent NN site
site IN of
of NN involvement
involvement VBD was
was DT the
the NN trunk
trunk NN (
( CD 40
40 NN %
% NN (
( CD 16/40
16/40 NN )
) NN )

This DT CAPITAL This
This NN condition
condition VBD was
was VBN aggravated
aggravated IN by
by NN sunlight
sunlight , ,
, NN heat
heat , ,
, CC or
or NN sweating
sweating IN in
in CD 42
42 NN %
% NN (
( CD 19/40
19/40 NN )
) IN of
of VBN reported
reported NNS cases
cases , ,
, CC and
and CD 38
38 NN %
% NN (
( CD 15/40
15/40 NN )
) IN of
of DT the
the NNS patients
patients VBD responded
responded TO to
to NN treatment
treatment IN with
with JJ topical
topical NN tretinoin

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: JJ CAPITAL Many
Many IN of
of DT the
the JJ clinical
clinical NNS features
features IN of
of JJ localized
localized NNP CAPITAL Darier
Darier NN disease
disease VB suggest
suggest IN that
that PRP it
it VBZ is
is DT a
a JJ genetic
genetic NN mosaic
mosaic IN of
of VBN generalized
generalized NNP CAPITAL Darier
Darier NN disease

Further RB CAPITAL Further
Further NNS studies
studies IN of
of JJ localized
localized NNP CAPITAL Darier
Darier NN disease
disease MD may
may RB therefore
therefore VB prove
prove TO to
to VB be
be JJ instrumental
instrumental IN in
in DT the
the NN search
search IN for
for DT the
the NNP CAPITAL Darier
Darier NN disease
disease NN gene

UV NN CAPITAL UV
UV NN radiation
radiation VBZ induces
induces CD two
two JJ major
major NN CAPITAL DNA
DNA NN damage
damage NNS products
products , ,
, DT the
the NN cyclobutane
cyclobutane NN pyrimidine
pyrimidine NN dimer
dimer NN (
( NN CAPITAL CPD
CPD NN )
) CC and
and , ,
, IN at
at DT a
a JJR lower
lower NN frequency
frequency , ,
, DT the
the NN pyrimidine
pyrimidine NN (
( CD 6-4
6-4 NN )
) NN pyrimidinone
pyrimidinone NN dimer
dimer NN (
( CD 6-4
6-4 NN product
product NN )

Although IN CAPITAL Although
Although FW CAPITAL Escherichia
Escherichia NN coli
coli CC and
and NNS CAPITAL Saccharomyes
Saccharomyes FW cerevisiae
cerevisiae VB produce
produce DT a
a JJ CAPITAL CPD-specific
CPD-specific NN photolyase
photolyase IN that
that VBZ eliminates
eliminates RB only
only DT this
this NN class
class IN of
of NN dimer
dimer , ,
, NNP CAPITAL Arabidopsis
Arabidopsis NN thaliana
thaliana , ,
, NN CAPITAL Drosphila
Drosphila FW melanogaster
melanogaster , ,
, NNP CAPITAL Crotalus
Crotalus NN atrox
atrox , ,
, CC and
and NN CAPITAL Xenopus
Xenopus NN laevis
laevis VB have
have RB recently
recently VBN been
been VBN shown
shown TO to
to NN photoreactivate
photoreactivate DT both
both NNS CAPITAL CPDs
CPDs CC and
and CD 6-4
6-4 NNS products

We PRP CAPITAL We
We VBP describe
describe DT the
the NN isolation
isolation CC and
and NN characterization
characterization IN of
of CD two
two JJ new
new NNS classes
classes IN of
of NNS mutants
mutants IN of
of NNP CAPITAL Arabidopsis
Arabidopsis , ,
, VBN termed
termed NN uvr2
uvr2 CC and
and NN uvr3
uvr3 , ,
, IN that
that VBP are
are JJ defective
defective IN in
in DT the
the NN photoreactivation
photoreactivation IN of
of NNS CAPITAL CPDs
CPDs CC and
and CD 6-4
6-4 NNS products
products , ,
, RB respectively

We PRP CAPITAL We
We VB demonstrate
demonstrate IN that
that DT the
the NN CAPITAL CPD
CPD NN photolyase
photolyase NN mutation
mutation VBZ is
is RB genetically
genetically VBN linked
linked TO to
to DT a
a NN CAPITAL DNA
DNA NN sequence
sequence VBG encoding
encoding DT a
a NN type
type NNP CAPITAL II
II NN (
( NN metazoan
metazoan NN )
) NN CAPITAL CPD
CPD NN photolyase

In IN CAPITAL In
In NN addition
addition , ,
, PRP we
we VBP are
are JJ able
able TO to
to VB generate
generate NNS plants
plants IN in
in WDT which
which RB only
only NNS CAPITAL CPDs
CPDs CC or
or CD 6-4
6-4 NNS products
products VBP are
are VBN photoreactivated
photoreactivated IN in
in DT the
the JJ nuclear
nuclear NN genome
genome IN by
by VBG exposing
exposing DT these
these NNS mutants
mutants TO to
to NN CAPITAL UV
UV NN light
light CC and
and RB then
then VBG allowing
allowing PRP them
them TO to
to NN repair
repair CD one
one CC or
or DT the
the JJ other
other NN class
class IN of
of NNS dimers

This DT CAPITAL This
This VBZ provides
provides PRP us
us IN with
with DT a
a JJ unique
unique NN opportunity
opportunity TO to
to NN study
study DT the
the JJ biological
biological NNS consequences
consequences IN of
of DT each
each IN of
of DT these
these CD two
two JJ major
major JJ CAPITAL UV-induced
UV-induced NNS photoproducts
photoproducts IN in
in DT an
an JJ intact
intact VBG living
living NN system

A DT CAPITAL A
A NN diffuse
diffuse JJ macular
macular NN erythroderma
erythroderma CC and
and JJ subsequent
subsequent NN desquamation
desquamation IN after
after CD 1
1 TO to
to CD 2
2 NNS weeks
weeks VBP are
are CD two
two IN of
of DT the
the CD five
five JJ major
major JJ diagnostic
diagnostic NNS criteria
criteria IN of
of JJ toxic
toxic NN shock
shock NN syndrome
syndrome NN (
( NN CAPITAL TSS
TSS NN )

We PRP CAPITAL We
We JJ present
present DT the
the NN case
case IN of
of DT a
a JJ 15-month-old
15-month-old NN girl
girl IN with
with NN CAPITAL TSS
TSS , ,
, CC but
but IN without
without NN erythroderma
erythroderma CC or
or NN desquamation

She PRP CAPITAL She
She VBD was
was VBN admitted
admitted IN with
with JJ high
high NN fever
fever , ,
, NN shock
shock , ,
, CC and
and JJ multiorgan
multiorgan NN involvement

Minimal JJ CAPITAL Minimal
Minimal CC or
or DT no
no JJ cutaneous
cutaneous NNS signs
signs VBD were
were JJ present

Initially RB CAPITAL Initially
Initially DT the
the NN diagnosis
diagnosis IN of
of DT the
the NN syndrome
syndrome IN of
of JJ hemorrhagic
hemorrhagic NN shock
shock CC and
and NN encephalopathy
encephalopathy VBD was
was VBN made

After IN CAPITAL After
After CD 7
7 NNS days
days , ,
, DT a
a NN CAPITAL TSS
TSS NN toxin
toxin JJ 1-producing
1-producing NN strain
strain IN of
of FW CAPITAL Staphylococcus
Staphylococcus NN aureus
aureus VBD was
was VBN cultured
cultured IN from
from DT an
an JJ inguinal
inguinal NN lymph
lymph NN node
node , ,
, WRB where
where NN inflammation
inflammation VBD had
had RB already
already VBN been
been VBN noticed
noticed IN on
on NN admission

Moreover RB CAPITAL Moreover
Moreover , ,
, DT the
the NN girl
girl VBD had
had DT no
no NNS antibodies
antibodies IN against
against DT this
this NN toxin

The DT CAPITAL The
The NN serum
serum NN cytokine
cytokine NN profile
profile IN during
during DT the
the JJ acute
acute NN phase
phase IN of
of PRP$ her
her NN illness
illness VBD showed
showed JJ high
high NNS levels
levels IN of
of NN tumor
tumor NN necrosis
necrosis NN factor-alpha
factor-alpha , ,
, NN interleukin-6
interleukin-6 CC and
and NN interferon-gamma
interferon-gamma , ,
, IN as
as VBZ is
is VBN seen
seen IN during
during NN activation
activation IN of
of DT the
the JJ immune
immune NN system
system IN by
by NN CAPITAL TSS
TSS NN toxin
toxin CD 1

Other JJ CAPITAL Other
Other JJ possible
possible NNS causes
causes IN for
for DT the
the NN patient
patient POS 's
's NN illness
illness VBD were
were VBN excluded

We PRP CAPITAL We
We VBP conclude
conclude IN that
that DT the
the NN patient
patient VBD had
had NN CAPITAL TSS
TSS IN without
without NN rash

Without IN CAPITAL Without
Without DT the
the NN evidence
evidence VBG implicating
implicating DT a
a NN CAPITAL TSS
TSS NN toxin
toxin JJ 1-producing
1-producing NN strain
strain IN of
of NNP CAPITAL S.
S. NN aureus
aureus IN as
as DT the
the NN cause
cause IN of
of PRP$ her
her NN disease
disease , ,
, DT a
a NN diagnosis
diagnosis IN of
of NN syndrome
syndrome IN of
of JJ hemorrhagic
hemorrhagic NN shock
shock CC and
and NN encephalopathy
encephalopathy MD would
would VB have
have VBN been
been VBN made

It PRP CAPITAL It
It VBZ is
is JJ possible
possible IN that
that DT some
some NNS cases
cases IN of
of NN syndrome
syndrome IN of
of JJ hemorrhagic
hemorrhagic NN shock
shock CC and
and NN encephalopathy
encephalopathy VB represent
represent DT a
a NN variant
variant IN of
of NN CAPITAL TSS
TSS IN in
in JJ small
small NNS children

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL BACKGROUND
BACKGROUND : :
: DT CAPITAL The
The VBG growing
growing NN teratoma
teratoma NN syndrome
syndrome VBZ refers
refers TO to
to DT the
the NN phenomenon
phenomenon WRB whereby
whereby NN germ
germ NN cell
cell NNS tumors
tumors VB enlarge
enlarge IN after
after NN chemotherapy
chemotherapy IN despite
despite JJ complete
complete NN eradication
eradication IN of
of JJ malignant
malignant NNS cells
cells CC and
and NN normalization
normalization IN of
of NN serum
serum NN tumor
tumor NNS markers

This DT CAPITAL This
This JJ clinical
clinical NN scenario
scenario MD must
must VB be
be VBN differentiated
differentiated IN from
from IN that
that IN in
in WDT which
which NN germ
germ NN cell
cell NNS tumors
tumors VB maintain
maintain PRP$ their
their JJ malignant
malignant NNS characteristics
characteristics IN with
with JJ elevated
elevated NNS levels
levels IN of
of NN serum
serum NN tumor
tumor NNS markers

METHODS NNS CAPITAL METHODS
METHODS : :
: NN CAPITAL Hospital
Hospital NN record
record NN review
review VBD was
was VBN conducted
conducted IN of
of CD 2
2 NNS cases

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: CD CAPITAL Two
Two NN male
male NNS patients
patients VBP are
are VBN presented
presented , ,
, CD 1
1 IN with
with DT a
a JJ metastatic
metastatic NN germ
germ NN cell
cell NN tumor
tumor IN of
of DT both
both DT the
the NN retroperitoneum
retroperitoneum CC and
and NN mediastinum
mediastinum NN (
( IN with
with JJ elevated
elevated NN alpha-fetoprotein
alpha-fetoprotein NN level
level NN )
) CC and
and CD 1
1 IN with
with DT a
a JJ primary
primary NN germ
germ NN cell
cell NN tumor
tumor IN of
of DT the
the NN mediastinum
mediastinum NN (
( IN with
with JJ elevated
elevated NN alpha-fetoprotein
alpha-fetoprotein CC and
and NN beta-human
beta-human JJ chorionic
chorionic NN gonadotropin
gonadotropin NNS levels
levels NN )

After IN CAPITAL After
After NN completion
completion IN of
of NN chemotherapy
chemotherapy CC and
and NN normalization
normalization IN of
of NN tumor
tumor NNS markers
markers , ,
, DT both
both NNS patients
patients VBN presented
presented IN with
with JJ pulmonary
pulmonary NNS symptoms
symptoms JJ attributable
attributable TO to
to PRP$ their
their RB massively
massively VBG enlarging
enlarging JJ mediastinal
mediastinal NNS teratomas
teratomas . .

The DT CAPITAL The
The JJ clinical
clinical CC and
and JJ roentgenographic
roentgenographic NNS features
features IN of
of NNS patients
patients IN with
with JJ thoracic
thoracic NNS manifestations
manifestations IN of
of DT the
the VBG growing
growing NN teratoma
teratoma NN syndrome
syndrome , ,
, IN as
as RB well
well IN as
as PRP$ its
its NN management
management , ,
, VBP are
are VBN reviewed

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: IN CAPITAL After
After NN chemotherapy
chemotherapy IN in
in NNS patients
patients IN with
with JJ primary
primary CC or
or JJ metastatic
metastatic JJ mediastinal
mediastinal NN germ
germ NN cell
cell NNS tumors
tumors WP$ whose
whose NN tumor
tumor NNS markers
markers VB normalize
normalize , ,
, DT a
a VBG growing
growing NN mass
mass IN in
in DT the
the NN mediastinum
mediastinum MD may
may VB represent
represent DT the
the VBG growing
growing NN teratoma
teratoma NN syndrome

The DT CAPITAL The
The NN chicken
chicken NN calmodulin
calmodulin PRP CAPITAL I
I NN (
( NN CAPITAL CaMI
CaMI NN )
) NN gene
gene VBZ has
has VBN been
been VBN isolated
isolated CC and
and VBN characterized
characterized IN on
on DT the
the NN level
level IN of
of NN cDNA
cDNA CC and
and JJ genomic
genomic NN CAPITAL DNA

The DT CAPITAL The
The VBN deduced
deduced NN amino
amino NN acid
acid NN (
( NN aa
aa NN )
) NN sequence
sequence VBZ is
is JJ identical
identical TO to
to DT the
the CD one
one IN of
of NN chicken
chicken NN CAPITAL CaMII
CaMII WDT which
which VBZ consists
consists IN of
of CD 148
148 NN aa

The DT CAPITAL The
The NN CAPITAL CaMI
CaMI NN gene
gene VBZ contains
contains CD six
six NNS exons

Its PRP$ CAPITAL Its
Its NN intron/exon
intron/exon NN organization
organization VBZ is
is JJ identical
identical TO to
to IN that
that IN of
of DT the
the NN chicken
chicken NN CAPITAL CaMII
CaMII CC and
and DT the
the NN CAPITAL CaMI
CaMI CC and
and NN CAPITAL CaMIII
CaMIII NNS genes
genes IN of
of NN rat
rat CC and
and JJ human

Expression NN CAPITAL Expression
Expression IN of
of DT the
the NN CAPITAL CaMI
CaMI NN gene
gene VBD was
was VBN detected
detected IN in
in DT all
all NN chicken
chicken NNS tissues
tissues VBN examined
examined , ,
, IN although
although IN at
at VBG varying
varying NNS levels

The DT CAPITAL The
The NN gene
gene VBZ is
is VBN transcribed
transcribed IN into
into CD four
four NNS mRNAs
mRNAs IN of
of CD 0.8
0.8 , ,
, CD 1.4
1.4 , ,
, CD 1.7
1.7 CC and
and CD 4.4
4.4 NN kb
kb IN as
as VBN determined
determined IN by
by NN CAPITAL Northern
Northern NN blot
blot NN analysis

Our PRP$ CAPITAL Our
Our NNS results
results VB demonstrate
demonstrate IN that
that DT the
the `` ``
`` JJ multigene-one-protein
multigene-one-protein '' ''
'' NN principle
principle IN of
of NN CAPITAL CaM
CaM NN synthesis
synthesis VBZ is
is RB not
not RB only
only JJ applicable
applicable TO to
to NNS mammals
mammals WP$ whose
whose NN CAPITAL CaM
CaM VBZ is
is VBN encoded
encoded IN by
by CD three
three JJ different
different NNS genes
genes , ,
, CC but
but RB also
also TO to
to NNS chickens

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: PRP CAPITAL We
We VBN assessed
assessed DT the
the NN accuracy
accuracy IN of
of CD two
two NN electron
electron NN beam
beam VBN computed
computed NN tomography
tomography NN (
( NN CAPITAL EBCT
EBCT NN )
) NNS protocols
protocols IN for
for VBG predicting
predicting JJ coronary
coronary NNS events

METHODS NNS CAPITAL METHODS
METHODS CC CAPITAL AND
AND NNS CAPITAL RESULTS
RESULTS : :
: IN CAPITAL In
In CD 1994
1994 , ,
, CD 24
24 NNS months
months IN after
after NN enrollment
enrollment IN in
in DT a
a JJ longitudinal
longitudinal NN study
study , ,
, CD 326
326 JJ high-risk
high-risk NNS adults
adults VBD underwent
underwent DT both
both CD 3-
3- CC and
and JJ 6-mm
6-mm NN image-slice
image-slice NN thickness
thickness NN CAPITAL EBCT
EBCT NN scanning
scanning CC and
and VBD were
were VBN followed
followed RB up
up IN for
for CD 32.0+/-4.0
32.0+/-4.0 JJ additional
additional NNS months

Events NNS CAPITAL Events
Events VBD were
were VBN defined
defined IN as
as DT either
either JJ coronary
coronary NN death
death , ,
, JJ myocardial
myocardial NN infarction
infarction , ,
, CC or
or NN revascularization

We PRP CAPITAL We
We VBN monitored
monitored DT these
these NNS subjects
subjects IN for
for DT the
the JJ 32-month
32-month VBG postscanning
postscanning NN period
period IN with
with JJ yearly
yearly NN phone
phone NNS calls
calls CC and
and NN acquisition
acquisition IN of
of NNS records
records IN for
for DT all
all NN hospital
hospital NNS admissions

At IN CAPITAL At
At DT the
the NN time
time IN of
of NN scanning
scanning , ,
, CD 11
11 NNS subjects
subjects NN (
( CD 3
3 NN %
% NN )
) VBD had
had RB already
already VBN suffered
suffered CD 12
12 NNS events
events NN (
( CD 5
5 NNS infarctions
infarctions CC and
and CD 7
7 NNS revascularizations
revascularizations NN )
) IN during
during DT the
the JJ 24-month
24-month VBG prescanning
prescanning NN period

During IN CAPITAL During
During DT the
the VBG postscanning
postscanning NN period
period , ,
, CD 18
18 NNS subjects
subjects NN (
( CD 6
6 NN %
% NN )
) VBN suffered
suffered CD 23
23 NNS events
events NN (
( CD 5
5 JJ coronary
coronary NNS deaths
deaths , ,
, CD 6
6 NNS infarctions
infarctions , ,
, CC and
and CD 12
12 NNS revascularizations
revascularizations NN )

Thus RB CAPITAL Thus
Thus , ,
, CD 28
28 NNS subjects
subjects NN (
( CD 9
9 NN %
% NN )
) VBN suffered
suffered CD 35
35 NNS events

Calcium NN CAPITAL Calcium
Calcium NNS quantities
quantities VBN calculated
calculated IN for
for DT both
both NNS protocols
protocols , ,
, VBN performed
performed IN on
on DT the
the JJ same
same NNS subjects
subjects , ,
, VBD were
were VBN sorted
sorted IN in
in VBG ascending
ascending NN order
order CC and
and VBN divided
divided IN into
into JJ equal
equal NNS quartiles

When WRB CAPITAL When
When NNS revascularizations
revascularizations VBD were
were VBN included
included , ,
, RB there
there VBD was
was DT a
a JJ significant
significant NN trend
trend IN toward
toward JJR higher
higher NNS frequencies
frequencies IN of
of NNS events
events IN with
with VBG increasing
increasing NN calcium
calcium NN quantity
quantity NN (
( NN CAPITAL P
P CC &
& # #
# CD 60
60 : ;
; CD .01
.01 NN )

However RB CAPITAL However
However , ,
, JJ coronary
coronary NN death
death CC and
and NN infarction
infarction VBD were
were RB not
not RB significantly
significantly RBR more
more JJ frequent
frequent IN in
in JJR higher
higher NNS quartiles

These DT CAPITAL These
These NNS relationships
relationships VBD were
were JJ preserved
preserved IN in
in DT the
the NNS subjects
subjects IN without
without RB prior
prior NNS events
events IN at
at DT the
the NN time
time IN of
of NN scanning

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NN CAPITAL Calcium
Calcium NNS quantities
quantities IN from
from DT the
the NN 3-mm
3-mm CC and
and DT the
the RBR more
more JJ reproducible
reproducible JJ 6-mm
6-mm NN scanning
scanning VBP are
are RB equally
equally JJ accurate
accurate IN for
for VBG predicting
predicting NNS events

Coronary JJ CAPITAL Coronary
Coronary NN calcium
calcium NN amount
amount VBZ appears
appears TO to
to VB be
be DT a
a JJ weak
weak NN predictor
predictor IN of
of JJ coronary
coronary NN death
death CC and
and NN infarction

Its PRP$ CAPITAL Its
Its JJ predictive
predictive NN accuracy
accuracy VBZ is
is JJ superior
superior IN for
for VBG predicting
predicting NN revascularization

Research NNP CAPITAL Research
Research IN into
into DT the
the JJ genetic
genetic NN component
component IN of
of DT some
some NN complex
complex NNS behaviors
behaviors RB often
often NNS causes
causes NN controversy
controversy , ,
, VBG depending
depending IN on
on DT the
the JJ social
social VBG meaning
meaning CC and
and NN significance
significance IN of
of DT the
the NN behavior
behavior IN under
under NN study

Research NNP CAPITAL Research
Research IN into
into JJ sexual
sexual RB orientation-simplistically
orientation-simplistically VBN referred
referred TO to
to IN as
as `` ``
`` JJ gay
gay NN gene
gene '' ''
'' JJ research-is
research-is DT an
an NN example
example IN of
of NN research
research IN that
that VBZ provokes
provokes JJ intense
intense NN controversy

This DT CAPITAL This
This NN research
research VBZ is
is JJ worrisome
worrisome IN for
for JJ many
many NNS reasons
reasons , ,
, VBG including
including DT the
the NN fact
fact IN that
that PRP it
it VBZ has
has VBN been
been VBN used
used TO to
to NN harm
harm NNS lesbians
lesbians CC and
and JJ gay
gay NNS men

Many JJ CAPITAL Many
Many NN homosexual
homosexual NNS people
people VB have
have VBN been
been VBN forced
forced TO to
to VB undergo
undergo `` ``
`` NNS treatments
treatments '' ''
'' TO to
to NN change
change PRP$ their
their JJ sexual
sexual NN orientation

Other JJ CAPITAL Other
Other VBD chose
chose TO to
to VB undergo
undergo PRP them
them TO to
to NN escape
escape NN discrimination
discrimination CC and
and JJ social
social NN disapprobation

But CC CAPITAL But
But RB there
there VBP are
are JJ other
other NNS reasons
reasons TO to
to NN worry
worry IN about
about JJ such
such NN research

The DT CAPITAL The
The RB very
very NN motivation
motivation IN for
for VBG seeking
seeking DT an
an `` ``
`` NN origin
origin '' ''
'' IN of
of NN homosexuality
homosexuality VBZ reveals
reveals NN homophobia

Moreover RB CAPITAL Moreover
Moreover , ,
, JJ such
such NN research
research MD may
may NN lead
lead TO to
to JJ prenatal
prenatal NNS tests
tests IN that
that NN claim
claim TO to
to VB predict
predict IN for
for NN homosexuality

For IN CAPITAL For
For NN homosexual
homosexual NNS people
people WP who
who VB live
live IN in
in NNS countries
countries IN with
with DT no
no JJ legal
legal NNS protections
protections DT these
these NNS dangers
dangers VBP are
are RB particularly
particularly JJ serious

The DT CAPITAL The
The NN efficiency
efficiency IN of
of JJ testicular
testicular NN sperm
sperm NN retrieval
retrieval IN by
by JJ testicular
testicular NN fine
fine NN needle
needle NN aspiration
aspiration NN (
( NN CAPITAL TEFNA
TEFNA NN )
) VBD was
was VBN compared
compared IN with
with JJ open
open NN biopsy
biopsy CC and
and JJ testicular
testicular NN sperm
sperm NN extraction
extraction NN (
( NN CAPITAL TESE
TESE NN )
) , ,
, IN in
in CD 37
37 RB rigorously
rigorously VBN selected
selected NNS patients
patients IN with
with JJ non-obstructive
non-obstructive NN azoospermia

All DT CAPITAL All
All NNS patients
patients VBD underwent
underwent NN CAPITAL TEFNA
TEFNA CC and
and NN CAPITAL TESE
TESE RB consecutively

Thus RB CAPITAL Thus
Thus , ,
, DT each
each NN patient
patient VBD served
served IN as
as PRP$ his
his JJ own
own NN control

The DT CAPITAL The
The NN case
case VBD was
was VBN regarded
regarded IN as
as JJ successful
successful IN if
if IN at
at JJS least
least CD one
one JJ testicular
testicular NN spermatozoon
spermatozoon VBD was
was VBN found
found VBG allowing
allowing JJ intracytoplasmic
intracytoplasmic NN sperm
sperm NN injection
injection NN (
( NN CAPITAL ICSI
ICSI NN )
) IN of
of IN at
at JJS least
least CD one
one NN oocyte

The DT CAPITAL The
The VB mean
mean NN age
age IN of
of DT the
the NN male
male NNS patients
patients VBD was
was CD 32.7
32.7 NNS years
years NN (
( NN range
range CD 24-47
24-47 NN )

Whereas IN CAPITAL Whereas
Whereas IN by
by NN CAPITAL TEFNA
TEFNA NN spermatozoa
spermatozoa VBG enabling
enabling NN performance
performance IN of
of NN CAPITAL ICSI
ICSI VBD were
were VBN found
found IN in
in RB only
only CD four
four NNS patients
patients IN out
out IN of
of CD 37
37 NN (
( CD 11
11 NN %
% NN )
) , ,
, JJ open
open NN biopsy
biopsy CC and
and NN CAPITAL TESE
TESE VBD yielded
yielded NN spermatozoa
spermatozoa IN in
in CD 16
16 NNS cases
cases NN (
( CD 43
43 NN %
% NN )

The DT CAPITAL The
The JJ negative
negative JJ predictive
predictive NN value
value IN of
of JJ high
high NN serum
serum NN follicle
follicle VBG stimulating
stimulating NN hormone
hormone NN (
( NN CAPITAL FSH
FSH NN )
) NNS concentrations
concentrations NN (
( JJR >
> CC or
or CD =10
=10 NN CAPITAL IU/l
IU/l NN )
) NN (
( VBG predicting
predicting NN failure
failure TO to
to VB find
find NN spermatozoa
spermatozoa IN for
for NN CAPITAL ICSI
ICSI NN )
) VBD was
was JJ low
low NN (
( CD 38.4
38.4 NN %
% NN )

The DT CAPITAL The
The JJ positive
positive JJ predictive
predictive NN value
value NN (
( VBG predicting
predicting DT the
the NN chance
chance TO to
to VB find
find NN spermatozoa
spermatozoa IN for
for NN CAPITAL ICSI
ICSI NN )
) IN of
of JJ normal-sized
normal-sized NN testicle
testicle VBD was
was RB not
not JJ different
different IN from
from IN that
that IN of
of JJ small-sized
small-sized NN (
( CC &
& # #
# CD 60
60 : ;
; CD 15
15 NN ml
ml NN )
) NN testicle
testicle NN (
( CD 50
50 NN %
% NN )

Complications NNS CAPITAL Complications
Complications VBN included
included CD one
one NN case
case IN of
of JJ testicular
testicular VBG bleeding
bleeding VBG following
following NN fine
fine NN needle
needle NN aspiration
aspiration , ,
, VBN treated
treated RB locally
locally , ,
, CC and
and CD two
two NNS cases
cases IN of
of JJ extratunical
extratunical NN haematomata
haematomata VBG following
following NN CAPITAL TESE
TESE VBG requiring
requiring DT no
no NN intervention

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL In
In NNS patients
patients IN with
with JJ non-obstructive
non-obstructive NN azoospermia
azoospermia , ,
, NN CAPITAL TEFNA
TEFNA VBZ has
has DT a
a RB significantly
significantly JJR lower
lower NN yield
yield VBN compared
compared TO to
to NN CAPITAL TESE

Performance NNP CAPITAL Performance
Performance IN of
of NN CAPITAL ICSI
ICSI IN with
with JJ testicular
testicular NN sperm
sperm IN in
in DT these
these NNS cases
cases VBD resulted
resulted IN in
in JJ satisfactory
satisfactory NN fertilization
fertilization CC and
and JJ high
high NN embryo
embryo NN transfer
transfer NNS rates

The DT CAPITAL The
The NN implantation
implantation CC and
and NN pregnancy
pregnancy NNS rates
rates IN per
per NN embryo
embryo NN transfer
transfer VBD were
were CD 13
13 CC and
and CD 29
29 NN %
% RB respectively

Neither DT CAPITAL Neither
Neither NN serum
serum NN CAPITAL FSH
FSH NNS values
values CC nor
nor JJ testicular
testicular NN size
size VBD were
were JJ predictive
predictive IN of
of DT the
the NNS chances
chances TO to
to VB find
find NN spermatozoa
spermatozoa IN for
for NN CAPITAL ICSI

Some DT CAPITAL Some
Some NNS complications
complications MD may
may VB occur
occur RB even
even VBG following
following NN CAPITAL TEFNA

Cyclin NN CAPITAL Cyclin
Cyclin NN CAPITAL D1
D1 , ,
, DT the
the JJ regulatory
regulatory NN subunit
subunit IN of
of JJ certain
certain NN protein
protein NNS kinases
kinases NN thought
thought TO to
to NN advance
advance DT the
the NN CAPITAL G1
G1 NN phase
phase IN of
of DT the
the NN cell
cell NN cycle
cycle , ,
, VBZ is
is RB now
now VBN established
established IN as
as DT a
a NN proto-oncogene
proto-oncogene , ,
, IN with
with NN evidence
evidence VBG indicating
indicating IN that
that PRP$ its
its NN derangement
derangement MD may
may VB contribute
contribute TO to
to DT the
the JJ uncontrolled
uncontrolled NN cell
cell NN growth
growth JJ characteristic
characteristic IN of
of NNS tumors

The DT CAPITAL The
The JJ chromosomal
chromosomal NN translocation
translocation NN t
t NN (
( CD 11
11 : ;
; CD 14
14 NN )
) NN (
( NN q13
q13 : :
: NN q32
q32 NN )
) , ,
, VBG involving
involving NN rearrangement
rearrangement IN of
of DT the
the NN CAPITAL BCL-1
BCL-1 NN locus
locus , ,
, VBZ is
is RB closely
closely VBN associated
associated IN with
with JJ human
human JJ lymphoid
lymphoid NN neoplasia
neoplasia VBG affecting
affecting NN mantle
mantle NN cell
cell NNS lymphomas
lymphomas NN (
( NN CAPITAL MCL
MCL NN )

Recently RB CAPITAL Recently
Recently , ,
, DT the
the JJ putative
putative NN CAPITAL BCL-1
BCL-1 NN proto-oncogene
proto-oncogene VBD turned
turned IN out
out TO to
to VB be
be NN none
none JJ other
other IN than
than DT the
the NN cyclin
cyclin NN CAPITAL D1
D1 NN gene

Although IN CAPITAL Although
Although DT the
the VBN observed
observed NN break
break NNS points
points IN in
in DT the
the NN CAPITAL BCL-1
BCL-1 NN locus
locus VBP are
are RB not
not RB tightly
tightly VBN clustered
clustered , ,
, PRP$ its
its NN rearrangement
rearrangement VBZ has
has VBN been
been VBN documented
documented IN in
in CD 40-70
40-70 NN %
% IN of
of NNS cases
cases IN of
of NN mantle
mantle NN cell
cell NN lymphoma
lymphoma , ,
, IN whereas
whereas PRP it
it RB only
only RB rarely
rarely VBZ occurs
occurs IN in
in JJ other
other NN CAPITAL B
B NN cell
cell NNS lymphomas

Of IN CAPITAL Of
Of NN note
note , ,
, DT all
all IN of
of DT the
the VBN known
known NN break
break NNS points
points NN leave
leave DT the
the NN cyclin
cyclin NN CAPITAL D1
D1 VBG coding
coding NN region
region RB structurally
structurally JJ intact
intact CC and
and NN result
result IN in
in VBN increased
increased NN protein
protein NN expression
expression , ,
, VBG implying
implying IN that
that DT this
this MD may
may VB provide
provide DT a
a RB highly
highly JJ sensitive
sensitive CC and
and JJ specific
specific NN marker
marker IN for
for NN CAPITAL MCL

Recent JJ CAPITAL Recent
Recent NNS studies
studies VBN demonstrated
demonstrated IN that
that JJ immunohistochemical
immunohistochemical NN detection
detection IN in
in JJ paraffin-embedded
paraffin-embedded NN material
material , ,
, VBG using
using DT a
a JJ monoclonal
monoclonal NN antibody
antibody , ,
, VBZ is
is RB very
very JJ useful
useful IN for
for JJ routine
routine NN diagnosis

Current JJ CAPITAL Current
Current NN knowledge
knowledge IN of
of NN cyclin
cyclin NN CAPITAL D1
D1 NN overexpression
overexpression IN in
in JJ malignant
malignant NNS lymphomas
lymphomas , ,
, IN with
with NN emphasis
emphasis IN on
on PRP$ its
its JJ clinicopathologic
clinicopathologic NN significance
significance , ,
, VBZ is
is VBN reviewed

In IN CAPITAL In
In DT the
the JJ mammalian
mammalian JJ central
central JJ nervous
nervous NN system
system , ,
, DT a
a JJ diverse
diverse NN group
group IN of
of JJ basic
basic JJ helix-loop-helix
helix-loop-helix NN (
( JJ bHLH
bHLH NN )
) NNS proteins
proteins VBZ is
is VBN involved
involved IN in
in DT the
the NN determination
determination IN of
of NN progenitor
progenitor NNS cells
cells CC and
and , ,
, RB subsequently
subsequently , ,
, IN in
in VBG regulating
regulating JJ neuronal
neuronal NN differentiation

Here RB CAPITAL Here
Here PRP we
we NN report
report DT the
the NN identification
identification IN of
of DT a
a JJ novel
novel NN subfamily
subfamily IN of
of JJ bHLH
bHLH NNS proteins
proteins , ,
, VBN defined
defined IN by
by CD two
two JJ mammalian
mammalian JJ enhancer-of-split-
enhancer-of-split- CC and
and JJ hairy-related
hairy-related NNS proteins
proteins , ,
, VBN termed
termed NN CAPITAL SHARP-1
SHARP-1 CC and
and NN CAPITAL SHARP-2

In IN CAPITAL In
In NN contrast
contrast TO to
to VBN known
known JJ bHLH
bHLH NNS genes
genes , ,
, JJ detectable
detectable NN transcription
transcription IN of
of JJ CAPITAL SHARP
SHARP NNS genes
genes VBZ begins
begins IN at
at DT the
the NN end
end IN of
of JJ embryonic
embryonic NN development
development VBG marking
marking VBN differentiated
differentiated NNS neurons
neurons IN that
that VB have
have VBN reached
reached DT a
a JJ final
final NN position
position , ,
, CC and
and NNS increases
increases IN as
as JJ postnatal
postnatal NN development
development NNS proceeds

In IN CAPITAL In
In DT the
the JJ adult
adult , ,
, JJ CAPITAL SHARP
SHARP NNS genes
genes VBP are
are VBN expressed
expressed IN in
in NNS subregions
subregions IN of
of DT the
the NNS CAPITAL CNS
CNS IN that
that VB have
have VBN been
been VBN associated
associated IN with
with JJ adult
adult NN plasticity

In IN CAPITAL In
In NN CAPITAL PC12
PC12 NNS cells
cells , ,
, DT a
a NN model
model NN system
system TO to
to NN study
study NN neurite
neurite NN outgrowth
outgrowth , ,
, JJ CAPITAL SHARP
SHARP NNS genes
genes MD can
can VB be
be VBN induced
induced IN by
by NN CAPITAL NGF
NGF IN with
with DT the
the NNS kinetics
kinetics IN of
of DT an
an JJ immediate-early
immediate-early NN gene

Similarly RB CAPITAL Similarly
Similarly , ,
, IN within
within CD 1
1 NN h
h IN after
after DT the
the NN administration
administration IN of
of JJ kainic
kainic NN acid
acid IN in
in FW vivo
vivo , ,
, NN CAPITAL SHARP-2
SHARP-2 VBZ is
is VBN induced
induced IN in
in NNS neurons
neurons IN throughout
throughout DT the
the NN rat
rat JJ cerebral
cerebral NN cortex

This DT CAPITAL This
This VBZ suggests
suggests IN that
that JJ neuronal
neuronal JJ bHLH
bHLH NNS proteins
proteins VBP are
are RB also
also VBN involved
involved IN in
in DT the
the `` ``
`` JJ adaptive
adaptive '' ''
'' NNS changes
changes IN of
of JJ mature
mature NNS CAPITAL CNS
CNS NNS neurons
neurons WDT which
which VBP are
are VBN coupled
coupled TO to
to JJ glutamatergic
glutamatergic NN stimulation

The DT CAPITAL The
The JJ embryonic
embryonic NN development
development IN of
of DT the
the NN face
face VBZ has
has VBN been
been VBN studied
studied IN in
in JJ many
many NNS reviews
reviews , ,
, DT this
this NN work
work NNS purposes
purposes RB only
only TO to
to JJ clear
clear RB up
up DT some
some NNS points
points WDT which
which VB remain
remain JJ obscure
obscure VBG concerning
concerning JJ cervico-facial
cervico-facial NN morphogenesis

In IN CAPITAL In
In DT the
the RB first
first NN part
part IN of
of DT this
this NN study
study RB only
only DT the
the JJ facial
facial NN development
development , ,
, RB properly
properly VBG speaking
speaking , ,
, VBZ is
is VBN considered
considered , ,
, IN although
although PRP it
it MD can
can RB not
not VB be
be JJ separate
separate IN of
of JJ cervical
cervical NN development
development TO to
to WDT which
which DT a
a JJ second
second NN study
study MD will
will VB be
be VBN reserved

In IN CAPITAL In
In DT the
the JJ present
present NN study
study PRP we
we NN recall
recall DT the
the JJ particular
particular NNS aspects
aspects IN of
of DT the
the NN neurulation
neurulation IN in
in DT the
the JJ cephalic
cephalic NN area
area , ,
, RB then
then DT the
the NN establishment
establishment IN of
of DT the
the JJ facial
facial NNS processes

Then RB CAPITAL Then
Then PRP we
we NN approach
approach IN among
among JJ other
other NNS things
things DT the
the NN way
way TO to
to VB consider
consider DT the
the JJ maxillary
maxillary NN process
process IN with
with NN regard
regard TO to
to DT the
the JJ other
other JJ facial
facial NNS processes

After IN CAPITAL After
After VBZ is
is VBN considered
considered NN constitution
constitution CC and
and JJ natured
natured IN of
of DT the
the JJ prechordal
prechordal NN plate
plate WDT which
which VBZ has
has VBN been
been RB diversely
diversely VBN explained

Finally RB CAPITAL Finally
Finally , ,
, DT the
the NN modelling
modelling IN of
of DT the
the NN face
face VBZ is
is VBN evocated
evocated , ,
, IN in
in WDT which
which DT the
the NN dissociation
dissociation IN between
between DT the
the JJ olfactive
olfactive CC and
and JJ buccal
buccal NNS spheres
spheres VBZ is
is JJ pointed
pointed IN out
out , ,
, IN with
with DT the
the NN disparition
disparition IN of
of DT the
the NN muzzle
muzzle , ,
, IN as
as PRP it
it VBZ is
is VBN established
established IN in
in DT the
the NN haplorhinae
haplorhinae , ,
, DT a
a NN class
class IN of
of NNS primates
primates IN in
in WDT which
which DT the
the JJ human
human VBG being
being VBZ is
is VBN involved

This DT CAPITAL This
This NN phenomenon
phenomenon VBZ raises
raises JJ different
different NNS questions
questions , ,
, IN in
in JJ particular
particular IN about
about DT the
the NN relation
relation IN of
of DT this
this NN disposition
disposition IN with
with DT the
the JJ nasoseptal
nasoseptal NN center
center , ,
, DT the
the JJ medial
medial NN part
part IN of
of DT the
the NN nasodorsal
nasodorsal NN center

A DT CAPITAL A
A JJ case-control
case-control NN study
study VBD was
was VBN performed
performed IN in
in CD eight
eight NNS pairs
pairs IN of
of NNS women
women TO to
to VB determine
determine IN whether
whether JJ preeclamptic
preeclamptic NNS women
women VBN developed
developed NNS abnormalities
abnormalities IN in
in JJ minor
minor NNS hemoglobins
hemoglobins , ,
, JJ glycolytic
glycolytic NNS enzymes
enzymes , ,
, CC or
or JJ other
other NN blood
blood NNS components
components IN that
that MD might
might VB provide
provide NN insight
insight IN into
into DT the
the NN pathophysiology
pathophysiology IN of
of NN preeclampsia
preeclampsia , ,
, CC or
or IN that
that IN in
in NN combination
combination MD might
might VB be
be VBN used
used IN as
as DT a
a NN marker
marker IN for
for DT the
the NN condition

These DT CAPITAL These
These NNS variables
variables CC and
and NN standard
standard JJ clinical
clinical NNS tests
tests VBD were
were VBN analyzed
analyzed IN as
as NNS discriminators
discriminators IN between
between JJ preeclamptic
preeclamptic CC and
and NN control
control NNS women

The DT CAPITAL The
The NNS subjects
subjects VBD were
were VBN matched
matched IN for
for NN age
age , ,
, NN ethnicity
ethnicity , ,
, NN parity
parity , ,
, CC and
and JJ gestational
gestational NN age

Blood NN CAPITAL Blood
Blood NNS samples
samples VBD were
were VBN taken
taken IN at
at DT the
the NN time
time IN of
of NN diagnosis
diagnosis IN of
of NN preeclampsia
preeclampsia CC and
and IN at
at JJ comparable
comparable JJ gestational
gestational NNS ages
ages IN for
for VBN matched
matched JJ normal
normal NNS controls

Variables NNS CAPITAL Variables
Variables VBG differing
differing RB significantly
significantly IN between
between NNS groups
groups VBN included
included NNS increases
increases IN in
in JJ uric
uric NN acid
acid NN (
( NNP CAPITAL UA
UA NN )
) , ,
, NN low-density
low-density NNS lipoproteins
lipoproteins NN (
( NN CAPITAL LDL
LDL NN )
) , ,
, NN phosphoglycerate
phosphoglycerate NN kinase
kinase NN (
( NN CAPITAL PGK
PGK NN )
) , ,
, CC and
and VB mean
mean NN platelet
platelet NN volume
volume NN (
( NN CAPITAL MPV
MPV NN )
) , ,
, CC and
and NNS decreases
decreases IN in
in NN glyceraldehyde
glyceraldehyde NN phosphate
phosphate NN dehydrogenase
dehydrogenase NN (
( NN CAPITAL G3PD
G3PD NN )
) IN in
in JJ preeclamptic
preeclamptic NNS women
women VBN compared
compared TO to
to JJ normal
normal NNS controls

Discriminant JJ CAPITAL Discriminant
Discriminant NN analysis
analysis VBD revealed
revealed DT the
the VBG following
following NN function
function TO to
to JJ separate
separate DT the
the NNS groups
groups : :
: CD 0.7764
0.7764 NN (
( NNP CAPITAL UA
UA NN )
) CC +
+ CD 0.8086
0.8086 NN (
( NN CAPITAL PGK
PGK NN )
) CD -0.7032
-0.7032 NN (
( NN CAPITAL G3PD
G3PD NN )
) CC +
+ CD 0.1399
0.1399 NN (
( NN CAPITAL LDL
LDL NN )
) CD -0.2386
-0.2386 NN (
( NN CAPITAL MPV
MPV NN )

A DT CAPITAL A
A JJ discriminant
discriminant NN score
score IN of
of JJR >
> CC or
or JJ =
= CD 275
275 VBD indicated
indicated DT a
a JJR >
> CC or
or JJ =
= CD 90
90 NN %
% NN probability
probability IN of
of NN preeclampsia

The DT CAPITAL The
The NNS results
results VBP are
are JJ consistent
consistent IN with
with NNS perturbations
perturbations IN in
in JJ red
red NN cell
cell NN glycolysis
glycolysis IN in
in NN preeclampsia

Further RB CAPITAL Further
Further JJ prospective
prospective NNS studies
studies VBP are
are VBN warranted
warranted TO to
to NN test
test DT the
the NN efficacy
efficacy IN of
of DT this
this JJ discriminant
discriminant NN function
function IN in
in VBG predicting
predicting NN preeclampsia

A DT CAPITAL A
A JJ novel
novel NN technique
technique IN for
for NN patterning
patterning VBN immobilized
immobilized NN antibody
antibody NNS layers
layers VBN based
based IN upon
upon NN photolithography
photolithography CC and
and NN oxygen
oxygen NN plasma
plasma NN exposure
exposure VBZ has
has VBN been
been VBN developed

Mouse NN CAPITAL Mouse
Mouse JJ monoclonal
monoclonal NNS antibodies
antibodies JJ specific
specific IN for
for NN thiabendazole
thiabendazole NN (
( DT a
a JJ post-harvest
post-harvest NN fungicide
fungicide CC and
and JJ veterinary
veterinary JJ anthelmintic
anthelmintic NN )
) VBD were
were RB covalently
covalently VBN linked
linked IN through
through JJ free
free NN amine
amine NNS groups
groups TO to
to VBN aminosilanized
aminosilanized NN silicon
silicon NN dioxide
dioxide NNS films
films VBG using
using NN glutaraldehyde

Immobilized VBN CAPITAL Immobilized
Immobilized NN antibody
antibody NNS layers
layers VBD were
were VBN stabilized
stabilized IN with
with NN sucrose
sucrose , ,
, VBN dehydrated
dehydrated , ,
, CC and
and VBN stored
stored VBN refrigerated
refrigerated IN with
with NN desiccant

Photolithographic JJ CAPITAL Photolithographic
Photolithographic NN patterning
patterning VBD was
was VBN performed
performed IN with
with DT a
a JJ positive
positive NN photoresist
photoresist IN with
with VBN modified
modified VB bake
bake NNS temperatures
temperatures CC and
and NNS times
times , ,
, JJ selective
selective NN CAPITAL UV
UV NN exposure
exposure IN with
with DT a
a NN contact
contact NN mask
mask , ,
, CC and
and JJ aqueous
aqueous NN alkaline
alkaline NN solubilization
solubilization IN of
of VBN exposed
exposed VB resist

Exposed VBN CAPITAL Exposed
Exposed NNS regions
regions IN of
of VBN immobilized
immobilized NN antibody
antibody VBD were
were RB then
then VBN removed
removed IN by
by NN exposure
exposure TO to
to DT a
a JJ low
low NN power
power , ,
, NN radio
radio NN frequency
frequency NN oxygen
oxygen NN discharge

Residual JJ CAPITAL Residual
Residual VB resist
resist VBD was
was VBN stripped
stripped IN with
with NN acetone

Successful JJ CAPITAL Successful
Successful NN patterning
patterning VBD was
was VBN demonstrated
demonstrated IN by
by VBG challenging
challenging NNS surfaces
surfaces IN with
with NN goat
goat JJ anti-mouse
anti-mouse NN antibody
antibody VBN conjugated
conjugated TO to
to NN tetramethylrhodamine
tetramethylrhodamine NN isothiocyanate

Sucrose NN CAPITAL Sucrose
Sucrose NN stabilization
stabilization VBD was
was JJ necessary
necessary IN for
for NN antibody
antibody TO to
to VB undergo
undergo NN photoresist
photoresist NN processing
processing IN without
without NN loss
loss IN of
of NN binding
binding NN activity

Challenge NN CAPITAL Challenge
Challenge IN with
with NN enzyme
enzyme VBN linked
linked NN antigen
antigen IN of
of NN oxygen
oxygen NN plasma
plasma VBN exposed
exposed NN antibody
antibody NNS layers
layers VBN demonstrated
demonstrated IN that
that NN plasma
plasma NN treatment
treatment RB completely
completely VBN neutralized
neutralized NN antibody
antibody NN capture
capture NN ability

Ellipsometry NN CAPITAL Ellipsometry
Ellipsometry NNS measurements
measurements IN of
of NN oxygen
oxygen NN plasma
plasma VBN exposed
exposed NN antibody
antibody NNS layers
layers VBD indicated
indicated JJ complete
complete NN removal
removal IN of
of VBN immobilized
immobilized NNS antibodies

Fluorescent JJ CAPITAL Fluorescent
Fluorescent NN imaging
imaging VBN demonstrated
demonstrated JJS smallest
smallest NN line
line NNS widths
widths IN of
of CD 2-3
2-3 NNS microns

Immune NNP CAPITAL Immune
Immune NNS cells
cells IN in
in FW vivo
vivo RB routinely
routinely VB perform
perform RB highly
highly JJ selective
selective NN immunosensing
immunosensing IN in
in NN blood
blood CC and
and NNS tissues
tissues IN as
as NN part
part IN of
of PRP$ their
their JJ normal
normal JJ immune
immune NN surveillance
surveillance NNS functions

We PRP CAPITAL We
We VB have
have VBN been
been VBG investigating
investigating DT the
the NN potential
potential IN of
of VBG exploiting
exploiting DT the
the NN immunosensing
immunosensing NN detection
detection NNS abilities
abilities IN of
of JJ excitable
excitable JJ immune
immune NNS cells
cells NN (
( NN i.e
i.e . .
. DT the
the NN mast
mast NN cell
cell NN )
) IN for
for DT the
the NN development
development IN of
of JJ whole
whole NN cell
cell NNS immunobiosensors

A DT CAPITAL A
A NN key
key NN feature
feature VBZ is
is IN that
that DT these
these JJ immune
immune NNS cells
cells MD can
can VB be
be RB selectively
selectively VBN engineered
engineered TO to
to VB recognize
recognize JJ specific
specific NNS antigens
antigens IN in
in NN vitro

In IN CAPITAL In
In DT the
the NN presence
presence IN of
of NN antigen
antigen , ,
, DT these
these NNS cells
cells VB undergo
undergo JJ excitable
excitable NN activation
activation NNS responses
responses WDT which
which NN result
result IN in
in VBN increased
increased NN metabolism
metabolism CC and
and DT the
the NN exocytosis
exocytosis IN of
of VBN stored
stored JJ intracellular
intracellular NNS mediators

We PRP CAPITAL We
We VB have
have RB previously
previously VBN determined
determined IN that
that NN mast
mast NN cell
cell JJ metabolic
metabolic NNS responses
responses MD can
can VB be
be RB thermally
thermally VBN transduced
transduced IN in
in RB real
real NN time
time , ,
, RB thus
thus VBG indicating
indicating DT the
the NN possibility
possibility IN of
of JJ whole
whole NN cell
cell IN thermoelectric
thermoelectric NN immunobiosensing

In IN CAPITAL In
In DT this
this NN work
work PRP we
we VBN investigated
investigated DT the
the NN use
use IN of
of NN enzyme
enzyme NN amplification
amplification NNS systems
systems TO to
to VB enhance
enhance DT the
the JJ direct
direct NN transduction
transduction IN of
of JJ immune
immune NN cell
cell NNS responses
responses TO to
to NN analyte

It PRP CAPITAL It
It VBD was
was VBN found
found IN that
that IN with
with JJ appropriate
appropriate NNS enzymes
enzymes , ,
, NN peak
peak NNS outputs
outputs VBD occurred
occurred IN within
within RB approximately
approximately CD 5
5 NN min
min NN (
( CD 4-20
4-20 NNS times
times RBR faster
faster IN than
than IN without
without NNS enzymes
enzymes NN )
) CC and
and NN peak
peak NN response
response NNS magnitudes
magnitudes VBD were
were RB up
up TO to
to RB nine-fold
nine-fold JJR greater
greater IN than
than IN without
without NNS enzymes

An DT CAPITAL An
An JJ easy-to-use
easy-to-use NN technique
technique IN for
for NN detection
detection IN of
of NNS antibodies
antibodies JJ specific
specific IN for
for DT the
the NN parasite
parasite NNP CAPITAL L.
L. NNS donovani
donovani IN in
in JJ human
human NN serum
serum NN sample
sample VBZ has
has VBN been
been VBN developed

The DT CAPITAL The
The NN method
method VBZ is
is VBN based
based IN on
on DT an
an JJ evanescent
evanescent NN wave
wave VBN generated
generated IN from
from DT a
a VBN tapered
tapered NN configuration
configuration IN of
of VBN decladded
decladded JJ optical
optical NN fibre
fibre CC and
and VBZ does
does RB not
not VB require
require DT any
any JJ volumetric
volumetric NN measurement

Tapered VBN CAPITAL Tapered
Tapered NNS fibres
fibres VBP are
are VBN immobilized
immobilized IN with
with DT the
the VBN purified
purified NN cell
cell NN surface
surface NN protein
protein IN of
of NNP CAPITAL L.
L. NNS donovani
donovani IN by
by JJ covalent
covalent NN bonding

Treated VBN CAPITAL Treated
Treated NNS fibres
fibres VBP are
are VBN incubated
incubated IN with
with DT the
the NN patient
patient NN serum
serum IN for
for CD 10
10 NN min
min VBN followed
followed IN by
by NN incubation
incubation IN with
with NN goat
goat JJ anti
anti JJ human
human NN CAPITAL IgG
IgG VBN tagged
tagged NN CAPITAL FITC

Fluorescent JJ CAPITAL Fluorescent
Fluorescent NN intensity
intensity IN from
from DT the
the NN fibre
fibre VBZ has
has VBN been
been VBN shown
shown TO to
to VB be
be JJ proportional
proportional TO to
to NNP CAPITAL L.
L. NNS donovani
donovani JJ specific
specific NNS antibodies
antibodies JJ present
present IN in
in DT the
the NN test
test NNS sera

Direct JJ CAPITAL Direct
Direct NNS readings
readings MD can
can VB be
be VBN obtained
obtained IN after
after NN signal
signal NN enhancement
enhancement IN through
through DT a
a NN photomultiplier
photomultiplier NN tube
tube IN within
within CD 5
5 NN min

The DT CAPITAL The
The NN system
system , ,
, WRB when
when VBN tested
tested IN on
on CD 12
12 JJ positive
positive NNS sera
sera , ,
, VBD did
did RB not
not NN show
show DT any
any JJ false
false JJ negative
negative NN result

Also RB CAPITAL Also
Also , ,
, DT no
no JJ false
false JJ positive
positive NN result
result VBD was
was VBN obtained
obtained IN with
with NN serum
serum NNS samples
samples IN of
of NNS patients
patients JJ infected
infected IN with
with NNP leprosy
leprosy , ,
, NN tuberculosis
tuberculosis , ,
, NN typhoid
typhoid CC and
and NN malaria
malaria , ,
, VBG showing
showing DT the
the NN specificity
specificity IN of
of DT the
the NN sensor
sensor CC and
and NN efficacy
efficacy IN of
of DT the
the NN technique

We PRP CAPITAL We
We JJ present
present DT an
an JJ optical
optical NN biosensor
biosensor NN design
design IN that
that NNS expands
expands DT the
the NN utility
utility IN of
of NN enzyme
enzyme NNS biosensors

These DT CAPITAL These
These NNS biosensors
biosensors VBP are
are VBN fabricated
fabricated IN by
by JJ site-selective
site-selective NN photodeposition
photodeposition IN of
of JJ analyte-sensitive
analyte-sensitive NN polymer
polymer NNS matrices
matrices IN on
on JJ optical
optical NN imaging
imaging NNS fibres

These DT CAPITAL These
These NN dual-analyte
dual-analyte NNS arrays
arrays VB allow
allow IN for
for DT the
the JJ simultaneous
simultaneous , ,
, JJ independent
independent NN measurement
measurement IN of
of DT the
the NN analyte
analyte IN of
of NN interest
interest CC and
and DT the
the VBG transducing
transducing NN analyte

The DT CAPITAL The
The RB first
first VBN integrated
integrated NNS optical-biosensors
optical-biosensors VBG using
using DT this
this NN design
design VB have
have VBN been
been JJ prepared
prepared IN that
that VB allow
allow DT both
both DT the
the JJ dependent
dependent CC and
and JJ independent
independent NNS analytes
analytes TO to
to VB be
be VBN measured
measured RB simultaneously
simultaneously , ,
, IN for
for NN example
example NN penicillin
penicillin CC and
and NN pH
pH NN (
( NNP CAPITAL Healey
Healey CC &
& # #
# CD 38
38 : ;
; NNP CAPITAL Walt
Walt , ,
, CD 1995
1995 NN )
) CC or
or NN glucose
glucose CC and
and CD CAPITAL O2
O2 NN (
( NNP CAPITAL Li
Li CC &
& # #
# CD 38
38 : ;
; NNP CAPITAL Walt
Walt , ,
, CD 1995
1995 NN )

Independent NNP CAPITAL Independent
Independent NN measurement
measurement IN of
of DT the
the VBG transducing
transducing NN analyte
analyte VBZ allows
allows NN penicillin
penicillin CC or
or NN glucose
glucose TO to
to VB be
be VBN quantitated
quantitated IN in
in DT the
the NN presence
presence IN of
of DT a
a JJ concurrent
concurrent NN pH
pH CC or
or CD CAPITAL O2
O2 NN change
change , ,
, RB respectively

Penicillin NN CAPITAL Penicillin
Penicillin MD can
can VB be
be VBN measured
measured IN in
in DT the
the NN range
range CD 0.25-10.0
0.25-10.0 NN mM
mM IN in
in DT the
the NN pH
pH NN range
range CD 6.2-7.5

Glucose NN CAPITAL Glucose
Glucose MD can
can VB be
be VBN measured
measured IN in
in DT the
the NN range
range CD 0.6-20.0
0.6-20.0 NN mM
mM IN in
in DT the
the CD CAPITAL O2
O2 NN range
range CD 20-100
20-100 NN %

The DT CAPITAL The
The NN utility
utility IN of
of DT the
the NN sensor
sensor NN design
design VBD was
was VBN demonstrated
demonstrated IN by
by VBG using
using DT the
the NN penicillin-dual-analyte
penicillin-dual-analyte NN biosensor
biosensor TO to
to VB quantitate
quantitate NN penicillin
penicillin VBN produced
produced IN during
during DT a
a NNP CAPITAL Penicillium
Penicillium NN chrysogenum
chrysogenum NN fermentation

The DT CAPITAL The
The NN characterization
characterization IN of
of JJ low
low JJ molecular
molecular NN weight
weight NN ligand
ligand NN interaction
interaction IN with
with NN receptor
receptor NNS molecules
molecules VBZ is
is IN of
of NN importance
importance IN for
for DT the
the NN investigation
investigation IN of
of JJ biological
biological NNS processes
processes CC and
and IN for
for NN drug
drug NN research

We PRP CAPITAL We
We NN report
report IN on
on DT the
the NN investigation
investigation IN of
of DT the
the NN binding
binding IN of
of JJ low
low JJ molecular
molecular NN weight
weight NNS ligands
ligands TO to
to VBN immobilized
immobilized NNS receptors
receptors IN by
by JJ label-free
label-free NN detection

Reflectometric JJ CAPITAL Reflectometric
Reflectometric NN interference
interference NN spectroscopy
spectroscopy , ,
, DT an
an JJ optical
optical NN transducer
transducer WDT which
which VBZ allows
allows DT the
the VBG monitoring
monitoring IN of
of DT a
a JJ few
few NNS picograms
picograms IN per
per NN square
square JJ millimetre
millimetre NNS changes
changes IN in
in NN surface
surface NN coverage
coverage , ,
, VBD was
was VBN used
used TO to
to NN study
study CD two
two NN model
model NNS systems

In IN CAPITAL In
In DT both
both NNS cases
cases NN detection
detection IN of
of DT the
the NN binding
binding NN event
event VBD was
was JJ successful

High JJ CAPITAL High
High NN affinity
affinity NN binding
binding IN of
of NN biotin
biotin TO to
to VBN immobilized
immobilized NN streptavidin
streptavidin VBD was
was RB clearly
clearly JJ detectable
detectable IN at
at NN receptor
receptor NN surface
surface NNS concentrations
concentrations IN as
as JJ low
low IN as
as CD 1-2
1-2 NN x
x CD 10
10 NN (
( CD 10
10 NN )
) NN binding
binding NN sites/mm2

Linear JJ CAPITAL Linear
Linear NN correlation
correlation IN between
between DT the
the NN receptor
receptor NN surface
surface NN concentration
concentration CC and
and DT the
the NN response
response TO to
to NN biotin
biotin NN binding
binding VBD was
was VBN observed

Using VBG CAPITAL Using
Using VBN immobilized
immobilized NN CAPITAL DNA
DNA , ,
, PRP we
we VBN investigated
investigated DT the
the NN binding
binding IN of
of JJ common
common NNS intercalators
intercalators IN with
with NN respect
respect TO to
to NNS kinetics
kinetics CC and
and NNS thermodynamics
thermodynamics IN by
by NN evaluation
evaluation IN of
of DT the
the NN association
association CC and
and DT the
the NN dissociation
dissociation NN part
part IN of
of DT the
the NN binding
binding NN curve

Bi-exponential JJ CAPITAL Bi-exponential
Bi-exponential NN increase
increase CC and
and NN decrease
decrease IN of
of NN intercalator
intercalator VBG loading
loading VBD was
was VBN observed
observed , ,
, VBG indicating
indicating NN complex
complex NN interaction
interaction NNS kinetics

The DT CAPITAL The
The CD four
four RB structurally
structurally JJ different
different NNS intercalators
intercalators VBD showed
showed JJ significant
significant NN distinction
distinction IN in
in NN binding
binding NNS kinetics
kinetics CC and
and NN equilibrium
equilibrium NNS signals

Improvement NN CAPITAL Improvement
Improvement IN of
of JJ experimental
experimental NNS parameters
parameters VBZ is
is VBN required
required TO to
to VB obtain
obtain RBR more
more JJ reliable
reliable JJ kinetic
kinetic NNS data

An DT CAPITAL An
An JJ amperometric
amperometric NN lactate
lactate NN oxidase
oxidase NN catheter
catheter VBZ has
has VBN been
been VBN developed
developed IN for
for IN in
in FW vivo
vivo NN application
application TO to
to JJ real-time
real-time NN lactate
lactate VBG monitoring

The DT CAPITAL The
The JJ electrochemical
electrochemical NN behaviour
behaviour IN of
of DT the
the CD 1
1 NN x
x CD 3
3 NN mm
mm NN CAPITAL Pt-Ag/AgCl
Pt-Ag/AgCl JJ thin
thin NN film
film NN electrode
electrode VBZ is
is RB not
not RB significantly
significantly VBN influenced
influenced IN by
by NN lactate
lactate NN oxidase-polyurethane
oxidase-polyurethane VBG covering

Gamma-irradiation NN CAPITAL Gamma-irradiation
Gamma-irradiation NN (
( CD 25
25 NN kGy
kGy NN )
) VBZ is
is JJ suitable
suitable IN for
for DT the
the NN sterilization
sterilization NN procedure

The DT CAPITAL The
The JJ final
final NN lactate
lactate NN catheter
catheter VBZ is
is VBN characterized
characterized IN by
by DT a
a JJ linear
linear NN concentration
concentration NN range
range IN between
between CD 0.5
0.5 CC and
and CD 20
20 NN mmol/l
mmol/l NN lactate
lactate IN with
with DT a
a NN sensitivity
sensitivity IN around
around CD 2
2 NN nA
nA NN mmol-1
mmol-1 NN l-1
l-1 NN lactate

The DT CAPITAL The
The NN accuracy
accuracy VBZ is
is VBN demonstrated
demonstrated IN by
by DT the
the NN measurement
measurement IN of
of NN control
control NNS sera

Both DT CAPITAL Both
Both JJ physiological
physiological CC and
and JJ pathological
pathological NNS materials
materials NN correlate
correlate RB well
well IN with
with DT the
the VBN declared
declared NNS values

The DT CAPITAL The
The JJ dry
dry VBN stored
stored NN lactate
lactate NN catheter
catheter NNS needs
needs IN about
about CD 10
10 NN min
min IN for
for NN hydration
hydration CC and
and VBZ is
is VBN characterized
characterized IN by
by NN response
response NNS times
times NN t98
t98 NN %
% IN of
of JJR less
less IN than
than CD 2
2 NN min

Ex FW CAPITAL Ex
Ex FW vivo
vivo JJ whole
whole NN blood
blood NNS measurements
measurements VBG using
using DT the
the NN lactate
lactate NN catheter
catheter NN (
( NN y
y NN )
) VB give
give DT a
a NN correlation
correlation IN with
with DT the
the NNP CAPITAL BIOSEN
BIOSEN VBN CAPITAL Med
Med NN CAPITAL L
L NN (
( NN x
x NN )
) IN of
of NN y
y JJ =
= NN (
( NN 1.010x
1.010x CC +
+ CD 0.513
0.513 NN )
) NN mmol/l
mmol/l NN (
( NN r
r JJ =
= CD 0.9748
0.9748 NN )

Lactate NN CAPITAL Lactate
Lactate NNS values
values VBN obtained
obtained IN by
by JJ continuous
continuous NN catheter
catheter NN operation
operation FW ex
ex FW vivo
vivo NN correlate
correlate RB well
well IN with
with DT those
those VBN obtained
obtained IN by
by NNP CAPITAL BIOSEN
BIOSEN VBN CAPITAL Med
Med NNP CAPITAL L.
L. NNP CAPITAL First
First JJ subcutaneous
subcutaneous NN implantation
implantation NN (
( NN dog
dog NN )
) NNS underlines
underlines DT the
the NNS characteristics
characteristics VBN obtained
obtained FW ex
ex FW vivo
vivo : :
: IN after
after CD 30
30 NN min
min NN hydration
hydration DT the
the NN lactate
lactate NN catheter
catheter VBZ follows
follows DT the
the NN lactate
lactate NN concentration
concentration VBN measured
measured FW ex
ex FW vivo
vivo IN with
with NNS samples
samples IN from
from DT the
the NN leg
leg NN vein
vein IN by
by NNP CAPITAL BIOSEN
BIOSEN VBN CAPITAL Med
Med NNP CAPITAL L.

The DT CAPITAL The
The JJ diffusion-limited
diffusion-limited NN binding
binding NNS kinetics
kinetics IN of
of NN antigen
antigen NN (
( CC or
or NN antibody
antibody NN )
) IN in
in NN solution
solution TO to
to NN antibody
antibody NN (
( CC or
or NN antigen
antigen NN )
) VBN immobilized
immobilized IN on
on DT a
a NN biosensor
biosensor CC and
and JJ other
other NNS surfaces
surfaces VBZ is
is VBN analyzed
analyzed IN within
within DT a
a JJ fractal
fractal NN framework

Often RB CAPITAL Often
Often , ,
, DT the
the NN binding
binding NNS kinetics
kinetics MD may
may VB be
be VBN described
described IN by
by DT a
a JJ single-fractal
single-fractal NN analysis

In IN CAPITAL In
In DT some
some NNS cases
cases , ,
, DT the
the NN binding
binding NN curve
curve NNS exhibits
exhibits NNS complexities

Then RB CAPITAL Then
Then , ,
, IN for
for DT these
these NNS cases
cases , ,
, DT the
the JJ dual-fractal
dual-fractal NN analysis
analysis VBZ provides
provides DT an
an VBN improved
improved NN fit
fit WRB when
when VBN compared
compared IN with
with DT a
a JJ single-fractal
single-fractal NN analysis

This DT CAPITAL This
This VBZ indicates
indicates DT a
a NN change
change IN in
in DT the
the NN reaction
reaction NN mechanism
mechanism IN on
on DT the
the NN surface

It PRP CAPITAL It
It VBZ is
is IN of
of NN interest
interest TO to
to NN note
note IN that
that DT the
the NN state
state IN of
of NN disorder
disorder NN (
( CC or
or DT the
the JJ fractal
fractal NN dimension
dimension NN )
) CC and
and DT the
the NN binding
binding NN rate
rate NN coefficient
coefficient DT both
both NN increase
increase IN as
as DT the
the NN reaction
reaction VBZ progresses
progresses IN on
on DT the
the NN biosensor
biosensor NN surface

For IN CAPITAL For
For NN example
example , ,
, IN for
for DT the
the NN binding
binding IN of
of CD 10
10 NN nM
nM NN insulin
insulin NN growth
growth NN factor-1
factor-1 IN in
in NN solution
solution TO to
to NN insulin
insulin NN growth
growth NN factor
factor NN binding
binding NN protein-1
protein-1 VBN immobilized
immobilized IN on
on DT a
a NN biosensor
biosensor NN surface
surface , ,
, DT a
a CD 64
64 NN %
% NN increase
increase IN in
in DT the
the JJ fractal
fractal NN dimension
dimension IN from
from CD 1.73
1.73 NN (
( NN CAPITAL Df1
Df1 NN )
) TO to
to CD 2.85
2.85 NN (
( NN CAPITAL Df2
Df2 NN )
) NNS leads
leads TO to
to DT an
an NN increase
increase IN in
in DT the
the NN binding
binding NN rate
rate NN coefficient
coefficient IN by
by DT a
a NN factor
factor IN of
of CD 31.8
31.8 IN from
from CD 3.92
3.92 NN (
( NN k1
k1 NN )
) TO to
to CD 125
125 NN (
( NN k2
k2 NN )

Furthermore RB CAPITAL Furthermore
Furthermore , ,
, IN as
as DT the
the NN CAPITAL IGF-1
IGF-1 NN concentration
concentration IN in
in NN solution
solution NNS increases
increases IN from
from CD 10
10 TO to
to CD 80
80 NN nM
nM IN in
in NN solution
solution , ,
, NN k2
k2 CC and
and NN CAPITAL Df2
Df2 NN exhibit
exhibit DT a
a JJ linear
linear NN increase

k1 NN k1
k1 CC and
and NN CAPITAL Df1
Df1 NN exhibit
exhibit DT a
a JJ linear
linear NN increase
increase IN with
with DT the
the JJ reciprocal
reciprocal IN of
of DT the
the NN CAPITAL IGF-1
IGF-1 NN concentration
concentration IN in
in NN solution

The DT CAPITAL The
The JJ different
different NNS examples
examples VBN analyzed
analyzed CC and
and VBN presented
presented RB together
together VB provide
provide DT a
a NNS means
means IN by
by WDT which
which DT the
the JJ antigen-antibody
antigen-antibody NNS reactions
reactions MD may
may VB be
be RB better
better VBN controlled
controlled IN by
by VBG noting
noting DT the
the NN magnitude
magnitude IN of
of DT the
the NNS changes
changes IN in
in DT the
the JJ fractal
fractal NN dimension
dimension CC and
and IN in
in DT the
the NN binding
binding NN rate
rate NN coefficient
coefficient IN as
as DT the
the NN reaction
reaction VBZ progresses
progresses IN on
on DT the
the NN biosensor
biosensor NN surface

Also RB CAPITAL Also
Also , ,
, DT the
the NN magnitude
magnitude IN of
of DT the
the NNS changes
changes IN in
in DT the
the NN binding
binding NN rate
rate NNS coefficients
coefficients NN (
( NN k1
k1 CC and
and NN k2
k2 NN )
) CC and
and IN in
in DT the
the JJ fractal
fractal NNS dimensions
dimensions NN (
( NN CAPITAL Df1
Df1 CC and
and NN CAPITAL Df2
Df2 NN )
) IN as
as JJ different
different NNS parameters
parameters VBP are
are VBN changed
changed IN for
for DT the
the JJ different
different NN biosensor
biosensor NNS applications
applications VBP are
are IN of
of JJ particular
particular NN value
value , ,
, IN since
since PRP they
they VB provide
provide PRP us
us IN with
with DT a
a NN measure
measure CC or
or NN extent
extent IN of
of NNS changes
changes IN in
in DT the
the NN binding
binding NN rate
rate NN coefficient
coefficient IN on
on VBG changing
changing JJ different
different JJ experimental
experimental NN parameter
parameter NNS values

It PRP CAPITAL It
It VBZ is
is IN of
of NN interest
interest TO to
to NN note
note DT the
the NN effect
effect IN of
of JJ different
different NNS parameters
parameters IN on
on DT the
the NN extent
extent CC or
or NN heterogeneity
heterogeneity IN that
that VBZ exists
exists IN on
on DT the
the NN surface
surface CC and
and WRB how
how DT this
this NNS influences
influences DT the
the NN binding
binding NN rate
rate NNS coefficients

This DT CAPITAL This
This MD may
may VB be
be CD one
one NN method
method TO to
to NN help
help VB manipulate
manipulate CC or
or NN control
control DT the
the NN binding
binding NN rate
rate NNS coefficients
coefficients IN on
on DT the
the NN reaction
reaction NN surface

To TO CAPITAL To
To VB determine
determine IN if
if JJ microscopic
microscopic NN urinalysis
urinalysis VBZ is
is VBN needed
needed IN in
in DT all
all JJ pediatric
pediatric NN emergency
emergency NN room
room NNS patients
patients VBN screened
screened IN for
for JJ urinary
urinary NN tract
tract NNS infections
infections NN (
( NN CAPITAL UTI
UTI NN )
) , ,
, PRP we
we VBN compared
compared DT the
the NN dipstick
dipstick NN urinalysis
urinalysis CC and
and JJ complete
complete NN urinalysis
urinalysis NN (
( NN dipstick
dipstick CC and
and NN microscopy
microscopy NN )
) IN with
with NN urine
urine NNS cultures
cultures IN in
in CD 236
236 NNS children
children , ,
, JJ aged
aged CD 3
3 NNS weeks
weeks TO to
to CD 21
21 NNS years

The DT CAPITAL The
The NN ability
ability TO to
to VB detect
detect NN CAPITAL UTI
UTI IN by
by NN dipstick
dipstick RB only
only CC and
and IN by
by JJ complete
complete NN urinalysis
urinalysis VBD was
was DT the
the JJ same
same , ,
, RB however
however JJ microscopic
microscopic NN evaluation
evaluation VBN added
added JJ many
many JJ false-positive
false-positive NNS results
results IN without
without VBG detecting
detecting JJ additional
additional NNS CAPITAL UTIs

Because IN CAPITAL Because
Because DT the
the NN ability
ability TO to
to VB detect
detect NN CAPITAL UTI
UTI NN (
( NN sensitivity
sensitivity NN )
) VBZ is
is VBN maintained
maintained , ,
, PRP we
we RB now
now NN offer
offer DT a
a NN dipstick
dipstick RB only
only NN urinalysis
urinalysis TO to
to PRP$ our
our NN emergency
emergency NN room
room IN for
for NNS children
children CD 2
2 NNS years
years IN of
of NN age
age CC or
or JJR older
older , ,
, IN with
with DT a
a JJ microscopic
microscopic NN analysis
analysis VBN performed
performed RB automatically
automatically IN if
if NN dipstick
dipstick NNS results
results VBP are
are JJ positive

If IN CAPITAL If
If DT no
no JJ microscopic
microscopic NN urinalysis
urinalysis VBZ is
is VBN required
required , ,
, NN testing
testing NN turn-around
turn-around NN time
time VBZ is
is VBN reduced
reduced IN by
by CD 12.3
12.3 JJS min/test
min/test CC and
and DT the
the NN hospital
hospital NN charge
charge VBZ is
is VBN reduced
reduced IN from
from NNP CAPITAL U.S

$ $ $
$ CD 32
32 TO to
to NNP CAPITAL U.S

$ $ $
$ CD 12

Using VBG CAPITAL Using
Using JJ video-intensified
video-intensified NN fluorescence
fluorescence NN microscopy
microscopy CC and
and DT a
a NN pseudocolor
pseudocolor NN display
display IN of
of NN fluorescence
fluorescence NN intensity
intensity , ,
, PRP we
we VBN analyzed
analyzed DT the
the NN distribution
distribution IN of
of VBN microinjected
microinjected NNS molecules
molecules IN within
within DT the
the NN nurse-cell/oocyte
nurse-cell/oocyte NN syncytium
syncytium IN of
of FW CAPITAL Drosophila
Drosophila JJ ovarian
ovarian NNS follicles

We PRP CAPITAL We
We VBD varied
varied DT the
the NN composition
composition CC and
and DT the
the NN osmolarity
osmolarity IN of
of DT the
the NN culture
culture NN solution
solution IN as
as RB well
well IN as
as DT the
the JJ electrical
electrical NN charge
charge CC and
and DT the
the JJ molecular
molecular NN mass
mass IN of
of DT the
the VBN microinjected
microinjected JJ fluorescent
fluorescent NN probe

As IN CAPITAL As
As NN culture
culture NNS solutions
solutions , ,
, PRP we
we VBN used
used CD four
four JJ simple
simple NNS salines
salines NN (
( NN CAPITAL IMADS
IMADS NN )
) CC and
and DT a
a NN complex
complex NN tissue-culture
tissue-culture NN medium
medium NN (
( NN CAPITAL R-14
R-14 NN )
) IN that
that VBN matched
matched DT the
the NN osmolarity
osmolarity IN of
of JJ adult
adult NN hemolymph

Small JJ CAPITAL Small
Small NNS amounts
amounts IN of
of CD two
two JJ anionic
anionic NNS dyes
dyes NN (
( NNP CAPITAL Lucifer
Lucifer JJ CAPITAL Yellow
Yellow NN CAPITAL CH
CH CC and
and NNP CAPITAL Lucifer
Lucifer JJ CAPITAL Yellow
Yellow NN dextran
dextran NN )
) IN as
as RB well
well IN as
as IN of
of CD two
two NN cationic
cationic NNS dyes
dyes NN (
( NN rhodamine
rhodamine NN 6G
6G CC and
and NN tetramethylrhodamine
tetramethylrhodamine NN dextran-lysine
dextran-lysine NN )
) VBD were
were RB iontophoretically
iontophoretically VBN microinjected
microinjected DT either
either IN into
into DT a
a NN nurse
nurse NN cell
cell CC or
or IN into
into DT the
the NN oocyte
oocyte IN of
of NN stage-10
stage-10 NNS follicles

In IN CAPITAL In
In DT the
the NN tissue-culture
tissue-culture NN medium
medium , ,
, IN within
within DT a
a JJ few
few NNS seconds
seconds VBG following
following NN microinjection
microinjection , ,
, DT all
all VBN tested
tested NNS dyes
dyes VBN passed
passed IN through
through DT the
the JJ intercellular
intercellular NNS bridges
bridges IN in
in DT both
both DT the
the JJ anterior
anterior NN direction
direction NN (
( TO to
to DT the
the NN nurse
nurse NNS cells
cells NN )
) CC and
and DT the
the NN posterior
posterior NN direction
direction NN (
( TO to
to DT the
the NN oocyte
oocyte NN )
) , ,
, JJ independent
independent IN of
of PRP$ their
their JJ electrical
electrical NN charge
charge CC or
or JJ molecular
molecular NN mass

In IN CAPITAL In
In DT all
all JJ simple
simple NNS salines
salines , ,
, RB irrespective
irrespective IN of
of PRP$ their
their NN osmolarity
osmolarity , ,
, NNP CAPITAL Lucifer
Lucifer JJ CAPITAL Yellow
Yellow NN CAPITAL CH
CH VBD was
was VBN found
found TO to
to RB preferentially
preferentially VB migrate
migrate IN in
in DT the
the NN posterior
posterior NN direction
direction CC and
and TO to
to VB accumulate
accumulate IN in
in DT the
the NN oocyte
oocyte JJ due
due TO to
to JJ progressive
progressive NN binding
binding TO to
to NN yolk
yolk NNS spheres

Thus RB CAPITAL Thus
Thus , ,
, IN with
with DT this
this JJ sensitive
sensitive NN method
method , ,
, DT no
no NN correlation
correlation VBD was
was JJ detectable
detectable IN between
between DT the
the JJ external
external NN osmolarity
osmolarity , ,
, DT the
the JJ electrical
electrical NN charge
charge CC and
and DT the
the JJ preferential
preferential NN direction
direction IN of
of NN migration
migration IN of
of DT a
a VBN microinjected
microinjected NN probe

Our PRP$ CAPITAL Our
Our NNS results
results VBP indicate
indicate IN that
that DT the
the JJ electrical
electrical NN gradient
gradient VBN described
described IN by
by JJ other
other NNS authors
authors VBZ does
does RB not
not VB exert
exert JJ significant
significant NN influence
influence IN on
on DT the
the NN migration
migration IN of
of VBN charged
charged NNS molecules
molecules IN through
through JJ intercellular
intercellular NNS bridges
bridges IN in
in FW situ

The DT CAPITAL The
The NN CAPITAL AF-4
AF-4 NN gene
gene IN on
on JJ human
human NN chromosome
chromosome NN 4q21
4q21 VBZ is
is VBN involved
involved IN in
in JJ reciprocal
reciprocal NNS translocations
translocations TO to
to DT the
the NN CAPITAL ALL-1
ALL-1 NN gene
gene IN on
on NN chromosome
chromosome NN 11q23
11q23 , ,
, WDT which
which VBP are
are VBN associated
associated IN with
with JJ acute
acute JJ lymphoblastic
lymphoblastic NNS leukaemias

A DT CAPITAL A
A NN set
set IN of
of JJ recombinant
recombinant NN phage
phage VBG carrying
carrying JJ genomic
genomic NNS fragments
fragments IN for
for DT the
the VBG coding
coding NN region
region CC and
and VBG flanking
flanking NNS sequences
sequences IN of
of DT the
the NN CAPITAL AF-4
AF-4 NN gene
gene VBD were
were VBN isolated

Phage NN CAPITAL Phage
Phage NNS inserts
inserts VBD were
were VBN assembled
assembled IN into
into CD four
four NNS contigs
contigs IN with
with CD 21
21 NNS exons
exons , ,
, CC and
and DT an
an NN intron
intron NN phase
phase NN map
map VBD was
was VBN produced
produced VBG enabling
enabling DT the
the NN interpretation
interpretation IN of
of JJ translocation-generated
translocation-generated NN fusion
fusion NNS proteins

The DT CAPITAL The
The NN gene
gene VBZ contains
contains CD two
two NN alternative
alternative RB first
first NNS exons
exons , ,
, NN 1a
1a CC and
and NN 1b
1b , ,
, DT both
both VBG including
including DT a
a NN translation
translation NN initiation
initiation NN codon

The DT CAPITAL The
The NN translocation
translocation NN breakpoint
breakpoint NN cluster
cluster NN region
region VBZ is
is VBN flanked
flanked IN by
by NNS exons
exons CD 3
3 CC and
and CD 6
6 CC and
and CD two
two JJ different
different NN polyadenylation
polyadenylation NNS signals
signals VBD were
were VBN identified

Polyclonal JJ CAPITAL Polyclonal
Polyclonal NNS antisera
antisera VBN directed
directed IN against
against CD three
three JJ different
different NNS portions
portions IN of
of DT the
the NN CAPITAL AF-4
AF-4 NN protein
protein VBD were
were VBN produced
produced CC and
and VBN used
used TO to
to VB detect
detect DT a
a CD 116
116 NN kD
kD NN protein
protein IN in
in JJ cellular
cellular NNS extracts
extracts IN of
of JJ human
human JJ CAPITAL B-lymphoblastoid
B-lymphoblastoid CC and
and NN proB
proB NN cell
cell NNS lines

In IN CAPITAL In
In JJ mitogen-stimulated
mitogen-stimulated JJ human
human JJ peripheral
peripheral NN blood
blood JJ mononuclear
mononuclear NNS cells
cells DT the
the NN CAPITAL AF-4
AF-4 NN antigen
antigen VBD was
was RB predominantly
predominantly JJ located
located IN in
in DT the
the NN nucleus

The DT CAPITAL The
The NN CAPITAL AF-4
AF-4 NN gene
gene VBZ is
is DT a
a NN member
member IN of
of DT the
the NN CAPITAL AF-4
AF-4 , ,
, NN CAPITAL LAF-4
LAF-4 CC and
and NN CAPITAL FMR-2
FMR-2 NN gene
gene NN family

The DT CAPITAL The
The NNS members
members IN of
of DT this
this NN family
family VBP encode
encode JJ serine-proline-rich
serine-proline-rich NNS proteins
proteins IN with
with NNS properties
properties IN of
of JJ nuclear
nuclear NN transcription
transcription NNS factors

Comparison NN CAPITAL Comparison
Comparison IN of
of NN CAPITAL AF-4
AF-4 NN protein
protein VBG coding
coding NNS sequences
sequences IN with
with DT the
the NN CAPITAL LAF-4
LAF-4 CC and
and NN CAPITAL FMR-2
FMR-2 NNS sequences
sequences VBD revealed
revealed CD five
five RB highly
highly VBN conserved
conserved NNS domains
domains IN of
of NN potential
potential JJ functional
functional NN relevance

Immunoglobulin NN CAPITAL Immunoglobulin
Immunoglobulin NN superfamily
superfamily NNS molecules
molecules IN in
in DT the
the NN brain
brain VBP are
are VBN involved
involved IN in
in JJ distinct
distinct NNS aspects
aspects IN of
of JJ nervous
nervous NN system
system NN histogenesis
histogenesis , ,
, IN for
for NN example
example JJ neuronal
neuronal NN migration
migration CC and
and IN axonal
axonal NN growth

To TO CAPITAL To
To VB identify
identify JJ novel
novel NNS members
members IN of
of DT this
this NN superfamily
superfamily IN in
in DT the
the NN chick
chick JJ nervous
nervous NN system
system , ,
, PRP we
we VBN developed
developed DT a
a NN polymerase
polymerase NN chain
chain JJ reaction-based
reaction-based NN approach
approach VBG making
making NN use
use IN of
of NN sequence
sequence NNS motifs
motifs IN of
of JJ immunoglobulin-like
immunoglobulin-like NNS domains

In IN CAPITAL In
In DT the
the JJ present
present NN study
study , ,
, PRP we
we NN report
report DT the
the JJ molecular
molecular VBG cloning
cloning IN of
of CD three
three NNS isoforms
isoforms , ,
, DT the
the JJ biochemical
biochemical NN analysis
analysis CC and
and DT the
the JJ immunohistochemical
immunohistochemical NN characterization
characterization IN of
of CD one
one IN of
of DT the
the NNS proteins
proteins VBN identified
identified IN in
in DT this
this NN screen

This DT CAPITAL This
This NN molecule
molecule VBZ has
has CD 91
91 NN %
% NN sequence
sequence NN identity
identity IN with
with DT the
the JJ limbic
limbic JJ system-associated
system-associated NN membrane
membrane NN protein
protein NN (
( NN CAPITAL LAMP
LAMP NN )
) VBN characterized
characterized IN in
in DT the
the NN rat
rat CC and
and VBZ is
is RB therefore
therefore VBN referred
referred TO to
to IN as
as DT the
the NN chicken
chicken NN homologue
homologue IN of
of DT the
the JJ latter
latter NN (
( NN chLAMP
chLAMP NN )

The DT CAPITAL The
The NN molecule
molecule VBZ is
is DT a
a JJ glycosylphosphatidyl-inositol-anchored
glycosylphosphatidyl-inositol-anchored CD 60
60 NN kDa
kDa NN protein
protein IN with
with CD three
three JJ immunoglobulin-like
immunoglobulin-like NNS domains
domains CC and
and VBZ contains
contains CD 40
40 NN %
% JJ CAPITAL N-linked
N-linked NN carbohydrate

We PRP CAPITAL We
We VB identify
identify CD three
three JJ different
different NN mRNA
mRNA NNS forms
forms IN of
of NN chLAMP
chLAMP CC and
and NN show
show IN that
that CD two
two NNS forms
forms IN with
with JJ distinct
distinct JJ 5'-termini
5'-termini VBP are
are RB differentially
differentially VBN transcribed
transcribed IN in
in JJ neural
neural NN development

In IN CAPITAL In
In NN addition
addition , ,
, PRP we
we VB demonstrate
demonstrate VBG using
using DT a
a NN fusion
fusion NN protein
protein VBN expressed
expressed IN in
in JJ eukaryotic
eukaryotic NNS cells
cells IN that
that NN chLAMP
chLAMP VBZ has
has JJ homophilic
homophilic NN binding
binding NN activity

The DT CAPITAL The
The NN protein
protein VBD was
was VBN found
found IN on
on DT a
a NN subset
subset IN of
of NNS axons
axons IN in
in DT the
the JJ central
central CC and
and JJ peripheral
peripheral JJ nervous
nervous NN system
system CC and
and VBZ is
is RB likely
likely TO to
to VB be
be VBN involved
involved IN in
in JJ specific
specific JJ cell-cell
cell-cell NNS interactions
interactions IN in
in NN neurohistogenesis

Two CD CAPITAL Two
Two JJ novel
novel NNS cDNAs
cDNAs , ,
, NN CAPITAL DNAS1L2
DNAS1L2 CC and
and NN CAPITAL DNAS1L3
DNAS1L3 , ,
, VBP are
are VBN predicted
predicted TO to
to VBP encode
encode NNS proteins
proteins IN of
of CD 299
299 CC and
and CD 305
305 NN amino
amino NNS acids
acids IN with
with CD 56
56 CC and
and CD 46
46 NN %
% NN residue
residue NN identity
identity NN (
( CD 71
71 CC and
and CD 63
63 NN %
% NN similarity
similarity NN )
) , ,
, RB respectively
respectively , ,
, TO to
to NN deoxyribonuclease
deoxyribonuclease PRP CAPITAL I
I NN (
( NN CAPITAL DNase
DNase PRP CAPITAL I
I NN )

DNAS1L2 NN CAPITAL DNAS1L2
DNAS1L2 VBZ is
is JJ located
located IN on
on DT a
a NN 16p13.3
16p13.3 NN cosmid
cosmid , ,
, IN while
while NN CAPITAL DNAS1L3
DNAS1L3 NNS maps
maps TO to
to NN 3p14.3-p21.1
3p14.3-p21.1 IN by
by NN fluorescence
fluorescence IN in
in FW situ
situ NN hybridization
hybridization CC and
and IN by
by NN CAPITAL PCR
PCR NN analysis
analysis IN of
of DT a
a NN radiation
radiation NN hybrid
hybrid NN panel

Northern NN CAPITAL Northern
Northern NN analysis
analysis VBD revealed
revealed NN CAPITAL DNAS1L3
DNAS1L3 NN expression
expression RB nearly
nearly RB exclusively
exclusively IN in
in NN liver
liver , ,
, IN while
while NN CAPITAL DNAS1L2
DNAS1L2 NN expression
expression VBD was
was VBN detected
detected IN in
in NN brain
brain IN by
by NN CAPITAL RT-PCR

The DT CAPITAL The
The RB previously
previously VBN defined
defined NN CAPITAL DNL1L
DNL1L CC or
or NN CAPITAL DNAS1L1
DNAS1L1 VBZ is
is VBN expressed
expressed JJS highest
highest IN in
in NN heart
heart CC and
and JJ skeletal
skeletal NN muscle
muscle , ,
, IN while
while NN CAPITAL DNase
DNase PRP CAPITAL I
I VBZ is
is VBN expressed
expressed IN in
in DT the
the NN pancreas
pancreas , ,
, NN parotid
parotid NN gland
gland , ,
, CC and
and NN kidney

Thus RB CAPITAL Thus
Thus , ,
, TO to
to NN date
date , ,
, CD four
four NN CAPITAL DNase
DNase JJ CAPITAL I-like
I-like NNS genes
genes IN that
that NN show
show JJ different
different NN tissue
tissue NN expression
expression NNS patterns
patterns VBP are
are VBN known

A DT CAPITAL A
A NN comparison
comparison IN of
of NN CAPITAL DNAS1L1
DNAS1L1 , ,
, NN CAPITAL DNAS1L2
DNAS1L2 , ,
, CC and
and NN CAPITAL DNAS1L3
DNAS1L3 IN with
with DT the
the JJ well-characterized
well-characterized NN CAPITAL DNase
DNase PRP CAPITAL I
I VBZ suggests
suggests IN that
that DT the
the NN CAPITAL DNAS1L
DNAS1L NNS proteins
proteins VBP are
are JJ unlikely
unlikely TO to
to VB be
be VBN glycosylated
glycosylated CC or
or NN bind
bind NN actin
actin : ;
; RB however
however , ,
, JJ catalytic
catalytic CC and
and NN calcium-
calcium- CC and
and JJ CAPITAL DNA-binding
DNA-binding NNS residues
residues VBP are
are VBN conserved
conserved , ,
, CC and
and RB potentially
potentially JJ cleavable
cleavable NN signal
signal NNS peptides
peptides VBP are
are JJ present
present IN among
among DT all
all DT these
these NNS proteins

This DT CAPITAL This
This NN analysis
analysis RB also
also VBZ identifies
identifies NNS regions
regions IN of
of JJ high
high NN conservation
conservation IN among
among DT these
these NNS proteins
proteins IN with
with DT no
no RB currently
currently VBN assigned
assigned NN function

Two CD CAPITAL Two
Two JJ different
different NNS responses
responses TO to
to DT the
the NN therapy
therapy VBD were
were VBN observed
observed IN in
in DT a
a NN group
group IN of
of NNS patients
patients VBG receiving
receiving DT the
the NN protease
protease NN inhibitor
inhibitor NN indinavir

In IN CAPITAL In
In CD one
one , ,
, NN suppression
suppression IN of
of NN virus
virus NN replication
replication VBD occurred
occurred CC and
and VBZ has
has VBD persisted
persisted IN for
for CD 90
90 NNS weeks
weeks NN (
( NN bDNA
bDNA , ,
, CC &
& # #
# CD 60
60 : ;
; CD 500
500 JJ human
human NN immunodeficiency
immunodeficiency NN virus
virus NN type
type CD 1
1 NN (
( NN CAPITAL HIV-1
HIV-1 NN )
) NN CAPITAL RNA
RNA NN copies/ml
copies/ml NN )

In IN CAPITAL In
In DT the
the JJ second
second NN group
group , ,
, DT a
a NN rebound
rebound IN in
in NN virus
virus NNS levels
levels IN in
in NN plasma
plasma VBN followed
followed DT the
the JJ initial
initial JJ sharp
sharp NN decline
decline VBN observed
observed IN at
at DT the
the NN start
start IN of
of NN therapy

This DT CAPITAL This
This VBD was
was VBN associated
associated IN with
with DT the
the NN emergence
emergence IN of
of JJ drug-resistant
drug-resistant NNS variants

Sequence NN CAPITAL Sequence
Sequence NN analysis
analysis IN of
of DT the
the NN protease
protease NN gene
gene IN during
during DT the
the NN course
course IN of
of NN therapy
therapy VBD revealed
revealed IN that
that IN in
in DT this
this JJ second
second NN group
group RB there
there VBD was
was DT a
a JJ sequential
sequential NN acquisition
acquisition IN of
of NN protease
protease NNS mutations
mutations IN at
at NN amino
amino NNS acids
acids CD 46
46 , ,
, CD 82
82 , ,
, CD 54
54 , ,
, CD 71
71 , ,
, CD 89
89 , ,
, CC and
and CD 90

In IN CAPITAL In
In DT the
the CD six
six NNS patients
patients IN in
in DT this
this NN group
group , ,
, RB there
there VBD was
was RB also
also DT an
an JJ identical
identical NN mutation
mutation IN in
in DT the
the NN gag
gag NN p7/p1
p7/p1 NN gag
gag NN protease
protease NN cleavage
cleavage NN site

In IN CAPITAL In
In CD three
three IN of
of DT the
the NNS patients
patients , ,
, DT this
this NN change
change VBD was
was VBN seen
seen IN as
as RB early
early IN as
as CD 6
6 TO to
to CD 10
10 NNS weeks
weeks IN after
after DT the
the NN start
start IN of
of NN therapy

In IN CAPITAL In
In CD one
one NN patient
patient , ,
, DT a
a JJ second
second NN mutation
mutation VBD occurred
occurred IN at
at DT the
the NN gag
gag NN p1/p6
p1/p6 NN cleavage
cleavage NN site
site , ,
, CC but
but PRP it
it VBD appeared
appeared CD 18
18 NNS weeks
weeks IN after
after DT the
the NN time
time IN of
of NN appearance
appearance IN of
of DT the
the NN p7/p1
p7/p1 NN mutation

Recombinant JJ CAPITAL Recombinant
Recombinant NN CAPITAL HIV-1
HIV-1 NNS variants
variants VBG containing
containing CD two
two CC or
or CD three
three NNS mutations
mutations IN in
in DT the
the NN protease
protease NN gene
gene VBD were
were VBN constructed
constructed DT either
either IN with
with NNS mutations
mutations IN at
at DT the
the NN p7/p1
p7/p1 NN cleavage
cleavage NN site
site CC or
or IN with
with JJ wild-type
wild-type NN (
( JJ CAPITAL WT
WT NN )
) NN gag
gag NNS sequences

When WRB CAPITAL When
When JJ recombinant
recombinant JJ CAPITAL HIV-1-containing
HIV-1-containing NN protease
protease NNS mutations
mutations IN at
at CD 46
46 CC and
and CD 82
82 VBD was
was VBN grown
grown IN in
in NN CAPITAL MT2
MT2 NNS cells
cells , ,
, RB there
there VBD was
was DT a
a CD 68
68 NN %
% NN reduction
reduction IN in
in PRP$ its
its NN rate
rate IN of
of NN replication
replication VBN compared
compared TO to
to DT the
the JJ CAPITAL WT
WT NN virus

Introduction NN CAPITAL Introduction
Introduction IN of
of DT an
an JJ additional
additional NN mutation
mutation IN at
at DT the
the NN gag
gag NN p7/p1
p7/p1 NN protease
protease NN cleavage
cleavage NN site
site VBN compensated
compensated IN for
for DT the
the RB partially
partially JJ defective
defective NN protease
protease NN gene

Similarly RB CAPITAL Similarly
Similarly , ,
, NNS rates
rates IN of
of NN replication
replication IN of
of NNS viruses
viruses IN with
with NNS mutations
mutations NN CAPITAL M46L/I
M46L/I , ,
, NN CAPITAL I54V
I54V , ,
, CC and
and NN CAPITAL V82A
V82A IN in
in NN protease
protease VBD were
were VBN enhanced
enhanced DT both
both IN in
in DT the
the NN presence
presence CC and
and IN in
in DT the
the NN absence
absence IN of
of NNP CAPITAL Indinavir
Indinavir WRB when
when VBN combined
combined IN with
with NNS mutations
mutations IN in
in DT the
the NN gag
gag NN p7/p1
p7/p1 CC and
and DT the
the NN gag
gag NN p1/p6
p1/p6 NN cleavage
cleavage NNS sites

Optimal JJ CAPITAL Optimal
Optimal NNS rates
rates IN of
of NN virus
virus NN replication
replication VB require
require NN protease
protease NN cleavage
cleavage IN of
of NN precursor
precursor NNS polyproteins

A DT CAPITAL A
A NN mutation
mutation IN in
in DT the
the NN cleavage
cleavage NN site
site IN that
that VBN enhanced
enhanced DT the
the NN availability
availability IN of
of DT a
a NN protein
protein IN that
that VBD was
was NN rate
rate VBG limiting
limiting IN for
for NN virus
virus NN maturation
maturation MD would
would VB confer
confer IN on
on IN that
that NN virus
virus DT a
a JJ significant
significant NN growth
growth NN advantage
advantage CC and
and MD may
may VB explain
explain DT the
the NN uniform
uniform NN emergence
emergence IN of
of NNS viruses
viruses IN with
with NNS alterations
alterations IN at
at DT the
the NN p7/p1
p7/p1 NN cleavage
cleavage NN site

This DT CAPITAL This
This VBZ is
is DT the
the RB first
first NN report
report IN of
of DT the
the NN emergence
emergence IN of
of NNS mutations
mutations IN in
in DT the
the NN gag
gag NN p7/p1
p7/p1 NN protease
protease NN cleavage
cleavage NNS sites
sites IN in
in NNS patients
patients VBG receiving
receiving NN protease
protease NN therapy
therapy CC and
and VBZ identifies
identifies DT this
this NN change
change IN as
as DT an
an JJ important
important NN determinant
determinant IN of
of NN CAPITAL HIV-1
HIV-1 NN resistance
resistance TO to
to NN protease
protease NNS inhibitors
inhibitors IN in
in NN patient
patient NNS populations

A DT CAPITAL A
A JJ novel
novel JJ intracellular
intracellular JJ calcium-binding
calcium-binding NN protein
protein IN from
from NN CAPITAL Echinococcus
Echinococcus NN granulosus
granulosus VBZ is
is VBN described
described IN in
in DT this
this NN work

A DT CAPITAL A
A NN cDNA
cDNA VBD was
was VBN isolated
isolated IN from
from DT a
a NN lambdagt11
lambdagt11 NN protoscolex
protoscolex NN expression
expression NN library
library CC and
and DT the
the VBN deduced
deduced NN amino
amino NN acid
acid NN sequence
sequence VBZ has
has IN at
at JJS least
least CD fifteen
fifteen RB sequentially
sequentially VBN repeated
repeated JJ twelve-residue
twelve-residue NNS repeats
repeats IN that
that VB resemble
resemble DT the
the JJ calcium-binding
calcium-binding NN loop
loop IN of
of NNS CAPITAL EF-hands
EF-hands : ;
; RB however
however , ,
, DT the
the NN dodecamer
dodecamer NN motif
motif VBZ has
has DT no
no VBG flanking
flanking NNS helices

The DT CAPITAL The
The NN cDNA
cDNA VBD was
was VBN expressed
expressed IN in
in FW CAPITAL Escherichia
Escherichia NN coli
coli VBG using
using DT the
the NN pGEX
pGEX NN vector
vector , ,
, CC and
and DT a
a JJ recombinant
recombinant NN fusion
fusion NN protein
protein NN (
( NN CAPITAL EgCaBP1-GST
EgCaBP1-GST NN )
) VBD was
was VBN obtained

The DT CAPITAL The
The JJ recombinant
recombinant NN fusion
fusion NN protein
protein VBZ binds
binds NN calcium
calcium WRB when
when VBN assayed
assayed IN with
with NN 45Ca

It PRP CAPITAL It
It VBZ is
is JJ possible
possible IN that
that DT the
the JJ calcium-binding
calcium-binding NNS motifs
motifs JJ present
present DT a
a JJ secondary
secondary NN structure
structure JJ similar
similar TO to
to DT the
the NN parallel
parallel NN beta
beta NN roll
roll NN structure
structure VBN described
described IN for
for DT an
an NN alkaline
alkaline NN protease
protease IN from
from FW CAPITAL Pseudomonas
Pseudomonas FW aeruginosa

A DT CAPITAL A
A JJ native
native NN protein
protein IN of
of RBR more
more IN than
than CD 300
300 NN kDa
kDa VBD was
was VBN recognized
recognized IN by
by DT an
an JJ anti-EgCaBP1
anti-EgCaBP1 JJ monoclonal
monoclonal NN antibody
antibody IN by
by JJ CAPITAL Western-blot
Western-blot NN analysis

Immunohistochemistry NN CAPITAL Immunohistochemistry
Immunohistochemistry VBG using
using DT a
a NN pool
pool IN of
of JJ anti-EgCaBP1-GST
anti-EgCaBP1-GST NN mouse
mouse NNS sera
sera VBN demonstrated
demonstrated DT a
a JJ strong
strong NN association
association IN of
of DT the
the NN protein
protein IN with
with JJ calcareous
calcareous NNS corpuscles

The DT CAPITAL The
The JJ possible
possible NN role
role IN of
of DT this
this NN protein
protein CC and
and IN that
that IN of
of DT the
the JJ calcareous
calcareous NNS corpuscles
corpuscles IN in
in DT the
the NN protoscolex
protoscolex VBP are
are VBN discussed

The DT CAPITAL The
The NN enzyme
enzyme NN activity
activity IN of
of JJ mitogen-activated
mitogen-activated NN protein
protein NN kinase
kinase NN (
( NN CAPITAL MAP
MAP NN kinase
kinase NN )
) NNS increases
increases IN in
in NN response
response TO to
to NNS agents
agents VBG acting
acting IN on
on DT a
a NN variety
variety IN of
of NN cell
cell NN surface
surface NNS receptors
receptors , ,
, VBG including
including NNS receptors
receptors VBN linked
linked TO to
to JJ heterotrimeric
heterotrimeric NN CAPITAL G
G NNS proteins

In IN CAPITAL In
In DT this
this NN report
report , ,
, PRP we
we VBN demonstrated
demonstrated IN that
that NN CAPITAL Raf-1
Raf-1 NN protein
protein NN kinase
kinase NN activity
activity IN in
in DT the
the NN mouse
mouse NN parotid
parotid NNS glands
glands VBD was
was VBN induced
induced IN by
by JJ chronic
chronic NN isoproterenol
isoproterenol NN administration
administration IN in
in JJ whole
whole NNS animals

To TO CAPITAL To
To VB investigate
investigate DT the
the JJ molecular
molecular NN nature
nature VBG underlying
underlying JJ cellular
cellular NNS responses
responses TO to
to NN CAPITAL Raf-1
Raf-1 NN activation
activation , ,
, PRP we
we VB have
have RB stably
stably VBN transfected
transfected NN rat
rat JJ salivary
salivary JJ epithelial
epithelial NN CAPITAL Pa-4
Pa-4 NNS cells
cells IN with
with JJ human
human NN CAPITAL Raf-1-estrogen
Raf-1-estrogen NN receptor
receptor NN fusion
fusion NN gene
gene NN (
( NN CAPITAL DeltaRaf-1
DeltaRaf-1 : :
: NN CAPITAL ER
ER NN )
) CC and
and VBN used
used NN mRNA
mRNA JJ differential
differential NN display
display IN in
in NN search
search IN of
of NNS messages
messages VBN induced
induced IN by
by NN CAPITAL DeltaRaf-1
DeltaRaf-1 : :
: NN CAPITAL ER
ER NN activation

Through IN CAPITAL Through
Through DT this
this NN approach
approach , ,
, DT the
the NN gene
gene VBG encoding
encoding JJ non-histone
non-histone JJ chromosomal
chromosomal NN protein
protein NN CAPITAL HMGI-C
HMGI-C VBD was
was VBN identified
identified IN as
as CD one
one IN of
of DT the
the NN target
target NNS genes
genes VBN activated
activated IN by
by JJ oncogenic
oncogenic NN CAPITAL Raf-1
Raf-1 NN kinase

Activation NN CAPITAL Activation
Activation IN of
of NN CAPITAL Raf-1
Raf-1 NN kinase
kinase VBD resulted
resulted IN in
in DT a
a VBN delayed
delayed CC and
and JJ sustained
sustained NN increase
increase IN of
of NN CAPITAL HMGI-C
HMGI-C NN expression
expression IN in
in DT the
the NN CAPITAL Pa-4
Pa-4 NNS cells

The DT CAPITAL The
The NN induction
induction IN of
of NN CAPITAL HMGI-C
HMGI-C NN mRNA
mRNA NN level
level VBZ is
is JJ sensitive
sensitive TO to
to DT both
both DT the
the NN protein
protein NN synthesis
synthesis NN inhibitor
inhibitor NN cycloheximide
cycloheximide CC and
and NN transcription
transcription NN inhibitor
inhibitor NN actinomycin
actinomycin NN CAPITAL D

The DT CAPITAL The
The NN role
role IN of
of DT the
the JJ extracellular
extracellular JJ signal-related
signal-related NN kinase
kinase NN (
( NN CAPITAL ERK
ERK NN )
) NN signaling
signaling NN pathway
pathway IN in
in DT the
the NN CAPITAL HMGI-C
HMGI-C NN induction
induction VBD was
was VBN highlighted
highlighted IN by
by DT the
the NN result
result IN that
that DT the
the NN CAPITAL MAP
MAP NN kinase
kinase NN kinase
kinase NN (
( NN CAPITAL MEK
MEK NN )
) NN inhibitor
inhibitor , ,
, NN CAPITAL PD
PD CD 98059
98059 , ,
, VBN blocked
blocked NN CAPITAL DeltaRaf-1
DeltaRaf-1 : :
: JJ CAPITAL ER-
ER- CC and
and JJ 12-O-tetradecanoylphorbol-13-acetate-stimulated
12-O-tetradecanoylphorbol-13-acetate-stimulated NN CAPITAL HMGI-C
HMGI-C NN induction

Altogether RB CAPITAL Altogether
Altogether , ,
, DT these
these NNS findings
findings NN support
support DT the
the NN notion
notion IN that
that DT the
the NN CAPITAL Raf/MEK/ERK
Raf/MEK/ERK NN signaling
signaling NN module
module , ,
, IN at
at JJS least
least IN in
in NN part
part , ,
, VBZ regulates
regulates JJ transcriptional
transcriptional NN activation
activation IN of
of DT the
the JJ chromosomal
chromosomal JJ architectural
architectural NN protein
protein NN CAPITAL HMGI-C

Pendred NNP CAPITAL Pendred
Pendred NN syndrome
syndrome VBZ is
is DT a
a RB recessively
recessively VBN inherited
inherited NN disorder
disorder IN with
with DT the
the NN hallmark
hallmark NNS features
features IN of
of JJ congenital
congenital NN deafness
deafness CC and
and NN thyroid
thyroid NN goitre

By IN CAPITAL By
By DT some
some NNS estimates
estimates , ,
, DT the
the NN disorder
disorder MD may
may NN account
account IN for
for NNS upwards
upwards IN of
of CD 10
10 NN %
% IN of
of JJ hereditary
hereditary NN deafness

Previous JJ CAPITAL Previous
Previous JJ genetic
genetic NN linkage
linkage NNS studies
studies JJ localized
localized DT the
the NN gene
gene TO to
to DT a
a JJ broad
broad NN interval
interval IN on
on JJ human
human NN chromosome
chromosome NN 7q22-31.1

Using VBG CAPITAL Using
Using DT a
a JJ positional
positional VBG cloning
cloning NN strategy
strategy , ,
, PRP we
we VB have
have VBN identified
identified DT the
the NN gene
gene NN (
( NN CAPITAL PDS
PDS NN )
) VBN mutated
mutated IN in
in NNP CAPITAL Pendred
Pendred NN syndrome
syndrome CC and
and VBN found
found CD three
three RB apparently
apparently JJ deleterious
deleterious NNS mutations
mutations , ,
, DT each
each VBG segregating
segregating IN with
with DT the
the NN disease
disease IN in
in DT the
the JJ respective
respective NNS families
families IN in
in WDT which
which PRP they
they VB occur

PDS NN CAPITAL PDS
PDS VBZ produces
produces DT a
a NN transcript
transcript IN of
of RB approximately
approximately CD 5
5 NN kb
kb IN that
that VBD was
was VBN found
found TO to
to VB be
be VBN expressed
expressed IN at
at JJ significant
significant NNS levels
levels RB only
only IN in
in DT the
the NN thyroid

The DT CAPITAL The
The VBN predicted
predicted NN protein
protein , ,
, NN pendrin
pendrin , ,
, VBZ is
is RB closely
closely JJ related
related TO to
to DT a
a NN number
number IN of
of VBN known
known NN sulphate
sulphate NNS transporters

These DT CAPITAL These
These NNS studies
studies VB provide
provide JJ compelling
compelling NN evidence
evidence IN that
that NNS defects
defects IN in
in NN pendrin
pendrin NN cause
cause NNP CAPITAL Pendred
Pendred NN syndrome
syndrome RB thereby
thereby VBG launching
launching DT a
a JJ new
new NN area
area IN of
of NN investigation
investigation IN into
into NN thyroid
thyroid NN physiology
physiology , ,
, DT the
the NN pathogenesis
pathogenesis IN of
of JJ congenital
congenital NN deafness
deafness CC and
and DT the
the NN role
role IN of
of JJ altered
altered NN sulphate
sulphate NN transport
transport IN in
in JJ human
human NN disease

We PRP CAPITAL We
We NN report
report DT the
the NN cDNA
cDNA VBG cloning
cloning , ,
, JJ partial
partial JJ genomic
genomic NN organization
organization , ,
, CC and
and NN expression
expression NN pattern
pattern IN of
of NN CAPITAL Stra10
Stra10 , ,
, DT a
a JJ novel
novel JJ retinoic
retinoic JJ acid-inducible
acid-inducible NN gene
gene IN in
in NN CAPITAL P19
P19 JJ embryonal
embryonal NN carcinoma
carcinoma NNS cells

Four CD CAPITAL Four
Four JJ murine
murine NN cDNA
cDNA NNS isoforms
isoforms VB have
have VBN been
been VBN isolated
isolated , ,
, WDT which
which VBP are
are RB likely
likely TO to
to NN result
result IN from
from NN alternative
alternative NN splicing

The DT CAPITAL The
The VBN predicted
predicted NN protein
protein NNS sequences
sequences NN exhibit
exhibit RB approximately
approximately CD 85
85 NN %
% NN identity
identity IN with
with DT the
the JJ CAPITAL Pbx-related
Pbx-related NN CAPITAL Meis1
Meis1 NN homeobox
homeobox NN gene
gene NNS products
products , ,
, WDT which
which VBP are
are VBN involved
involved IN in
in JJ myeloid
myeloid NN leukemia
leukemia IN in
in NN CAPITAL BXH-2
BXH-2 NNS mice
mice , ,
, CC and
and CD one
one IN of
of DT the
the NN CAPITAL Stra10
Stra10 NNS isoforms
isoforms VBZ corresponds
corresponds TO to
to DT the
the RB recently
recently VBN published
published NN CAPITAL Meis2
Meis2 NN sequence
sequence NN (
( NNP CAPITAL Nakamura
Nakamura FW et
et NNP al
al . .
. NN (
( CD 1996
1996 NN )
) NN CAPITAL Oncogene
Oncogene CD 13
13 : :
: CD 2235-2242
2235-2242 NN )

The DT CAPITAL The
The NN CAPITAL Meis2
Meis2 NN homeodomain
homeodomain VBZ is
is JJ identical
identical TO to
to IN that
that IN of
of NN CAPITAL Meis1
Meis1 , ,
, CC and
and VBZ is
is RBS most
most RB closely
closely JJ related
related TO to
to DT those
those IN of
of DT the
the NN CAPITAL Pbx/TGIF
Pbx/TGIF NN homeobox
homeobox NN gene
gene NNS products

By IN CAPITAL By
By IN in
in FW situ
situ NN hybridization
hybridization NN analysis
analysis , ,
, PRP we
we NN show
show IN that
that DT the
the NN CAPITAL Meis2
Meis2 NN gene
gene NNS displays
displays RB spatially
spatially JJ restricted
restricted NN expression
expression NNS patterns
patterns IN in
in DT the
the VBG developing
developing JJ nervous
nervous NN system
system , ,
, NNS limbs
limbs , ,
, NN face
face , ,
, CC and
and IN in
in JJ various
various NN viscera

In IN CAPITAL In
In JJ adult
adult NNS mice
mice , ,
, NN CAPITAL Meis2
Meis2 VBZ is
is RB mainly
mainly VBN expressed
expressed IN in
in DT the
the NN brain
brain CC and
and NN female
female JJ genital
genital NN tract
tract , ,
, IN with
with DT a
a JJ different
different NN distribution
distribution IN of
of DT the
the NN alternative
alternative NN splice
splice NNS forms
forms IN in
in DT these
these NNS organs

A DT CAPITAL A
A JJ methodical
methodical NN strategy
strategy IN for
for DT the
the NN isolation
isolation IN of
of NN microsatellite
microsatellite NNS markers
markers JJ specific
specific IN for
for VBN targeted
targeted NNS regions
regions IN of
of JJ bovine
bovine NNS chromosomes
chromosomes VBZ is
is VBN presented

The DT CAPITAL The
The NN procedure
procedure VBZ involves
involves VBN directed
directed NN microdissection
microdissection IN of
of CD one
one VBN defined
defined JJ subchromosomal
subchromosomal NN area
area , ,
, PRP$ its
its NN CAPITAL DOP-PCR-amplification
DOP-PCR-amplification CC and
and VBG cloning

With IN CAPITAL With
With DT this
this NN approach
approach , ,
, DT a
a NN library
library JJ specific
specific TO to
to DT the
the NN CAPITAL BTA
BTA NN 6q21-31
6q21-31 JJ chromosomal
chromosomal NN region
region VBD was
was VBN constructed

Eleven CD CAPITAL Eleven
Eleven JJ unique
unique JJ microsatellite-containing
microsatellite-containing NNS sequences
sequences VBD were
were VBN isolated
isolated , ,
, VBN converted
converted IN into
into JJ sequence-tagged
sequence-tagged NN microsatellite
microsatellite NNS sites
sites , ,
, CC and
and VBN characterized
characterized VBG concerning
concerning PRP$ their
their JJ species-specific
species-specific NN origin

Seven CD CAPITAL Seven
Seven NN primer
primer NNS pairs
pairs VBN generated
generated JJ bovine-specific
bovine-specific NN CAPITAL PCR
PCR NNS products
products CC and
and VBN provided
provided DT a
a NN set
set IN of
of NN microsatellite
microsatellite NNS markers
markers IN that
that RB generally
generally VBD revealed
revealed JJ high
high NN informativity
informativity IN in
in DT the
the NN CAPITAL HF
HF NN breed

Linkage NN CAPITAL Linkage
Linkage NN analysis
analysis VBN assigned
assigned CD six
six IN of
of PRP them
them TO to
to PRP$ their
their VBN predefined
predefined JJ subchromosomal
subchromosomal NN origin
origin IN on
on NN CAPITAL BTA
BTA CD 6
6 VBG corresponding
corresponding TO to
to DT the
the JJ specific
specific NN rehybridization
rehybridization NN signal
signal IN of
of DT the
the NN CAPITAL DOP-PCR
DOP-PCR NN product
product VBN generated
generated IN from
from DT the
the VBN microdissected
microdissected NN chromosome
chromosome NN area
area NN 6q21-31

The DT CAPITAL The
The NNS results
results VB underline
underline DT the
the NN usefulness
usefulness IN of
of DT the
the NN CAPITAL BTA
BTA NN 6q21-31
6q21-31 NN library
library IN for
for VBN targeted
targeted NN isolation
isolation IN of
of JJ unique
unique NNS sequences
sequences IN that
that VBP are
are JJ specific
specific IN for
for DT the
the VBN dissected
dissected JJ chromosomal
chromosomal NN region
region IN as
as VBN demonstrated
demonstrated RB here
here IN by
by DT the
the NN isolation
isolation IN of
of NN microsatellite
microsatellite NNS markers

Phylogeographic JJ CAPITAL Phylogeographic
Phylogeographic NN structure
structure VBD was
was VBN determined
determined IN for
for DT the
the JJ yellow
yellow NN mongoose
mongoose , ,
, NNP CAPITAL Cynictis
Cynictis NN penicillata
penicillata , ,
, VBG using
using NN mtDNA
mtDNA NNS CAPITAL RFLPs
RFLPs CC and
and NN control
control NN region
region NNS sequences

The DT CAPITAL The
The NN CAPITAL RFLP
RFLP NN analysis
analysis VBD revealed
revealed CD 13
13 NNS haplotypes
haplotypes WDT which
which VBD showed
showed JJ weak
weak JJ geographical
geographical NN patterning
patterning JJ consistent
consistent IN with
with DT a
a JJ recent
recent NN range
range NN expansion
expansion IN from
from DT a
a JJ refugial
refugial NN population
population NN (
( NNS s
s NN )

An DT CAPITAL An
An NN analysis
analysis IN of
of JJ molecular
molecular NN variance
variance NN (
( NNP CAPITAL AMOVA
AMOVA NN )
) VBD revealed
revealed DT no
no NN correspondence
correspondence IN between
between NN mtDNA
mtDNA NN phylogeography
phylogeography CC and
and NNS subspecies
subspecies NN delimitation
delimitation , ,
, CC nor
nor IN between
between NNS matrilines
matrilines CC and
and NNS areas
areas VBN characterized
characterized IN by
by DT a
a JJ high
high NN incidence
incidence IN of
of DT the
the JJ viverrid-type
viverrid-type NNP rabies
rabies , ,
, IN of
of WDT which
which DT the
the JJ yellow
yellow NN mongoose
mongoose VBZ is
is DT the
the NN principal
principal NN vector

The DT CAPITAL The
The NN lack
lack IN of
of NN structure
structure VBD was
was RB also
also VBN shown
shown IN by
by NN control
control NN region
region NNS sequences
sequences IN although
although CD four
four IN of
of DT the
the JJ maternal
maternal NNS lineages
lineages VBN shared
shared DT a
a JJ near-perfect
near-perfect CD 81
81 NN bp
bp NN repeat

We PRP CAPITAL We
We VB speculate
speculate IN that
that JJ regional
regional JJ hot
hot NNS spots
spots IN of
of DT the
the NN viverrid
viverrid NNP rabies
rabies NN biotype
biotype VB reflect
reflect NN population
population NN density
density NNS differences
differences IN in
in DT the
the JJ yellow
yellow NN mongoose
mongoose IN that
that VBP are
are RB not
not VBN underscored
underscored IN by
by JJ genetic
genetic VBG partitioning
partitioning , ,
, IN at
at JJS least
least IN at
at DT the
the NN level
level IN of
of NN resolution
resolution VBN provided
provided IN by
by PRP$ our
our NNS analyses

The DT CAPITAL The
The JJ indoor
indoor NN pollution
pollution , ,
, WRB where
where DT the
the NNS patients
patients NN pass
pass IN in
in JJ general
general RB close
close TO to
to CD 90
90 NN %
% IN of
of PRP$ their
their NN time
time , ,
, VBZ is
is DT an
an JJ important
important NN factor
factor TO to
to VB take
take IN in
in NN consideration
consideration IN if
if CD one
one VBZ wants
wants TO to
to VB evaluate
evaluate RB suitably
suitably DT the
the NNS effects
effects IN of
of DT the
the NN air
air NN pollution
pollution IN on
on DT the
the NN health

Causes NNS CAPITAL Causes
Causes IN of
of DT this
this NN kind
kind IN of
of NN pollution
pollution VBP are
are RB partially
partially VBN linked
linked TO to
to DT the
the JJ external
external NN pollution
pollution CC and
and DT the
the JJ outdoor
outdoor NN environment
environment CC and
and RB also
also VBP are
are NN function
function IN of
of JJ human
human NNS activities
activities CC and
and VBN introduced
introduced NNS products
products IN in
in DT the
the NN habitat
habitat NN (
( NN heating
heating , ,
, NN tabagisme
tabagisme , ,
, NN handywork
handywork , ,
, NNS products
products IN of
of NN maintenance
maintenance , ,
, NNS coatings
coatings , ,
, NNS materials
materials IN of
of NN construction
construction , ,
, FW etc

) NN )

The DT CAPITAL The
The NNS effects
effects IN on
on NN health
health VBP are
are IN as
as JJ various
various IN as
as DT the
the NNS pollutants
pollutants , ,
, VBG going
going IN from
from JJ sharp
sharp NN intoxication
intoxication TO to
to NNS irritations
irritations CC or
or RB simply
simply NNS desagreements

In IN CAPITAL In
In DT this
this NN problem
problem IN of
of NN public
public NN health
health PRP we
we MD may
may RB not
not VBD underestimated
underestimated JJ sensitive
sensitive NNS persons
persons CC and
and JJ risky
risky NN group
group IN as
as RB well
well IN as
as RB long
long IN terme
terme NNS effects
effects , ,
, CC and
and JJ chronic
chronic NN exposition
exposition NNS effects

The DT CAPITAL The
The NN search
search IN of
of NNS solutions
solutions NNS needs
needs JJ multiple
multiple NNS competences
competences IN from
from DT the
the NN physician
physician , ,
, WP who
who VBZ has
has TO to
to NN play
play DT an
an JJ essential
essential NN role

Dioxins NNS CAPITAL Dioxins
Dioxins VBP are
are DT a
a NN family
family IN of
of VBN chlorinated
chlorinated JJ aromatic
aromatic NNS hydrocarbons
hydrocarbons IN that
that VBP are
are VBN produced
produced IN during
during NN combustion
combustion NNS processes
processes IN in
in DT the
the NN presence
presence IN of
of DT a
a NN chlorine
chlorine NN donor
donor CC and
and IN as
as NNS by-products
by-products IN of
of DT the
the NN chlorine-processing
chlorine-processing NN chemical
chemical NNS industries

Several JJ CAPITAL Several
Several NNS dioxins
dioxins VBP are
are RB extremely
extremely JJ stable
stable NNS compounds
compounds CC and
and VB persist
persist IN for
for NNS years
years IN in
in DT the
the NN environment

Exposure NN CAPITAL Exposure
Exposure TO to
to NNS dioxins
dioxins VBZ occurs
occurs RB mainly
mainly IN via
via DT the
the NN ingestion
ingestion IN of
of VBN contaminated
contaminated NN food

The DT CAPITAL The
The JJ lipophilic
lipophilic NN character
character IN of
of NNS dioxins
dioxins VBZ prevents
prevents PRP$ their
their NN excretion
excretion IN in
in DT the
the NN urine
urine CC and
and NNS causes
causes PRP$ their
their NN accumulation
accumulation IN in
in NN body
body NN fat

The DT CAPITAL The
The NNS mechanisms
mechanisms IN of
of NN dioxin
dioxin NN action
action VBP are
are JJ similar
similar TO to
to DT those
those IN of
of DT a
a NN hormone

Dioxins NNS CAPITAL Dioxins
Dioxins NN bind
bind TO to
to DT a
a JJ specific
specific JJ intracellular
intracellular NN receptor
receptor CC and
and DT the
the NN complex
complex NNS acts
acts IN as
as DT a
a NN transcription
transcription NN factor
factor IN that
that VBZ induces
induces DT the
the NN production
production IN of
of DT a
a JJ great
great NN number
number IN of
of NNS proteins

Certain JJ CAPITAL Certain
Certain NNS dioxins
dioxins , ,
, RB particularly
particularly CD 2
2 , ,
, CD 3
3 , ,
, CD 7
7 , ,
, NN 8-tetrachlorodibenzo-p-dioxin
8-tetrachlorodibenzo-p-dioxin , ,
, VBP are
are RB very
very JJ toxic
toxic CC and
and JJ able
able TO to
to VB induce
induce JJ numerous
numerous JJ clinical
clinical NNS conditions

The DT CAPITAL The
The NN carcinogenicity
carcinogenicity IN of
of NNS dioxins
dioxins VBZ is
is RB well
well VBN documented
documented IN in
in NN animal
animal NNS models
models CC and
and VBZ has
has VBN been
been VBN described
described IN in
in NNS humans
humans IN after
after JJ professional
professional CC and
and JJ accidental
accidental NNS exposures

Recent JJ CAPITAL Recent
Recent JJ experimental
experimental NNS data
data RB also
also VBP indicate
indicate IN that
that NNS dioxins
dioxins MD can
can NN cause
cause NN dysfunction
dysfunction IN of
of DT the
the JJ sexual
sexual CC and
and NN thyroid
thyroid NN hormone
hormone NNS systems
systems CC and
and IN that
that DT the
the NN administration
administration IN of
of NNS dioxins
dioxins VBZ induces
induces JJ several
several NNS conditions
conditions JJ related
related TO to
to JJ hormonal
hormonal NN dysfunction

Chronic JJ CAPITAL Chronic
Chronic NN exposure
exposure IN of
of NN female
female NN CAPITAL Rhesus
Rhesus NNS monkeys
monkeys NNS increases
increases DT the
the NN incidence
incidence CC and
and NN severity
severity IN of
of NN endometriosis

The DT CAPITAL The
The NN administration
administration IN of
of NNS dioxins
dioxins IN during
during NN pregnancy
pregnancy CC and
and NN nursing
nursing NNS causes
causes JJ altered
altered NN development
development IN of
of DT the
the JJ reproductive
reproductive NN system
system , ,
, VBN decreased
decreased NN spermatogenesis
spermatogenesis , ,
, NN hypothyroidism
hypothyroidism CC and
and JJ disturbed
disturbed NN psychomotor
psychomotor NN development
development IN in
in DT the
the NN offspring

The DT CAPITAL The
The JJ particular
particular NN sensibility
sensibility IN of
of DT the
the NN fetus
fetus CC and
and JJ newborn
newborn VBZ is
is IN of
of NN concern
concern IN because
because DT the
the NN exposition
exposition TO to
to NNS dioxins
dioxins VBZ is
is RB particularly
particularly JJ important
important IN during
during DT those
those NNS periods
periods IN of
of NN life

In IN CAPITAL In
In NNS humans
humans DT a
a NN series
series IN of
of NNS conditions
conditions JJ related
related TO to
to JJ hormonal
hormonal NN dysfunction
dysfunction IN as
as JJ undescended
undescended NN testis
testis , ,
, VBN decreased
decreased NN spermatogenesis
spermatogenesis , ,
, JJ testicular
testicular NN cancer
cancer CC and
and NN endometriosis
endometriosis VB have
have VBN increased
increased IN in
in NN incidence
incidence IN during
during DT the
the JJ last
last NNS decades

The DT CAPITAL The
The JJ chronological
chronological NN parallelism
parallelism IN with
with DT the
the NN appearance
appearance IN of
of NNS dioxins
dioxins IN in
in DT the
the NN environment
environment VBZ suggests
suggests IN that
that DT these
these MD might
might VB exert
exert JJ biological
biological NNS effects
effects IN at
at DT the
the VBG prevailing
prevailing NN level
level IN of
of NN exposure

Nevertheless RB CAPITAL Nevertheless
Nevertheless DT this
this NN hypothesis
hypothesis VBZ is
is RB currently
currently JJ unconfirmed
unconfirmed IN by
by JJ epidemiological
epidemiological NNS studies

The DT CAPITAL The
The NNS implications
implications IN of
of DT this
this JJ scientific
scientific NN incertitude
incertitude IN for
for DT the
the NN implementation
implementation IN of
of JJ preventive
preventive NNS measures
measures VBP are
are NN briefly
briefly VBN discussed

This DT CAPITAL This
This NN presentation
presentation VBZ summarizes
summarizes DT the
the NN debate
debate IN on
on DT the
the VBN suggested
suggested JJ progressive
progressive NN impairment
impairment IN of
of NN semen
semen NN quality
quality NN (
( DT the
the `` ``
`` NN sperm
sperm NN fall
fall '' ''
'' NN )
) IN in
in DT the
the JJ last
last CD forty
forty NNS years
years IN in
in DT the
the VBN developed
developed NNS countries

The DT CAPITAL The
The JJ various
various JJ available
available NNS data
data RB strongly
strongly VBG suggesting
suggesting DT an
an JJ environmental
environmental JJ toxic
toxic NN origin
origin IN for
for DT the
the `` ``
`` NN sperm
sperm NN fall
fall '' ''
'' MD will
will VB be
be VBN presented
presented IN as
as RB well
well IN as
as DT the
the RBS most
most RB frequently
frequently VBN suspected
suspected NN class
class IN of
of NNS substances
substances , ,
, DT the
the NNS xenoestrogens

Diabetes NNP CAPITAL Diabetes
Diabetes NN mellitus
mellitus VBZ is
is DT a
a RB still
still VBG growing
growing NN disease

New NNP CAPITAL New
New JJ diagnostic
diagnostic NNS criteria
criteria VBN lowered
lowered DT the
the NN cut
cut IN off
off NN value
value TO to
to CD 126
126 NN mg/dl
mg/dl , ,
, IN in
in NN order
order TO to
to VB detect
detect RBR more
more RB rapidly
rapidly NN diabetes
diabetes CC and
and PRP$ its
its NNS complications

The DT CAPITAL The
The NN treatment
treatment IN of
of NN diabetes
diabetes CD 2
2 IN by
by DT the
the JJ classic
classic JJ oral
oral JJ antidiabetic
antidiabetic NNS drugs
drugs NN (
( NNS sulfamides
sulfamides CC and
and NNS biguanides
biguanides NN )
) VBZ is
is VBN completed
completed IN by
by JJ intestinal
intestinal NNS glycosidases
glycosidases NNS inhibitors
inhibitors CC and
and NNS thiazolidendiones

These DT CAPITAL These
These JJ last
last NNS drugs
drugs VB seem
seem RB very
very JJ attractive
attractive IN because
because PRP they
they NN decrease
decrease NN insulin
insulin NN resistance
resistance IN in
in JJ obese
obese , ,
, NNS diabetics

Their PRP$ CAPITAL Their
Their JJ hepatic
hepatic NN side
side NNS effects
effects MD must
must VB be
be RB however
however IN under
under NN control

Better RBR CAPITAL Better
Better NN knowledge
knowledge IN of
of JJ non
non JJ lipidic
lipidic NNS effects
effects IN of
of NNS statins
statins IN on
on DT the
the JJ arterial
arterial NN wall
wall CC and
and DT the
the NN discovery
discovery IN of
of DT the
the NN action
action IN of
of NNS fibrates
fibrates IN on
on NN CAPITAL PPAR
PPAR NN (
( NN CAPITAL Peroxisome
Peroxisome NN CAPITAL Proliferator
Proliferator VBN CAPITAL Activated
Activated NNS CAPITAL Receptors
Receptors NN )
) VBN improved
improved RB strongly
strongly DT the
the JJ therapeutic
therapeutic NN management
management IN of
of NNS hyperlipidemias

Recent JJ CAPITAL Recent
Recent NN intervention
intervention NNS studies
studies VB have
have VBN demonstrated
demonstrated DT the
the NN necessity
necessity TO to
to NN treat
treat RB vigorously
vigorously NNS dysipidemias

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL Despite
Despite NN CAPITAL Beta-blockade
Beta-blockade NN therapy
therapy VBZ has
has VBN been
been VBN considered
considered IN as
as DT an
an JJ absolute
absolute NN contraindication
contraindication IN in
in DT the
the NN treatment
treatment IN of
of NN heart
heart NN failure
failure , ,
, PRP it
it VBZ has
has VBN been
been VBN shown
shown IN that
that PRP they
they MD could
could VB have
have DT a
a JJ beneficial
beneficial NN effect
effect , ,
, VBN provided
provided IN that
that PRP they
they VBD were
were VBN introduced
introduced IN at
at RB very
very JJ low
low NN dose
dose , ,
, CC and
and RB very
very RB progressively
progressively IN in
in NN addition
addition IN of
of DT the
the JJ traditional
traditional NN treatment

The DT CAPITAL The
The NNS advances
advances IN in
in DT the
the VBG understanding
understanding IN of
of DT the
the JJ neuro-hormonal
neuro-hormonal NNS mechanisms
mechanisms IN of
of NN heart
heart NN failure
failure VB have
have VBN modified
modified DT the
the JJ therapeutic
therapeutic NN strategy
strategy : :
: DT the
the JJ deleterious
deleterious NN effect
effect IN of
of DT the
the NN activation
activation IN of
of DT the
the JJ sympathetic
sympathetic JJ nervous
nervous NN system
system IN on
on DT the
the NN myocardium
myocardium VBZ has
has VBD served
served IN as
as DT the
the NN rationale
rationale IN for
for VBN randomized
randomized JJ clinical
clinical NNS trials
trials VBG comparing
comparing NN beta-blockade
beta-blockade TO to
to NN placebo
placebo : :
: DT the
the JJ current
current NNS data
data VBP are
are VBG promising
promising , ,
, VBG suggesting
suggesting DT a
a JJ beneficial
beneficial NN effect
effect IN on
on NN survival
survival IN as
as RB well
well IN as
as IN on
on NN quality
quality IN of
of NN life

However RB CAPITAL However
However , ,
, DT these
these NNS results
results VB have
have TO to
to VB be
be VBN confirmed
confirmed IN by
by JJR larger
larger NNS trials
trials , ,
, RB currently
currently NN underway
underway , ,
, IN before
before TO to
to VB consider
consider IN that
that NN beta-blockade
beta-blockade MD should
should RB definitely
definitely VB be
be VBN incorporated
incorporated IN in
in DT the
the NN treatment
treatment IN of
of NN heart
heart NN failure

Calcium NN CAPITAL Calcium
Calcium NNS antagonists
antagonists VB have
have VBN been
been VBN used
used IN for
for NN treatment
treatment IN of
of JJ cardiovascular
cardiovascular NNS diseases
diseases IN for
for RBR more
more IN than
than CD 25
25 NNS years

Several JJ CAPITAL Several
Several JJ recent
recent NN retrospective
retrospective NNS studies
studies VB have
have VBN suggested
suggested IN that
that JJ chronic
chronic NN treatment
treatment IN with
with JJ short-acting
short-acting NNS dihydropyridines
dihydropyridines VBN increased
increased DT the
the NN incidence
incidence IN of
of JJ cardiac
cardiac NNS events
events , ,
, NN cancer
cancer CC and
and JJ gastrointestinal
gastrointestinal NNS bleedings

Randomized VBN CAPITAL Randomized
Randomized JJ prospective
prospective NNS studies
studies VB have
have , ,
, RB however
however , ,
, RB never
never VBN been
been JJ able
able TO to
to VB confirm
confirm DT these
these NNS observations

In IN CAPITAL In
In NN addition
addition , ,
, JJ well-conducted
well-conducted NNS studies
studies VBG using
using NN verapamil
verapamil CC and
and NN diltiazem
diltiazem VB have
have VBN suggested
suggested IN that
that DT these
these NN calcium
calcium NNS antagonists
antagonists MD may
may RB even
even VB improve
improve JJ cardiovascular
cardiovascular NN mortality
mortality CC and
and NN morbidity
morbidity IN of
of DT the
the JJ hypertensive
hypertensive NN patient

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> EX CAPITAL There
There VBZ is
is RB therefore
therefore DT no
no NN reason
reason TO to
to VB believe
believe IN that
that DT the
the JJ questionable
questionable NNS results
results VBN derived
derived IN from
from NN retrospective
retrospective NNS studies
studies IN of
of DT the
the NNS effects
effects IN of
of JJ short-acting
short-acting NN calcium
calcium NNS antagonists
antagonists IN on
on JJ cardiac
cardiac CC and
and JJ noncardiac
noncardiac NNS events
events MD may
may VB apply
apply TO to
to DT the
the JJR newer
newer NN generation
generation IN of
of JJ long-acting
long-acting NN calcium
calcium NNS antagonists

Sumatriptan NNP CAPITAL Sumatriptan
Sumatriptan CC and
and JJ other
other JJ selective
selective NN serotonin
serotonin NNS agonists
agonists VB represent
represent DT a
a JJ major
major NN breakthrough
breakthrough IN in
in JJ acute
acute NN migraine
migraine NN treatment

These DT CAPITAL These
These NNS drugs
drugs VBP are
are RB very
very JJ efficacious
efficacious CC and
and RB generally
generally VBN devoided
devoided IN of
of JJ important
important NN side
side NNS effects
effects , ,
, CC but
but PRP they
they VBP are
are JJ expensive
expensive CC and
and RB therefore
therefore VB have
have TO to
to VB be
be VBN compared
compared IN with
with JJ other
other , ,
, RBR more
more JJ conventional
conventional NNS drugs
drugs IN with
with VBN established
established CC or
or VBN assumed
assumed NN efficacy

We PRP CAPITAL We
We VB summarize
summarize DT the
the JJ pharmacologic
pharmacologic NNS characteristics
characteristics IN of
of NNP CAPITAL Sumatriptan
Sumatriptan CC and
and VB give
give NNS recommendations
recommendations IN about
about PRP$ its
its NN use
use IN in
in JJ clinical
clinical NN practice

Fiercer JJR CAPITAL Fiercer
Fiercer NN competition
competition IN between
between NNS athletes
athletes CC and
and DT a
a JJR wider
wider NN knowledge
knowledge IN of
of JJ optimal
optimal NN training
training NNS regimens
regimens RB dramatically
dramatically NN influence
influence JJ current
current NN training
training NNS methods

A DT CAPITAL A
A JJ single
single NN training
training NN bout
bout IN per
per NN day
day VBD was
was RB previously
previously VBN considered
considered JJ sufficient
sufficient , ,
, IN whereas
whereas NN today
today NNS athletes
athletes RB regularly
regularly NN train
train RB twice
twice DT a
a NN day
day CC or
or RBR more

Consequently RB CAPITAL Consequently
Consequently , ,
, DT the
the NN number
number IN of
of NNS athletes
athletes WP who
who VBP are
are VBG overtraining
overtraining CC and
and VB have
have JJ insufficient
insufficient NN rest
rest VBZ is
is VBG increasing

Positive JJ CAPITAL Positive
Positive VBG overtraining
overtraining MD can
can VB be
be VBN regarded
regarded IN as
as DT a
a JJ natural
natural NN process
process WRB when
when DT the
the NN end
end NN result
result VBZ is
is NN adaptation
adaptation CC and
and VBN improved
improved NN performance
performance : :
: DT the
the NN supercompensation
supercompensation NN principle
principle : --
-- WDT which
which VBZ includes
includes DT the
the NN breakdown
breakdown NN process
process NN (
( NN training
training NN )
) VBN followed
followed IN by
by DT the
the NN recovery
recovery NN process
process NN (
( NN rest
rest NN )
) : --
-- VBZ is
is RB well
well VBN known
known IN in
in NNS sports

However RB CAPITAL However
However , ,
, JJ negative
negative VBG overtraining
overtraining , ,
, VBG causing
causing NN maladaptation
maladaptation CC and
and JJ other
other JJ negative
negative NNS consequences
consequences JJ such
such IN as
as NN staleness
staleness , ,
, MD can
can VB occur

Physiological JJ CAPITAL Physiological
Physiological , ,
, JJ psychological
psychological , ,
, JJ biochemical
biochemical CC and
and JJ immunological
immunological NNS symptoms
symptoms MD must
must VB be
be VBN considered
considered , ,
, DT both
both RB independently
independently CC and
and RB together
together , ,
, TO to
to RB fully
fully VB understand
understand DT the
the NN 'staleness
'staleness '' '
' NN syndrome

However RB CAPITAL However
However , ,
, JJ psychological
psychological NN testing
testing MD may
may VB reveal
reveal JJ early-warning
early-warning NNS signs
signs RBR more
more RB readily
readily IN than
than DT the
the JJ various
various JJ physiological
physiological CC or
or JJ immunological
immunological NNS markers

The DT CAPITAL The
The NN time
time NN frame
frame IN of
of NN training
training CC and
and NN recovery
recovery VBZ is
is RB also
also JJ important
important IN since
since DT the
the NNS consequences
consequences IN of
of JJ negative
negative VBG overtraining
overtraining VBP comprise
comprise DT an
an NN overtraining-response
overtraining-response NN continuum
continuum IN from
from RB short
short TO to
to RB long
long NN term
term NNS effects

An DT CAPITAL An
An NN athlete
athlete VBG failing
failing TO to
to VB recover
recover IN within
within CD 72
72 NNS hours
hours VBZ has
has RB presumably
presumably RB negatively
negatively VBN overtrained
overtrained CC and
and VBZ is
is IN in
in DT an
an VBD overreached
overreached NN state

For IN CAPITAL For
For DT an
an NN elite
elite NN athlete
athlete TO to
to NN refrain
refrain IN from
from NN training
training IN for
for JJR >
> CD 72
72 NNS hours
hours VBZ is
is RB extremely
extremely JJ undesirable
undesirable , ,
, VBG highlighting
highlighting DT the
the NN importance
importance IN of
of DT a
a RB carefully
carefully VBN monitored
monitored NN recovery
recovery NN process

There EX CAPITAL There
There VBP are
are JJ many
many NNS methods
methods VBN used
used TO to
to NN measure
measure DT the
the NN training
training NN process
process CC but
but JJ few
few IN with
with WDT which
which TO to
to NN match
match DT the
the NN recovery
recovery NN process
process IN against
against PRP it

One CD CAPITAL One
One JJ such
such NN framework
framework IN for
for DT this
this VBZ is
is VBN referred
referred TO to
to IN as
as DT the
the NN total
total NN quality
quality NN recovery
recovery NN (
( NN CAPITAL TQR
TQR NN )
) NN process

By IN CAPITAL By
By VBG using
using DT a
a NN CAPITAL TQR
TQR NN scale
scale , ,
, VBN structured
structured IN around
around DT the
the NN scale
scale VBN developed
developed IN for
for NNS ratings
ratings IN of
of VBN perceived
perceived NN exertion
exertion NN (
( NN CAPITAL RPE
RPE NN )
) , ,
, DT the
the NN recovery
recovery NN process
process MD can
can VB be
be VBN monitored
monitored CC and
and VBN matched
matched IN against
against DT the
the NN breakdown
breakdown NN (
( NN training
training NN )
) NN process
process NN (
( NN CAPITAL TQR
TQR CC versus
versus NN CAPITAL RPE
RPE NN )

The DT CAPITAL The
The NN CAPITAL TQR
TQR NN scale
scale VBZ emphasises
emphasises DT both
both DT the
the NN athlete
athlete POS 's
's NN perception
perception IN of
of NN recovery
recovery CC and
and DT the
the NN importance
importance IN of
of JJ active
active NNS measures
measures TO to
to VB improve
improve DT the
the NN recovery
recovery NN process

Furthermore RB CAPITAL Furthermore
Furthermore , ,
, VBG directing
directing NN attention
attention TO to
to JJ psychophysiological
psychophysiological NNS cues
cues VBZ serves
serves DT the
the JJ same
same NN purpose
purpose IN as
as IN in
in NN CAPITAL RPE
RPE , ,
, NN i.e
i.e . .
. VBG increasing
increasing NN self-awareness

This DT CAPITAL This
This NN article
article NNS reviews
reviews CC and
and NNS conceptualises
conceptualises DT the
the JJ whole
whole VBG overtraining
overtraining NN process

In IN CAPITAL In
In VBG doing
doing RB so
so , ,
, PRP it
it NN (
( LS i
i NN )
) NNS aims
aims TO to
to VB differentiate
differentiate IN between
between DT the
the NNS types
types IN of
of NN stress
stress VBG affecting
affecting DT an
an NN athlete
athlete POS 's
's NN performance
performance : :
: NN (
( LS ii
ii NN )
) VBZ identifies
identifies NNS factors
factors VBG influencing
influencing DT an
an NN athlete
athlete POS 's
's NN ability
ability TO to
to VB adapt
adapt TO to
to JJ physical
physical NN training
training : :
: NN (
( LS iii
iii NN )
) NNS structures
structures DT the
the NN recovery
recovery NN process

The DT CAPITAL The
The NN CAPITAL TQR
TQR NN method
method TO to
to VB facilitate
facilitate VBG monitoring
monitoring IN of
of DT the
the NN recovery
recovery NN process
process VBZ is
is RB then
then VBN suggested
suggested CC and
and DT a
a JJ conceptual
conceptual NN model
model IN that
that VBZ incorporates
incorporates DT all
all IN of
of DT the
the JJ important
important NNS parameters
parameters IN for
for NN performance
performance NN gain
gain NN (
( NN adaptation
adaptation NN )
) CC and
and NN loss
loss NN (
( NN maladaptation
maladaptation NN )

Little JJ CAPITAL Little
Little NN attention
attention VBZ has
has VBN been
been VBN directed
directed IN toward
toward VBG identifying
identifying DT the
the NNS changes
changes WDT which
which VB occur
occur IN in
in JJ salivary
salivary NN composition
composition IN in
in NN response
response TO to
to NN exercise

To TO CAPITAL To
To NN address
address DT this
this , ,
, PRP$ our
our NN article
article RB first
first VBZ refers
refers TO to
to DT the
the JJ main
main NNS aspects
aspects IN of
of JJ salivary
salivary NN gland
gland NN physiology

A DT CAPITAL A
A NN knowledge
knowledge IN of
of DT the
the JJ neural
neural NN control
control IN of
of JJ salivary
salivary NN secretion
secretion VBZ is
is RB especially
especially JJ important
important IN for
for DT the
the VBG understanding
understanding IN of
of DT the
the NNS effects
effects IN of
of NN exertion
exertion IN on
on JJ salivary
salivary NN secretion

Both DT CAPITAL Both
Both JJ salivary
salivary NN output
output CC and
and NN composition
composition VB depend
depend IN on
on DT the
the NN activity
activity IN of
of DT the
the JJ autonomic
autonomic JJ nervous
nervous NN system
system CC and
and DT any
any NN modification
modification IN of
of DT this
this NN activity
activity MD can
can VB be
be VBN observed
observed RB indirectly
indirectly IN by
by NNS alternations
alternations IN in
in DT the
the JJ salivary
salivary NN excretion

The DT CAPITAL The
The NNS effects
effects IN of
of JJ physical
physical NN activity
activity NN (
( IN with
with NN reference
reference TO to
to NNS factors
factors JJ such
such IN as
as NN exercise
exercise NN intensity
intensity CC and
and NN duration
duration , ,
, CC or
or NN type
type IN of
of NN exercise
exercise NN protocol
protocol NN )
) IN on
on JJ salivary
salivary NN composition
composition VBP are
are RB then
then VBN considered

Exercise NN CAPITAL Exercise
Exercise MD might
might RB indeed
indeed VB induce
induce NNS changes
changes IN in
in JJ several
several JJ salivary
salivary NNS components
components JJ such
such IN as
as NNS immunoglobulins
immunoglobulins , ,
, NNS hormones
hormones , ,
, NN lactate
lactate , ,
, NNS proteins
proteins CC and
and NNS electrolytes

Saliva FW CAPITAL Saliva
Saliva NN composition
composition MD might
might RB therefore
therefore VB be
be VBN used
used IN as
as DT an
an NN alternative
alternative JJ noninvasive
noninvasive NN indicator
indicator IN of
of DT the
the NN response
response IN of
of DT the
the JJ different
different NN body
body NNS tissues
tissues CC and
and NNS systems
systems TO to
to JJ physical
physical NN exertion

In IN CAPITAL In
In DT this
this NN respect
respect , ,
, DT the
the NN response
response IN of
of JJ salivary
salivary NN amylase
amylase CC and
and JJ salivary
salivary NNS electrolytes
electrolytes TO to
to JJ incremental
incremental NNS levels
levels IN of
of NN exercise
exercise VBZ is
is IN of
of JJ particular
particular NN interest

Beyond IN CAPITAL Beyond
Beyond DT a
a JJ certain
certain NN intensity
intensity IN of
of NN exercise
exercise , ,
, CC and
and VBG coinciding
coinciding IN with
with DT the
the NN accumulation
accumulation IN of
of NN blood
blood NN lactate
lactate NN (
( JJ anaerobic
anaerobic NN threshold
threshold CC or
or IN CAPITAL AT
AT NN )
) , ,
, DT a
a NN 'saliva
'saliva NN threshold
threshold '' '
' NN (
( NN CAPITAL Tsa
Tsa NN )
) VBZ does
does RB indeed
indeed VB exist

Tsa NN CAPITAL Tsa
Tsa VBZ is
is DT the
the NN point
point IN during
during NN exercise
exercise IN at
at WDT which
which DT the
the NNS levels
levels IN of
of JJ salivary
salivary NN alpha-amylase
alpha-amylase CC and
and NNS electrolytes
electrolytes NN (
( RB especially
especially NN CAPITAL Na+
Na+ NN )
) RB also
also VB begin
begin TO to
to NN rise
rise IN above
above NN baseline
baseline NNS levels

The DT CAPITAL The
The NN occurrence
occurrence IN of
of DT the
the CD 2
2 NNS thresholds
thresholds NN (
( IN CAPITAL AT
AT CC and
and NN CAPITAL Tsa
Tsa NN )
) MD might
might , ,
, IN in
in NN turn
turn , ,
, VB be
be JJ attributable
attributable TO to
to DT the
the JJ same
same VBG underlying
underlying NN mechanism
mechanism , ,
, IN that
that IN of
of VBN increased
increased JJ adrenal
adrenal JJ sympathetic
sympathetic NN activity
activity IN at
at JJ high
high NN exercise
exercise NNS intensities

Fat NNP CAPITAL Fat
Fat VBZ is
is DT an
an RB extremely
extremely JJ important
important NN substrate
substrate IN for
for NN muscle
muscle NN contraction
contraction , ,
, DT both
both IN at
at NN rest
rest CC and
and IN during
during NN exercise

Triglycerides NNS CAPITAL Triglycerides
Triglycerides NN (
( NNS CAPITAL TGs
TGs NN )
) , ,
, VBN stored
stored IN in
in NN adipose
adipose NN tissue
tissue CC and
and IN within
within NN muscle
muscle NNS fibres
fibres , ,
, VBP are
are VBN considered
considered TO to
to VB be
be DT the
the JJ main
main NN source
source IN of
of DT the
the JJ free
free NN fatty
fatty NNS acids
acids NN (
( NNS CAPITAL FFAs
FFAs NN )
) VBN oxidised
oxidised IN during
during NN exercise

It PRP CAPITAL It
It VBZ is
is RB still
still JJ unclear
unclear , ,
, RB however
however , ,
, WRB how
how DT the
the NN use
use IN of
of DT these
these NNS substrates
substrates VBZ is
is VBN regulated
regulated IN during
during NN exercise

The DT CAPITAL The
The NN regulation
regulation VBZ seems
seems TO to
to VB be
be JJ multifactorial
multifactorial CC and
and VBZ includes
includes : :
: NN (
( LS i
i NN )
) JJ dietary
dietary CC and
and JJ nutritional
nutritional NN status
status : ;
; NN (
( LS ii
ii NN )
) JJ hormonal
hormonal NN milieu
milieu : ;
; NN (
( LS iii
iii NN )
) NN exercise
exercise NN mode
mode , ,
, NN intensity
intensity CC and
and NN duration
duration : ;
; CC and
and NN (
( NN iv
iv NN )
) NN training
training NN status

On IN CAPITAL On
On DT the
the JJ other
other NN hand
hand , ,
, DT the
the NN mechanism
mechanism IN for
for SYM CAPITAL FFA
FFA NN transport
transport IN from
from PRP$ its
its NN storage
storage IN as
as NNS triglycerides
triglycerides IN in
in NN adipose
adipose NN tissue
tissue CC and
and NN muscle
muscle TO to
to PRP$ its
its NN place
place IN of
of NN utilisation
utilisation IN in
in NN heart
heart , ,
, JJ skeletal
skeletal NN muscle
muscle , ,
, NN kidney
kidney CC and
and NN liver
liver VBZ is
is RBR more
more RB clearly
clearly VBN understood

It PRP CAPITAL It
It VBZ has
has VBN been
been VBN determined
determined IN that
that DT the
the NN plasma
plasma SYM CAPITAL FFA
FFA NN turnover
turnover NN rate
rate VBZ is
is RB sufficiently
sufficiently JJ rapid
rapid TO to
to NN account
account IN for
for RBS most
most IN of
of DT the
the NN fat
fat VBN metabolised
metabolised IN during
during JJ low
low NN intensity
intensity NN exercise
exercise NN (
( CD 25
25 TO to
to CD 40
40 NN %
% NN CAPITAL VO2max
VO2max NN )

However RB CAPITAL However
However , ,
, DT an
an NN exercise
exercise NN intensity
intensity IN of
of CD 65
65 NN %
% NN CAPITAL VO2max
VO2max NNS results
results IN in
in DT a
a JJ slight
slight NN decrease
decrease IN in
in DT the
the NN amount
amount IN of
of NN plasma
plasma SYM CAPITAL FFA
FFA NN uptake
uptake IN by
by NN muscle
muscle NN tissue

Other JJ CAPITAL Other
Other NNS studies
studies VB have
have VBN found
found IN that
that IN during
during JJ prolonged
prolonged NN exercise
exercise , ,
, NN muscle
muscle NNS CAPITAL TGs
TGs VB become
become DT the
the JJ predominant
predominant NN source
source IN of
of NN energy
energy VBN obtained
obtained IN from
from NN fat

Furthermore RB CAPITAL Furthermore
Furthermore , ,
, PRP it
it VBZ is
is RB widely
widely VBN documented
documented IN that
that JJ endurance
endurance NNS activities
activities NN increase
increase DT the
the NN energy
energy NN utilisation
utilisation IN from
from NN fat
fat IN while
while VBG sparing
sparing NN carbohydrate
carbohydrate NNS sources

For IN CAPITAL For
For NN example
example , ,
, IN during
during NN exercise
exercise IN on
on DT a
a NN cycle
cycle NN ergometer
ergometer , ,
, NN nonplasma
nonplasma NNS CAPITAL FFAs
FFAs CC and
and NN plasma
plasma NNS CAPITAL FFAs
FFAs VB contribute
contribute CD 40
40 NN %
% , ,
, CC and
and NNS carbohydrates
carbohydrates CD 60
60 NN %
% , ,
, IN of
of DT the
the NN total
total VBN calculated
calculated NN amount
amount IN of
of NN energy
energy NN expenditure
expenditure IN before
before NN exercise
exercise CC and
and NN vice
vice RB versa
versa IN after
after NN exercise
exercise NN (
( CD 60
60 NN %
% NN nonplasma
nonplasma CC and
and NN plasma
plasma NNS CAPITAL FFAs
FFAs CC and
and CD 40
40 NN %
% NNS carbohydrates
carbohydrates NN )

Although IN CAPITAL Although
Although PRP it
it VBD was
was JJ many
many NNS years
years IN before
before PRP it
it VBD was
was RB fully
fully VBN demonstrated
demonstrated , ,
, NN fat
fat VBZ is
is RB now
now VBN known
known TO to
to VB be
be VBN transported
transported IN in
in DT the
the NN blood
blood IN as
as SYM CAPITAL FFA
FFA VBN bound
bound TO to
to DT the
the NN protein
protein NN carrier
carrier NN albumin

The DT CAPITAL The
The NN mobilisation
mobilisation IN of
of SYM CAPITAL FFA
FFA VBZ is
is RB primarily
primarily DT a
a NN function
function IN of
of JJ sympathetic
sympathetic JJ nervous
nervous NN activity
activity VBN directed
directed IN towards
towards DT the
the NNS adipocytes
adipocytes , ,
, CC or
or DT the
the NN 'fat
'fat NN pad
pad '' '
' . .
. DT CAPITAL This
This JJ nervous
nervous NN activity
activity MD can
can VB be
be JJ direct
direct CC or
or MD may
may VB be
be DT an
an NN effect
effect IN of
of VBG circulating
circulating NNS catecholamines
catecholamines JJ such
such IN as
as NN adrenaline
adrenaline NN (
( NN epinephrine
epinephrine NN )

This DT CAPITAL This
This NN article
article VBZ summarises
summarises DT the
the NN role
role IN of
of NN fat
fat NN metabolism
metabolism IN during
during NN exercise

As IN CAPITAL As
As DT the
the JJ clinical
clinical NN availability
availability IN of
of NN glycohaemoglobin/GHb
glycohaemoglobin/GHb NN measurement
measurement NNS increases
increases , ,
, RB so
so VBZ does
does DT the
the NN need
need IN for
for JJ comparable
comparable CC and
and JJ accurate
accurate NNS values
values IN among
among JJ different
different NNS laboratories
laboratories CC and
and JJ different
different NNS methods

At IN CAPITAL At
At JJS least
least RB there
there MD should
should VB be
be NN comparability
comparability , ,
, NN i.e
i.e . .
. , ,
, NN commutability
commutability CC or
or NN feasibility
feasibility IN of
of VBG providing
providing JJ comparable
comparable NNS results
results IN from
from JJ different
different NNS assays
assays IN in
in JJ different
different NNS laboratories

A DT CAPITAL A
A JJ clinical
clinical NN joint
joint NN study
study IN on
on NN insulin
insulin NN therapy
therapy , ,
, DT a
a NN survey
survey IN of
of DT the
the JJ actual
actual JJ inter-laboratory
inter-laboratory NNS differences
differences IN in
in NN CAPITAL GHb
GHb NN measurement
measurement IN among
among CD 41
41 NNS institutions
institutions CC and
and DT an
an NN assessment
assessment IN of
of CD 11
11 NN assay
assay NNS methods
methods IN for
for DT the
the NN determination
determination IN of
of NN CAPITAL GHb
GHb VBD were
were VBN performed
performed VBG using
using JJ commercial
commercial NNS calibrators
calibrators CC and
and JJ fresh
fresh NN blood
blood NNS samples

Data NNS CAPITAL Data
Data IN on
on DT the
the JJ actual
actual NN state
state IN of
of JJ inter-laboratory
inter-laboratory CC and
and NN inter-assay
inter-assay NNS differences
differences IN of
of VBN observed
observed NNS values
values VBD were
were JJ useful
useful IN for
for VBG comparing
comparing NNS results
results IN among
among NNS facilities

The DT CAPITAL The
The NN recommendation
recommendation IN of
of DT the
the NNP CAPITAL Japan
Japan NNP CAPITAL Diabetes
Diabetes NNP CAPITAL Society
Society TO to
to NN measure
measure RB only
only DT the
the JJ stable
stable NN CAPITAL GHb
GHb NN component
component CC and
and TO to
to JJ correct
correct DT the
the NN CAPITAL GHb
GHb NN percentage
percentage IN by
by JJ two-point
two-point NN calibration
calibration IN with
with VBN assigned
assigned NNS values
values , ,
, VBD was
was JJ effective
effective CC but
but RB not
not JJ sufficient

Even RB CAPITAL Even
Even IN after
after NN correction
correction , ,
, CD 8
8 IN out
out IN of
of CD 11
11 NNS methods
methods RB still
still VBD remained
remained IN of
of RB little
little JJ practical
practical NN use
use IN because
because IN of
of PRP$ their
their JJ large
large JJ relative
relative NNS errors

Inter-method NN CAPITAL Inter-method
Inter-method NNS differences
differences IN among
among CD 11
11 JJ available
available NN assay
assay NNS methods
methods VBD were
were JJ great
great RB even
even IN after
after NN correction
correction CC and
and VBD depended
depended IN on
on RB not
not RB only
only DT the
the NNS methods
methods CC but
but DT the
the NNS samples
samples VBN used
used IN for
for DT the
the NN determination

The DT CAPITAL The
The NN performance
performance IN of
of DT some
some NNS methods
methods CC or
or NNS instruments
instruments VBN used
used VBP are
are RB only
only JJ poor
poor IN at
at VBG distinguishing
distinguishing DT the
the JJ stable
stable VBN glycated
glycated NN haemoglobin
haemoglobin PRP itself

Some DT CAPITAL Some
Some NN alternative
alternative NN measurement
measurement NN system
system IN with
with NN comparability
comparability , ,
, NN commutability
commutability CC and
and NN precision
precision MD should
should VB be
be VBN established

An DT CAPITAL An
An JJ urgent
urgent CC and
and RB worldwide
worldwide NN problem
problem TO to
to VB remove
remove JJ inter-laboratory
inter-laboratory NNS differences
differences IN in
in DT the
the NN measurement
measurement IN of
of NN CAPITAL GHb
GHb NNS needs
needs TO to
to VB be
be VBD solved

Users NNS CAPITAL Users
Users IN in
in JJ clinical
clinical NN practice
practice MD must
must VB recognize
recognize DT these
these NNS problems
problems , ,
, CC and
and , ,
, IN before
before NN supply
supply , ,
, DT the
the NNS providers
providers MD should
should NN check
check PRP$ their
their NN method
method CC and
and VB keep
keep NNS records
records IN that
that VBP are
are RB readily
readily JJ traceable

A DT CAPITAL A
A JJ postal
postal NN survey
survey VBD was
was VBN performed
performed TO to
to VB determine
determine DT the
the JJ current
current NNS practices
practices CC and
and NNS attitudes
attitudes IN of
of NNS radiologists
radiologists IN towards
towards DT the
the NN imaging
imaging IN of
of VBN suspected
suspected JJR lower
lower NN limb
limb RB deep
deep NN vein
vein NN thrombosis
thrombosis NN (
( NN CAPITAL DVT
DVT NN )

One CD CAPITAL One
One CD hundred
hundred CC and
and CD twenty-seven
twenty-seven NNS departments
departments VBD responded
responded TO to
to DT a
a NN questionnaire
questionnaire VBN sent
sent IN in
in NNP CAPITAL March
March CD 1996

The DT CAPITAL The
The NNS results
results NN show
show IN that
that CD 87
87 NN %
% IN of
of NNS hospitals
hospitals VB possess
possess NN colour
colour NNP CAPITAL Doppler
Doppler NN ultrasound
ultrasound NN (
( NN CAPITAL CDUS
CDUS NN )
) NNS machines
machines CC and
and IN that
that CD 46
46 NN %
% IN of
of NNS departments
departments VB perform
perform NN ultrasound
ultrasound IN as
as DT the
the RB first
first NN line
line NN investigation
investigation IN in
in IN over
over CD 90
90 NN %
% IN of
of NNS cases

Thirty CD CAPITAL Thirty
Thirty IN per
per NN cent
cent IN of
of NNS departments
departments VBN considered
considered NN calf
calf NN vein
vein NN visualization
visualization TO to
to VB be
be RB generally
generally JJ adequate
adequate CC and
and CD 34
34 NN %
% NN thought
thought IN that
that NNS clinicians
clinicians IN in
in PRP$ their
their NNS hospitals
hospitals RB invariably
invariably JJ anticoagulated
anticoagulated NNS patients
patients IN with
with VBN isolated
isolated NN calf
calf NN thrombus

In IN CAPITAL In
In NNS hospitals
hospitals WRB where
where NN venography
venography VBD was
was RB routinely
routinely VBN used
used IN as
as DT the
the RB first
first NN line
line NN investigation
investigation , ,
, DT the
the RBS most
most JJ common
common NNS reasons
reasons VBD were
were : :
: DT the
the VBN perceived
perceived NN inferiority
inferiority IN of
of NN ultrasound
ultrasound NN (
( NNP CAPITAL US
US NN )
) IN in
in VBG demonstrating
demonstrating NN below-knee
below-knee NNS clot
clot , ,
, PRP$ its
its JJ time-consuming
time-consuming NN nature
nature CC and
and DT the
the JJ limited
limited NN access
access TO to
to JJ suitable
suitable NN ultrasound
ultrasound NNS machines

The DT CAPITAL The
The JJ widespread
widespread NN use
use IN of
of NN ultrasound
ultrasound VBZ is
is VBG encouraging
encouraging , ,
, RB however
however , ,
, RB there
there VBP are
are RB clearly
clearly JJ diverse
diverse NNS views

A DT CAPITAL A
A JJ significant
significant NN minority
minority IN of
of NNS departments
departments VB depend
depend RB principally
principally IN upon
upon NN venography
venography IN in
in DT the
the NN diagnosis
diagnosis IN of
of NN CAPITAL DVT

Existential JJ CAPITAL Existential
Existential NN phenomenology
phenomenology CC and
and DT the
the JJ sociological
sociological NN tradition

Dual JJ CAPITAL Dual
Dual NN leadership
leadership IN in
in NN complex
complex NNS organizations

Scientists NNS CAPITAL Scientists
Scientists IN at
at JJ major
major CC and
and JJ minor
minor NNS universities
universities : :
: DT a
a NN study
study IN of
of NN productivity
productivity CC and
and NN recognition

Demotion NN CAPITAL Demotion
Demotion IN in
in JJ industrial
industrial NN management

Career NNP CAPITAL Career
Career NN anchorage
anchorage : :
: JJ managerial
managerial NN mobility
mobility NNS motivations

Social NNP CAPITAL Social
Social NN class
class CC and
and JJ premarital
premarital JJ sexual
sexual NN permissiveness
permissiveness : :
: DT a
a NN re-examination

A DT CAPITAL A
A NN comment
comment IN on
on `` ``
`` NN anomy
anomy '' ''

A DT CAPITAL A
A NN factor
factor JJ analytic
analytic NN exploration
exploration IN of
of DT the
the NN alienation
alienation , ,
, NN anomia
anomia CC and
and NN authoritarianism
authoritarianism NN domain

Technical NNP CAPITAL Technical
Technical NN note
note IN on
on CD two
two NNS rates
rates IN of
of JJ mixed
mixed NN marriage

Some DT CAPITAL Some
Some NNS comments
comments IN on
on NN awareness

On IN CAPITAL On
On JJ experimental
experimental NN design

Observations NNS CAPITAL Observations
Observations IN on
on DT the
the NN incidence
incidence IN of
of VBG following
following IN of
of JJ visual
visual CC and
and NN auditory
auditory NNS stimuli
stimuli IN in
in JJ naive
naive NN mallard
mallard NNS ducklings
ducklings NN (
( NNP CAPITAL Anas
Anas NNS platyrhynchos
platyrhynchos NN )

The DT CAPITAL The
The NN comfort
comfort NNS movements
movements IN of
of NNP CAPITAL Anatidae

Potential JJ CAPITAL Potential
Potential JJ ethological
ethological VBG isolating
isolating NNS mechanisms
mechanisms CC and
and JJ assortative
assortative NN mating
mating IN in
in DT the
the JJ domestic
domestic NN fowl

An DT CAPITAL An
An JJ experimental
experimental NN study
study IN of
of NN conflict
conflict CC and
and NN fear
fear : :
: DT an
an NN analysis
analysis IN of
of NN behavior
behavior IN of
of JJ young
young NNS chicks
chicks IN toward
toward DT a
a NN mealworm

I PRP CAPITAL I
I . .
. DT CAPITAL The
The NN behavior
behavior IN of
of NNS chicks
chicks WDT which
which VB do
do RB not
not VB eat
eat DT the
the NN mealworm

The DT CAPITAL The
The VBG measuring
measuring NN function
function IN of
of DT the
the RB first
first NNS legs
legs IN of
of NNP CAPITAL Araneus
Araneus NN diadematus
diadematus NN CAPITAL Cl

The DT CAPITAL The
The NN transport
transport IN of
of NN prey
prey IN by
by NNS ants

Courtship NN CAPITAL Courtship
Courtship NN behaviour
behaviour IN in
in DT the
the FW CAPITAL Drosophila
Drosophila NN obscura
obscura NN group

II NNP CAPITAL II

Comparative JJ CAPITAL Comparative
Comparative NNS studies

Vision NNP CAPITAL Vision
Vision CC versus
versus NN touch
touch IN in
in NN form
form NN discrimination

Short-term JJ CAPITAL Short-term
Short-term NN retention
retention IN as
as DT a
a NN function
function IN of
of NN method
method IN of
of NN measurement
measurement , ,
, VBG recording
recording NN time
time , ,
, CC and
and NN meaningfulness
meaningfulness IN of
of DT the
the NN material

The DT CAPITAL The
The NN conservation
conservation IN of
of DT a
a NN shape
shape NN property
property CC and
and DT a
a NN proposal
proposal IN about
about DT the
the NN origin
origin IN of
of DT the
the NNS conservations

Persisting VBG CAPITAL Persisting
Persisting NNS odours
odours IN as
as DT a
a VBG biasing
biasing NN factor
factor IN in
in JJ open-field
open-field NN research
research IN with
with NNS mice

The DT CAPITAL The
The NN display
display IN of
of NN information
information CC and
and DT the
the NN judgment
judgment IN of
of NN contingency

Vividness NN CAPITAL Vividness
Vividness IN of
of NNS words
words CC and
and VBG learning
learning TO to
to VB learn
learn IN in
in NN free-recall
free-recall VBG learning

Genetic JJ CAPITAL Genetic
Genetic NN study
study IN of
of DT the
the NN memorization
memorization IN of
of NNS words
words CC and
and NNS pictures

Amylase NN CAPITAL Amylase
Amylase NN production
production IN by
by NNS CAPITAL Streptomyces
Streptomyces NNS species

Physico-chemical JJ CAPITAL Physico-chemical
Physico-chemical NNS studies
studies IN on
on DT the
the NN stability
stability IN of
of NN penicillin
penicillin NNS salts

IV CD CAPITAL IV

A DT CAPITAL A
A JJ statistical
statistical NN evaluation

Studies NNS CAPITAL Studies
Studies IN on
on NN nitrogen
nitrogen NN metabolism
metabolism IN of
of NNP CAPITAL Penicillium
Penicillium NN chrysogenum
chrysogenum NNP CAPITAL Thom
Thom . .
. PRP CAPITAL I
I . .
. NNS CAPITAL Effects
Effects IN of
of NN lactose
lactose CC and
and NN sucrose
sucrose NNS additions
additions IN on
on NN nitrogen
nitrogen NN metabolism

Studies NNS CAPITAL Studies
Studies IN on
on NN nitrogen
nitrogen NN metabolism
metabolism IN of
of NNP CAPITAL Penicillium
Penicillium NN chrysogenum
chrysogenum NNP CAPITAL Thom
Thom . .
. NNP CAPITAL II

Amino NN CAPITAL Amino
Amino NN acid
acid NN metabolism
metabolism CC and
and PRP$ its
its NN relation
relation TO to
to DT the
the NN biosynthesis
biosynthesis IN of
of NN penicillin

The DT CAPITAL The
The NN contribution
contribution IN of
of JJ thoracic
thoracic NN surgery
surgery TO to
to PRP$ our
our NN discipline

Research NNP CAPITAL Research
Research IN past
past CC and
and JJ present
present , ,
, IN with
with JJ particular
particular NN reference
reference TO to
to DT the
the NN application
application IN of
of DT the
the NNS techniques
techniques IN of
of JJ basic
basic NN science
science TO to
to DT the
the NNS problems
problems IN of
of JJ adrenal
adrenal NN pathology

Some DT CAPITAL Some
Some JJ inflammatory
inflammatory NNS disorders
disorders IN of
of DT the
the JJ large
large NN intestine

Coexistence NN CAPITAL Coexistence
Coexistence IN of
of JJ subdural
subdural CC and
and JJ archnoidal
archnoidal NNS collections
collections IN of
of NN fluid
fluid : :
: DT an
an JJ unusual
unusual NN case

The DT CAPITAL The
The NN scope
scope IN of
of NN sphincterotomy
sphincterotomy IN in
in JJ biliary
biliary CC and
and JJ pancreatic
pancreatic NN surgery

Sarcoidosis NN CAPITAL Sarcoidosis
Sarcoidosis VBG involving
involving DT the
the NN veriform
veriform NN appendix

`` `` ``
`` JJ CAPITAL Chronic
Chronic NN pancreatitis
pancreatitis `` ``
`` CC and
and NN carcinoma
carcinoma IN of
of DT the
the NN pancreas

A DT CAPITAL A
A NN method
method TO to
to NN aid
aid JJ correct
correct NN diagnosis

Control NN CAPITAL Control
Control IN of
of JJ post-haemorrhoidectomy
post-haemorrhoidectomy VBG bleeding
bleeding IN with
with DT a
a NNP CAPITAL Foley
Foley NN catheter
catheter CC and
and DT a
a NN pack

Diagnosis NN CAPITAL Diagnosis
Diagnosis CC and
and NN therapy
therapy IN of
of JJ chronic
chronic JJ aspecific
aspecific NN pancreatitis

Behavior NN CAPITAL Behavior
Behavior IN of
of DT the
the NN tetanus
tetanus NN patient
patient VBN subjected
subjected TO to
to NN resuscitation
resuscitation NN treatment

Further RB CAPITAL Further
Further NNS data
data IN on
on JJ mediastinal
mediastinal CC and
and JJ pulmonary
pulmonary NNS tumors
tumors IN of
of DT the
the NN child

Review NN CAPITAL Review
Review CC and
and JJ personal
personal NNS cases

Dextran NN CAPITAL Dextran
Dextran IN of
of JJ low
low JJ molecular
molecular NN weight
weight IN in
in JJ peripheral
peripheral JJ arterial
arterial NN insufficiency

Clinico-statistical JJ CAPITAL Clinico-statistical
Clinico-statistical NNS considerations
considerations IN on
on JJ vescicular
vescicular NN mole

On IN CAPITAL On
On DT the
the NN significance
significance IN of
of JJ histologic
histologic NNS findings
findings IN in
in NNS neoplasms
neoplasms IN of
of DT the
the NN trophoblast
trophoblast NN (
( NN case
case NNS contributions
contributions NN )

Diagnostic JJ CAPITAL Diagnostic
Diagnostic NN evaluation
evaluation IN of
of DT the
the NN patient
patient IN with
with JJ high
high NN blood
blood NN pressure

Epidemiology NNP CAPITAL Epidemiology
Epidemiology IN of
of NN hypertension

Renal JJ CAPITAL Renal
Renal JJ vascular
vascular NN hypertension
hypertension : ;
; NN diagnosis
diagnosis CC and
and NN treatment

The DT CAPITAL The
The NN use
use IN of
of JJ radioactive
radioactive NNS isotopes
isotopes IN in
in DT the
the NN diagnosis
diagnosis IN of
of NN hypertension

The DT CAPITAL The
The NN angiogram
angiogram IN in
in DT the
the NN study
study IN of
of NN hypertension

Guanethidine NN CAPITAL Guanethidine

Hepatocerebral JJ CAPITAL Hepatocerebral
Hepatocerebral NN degeneration
degeneration NN (
( NN portal
portal JJ systemic
systemic NN encephalopathy
encephalopathy NN )

The DT CAPITAL The
The NN relationship
relationship TO to
to NN fatty
fatty NNS acids

Oviposition NN CAPITAL Oviposition
Oviposition CC and
and PRP$ its
its NN regulation
regulation IN in
in DT the
the JJ polygynous
polygynous NN society
society IN of
of NNS CAPITAL Polistes
Polistes NN gallicus
gallicus NNP CAPITAL L.

Interaction NN CAPITAL Interaction
Interaction IN of
of JJ aggressive
aggressive CC and
and JJ sexual
sexual NN behavior
behavior IN in
in NN male
male NNS mice

Conflict NN CAPITAL Conflict
Conflict CC and
and VBN conditioned
conditioned JJ aversive
aversive NNS stimuli
stimuli IN in
in DT the
the NN development
development IN of
of JJ experimental
experimental NNS neuroses

Study NN CAPITAL Study
Study IN of
of DT the
the NN effect
effect IN of
of JJR newer
newer JJ analeptic
analeptic NN (
( NNP CAPITAL Micoren
Micoren NN )
) IN in
in NN hypoventilation
hypoventilation NN syndrome

Treatment NN CAPITAL Treatment
Treatment IN of
of DT a
a NN disorder
disorder IN of
of NN perception
perception CC and
and NN concept
concept NN formation
formation IN in
in DT a
a NN case
case IN of
of NN school
school NN failure

Rorschach NNP CAPITAL Rorschach
Rorschach VBZ correlates
correlates IN of
of NN time
time NN estimation

Use NN CAPITAL Use
Use IN of
of NN food
food IN in
in NN child
child NN psychotherapy

About IN CAPITAL About
About JJ genital
genital NN discharge
discharge IN with
with JJ special
special NN consideration
consideration IN of
of PRP$ its
its JJ cervical
cervical NN manifestation

Auto-uro NN CAPITAL Auto-uro
Auto-uro NN therapy
therapy : :
: NN status
status CC and
and NN future
future NNS prospects

Clinical JJ CAPITAL Clinical
Clinical NN experience
experience IN with
with DT the
the NN surface
surface NN anesthetic
anesthetic NN xylocaine
xylocaine IN in
in NNS obstetrics

The DT CAPITAL The
The NN problem
problem IN of
of JJ medicinal
medicinal NN management
management IN of
of NN labor

Conglutination NN CAPITAL Conglutination
Conglutination IN of
of DT the
the NN labia
labia NN minora

The DT CAPITAL The
The NN fight
fight IN against
against JJ hemolytic
hemolytic NN disease
disease IN of
of DT the
the JJ newborn
newborn IN in
in JJ general
general NN practice

Long NNP CAPITAL Long
Long NN term
term NNS results
results IN in
in DT the
the CD 300
300 RBS most
most NN grave
grave NNS cases
cases IN out
out IN of
of CD 4000
4000 JJ hyperthyroid
hyperthyroid NNS patients
patients VBN treated
treated IN with
with NN iodine
iodine NN CAPITAL I-131
I-131 IN at
at DT the
the NN center
center IN of
of NNP CAPITAL Ancona

On IN CAPITAL On
On JJ socalled
socalled JJ nervous
nervous NN exhaustion

Examination NN CAPITAL Examination
Examination IN of
of JJ neonatal
neonatal JJ archaic
archaic NN (
( JJ primitive
primitive NN )
) NNS reflexes
reflexes IN in
in NN icterus
icterus NN gravis

Urologic JJ CAPITAL Urologic
Urologic NNS complications
complications IN in
in JJ non-recurrent
non-recurrent NN cancer
cancer IN of
of DT the
the NN cervix

Prolonged JJ CAPITAL Prolonged
Prolonged NN cortisone
cortisone NN therapy
therapy IN in
in NN treatment
treatment IN of
of JJ allergic
allergic NNS diseases

The DT CAPITAL The
The VBG complexing
complexing IN of
of NN calcium
calcium IN by
by NN citrate
citrate , ,
, JJ ortho-
ortho- CC and
and NNS polyphosphates

A DT CAPITAL A
A NN method
method IN of
of VBG determining
determining DT the
the NN patency
patency IN of
of DT the
the NN nasolacrimal
nasolacrimal NN apparatus

Intra-arterial JJ CAPITAL Intra-arterial
Intra-arterial NN infusion
infusion IN of
of DT the
the NN head
head CC and
and NN neck

Anatomic JJ CAPITAL Anatomic
Anatomic CC and
and JJ distributional
distributional NNS problems

Lymphatics NNS CAPITAL Lymphatics
Lymphatics IN of
of DT the
the NN mouth
mouth CC and
and NN neck

Effect NN CAPITAL Effect
Effect IN of
of NN sodium
sodium NNS ions
ions IN on
on DT the
the NN behavior
behavior IN of
of NN rest
rest CC and
and NN action
action NNS potentials
potentials IN of
of DT the
the NN cell
cell NN membrane
membrane IN of
of DT the
the NN rat
rat NN myometrium

Studies NNS CAPITAL Studies
Studies IN on
on NN contractile
contractile NNS properties
properties IN of
of DT the
the NN blood
blood NN serum

Twin JJ CAPITAL Twin
Twin NN pregnancy
pregnancy CC and
and JJ fetal
fetal CC and
and JJ infantile
infantile JJ perinatal
perinatal NN mortality

Fate NNP CAPITAL Fate
Fate IN of
of DT the
the NN 2d
2d NN twin

Differential JJ CAPITAL Differential
Differential NN diagnosis
diagnosis IN of
of JJ infectious
infectious NN hepatitis
hepatitis IN in
in NN pregnancy

Epithelial JJ CAPITAL Epithelial
Epithelial NN metaplasia
metaplasia IN of
of DT the
the NN endometrium

Leukoplakia NN CAPITAL Leukoplakia
Leukoplakia IN of
of DT the
the JJ vaginal
vaginal NN portion
portion IN of
of DT the
the NN uterus
uterus CC and
and PRP$ its
its JJ clinical
clinical NN evaluation

Blood NN CAPITAL Blood
Blood NN loss
loss IN in
in JJ artificial
artificial NN interruption
interruption IN of
of NN pregnancy

Modified VBN CAPITAL Modified
Modified NN bra
bra IN in
in DT the
the NN prevention
prevention IN of
of NN mastitis
mastitis IN in
in NN nursing
nursing NNS mothers

Hormonal JJ CAPITAL Hormonal
Hormonal NN phenomenon
phenomenon IN after
after DT the
the NN excision
excision IN of
of NN hydatiform
hydatiform NN mole

Fetal JJ CAPITAL Fetal
Fetal NN chondrodystrophy

Malignant JJ CAPITAL Malignant
Malignant JJ mesodermal
mesodermal JJ mixed
mixed NN tumor
tumor IN of
of DT the
the NN uterus
uterus VBG following
following NN irradiation

Supportive JJ CAPITAL Supportive
Supportive NN role
role IN of
of NN nurse
nurse IN in
in RB first
first NN stage
stage IN of
of NN labor
labor `` ``
`` MD can
can RB not
not VB be
be VBN emphasized
emphasized RB enough
enough '' ''
'' , ,
, VBG according
according TO to
to NN patient

Toxemia NNP CAPITAL Toxemia
Toxemia IN of
of NN pregnancy

Outpatient NN CAPITAL Outpatient
Outpatient NN care
care : --
-- DT the
the NN role
role IN of
of DT the
the NN nurse

Abandonment NNP CAPITAL Abandonment
Abandonment : :
: JJS deepest
deepest NN fear
fear IN of
of VBN hospitalized
hospitalized NNS children

Support NN CAPITAL Support
Support IN in
in RB first
first NN stage
stage IN of
of NN labor

The DT CAPITAL The
The NN family
family NN physician
physician CC and
and JJ cervical
cervical NN carcinoma
carcinoma : --
-- NN challenge
challenge CC and
and NN opportunity

Purposeful JJ CAPITAL Purposeful
Purposeful `` ``
`` JJ heroic
heroic '' ''
'' NN heart
heart NN treatment

Skilled JJ CAPITAL Skilled
Skilled NNS workers
workers VBP are
are JJ vital
vital TO to
to NN maintenance
maintenance NN cost
cost NNS cuts

Karen NNP CAPITAL Karen
Karen : :
: DT the
the JJ other
other NN side
side IN of
of DT the
the NN picture

Rhesus NN CAPITAL Rhesus
Rhesus JJ haemolytic
haemolytic NN disease
disease : ;
; DT an
an NN approach
approach TO to
to NN prevention

Tumours NNP CAPITAL Tumours
Tumours IN of
of DT the
the NN uterus

2 CD 2

Malignancy NN CAPITAL Malignancy

Cancer NN CAPITAL Cancer
Cancer IN of
of DT the
the NN vulva

Effects NNS CAPITAL Effects
Effects IN of
of NN smoking
smoking IN on
on VBN selected
selected JJ clinical
clinical NN obstetric
obstetric NNS factors

Amniotic JJ CAPITAL Amniotic
Amniotic NN fluid
fluid NN embolism

A DT CAPITAL A
A NN review
review IN of
of DT the
the NN syndrome
syndrome IN with
with DT a
a NN report
report IN of
of CD 4
4 NNS cases

Chronic JJ CAPITAL Chronic
Chronic NN histiocytosis
histiocytosis NN CAPITAL X
X VBN associated
associated IN with
with NN pregnancy

Disseminated VBN CAPITAL Disseminated
Disseminated NN lupus
lupus NN erythematosus
erythematosus IN in
in NN pregnancy

Intralesional JJ CAPITAL Intralesional
Intralesional NN therapy
therapy IN with
with NN betamethasone

Strucutre NNP CAPITAL Strucutre
Strucutre IN of
of DT the
the NN influenza
influenza NN virus

2 CD 2
2 NNS students
students IN at
at NN CAPITAL Quo
Quo NNP CAPITAL Vadis

Double JJ CAPITAL Double
Double JJ aortic
aortic NN arch
arch VBN associated
associated IN with
with NN tetralogy
tetralogy IN of
of NNP CAPITAL Fallot
Fallot IN in
in NNS infants
infants : ;
; NN report
report IN of
of CD two
two NNS cases

Tested VBN CAPITAL Tested
Tested NNS questionnaires
questionnaires NN help
help NN administration
administration VB learn
learn IN if
if NNS programs
programs VBP are
are DT a
a NN success
success , ,
, CC and
and WRB why

Dumping VBG CAPITAL Dumping
Dumping NN syndrome
syndrome VBG following
following NN pyloroplasty
pyloroplasty . .

Measured VBN CAPITAL Measured
Measured JJ subtotal
subtotal NN gastrectomy
gastrectomy IN for
for JJ duodenal
duodenal NN ulcer

The DT CAPITAL The
The NNS lesions
lesions IN in
in JJ bovine
bovine NNS udders
udders VBG shedding
shedding JJ nonhemolytic
nonhemolytic JJ coagulase-negative
coagulase-negative NNS staphylococci

Repository JJ CAPITAL Repository
Repository NN vitamin
vitamin NN CAPITAL B
B CD 12
12 NNS preparations

Mass NNP CAPITAL Mass
Mass NN spectrometry
spectrometry IN in
in JJ structural
structural CC and
and JJ stereochemical
stereochemical NNS problems

93 CD 93

Further RB CAPITAL Further
Further NNS observations
observations IN on
on DT the
the NN importance
importance IN of
of JJ interatomic
interatomic NN distance
distance IN in
in DT the
the NN CAPITAL McLafferty
McLafferty NN rearrangement

Synthesis NN CAPITAL Synthesis
Synthesis CC and
and NN fragmentation
fragmentation NN behavior
behavior IN of
of JJ deuterium-labeled
deuterium-labeled JJ 12-keto
12-keto NNS steroids

Treatment NN CAPITAL Treatment
Treatment IN of
of NN childhood
childhood NN schizophrenia

A DT CAPITAL A
A JJ three-year
three-year NN comparison
comparison IN of
of NN day
day CC and
and JJ residental
residental NN treatment

Polycystic JJ CAPITAL Polycystic
Polycystic NNS ovaries
ovaries VBN associated
associated IN with
with JJ congenital
congenital JJ adrenal
adrenal NN hyperplasia

Beta-propiolactone NN CAPITAL Beta-propiolactone
Beta-propiolactone IN as
as VBN used
used IN in
in NN sterilization
sterilization IN of
of NNS homografts
homografts RB not
not JJ carcinogenic
carcinogenic IN for
for NNS mice

New NNP CAPITAL New
New NNS operations
operations IN in
in NNS children
children POS 's
's JJ cardiac
cardiac NN disease

Effect NN CAPITAL Effect
Effect IN of
of NN diabetes
diabetes CC and
and NN starvation
starvation IN on
on JJ myocardial
myocardial NN triglyceride
triglyceride CC and
and JJ free
free NN fatty
fatty NN acid
acid NN utilization

Effect NN CAPITAL Effect
Effect IN of
of NN epinephrine
epinephrine IN on
on JJ myocardial
myocardial NN triglyceride
triglyceride CC and
and JJ free
free NN fatty
fatty NN acid
acid NN utilization

Diurnal JJ CAPITAL Diurnal
Diurnal NN periodicity
periodicity IN in
in DT the
the JJ metabolic
metabolic NN activity
activity IN of
of NN bone
bone NN tissue

Fine NNP CAPITAL Fine
Fine NN structure
structure IN of
of NNS desmosomes

, , ,
, NNS hemidesmosomes
hemidesmosomes , ,
, CC and
and DT an
an JJ adepidermal
adepidermal JJ globular
globular NN layer
layer IN in
in VBG developing
developing NN newt
newt NN epidermis

Redundant JJ CAPITAL Redundant
Redundant JJ myelin
myelin NNS sheaths
sheaths CC and
and JJ other
other JJ ultrastructural
ultrastructural NNS features
features IN of
of DT the
the NN toad
toad NN cerebellum

A DT CAPITAL A
A JJ radioautographic
radioautographic NN study
study IN with
with NN CAPITAL H3-thymidine
H3-thymidine IN on
on JJ adrenal
adrenal NN medulla
medulla NNS nuclei
nuclei IN of
of NNS rats
rats RB intermittently
intermittently VBN exposed
exposed TO to
to JJ cold

A DT CAPITAL A
A NN fine
fine JJ structural
structural NN analysis
analysis IN of
of DT the
the NN epidermis
epidermis IN of
of DT the
the NN earthworm
earthworm , ,
, NN CAPITAL Lumbricus
Lumbricus NN terrestris
terrestris NNP CAPITAL L.

Effect NN CAPITAL Effect
Effect IN of
of JJ thoracic
thoracic NN cava
cava NN obstruction
obstruction IN on
on NN response
response IN of
of JJ proximal
proximal NN tubule
tubule NN sodium
sodium NN reabsorption
reabsorption TO to
to NN saline
saline NN infusion

The DT CAPITAL The
The NN metabolism
metabolism IN of
of RB intravenously
intravenously VBN injected
injected JJ isotopic
isotopic JJ cholic
cholic NN acid
acid IN in
in NNP CAPITAL Laennec
Laennec POS 's
's NN cirrhosis

The DT CAPITAL The
The NN origin
origin CC and
and NN glyceride
glyceride NN distribution
distribution IN of
of NN fatty
fatty NNS acids
acids IN in
in NN rat
rat NN adipose
adipose NN tissue

Absorption NN CAPITAL Absorption
Absorption IN of
of NN medium
medium CC and
and RB long
long NN chain
chain NNS triglycerides
triglycerides : :
: NNS factors
factors VBG influencing
influencing PRP$ their
their NN hydrolysis
hydrolysis CC and
and NN transport

The DT CAPITAL The
The NN effect
effect IN of
of NN epinephrine
epinephrine IN on
on JJ immunoreactive
immunoreactive NN insulin
insulin NNS levels
levels IN in
in NN man

The DT CAPITAL The
The NN role
role IN of
of DT the
the NN liver
liver IN in
in JJ serum-induced
serum-induced NN hypercoagulability

Comparative JJ CAPITAL Comparative
Comparative NNS fates
fates IN of
of RB intravenously
intravenously CC and
and RB orally
orally VBN administered
administered NN aldosterone
aldosterone : :
: NN evidence
evidence IN for
for JJ extrahepatic
extrahepatic NN formation
formation IN of
of JJ acid-hydrolyzable
acid-hydrolyzable NN conjugate
conjugate IN in
in NN man

Binding NN CAPITAL Binding
Binding IN of
of NN sulfobromophthalein
sulfobromophthalein NN (
( NN CAPITAL BSP
BSP NN )
) NN sodium
sodium IN by
by NN plasma
plasma NN albumin

Its PRP$ CAPITAL Its
Its NN role
role IN in
in JJ hepatic
hepatic NN CAPITAL BSP
BSP NN extraction

The DT CAPITAL The
The NN rationale
rationale IN of
of VBN extended
extended NN resection
resection IN for
for VBN complicated
complicated NN cancer
cancer IN of
of DT the
the JJ large
large NN bowel

Etiology NN CAPITAL Etiology
Etiology CC and
and NN incidence
incidence IN of
of JJ renal
renal NNS stones

Diagnosis NN CAPITAL Diagnosis
Diagnosis IN of
of NN stone
stone NN disease

Medical NNP CAPITAL Medical
Medical NN treatment
treatment IN of
of NN stone
stone NN disease

Surgical NNP CAPITAL Surgical
Surgical NN treatment
treatment IN of
of JJ urinary
urinary NNS stones

Prevention NNP CAPITAL Prevention
Prevention IN of
of NN stone
stone NN formation

Urinary JJ CAPITAL Urinary
Urinary NNS calculi

Is VBZ CAPITAL Is
Is DT the
the NN task
task JJ hopeless
hopeless . ?

The DT CAPITAL The
The NN family
family NN medicine
medicine NN program
program IN of
of DT the
the NNP CAPITAL University
University IN of
of NNP CAPITAL Miami

Electron NN CAPITAL Electron
Electron JJ microscopic
microscopic NNS studies
studies IN of
of NN CAPITAL Mycoplasma
Mycoplasma NN (
( NN CAPITAL PPLO
PPLO NN strain
strain CD 880
880 NN )
) IN in
in JJ artificial
artificial NN medium
medium CC and
and IN in
in NN tissue
tissue NN culture

Chemotherapeutic JJ CAPITAL Chemotherapeutic
Chemotherapeutic NNS effects
effects IN on
on JJ mammalian
mammalian NN tumor
tumor NNS cells

3 CD 3

Modification NN CAPITAL Modification
Modification IN of
of NN leukemia
leukemia NN CAPITAL L1210
L1210 NN growth
growth NNS kinetics
kinetics IN with
with DT an
an JJ antimetabolite

Comparison NN CAPITAL Comparison
Comparison IN of
of DT the
the NN sensitivity
sensitivity IN of
of JJ normal
normal JJ hematopoietic
hematopoietic CC and
and VBN transplanted
transplanted NN lymphoma
lymphoma JJ colony-forming
colony-forming NNS cells
cells IN of
of NNS mice
mice TO to
to NN vinblastine
vinblastine VBN administered
administered IN in
in FW vivo

Evidence NN CAPITAL Evidence
Evidence IN for
for DT an
an JJ immunological
immunological NN reaction
reaction IN of
of DT the
the NN host
host VBN directed
directed IN against
against PRP$ its
its JJ own
own RB actively
actively VBG growing
growing JJ primary
primary NN tumor

Hyperbaric JJ CAPITAL Hyperbaric
Hyperbaric NN oxygen
oxygen , ,
, JJ whole-body
whole-body NN CAPITAL X
X NN irradiation
irradiation , ,
, CC and
and NN cyclophosphamide
cyclophosphamide NN combination
combination NN therapy
therapy IN in
in NN mouse
mouse NN leukemia
leukemia NN CAPITAL L1210

Clinical JJ CAPITAL Clinical
Clinical NN staging
staging IN in
in NN cancer
cancer IN of
of DT the
the NN larynx
larynx : :
: DT a
a NN report
report IN on
on CD 788
788 NNS cases
cases VBG using
using DT the
the NNP CAPITAL American
American NNP CAPITAL Joint
Joint NNP CAPITAL Committee
Committee POS 's
's NN method
method IN of
of NN stage
stage NN classification

Comparison NN CAPITAL Comparison
Comparison IN of
of DT the
the JJ international
international CC and
and NNP CAPITAL American
American NNS systems
systems IN for
for DT the
the NN staging
staging IN of
of NN breast
breast NN cancer

Effects NNS CAPITAL Effects
Effects IN of
of NN tryptophan
tryptophan NN mustard
mustard IN on
on NN incorporation
incorporation IN of
of NN amino
amino NNS acids
acids IN into
into NNS proteins
proteins IN in
in JJ tumor-bearing
tumor-bearing NNS rats

An DT CAPITAL An
An NN electron
electron NN microscope
microscope NN study
study IN of
of NN plant
plant NN neoplasia
neoplasia VBN induced
induced IN by
by NN wound
wound NN tumor
tumor NN virus

Possibilities NNS CAPITAL Possibilities
Possibilities IN of
of JJ surgical
surgical NN correction
correction IN of
of NNS malformations
malformations IN of
of DT the
the NNS bones
bones IN of
of DT the
the NN foot

The DT CAPITAL The
The JJ postprandial
postprandial NN period
period IN of
of DT the
the VBN gastrectomized
gastrectomized NN patient

Radiocinematographic JJ CAPITAL Radiocinematographic
Radiocinematographic CC and
and JJ clinical
clinical NN correlation

Muscle NN CAPITAL Muscle
Muscle NN pathology
pathology : ;
; NN contribution
contribution IN of
of NN experimentation

Origin NN CAPITAL Origin
Origin IN of
of NN milk
milk NN cholesterol
cholesterol IN in
in DT the
the NN rat
rat : :
: JJ dietary
dietary CC versus
versus JJ endogenous
endogenous NNS sources

Comparative JJ CAPITAL Comparative
Comparative NNS effects
effects IN of
of CD two
two NN benzodiazepine
benzodiazepine NNS compounds
compounds IN on
on VBN isolated
isolated JJ human
human NN myometrium

Histochemistry NN CAPITAL Histochemistry
Histochemistry IN of
of JJ hydrolytic
hydrolytic CC and
and JJ oxidative
oxidative NNS enzymes
enzymes IN in
in DT the
the JJ human
human CC and
and RB experimentally
experimentally VBN induced
induced NN adenocarcinoma
adenocarcinoma IN of
of DT the
the NN endometrium

Cardiac JJ CAPITAL Cardiac
Cardiac NNS monitors
monitors NN work
work : --
-- CC but
but PRP they
they MD should
should NN report
report RBR more
more IN than
than PRP they
they VB do

Delivery NN CAPITAL Delivery
Delivery NN room
room NNS pediatrics

The DT CAPITAL The
The NNS responsibilities
responsibilities IN of
of DT the
the NN obstetrician

A DT CAPITAL A
A NN pediatrician
pediatrician POS 's
's NN checklist
checklist IN for
for NNS adolescents

Community NN CAPITAL Community
Community NN clinic
clinic NN treatment
treatment IN for
for JJ back-ward
back-ward NNS patients

Studies NNS CAPITAL Studies
Studies IN in
in JJ infantile
infantile NN malnutrition

V NN CAPITAL V

The DT CAPITAL The
The NN effect
effect IN of
of JJ dietary
dietary NN protein
protein NN source
source IN on
on NN serum
serum NNS proteins

Fish NN CAPITAL Fish
Fish NN protein
protein VBZ concentrates
concentrates IN in
in DT the
the NN treatment
treatment IN of
of NN kwashiorkor

athyrism NN athyrism
athyrism IN in
in DT the
the JJ fetal
fetal NN rat

Evidence NN CAPITAL Evidence
Evidence IN for
for NN impairment
impairment IN of
of NN elastin
elastin NN formation

Familial JJ CAPITAL Familial
Familial NN vitamin
vitamin NN CAPITAL D
D JJ resistant
resistant NN rickets
rickets IN in
in JJ untreated
untreated JJ adult

Bony NNP CAPITAL Bony
Bony NN proliferation
proliferation IN of
of JJ neural
neural NNS arches
arches IN with
with NN cord
cord NN compression

Amyloidosis NNP CAPITAL Amyloidosis
Amyloidosis IN of
of DT the
the NN cornea

Report NNP CAPITAL Report
Report IN of
of DT a
a NN case
case IN without
without NN conjunctival
conjunctival NN involvement

Effect NN CAPITAL Effect
Effect IN of
of VBG tranquilizing
tranquilizing NNS drugs
drugs IN on
on JJ postnatal
postnatal NN behavior

Fathers NNS CAPITAL Fathers
Fathers IN in
in DT the
the NN delivery
delivery NN room
room : --
-- DT an
an NN opposition
opposition NN standpoint

Fathers NNS CAPITAL Fathers
Fathers IN in
in DT the
the NN delivery
delivery : --
-- '' ''
'' JJ helpful
helpful CC and
and JJ supportive
supportive '' ''

`` `` ``
`` NN CAPITAL Return
Return DT the
the NN joy
joy IN of
of NN home
home NN delivery
delivery '' ''
'' IN with
with NNS fathers
fathers IN in
in DT the
the NN delivery
delivery NN room

Fathers NNS CAPITAL Fathers
Fathers IN in
in DT the
the NN delivery
delivery NN room
room : --
-- RB long
long NN experience
experience NNS molds
molds CD one
one NN viewpoint

Doctors NNS CAPITAL Doctors
Doctors : --
-- PRP we
we NN need
need PRP you

Pharmacological JJ CAPITAL Pharmacological
Pharmacological NN blockade
blockade IN of
of NN ovulation
ovulation IN in
in DT the
the NN ewe

Some DT CAPITAL Some
Some NNS factors
factors VBG affecting
affecting DT the
the NN response
response IN of
of DT the
the JJ immature
immature NN mouse
mouse TO to
to JJ pregnant
pregnant NN mare
mare NN serum
serum NN gonadotrophin
gonadotrophin CC and
and JJ human
human JJ chorionic
chorionic NN gonadotrophin

The DT CAPITAL The
The NN metabolism
metabolism IN of
of NN cortisol
cortisol IN by
by JJ human
human JJ extra-hepatic
extra-hepatic NNS tissues

Aromatization NN CAPITAL Aromatization
Aromatization IN of
of NN 7-alpha-hydroxydehydroepiandrosterone
7-alpha-hydroxydehydroepiandrosterone CC and
and IN of
of PRP$ its
its NN 3-sulphate
3-sulphate IN by
by JJ ovarian
ovarian CC and
and JJ placental
placental NN tissue
tissue NNS cultures

Metabolic JJ CAPITAL Metabolic
Metabolic CC and
and NN endocrine
endocrine NNS effects
effects IN of
of JJ lysergic
lysergic NN acid
acid NN diethylamide
diethylamide NN (
( CD CAPITAL LSD-25
LSD-25 NN )
) IN on
on NN male
male NNS rats

Mutation NN CAPITAL Mutation
Mutation NNS frequencies
frequencies VBN detected
detected VBG following
following NN irradiation
irradiation IN of
of JJ virgin
virgin CC and
and VBN inseminated
inseminated FW CAPITAL Drosophila
Drosophila FW melanogaster
melanogaster NNS females

Relationship NN CAPITAL Relationship
Relationship IN of
of NNS fractons
fractons IN of
of NNS soybeans
soybeans CC and
and DT a
a JJ crystalline
crystalline NN soybean
soybean NN trypsin
trypsin NN inhibitor
inhibitor TO to
to DT the
the NNS effects
effects IN of
of VBG feeding
feeding JJ unheated
unheated NN soybean
soybean NN meal
meal TO to
to NNS chicks

Metabolism NN CAPITAL Metabolism
Metabolism IN of
of JJ polyunsaturated
polyunsaturated NN fatty
fatty NNS acids
acids CC and
and NN serum
serum NN cholesterol
cholesterol NNS levels
levels IN in
in DT the
the NN rat

Comparison NN CAPITAL Comparison
Comparison IN of
of JJ neutral
neutral NN fat
fat CC and
and JJ free
free NN fatty
fatty NNS acids
acids IN in
in JJ high
high NN lipid-low
lipid-low NN carbohydrate
carbohydrate NNS diets
diets IN for
for DT the
the VBG growing
growing NN chicken

An DT CAPITAL An
An NN approach
approach TO to
to JJ quantitative
quantitative NN analysis
analysis IN of
of JJ intrauterine
intrauterine NN pressure
pressure NNS data

Intracranial JJ CAPITAL Intracranial
Intracranial NNS teratomas
teratomas IN in
in JJ fetal
fetal NN life
life CC and
and NN infancy

Twinning VBG CAPITAL Twinning
Twinning IN in
in NN relation
relation TO to
to NN birth
birth NN weight
weight , ,
, NN mortality
mortality , ,
, CC and
and JJ congenital
congenital NNS anomalies

Breast NN CAPITAL Breast
Breast NN engorgement
engorgement CC and
and NN postpartum
postpartum NN fever

Evolution NN CAPITAL Evolution
Evolution IN of
of DT a
a NN placenta
placenta NN circumvallata

Sequential JJ CAPITAL Sequential
Sequential NN estrogen-progestogen
estrogen-progestogen NN therapy
therapy IN in
in NN gynecology

Ovarian JJ CAPITAL Ovarian
Ovarian NN carcinoma

The DT CAPITAL The
The NNS problems
problems IN of
of NN staging
staging CC and
and VBG grading

Oxytocin NN CAPITAL Oxytocin
Oxytocin NN induction
induction IN in
in JJ pregnant
pregnant NNS rabbits
rabbits , ,
, IN with
with JJ special
special NN reference
reference TO to
to DT the
the NN stillbirth
stillbirth NN rate

Significance NN CAPITAL Significance
Significance IN of
of DT a
a JJ single
single JJ umbilical
umbilical NN artery

Report NNP CAPITAL Report
Report IN from
from DT the
the JJ collaborative
collaborative NN study
study IN of
of JJ cerebral
cerebral NN palsy

Perforated JJ CAPITAL Perforated
Perforated JJ peptic
peptic NN ulcer
ulcer IN in
in NN pregnancy

Poverty NN CAPITAL Poverty
Poverty IN as
as DT an
an VBN isolated
isolated NN factor
factor IN in
in NN relation
relation TO to
to JJ perinatal
perinatal NN asphyxia

Perforation NN CAPITAL Perforation
Perforation IN of
of DT the
the NN postpartum
postpartum NN uterus
uterus IN with
with DT an
an JJ intrauterine
intrauterine NN contraceptive
contraceptive NN device

Congenital JJ CAPITAL Congenital
Congenital NN heart
heart NN disease
disease , ,
, NN deaf-mutism
deaf-mutism CC and
and VBN associated
associated JJ somatic
somatic NNS malformations
malformations VBG occurring
occurring IN in
in JJ several
several NNS members
members IN of
of CD one
one NN family

Toward IN CAPITAL Toward
Toward DT a
a NN community
community NN alcoholism
alcoholism NN program

Cases NNS CAPITAL Cases
Cases CD 8
8 CC and
and CD 9

Anesthesia NNP CAPITAL Anesthesia
Anesthesia NNS accidents

Gynaecological JJ CAPITAL Gynaecological
Gynaecological NN pain

Profileplasty NNP CAPITAL Profileplasty

Hypertrophic JJ CAPITAL Hypertrophic
Hypertrophic JJ obstructive
obstructive NN cardiomyopathy

Oral JJ CAPITAL Oral
Oral NNS contraceptives
contraceptives , ,
, NN thrombosis
thrombosis , ,
, CC and
and JJ cyclical
cyclical NNS factors
factors VBG affecting
affecting NNS veins
veins . .

On IN CAPITAL On
On DT the
the NN influence
influence IN of
of JJ cytostatic
cytostatic NNS agents
agents CC and
and JJ immune
immune NNS bodies
bodies IN on
on NN choriocarcinoma
choriocarcinoma NNS cells
cells IN in
in NN tissue
tissue NN culture

Fat NNP CAPITAL Fat
Fat NN absorption
absorption : :
: DT a
a NN transport
transport NN problem

Corpora NNP CAPITAL Corpora
Corpora NN lutea
lutea IN in
in VBN proven
proven NNS mules

Reconstructive JJ CAPITAL Reconstructive
Reconstructive JJ tubal
tubal NN surgery

Studies NNS CAPITAL Studies
Studies IN on
on DT the
the JJ natural
natural NN posterior
posterior NN pituitary
pituitary NNS hormones

II NNP CAPITAL II

On IN CAPITAL On
On DT the
the NN official
official NN inspection
inspection IN of
of NN coal-tar
coal-tar NNS dyes
dyes IN in
in CD 1969

3 CD 3

Analysis NN CAPITAL Analysis
Analysis IN of
of NN CAPITAL Cr
Cr , ,
, NN CAPITAL Zn
Zn , ,
, NNP CAPITAL Fe
Fe CC and
and NN CAPITAL Pb
Pb NNS contaminants
contaminants IN in
in NN food
food NN coal-tar
coal-tar NNS dyes
dyes CC and
and PRP$ their
their NN aluminium
aluminium NNS lakes
lakes IN by
by JJ atomic
atomic NN absorption
absorption NN spectrophotometry

Radiosterilization NN CAPITAL Radiosterilization
Radiosterilization IN of
of JJ medical
medical NNS products

I PRP CAPITAL I
I . .
. NNS CAPITAL Effects
Effects IN of
of NN radiation
radiation IN on
on JJ physical
physical CC and
and NN chemical
chemical NNS properties
properties IN of
of NN injection
injection NNS needles

Screening VBG CAPITAL Screening
Screening NNS tests
tests IN of
of NNS microorganisms
microorganisms IN for
for DT the
the JJ microbial
microbial NN transformation
transformation IN of
of NN griseophenone
griseophenone DT CAPITAL A
A , ,
, NN CAPITAL N-methylcoclaurine
N-methylcoclaurine CC and
and NN sparteine

Gas NN CAPITAL Gas
Gas JJ chromatographic
chromatographic NNS studies
studies IN on
on JJ organic
organic NNS mercurials

Application NN CAPITAL Application
Application IN of
of JJ infra-red
infra-red NN absorption
absorption NN spectroscopy
spectroscopy TO to
to NN examination
examination IN of
of NNS drugs
drugs CC and
and PRP$ their
their NN preparation

XIX NNP CAPITAL XIX

Determination NN CAPITAL Determination
Determination IN of
of NN silicone
silicone NN oil
oil IN in
in JJ disposable
disposable NN plastic
plastic NNS syringes

Observation NN CAPITAL Observation
Observation IN of
of NN air
air NN pollution
pollution IN with
with DT the
the NN aid
aid IN of
of JJ continuous
continuous NNS analysers

3 CD 3

Correlation NN CAPITAL Correlation
Correlation IN between
between DT the
the NN concentration
concentration IN of
of JJ various
various NNS kinds
kinds IN of
of NNS pollutants
pollutants IN in
in NN atmosphere
atmosphere CC and
and NN wind
wind NN direction
direction CC and
and NN velocity
velocity IN at
at NNP CAPITAL Kasumigaseki
Kasumigaseki , ,
, JJ central
central NN district
district IN of
of NNP CAPITAL Tokyo

Ultramicro-analysis NN CAPITAL Ultramicro-analysis
Ultramicro-analysis IN of
of NN cyclohexylamine
cyclohexylamine CC and
and JJ low
low NN fatty
fatty NNS amines
amines IN by
by NN gas
gas NN chromatography

Some DT CAPITAL Some
Some NNS knowledges
knowledges IN on
on DT the
the NN potency
potency IN of
of NN heparin
heparin NNS fractions
fractions VBN obtained
obtained IN by
by NN gel
gel NN filtration

On IN CAPITAL On
On DT the
the JJ peripheral
peripheral NNS effects
effects IN of
of NN endotoxin
endotoxin CC and
and NN leucocyte
leucocyte NN pyrogen
pyrogen IN in
in NN rabbit

A DT CAPITAL A
A NN tentative
tentative NN draft
draft IN of
of JJ qualitative
qualitative NN test
test IN of
of NN fluoride
fluoride IN for
for NN adoption
adoption TO to
to DT the
the JJ general
general NNS tests
tests IN of
of JJ eighth
eighth VBN revised
revised NN edition
edition IN of
of DT the
the NNP CAPITAL Pharmacopoeia
Pharmacopoeia IN of
of NNP CAPITAL Japan

Identification NN CAPITAL Identification
Identification IN of
of NNS tranquillizers
tranquillizers IN by
by JJ thin-layer
thin-layer NN chromatography

Analysis NN CAPITAL Analysis
Analysis IN of
of NNS steroids

II NNP CAPITAL II

A DT CAPITAL A
A NN note
note IN on
on DT the
the NN assay
assay IN of
of NN corticoid
corticoid NNS preparations
preparations IN by
by NN tetrazolium
tetrazolium NN salt

Analysis NN CAPITAL Analysis
Analysis IN of
of NNS steroids

3 CD 3

Colorimetric NNP CAPITAL Colorimetric
Colorimetric NN assay
assay IN of
of NN thiomesterone

Studies NNS CAPITAL Studies
Studies IN on
on DT the
the NN radioimmunoassay
radioimmunoassay IN of
of NN insulin

I PRP CAPITAL I
I . .
. DT CAPITAL The
The NN production
production CC and
and NN detection
detection IN of
of JJ anti-insulin
anti-insulin NN serum
serum CC and
and JJ anti-guinea-pig
anti-guinea-pig NN globulin
globulin NN rabbit
rabbit NN serum

Synthesis NN CAPITAL Synthesis
Synthesis IN of
of JJ lysergic
lysergic NN acid
acid NN diethylamide
diethylamide NN (
( NN CAPITAL LSD
LSD NN )

Studies NNS CAPITAL Studies
Studies IN on
on DT the
the JJ anti-microbial
anti-microbial NN activity
activity IN of
of JJ nonionic
nonionic CC and
and JJ anionic
anionic NNS surfactants

On IN CAPITAL On
On DT the
the NNP CAPITAL National
National NNP CAPITAL Institute
Institute IN of
of JJ CAPITAL Hygienic
Hygienic NNPS CAPITAL Sciences
Sciences NNP CAPITAL Standard
Standard `` ``
`` NN lysozyme
lysozyme NN standard
standard '' ''

On IN CAPITAL On
On DT the
the NN examination
examination IN of
of NN ginseng
ginseng CC and
and JJ powdered
powdered NN ginseng
ginseng IN in
in CD 1969

On IN CAPITAL On
On DT the
the NN standardization
standardization IN of
of NN plastic
plastic NN suture

Undergraduate JJ CAPITAL Undergraduate
Undergraduate NN research
research NNS assistants
assistants IN in
in DT the
the NN CAPITAL Faculty
Faculty IN of
of NN CAPITAL Medicine

University NNP CAPITAL University
University NNP CAPITAL College
College IN of
of NNP CAPITAL Rhodesia

Congenital JJ CAPITAL Congenital
Congenital JJ aortic
aortic NN stenosis

Sodium NN CAPITAL Sodium
Sodium IN in
in NN heart
heart NN failure

Potassium NN CAPITAL Potassium
Potassium IN in
in NN heart
heart NN failure

Hydrogen NN CAPITAL Hydrogen
Hydrogen NN ion
ion NN equilibrium
equilibrium IN in
in NN heart
heart NN failure

Various JJ CAPITAL Various
Various NNS aspects
aspects IN of
of NN water-salt
water-salt NN metabolism
metabolism IN in
in NN heart
heart JJ congestive
congestive NN failure

Clinical JJ CAPITAL Clinical
Clinical NN physiopathology
physiopathology IN of
of DT the
the NN patency
patency IN of
of DT the
the JJ interatrial
interatrial NN septum

Various JJ CAPITAL Various
Various NNS aspects
aspects IN of
of NN diuresis
diuresis IN in
in NN heart
heart JJ congestive
congestive NN failure

Changes NNS CAPITAL Changes
Changes IN in
in DT the
the NN mechanism
mechanism IN of
of JJ renal
renal NN acidification
acidification IN in
in JJ congestive
congestive NN heart
heart NN failure
failure : :
: NNS effects
effects IN of
of JJ diuretic
diuretic NN treatment
treatment IN on
on DT the
the NN acid-base
acid-base NN equilibrium

Defects NNS CAPITAL Defects
Defects IN of
of DT the
the JJ interventricular
interventricular NN septum
septum RB not
not VBN associated
associated IN with
with JJ other
other NNS malformations

Clinical JJ CAPITAL Clinical
Clinical NN physiopathology
physiopathology IN of
of DT the
the NN patency
patency IN of
of NNP CAPITAL Botallo
Botallo POS 's
's NN ductus
ductus NN arteriosus

Clinical JJ CAPITAL Clinical
Clinical NN physiopathology
physiopathology IN of
of JJ congenital
congenital JJ cyanogenic
cyanogenic NNS cardiopathies

Electronic JJ CAPITAL Electronic
Electronic NNS computers
computers IN in
in JJ medical
medical NN education
education IN of
of DT the
the NN future

Anesthesiology NNP CAPITAL Anesthesiology
Anesthesiology CC and
and NNS computers

Immediate NNP CAPITAL Immediate
Immediate NN outcome
outcome CC and
and JJ long-term
long-term NNS results
results IN of
of CD 108
108 NNS sphincterotomies
sphincterotomies IN of
of NNP CAPITAL Oddi
Oddi POS 's
's NN sphincter
sphincter IN of
of JJ biliary
biliary NN indication

Neuraminic JJ CAPITAL Neuraminic
Neuraminic JJ acid-containing
acid-containing NNS oligosaccharides
oligosaccharides IN of
of JJ human
human NN urine
urine : :
: NN isolation
isolation CC and
and NN identification
identification IN of
of NN di-N-acetylneuraminyl-3-galactosyl-N-acetylgalactosamine
di-N-acetylneuraminyl-3-galactosyl-N-acetylgalactosamine , ,
, NN 6-2-Nacetylneuraminyl-lactose
6-2-Nacetylneuraminyl-lactose , ,
, NN 6-2-N-acetylneuraminyl-N-acetyllactosamine
6-2-N-acetylneuraminyl-N-acetyllactosamine CC and
and NN 3-2-N-acetylneuraminyl-lactose

Determination NN CAPITAL Determination
Determination IN of
of NN serum
serum NN oxytocinase
oxytocinase NN (
( NN 1-cystine-aminopeptidase
1-cystine-aminopeptidase NN )
) NN activity

Intolerance NN CAPITAL Intolerance
Intolerance TO to
to NN milk
milk IN in
in JJ ulcerative
ulcerative NN colitis

A DT CAPITAL A
A JJ preliminary
preliminary NN report

Rhinitis NN CAPITAL Rhinitis
Rhinitis IN in
in NNS herds
herds IN with
with NN piglet
piglet NN influenza

Research NNP CAPITAL Research
Research IN on
on VBG breeding
breeding NN hygiene
hygiene IN in
in NNS pigs
pigs CC and
and NNS piglets
piglets JJ free
free IN from
from JJ epidemic
epidemic NNS diseases

The DT CAPITAL The
The JJ stimulatory
stimulatory NN effect
effect IN of
of VBG luteinizing
luteinizing NN hormone
hormone IN on
on NN adenosine
adenosine CD 3
3 '' '
' , ,
, JJ 5'-monophosphate
5'-monophosphate NN accumulation
accumulation IN in
in NN corpus
corpus NN luteum
luteum NNS slices

Electrolyte NN CAPITAL Electrolyte
Electrolyte CC and
and NN acid-base
acid-base NN balance
balance IN in
in JJ fetal
fetal CC and
and JJ maternal
maternal NN blood

An DT CAPITAL An
An JJ experimental
experimental CC and
and DT a
a JJ clinical
clinical NN study

Q NNP CAPITAL Q
Q NN fever
fever IN at
at DT a
a VBN combined
combined NN meat
meat CC and
and NN poultry
poultry NN abattoir

Some DT CAPITAL Some
Some JJ functional
functional CC and
and JJ morphological
morphological NNS alterations
alterations VBG occurring
occurring IN during
during CC and
and IN after
after DT the
the NN adaptation
adaptation IN of
of NNP CAPITAL BHK
BHK CD 21
21 NN clone
clone CD 13
13 NNS cells
cells TO to
to NN suspension
suspension NN culture

Asbestos NN CAPITAL Asbestos
Asbestos IN as
as DT an
an JJ urban
urban NN air
air NN contaminant

Gas NN CAPITAL Gas
Gas NN permeability
permeability IN of
of NN plastic
plastic NNS membranes
membranes IN for
for JJ artificial
artificial NNS lungs

Technoogy NNP CAPITAL Technoogy
Technoogy , ,
, NN automation
automation CC and
and JJ human
human NN welfare

A DT CAPITAL A
A NN radium
radium NN accident
accident IN in
in DT a
a NN hospital

High JJ CAPITAL High
High NN energy
energy NN roentgen
roentgen NN ray
ray NN contamination
contamination IN of
of DT the
the NN electron
electron NN beam
beam IN from
from DT a
a JJ medical
medical NN betatron

The DT CAPITAL The
The RB genetically
genetically JJ significant
significant NN dose
dose IN from
from NN roentgen
roentgen NNS examinations
examinations IN in
in NNP CAPITAL Finland
Finland IN in
in CD 1963

Differential JJ CAPITAL Differential
Differential NN expression
expression IN of
of NN fibroblast
fibroblast NN growth
growth NN factor-2
factor-2 CC and
and NN receptor
receptor IN by
by JJ glial
glial NNS cells
cells IN in
in JJ experimental
experimental JJ autoimmune
autoimmune NN encephalomelitis
encephalomelitis NN (
( NNP CAPITAL EAE
EAE NN )

Cesarean NNP CAPITAL Cesarean
Cesarean NNS deliveries
deliveries IN at
at DT a
a NN university
university NN hospital
hospital : :
: NN analysis
analysis IN of
of NNS rates
rates CC and
and NNS indications

Increase NN CAPITAL Increase
Increase IN in
in JJ ambient
ambient NN temperature
temperature MD may
may VB explain
explain NN decrease
decrease IN in
in JJ amniotic
amniotic NN fluid
fluid NN index

Early RB CAPITAL Early
Early NN treatment
treatment IN of
of JJ gestational
gestational NN diabetes
diabetes VBZ reduces
reduces DT the
the NN rate
rate IN of
of JJ fetal
fetal NN macrosomia

Antenatally RB CAPITAL Antenatally
Antenatally JJ detectable
detectable NNS markers
markers IN for
for DT the
the NN diagnosis
diagnosis IN of
of RB autosomally
autosomally JJ trisomic
trisomic NNS fetuses
fetuses IN in
in NN at-risk
at-risk NNS pregnancies

The DT CAPITAL The
The NN rate
rate IN of
of JJ severe
severe NN preeclampsia
preeclampsia VBZ is
is VBN increased
increased IN in
in NN triplet
triplet IN as
as VBN compared
compared TO to
to NN twin
twin NNS gestations

Thermal JJ CAPITAL Thermal
Thermal NN equipment
equipment NN usage
usage NNS patterns
patterns IN in
in JJ neonatal
neonatal JJ intensive
intensive NN care
care NNS units
units : :
: NN interunit
interunit NN variability
variability CC and
and NN intraunit
intraunit NN consistency

Massive JJ CAPITAL Massive
Massive JJ fetomaternal
fetomaternal NN hemorrhage

Perinatal JJ CAPITAL Perinatal
Perinatal NNS features
features IN of
of JJ omphalocele-exstrophy-imperforate
omphalocele-exstrophy-imperforate JJ anus-spinal
anus-spinal NNS defects
defects NN (
( NNS CAPITAL OEIS
OEIS NN complex
complex NN )
) VBN associated
associated IN with
with JJ large
large NNS meningomyeloceles
meningomyeloceles CC and
and JJ severe
severe NN limb
limb NNS defects

Subchorial JJ CAPITAL Subchorial
Subchorial NN hematoma
hematoma : :
: DT a
a JJ probable
probable NN cause
cause IN of
of JJ reversible
reversible JJ nonimmune
nonimmune NNS hydrops
hydrops NN fetalis

Pregnancy NN CAPITAL Pregnancy
Pregnancy IN in
in JJ chronic
chronic JJ progressive
progressive JJ external
external NN ophthalmoplegia
ophthalmoplegia : :
: DT a
a NN case
case NN report

Effect NN CAPITAL Effect
Effect IN of
of NN magnesium
magnesium NN sulfate
sulfate IN on
on DT the
the NN development
development IN of
of JJ cystic
cystic JJ periventricular
periventricular NN leukomalacia
leukomalacia IN in
in NN preterm
preterm NNS infants

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> VBN CAPITAL Repeated
Repeated NNS courses
courses IN of
of NNS steroids
steroids IN in
in NN preterm
preterm NN membrane
membrane NN rupture
rupture VB do
do RB not
not NN increase
increase DT the
the NN risk
risk IN of
of JJ histologic
histologic NN chorioamnionitis

Intrapartum NNP CAPITAL Intrapartum
Intrapartum NN sonography
sonography IN of
of DT the
the JJR lower
lower NN uterine
uterine NN segment
segment IN in
in NNS patients
patients IN with
with NN breech-presenting
breech-presenting NNS fetuses

Isolated VBN CAPITAL Isolated
Isolated JJ persistent
persistent JJ fetal
fetal NN bradycardia
bradycardia IN in
in JJ complete
complete NN CAPITAL A-V
A-V NN block
block : :
: DT a
a JJ conservative
conservative NN approach
approach VBZ is
is JJ appropriate

A DT CAPITAL A
A NN case
case NN report
report CC and
and DT a
a NN review
review IN of
of DT the
the NN literature

Spontaneous JJ CAPITAL Spontaneous
Spontaneous NN rectus
rectus NN sheath
sheath NN hematoma
hematoma IN during
during NN pregnancy
pregnancy VBG mimicking
mimicking NN abruptio
abruptio NN placenta

Amnioinfusion NNP CAPITAL Amnioinfusion
Amnioinfusion IN for
for NN prevention
prevention IN of
of JJ pulmonary
pulmonary NN hypoplasia
hypoplasia IN in
in NN second-trimester
second-trimester NN rupture
rupture IN of
of NNS membranes

Trauma NN CAPITAL Trauma
Trauma CC and
and NN pregnancy

Fetal JJ CAPITAL Fetal
Fetal NN breathing
breathing NNS movements
movements IN within
within CD 24
24 NNS hours
hours IN of
of NN delivery
delivery IN in
in NN prematurity
prematurity VBP are
are JJ related
related TO to
to JJ histologic
histologic CC and
and JJ clinical
clinical NN evidence
evidence IN of
of NN amnionitis

Laerdal NNP CAPITAL Laerdal
Laerdal NN infant
infant NNS resuscitators
resuscitators VBP are
are JJ unreliable
unreliable IN as
as JJ free-flow
free-flow NN oxygen
oxygen NN delivery
delivery NNS devices

Laryngeal NN CAPITAL Laryngeal
Laryngeal NN obstruction
obstruction VBN caused
caused IN by
by NN lingual
lingual NN thyroglossal
thyroglossal NN duct
duct NN cyst
cyst VBG presenting
presenting IN at
at NN birth

Oligohydramnios NNS CAPITAL Oligohydramnios
Oligohydramnios CC and
and DT the
the RB appropriately
appropriately VBN grown
grown NN fetus

Ultrastructure NN CAPITAL Ultrastructure
Ultrastructure IN of
of JJ human
human NN colostral
colostral NNS cells

Dubowitz NNP CAPITAL Dubowitz
Dubowitz NN assessment
assessment IN of
of JJ gestational
gestational NN age
age CC and
and NN agreement
agreement IN with
with JJ prenatal
prenatal NNS methods

Low JJ CAPITAL Low
Low JJ prenatal
prenatal NN weight
weight NN gain
gain IN among
among JJ low-income
low-income NNS women
women : :
: WDT what
what VBP are
are DT the
the NN risk
risk NNS factors
factors . ?

Depression NN CAPITAL Depression
Depression IN after
after NN childbirth
childbirth : :
: DT the
the NNS views
views IN of
of JJ medical
medical NNS students
students CC and
and NNS women
women VBN compared

Breastfeeding VBG CAPITAL Breastfeeding
Breastfeeding CC and
and DT the
the NN use
use IN of
of NNS pacifiers

Care NNP CAPITAL Care
Care IN in
in JJ normal
normal NN birth
birth : :
: DT a
a JJ practical
practical NN guide

Technical NNP CAPITAL Technical
Technical VBG CAPITAL Working
Working NNP CAPITAL Group
Group , ,
, NNP CAPITAL World
World NNP CAPITAL Health
Health NNP CAPITAL Organization

Cesarean NNP CAPITAL Cesarean
Cesarean NNS sections
sections : :
: NNS women
women POS 's
's NN choice
choice IN for
for VBG giving
giving NN birth
birth . ?

Epidurals NNS CAPITAL Epidurals
Epidurals CC and
and VBG breastfeeding

Lamaze NN CAPITAL Lamaze
Lamaze CC and
and NNP CAPITAL Bradley
Bradley NN childbirth
childbirth NNS classes

Concerns NNS CAPITAL Concerns
Concerns IN about
about DT the
the NN institutionalization
institutionalization IN of
of NN childbirth
childbirth NN education

Index NN CAPITAL Index
Index TO to
to JJ current
current NN literature

A DT CAPITAL A
A VBN randomized
randomized NN trial
trial IN of
of JJ one-to-one
one-to-one NN nurse
nurse NN support
support IN of
of NNS women
women IN in
in NN labor

Commentary NN CAPITAL Commentary
Commentary : :
: VBP are
are NNS nurses
nurses JJ effective
effective NNS providers
providers IN of
of NN labor
labor NN support
support . ?
? MD CAPITAL Should
Should PRP they
they VB be
be . ?
? MD CAPITAL Can
Can PRP they
they VB be
be . ?

Women NNS CAPITAL Women
Women POS 's
's NNS views
views IN of
of JJ different
different NNS models
models IN of
of JJ antenatal
antenatal NN care
care IN in
in NNP CAPITAL Victoria
Victoria , ,
, NNP CAPITAL Australia

The DT CAPITAL The
The NN effect
effect IN of
of NN discharge
discharge NN pack
pack NN formula
formula CC and
and NN breast
breast NNS pumps
pumps IN on
on VBG breastfeeding
breastfeeding NN duration
duration CC and
and NN choice
choice IN of
of NN infant
infant VBG feeding
feeding NN method

Commentary NN CAPITAL Commentary
Commentary : :
: NN discharge
discharge NNS packs
packs : :
: WRB how
how RB much
much VB do
do PRP they
they NN matter
matter . ?

Quality JJ CAPITAL Quality
Quality NN framework
framework IN for
for NN force
force NN plate
plate NN testing

Bone NN CAPITAL Bone
Bone NN registration
registration NN method
method IN for
for NN robot
robot VBN assisted
assisted NN surgery
surgery : :
: NN pedicle
pedicle VB screw
screw NN insertion

Parameter NN CAPITAL Parameter
Parameter NN sensitivity
sensitivity IN of
of DT a
a JJ mathematical
mathematical NN model
model IN of
of DT the
the JJ anterior
anterior NN cruciate
cruciate NN ligament

Simultaneous JJ CAPITAL Simultaneous
Simultaneous NN measurement
measurement IN of
of NN stiffness
stiffness CC and
and NN energy
energy JJ absorptive
absorptive NNS properties
properties IN of
of JJ articular
articular NN cartilage
cartilage CC and
and NN subchondral
subchondral JJ trabecular
trabecular NN bone

Estimation NN CAPITAL Estimation
Estimation IN of
of NNS loads
loads CC and
and NNS stresses
stresses IN in
in JJ abdominal
abdominal NNS muscles
muscles IN during
during JJ slow
slow NNS lifts

Contralateral JJ CAPITAL Contralateral
Contralateral NN modification
modification IN of
of JJ transitory
transitory VBN evoked
evoked JJ otoacoustic
otoacoustic NNS emissions

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ cavernous
cavernous NNS hemangiomas
hemangiomas IN with
with DT the
the NN neodymium
neodymium : :
: NN CAPITAL YAG
YAG NN laser

Mucous JJ CAPITAL Mucous
Mucous NN membrane
membrane NNS melanomas
melanomas IN of
of DT the
the JJ upper
upper JJ aerodigestive
aerodigestive NN tract

An DT CAPITAL An
An NN analysis
analysis IN of
of CD 34
34 NNS cases

Are VBP CAPITAL Are
Are DT the
the NNS products
products IN of
of NN CAPITAL CD44
CD44 NNS exons
exons NN v5
v5 CC and
and NN v6
v6 NNS markers
markers IN for
for NN metastasis
metastasis IN of
of NN laryngeal
laryngeal NNS carcinomas
carcinomas . ?

Detection NN CAPITAL Detection
Detection IN of
of RB differentially
differentially VBN expressed
expressed NNS genes
genes IN in
in NN head-neck
head-neck NNS carcinomas

Tuberculosis NN CAPITAL Tuberculosis
Tuberculosis IN of
of DT the
the NN parotid
parotid NN gland
gland : :
: DT a
a JJ rare
rare JJ differential
differential NN diagnosis
diagnosis IN of
of NN parotid
parotid NN tumor

A DT CAPITAL A
A NN case
case IN of
of NN sarcoidosis
sarcoidosis IN of
of DT the
the NN mastoid

Genomic JJ CAPITAL Genomic
Genomic NN medicine

Internet NN CAPITAL Internet
Internet NNS resources
resources IN for
for JJ medical
medical NNS genetics

Genetics NNP CAPITAL Genetics

A DT CAPITAL A
A NN piece
piece IN of
of PRP$ my
my NN mind

A DT CAPITAL A
A JJ 'normal
'normal '' '
' NN practice

Predisposition NN CAPITAL Predisposition
Predisposition JJ genetic
genetic NN testing
testing IN for
for NN late-onset
late-onset NNS disorders
disorders IN in
in NNS adults

A DT CAPITAL A
A NN position
position NN paper
paper IN of
of DT the
the NNP CAPITAL National
National NNP CAPITAL Society
Society IN of
of JJ CAPITAL Genetic
Genetic NNS CAPITAL Counselors

Scientists NNS CAPITAL Scientists
Scientists VB revel
revel IN in
in JJ new
new NN research
research NN tool
tool : :
: DT an
an NN online
online NN index
index IN of
of NN cancer
cancer NNS genes

Center NNP CAPITAL Center
Center IN for
for JJ genetic
genetic NN research
research IN on
on NN scleroderma

As IN CAPITAL As
As NNS discoveries
discoveries VB unfold
unfold , ,
, DT a
a JJ new
new NN urgency
urgency TO to
to VB bring
bring JJ genetic
genetic NN literacy
literacy TO to
to NNS physicians

> JJR >
> IN CAPITAL From
From DT the
the NNPS CAPITAL Centers
Centers IN for
for NN CAPITAL Disease
Disease NN CAPITAL Control
Control CC and
and NNP CAPITAL Prevention

Gonorrhea NNP CAPITAL Gonorrhea
Gonorrhea IN among
among NNS men
men WP who
who VB have
have NN sex
sex IN with
with NNS men
men : --
-- VBN selected
selected RB sexually
sexually VBN transmitted
transmitted NNS diseases
diseases NNS clinics
clinics , ,
, CD 1993-1996

> JJR >
> IN CAPITAL From
From DT the
the NNPS CAPITAL Centers
Centers IN for
for NN CAPITAL Disease
Disease NN CAPITAL Control
Control CC and
and NNP CAPITAL Prevention

Chlamydia NN CAPITAL Chlamydia
Chlamydia NN screening
screening NNS practices
practices IN of
of JJ primary-care
primary-care NNS providers
providers : --
-- VB CAPITAL Wake
Wake NNP CAPITAL County
County , ,
, NNP CAPITAL North
North NNP CAPITAL Carolina
Carolina , ,
, CD 1996

Social NNP CAPITAL Social
Social NNS ties
ties CC and
and NN susceptibility
susceptibility TO to
to DT the
the JJ common
common JJ cold

Prevention NNP CAPITAL Prevention
Prevention IN of
of JJ bacterial
bacterial NN endocarditis
endocarditis : :
: NNP CAPITAL American
American NNP CAPITAL Heart
Heart NNP CAPITAL Association
Association NNS recommendations

Issues NNS CAPITAL Issues
Issues VBG regarding
regarding JJ antiretroviral
antiretroviral NN treatment
treatment IN for
for NNS patients
patients IN with
with NN CAPITAL HIV-1
HIV-1 NN infection

Prescribing VBG CAPITAL Prescribing
Prescribing NN protease
protease NNS inhibitors
inhibitors IN for
for DT the
the NN homeless

Treatment NN CAPITAL Treatment
Treatment IN of
of NN verruca
verruca NN vulgaris
vulgaris IN with
with JJ topical
topical NN cidofovir

Complete JJ CAPITAL Complete
Complete JJ genomic
genomic NN screen
screen IN in
in NN late-onset
late-onset JJ familial
familial NN CAPITAL Alzheimer
Alzheimer NN disease

Evidence NN CAPITAL Evidence
Evidence IN for
for DT a
a JJ new
new NN locus
locus IN on
on NN chromosome
chromosome CD 12

BRCA1 NN CAPITAL BRCA1
BRCA1 NN sequence
sequence NN analysis
analysis IN in
in NNS women
women IN at
at JJ high
high NN risk
risk IN for
for NN susceptibility
susceptibility NNS mutations

Risk NN CAPITAL Risk
Risk NN factor
factor NN analysis
analysis CC and
and NNS implications
implications IN for
for JJ genetic
genetic NN testing

Characteristics NNS CAPITAL Characteristics
Characteristics IN of
of NN prostate
prostate NN cancer
cancer IN in
in NNS families
families RB potentially
potentially VBN linked
linked TO to
to DT the
the JJ hereditary
hereditary NN prostate
prostate NN cancer
cancer CD 1
1 NN (
( NN CAPITAL HPC1
HPC1 NN )
) NN locus

Chromosome NN CAPITAL Chromosome
Chromosome CD 19
19 NN single-locus
single-locus CC and
and NN multilocus
multilocus NN haplotype
haplotype NNS associations
associations IN with
with JJ multiple
multiple NN sclerosis

Evidence NN CAPITAL Evidence
Evidence IN of
of DT a
a JJ new
new NN susceptibility
susceptibility NN locus
locus IN in
in JJ CAPITAL Caucasian
Caucasian CC and
and JJ CAPITAL Chinese
Chinese NNS patients

Cancer NN CAPITAL Cancer
Cancer NN incidence
incidence IN after
after NN retinoblastoma

Radiation NNP CAPITAL Radiation
Radiation NN dose
dose CC and
and NN sarcoma
sarcoma NN risk

Genetic JJ CAPITAL Genetic
Genetic NN testing
testing IN in
in JJ hereditary
hereditary JJ colorectal
colorectal NN cancer

Molecular JJ CAPITAL Molecular
Molecular NNS neurogenetics
neurogenetics : :
: DT the
the NN genome
genome VBZ is
is VBG settling
settling DT the
the NN issue

Family NNP CAPITAL Family
Family NN history
history CC and
and JJ genetic
genetic NN risk
risk NNS factors
factors : :
: RB forward
forward TO to
to DT the
the NN future

Preparing VBG CAPITAL Preparing
Preparing NN health
health NNS professionals
professionals IN for
for DT the
the JJ genetic
genetic NN revolution

Preterm NNP CAPITAL Preterm
Preterm JJ premature
premature NN rupture
rupture IN of
of DT the
the NNS membranes
membranes VBN associated
associated IN with
with JJ recent
recent NN cocaine
cocaine NN use

Attitudes NNS CAPITAL Attitudes
Attitudes IN toward
toward NN health-care
health-care , ,
, NN CAPITAL HIV
HIV NN infection
infection , ,
, CC and
and JJ perinatal
perinatal NN transmission
transmission NNS interventions
interventions IN in
in DT a
a NN cohort
cohort IN of
of NN inner-city
inner-city , ,
, JJ pregnant
pregnant NNS women

Association NNP CAPITAL Association
Association IN of
of NN parvovirus
parvovirus NN infection
infection IN with
with VBN isolated
isolated JJ fetal
fetal NNS effusions

Early RB CAPITAL Early
Early CC and
and JJ long-term
long-term NNS results
results IN of
of NN rehabilitation
rehabilitation IN of
of NN cochlear
cochlear VB implant
implant NNS patients
patients NN )

Principles NNS CAPITAL Principles
Principles IN of
of NN signal
signal NN detection
detection IN in
in NN pharmacovigilance

Homology NN CAPITAL Homology
Homology NN modeling
modeling IN of
of JJ adenylosuccinate
adenylosuccinate NN synthetase
synthetase IN from
from FW CAPITAL Saccharomyces
Saccharomyces FW cerevisiae
cerevisiae VBZ reveals
reveals DT a
a JJ possible
possible NN binding
binding NN region
region IN for
for JJ single-stranded
single-stranded NN CAPITAL ARS
ARS NNS sequences

Deletion NN CAPITAL Deletion
Deletion NN analysis
analysis IN of
of DT the
the NN p16/CDKN2
p16/CDKN2 NN gene
gene IN in
in NN head
head CC and
and NN neck
neck JJ squamous
squamous NN cell
cell NN carcinoma
carcinoma VBG using
using JJ quantitative
quantitative NN polymerase
polymerase NN chain
chain NN reaction
reaction NN method

Ribosomal JJ CAPITAL Ribosomal
Ribosomal NN CAPITAL S6
S6 NN kinase
kinase NN p90rsk
p90rsk CC and
and NN mRNA
mRNA JJ cap-binding
cap-binding NN protein
protein NN eIF4E
eIF4E NNS phosphorylations
phosphorylations NN correlate
correlate IN with
with NN CAPITAL MAP
MAP NN kinase
kinase NN activation
activation IN during
during JJ meiotic
meiotic NN reinitiation
reinitiation IN of
of NN mouse
mouse NNS oocytes

Hyaluronidase NN CAPITAL Hyaluronidase
Hyaluronidase NN activity
activity IN of
of JJ macaque
macaque NN sperm
sperm VBN assessed
assessed IN by
by DT an
an IN in
in NN vitro
vitro NN cumulus
cumulus NN penetration
penetration NN assay

The DT CAPITAL The
The NN comparison
comparison IN of
of DT the
the NN responsiveness
responsiveness IN of
of JJ human
human VBN isolated
isolated JJ internal
internal JJ mammary
mammary CC and
and JJ gastroepiploic
gastroepiploic NNS arteries
arteries TO to
to NN levcromakalim
levcromakalim : :
: DT an
an NN alternative
alternative NN approach
approach TO to
to DT the
the NN management
management IN of
of NN graft
graft NN spasm

Single-dose JJ CAPITAL Single-dose
Single-dose NNS pharmacokinetics
pharmacokinetics IN of
of NN felbamate
felbamate IN in
in NNS patients
patients IN with
with JJ renal
renal NN dysfunction

Reporting NNP CAPITAL Reporting
Reporting IN of
of JJ adverse
adverse NN drug
drug NNS reactions
reactions IN by
by NN hospital
hospital NNS doctors
doctors CC and
and DT the
the NN response
response TO to
to NN intervention

Glutamate NNP CAPITAL Glutamate
Glutamate NNS receptors
receptors CC and
and NN gene
gene NN induction
induction : :
: NN signalling
signalling IN from
from NN receptor
receptor TO to
to NN nucleus

Role NN CAPITAL Role
Role IN of
of NN phosphatidylinositol
phosphatidylinositol NN 3-kinase
3-kinase IN in
in NN degranulation
degranulation VBN induced
induced IN by
by JJ CAPITAL IgE-dependent
IgE-dependent CC and
and JJ -independent
-independent NNS mechanisms
mechanisms IN in
in NN rat
rat JJ basophilic
basophilic NN CAPITAL RBL-2H3
RBL-2H3 NN (
( NN ml
ml NN )
) NNS cells

Platelet-derived JJ CAPITAL Platelet-derived
Platelet-derived NN growth
growth NN factor
factor VBZ activates
activates DT a
a JJ mammalian
mammalian NN CAPITAL Ste20
Ste20 VBN coupled
coupled JJ mitogen-activated
mitogen-activated NN protein
protein NN kinase
kinase IN in
in NN airway
airway NN smooth
smooth NN muscle

Cyclic JJ CAPITAL Cyclic
Cyclic NN CAPITAL AMP
AMP NNS inhibitors
inhibitors VBZ inhibits
inhibits JJ CAPITAL PDGF-stimulated
PDGF-stimulated JJ mitogen-activated
mitogen-activated NN protein
protein NN kinase
kinase NN activity
activity IN in
in NN rat
rat JJ aortic
aortic NN smooth
smooth NN muscle
muscle NNS cells
cells IN via
via NN inactivation
inactivation IN of
of NN c-Raf-1
c-Raf-1 NN kinase
kinase CC and
and NN induction
induction IN of
of NN CAPITAL MAP
MAP NN kinase
kinase NN phosphatase-1

Mitochondrial JJ CAPITAL Mitochondrial
Mitochondrial NNS cytopathies
cytopathies CC and
and JJ renal
renal JJ tubular
tubular NN acidosis

Elective JJ CAPITAL Elective
Elective NN surgery
surgery IN for
for JJ colorectal
colorectal NN cancer
cancer IN in
in DT the
the JJ aged
aged : :
: DT a
a JJ clinical-economical
clinical-economical NN evaluation

Leukaemia NN CAPITAL Leukaemia
Leukaemia CC and
and JJ non-Hodgkin
non-Hodgkin POS 's
's NN lymphoma
lymphoma IN in
in NNS children
children CC and
and JJ young
young NNS adults
adults : :
: VBP are
are JJ prenatal
prenatal CC and
and JJ neonatal
neonatal NNS factors
factors JJ important
important NNS determinants
determinants IN of
of NN disease
disease . ?

Inverse JJ CAPITAL Inverse
Inverse NN correlation
correlation IN between
between NN loss
loss IN of
of NN heterozygosity
heterozygosity IN of
of DT the
the RB short
short NN arm
arm IN of
of NN chromosome
chromosome CD 12
12 CC and
and NN p15ink4B/p16ink4
p15ink4B/p16ink4 NN gene
gene NN inactivation
inactivation IN in
in NN childhood
childhood JJ acute
acute JJ lymphoblastic
lymphoblastic NN leukaemia

Drug NN CAPITAL Drug
Drug NN resistance
resistance NNS markers
markers : :
: VBP are
are PRP they
they JJ bad
bad CC or
or JJ good
good . ?

Elective JJ CAPITAL Elective
Elective NN surgery
surgery IN for
for JJ gastrointestinal
gastrointestinal NNS tumours
tumours IN in
in DT the
the JJ elderly

Folate NNP CAPITAL Folate
Folate CC and
and NN heart
heart NN disease
disease : :
: JJ theoretical
theoretical NN link
link NNS needs
needs NN study
study . .

A DT CAPITAL A
A NN call
call IN for
for JJ stepped-up
stepped-up NN melanoma
melanoma NN screening

New NNP CAPITAL New
New NNS approaches
approaches TO to
to NN stroke
stroke VB require
require JJ immediate
immediate NN action

The DT CAPITAL The
The NN focus
focus VBZ is
is RB now
now IN on
on NNS standards
standards CC and
and NN privacy
privacy IN in
in JJ electronic
electronic NN patient
patient NNS records

Osteopathic JJ CAPITAL Osteopathic
Osteopathic NN manifesto

I PRP CAPITAL I
I . .
. NN CAPITAL Introduction

II NNP CAPITAL II

The DT CAPITAL The
The NNS roots

1981 CD 1981

Treatment NN CAPITAL Treatment
Treatment NNS uncertainties
uncertainties VB surround
surround RB early
early NN diagnosis
diagnosis IN of
of NN breast
breast NN cancer

Depression NN CAPITAL Depression
Depression IN in
in DT the
the RB chronically
chronically RB ill
ill NNS needs
needs JJ separate
separate NN treatment

Medical NNP CAPITAL Medical
Medical NNS centers
centers VB tackle
tackle NNS delays
delays , ,
, VB reduce
reduce NN wait
wait NNS times

Epilepsy NNP CAPITAL Epilepsy
Epilepsy CC and
and NN attention
attention NN deficit
deficit NN hyperactivity
hyperactivity NN disorder
disorder : :
: VBZ is
is NN methylphenidate
methylphenidate JJ safe
safe CC and
and JJ effective
effective . ?

Applying VBG CAPITAL Applying
Applying DT the
the NN CAPITAL AIDS
AIDS NN paradigm
paradigm TO to
to NN hepatitis

New NNP CAPITAL New
New NN asthma
asthma NNS guidelines
guidelines VB emphasize
emphasize RB better
better NN diagnosis
diagnosis , ,
, JJR stricter
stricter NN control

Osteopathic JJ CAPITAL Osteopathic
Osteopathic NN manifesto

IV CD CAPITAL IV

The DT CAPITAL The
The NN search

1981 CD 1981

Researchers NNS CAPITAL Researchers
Researchers NN puzzle
puzzle IN over
over NN origin
origin IN of
of NN type
type CD 2
2 NN diabetes

Ovarian JJ CAPITAL Ovarian
Ovarian NN cancer
cancer : :
: JJ diagnostic
diagnostic NNS limitations
limitations , ,
, NN treatment
treatment NNS obstacles

Osteopathic JJ CAPITAL Osteopathic
Osteopathic NN manifesto

V NN CAPITAL V

Legislative JJ CAPITAL Legislative
Legislative CC and
and JJ legal
legal NN vigilance

1981 CD 1981

Osteopathic JJ CAPITAL Osteopathic
Osteopathic NN manifesto

VI NNP CAPITAL VI

The DT CAPITAL The
The NN light
light IN of
of DT the
the NN profession

1981 CD 1981

Electrophysiological JJ CAPITAL Electrophysiological
Electrophysiological NN evidence
evidence IN on
on DT the
the NN time
time NN course
course IN of
of JJ semantic
semantic CC and
and JJ phonological
phonological NNS processes
processes IN in
in NN speech
speech NN production

Effects NNS CAPITAL Effects
Effects IN of
of NN alanine
alanine CC and
and NN glycine
glycine NN substitution
substitution IN for
for NN tryptophan
tryptophan IN on
on DT the
the NN heterogeneity
heterogeneity IN of
of NN gramicidin
gramicidin DT CAPITAL A
A NNS analogs
analogs IN in
in NNS micelles

Torsion-angle JJ CAPITAL Torsion-angle
Torsion-angle JJ molecular
molecular NNS dynamics
dynamics IN as
as DT a
a JJ new
new JJ efficient
efficient NN tool
tool IN for
for NN CAPITAL NMR
NMR NN structure
structure NN calculation

Time-domain NN CAPITAL Time-domain
Time-domain NN quanification
quanification IN of
of NN amplitude
amplitude , ,
, NN chemical
chemical NN shift
shift , ,
, JJ apparent
apparent NN relaxation
relaxation NN time
time NN CAPITAL T2
T2 , ,
, CC and
and NN phase
phase IN by
by NN wavelet-transform
wavelet-transform NN analysis

Application NN CAPITAL Application
Application TO to
to JJ biomedical
biomedical JJ magnetic
magnetic NN resonance
resonance NN spectroscopy

Investigation NN CAPITAL Investigation
Investigation IN of
of NNS uncertainties
uncertainties IN in
in NN relaxation
relaxation NN analysis
analysis IN of
of NN 2D
2D NNP CAPITAL NOE
NOE WDT which
which VB arise
arise IN from
from JJ spectral
spectral NN noise

An DT CAPITAL An
An JJ efficient
efficient NN CAPITAL HN
HN NN (
( NNP CAPITAL CA
CA NN )
) NNP CAPITAL NH
NH NN pluse
pluse NN scheme
scheme IN for
for NN triple-resonance
triple-resonance NN 4D
4D NN correlation
correlation IN of
of JJ sequential
sequential NN amide
amide NNS protons
protons CC and
and NN nitrogens-15
nitrogens-15 IN in
in VBN deuterated
deuterated NNS proteins

Optimal JJ CAPITAL Optimal
Optimal NN detection
detection IN of
of JJ weak
weak NN nJ
nJ NN (
( CD 1H-
1H- NN 119Sn
119Sn NN )
) NNS couplings
couplings IN by
by JJ gradient-enhanced
gradient-enhanced NN 1D
1D CC and
and NN 2D
2D NN heteronuclear
heteronuclear JJ multiple-quantum
multiple-quantum NN correlation
correlation NN spectroscopy

Application NN CAPITAL Application
Application TO to
to DT a
a JJ novel
novel NN tin
tin NN derivative
derivative IN of
of NN erythromycin
erythromycin DT CAPITAL A

Thermoelectric NNP CAPITAL Thermoelectric
Thermoelectric VBG cooling
cooling IN for
for NN CAPITAL NMR
NMR NN sample
sample NN temperature
temperature NN control

H2NCO-E.COSY NN CAPITAL H2NCO-E.COSY
H2NCO-E.COSY , ,
, DT a
a JJ simple
simple NN method
method IN for
for DT the
the JJ sterospecific
sterospecific NN assignment
assignment IN of
of NN side-chain
side-chain NN amide
amide NNS protons
protons IN in
in NNS proteins

Applying VBG CAPITAL Applying
Applying NN excitation
excitation VBG sculpting
sculpting TO to
to NN construct
construct RB singly
singly CC and
and RB doubly
doubly JJ selective
selective NN 1D
1D NN CAPITAL NMR
NMR NNS experiments

Radiation NNP CAPITAL Radiation
Radiation NN dosimetry
dosimetry IN by
by JJ localized
localized JJ magnetic
magnetic NN resonance
resonance NN spectroscopy

The DT CAPITAL The
The NN 2D
2D NN CAPITAL NMR
NMR NNS experiments
experiments NN CAPITAL H
H NN (
( NN CAPITAL C
C NN )
) NN CAPITAL CO2
CO2 CC and
and NN CAPITAL HCCO2
HCCO2 IN for
for NN assignment
assignment CC and
and NN pH
pH NN titration
titration IN of
of NN carboxylate
carboxylate NNS groups
groups IN in
in RB uniformly
uniformly JJ 15N/13C-labeled
15N/13C-labeled NNS proteins

Post-acquisition NN CAPITAL Post-acquisition
Post-acquisition JJ solvent
solvent NN suppression
suppression IN by
by JJ singular-value
singular-value NN decomposition

Osteopathic JJ CAPITAL Osteopathic
Osteopathic NN manifesto

IX CD CAPITAL IX

What WDT CAPITAL What
What IN about
about PRP$ our
our NN distinctiveness
distinctiveness . ?
? CD 1981

Preparing VBG CAPITAL Preparing
Preparing IN for
for IN thalidomide
thalidomide POS 's
's NN comeback

Heart NNP CAPITAL Heart
Heart NN disease
disease : :
: NNS women
women POS 's
's JJ unique
unique NNS risks
risks NN demand
demand NN attention

Resolution NN CAPITAL Resolution
Resolution JJ due
due IN in
in JJ medical
medical NN software
software NN regulation

Osteopathic JJ CAPITAL Osteopathic
Osteopathic NN manifesto

VII NN CAPITAL VII

Shadows NNS CAPITAL Shadows
Shadows CC and
and NNS images

1981 CD 1981

The DT CAPITAL The
The JJ practical
practical NN use
use IN of
of NN CAPITAL PCR
PCR IN for
for JJ rapid
rapid NN detection
detection IN of
of NN methicillin
methicillin NN resistance
resistance IN among
among NN staphylococcal
staphylococcal JJ clinical
clinical NNS isolates
isolates IN from
from JJ CAPITAL Turkish
Turkish NNS hospitals

Randomised VBN CAPITAL Randomised
Randomised JJ double-blind
double-blind NN trial
trial IN of
of VBN fixed
fixed JJ low-dose
low-dose NN warfarin
warfarin IN with
with NN aspirin
aspirin IN after
after JJ myocardial
myocardial NN infarction

Coumadin NNP CAPITAL Coumadin
Coumadin NN CAPITAL Aspirin
Aspirin NN CAPITAL Reinfarction
Reinfarction NN CAPITAL Study
Study NN (
( NNS CAPITAL CARS
CARS NN )
) NNS CAPITAL Investigators

Randomised VBN CAPITAL Randomised
Randomised NN trial
trial IN of
of NN roxithromycin
roxithromycin IN in
in JJ non-Q-wave
non-Q-wave JJ coronary
coronary NNS syndromes
syndromes : :
: NNS CAPITAL ROXIS
ROXIS NN CAPITAL Pilot
Pilot NN CAPITAL Study

ROXIS NNS CAPITAL ROXIS
ROXIS NN CAPITAL Study
Study NNP CAPITAL Group

Association NNP CAPITAL Association
Association IN between
between NN 5-HT2A
5-HT2A NN gene
gene NN promoter
promoter NN polymorphism
polymorphism CC and
and NN anorexia
anorexia NN nervosa

Randomised VBN CAPITAL Randomised
Randomised NN study
study IN of
of NN radical
radical NN surgery
surgery CC versus
versus NN radiotherapy
radiotherapy IN for
for NN stage
stage NN CAPITAL Ib-IIa
Ib-IIa JJ cervical
cervical NN cancer

State NN CAPITAL State
State NN regulation
regulation IN in
in DT a
a NN world
world IN of
of `` ``
`` JJ boundary-less
boundary-less '' ''
'' NN technology

Screening VBG CAPITAL Screening
Screening IN for
for NN CAPITAL Chlamydia
Chlamydia NN trachomatis
trachomatis . ?

Physician-assisted JJ CAPITAL Physician-assisted
Physician-assisted NN suicide
suicide IN in
in NNP CAPITAL Oregon

Common JJ CAPITAL Common
Common JJ nutritional
nutritional NNS issues
issues IN in
in JJ pediatric
pediatric CC and
and JJ adult
adult JJ critical
critical NN care
care NN medicine

A DT CAPITAL A
A JJ multifactorial
multifactorial NN analysis
analysis IN of
of JJ facial
facial NN nerve
nerve NNS results
results IN in
in NN surgery
surgery IN for
for NN cerebellopontine
cerebellopontine NN angle
angle NNS tumors

Osteopathic JJ CAPITAL Osteopathic
Osteopathic NN manifesto

VIII CD CAPITAL VIII

Our PRP$ CAPITAL Our
Our JJ distinct
distinct NN image

1981 CD 1981

Quality JJ CAPITAL Quality
Quality IN in
in JJ general
general NN practice

Winning VBG CAPITAL Winning
Winning DT the
the NN war
war IN on
on NN cancer

Clinical JJ CAPITAL Clinical
Clinical JJ problem-solving
problem-solving : --
-- WRB where
where VBD did
did JJ good
good JJ old
old JJ clinical
clinical NN diagnosis
diagnosis VB go
go . ?

The DT CAPITAL The
The VBN named
named NN nurse
nurse : :
: NN patient
patient CC and
and NN nurse
nurse NNS expectations

Genetic JJ CAPITAL Genetic
Genetic NN testing
testing VBZ opens
opens VB brave
brave JJ new
new NN world

Heterologous JJ CAPITAL Heterologous
Heterologous NNS vaccines
vaccines : :
: NN proponent
proponent VBZ sparks
sparks DT some
some NN interest

Steps NNS CAPITAL Steps
Steps RB still
still VBG being
being VBN taken
taken TO to
to VB undo
undo NN damage
damage IN of
of `` ``
`` NNP CAPITAL America
America POS 's
's NNP CAPITAL Nuremberg
Nuremberg '' ''

Patient-centered JJ CAPITAL Patient-centered
Patient-centered NNS ethics
ethics VBG reclaiming
reclaiming NN center
center NN stage

Social NNP CAPITAL Social
Social NNS ties
ties CC and
and NN susceptibility
susceptibility TO to
to DT the
the JJ common
common JJ cold

Connecting VBG CAPITAL Connecting
Connecting NN peptide
peptide , ,
, VBG correcting
correcting NN peptide
peptide . ?

Winning VBG CAPITAL Winning
Winning NN health
health NNS victories
victories IN with
with NN community
community NN commitment

Telemedicine NNP CAPITAL Telemedicine
Telemedicine VBZ gets
gets DT a
a NN chance
chance TO to
to VB prove
prove PRP itself

Additional JJ CAPITAL Additional
Additional NNS opinions
opinions IN on
on DT the
the NN mortality
mortality IN of
of NN animal
animal NN research

Recurrent JJ CAPITAL Recurrent
Recurrent NNS strokes
strokes IN in
in DT a
a JJ 34-year-old
34-year-old NN man

A DT CAPITAL A
A NN plan
plan IN for
for VBG improving
improving NNS outcomes
outcomes IN for
for NNS patients
patients IN with
with JJ chronic
chronic JJ renal
renal NN failure

Scientific NNP CAPITAL Scientific
Scientific NN evidence
evidence IN in
in NN family
family CC and
and NN community
community NN medicine

Evidence NN CAPITAL Evidence
Evidence IN that
that DT the
the NN expression
expression IN of
of JJ progesterone-induced
progesterone-induced VBG blocking
blocking NN factor
factor IN by
by JJ maternal
maternal NNS CAPITAL T-lymphocytes
T-lymphocytes VBZ is
is RB positively
positively VBD correlated
correlated IN with
with NN conception

Another DT CAPITAL Another
Another NN use
use IN of
of NNS androgens
androgens : :
: NN treatment
treatment IN of
of NN anemia
anemia IN of
of NN end-stage
end-stage JJ renal
renal NN disease

Isotopic JJ CAPITAL Isotopic
Isotopic NN evidence
evidence IN for
for JJ extraterrestrial
extraterrestrial JJ non-racemic
non-racemic NN amino
amino NNS acids
acids IN in
in DT the
the NNP CAPITAL Murchison
Murchison NN meteorite

The DT CAPITAL The
The NNP CAPITAL American
American NNP CAPITAL Medical
Medical NNP CAPITAL Association
Association NNS CAPITAL Guidelines
Guidelines IN for
for JJ CAPITAL Adolescent
Adolescent JJ CAPITAL Preventive
Preventive NNPS CAPITAL Services

Classification NN CAPITAL Classification
Classification IN of
of JJ malignant
malignant NNS lymphomas
lymphomas : :
: DT the
the VBN updated
updated NNP CAPITAL Kiel
Kiel NN classification

Rethink VB CAPITAL Rethink
Rethink IN on
on NN screening
screening IN for
for NN breast
breast NN cancer

Sports-related JJ CAPITAL Sports-related
Sports-related JJ ocular
ocular NNS injuries

Fruit NNP CAPITAL Fruit
Fruit NN juice
juice NN consumption

The DT CAPITAL The
The NN case
case IN of
of DT the
the VBG missing
missing NN methylphenidate

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Intensive
Intensive NN insulin
insulin NN treatment
treatment IN after
after JJ acute
acute JJ myocardial
myocardial NN infarction
infarction IN in
in NN diabetes
diabetes NN mellitus

Intensive JJ CAPITAL Intensive
Intensive NN insulin
insulin NNS regimens
regimens IN in
in JJ primary
primary NN prevention
prevention MD should
should VB be
be VBN assessed

GPs NNS CAPITAL GPs
GPs '' '
' NNS perceptions
perceptions IN of
of NN tolerability
tolerability IN of
of JJ selective
selective NN serotonin
serotonin NN reuptake
reuptake NNS inhibitors
inhibitors CC and
and JJ tricyclic
tricyclic NNS antidepressants

Research NNP CAPITAL Research
Research IN into
into RB long
long NN term
term NN use
use VBZ is
is VBN needed

Diagnosing VBG CAPITAL Diagnosing
Diagnosing CC and
and VBG managing
managing NN polymyalgia
polymyalgia NN rheumatica
rheumatica CC and
and JJ temporal
temporal NN arteritis

Sensitivity NN CAPITAL Sensitivity
Sensitivity IN of
of JJ temporal
temporal NN artery
artery NN biopsy
biopsy VBZ varies
varies IN with
with NN biopsy
biopsy NN length
length CC and
and NN sectioning
sectioning NN strategy

Obstructive JJ CAPITAL Obstructive
Obstructive NN sleep
sleep NN apnoea

Authors NNS CAPITAL Authors
Authors '' '
' NN reply

Impact NN CAPITAL Impact
Impact IN of
of JJ postmenopausal
postmenopausal NN hormone
hormone NN therapy
therapy IN on
on JJ cardiovascular
cardiovascular NNS events
events CC and
and NN cancer
cancer . .

Search VB CAPITAL Search
Search IN for
for NNS studies
studies VBD was
was JJ limited

Treating VBG CAPITAL Treating
Treating NN shoulder
shoulder NNS complaints
complaints IN in
in JJ general
general NN practice

Diagnostic JJ CAPITAL Diagnostic
Diagnostic NNS criteria
criteria MD must
must VB be
be VBN used
used CC and
and JJ therapeutic
therapeutic NNS regimens
regimens VBN standardised

Authorship NN CAPITAL Authorship

System NNP CAPITAL System
System VBG acknowledging
acknowledging NNS roles
roles IN of
of NNS contributors
contributors VBZ is
is RB best

Authorship NN CAPITAL Authorship

New NNP CAPITAL New
New NN authorship
authorship NNS practices
practices VBP are
are VBN needed
needed IN in
in VBG developing
developing NNS countries

Authorship NN CAPITAL Authorship

Researchers NNS CAPITAL Researchers
Researchers '' '
' NN objective
objective VBZ is
is TO to
to VB get
get DT the
the NN job
job VBN done

Quality JJ CAPITAL Quality
Quality CC and
and JJ clinical
clinical NN audit

Transurethral JJ CAPITAL Transurethral
Transurethral NN microwave
microwave NN thermotherapy

Management NN CAPITAL Management
Management IN of
of NN ileosigmoid
ileosigmoid VBG knotting

Epitome NNP CAPITAL Epitome
Epitome IN of
of NN myocarditis

Producing NNP CAPITAL Producing
Producing JJ consistent
consistent NNS estimates
estimates IN of
of DT the
the NN power
power JJ spectral
spectral NN density
density IN of
of NNP CAPITAL NN
NN NNS sequences

Environmental NNP CAPITAL Environmental
Environmental NN tobacco
tobacco NN smoke
smoke CC and
and JJ coronary
coronary NN heart
heart NN disease

Long-term JJ CAPITAL Long-term
Long-term NN benefit
benefit IN of
of CD one
one JJ thrombolytic
thrombolytic IN over
over DT another

Coupling NN CAPITAL Coupling
Coupling IN of
of JJ hemodynamic
hemodynamic NNS measurements
measurements IN with
with NN oxygen
oxygen IN during
during NN exercise
exercise VBZ does
does RB not
not VB improve
improve NN risk
risk NN stratification
stratification IN in
in NNS patients
patients IN with
with NN heart
heart NN failure

Smoking NN CAPITAL Smoking
Smoking : --
-- JJ good
good CC or
or JJ bad
bad IN for
for NN semen
semen . ?

The DT CAPITAL The
The NN pruning
pruning IN of
of NN CAPITAL Doctor
Doctor NNP CAPITAL McDonough
McDonough CC and
and DT the
the `` ``
`` VBG humanizing
humanizing '' ''
'' IN of
of NNS statistics

Violence NN CAPITAL Violence

Prevention NNP CAPITAL Prevention
Prevention IN in
in DT the
the NN home
home NN health
health VBG setting

Contempo NNP CAPITAL Contempo
Contempo CD 1997
1997 : :
: NNS obstetrics
obstetrics CC and
and NN gynecology

Mortality NN CAPITAL Mortality
Mortality CC and
and NN refusal
refusal IN of
of NN CAPITAL ICU
ICU NN admission

Extracorporeal NNP CAPITAL Extracorporeal
Extracorporeal NN photopheresis
photopheresis IN in
in CAPITAL S
S NN (
( NN c
c NN )
) NN zary
zary NN syndrome

Attacks NNS CAPITAL Attacks
Attacks IN on
on NN tobacco
tobacco NN industry

Does VBZ CAPITAL Does
Does VBG blinding
blinding IN of
of NNS readers
readers VB affect
affect NNS results
results IN of
of NNS meta-analyses
meta-analyses . ?

Consumption NN CAPITAL Consumption
Consumption IN of
of NN alcohol
alcohol CC and
and NN mortality
mortality IN in
in NNP CAPITAL Russia

Presenilin NNP CAPITAL Presenilin
Presenilin NNS polymorphisms
polymorphisms IN in
in NN CAPITAL Alzheimer
Alzheimer POS 's
's NN disease

Autoimmune NN CAPITAL Autoimmune
Autoimmune NN enteropathy
enteropathy IN in
in NNS adults

Cyclosporiasis NNP CAPITAL Cyclosporiasis
Cyclosporiasis CC and
and NNS raspberries

Protean JJ CAPITAL Protean
Protean NNS agonists

Keys NNP CAPITAL Keys
Keys TO to
to NN receptor
receptor JJ active
active NNS states
states . ?

Kinetic JJ CAPITAL Kinetic
Kinetic NNS models
models IN of
of NN ion
ion NNS channels

Agonist NN CAPITAL Agonist
Agonist NN efficacy
efficacy CC and
and JJ allosteric
allosteric NNS models
models IN of
of NN receptor
receptor NN action

Receptor NN CAPITAL Receptor
Receptor NN CAPITAL Classification
Classification : :
: DT CAPITAL The
The NN CAPITAL Integration
Integration IN of
of JJ CAPITAL Operational
Operational , ,
, NNP CAPITAL Structural
Structural , ,
, CC and
and JJ CAPITAL Transductional
Transductional NN CAPITAL Information

Conference NN CAPITAL Conference
Conference NNS proceedings

Verona NNP CAPITAL Verona
Verona , ,
, NNP CAPITAL Italy
Italy , ,
, NNP CAPITAL September
September CD 21-22
21-22 , ,
, CD 1995

Policies NNS CAPITAL Policies
Policies IN for
for VBG posting
posting JJ biomedical
biomedical NN journal
journal NN information
information IN on
on DT the
the NN CAPITAL Internet

International NNP CAPITAL International
International NNP CAPITAL Committee
Committee IN of
of NNP CAPITAL Medical
Medical NNP CAPITAL Journal
Journal NNS CAPITAL Editors

Who WP CAPITAL Who
Who VBZ understands
understands DT the
the NN menopause
menopause . ?

Comparison NN CAPITAL Comparison
Comparison IN of
of CD two
two NNS methods
methods IN of
of NN screening
screening IN for
for JJ genital
genital JJ chlamydial
chlamydial NN infection
infection IN in
in NNS women
women VBG attending
attending IN in
in JJ general
general NN practice
practice : :
: NN cross
cross JJ sectional
sectional NN survey

Antimicrobial JJ CAPITAL Antimicrobial
Antimicrobial NN therapy
therapy IN in
in NN neutropenia

M1/4llerian CAPITAL M1/4llerian
M1/4llerian NN agenesis
agenesis : :
: DT an
an VB update

The DT CAPITAL The
The NNP CAPITAL US
US NN attack
attack IN on
on NNP CAPITAL Cuba
Cuba POS 's
's NN health

Patient NN CAPITAL Patient
Patient NN consent
consent IN for
for NN publication
publication CC and
and DT the
the NN health
health IN of
of DT the
the NN public

Brain NN CAPITAL Brain
Brain NN serotonin
serotonin NN neurotoxicity
neurotoxicity CC and
and JJ primary
primary JJ pulmonary
pulmonary NN hypertension
hypertension IN from
from NN fenfluramine
fenfluramine CC and
and NN dexfenfluramine

Battling VBG CAPITAL Battling
Battling NN CAPITAL HI
HI IN on
on JJ many
many NNS fronts

Medical NNP CAPITAL Medical
Medical NNP CAPITAL Injury
Injury NNP CAPITAL Compensation
Compensation NN CAPITAL Reform
Reform NNP CAPITAL Act
Act : :
: JJ good
good CC or
or JJ bad
bad . ?

Fever NN CAPITAL Fever
Fever IN of
of JJ unknown
unknown NN origin

Moxonidine NN CAPITAL Moxonidine
Moxonidine IN for
for NN hypertension

Researchers NNS CAPITAL Researchers
Researchers VB make
make JJ slow
slow NN headway
headway IN in
in VBG managing
managing JJ dry
dry NN mouth

A DT CAPITAL A
A JJR kinder
kinder , ,
, JJR gentler
gentler NN approach

Putting VBG CAPITAL Putting
Putting NNS patients
patients RB first
first . ?

Managing VBG CAPITAL Managing
Managing DT the
the JJ anxious
anxious CC and
and JJ phobic
phobic JJ dental
dental NN patient

Do VB CAPITAL Do
Do PRP it
it CC or
or VB lose
lose PRP it

Assessment NNP CAPITAL Assessment
Assessment IN of
of JJ fetal
fetal JJ nuchal
nuchal NN translucency
translucency NN test
test IN for
for NN CAPITAL Down
Down POS 's
's NN syndrome

Amiodarone NNP CAPITAL Amiodarone
Amiodarone CC and
and NN thyroid
thyroid NN function

Chemotherapy NN CAPITAL Chemotherapy
Chemotherapy IN with
with NN praziquantel
praziquantel VBZ has
has DT the
the NN potential
potential TO to
to VB reduce
reduce DT the
the NN prevalence
prevalence IN of
of NN CAPITAL Echinococcus
Echinococcus NNS multilocularis
multilocularis IN in
in JJ wild
wild NNS foxes
foxes NN (
( NNP CAPITAL Vulpes
Vulpes NNS vulpes
vulpes NN )

Death NN CAPITAL Death
Death NNS rates
rates IN from
from NN childhood
childhood NN leukaemia
leukaemia IN near
near JJ nuclear
nuclear NNS sites

Other JJ CAPITAL Other
Other NNS studies
studies VBD showed
showed IN that
that NN radiation
radiation NNS levels
levels IN in
in NNP CAPITAL Newbury
Newbury NN area
area VBD were
were JJ low

Haemoptysis NNP CAPITAL Haemoptysis
Haemoptysis : :
: DT a
a JJ rare
rare NN cause

Human JJ CAPITAL Human
Human NN papillomavirus
papillomavirus NNS types
types CD 52
52 CC and
and CD 58
58 VBP are
are JJ prevalent
prevalent IN in
in JJ cervical
cervical NN cancer
cancer IN from
from JJ CAPITAL Chinese
Chinese NNS women

Breastfeeding VBG CAPITAL Breastfeeding
Breastfeeding IN after
after RB early
early NN discharge

Malnutrition NN CAPITAL Malnutrition
Malnutrition CC and
and NN microcephaly
microcephaly IN in
in JJ CAPITAL Australian
Australian NN aboriginal
aboriginal NNS children

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Probucol
Probucol CC and
and NNS multivitamins
multivitamins IN in
in DT the
the NN prevention
prevention IN of
of NN restenosis
restenosis IN after
after JJ coronary
coronary NN angioplasty

Generalised VBN CAPITAL Generalised
Generalised JJ caseous
caseous NN lymphadenitis

Public NNP CAPITAL Public
Public NN health
health NN approach
approach TO to
to VBN activated
activated NN protein
protein NN CAPITAL C
C NN resistance
resistance NN assay

Hormone NN CAPITAL Hormone
Hormone NN replacement
replacement NN therapy

Dose-volume NN CAPITAL Dose-volume
Dose-volume NNS histograms
histograms MD can
can VB be
be VBN interpreted
interpreted IN in
in JJ different
different NNS ways

Addressing VBG CAPITAL Addressing
Addressing NN needle-stick
needle-stick NNS concerns

Cervical JJ CAPITAL Cervical
Cervical NN cancer
cancer NN screening

CyberCHEST NN CAPITAL CyberCHEST

An DT CAPITAL An
An JJ open
open NN future

Keeping VBG CAPITAL Keeping
Keeping PRP us
us IN on
on PRP$ our
our NNS toes
toes . !

Thalidomide NNP CAPITAL Thalidomide
Thalidomide IN in
in JJ oral
oral NN CAPITAL Crohn
Crohn POS 's
's NN disease
disease JJ refractory
refractory TO to
to JJ conventional
conventional JJ medical
medical NN treatment

Mortality NN CAPITAL Mortality
Mortality CC and
and NN length
length IN of
of NN stay
stay IN in
in NN teaching
teaching CC vs
vs VBG nonteaching
nonteaching NNS hospitals

Early RB CAPITAL Early
Early NN discharge
discharge IN of
of NNS newborns

Patient NN CAPITAL Patient
Patient NN consent
consent IN for
for NN publication

Flucticasone NN CAPITAL Flucticasone
Flucticasone NN propionate
propionate VBZ is
is JJ safe
safe IN in
in VBN recommended
recommended NNS doses

Fetal JJ CAPITAL Fetal
Fetal JJ nuchal
nuchal NN translucency
translucency NN test
test IN for
for NN CAPITAL Down
Down POS 's
's NN syndrome

Treatment NN CAPITAL Treatment
Treatment IN of
of NN hypertension
hypertension IN in
in JJ elderly
elderly NNS patients

Meta-analyses NNS CAPITAL Meta-analyses
Meta-analyses CC and
and JJ large
large VBN randomized
randomized , ,
, VBN controlled
controlled NNS trials

Low-fat NN CAPITAL Low-fat
Low-fat NNS diets

Ultrasonographic JJ CAPITAL Ultrasonographic
Ultrasonographic NN evaluation
evaluation IN of
of JJ parathyroid
parathyroid NN hyperplasia

Misconceptions NNS CAPITAL Misconceptions
Misconceptions IN about
about NN mosaicism

Are VBP CAPITAL Are
Are JJ normal
normal NN hearing
hearing NNS thresholds
thresholds DT a
a JJ sufficient
sufficient NN condition
condition IN for
for JJ click-evoked
click-evoked JJ otoacoustic
otoacoustic NNS emissions
emissions . ?

Structure NN CAPITAL Structure
Structure CC and
and IN in
in NN vitro
vitro NN substrate
substrate NN specificity
specificity IN of
of DT the
the JJ murine
murine JJ multidrug
multidrug JJ resistance-associated
resistance-associated NN protein

ATP-dependent JJ CAPITAL ATP-dependent
ATP-dependent NN transport
transport IN of
of JJ lipophilic
lipophilic JJ cytotoxic
cytotoxic NNS drugs
drugs IN by
by NN membrane
membrane NNS vesicles
vesicles JJ prepared
prepared IN from
from JJ CAPITAL MRP-overexpressing
MRP-overexpressing NN CAPITAL HL60/ADR
HL60/ADR NNS cells

Cellular JJ CAPITAL Cellular
Cellular CC and
and IN in
in NN vitro
vitro NN transport
transport IN of
of NN glutathione
glutathione NNS conjugates
conjugates IN by
by NN CAPITAL MRP

Dominant JJ CAPITAL Dominant
Dominant JJ negative
negative CC and
and JJ cooperative
cooperative NNS effects
effects IN of
of NN mutant
mutant NNS forms
forms IN of
of NN prolactin
prolactin NN receptor

Effect NN CAPITAL Effect
Effect IN of
of NN calcium
calcium CC and
and NN vitamin
vitamin NN CAPITAL D
D NN supplementation
supplementation IN on
on NN bone
bone NN density
density IN in
in NNS men
men CC and
and NNS women
women CD 65
65 NNS years
years IN of
of NN age
age CC or
or JJR older

Infection NN CAPITAL Infection
Infection NN control
control CC and
and VBN contaminated
contaminated NN waste
waste NN disposal
disposal NNS practices
practices IN in
in NNP CAPITAL Southern
Southern NNP CAPITAL Sydney
Sydney NN CAPITAL Area
Area NNP CAPITAL Health
Health NNP CAPITAL Service
Service JJ CAPITAL Dental
Dental NNS CAPITAL Clinics

Vitamins NNS CAPITAL Vitamins
Vitamins CC and
and NNS minerals
minerals : :
: NN efficacy
efficacy CC and
and NN safety

Joint NNP CAPITAL Joint
Joint NNP CAPITAL Commission
Commission IN on
on NN CAPITAL Accreditation
Accreditation IN of
of NNP CAPITAL Healthcare
Healthcare NNP CAPITAL Organizations
Organizations '' '
' NN infection
infection NN control
control NNS requirements
requirements : :
: NN fact
fact CC or
or NN fiction
fiction . ?

Poppy NNP CAPITAL Poppy
Poppy NN tea
tea CC and
and DT the
the NN baker
baker POS 's
's RB first
first NN seizure

ABC NNP CAPITAL ABC
ABC IN of
of JJ mental
mental NN health

Mental JJ CAPITAL Mental
Mental NN health
health CC and
and DT the
the NN law

Female JJ CAPITAL Female
Female JJ embryonic
embryonic NN lethality
lethality IN in
in NNS mice
mice JJ nullizygous
nullizygous IN for
for DT both
both NN CAPITAL Msh2
Msh2 CC and
and NN p53

Tests NNS CAPITAL Tests
Tests IN of
of DT the
the NN double-strand
double-strand NN break
break , ,
, RB lethal-potentially
lethal-potentially JJ lethal
lethal CC and
and NN repair-misrepair
repair-misrepair NNS models
models IN for
for JJ mammalian
mammalian NN cell
cell NN survival
survival VBG using
using NNS data
data IN for
for NN survival
survival IN as
as DT a
a NN function
function IN of
of JJ delayed-plating
delayed-plating NN interval
interval IN for
for NN log-phase
log-phase JJ CAPITAL Chinese
Chinese NN hamster
hamster NN CAPITAL V79
V79 NNS cells

Influence NN CAPITAL Influence
Influence IN of
of NN physician
physician NN confidentiality
confidentiality NNS assurances
assurances IN on
on NNS adolescents
adolescents '' '
' NN willingness
willingness TO to
to VB disclose
disclose NN information
information CC and
and VB seek
seek NN future
future NN health
health NN care

A DT CAPITAL A
A VBN randomized
randomized VBN controlled
controlled NN trial

Fever NN CAPITAL Fever
Fever IN in
in NNP CAPITAL Africa
Africa : :
: VB do
do NNS patients
patients VB know
know WRB when
when PRP they
they VBP are
are JJ hot
hot . ?

Randomised VBN CAPITAL Randomised
Randomised JJ placebo-controlled
placebo-controlled NN trial
trial IN of
of JJ granulocyte-colony
granulocyte-colony VBG stimulating
stimulating NN factor
factor IN in
in JJ diabetic
diabetic NN foot
foot NN infection

Systemic JJ CAPITAL Systemic
Systemic NN absorption
absorption IN of
of NN sunscreen
sunscreen IN after
after JJ topical
topical NN application

A DT CAPITAL A
A NN comparison
comparison IN of
of JJ continuous
continuous NN infusion
infusion IN of
of RB alteplase
alteplase IN with
with JJ double-bolus
double-bolus NN administration
administration IN for
for JJ acute
acute JJ myocardial
myocardial NN infarction

The DT CAPITAL The
The JJ CAPITAL Continuous
Continuous NN CAPITAL Infusion
Infusion CC versus
versus JJ CAPITAL Double-Bolus
Double-Bolus NN CAPITAL Administration
Administration IN of
of RB CAPITAL Alteplase
Alteplase NN (
( NNP CAPITAL COBALT
COBALT NN )
) NNS CAPITAL Investigators

Evaluation NN CAPITAL Evaluation
Evaluation CC and
and NN management
management IN of
of JJ traumatic
traumatic NNS lacerations

Atrial NNP CAPITAL Atrial
Atrial NN fibrillation
fibrillation VBZ begets
begets NN trouble

Ethics NNS CAPITAL Ethics
Ethics IN of
of NN CAPITAL HIV
HIV NNS trials

The DT CAPITAL The
The NNS ethics
ethics NN industry

Fever NN CAPITAL Fever
Fever IN in
in NNP CAPITAL Africa
Africa CC and
and WP CAPITAL WHO
WHO NN recommendation

`` `` ``
`` NN CAPITAL Whiplash
Whiplash '' ''
'' NN injury
injury IN of
of DT the
the JJ cervical
cervical NN spine
spine : :
: NN value
value IN of
of JJ modern
modern JJ diagnostic
diagnostic NN imaging

Guidelines NNS CAPITAL Guidelines
Guidelines CC and
and JJ cardiac
cardiac NNS anaesthetists

Antibiotic JJ CAPITAL Antibiotic
Antibiotic NN management
management IN of
of JJ sore
sore NN throat

Lansoprazole NN CAPITAL Lansoprazole
Lansoprazole , ,
, NNP CAPITAL H.
H. NN pylori
pylori , ,
, CC and
and JJ atrophic
atrophic NN gastritis
gastritis . .

Help VB CAPITAL Help
Help VBD wanted
wanted : :
: NNS ultrasonographers

`` `` ``
`` NNS CAPITAL Children
Children VBP are
are RB not
not VBN supposed
supposed TO to
to VB die

'' '' ''
'' VBN CAPITAL Combined
Combined JJ pediatric
pediatric CC and
and NN radiation
radiation NN oncology
oncology JJ grand
grand NNS rounds
rounds NNS addresses
addresses JJ severe
severe NN illness
illness CC and
and NN death

Structure-activity JJ CAPITAL Structure-activity
Structure-activity CC and
and NN mechanism
mechanism NNS studies
studies IN on
on NN silicon
silicon NNS phthalocyanines
phthalocyanines IN with
with NN CAPITAL Plasmodium
Plasmodium NN falciparum
falciparum IN in
in DT the
the JJ dark
dark CC and
and IN under
under JJ red
red NN light

The DT CAPITAL The
The NN importance
importance IN of
of VBG being
being WRB where
where . ?
? VBG CAPITAL Balancing
Balancing DT the
the NN perspective
perspective IN on
on NN practice
practice NN coverage

Effects NNS CAPITAL Effects
Effects IN of
of NN dobutamine
dobutamine IN at
at RB maximally
maximally VBN tolerated
tolerated NN dose
dose IN on
on JJ myocardial
myocardial NN blood
blood NN flow
flow IN in
in NNS humans
humans IN with
with JJ ischemic
ischemic NN heart
heart NN disease
disease . .

Cholesterol-lowering JJ CAPITAL Cholesterol-lowering
Cholesterol-lowering NN therapy

Ion NN CAPITAL Ion
Ion NN composition
composition IN of
of NN airway
airway NN surface
surface NN liquid
liquid IN of
of NNS patients
patients IN with
with JJ cystic
cystic NN fibrosis
fibrosis IN as
as VBN compared
compared IN with
with JJ normal
normal CC and
and JJ disease-control
disease-control NNS subjects

Research NNP CAPITAL Research
Research IN in
in NNP CAPITAL Copenhagen
Copenhagen NNS hospitals
hospitals : --
-- DT a
a JJ bibliometric
bibliometric NN evaluation

More RBR CAPITAL More
More IN on
on NN infertility

Dermatobia NNP CAPITAL Dermatobia
Dermatobia : --
-- JJ tropical
tropical NN myiasis

Progressive JJ CAPITAL Progressive
Progressive NN sensorineural
sensorineural NN hearing
hearing NN loss
loss , ,
, JJ subjective
subjective NN tinnitus
tinnitus CC and
and NN vertigo
vertigo VBN caused
caused IN by
by JJ elevated
elevated NN blood
blood NNS lipids

Chronic JJ CAPITAL Chronic
Chronic NN telogen
telogen NN effluvium
effluvium : :
: NN potential
potential NN complication
complication IN for
for JJ clinical
clinical NNS trials
trials IN in
in NN female
female JJ androgenetic
androgenetic NN alopecia
alopecia . ?

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNP CAPITAL Measles
Measles NN vaccination
vaccination CC and
and JJ inflammatory
inflammatory NN bowel
bowel NN disease

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ suicidal
suicidal NNS patients

The DT CAPITAL The
The JJ systemic
systemic NNS amyloidoses

Cancer NN CAPITAL Cancer
Cancer NN therapy
therapy CC and
and NN tumor
tumor NN physiology

Mutual JJ CAPITAL Mutual
Mutual NNS relationships
relationships VBN based
based IN on
on NN equality

Specialists NNS CAPITAL Specialists
Specialists CC and
and NNS nurses
nurses : :
: DT the
the NNS pillars
pillars IN of
of NN hospital
hospital NN care

Disability NN CAPITAL Disability
Disability NNS models
models IN in
in NNS geriatrics
geriatrics : :
: JJ comprehensive
comprehensive RB rather
rather IN than
than VBG competing
competing NNS models
models MD should
should VB be
be VBN promoted

Ethical JJ CAPITAL Ethical
Ethical NNS issues
issues IN in
in JJ interventional
interventional NN radiology

Taking VBG CAPITAL Taking
Taking NN issue
issue IN with
with NNP CAPITAL UK
UK NN funding
funding NNS priorities

Phototherapeutic JJ CAPITAL Phototherapeutic
Phototherapeutic NN keratectomy
keratectomy IN in
in JJ recurrent
recurrent NN corneal
corneal NNS erosions
erosions JJ refractory
refractory TO to
to JJ other
other NNS forms
forms IN of
of NN treatment

Wegener NNP CAPITAL Wegener
Wegener POS 's
's NN granulomatosis
granulomatosis IN from
from NN infancy
infancy TO to
to NN adolescence

Hormonal JJ CAPITAL Hormonal
Hormonal NNS responses
responses TO to
to NN restraint
restraint IN in
in NN rhesus
rhesus NNS monkeys

Planned NNP CAPITAL Planned
Planned NN parenthood
parenthood CC and
and JJ artifical
artifical NN selection

Valvular JJ CAPITAL Valvular
Valvular NN heart
heart NN disease
disease VBN associated
associated IN with
with NN fenfluramine-phentermine

The DT CAPITAL The
The NN role
role IN of
of NNS procedures
procedures IN in
in NN family
family NN practice
practice : :
: VBZ is
is RB there
there DT a
a RB right
right NN answer
answer . ?

Arthrodesis FW CAPITAL Arthrodesis
Arthrodesis IN of
of DT the
the RB first
first NN metatarsophalangeal
metatarsophalangeal NN joint
joint TO to
to NN salvage
salvage VBD failed
failed NN silicone
silicone VB implant
implant NN arthroplasty

Methadone NNP CAPITAL Methadone
Methadone NN maintenance
maintenance NN treatment
treatment : :
: DT a
a JJ CAPITAL Canadian
Canadian NN perspective

Survey NN CAPITAL Survey
Survey IN on
on NN rotavirus
rotavirus NNS infections
infections IN in
in DT a
a JJ CAPITAL German
German JJ pediatric
pediatric NN hospital

Stroke NN CAPITAL Stroke
Stroke NN incidence
incidence NNS rates
rates IN among
among JJ black
black NNS residents
residents IN of
of NNP CAPITAL Harare
Harare : --
-- DT a
a JJ prospective
prospective JJ community-based
community-based NN study

Long-term JJ CAPITAL Long-term
Long-term NN effect
effect IN of
of NN calcium
calcium NN supplementation
supplementation IN during
during NN pregnancy
pregnancy IN on
on DT the
the NN blood
blood NN pressure
pressure IN of
of NN offspring
offspring : :
: VB follow
follow RB up
up IN of
of DT a
a VBN randomised
randomised VBN controlled
controlled NN trial

The DT CAPITAL The
The JJ catalytic
catalytic NN role
role IN of
of NN carbon
carbon NN dioxide
dioxide IN in
in DT the
the NN decomposition
decomposition IN of
of NN peroxynitrite

Unethical JJ CAPITAL Unethical
Unethical NNS trials
trials IN of
of NNS interventions
interventions TO to
to VB reduce
reduce JJ perinatal
perinatal NN transmission
transmission IN of
of DT the
the JJ human
human NN immunodeficiency
immunodeficiency NN virus
virus IN in
in VBG developing
developing NNS countries

Ropinirole NNP CAPITAL Ropinirole
Ropinirole IN for
for DT the
the NN treatment
treatment IN of
of RB early
early NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease

The DT CAPITAL The
The NNP CAPITAL Ropinirole
Ropinirole NN CAPITAL Study
Study NNP CAPITAL Group

DOTS NNS CAPITAL DOTS
DOTS : --
-- VBP are
are PRP we
we JJ over-optimistic
over-optimistic . ?

Activation NN CAPITAL Activation
Activation IN at
at DT the
the JJ germinal
germinal NN vesicle
vesicle NN stage
stage IN of
of NN starfish
starfish NNS oocytes
oocytes VBZ produces
produces JJ parthenogenetic
parthenogenetic NN development
development IN through
through DT the
the NN failure
failure IN of
of JJ polar
polar NN body
body NN extrusion

Female JJ CAPITAL Female
Female JJ genital
genital NN mutilation
mutilation : :
: DT a
a JJ contemporary
contemporary NN issue
issue , ,
, CC and
and DT a
a JJ CAPITAL Victorian
Victorian NN obsession

Early RB CAPITAL Early
Early NN death
death IN amongst
amongst NNS anaesthetists

Fluoride NN CAPITAL Fluoride
Fluoride NN treatment
treatment VBN increased
increased NN serum
serum NN CAPITAL IGF-1
IGF-1 , ,
, NN bone
bone NN turnover
turnover , ,
, CC and
and NN bone
bone NN mass
mass , ,
, CC but
but RB not
not NN bone
bone NN strength
strength , ,
, IN in
in NNS rabbits

Retrospective JJ CAPITAL Retrospective
Retrospective NN comparison
comparison IN of
of NNS techniques
techniques TO to
to VB prevent
prevent JJ secondary
secondary NN cataract
cataract NN formation
formation IN after
after NN posterior
posterior NN chamber
chamber JJ intraocular
intraocular NN lens
lens NN implantation
implantation IN in
in NNS infants
infants CC and
and NNS children

Serotonin NN CAPITAL Serotonin
Serotonin IN as
as DT a
a NN regulator
regulator IN of
of JJ hypothalamic-pituitary-interrenal
hypothalamic-pituitary-interrenal NN activity
activity IN in
in IN teleost
teleost NN fish

Predicting VBG CAPITAL Predicting
Predicting JJ functional
functional NN appliance
appliance NN treatment
treatment NN outcome
outcome IN in
in NN CAPITAL Class
Class NNP CAPITAL II
II NNS malocclusions
malocclusions : --
-- DT a
a NN review

Effect NN CAPITAL Effect
Effect IN of
of NN cereal
cereal NN fibre
fibre NN source
source CC and
and NN processing
processing IN on
on JJ rectal
rectal JJ epithelial
epithelial NN cell
cell NN proliferation

Update NNP CAPITAL Update
Update : :
: NN influenza
influenza NN activity
activity : --
-- RB worldwide
worldwide , ,
, NNP CAPITAL March-August
March-August CD 1997

A DT CAPITAL A
A NN drop
drop IN in
in JJ pediatric
pediatric NN subject
subject NN examination
examination NNS scores
scores IN after
after NN curriculum
curriculum NNS changes
changes IN that
that VB emphasize
emphasize JJ general
general JJ pediatric
pediatric NNS topics

Paradigms NNS CAPITAL Paradigms
Paradigms CC and
and DT the
the NN rise
rise NN (
( CC or
or NN fall
fall . ?
? NN )
) IN of
of JJ molecular
molecular NN biology

Water NN CAPITAL Water
Water NN fluoridation
fluoridation , ,
, NN tooth
tooth NN decay
decay IN in
in CD 5
5 NN year
year NNS olds
olds , ,
, CC and
and JJ social
social NN deprivation
deprivation VBN measured
measured IN by
by DT the
the NNP CAPITAL Jarman
Jarman NN score
score : :
: NN analysis
analysis IN of
of NNS data
data IN from
from JJ CAPITAL British
British JJ dental
dental NNS surveys

The DT CAPITAL The
The NN diabetes
diabetes NN audit
audit CC and
and NN research
research IN in
in NNP CAPITAL Tayside
Tayside NNP CAPITAL Scotland
Scotland NN (
( NN CAPITAL DARTS
DARTS NN )
) NN study
study : :
: JJ electronic
electronic NN record
record NN linkage
linkage TO to
to VB create
create DT a
a NN diabetes
diabetes NN register

DARTS/MEMO NN CAPITAL DARTS/MEMO
DARTS/MEMO NN CAPITAL Collaboration

Pharmaceutical NNP CAPITAL Pharmaceutical
Pharmaceutical NN industry
industry VBZ is
is VBN invited
invited TO to
to NN respond
respond TO to
to NN amnesty
amnesty IN for
for JJ unreported
unreported NNS trials

Should MD CAPITAL Should
Should PRP we
we NN screen
screen IN for
for JJ gestational
gestational NN diabetes
diabetes . ?

Vesico-uterine JJ CAPITAL Vesico-uterine
Vesico-uterine NN fistula
fistula : --
-- DT a
a JJ rare
rare NN complication
complication IN of
of NN vacuum
vacuum NN extraction
extraction IN in
in DT a
a NN patient
patient IN with
with JJ previous
previous NN caesarean
caesarean NN section

Managing VBG CAPITAL Managing
Managing NN endophthalmitis

The DT CAPITAL The
The NN plug
plug CC and
and NN patch
patch NN repair
repair IN for
for VBG managing
managing DT the
the JJ inguinal
inguinal NN hernia
hernia IN of
of DT the
the JJ adult

Human JJ CAPITAL Human
Human NN herpesvirus
herpesvirus CD 8
8 NNS variants
variants IN in
in NN sarcoid
sarcoid NNS tissues

Practice NN CAPITAL Practice
Practice NNS parameters
parameters IN for
for DT the
the NN assessment
assessment CC and
and NN treatment
treatment IN of
of NNS children
children CC and
and NNS adolescents
adolescents IN with
with NN schizophrenia

American NNP CAPITAL American
American NNP CAPITAL Academy
Academy IN of
of NN CAPITAL Child
Child CC and
and JJ CAPITAL Adolescent
Adolescent NNP CAPITAL Psychiatry

Practice NN CAPITAL Practice
Practice NNS parameters
parameters IN for
for DT the
the JJ psychiatric
psychiatric NN assessment
assessment IN of
of NNS infants
infants CC and
and NNS toddlers
toddlers NN (
( CD 0-36
0-36 NNS months
months NN )

American NNP CAPITAL American
American NNP CAPITAL Academy
Academy IN of
of NN CAPITAL Child
Child CC and
and JJ CAPITAL Adolescent
Adolescent NNP CAPITAL Psychiatry

Practice NN CAPITAL Practice
Practice NNS parameters
parameters IN for
for DT the
the JJ forensic
forensic NN evaluation
evaluation IN of
of NNS children
children CC and
and NNS adolescents
adolescents WP who
who MD may
may VB have
have VBN been
been RB physically
physically CC or
or RB sexually
sexually JJ abused

American NNP CAPITAL American
American NNP CAPITAL Academy
Academy IN of
of NN CAPITAL Child
Child CC and
and JJ CAPITAL Adolescent
Adolescent NNP CAPITAL Psychiatry

Practice NN CAPITAL Practice
Practice NNS parameters
parameters IN for
for DT the
the JJ psychiatric
psychiatric NN assessment
assessment IN of
of NNS children
children CC and
and NNS adolescents

American NNP CAPITAL American
American NNP CAPITAL Academy
Academy IN of
of NN CAPITAL Child
Child CC and
and JJ CAPITAL Adolescent
Adolescent NNP CAPITAL Psychiatry

Alternative NNP CAPITAL Alternative
Alternative NN medicine

Leprosy NNP CAPITAL Leprosy
Leprosy IN beyond
beyond DT the
the NN year
year CD 2000

Effect NN CAPITAL Effect
Effect IN of
of JJ danaparoid
danaparoid NN sodium
sodium IN on
on RB hard
hard NNS exudates
exudates IN in
in JJ diabetic
diabetic NN retinopathy
retinopathy . .

Lead JJ CAPITAL Lead
Lead VBN based
based NN paint
paint NNS hazards
hazards IN in
in RB early
early NN childhood
childhood NNS centres
centres IN in
in DT the
the NNP CAPITAL Wellington
Wellington NN region

Gene NN CAPITAL Gene
Gene NN technology
technology CC and
and NN democracy

Use NN CAPITAL Use
Use IN of
of NNS statins

Adequacy NN CAPITAL Adequacy
Adequacy IN of
of NN CAPITAL SMAC
SMAC POS 's
's NN statement
statement MD should
should VB be
be VBN judged
judged IN by
by NNS clinicians
clinicians , ,
, RB not
not NN health
health NNS economists

Glasgow NNP CAPITAL Glasgow
Glasgow VBZ has
has RB already
already VBN produced
produced NN strategy
strategy IN for
for NN treatment

Evidence NN CAPITAL Evidence
Evidence IN on
on NN effectiveness
effectiveness VBZ is
is JJR stronger
stronger IN for
for NNS statins
statins IN than
than IN for
for JJ other
other NNS treatments

Evidence NN CAPITAL Evidence
Evidence VBN based
based NN advertising
advertising . ?
? NN CAPITAL Half
Half IN of
of NN drug
drug NNS advertisements
advertisements IN in
in NNP CAPITAL BMJ
BMJ IN over
over CD six
six NNS months
months VBN cited
cited DT no
no VBG supporting
supporting NN evidence

Non-steroidal JJ CAPITAL Non-steroidal
Non-steroidal JJ anti-inflammatory
anti-inflammatory NN therapy
therapy IN for
for JJ bronchial
bronchial NN asthma

Drugs NNS CAPITAL Drugs
Drugs IN for
for DT the
the NNP CAPITAL Third
Third NNP CAPITAL World

Getting VBG CAPITAL Getting
Getting DT a
a VB handle
handle IN on
on DT the
the NNS molecules
molecules IN that
that NN guide
guide NNS axons

The DT CAPITAL The
The JJ functional
functional NN neuroanatomy
neuroanatomy IN of
of JJ episodic
episodic NN memory
memory NN retrieval

Re NNP CAPITAL Re
Re : :
: `` ``
`` JJ CAPITAL Biologic
Biologic NN synergism
synergism CC and
and NN parallelism
parallelism '' ''

Shifting VBG CAPITAL Shifting
Shifting JJ medical
medical NN education
education IN from
from DT the
the NN icebox
icebox TO to
to DT the
the NN refrigerator

Reattendance NN CAPITAL Reattendance
Reattendance CC and
and NNS complications
complications IN in
in DT a
a VBN randomised
randomised NN trial
trial IN of
of VBG prescribing
prescribing NNS strategies
strategies IN for
for JJ sore
sore NN throat
throat : :
: DT the
the VBG medicalising
medicalising NN effect
effect IN of
of VBG prescribing
prescribing NNS antibiotics

Pure JJ CAPITAL Pure
Pure IN alexia
alexia MD could
could RB not
not VB be
be DT a
a NN disconnection
disconnection NN syndrome

A DT CAPITAL A
A VBN randomized
randomized , ,
, JJ double-blind
double-blind , ,
, NN dose-response
dose-response NN comparison
comparison IN of
of JJ epidural
epidural NN fentanyl
fentanyl CC versus
versus NN sufentanil
sufentanil NN analgesia
analgesia IN after
after NN cesarean
cesarean NN section

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Coronary
Coronary NN artery
artery NNS problems
problems IN during
during NN homograft
homograft JJ aortic
aortic NN valve
valve NN replacement
replacement : :
: NN role
role IN of
of NN transesophageal
transesophageal NN echocardiography

Spontaneous JJ CAPITAL Spontaneous
Spontaneous JJ splenic
splenic NN rupture
rupture VBG following
following NN administration
administration IN of
of NN granulocyte
granulocyte JJ colony-stimulating
colony-stimulating NN factor
factor NN (
( NN CAPITAL G-CSF
G-CSF NN )
) : :
: NN occurrence
occurrence IN in
in DT an
an JJ allogeneic
allogeneic NN donor
donor IN of
of JJ peripheral
peripheral NN blood
blood NN stem
stem NNS cells

Evidence-based JJ CAPITAL Evidence-based
Evidence-based NN medicine
medicine CC and
and JJ general
general NN practice

Koch NNP CAPITAL Koch
Koch POS 's
's CC or
or NN CAPITAL Crohn
Crohn POS 's
's . ?

Female JJ CAPITAL Female
Female NN CAPITAL Stress
Stress JJ CAPITAL Urinary
Urinary NN CAPITAL Incontinence
Incontinence JJ CAPITAL Clinical
Clinical NNS CAPITAL Guidelines
Guidelines NN CAPITAL Panel
Panel NN summary
summary NN report
report IN on
on JJ surgical
surgical NN management
management IN of
of NN female
female NN stress
stress JJ urinary
urinary NN incontinence

The DT CAPITAL The
The NNP CAPITAL American
American JJ CAPITAL Urological
Urological NNP CAPITAL Association

Haemodynamic JJ CAPITAL Haemodynamic
Haemodynamic NN performance
performance IN of
of DT a
a NN 16-mm
16-mm NNS CAPITAL Carbomedics
Carbomedics JJ aortic
aortic NN prosthesis

Case NN CAPITAL Case
Case NNS records
records IN of
of DT the
the NNP CAPITAL Massachusetts
Massachusetts NNP CAPITAL General
General NN CAPITAL Hospital

Weekly NNP CAPITAL Weekly
Weekly JJ clinicopathological
clinicopathological NNS exercises

Case NN CAPITAL Case
Case CD 30-1997

A DT CAPITAL A
A NN preterm
preterm JJ newborn
newborn NN female
female NN triplet
triplet IN with
with NN diffuse
diffuse JJ cystic
cystic NNS changes
changes IN in
in DT the
the RB left
left NN lung

Cure VB CAPITAL Cure
Cure IN of
of NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN infection
infection VBZ improves
improves JJ gastric
gastric NN acid
acid NN secretion
secretion IN in
in NNS patients
patients IN with
with NN corpus
corpus NN gastritis

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> VBN CAPITAL Increased
Increased NN incidence
incidence IN of
of NN preeclampsia
preeclampsia IN in
in NNS women
women VBG conceiving
conceiving IN by
by JJ intrauterine
intrauterine NN insemination
insemination IN with
with NN donor
donor CC versus
versus NN partner
partner NN sperm
sperm IN for
for NN treatment
treatment IN of
of JJ primary
primary NN infertility

Pediatric NNP CAPITAL Pediatric
Pediatric JJ cervical
cervical NN spine
spine NN injury
injury JJ sustained
sustained IN in
in VBZ falls
falls IN from
from JJ low
low NNS heights

Prophylaxis NNP CAPITAL Prophylaxis
Prophylaxis IN after
after JJ occupational
occupational NN exposure
exposure TO to
to NN CAPITAL HIV

How WRB CAPITAL How
How JJ critical
critical VBP are
are JJ critical
critical NNS values
values . ?

Back RB CAPITAL Back
Back IN from
from DT the
the JJ dead
dead : :
: JJ extracorporeal
extracorporeal VBG rewarming
rewarming IN of
of JJ severe
severe JJ accidental
accidental NN hypothermia
hypothermia NNS victims
victims IN in
in NN accident
accident CC and
and NN emergency

A DT CAPITAL A
A NN classification
classification IN of
of JJ nucleotide-diphospho-sugar
nucleotide-diphospho-sugar NNS glycosyltransferases
glycosyltransferases VBN based
based IN on
on NN amino
amino NN acid
acid NN sequence
sequence NNS similarities

EU NNP CAPITAL EU
EU NN directive
directive IN on
on JJ bovine
bovine NN spongiform
spongiform NN encephalopathy
encephalopathy MD will
will RB not
not VB affect
affect NNS drugs

Management NN CAPITAL Management
Management IN of
of NNS patients
patients IN with
with NN CAPITAL HIV/AIDS

Who WP CAPITAL Who
Who MD should
should NN care
care . ?

Anesthesiology NNP CAPITAL Anesthesiology

Second JJ CAPITAL Second
Second IN of
of CD two
two NNS parts

Overdrugging VBG CAPITAL Overdrugging
Overdrugging CC and
and NN undertreatment
undertreatment IN in
in JJ primary
primary NN health
health NN care

Transesophageal NN CAPITAL Transesophageal
Transesophageal NN echocardiography
echocardiography NN probe
probe NN holder

Pregnancy NN CAPITAL Pregnancy
Pregnancy NNS outcomes
outcomes IN in
in NNS women
women IN with
with JJ gestational
gestational NN diabetes
diabetes VBN compared
compared IN with
with DT the
the JJ general
general NN obstetric
obstetric NN population

Confidentiality NN CAPITAL Confidentiality
Confidentiality IN as
as DT a
a NN barrier
barrier TO to
to NN treatment

Recombinant JJ CAPITAL Recombinant
Recombinant JJ human
human NN CAPITAL DNase
DNase NN (
( NN rhDNase
rhDNase NN )
) NNS influences
influences NN phospholipid
phospholipid NN composition
composition , ,
, NN surface
surface NN activity
activity , ,
, NN rheology
rheology CC and
and RB consecutively
consecutively NN clearance
clearance NNS indices
indices IN of
of JJ cystic
cystic NN fibrosis
fibrosis NN sputum

Palliative NN CAPITAL Palliative
Palliative NNS options
options IN of
of JJ last
last NN resort
resort : :
: DT a
a NN comparison
comparison IN of
of RB voluntarily
voluntarily VBG stopping
stopping VBG eating
eating CC and
and NN drinking
drinking , ,
, JJ terminal
terminal NN sedation
sedation , ,
, JJ physician-assisted
physician-assisted NN suicide
suicide , ,
, CC and
and JJ voluntary
voluntary JJ active
active NN euthanasia

Automation NN CAPITAL Automation
Automation IN in
in JJ cervical
cervical NN cytology
cytology : :
: WP$ whose
whose NN cost
cost CC and
and WP$ whose
whose NN benefit
benefit . ?

Losing VBG CAPITAL Losing
Losing NN weight
weight : --
-- DT an
an JJ ill-fated
ill-fated NNP CAPITAL New
New NN CAPITAL Year
Year POS 's
's NN resolution

Lumbar NNP CAPITAL Lumbar
Lumbar NN puncture
puncture NN need
need RB n't
n't VB be
be DT a
a NN headache

Profiting VBG CAPITAL Profiting
Profiting IN from
from NN closure
closure : :
: DT the
the JJ private
private NN finance
finance NN initiative
initiative CC and
and DT the
the NNS CAPITAL NHS

Incidence NN CAPITAL Incidence
Incidence IN of
of NN dog
dog VB bite
bite NNS injuries
injuries VBN treated
treated IN in
in NN emergency
emergency NNS departments

Use NN CAPITAL Use
Use IN of
of JJ rotational
rotational NNS movements
movements TO to
to VB remove
remove JJ mandibular
mandibular NNS molars

Comparison NN CAPITAL Comparison
Comparison IN of
of CD three
three NNS methods
methods VBN used
used IN for
for NN assessment
assessment IN of
of NN pain
pain IN in
in NNS dogs

Randomised VBN CAPITAL Randomised
Randomised VBN controlled
controlled NN trial
trial IN of
of NN magnetic-resonance
magnetic-resonance NN pelvimetry
pelvimetry IN in
in NN breech
breech NN presentation
presentation IN at
at NN term

Single-breath JJ CAPITAL Single-breath
Single-breath VBG diffusing
diffusing NNS capacities
capacities IN for
for NN CAPITAL NO
NO , ,
, NNP CAPITAL CO
CO CC and
and NN CAPITAL C18O2
C18O2 IN in
in NNS rabbits

Improved VBN CAPITAL Improved
Improved NN control
control MD will
will VB provide
provide RB better
better NN quality

Interview NN CAPITAL Interview
Interview IN by
by NNP CAPITAL Tom
Tom NNP CAPITAL Heinemann

Case NN CAPITAL Case
Case IN of
of DT the
the NN month

Autopsy NN CAPITAL Autopsy
Autopsy NNP CAPITAL Committee
Committee IN of
of DT the
the NNP CAPITAL College
College IN of
of NNP CAPITAL American
American NNS CAPITAL Pathologists

Cor NNP CAPITAL Cor
Cor NN pulmonale

Human JJ CAPITAL Human
Human NN papillomavirus
papillomavirus IN in
in DT the
the NN woman
woman IN with
with NN CAPITAL HIV

Reducing VBG CAPITAL Reducing
Reducing NN risk
risk VBZ is
is RB best
best NN strategy

The DT CAPITAL The
The NN realpolitik
realpolitik IN of
of DT a
a JJ new
new NNP CAPITAL National
National NNP CAPITAL Health
Health NNP CAPITAL Service
Service IN for
for DT the
the NNP CAPITAL UK

What WDT CAPITAL What
What VBZ is
is PRP$ your
your NN diagnosis
diagnosis . ?
? NNP CAPITAL Foreign
Foreign NN body
body IN in
in DT the
the NN abdomen

Septic JJ CAPITAL Septic
Septic NN arthritis

Brain NN CAPITAL Brain
Brain NNS tumours
tumours CC and
and JJ mobile
mobile NNS phones
phones . ?

Lung NN CAPITAL Lung
Lung NN cancer
cancer , ,
, NN tobacco
tobacco NN smoking
smoking CC and
and JJ environmental
environmental NNS factors
factors IN in
in NNP CAPITAL Denmark

Emergency NN CAPITAL Emergency
Emergency NN department
department NN use
use IN as
as DT a
a NN component
component IN of
of NN total
total JJ ambulatory
ambulatory NN care
care : :
: DT a
a NN population
population NN perspective

Occupational JJ CAPITAL Occupational
Occupational NN therapy
therapy CC and
and NNS outcomes
outcomes IN for
for JJR older
older NNS adults

Anesthesiology NNP CAPITAL Anesthesiology

Low-molecular-weight JJ CAPITAL Low-molecular-weight
Low-molecular-weight NNS heparins

Case NN CAPITAL Case
Case CD 30-1997
30-1997 : :
: JJ pulmonary
pulmonary JJ interstitial
interstitial NN emphysema
emphysema IN in
in NN infancy

The DT CAPITAL The
The NN tobacco
tobacco NN settlement

Two CD CAPITAL Two
Two NNS actions
actions VBP are
are JJ possible
possible IN for
for NNS doctors
doctors VBG wanting
wanting TO to
to VB promote
promote JJ human
human NN welfare
welfare IN in
in NNP CAPITAL Africa

Carcinogenesis NN CAPITAL Carcinogenesis
Carcinogenesis IN in
in JJ transgenic
transgenic NN mouse
mouse NNS models

Trouble NN CAPITAL Trouble
Trouble IN in
in NN paradise

Atomic JJ CAPITAL Atomic
Atomic NN legacy
legacy IN in
in DT the
the NNP CAPITAL Marshall
Marshall NNPS CAPITAL Islands

The DT CAPITAL The
The NN road
road TO to
to NN justice

Solvent JJ CAPITAL Solvent
Solvent NN solution

Role NN CAPITAL Role
Role IN of
of JJ free
free NNS radicals
radicals , ,
, NNS telomeres
telomeres , ,
, CC and
and NNS telomerases
telomerases IN in
in VBG aging
aging CC and
and NN cancerogenesis

The DT CAPITAL The
The NN effect
effect IN of
of NN ephedrine
ephedrine IN on
on DT the
the NN onset
onset NN time
time IN of
of NN rocuronium

Antibody NN CAPITAL Antibody
Antibody NN class
class NN switch
switch NN recombinase
recombinase NN activity
activity VBZ is
is NN CAPITAL B
B NN cell
cell NN stage
stage JJ specific
specific CC and
and NNS functions
functions RB stochastically
stochastically IN in
in DT the
the NN absence
absence IN of
of VBN 'targeted
'targeted NN accessibility
accessibility '' '
' NN control

Systematic JJ CAPITAL Systematic
Systematic NN review
review IN of
of NN prophylactic
prophylactic CC vs
vs NN rescue
rescue NN surfactant

The DT CAPITAL The
The NN safety-net
safety-net NN role
role IN of
of JJ international
international JJ medical
medical NNS graduates

The DT CAPITAL The
The NN prevalence
prevalence IN of
of NN chemical
chemical NN substance
substance CC and
and NN alcohol
alcohol NN abuse
abuse IN in
in DT an
an NN obstetric
obstetric NN population
population IN in
in NNP CAPITAL Dublin

schizophrenia NN schizophrenia
schizophrenia IN as
as NN failure
failure IN of
of JJ hemispheric
hemispheric NN dominance
dominance IN for
for NN language

Late RB CAPITAL Late
Late JJ prenatal
prenatal NN ultrasound
ultrasound NNS features
features IN of
of NNS hydrometrocolpos
hydrometrocolpos JJ secondary
secondary TO to
to JJ cloacal
cloacal RB anomaly
anomaly : :
: NN case
case NNS reports
reports CC and
and NN review
review IN of
of DT the
the NN literature

Familial JJ CAPITAL Familial
Familial CC and
and JJ primary
primary NN (
( NNP CAPITAL AL
AL NN )
) JJ cardiac
cardiac NN amyloidosis
amyloidosis : :
: RB echocardiographically
echocardiographically JJ similar
similar NNS diseases
diseases IN with
with RB distinctly
distinctly JJ different
different JJ clinical
clinical NNS outcomes

Diabetic NNP CAPITAL Diabetic
Diabetic NN retinopathy
retinopathy , ,
, NN promoter
promoter NN (
( NN 4G/5G
4G/5G NN )
) NN polymorphism
polymorphism IN of
of NN CAPITAL PAI-1
PAI-1 NN gene
gene , ,
, CC and
and NN CAPITAL PAI-1
PAI-1 NN activity
activity IN in
in NNP CAPITAL Pima
Pima NNPS CAPITAL Indians
Indians IN with
with NN type
type CD 2
2 NN diabetes

Evaluation NN CAPITAL Evaluation
Evaluation IN of
of JJ diagnostic
diagnostic NN peritoneal
peritoneal NN lavage
lavage IN in
in JJ stable
stable NNS patients
patients IN with
with NN gunshot
gunshot NNS wounds
wounds TO to
to DT the
the NN abdomen

Cerebral JJ CAPITAL Cerebral
Cerebral NNS abscesses
abscesses IN in
in DT a
a NN patient
patient IN with
with NN CAPITAL AIDS
AIDS VBN caused
caused IN by
by JJ methicillin-resistant
methicillin-resistant FW CAPITAL Staphylococcus
Staphylococcus NN aureus
aureus NN (
( NNP CAPITAL MRSA
MRSA NN )

A DT CAPITAL A
A VBN randomised
randomised NN comparison
comparison IN of
of DT the
the NNP CAPITAL EuroQol
EuroQol CC and
and JJ CAPITAL Short
Short NN CAPITAL Form-36
Form-36 IN after
after NN stroke

United NNP CAPITAL United
United NNP CAPITAL Kingdom
Kingdom NNS collaborators
collaborators IN in
in DT the
the NNP CAPITAL International
International NN CAPITAL Stroke
Stroke NN CAPITAL Trial

Clinical JJ CAPITAL Clinical
Clinical NN significance
significance IN of
of NNP CAPITAL Blastocystis
Blastocystis NNS hominis
hominis NN infection
infection : :
: JJ epidemiologic
epidemiologic NN study

Karolinska NNP CAPITAL Karolinska
Karolinska NNP CAPITAL Institute
Institute VBD rocked
rocked IN by
by NN research
research NN misconduct

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Hepatic
Hepatic NN glutamine
glutamine NN synthetase
synthetase NN deficiency
deficiency IN in
in JJ fatal
fatal NN hyperammonemia
hyperammonemia IN after
after NN lung
lung NN transplantation

Where WRB CAPITAL Where
Where IN next
next IN in
in DT the
the NN treatment
treatment IN of
of JJ rectal
rectal NN cancer
cancer . ?

GAPS NNS CAPITAL GAPS
GAPS NN (
( NNP CAPITAL AMA
AMA NNS CAPITAL Guidelines
Guidelines IN for
for JJ CAPITAL Adolescent
Adolescent JJ CAPITAL Preventive
Preventive NNPS CAPITAL Services
Services NN )

Protocols NNS CAPITAL Protocols
Protocols IN for
for NN wound
wound NN management

Chronic JJ CAPITAL Chronic
Chronic NN leg
leg NNS ulcers
ulcers : :
: NN beware
beware DT the
the NN 'wolf
'wolf IN in
in NN sheep
sheep POS 's
's NN clothing
clothing . !
! '' '
' . .

Role NN CAPITAL Role
Role IN of
of NN fine
fine NN needle
needle NN aspiration
aspiration NN cytology
cytology IN in
in DT the
the NN management
management IN of
of DT the
the JJ discrete
discrete NN parotid
parotid NN lump

More RBR CAPITAL More
More IN than
than CD 20
20 NNS years
years NN second-look
second-look NN surgery
surgery IN in
in VBN advanced
advanced JJ epithelial
epithelial JJ ovarian
ovarian NN cancer
cancer : :
: WDT what
what VBD did
did PRP we
we VB learn
learn . ?

Evaluating VBG CAPITAL Evaluating
Evaluating NN prostate
prostate NN needle
needle NN biopsy
biopsy : :
: JJ therapeutic
therapeutic CC and
and JJ prognostic
prognostic NN importance

Sudden JJ CAPITAL Sudden
Sudden JJ cryptococcal
cryptococcal NN deafness

Methicillin-resistant JJ CAPITAL Methicillin-resistant
Methicillin-resistant FW CAPITAL Staphylococcus
Staphylococcus NN aureus
aureus JJ clinical
clinical NN strain
strain IN with
with VBN reduced
reduced NN vancomycin
vancomycin NN susceptibility

HIV NN CAPITAL HIV
HIV CC and
and NN CAPITAL AIDS
AIDS NN awareness
awareness : :
: DT an
an NN evaluation
evaluation IN of
of DT a
a RB short
short NN training
training NN programme
programme IN for
for NNS midwives

What WDT CAPITAL What
What NNS investigations
investigations CC and
and NNS procedures
procedures VB do
do NNS patients
patients IN in
in NNS hospices
hospices VB want
want . ?
? NN CAPITAL Interview
Interview VBN based
based NN survey
survey IN of
of NNS patients
patients CC and
and PRP$ their
their NNS nurses

Occupational JJ CAPITAL Occupational
Occupational NN asthma
asthma JJ due
due TO to
to NN porcine
porcine JJ pancreatic
pancreatic NN amylase

Double-blind JJ CAPITAL Double-blind
Double-blind NN study
study IN of
of VBG pulsing
pulsing JJ magnetic
magnetic NN field
field NNS effects
effects IN on
on JJ multiple
multiple NN sclerosis
sclerosis . .

CDA NNP CAPITAL CDA
CDA VBZ opposes
opposes VBN proposed
proposed NN CAPITAL HBV
HBV NNS recommendations

The DT CAPITAL The
The NN influence
influence IN of
of NN allergy
allergy CC and
and NN smoking
smoking IN on
on DT the
the NN sulphation
sulphation IN of
of JJ nasal
nasal NNS mucins

Clinical JJ CAPITAL Clinical
Clinical JJ problem-solving

A DT CAPITAL A
A VBN hidden
hidden NN agenda

A DT CAPITAL A
A NN comparison
comparison IN of
of DT the
the RB early
early NN outcome
outcome IN of
of JJ acute
acute JJ myocardial
myocardial NN infarction
infarction IN in
in NNS women
women CC and
and NNS men

The DT CAPITAL The
The NNP CAPITAL Third
Third NNP CAPITAL International
International NN CAPITAL Study
Study IN of
of NNP CAPITAL Infarct
Infarct NN CAPITAL Survival
Survival JJ CAPITAL Collaborative
Collaborative NNP CAPITAL Group

Management NN CAPITAL Management
Management IN of
of JJ life-threatening
life-threatening NN acid-base
acid-base NNS disorders

Second JJ CAPITAL Second
Second IN of
of CD two
two NNS parts

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Freeze-dried
Freeze-dried JJ cortical
cortical NN allograft
allograft IN in
in NN posterior
posterior JJ spinal
spinal NN arthrodesis
arthrodesis : :
: NN use
use IN with
with JJ segmental
segmental NN instrumentation
instrumentation IN for
for JJ idiopathic
idiopathic JJ adolescent
adolescent NN scoliosis

Removal NN CAPITAL Removal
Removal IN of
of DT a
a VBN broken
broken NN solid-core
solid-core JJ intramedullary
intramedullary JJ femoral
femoral NN nail
nail VBG using
using DT both
both NN antegrade
antegrade CC and
and NN retrograde
retrograde VBG starting
starting NNS points

Do VB CAPITAL Do
Do DT no
no NN harm

Thalidomide NNP CAPITAL Thalidomide
Thalidomide , ,
, NN laser
laser NN cavity
cavity NN preparation
preparation CC and
and JJ oral
oral NN hydrogen
hydrogen NN peroxide

Emergency NN CAPITAL Emergency
Emergency . !
! JJ CAPITAL Meningococcal
Meningococcal NN disease

First NNP CAPITAL First
First DT the
the JJ bad
bad NN news
news : ...

Does VBZ CAPITAL Does
Does NN hyperglycemia
hyperglycemia RB really
really NN cause
cause JJ coronary
coronary NN heart
heart NN disease
disease . ?

Diagnosis NN CAPITAL Diagnosis
Diagnosis CC and
and NN therapy
therapy IN of
of JJ primary
primary NN stomach
stomach NN lymphoma

Consensus NN CAPITAL Consensus
Consensus IN of
of DT the
the NNP CAPITAL Surgical
Surgical VBG CAPITAL Working
Working NNP CAPITAL Group
Group IN for
for NNP CAPITAL Oncology
Oncology , ,
, DT the
the VBG CAPITAL Working
Working NNP CAPITAL Group
Group IN for
for NNP CAPITAL Medical
Medical NNP CAPITAL Oncology
Oncology CC and
and DT the
the VBG CAPITAL Working
Working NNP CAPITAL Group
Group IN for
for JJ CAPITAL Radiologic
Radiologic NNP CAPITAL Oncology

Rate NN CAPITAL Rate
Rate IN of
of NN CAPITAL RhD
RhD NN sensitisation
sensitisation IN before
before CC and
and IN after
after NN implementation
implementation IN of
of DT a
a NN community
community VBN based
based JJ antenatal
antenatal NN prophylaxis
prophylaxis NN programme

Ovine NNP CAPITAL Ovine
Ovine NNP CAPITAL Johne
Johne POS 's
's NN disease

Effect NN CAPITAL Effect
Effect IN of
of NNP CAPITAL HAART
HAART IN on
on JJ natural
natural NN history
history IN of
of JJ CAPITAL AIDS-related
AIDS-related JJ opportunistic
opportunistic NNS disorders

Psoas NNS CAPITAL Psoas
Psoas NN abscess

Diagnosed VBN CAPITAL Diagnosed
Diagnosed IN if
if VBN suspected

Breastfeeding VBG CAPITAL Breastfeeding
Breastfeeding CC and
and NN catch-up
catch-up NN growth
growth IN in
in NNS infants
infants VBN born
born JJ small
small IN for
for JJ gestational
gestational NN age

Health NNP CAPITAL Health
Health NNS practices
practices IN of
of JJ critical
critical NN care
care NNS nurses
nurses : :
: VBP are
are DT these
these NNS nurses
nurses JJ good
good NN role
role NNS models
models IN for
for NNS patients
patients . ?

Testing VBG CAPITAL Testing
Testing IN for
for NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN infection
infection IN after
after JJ antibiotic
antibiotic NN treatment
treatment . .

Bullous JJ CAPITAL Bullous
Bullous NN eruption
eruption IN in
in DT a
a NN patient
patient IN with
with JJ systemic
systemic NN lupus
lupus NN erythematosus
erythematosus : :
: JJ mite
mite NN dermatitis
dermatitis VBN caused
caused IN by
by NNP CAPITAL Cheyletiella
Cheyletiella FW blakei

A DT CAPITAL A
A JJ case-control
case-control NN study
study IN of
of NN cytochrome
cytochrome NN CAPITAL P450
P450 NN 1A1
1A1 , ,
, NN glutathione
glutathione NN CAPITAL S-transferase
S-transferase NN CAPITAL M1
M1 , ,
, NN cigarette
cigarette NN smoking
smoking CC and
and NN lung
lung NN cancer
cancer NN susceptibility
susceptibility NN (
( NNP CAPITAL Massachusetts
Massachusetts , ,
, NNP CAPITAL United
United NNPS CAPITAL States
States NN )

Association NNP CAPITAL Association
Association IN between
between JJ thrombolytic
thrombolytic NN treatment
treatment CC and
and DT the
the NN prognosis
prognosis IN of
of RB hemodynamically
hemodynamically JJ stable
stable NNS patients
patients IN with
with JJ major
major JJ pulmonary
pulmonary NN embolism
embolism : :
: NNS results
results IN of
of DT a
a NN multicenter
multicenter NN registry
registry . .

Metastatic JJ CAPITAL Metastatic
Metastatic JJ malignant
malignant NN mesothelioma
mesothelioma VBG presenting
presenting IN as
as JJ colonic
colonic NNS polyps

Microelectrode-guided JJ CAPITAL Microelectrode-guided
Microelectrode-guided JJ posteroventral
posteroventral NN pallidotomy
pallidotomy IN for
for NN treatment
treatment IN of
of NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease
disease : :
: JJ postoperative
postoperative JJ magnetic
magnetic NN resonance
resonance NN imaging
imaging NN analysis

A DT CAPITAL A
A JJ positive
positive NNS cannabinoids
cannabinoids NN workplace
workplace NN drug
drug NN test
test VBG following
following DT the
the NN ingestion
ingestion IN of
of RB commercially
commercially JJ available
available NN hemp
hemp NN seed
seed NN oil

Congenital JJ CAPITAL Congenital
Congenital NN diaphragmatic
diaphragmatic NN hernia
hernia : :
: WDT what
what VBZ happens
happens IN after
after NN discharge
discharge . ?

Goldilocks NNP CAPITAL Goldilocks
Goldilocks CC and
and NNP CAPITAL Mrs

Ilych NNP CAPITAL Ilych
Ilych : :
: DT a
a JJ critical
critical NN look
look IN at
at DT the
the `` ``
`` NN philosophy
philosophy IN of
of NN hospice
hospice '' ''

Sensitivity NN CAPITAL Sensitivity
Sensitivity CC and
and NN specificity
specificity IN of
of DT the
the JJ neonatal
neonatal NN brain-stem
brain-stem NN auditory
auditory VBN evoked
evoked NN potential
potential IN for
for NN hearing
hearing CC and
and NN language
language NNS deficits
deficits IN in
in NNS survivors
survivors IN of
of JJ extracorporeal
extracorporeal NN membrane
membrane NN oxygenation

The DT CAPITAL The
The NNP CAPITAL Federated
Federated NNP CAPITAL Council
Council IN of
of JJ CAPITAL Internal
Internal NN CAPITAL Medicine
Medicine POS 's
's NN resource
resource NN guide
guide IN for
for NN residency
residency NN education
education : :
: DT an
an NN instrument
instrument IN for
for JJ curricular
curricular NN change

A DT CAPITAL A
A JJ reluctant
reluctant NN doctor
doctor NN shopper

Frequent JJ CAPITAL Frequent
Frequent NNS users
users IN of
of NN emergency
emergency NNS services

Localized JJ CAPITAL Localized
Localized NNP CAPITAL Darier
Darier NN disease

Implications NNS CAPITAL Implications
Implications IN for
for JJ genetic
genetic NNS studies

Follow VB CAPITAL Follow
Follow RB up
up IN after
after NN potential
potential JJ curative
curative NN surgery
surgery IN of
of JJ colorectal
colorectal NN cancer

Guidelines NNS CAPITAL Guidelines
Guidelines IN from
from DT the
the JJ CAPITAL Norwegian
Norwegian JJ CAPITAL Gastrointestinal
Gastrointestinal NN CAPITAL Cancer
Cancer NNP CAPITAL Group

The DT CAPITAL The
The NN prison
prison NN patient

Fulminant JJ CAPITAL Fulminant
Fulminant JJ hepatic
hepatic NN failure
failure IN in
in JJ murine
murine NN hepatitis
hepatitis NN virus
virus NN strain
strain CD 3
3 NN infection
infection : :
: JJ tissue-specific
tissue-specific NN expression
expression IN of
of DT a
a JJ novel
novel NN fgl2
fgl2 NN prothrombinase

Lung NN CAPITAL Lung
Lung NN volume
volume NN reduction
reduction NN surgery
surgery IN for
for NN emphysema

The DT CAPITAL The
The NN use
use CC and
and NNS effects
effects IN of
of JJ postcoital
postcoital NN contraception

Vancomycin-resistant JJ CAPITAL Vancomycin-resistant
Vancomycin-resistant FW CAPITAL Staphylococcus
Staphylococcus NN aureus
aureus : :
: NN apocalypse
apocalypse RB now
now . ?

Reflex NN CAPITAL Reflex
Reflex JJ sympathetic
sympathetic NN dystrophy
dystrophy : :
: NN fact
fact CC and
and NN fiction

Acute JJ CAPITAL Acute
Acute NN hydrocephalus
hydrocephalus CC and
and NN brain
brain NN abscess
abscess IN in
in NN CAPITAL Listeria
Listeria NNS monocytogenes
monocytogenes NN meningitis

Antisense JJ CAPITAL Antisense
Antisense NN suppression
suppression IN of
of JJ 4-coumarate
4-coumarate : :
: NN coenzyme
coenzyme DT CAPITAL A
A NN ligase
ligase NN activity
activity IN in
in NNP CAPITAL Arabidopsis
Arabidopsis NNS leads
leads TO to
to JJ altered
altered NN lignin
lignin NN subunit
subunit NN composition

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNP CAPITAL Alopecia
Alopecia IN as
as DT a
a NN consequence
consequence IN of
of NN tacrolimus
tacrolimus NN therapy
therapy IN in
in JJ renal
renal NN transplantation
transplantation . ?

Implementation NN CAPITAL Implementation
Implementation IN of
of JJ pharmaceutical
pharmaceutical NN practice
practice NNS guidelines

In IN CAPITAL In
In NN vitro
vitro NNS interactions
interactions IN of
of RB oxidatively
oxidatively VBN modified
modified NN CAPITAL LDL
LDL IN with
with NN type
type PRP CAPITAL I
I , ,
, NNP CAPITAL II
II , ,
, NNP CAPITAL III
III , ,
, CD CAPITAL IV
IV , ,
, CC and
and NN CAPITAL V
V NN collagen
collagen , ,
, NN laminin
laminin , ,
, NN fibronectin
fibronectin , ,
, CC and
and NN poly-D-lysine

Factors NNS CAPITAL Factors
Factors VBG influencing
influencing NN blood
blood NN flow
flow IN in
in DT the
the JJ optic
optic NN nerve
nerve NN head

Mutations NNS CAPITAL Mutations
Mutations IN of
of DT the
the FW CAPITAL Drosophila
Drosophila NN dDP
dDP , ,
, NN dE2F
dE2F , ,
, CC and
and NN cyclin
cyclin NN CAPITAL E
E NNS genes
genes VB reveal
reveal JJ distinct
distinct NNS roles
roles IN for
for DT the
the NN CAPITAL E2F-DP
E2F-DP NN transcription
transcription NN factor
factor CC and
and NN cyclin
cyclin NN CAPITAL E
E IN during
during DT the
the NN CAPITAL G1-S
G1-S NN transition

SYT-SSX NN CAPITAL SYT-SSX
SYT-SSX NN gene
gene NN fusion
fusion IN as
as DT a
a NN determinant
determinant IN of
of NN morphology
morphology CC and
and NN prognosis
prognosis IN in
in JJ synovial
synovial NN sarcoma

A DT CAPITAL A
A JJ rapid
rapid JJ molecular
molecular NN method
method NN (
( NN polymerase
polymerase NN chain
chain NN reaction
reaction IN with
with JJ sequence-specific
sequence-specific NNS primers
primers NN )
) TO to
to NN genotype
genotype IN for
for NN CAPITAL ABO
ABO NN blood
blood NN group
group CC and
and NN secretor
secretor NN status
status CC and
and PRP$ its
its NN potential
potential IN for
for NN organ
organ NNS transplants

A DT CAPITAL A
A JJ population-based
population-based NN registry
registry IN on
on NN paraproteinaemia
paraproteinaemia IN in
in DT CAPITAL The
The NNP CAPITAL Netherlands

Comprehensive NNP CAPITAL Comprehensive
Comprehensive NN CAPITAL Cancer
Cancer NNP CAPITAL Centre
Centre NNP CAPITAL West
West , ,
, NNP CAPITAL Leiden
Leiden , ,
, DT CAPITAL The
The NNP CAPITAL Netherlands

Intra- JJ CAPITAL Intra-
Intra- CC and
and JJ inter-individual
inter-individual JJ biological
biological NN variability
variability NNS data
data NN bank

Genetic JJ CAPITAL Genetic
Genetic NN testing
testing IN for
for NN cancer
cancer NN risk
risk : :
: WRB how
how TO to
to VB reconcile
reconcile DT the
the NNS conflicts

Run-in NN CAPITAL Run-in
Run-in NNS periods
periods IN in
in VBN randomized
randomized NNS trials
trials : :
: NNS implications
implications IN for
for DT the
the NN application
application IN of
of NNS results
results IN in
in JJ clinical
clinical NN practice

Rapid JJ CAPITAL Rapid
Rapid CC and
and NN ultrarapid
ultrarapid NN opioid
opioid NN detoxification
detoxification NNS techniques

Fulminant JJ CAPITAL Fulminant
Fulminant NN hepatitis
hepatitis VBN associated
associated IN with
with NN hepatitis
hepatitis DT CAPITAL A
A NN virus
virus NN superinfection
superinfection IN in
in NNS patients
patients IN with
with JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL C

The DT CAPITAL The
The JJ CAPITAL Overactive
Overactive NN CAPITAL Bladder
Bladder : :
: IN CAPITAL From
From JJ CAPITAL Basic
Basic NN CAPITAL Science
Science TO to
to JJ CAPITAL Clinical
Clinical NN CAPITAL Management
Management NN CAPITAL Consensus
Consensus NN CAPITAL Conference

Proceedings NNP CAPITAL Proceedings

London NNP CAPITAL London
London , ,
, NNP CAPITAL England
England , ,
, NNP CAPITAL June
June CD 29
29 , ,
, CD 1997

Techniques NNS CAPITAL Techniques
Techniques IN for
for NN erbium
erbium : :
: NN CAPITAL YAG
YAG NN laser
laser NN skin
skin VBG resurfacing
resurfacing : :
: JJ initial
initial NNS pearls
pearls IN from
from DT the
the RB first
first CD 100
100 NNS patients

Predicting VBG CAPITAL Predicting
Predicting NNS changes
changes IN in
in DT the
the NN distribution
distribution IN of
of NN sweating
sweating VBG following
following JJ thoracoscopic
thoracoscopic NN sympathectomy
sympathectomy . .

The DT CAPITAL The
The NN CAPITAL AACC
AACC NN CAPITAL Lectureship
Lectureship NN CAPITAL Award
Award NN CAPITAL Address

The DT CAPITAL The
The NN market
market IN for
for NN health
health NN care
care : :
: WRB where
where VBZ is
is DT the
the NN patient
patient . ?

Human JJ CAPITAL Human
Human JJ fetal
fetal NN pituitary
pituitary VBZ expresses
expresses JJ functional
functional NN growth
growth NN hormone-releasing
hormone-releasing NN peptide
peptide NNS receptors

The DT CAPITAL The
The NNP CAPITAL Bizarro
Bizarro NN world
world IN of
of NN osteodistraction

A DT CAPITAL A
A NN piece
piece IN of
of PRP$ my
my NN mind

Leaders NNS CAPITAL Leaders
Leaders CC or
or NNS lemmings
lemmings . ?

Sales NNS CAPITAL Sales
Sales IN of
of NN food
food NN aid
aid IN as
as NN sign
sign IN of
of NN distress
distress , ,
, RB not
not NN excess

Gastrointestinal JJ CAPITAL Gastrointestinal
Gastrointestinal NN absorption
absorption IN of
of NNS metals

Embryonic JJ CAPITAL Embryonic
Embryonic NN stem
stem NNS cells
cells CC and
and JJ hematopoietic
hematopoietic NN stem
stem NN cell
cell NN biology

Shark NN CAPITAL Shark
Shark NN cartilage
cartilage IN for
for NN cancer
cancer . ?

The DT CAPITAL The
The NN role
role IN of
of DT the
the NN school
school IN in
in DT the
the NN management
management IN of
of NN attention
attention NN deficit
deficit NN hyperactivity
hyperactivity NN disorder

Photorepair NNP CAPITAL Photorepair
Photorepair NNS mutants
mutants IN of
of NNP CAPITAL Arabidopsis

Toxic JJ CAPITAL Toxic
Toxic NN shock
shock NN syndrome
syndrome IN without
without NN rash
rash IN in
in DT a
a JJ young
young NN child
child : :
: NN link
link IN with
with NN syndrome
syndrome IN of
of JJ hemorrhagic
hemorrhagic NN shock
shock CC and
and NN encephalopathy
encephalopathy . ?

Mediastinal JJ CAPITAL Mediastinal
Mediastinal VBG growing
growing NN teratoma
teratoma NN syndrome

Structure NN CAPITAL Structure
Structure CC and
and NN expression
expression IN of
of DT the
the NN chicken
chicken NN calmodulin
calmodulin PRP CAPITAL I
I NN gene

Fibromyalgia NNP CAPITAL Fibromyalgia
Fibromyalgia : --
-- IN out
out IN of
of NN control
control . ?

Fibromyalgia NNP CAPITAL Fibromyalgia
Fibromyalgia : :
: NNP CAPITAL La
La NNP CAPITAL Maladie
Maladie IN est
est NNP CAPITAL Morte

Vive NNP CAPITAL Vive
Vive DT le
le NNP CAPITAL Malade
Malade . !

Electron NN CAPITAL Electron
Electron NN beam
beam VBN computed
computed NN tomographic
tomographic JJ coronary
coronary NN calcium
calcium IN as
as DT a
a NN predictor
predictor IN of
of JJ coronary
coronary NNS events
events : :
: NN comparison
comparison IN of
of CD two
two NNS protocols

The DT CAPITAL The
The NNS ethics
ethics IN of
of JJ genetic
genetic NN research
research IN on
on JJ sexual
sexual NN orientation

Testicular JJ CAPITAL Testicular
Testicular NN sperm
sperm NN retrieval
retrieval IN by
by JJ percutaneous
percutaneous NN fine
fine NN needle
needle NN sperm
sperm NN aspiration
aspiration VBN compared
compared IN with
with JJ testicular
testicular NN sperm
sperm NN extraction
extraction IN by
by JJ open
open NN biopsy
biopsy IN in
in NNS men
men IN with
with JJ non-obstructive
non-obstructive NN azoospermia

Cyclin NN CAPITAL Cyclin
Cyclin NN CAPITAL D1
D1 NN overexpression
overexpression IN in
in JJ malignant
malignant NNS lymphomas

Patient NN CAPITAL Patient
Patient NN safety
safety CC and
and JJ scented
scented JJ pediatric
pediatric NN anesthesia
anesthesia NNS facemasks

Ion NN CAPITAL Ion
Ion NNS channels

SHARPs NNS CAPITAL SHARPs
SHARPs : :
: JJ mammalian
mammalian JJ enhancer-of-split-
enhancer-of-split- CC and
and JJ hairy-related
hairy-related NNS proteins
proteins VBN coupled
coupled TO to
to JJ neuronal
neuronal NN stimulation

Complementary JJ CAPITAL Complementary
Complementary CC and
and NN alternative
alternative NN medicine
medicine : :
: NN friend
friend , ,
, NN foe
foe , ,
, CC or
or NNP CAPITAL OWA
OWA . ?

Ondansetron NNP CAPITAL Ondansetron
Ondansetron VBZ is
is RB not
not DT a
a NN panacea

Masking VBG CAPITAL Masking
Masking , ,
, VBG blinding
blinding , ,
, CC and
and VB peer
peer NN review
review : :
: DT the
the JJ blind
blind VBG leading
leading DT the
the VBN blinded

Human JJ CAPITAL Human
Human JJ cervico-facial
cervico-facial NN morphogenesis

Evaluation NN CAPITAL Evaluation
Evaluation IN of
of VBN acquired
acquired NNS data
data CC and
and JJ current
current NN outlook

( NN (
( NN CAPITAL Part
Part CD 1
1 : :
: JJ facial
facial NN morphogenesis
morphogenesis NN )

The DT CAPITAL The
The NN effect
effect IN of
of NN CAPITAL TRK-530
TRK-530 IN on
on JJ experimental
experimental NN arthritis
arthritis IN in
in NNS mice

Spontaneous JJ CAPITAL Spontaneous
Spontaneous NN exfoliation
exfoliation IN of
of NNS teeth
teeth VBG following
following JJ severe
severe JJ elemental
elemental NN mercury
mercury NN poisoning
poisoning : :
: NN case
case NN report
report CC and
and JJ histological
histological NN investigation
investigation IN for
for NN mechanism

Small JJ CAPITAL Small
Small NN cell
cell NN lung
lung NN cancer
cancer MD can
can VB express
express NN CAPITAL CD34
CD34 NN antigen

X NN CAPITAL X
X NN inactivation
inactivation IN in
in NNS females
females IN with
with JJ CAPITAL X-linked
X-linked NN disease

Report NNP CAPITAL Report
Report IN of
of NNS spores
spores IN of
of NN CAPITAL Henneguya
Henneguya NN salminicola
salminicola NN (
( NN CAPITAL Myxozoa
Myxozoa NN )
) IN in
in JJ human
human NN stool
stool NNS specimens
specimens : :
: JJ possible
possible NN source
source IN of
of NN confusion
confusion IN with
with JJ human
human NN spermatozoa

Evaluation NN CAPITAL Evaluation
Evaluation IN of
of DT a
a NN ventilation
ventilation NN strategy
strategy TO to
to VB prevent
prevent NN barotrauma
barotrauma IN in
in NNS patients
patients IN at
at JJ high
high NN risk
risk IN for
for JJ acute
acute JJ respiratory
respiratory NN distress
distress NN syndrome

Pressure- NN CAPITAL Pressure-
Pressure- CC and
and JJ CAPITAL Volume-Limited
Volume-Limited NN CAPITAL Ventilation
Ventilation NN CAPITAL Strategy
Strategy NNP CAPITAL Group

Audit NNP CAPITAL Audit
Audit NN commission
commission VBZ tackles
tackles NN anaesthetic
anaesthetic NNS services

Abdominal JJ CAPITAL Abdominal
Abdominal NN tuberculosis
tuberculosis VBG involving
involving JJ hepatic
hepatic JJ hilar
hilar NN lymph
lymph NNS nodes

A DT CAPITAL A
A NN cause
cause IN of
of NN portal
portal NN vein
vein NN thrombosis
thrombosis CC and
and NN portal
portal NN hypertension

Treatment NN CAPITAL Treatment
Treatment IN of
of NNS men
men IN with
with NN paraphilia
paraphilia IN with
with DT a
a JJ long-acting
long-acting NN analogue
analogue IN of
of NN gonadotropin-releasing
gonadotropin-releasing NN hormone

Analgesic JJ CAPITAL Analgesic
Analgesic NN nephropathy

Translocations NNS CAPITAL Translocations
Translocations IN of
of NN 11q13
11q13 IN in
in NN mantle
mantle NN cell
cell NN lymphoma
lymphoma VB fail
fail TO to
to VB disrupt
disrupt DT the
the NN CAPITAL S
S NN mu
mu NN bp-2
bp-2 NN gene

Variation NN CAPITAL Variation
Variation IN in
in NN proficiency
proficiency NN testing
testing NN performance
performance IN by
by NN testing
testing NN site

The DT CAPITAL The
The `` ``
`` NN CAPITAL H
H '' ''
'' NN graft
graft : :
: DT an
an NN alternative
alternative NN approach
approach IN for
for VBG performing
performing RB minimally
minimally JJ invasive
invasive JJ direct
direct JJ coronary
coronary NN artery
artery NN bypass

Effect NN CAPITAL Effect
Effect IN of
of NN interferon
interferon IN on
on NN hepatitis
hepatitis NN CAPITAL B
B . .

Health NNP CAPITAL Health
Health NN insurance
insurance IN for
for NNS children
children : --
-- DT a
a NN model
model IN for
for JJ incremental
incremental NN health
health NN reform
reform . ?

Distinction NN CAPITAL Distinction
Distinction NNS awards
awards CC and
and JJ racial
racial NN discrimination

Potential JJ CAPITAL Potential
Potential NNS biases
biases VBD were
were RB not
not VBN taken
taken IN into
into NN account
account IN in
in NN study
study IN of
of VBG waiting
waiting NNS times

Factors NNS CAPITAL Factors
Factors VBG affecting
affecting NN uptake
uptake IN of
of JJ antenatal
antenatal NN CAPITAL HIV
HIV NN testing
testing IN in
in NNP CAPITAL London
London : :
: NNS results
results IN of
of DT a
a JJ multicentre
multicentre NN study

Coronary JJ CAPITAL Coronary
Coronary JJ arterioluminal
arterioluminal NNS communications
communications IN in
in JJ routine
routine NN angiography

Peptide NN CAPITAL Peptide
Peptide JJ nucleic
nucleic NN acid
acid NN (
( NN CAPITAL PNA
PNA NN )
) IN from
from NN CAPITAL DNA
DNA NN recognition
recognition TO to
to JJ antisense
antisense CC and
and NN CAPITAL DNA
DNA NN structure

Homeopathy NNP CAPITAL Homeopathy
Homeopathy IN for
for JJ postoperative
postoperative NN ileus
ileus . ?
? DT CAPITAL A
A NN meta-analysis

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ postmenopausal
postmenopausal NN osteoporosis

Fascioloidiasis NN CAPITAL Fascioloidiasis
Fascioloidiasis IN in
in JJ game-ranched
game-ranched NN elk
elk IN from
from NNP CAPITAL Montana

Connexin-26 NN CAPITAL Connexin-26
Connexin-26 NNS mutations
mutations IN in
in JJ sporadic
sporadic JJ non-syndromal
non-syndromal NN sensorineural
sensorineural NN deafness

Lyme NN CAPITAL Lyme
Lyme NN disease
disease VBG presenting
presenting IN as
as NNP CAPITAL Tourette
Tourette POS 's
's NN syndrome

The DT CAPITAL The
The NN screening
screening VB muddle

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ hypertensive
hypertensive NNS patients
patients IN with
with NN diabetes

China NNP CAPITAL China
China POS 's
's JJ human-organ
human-organ NN trade
trade VBN highlighted
highlighted IN by
by NNP CAPITAL US
US NN arrest
arrest IN of
of `` ``
`` NN salesman
salesman '' ''

Dimension NN CAPITAL Dimension
Dimension IN in
in VBG defining
defining NN tumor
tumor NN response

Administration NN CAPITAL Administration
Administration IN of
of NN dexamethasone
dexamethasone VBZ induces
induces NN proteinuria
proteinuria IN of
of JJ glomerular
glomerular NN origin
origin IN in
in NNS mice

Preoperative JJ CAPITAL Preoperative
Preoperative NN thromboxane
thromboxane NN CAPITAL A2/prostaglandin
A2/prostaglandin NN CAPITAL H2
H2 NN receptor
receptor NN activity
activity VBZ predicts
predicts RB early
early NN graft
graft NN thrombosis

Hypertension NN CAPITAL Hypertension
Hypertension NN treatment
treatment CC and
and NN control
control IN in
in JJ sub-Saharan
sub-Saharan NNP CAPITAL Africa
Africa : :
: DT the
the JJ epidemiological
epidemiological NN basis
basis IN for
for NN policy

Needle-exchange NN CAPITAL Needle-exchange
Needle-exchange NNS programmes
programmes IN in
in DT the
the NNP CAPITAL USA

A DT CAPITAL A
A JJ discriminant
discriminant NN function
function IN for
for NN preeclampsia
preeclampsia : :
: JJ case-control
case-control NN study
study IN of
of JJ minor
minor NNS hemoglobins
hemoglobins , ,
, JJ red
red NN cell
cell NNS enzymes
enzymes , ,
, CC and
and JJ clinical
clinical NN laboratory
laboratory NNS values

Patterning NN CAPITAL Patterning
Patterning IN of
of VBN immobilized
immobilized NN antibody
antibody NNS layers
layers IN via
via NN photolithography
photolithography CC and
and NN oxygen
oxygen NN plasma
plasma NN exposure

A DT CAPITAL A
A JJ cell-based
cell-based NN immunobiosensor
immunobiosensor IN with
with VBN engineered
engineered JJ molecular
molecular NN recognition
recognition : --
-- NN CAPITAL Part
Part NNP CAPITAL II
II : :
: NN CAPITAL Enzyme
Enzyme NN amplification
amplification NNS systems

Evanescent JJ CAPITAL Evanescent
Evanescent NN wave
wave NN fibre
fibre JJ optic
optic NN sensor
sensor IN for
for NN detection
detection IN of
of NNP CAPITAL L.
L. NNS donovani
donovani JJ specific
specific NNS antibodies
antibodies IN in
in NNS sera
sera IN of
of NN kala
kala IN azar
azar NNS patients

Multianalyte JJ CAPITAL Multianalyte
Multianalyte NNS biosensors
biosensors IN on
on JJ optical
optical NN imaging
imaging NNS bundles

Specific JJ CAPITAL Specific
Specific NN binding
binding IN of
of JJ low
low JJ molecular
molecular NN weight
weight NNS ligands
ligands IN with
with JJ direct
direct JJ optical
optical NN detection

Amperometric JJ CAPITAL Amperometric
Amperometric NN lactate
lactate NN oxidase
oxidase NN catheter
catheter IN for
for JJ real-time
real-time NN lactate
lactate VBG monitoring
monitoring VBN based
based IN on
on JJ thin
thin NN film
film NN technology

Dual-fractal JJ CAPITAL Dual-fractal
Dual-fractal NN analysis
analysis IN for
for NN antigen
antigen : --
-- NN antibody
antibody NN binding
binding NNS kinetics
kinetics IN for
for NN biosensor
biosensor NNS applications

Dipstick NNP CAPITAL Dipstick
Dipstick RB only
only NN urinalysis
urinalysis NN screen
screen IN for
for DT the
the JJ pediatric
pediatric NN emergency
emergency NN room

Cytoplasmic JJ CAPITAL Cytoplasmic
Cytoplasmic NN transport
transport IN in
in FW CAPITAL Drosophila
Drosophila JJ ovarian
ovarian NNS follicles
follicles : :
: DT the
the NN migration
migration IN of
of VBN microinjected
microinjected JJ fluorescent
fluorescent NNS probes
probes IN through
through JJ intercellular
intercellular NNS bridges
bridges VBZ depends
depends DT neither
neither IN on
on JJ electrical
electrical NN charge
charge CC nor
nor IN on
on JJ external
external NN osmolarity

Further RB CAPITAL Further
Further NN evidence
evidence IN for
for DT the
the NN importance
importance IN of
of DT an
an NN androgen
androgen NN response
response NN element
element IN in
in DT the
the NN factor
factor CD CAPITAL IX
IX NN promoter

The DT CAPITAL The
The NN obstetric
obstetric NN experience
experience IN of
of NNS carriers
carriers IN of
of NN haemophilia

Acquired VBN CAPITAL Acquired
Acquired NN haemophilia
haemophilia , ,
, DT an
an JJ unusual
unusual NN cause
cause IN of
of JJ severe
severe NN postpartum
postpartum NN haemorrhage

Zoonotic JJ CAPITAL Zoonotic
Zoonotic CC and
and JJ viral
viral NN infection
infection IN in
in JJ fetal
fetal NN loss
loss IN after
after CD 12
12 NNS weeks

High-affinity JJ CAPITAL High-affinity
High-affinity NN binding
binding IN of
of DT the
the JJ neonatal
neonatal NN CAPITAL Fc
Fc NN receptor
receptor TO to
to PRP$ its
its NN CAPITAL IgG
IgG NN ligand
ligand VBZ requires
requires NN receptor
receptor NN immobilization

Molecular JJ CAPITAL Molecular
Molecular NNS distances
distances IN from
from NN dipolar
dipolar VBN coupled
coupled NNS spin-labels
spin-labels : :
: DT the
the JJ global
global NN analysis
analysis IN of
of NN multifrequency
multifrequency JJ continuous
continuous NN wave
wave NN electron
electron JJ paramagnetic
paramagnetic NN resonance
resonance NNS data

Computer NN CAPITAL Computer
Computer NN science
science CC and
and NN biology
biology : --
-- DT the
the JJ CAPITAL German
German NN CAPITAL Conference
Conference IN on
on NNS CAPITAL Bioinformatics
Bioinformatics NN (
( NN CAPITAL GCB'96
GCB'96 NN )

Surface NN CAPITAL Surface
Surface NNS plasmon
plasmon NN resonance
resonance NN analysis
analysis IN of
of NN topoisomerase
topoisomerase NN CAPITAL I-DNA
I-DNA NN binding
binding : :
: NN effect
effect IN of
of NN CAPITAL Mg2+
Mg2+ CC and
and NN CAPITAL DNA
DNA NN sequence

The DT CAPITAL The
The CD 1996
1996 NN list

Proposed VBN CAPITAL Proposed
Proposed JJ new
new JJ bacterial
bacterial NN taxa
taxa CC and
and VBN proposed
proposed NNS changes
changes IN of
of JJ bacterial
bacterial NNS names
names VBN published
published IN during
during CD 1996
1996 CC and
and VBN considered
considered TO to
to VB be
be IN of
of NN interest
interest TO to
to JJ medical
medical CC or
or JJ veterinary
veterinary NN bacteriology

An DT CAPITAL An
An JJ informational
informational NN note

The DT CAPITAL The
The CD 1995
1995 NN list

Proposed VBN CAPITAL Proposed
Proposed JJ new
new JJ bacterial
bacterial NN taxa
taxa CC and
and VBN proposed
proposed NNS changes
changes IN of
of JJ bacterial
bacterial NNS names
names VBN published
published IN during
during CD 1995
1995 CC and
and VBN considered
considered TO to
to VB be
be IN of
of NN interest
interest TO to
to JJ medical
medical CC or
or JJ veterinary
veterinary NN bacteriology

An DT CAPITAL An
An JJ informational
informational NN note

Biobehavioral NNP CAPITAL Biobehavioral
Biobehavioral NN pain
pain NN research
research : :
: DT a
a JJ multi-institute
multi-institute NN assessment
assessment IN of
of NN cross-cutting
cross-cutting NNS issues
issues CC and
and NN research
research NNS needs

Use NN CAPITAL Use
Use IN of
of NN surface
surface NNS plasmon
plasmon NN resonance
resonance TO to
to NN probe
probe DT the
the NN equilibrium
equilibrium CC and
and JJ dynamic
dynamic NNS aspects
aspects IN of
of NNS interactions
interactions IN between
between JJ biological
biological NNS macromolecules

ABC NNP CAPITAL ABC
ABC IN of
of JJ mental
mental NN health

Psychosexual JJ CAPITAL Psychosexual
Psychosexual NNS problems

Hazards NNS CAPITAL Hazards
Hazards IN of
of VBG running
running DT a
a NN marathon

Troponin-T NN CAPITAL Troponin-T
Troponin-T NNS concentrations
concentrations MD should
should VB be
be VBN measured

Second JJ CAPITAL Second
Second NNP CAPITAL Strang
Strang NNP CAPITAL International
International NN CAPITAL Cancer
Cancer NN CAPITAL Conference
Conference : :
: NNS genetics
genetics CC and
and DT the
the NN environment
environment NNP CAPITAL New
New NNP CAPITAL York
York , ,
, NNP CAPITAL USA
USA , ,
, CD 15-16
15-16 NNP CAPITAL November
November CD 1996

Use NN CAPITAL Use
Use IN of
of DT a
a VBN modified
modified NN version
version IN of
of DT the
the JJ CAPITAL Overt
Overt NNP CAPITAL Aggression
Aggression NNP CAPITAL Scale
Scale IN in
in DT the
the NN measurement
measurement CC and
and NN assessment
assessment IN of
of JJ aggressive
aggressive NNS behaviours
behaviours VBG following
following NN brain
brain NN injury

Ectopic JJ CAPITAL Ectopic
Ectopic NN pregnancy
pregnancy NN recurrence
recurrence : :
: NN role
role IN of
of JJ gynecologic
gynecologic , ,
, NN obstetric
obstetric , ,
, NN contraceptive
contraceptive CC and
and NN smoking
smoking NN history

AIDS NN CAPITAL AIDS
AIDS : :
: DT a
a NN world
world , ,
, DT a
a NN desire

Urogynaecology NNP CAPITAL Urogynaecology
Urogynaecology NNS proceedings
proceedings IN of
of DT the
the NN joint
joint NN CAPITAL RCOG/BAUS
RCOG/BAUS NN urogynaecology
urogynaecology NN meeting

19 CD 19
19 NNP CAPITAL September
September CD 1996

The DT CAPITAL The
The VBG naming
naming IN of
of DT a
a NN syndrome

The DT CAPITAL The
The NN use
use IN of
of JJ implantable
implantable JJ venous
venous NN access
access NNS devices
devices NN (
( NNS CAPITAL IVADs
IVADs NN )
) IN in
in NNS children
children IN with
with NN hemophilia

Nephrotic JJ CAPITAL Nephrotic
Nephrotic NN syndrome
syndrome VBN associated
associated IN with
with NN hypocomplementemia
hypocomplementemia IN in
in DT a
a JJ 4-year-old
4-year-old NN boy
boy IN with
with NN hemophilia
hemophilia NN CAPITAL B

Growth NN CAPITAL Growth
Growth NN hormone
hormone NN secretion
secretion IN in
in JJ CAPITAL HIV-positive
HIV-positive CC versus
versus JJ CAPITAL HIV-negative
HIV-negative JJ hemophilic
hemophilic NNS males
males IN with
with JJ abnormal
abnormal NN growth
growth CC and
and JJ pubertal
pubertal NN development

The DT CAPITAL The
The NNP CAPITAL Hemophilia
Hemophilia NN CAPITAL Growth
Growth CC and
and NNP CAPITAL Development
Development NN CAPITAL Study

Trends NNS CAPITAL Trends
Trends IN in
in NN CAPITAL HIV
HIV NN counseling
counseling CC and
and NN testing
testing IN of
of NNS clients
clients VBG attending
attending DT a
a NN public
public RB sexually
sexually VBN transmitted
transmitted NN disease
disease NN clinic
clinic IN in
in NNP CAPITAL Portland
Portland , ,
, NNP CAPITAL Oregon
Oregon , ,
, CD 1989-1995

Risk NN CAPITAL Risk
Risk NNS factors
factors IN for
for NN CAPITAL HIV-1
HIV-1 NN infection
infection IN among
among JJ pregnant
pregnant NNS women
women IN in
in JJ CAPITAL French
French NNP CAPITAL Guiana

Angiogenesis NN CAPITAL Angiogenesis
Angiogenesis IN in
in JJ inflammatory
inflammatory NN disease

Epidemiology NNP CAPITAL Epidemiology
Epidemiology CC and
and NN association
association IN with
with JJ extra-gastrointestinal
extra-gastrointestinal NNS diseases

Extra-gastrointestinal JJ CAPITAL Extra-gastrointestinal
Extra-gastrointestinal NNS diseases
diseases CC and
and NNP CAPITAL Helicobacter
Helicobacter NN pylori

Update NNP CAPITAL Update
Update IN on
on NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN research

Diagnosis NN CAPITAL Diagnosis

Uptake NN CAPITAL Uptake
Uptake IN on
on NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN research

Pathogenesis NN CAPITAL Pathogenesis
Pathogenesis CC and
and NN host
host NN response

Update NNP CAPITAL Update
Update IN on
on NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN research

Malignancies NNS CAPITAL Malignancies

Update NNP CAPITAL Update
Update IN on
on NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN research

Dyspepsia NN CAPITAL Dyspepsia

Update NNP CAPITAL Update
Update IN on
on NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori NN research

Eradication NN CAPITAL Eradication

Sequence NN CAPITAL Sequence
Sequence NN analysis
analysis IN of
of DT the
the JJ 36-kb
36-kb NN region
region IN between
between NN gntZ
gntZ CC and
and NN trnY
trnY NNS genes
genes IN of
of NN CAPITAL Bacillus
Bacillus NNS subtilis
subtilis NN genome

A DT CAPITAL A
A NN review
review IN of
of NN interferon
interferon NN immunogenicity

Based VBN CAPITAL Based
Based IN on
on DT a
a NN roundtable
roundtable NN workshop
workshop VBN held
held IN in
in NNP CAPITAL London
London , ,
, NNP CAPITAL United
United NNP CAPITAL Kingdom
Kingdom , ,
, CD 9
9 NNP CAPITAL February
February CD 1996

Histologic JJ CAPITAL Histologic
Histologic NN diagnosis
diagnosis IN of
of JJ chronic
chronic NN hepatitis
hepatitis , ,
, VBG grading
grading CC and
and NN staging

Inositol NN CAPITAL Inositol
Inositol NN treatment
treatment IN of
of NN autism

Current JJ CAPITAL Current
Current NN progress
progress IN in
in RB early
early NN pregnancy
pregnancy NN investigation

Truncated-gene JJ CAPITAL Truncated-gene
Truncated-gene NN reporter
reporter NN system
system IN for
for VBG studying
studying DT the
the NN regulation
regulation IN of
of NN manganese
manganese NN peroxidase
peroxidase NN expression

Disparate JJ CAPITAL Disparate
Disparate NN sequence
sequence NNS characteristics
characteristics IN of
of DT the
the NNP CAPITAL Erysiphe
Erysiphe NN graminis
graminis NN f.sp

hordei NN hordei
hordei NN glyceraldehyde-3-phosphate
glyceraldehyde-3-phosphate NN dehydrogenase
dehydrogenase NN gene

The DT CAPITAL The
The JJ CAPITAL Integrative
Integrative NNP CAPITAL Neurobiology
Neurobiology IN of
of NN CAPITAL Affiliation

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT a
a NN conference

Washington NNP CAPITAL Washington
Washington , ,
, NN CAPITAL DC
DC , ,
, NNP CAPITAL USA

March NNP CAPITAL March
March CD 14-17
14-17 , ,
, CD 1996

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT the
the JJ 10th
10th NNP CAPITAL International
International NNP CAPITAL Symposium
Symposium IN on
on DT the
the NN CAPITAL Pharmacology
Pharmacology IN of
of NN CAPITAL Thermoregulation

Memphis NNP CAPITAL Memphis
Memphis , ,
, NNP CAPITAL Tennessee
Tennessee , ,
, NNP CAPITAL USA

August NNP CAPITAL August
August CD 17-22
17-22 , ,
, CD 1996

Neuropeptides NNS CAPITAL Neuropeptides
Neuropeptides IN in
in NNP CAPITAL Development
Development CC and
and NN CAPITAL Aging

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT a
a NN conference

Breckenridge NNP CAPITAL Breckenridge
Breckenridge , ,
, NNP CAPITAL Colorado
Colorado , ,
, NNP CAPITAL USA

February NNP CAPITAL February
February CD 3-6
3-6 , ,
, CD 1996

Receptor NN CAPITAL Receptor
Receptor NN CAPITAL Classification
Classification : :
: DT CAPITAL The
The NN CAPITAL Integration
Integration IN of
of JJ CAPITAL Operational
Operational , ,
, NNP CAPITAL Structural
Structural , ,
, CC and
and JJ CAPITAL Transductional
Transductional NN CAPITAL Information

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT a
a NN conference

Verona NNP CAPITAL Verona
Verona , ,
, NNP CAPITAL Italy
Italy , ,
, NNP CAPITAL September
September CD 21-22
21-22 , ,
, CD 1995

Psychobiology NN CAPITAL Psychobiology
Psychobiology IN of
of JJ CAPITAL Postraumatic
Postraumatic NN CAPITAL Stress
Stress NN CAPITAL Disorder

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT a
a NN conference

New NNP CAPITAL New
New NNP CAPITAL York
York , ,
, NNP CAPITAL New
New NNP CAPITAL York
York , ,
, NNP CAPITAL USA

September NNP CAPITAL September
September CD 7-10
7-10 , ,
, CD 1996

Adolescent JJ CAPITAL Adolescent
Adolescent NNP CAPITAL Gynecology
Gynecology CC and
and NNP CAPITAL Endocrinology
Endocrinology : :
: JJ CAPITAL Basic
Basic CC and
and JJ CAPITAL Clinical
Clinical NNS CAPITAL Aspects

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT the
the JJ 3rd
3rd NNP CAPITAL International
International NNP CAPITAL Congress

Athens NNP CAPITAL Athens
Athens , ,
, NNP CAPITAL Greece
Greece , ,
, NNP CAPITAL December
December CD 6-9
6-9 , ,
, CD 1995

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT the
the JJ 3rd
3rd NNP CAPITAL International
International NN CAPITAL Conference
Conference IN on
on JJ CAPITAL Neuroprotective
Neuroprotective NNS CAPITAL Agents
Agents : :
: JJ CAPITAL Clinical
Clinical CC and
and JJ CAPITAL Experimental
Experimental NNS CAPITAL Aspects

Lake NNP CAPITAL Lake
Lake NNP CAPITAL Como
Como , ,
, NNP CAPITAL Italy
Italy , ,
, NNP CAPITAL September
September CD 9-12
9-12 , ,
, CD 1996

Exon/intron NN CAPITAL Exon/intron
Exon/intron NN structure
structure IN of
of DT the
the JJ human
human NN CAPITAL AF-4
AF-4 NN gene
gene , ,
, DT a
a NN member
member IN of
of DT the
the NN CAPITAL AF-4/LAF-4/FMR-2
AF-4/LAF-4/FMR-2 NN gene
gene NN family
family VBG coding
coding IN for
for DT a
a JJ nuclear
nuclear NN protein
protein IN with
with JJ structural
structural NNS alterations
alterations IN in
in JJ acute
acute NN leukaemia

Cloning NN CAPITAL Cloning
Cloning CC and
and NN characterization
characterization IN of
of DT a
a JJ neural
neural NN cell
cell NN recognition
recognition NN molecule
molecule IN on
on NNS axons
axons IN of
of DT the
the JJ retinotectal
retinotectal NN system
system CC and
and JJ spinal
spinal NN cord

Identification NN CAPITAL Identification
Identification , ,
, NN localization
localization , ,
, CC and
and NN expression
expression IN of
of CD two
two JJ novel
novel JJ human
human NNS genes
genes JJ similar
similar TO to
to NN deoxyribonuclease
deoxyribonuclease PRP CAPITAL I
I . .

Drug NN CAPITAL Drug
Drug NN resistance
resistance IN during
during NN indinavir
indinavir NN therapy
therapy VBZ is
is VBN caused
caused IN by
by NNS mutations
mutations IN in
in DT the
the NN protease
protease NN gene
gene CC and
and IN in
in PRP$ its
its NN CAPITAL Gag
Gag NN substrate
substrate NN cleavage
cleavage NNS sites

A DT CAPITAL A
A NN protein
protein IN with
with DT a
a JJ novel
novel JJ calcium-binding
calcium-binding NN domain
domain VBN associated
associated IN with
with JJ calcareous
calcareous NNS corpuscles
corpuscles IN in
in NN CAPITAL Echinococcus
Echinococcus NN granulosus

Oncogenic JJ CAPITAL Oncogenic
Oncogenic NN raf-1
raf-1 VBZ induces
induces DT the
the NN expression
expression IN of
of JJ non-histone
non-histone JJ chromosomal
chromosomal JJ architectural
architectural NN protein
protein NN CAPITAL HMGI-C
HMGI-C IN via
via DT a
a NN p44/p42
p44/p42 JJ mitogen-activated
mitogen-activated NN protein
protein JJ kinase-dependent
kinase-dependent NN pathway
pathway IN in
in JJ salivary
salivary JJ epithelial
epithelial NNS cells

Pendred NNP CAPITAL Pendred
Pendred NN syndrome
syndrome VBZ is
is VBN caused
caused IN by
by NNS mutations
mutations IN in
in DT a
a JJ putative
putative NN sulphate
sulphate NN transporter
transporter NN gene
gene NN (
( NN CAPITAL PDS
PDS NN )

Meis2 NN CAPITAL Meis2
Meis2 , ,
, DT a
a JJ novel
novel NN mouse
mouse JJ CAPITAL Pbx-related
Pbx-related NN homeobox
homeobox NN gene
gene VBN induced
induced IN by
by JJ retinoic
retinoic NN acid
acid IN during
during NN differentiation
differentiation IN of
of NN CAPITAL P19
P19 JJ embryonal
embryonal NN carcinoma
carcinoma NNS cells

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT the
the NN CAPITAL VIIIth
VIIIth NNP CAPITAL International
International NN CAPITAL Conference
Conference IN on
on DT the
the NN CAPITAL Na/K-ATPase
Na/K-ATPase CC and
and VBN CAPITAL Related
Related NN CAPITAL Transport
Transport NNS CAPITAL ATPases

Mar NNP CAPITAL Mar
Mar DT del
del NNP CAPITAL Plata
Plata , ,
, NNP CAPITAL Argentina
Argentina , ,
, NNP CAPITAL August
August CD 26-30
26-30 , ,
, CD 1996

Targeted VBN CAPITAL Targeted
Targeted NN development
development IN of
of NN microsatellite
microsatellite NNS markers
markers IN from
from DT the
the VBN defined
defined NN region
region IN of
of JJ bovine
bovine NN chromosome
chromosome NN 6q21-31

Genetic JJ CAPITAL Genetic
Genetic NN population
population NN structure
structure IN in
in DT the
the JJ yellow
yellow NN mongoose
mongoose , ,
, NNP CAPITAL Cynictis
Cynictis NN penicillata

ETTIN NN CAPITAL ETTIN
ETTIN NNS patterns
patterns DT the
the NNP CAPITAL Arabidopsis
Arabidopsis JJ floral
floral NN meristem
meristem CC and
and JJ reproductive
reproductive NNS organs

Ancient JJ CAPITAL Ancient
Ancient NN CAPITAL DNA
DNA IN from
from NN amber
amber NN fossil
fossil NNS bees
bees . ?

The DT CAPITAL The
The NN histone
histone NN CAPITAL H1
H1 NNS genes
genes IN of
of DT the
the NN dipteran
dipteran NN insect
insect , ,
, NNP CAPITAL Chironomus
Chironomus IN thummi
thummi , ,
, NN fall
fall IN under
under CD two
two JJ divergent
divergent NNS classes
classes CC and
and VBP encode
encode NNS proteins
proteins IN with
with JJ distinct
distinct JJ intranuclear
intranuclear NN distribution
distribution CC and
and RB potentially
potentially JJ different
different NNS functions

Characterization NN CAPITAL Characterization
Characterization IN of
of DT the
the NN orf31-petG
orf31-petG NN gene
gene NN cluster
cluster IN from
from DT the
the NN plastid
plastid NN genome
genome IN of
of NN CAPITAL Populus
Populus NNS deltoides

Xenopus NN CAPITAL Xenopus
Xenopus NN CAPITAL Pax-2
Pax-2 NNS displays
displays JJ multiple
multiple NN splice
splice NNS forms
forms IN during
during NN embryogenesis
embryogenesis CC and
and JJ pronephric
pronephric NN kidney
kidney NN development

International NNP CAPITAL International
International NNP CAPITAL Workshop
Workshop IN on
on NN CAPITAL Bone
Bone NNP CAPITAL Research
Research IN in
in NN CAPITAL Space

Tokyo NNP CAPITAL Tokyo
Tokyo , ,
, NNP CAPITAL Japan
Japan , ,
, NNP CAPITAL November
November CD 11-13
11-13 , ,
, CD 1996

Proceedings NNP CAPITAL Proceedings

Joint NNP CAPITAL Joint
Joint NN meeting
meeting IN of
of DT the
the NNP CAPITAL Benelux
Benelux NNP CAPITAL Society
Society IN for
for NN CAPITAL Microcirculation
Microcirculation CC and
and DT the
the NN CAPITAL Gesellschaft
Gesellschaft f1/4r
f1/4r NN CAPITAL Mikrozirkulation
Mikrozirkulation NN e.V

Mainz NNP CAPITAL Mainz
Mainz , ,
, NNP CAPITAL Germany
Germany , ,
, NNP CAPITAL October
October CD 23-25
23-25 , ,
, CD 1997

Abstracts NNS CAPITAL Abstracts

3rd JJ 3rd
3rd NNP CAPITAL Congress
Congress IN of
of DT the
the JJ CAPITAL French
French NNP CAPITAL Society
Society IN of
of NN CAPITAL Blood
Blood NN CAPITAL Transfusion

Marseille NNP CAPITAL Marseille
Marseille , ,
, NNP CAPITAL France
France , ,
, CD 28-30
28-30 NNP CAPITAL April
April CD 1998

Central NNP CAPITAL Central
Central CC and
and NNP CAPITAL East
East JJ CAPITAL European
European NNP CAPITAL Regional
Regional NN CAPITAL INTERASMA
INTERASMA NN CAPITAL Conference

Budapest NNP CAPITAL Budapest
Budapest , ,
, NNP CAPITAL Hungary
Hungary , ,
, NNP CAPITAL August
August CD 24-27
24-27 , ,
, CD 1997

Summary NN CAPITAL Summary
Summary IN of
of NN symposium
symposium , ,
, JJ antisense
antisense NNS oligonucleotides
oligonucleotides : :
: NNS strategies
strategies CC and
and NNS successes

Sarasota NNP CAPITAL Sarasota
Sarasota , ,
, NNP CAPITAL Florida
Florida , ,
, NNP CAPITAL USA

April NNP CAPITAL April
April CD 21
21 , ,
, CD 1995

International NNP CAPITAL International
International JJ forensic
forensic NN science
science CC and
and NN justice

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT the
the JJ 6th
6th NNP CAPITAL Congress
Congress IN of
of DT the
the CAPITAL Soci
Soci NN (
( NN c
c NN )
) t
t NN (
( NN c
c NN )
) IN de
de NN CAPITAL Pharmaco-Toxicologie
Pharmaco-Toxicologie NNP CAPITAL Cellulaire
Cellulaire CC and
and DT the
the CAPITAL Soci
Soci NN (
( NN c
c NN )
) t
t NN (
( NN c
c NN )
) NN CAPITAL Franaise
Franaise IN de
de NN CAPITAL Toxicologie
Toxicologie CAPITAL G
G NN (
( NN c
c NN )
) n
n NN (
( NN c
c NN )
) NN tique

Paris NNP CAPITAL Paris
Paris , ,
, NNP CAPITAL France
France , ,
, NNP CAPITAL March
March CD 6-7
6-7 , ,
, CD 1997

The DT CAPITAL The
The JJ CAPITAL Italian
Italian NNP CAPITAL Association
Association IN for
for DT the
the NN CAPITAL Study
Study IN of
of FW CAPITAL Glaucoma

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT the
the JJ 12th
12th JJ annual
annual JJ general
general NN meeting

Rapallo NNP CAPITAL Rapallo
Rapallo , ,
, NNP CAPITAL Italy
Italy , ,
, CD 14-15
14-15 NNP CAPITAL March
March CD 1997

Report NNP CAPITAL Report
Report IN of
of DT the
the IN 61st
61st NNP CAPITAL National
National NNP CAPITAL Scientific
Scientific VBG CAPITAL Meeting
Meeting IN of
of DT the
the NNP CAPITAL American
American NNP CAPITAL College
College IN of
of NNP CAPITAL Rheumatology
Rheumatology , ,
, NNP CAPITAL Washington
Washington NN CAPITAL DC
DC , ,
, CD 8-12
8-12 NNP CAPITAL November
November CD 1997

Topical JJ CAPITAL Topical
Topical NN dictionary

USAN NNP CAPITAL USAN
USAN NNP CAPITAL Council

List NN CAPITAL List
List DT CAPITAL No

404 CD 404

New NNP CAPITAL New
New NNS names

Nagrestipen NN CAPITAL Nagrestipen

Proposed VBN CAPITAL Proposed
Proposed JJ genetic
genetic NN nomenclature
nomenclature NNS rules
rules IN for
for NNP CAPITAL Tetrahymena
Tetrahymena NN thermophila
thermophila , ,
, NN CAPITAL Paramecium
Paramecium NN primaurelia
primaurelia CC and
and NN CAPITAL Paramecium
Paramecium NN tetraurelia

The DT CAPITAL The
The NNP CAPITAL Seventh
Seventh NNP CAPITAL International
International VBG CAPITAL Meeting
Meeting IN on
on NNP CAPITAL Ciliate
Ciliate JJ CAPITAL Molecular
Molecular NN CAPITAL Biology
Biology NNP CAPITAL Genetics
Genetics NNP CAPITAL Nomenclature

Joint NNP CAPITAL Joint
Joint JJ annual
annual NN session
session IN of
of DT the
the NNP CAPITAL North
North JJ CAPITAL German
German NNP CAPITAL Society
Society IN of
of NNP CAPITAL Radiology
Radiology CC and
and DT the
the NNP CAPITAL Radiology
Radiology NNP CAPITAL Society
Society IN of
of JJR CAPITAL Lower
Lower NNP CAPITAL Saxony
Saxony CC and
and NNP CAPITAL Sachsen
Sachsen NNP CAPITAL Anhalt

Kiel NNP CAPITAL Kiel
Kiel , ,
, NN 20-21
20-21 NNP CAPITAL February
February CD 1998

Abstracts NNS CAPITAL Abstracts

Neurone NN CAPITAL Neurone
Neurone NN development
development CC and
and NN death
death , ,
, IN from
from DT a
a NN cell
cell NN biologist
biologist POS 's
's NN perspective

3rd JJ 3rd
3rd NN CAPITAL Neurotrauma/Polytrauma
Neurotrauma/Polytrauma NNP CAPITAL Symposium

Cologne NNP CAPITAL Cologne
Cologne , ,
, NNP CAPITAL Germany
Germany , ,
, NNP CAPITAL March
March CD 14-15
14-15 , ,
, CD 1998

Abstracts NNS CAPITAL Abstracts

Neuroimmunomodulation NN CAPITAL Neuroimmunomodulation
Neuroimmunomodulation : :
: JJ CAPITAL Molecular
Molecular NNS CAPITAL Aspects
Aspects , ,
, JJ CAPITAL Integrative
Integrative NNPS CAPITAL Systems
Systems , ,
, CC and
and JJ CAPITAL Clinical
Clinical NNS CAPITAL Advances

Proceedings NNP CAPITAL Proceedings
Proceedings IN of
of DT the
the JJ 3rd
3rd NNP CAPITAL Congress
Congress IN of
of DT the
the NNP CAPITAL International
International NNP CAPITAL Society
Society IN of
of NN CAPITAL NeuroImmunoModulation
NeuroImmunoModulation NN (
( NNP CAPITAL ISNIM
ISNIM NN )

Bethesda NNP CAPITAL Bethesda
Bethesda , ,
, NNP CAPITAL Maryland
Maryland , ,
, NNP CAPITAL USA

November NNP CAPITAL November
November CD 13-15
13-15 , ,
, CD 1996

8th JJ 8th
8th JJ CAPITAL European
European VBG CAPITAL Meeting
Meeting IN on
on NNP CAPITAL Dysmorphology

Strasbourg NNP CAPITAL Strasbourg
Strasbourg , ,
, NNP CAPITAL France
France , ,
, CD 3-6
3-6 NNP CAPITAL September
September CD 1997

Abstracts NNS CAPITAL Abstracts

EU NNP CAPITAL EU
EU VBG CAPITAL Working
Working NNP CAPITAL Group
Group IN on
on NN CAPITAL Tobacco
Tobacco CC and
and JJ CAPITAL Oral
Oral NNP CAPITAL Health
Health NN CAPITAL Consensus
Consensus VBG CAPITAL Meeting

Copenhagen NNP CAPITAL Copenhagen
Copenhagen , ,
, CD 23-26
23-26 NNP CAPITAL October
October CD 1997

Abstracts NNS CAPITAL Abstracts

Presentations NNS CAPITAL Presentations
Presentations IN from
from DT the
the JJ 2nd
2nd NNP CAPITAL NIH
NIH NNP CAPITAL Symposium
Symposium IN on
on JJ CAPITAL Therapeutic
Therapeutic NNS CAPITAL Oligonucleotides
Oligonucleotides : :
: NN CAPITAL Targeting
Targeting NN CAPITAL Transcription
Transcription NNS CAPITAL Factors
Factors CC and
and NN CAPITAL Signaling
Signaling NNS CAPITAL Pathways

Bethesda NNP CAPITAL Bethesda
Bethesda , ,
, NNP CAPITAL Maryland
Maryland , ,
, NNP CAPITAL USA

December NNP CAPITAL December
December CD 5
5 , ,
, CD 1997

Infectious JJ CAPITAL Infectious
Infectious NNS diseases
diseases : :
: PRP$ their
their NN impact
impact IN on
on NN dentistry

What WDT CAPITAL What
What POS 's
's JJ new
new IN in
in NN protein
protein JJ folding
folding . ?
? NNP CAPITAL EMBO
EMBO NN workshop
workshop : :
: NN protein
protein JJ folding
folding CC and
and NN misfolding
misfolding IN inside
inside CC and
and IN outside
outside DT the
the NN cell

Meeting VBG CAPITAL Meeting
Meeting IN of
of DT the
the JJ CAPITAL European
European NN forum
forum IN of
of NNS nurses

17th JJ 17th
17th JJ CAPITAL European
European NNP CAPITAL Workshop
Workshop IN on
on DT the
the NN CAPITAL Cell
Cell NN CAPITAL Biology
Biology IN of
of NNS CAPITAL Phagocytes

Catania NNP CAPITAL Catania
Catania , ,
, NNP CAPITAL Italy
Italy , ,
, NNP CAPITAL May
May CD 27-31
27-31 , ,
, CD 1998

Abstracts NNS CAPITAL Abstracts

Onset NN CAPITAL Onset
Onset IN of
of DT the
the JJ preovulatory
preovulatory VBG luteinizing
luteinizing NN hormone
hormone NN surge
surge : :
: JJ diurnal
diurnal NN timing
timing CC and
and JJ critical
critical JJ follicular
follicular NNS prerequisites

Municipal JJ CAPITAL Municipal
Municipal NN animal
animal NN control
control NNS ordinances
ordinances : --
-- DT some
some JJ legal
legal NNS issues

Psychosexual JJ CAPITAL Psychosexual
Psychosexual NN care
care IN in
in DT a
a JJ multi-ethnic
multi-ethnic NN society

Serologic JJ CAPITAL Serologic
Serologic NN evidence
evidence IN for
for JJ mother-to-child
mother-to-child NN transmission
transmission IN of
of NN CAPITAL Kaposi
Kaposi JJ sarcoma-associated
sarcoma-associated NN herpesvirus
herpesvirus NN infection

Brandon/Hill NNP CAPITAL Brandon/Hill
Brandon/Hill VBN selected
selected NN list
list IN of
of NN nursing
nursing NNS books
books CC and
and NNS journals

Retraction NN CAPITAL Retraction

The DT CAPITAL The
The NN CAPITAL TSG101
TSG101 NN tumor
tumor NN susceptibility
susceptibility NN gene
gene VBZ is
is JJ located
located IN in
in NN chromosome
chromosome CD 11
11 NN band
band NN p15
p15 CC and
and VBZ is
is VBN mutated
mutated IN in
in JJ human
human NN breast
breast NN cancer

An DT CAPITAL An
An NN omission

Indoor JJ CAPITAL Indoor
Indoor NN pollution
pollution CC and
and NN health

Dioxins NNS CAPITAL Dioxins
Dioxins : :
: JJ current
current NN knowledge
knowledge IN about
about NN health
health NNS effects

Influence NN CAPITAL Influence
Influence IN of
of JJ environmental
environmental NNS factors
factors IN on
on NN fertility
fertility : :
: NN example
example IN of
of DT the
the NN diminution
diminution IN of
of NN sperm
sperm NN quality

New NNP CAPITAL New
New NNS developments
developments IN in
in DT the
the NN treatment
treatment IN of
of NN diabetes
diabetes CC and
and NNS hyperlipidemias

Role NN CAPITAL Role
Role IN of
of NNS beta-blockers
beta-blockers IN in
in DT the
the NN treatment
treatment IN of
of JJ cardiac
cardiac NN insufficiency

Which WDT CAPITAL Which
Which NN calcium
calcium NNS antagonists
antagonists IN for
for NN hypertension
hypertension . ?

Correct JJ CAPITAL Correct
Correct NN use
use IN of
of NN serotonin
serotonin NNS agonists
agonists IN in
in NN migraine
migraine : :
: JJ oral
oral CC or
or JJ injectable
injectable NN form
form . ?

Overtraining VBG CAPITAL Overtraining
Overtraining CC and
and NN recovery

A DT CAPITAL A
A JJ conceptual
conceptual NN model

Saliva FW CAPITAL Saliva
Saliva NN composition
composition CC and
and NN exercise

Lipid NN CAPITAL Lipid
Lipid NN metabolism
metabolism IN during
during NN exercise

Golf NNP CAPITAL Golf
Golf NNS injuries

An DT CAPITAL An
An NN overview

Prevention NNP CAPITAL Prevention
Prevention IN of
of NN ankle
ankle NNS injuries

Academic NNP CAPITAL Academic
Academic NN medicine
medicine : --
-- NN alternative
alternative NN medicine
medicine IN from
from DT the
the NN viewpoint
viewpoint IN of
of NN public
public NN health
health NN public
public NN health
health NNS directors

Academic NNP CAPITAL Academic
Academic NN medicine
medicine CC and
and JJ complementary
complementary NN medicine
medicine : --
-- NN campaign
campaign IN for
for DT the
the NN truth
truth IN in
in JJ medical
medical NNS theories

The DT CAPITAL The
The JJ academic
academic NN medicine
medicine : --
-- NN alternative
alternative NN medicine
medicine NN tension
tension NN field

Are VBP CAPITAL Are
Are JJ academic
academic JJ medicine-alternative
medicine-alternative NN medicine
medicine JJ incompatible
incompatible , ,
, JJ compatible
compatible , ,
, JJ complementary
complementary . ?

Research NNP CAPITAL Research
Research IN in
in JJ complementary
complementary NN medicine
medicine : :
: NNS results
results CC and
and NNS problems

Subcutaneous NNP CAPITAL Subcutaneous
Subcutaneous NNS hematomas
hematomas , ,
, VBN reduced
reduced RB CAPITAL Quick
Quick NN value

Factor NN CAPITAL Factor
Factor NN CAPITAL VII
VII NN deficiency

Mononucleosis NN CAPITAL Mononucleosis
Mononucleosis NN infectiosa
infectiosa NN (
( JJ CAPITAL Epstein-Barr
Epstein-Barr NN virus
virus NN infection

Morphology NN CAPITAL Morphology
Morphology CC and
and JJ molecular
molecular NN biology
biology IN of
of JJ malignant
malignant JJ soft
soft NN tissue
tissue NNS sarcomas

Surgical NNP CAPITAL Surgical
Surgical NNS aspects
aspects IN in
in DT the
the JJ multidisciplinary
multidisciplinary NN treatment
treatment IN of
of JJ soft
soft NN tissue
tissue NNS sarcomas

Surgical NNP CAPITAL Surgical
Surgical NN management
management IN of
of JJ soft
soft NN tissue
tissue NNS sarcomas
sarcomas : :
: NNS principles
principles IN of
of NN resection
resection CC and
and NN reconstructive
reconstructive NN plastic
plastic NNS procedures

Adjuvant JJ CAPITAL Adjuvant
Adjuvant NN chemotherapy
chemotherapy IN in
in RB early
early JJ soft
soft NN tissue
tissue NN sarcoma
sarcoma CC and
and NN palliative
palliative NN chemotherapy
chemotherapy IN in
in VBN advanced
advanced JJ soft
soft NN tissue
tissue NN sarcoma
sarcoma IN in
in NNS adults

Radiotherapy NN CAPITAL Radiotherapy
Radiotherapy IN of
of JJ soft
soft NN tissue
tissue NNS sarcomas

Spinal JJ CAPITAL Spinal
Spinal JJ muscular
muscular NN atrophy
atrophy : :
: WRB where
where VBP are
are PRP we
we IN in
in CD 1998
1998 . ?

Diseases NNS CAPITAL Diseases
Diseases VBN transmitted
transmitted IN by
by JJ non-conventional
non-conventional NNS agents
agents NN (
( `` ``
`` NNS prions
prions '' ''
'' NN )
) : :
: NN nosology
nosology CC and
and NN diagnosis

A DT CAPITAL A
A NN note
note IN on
on DT the
the NN epidemiology
epidemiology IN of
of NN CAPITAL Creutzfeldt-Jakob
Creutzfeldt-Jakob NN syndrome

Biology NN CAPITAL Biology
Biology IN of
of JJ non-conventional
non-conventional JJ transmissible
transmissible NNS agents
agents CC or
or NNS prions

Cerebral JJ CAPITAL Cerebral
Cerebral NN hemosiderosis
hemosiderosis JJ related
related TO to
to JJ hereditary
hereditary NN ceruloplasmin
ceruloplasmin NN deficiency

Clinical JJ CAPITAL Clinical
Clinical JJ familial
familial NN case
case NN study

Intramedullary JJ CAPITAL Intramedullary
Intramedullary NNS metastases
metastases IN of
of JJ bronchogenic
bronchogenic NN carcinoma

Two CD CAPITAL Two
Two NNS cases

Nervous JJ CAPITAL Nervous
Nervous NN system
system NN borreliosis
borreliosis IN with
with NN pseudo-lymphoma
pseudo-lymphoma NNS cells
cells IN in
in JJ cerebrospinal
cerebrospinal NN fluid

Epidural JJ CAPITAL Epidural
Epidural CC and
and JJ intramedullary
intramedullary NN abscess
abscess IN of
of JJ acute
acute NN onset

Cranial JJ CAPITAL Cranial
Cranial NN nerve
nerve NNS injuries
injuries IN during
during JJ multifocal
multifocal NNS neuropathies
neuropathies IN with
with JJ persistent
persistent NN conduction
conduction NNS blocks

Cytokines NNS CAPITAL Cytokines
Cytokines CC and
and JJ peripheral
peripheral NNS neuropathies

Clinical JJ CAPITAL Clinical
Clinical NN diagnosis
diagnosis IN of
of NN frontotemporal
frontotemporal NN dementia

Study NN CAPITAL Study
Study IN of
of JJ cortical
cortical NN atrophy
atrophy IN with
with JJ magnetic
magnetic NN resonance
resonance NN imaging
imaging IN in
in NN corticobasal
corticobasal NN degeneration

Autosomal RB CAPITAL Autosomal
Autosomal JJ dominant
dominant JJ nocturnal
nocturnal JJ frontal
frontal NN lobe
lobe NN epilepsy

Eosinophilic JJ CAPITAL Eosinophilic
Eosinophilic NN meningitis
meningitis JJ due
due TO to
to JJ CAPITAL Angiostrongylus
Angiostrongylus NN cantonensis

Case NN CAPITAL Case
Case IN of
of JJ superficial
superficial NN hemosiderosis
hemosiderosis IN of
of DT the
the JJ central
central JJ nervous
nervous NN system
system VBN treated
treated IN with
with NN trientine

Germinal JJ CAPITAL Germinal
Germinal NN tumor
tumor NNS metastases

Case NN CAPITAL Case
Case NN report

Bradycardia NN CAPITAL Bradycardia
Bradycardia : :
: DT an
an JJ unrecognized
unrecognized NN complication
complication IN of
of DT some
some JJ epileptic
epileptic NNS crises

Facial JJ CAPITAL Facial
Facial NN palsy
palsy JJ relevant
relevant TO to
to NN CAPITAL HIV
HIV NN seropositivity

Pneumosinus NN CAPITAL Pneumosinus
Pneumosinus NNS dilatans
dilatans : :
: DT a
a JJ little-known
little-known JJ diagnostic
diagnostic NN tool

Current JJ CAPITAL Current
Current NN status
status IN of
of JJ mitochondrial
mitochondrial NNS diseases

Vascular JJ CAPITAL Vascular
Vascular NNP CAPITAL Parkinson
Parkinson NNS syndromes
syndromes : :
: DT a
a JJ controversial
controversial NN concept

Epilepsy NNP CAPITAL Epilepsy
Epilepsy CC and
and JJ psychiatric
psychiatric NNS disorders
disorders : :
: JJ epidemiological
epidemiological NNS data

Auditory NNP CAPITAL Auditory
Auditory NN perception
perception NNS disorders
disorders JJ due
due TO to
to JJ bilateral
bilateral JJ cortical
cortical NNS lesions

An DT CAPITAL An
An NN electrophysiology
electrophysiology NN study

Zinc NN CAPITAL Zinc
Zinc NN gluconate
gluconate NNS lozenges
lozenges IN for
for VBG treating
treating DT the
the JJ common
common JJ cold

Body NN CAPITAL Body
Body NN weight
weight CC and
and NN mortality
mortality IN among
among NNS women

Survey NN CAPITAL Survey
Survey CC and
and NN assessment
assessment IN of
of DT the
the JJ actual
actual NN state
state IN of
of JJ routine
routine NN measurement
measurement IN of
of NN glycohaemoglobin/GHb
glycohaemoglobin/GHb IN by
by JJ commercial
commercial NNS methods
methods : :
: VBG warning
warning TO to
to DT the
the NNS users
users CC and
and DT the
the NNS providers

The DT CAPITAL The
The JJ radiological
radiological NN investigation
investigation IN of
of VBN suspected
suspected JJR lower
lower NN limb
limb RB deep
deep NN vein
vein NN thrombosis

p53 NN p53
p53 NNS mutations
mutations IN in
in JJ CAPITAL BRCA1-associated
BRCA1-associated JJ familial
familial NN breast
breast NN cancer

Metronidazole NNP CAPITAL Metronidazole
Metronidazole NN (
( NNP CAPITAL Flagyl
Flagyl NN )

The DT CAPITAL The
The NNP CAPITAL Preterm
Preterm NN CAPITAL Prediction
Prediction NN CAPITAL Study
Study : :
: NN association
association IN of
of NN cesarean
cesarean NN delivery
delivery IN with
with NNS increases
increases IN in
in JJ maternal
maternal NN weight
weight CC and
and NN body
body NN mass
mass NN index

Controversies NNS CAPITAL Controversies
Controversies IN in
in VBG hydrating
hydrating DT the
the RB terminally
terminally RB ill
ill NN patient

Frequency NN CAPITAL Frequency
Frequency CC and
and NN significance
significance IN of
of JJ antinuclear
antinuclear NNS antibodies
antibodies IN in
in JJ multiple
multiple NN sclerosis

Magnetic JJ CAPITAL Magnetic
Magnetic NN resonance
resonance NN imaging
imaging IN of
of DT the
the NN bone
bone NN marrow
marrow IN in
in JJ hematologic
hematologic NNS malignancies

Generation NN CAPITAL Generation
Generation IN of
of NN diversity
diversity IN in
in JJ mammalian
mammalian JJ gut-associated
gut-associated JJ lymphoid
lymphoid NNS tissues
tissues : :
: JJ restricted
restricted NN CAPITAL V
V NN gene
gene NN usage
usage VBZ does
does RB not
not VB preclude
preclude NN complex
complex NN CAPITAL V
V NN gene
gene NN organization

A DT CAPITAL A
A JJ major
major JJ non-LTR
non-LTR NN retrotransposon
retrotransposon IN of
of NNP CAPITAL Bombyx
Bombyx NN mori
mori , ,
, NN CAPITAL L1Bm

Algae NNP CAPITAL Algae
Algae CC or
or NN protozoa
protozoa : :
: JJ phylogenetic
phylogenetic NN position
position IN of
of NNS euglenophytes
euglenophytes CC and
and NNS dinoflagellates
dinoflagellates IN as
as VBN inferred
inferred IN from
from JJ mitochondrial
mitochondrial NNS sequences

Structure NN CAPITAL Structure
Structure CC and
and NN function
function IN of
of DT the
the RB long
long JJ terminal
terminal NNS repeats
repeats IN of
of JJ feline
feline NN leukemia
leukemia NNS viruses
viruses VBN derived
derived IN from
from RB naturally
naturally VBG occurring
occurring JJ acute
acute JJ myeloid
myeloid NNS leukemias
leukemias IN in
in NNS cats

Use NN CAPITAL Use
Use IN of
of JJ protein-C
protein-C NN concentrate
concentrate , ,
, NN heparin
heparin , ,
, CC and
and NN haemodiafiltration
haemodiafiltration IN in
in JJ meningococcus-induced
meningococcus-induced NN purpura
purpura NNS fulminans

Satellite NNP CAPITAL Satellite
Satellite NN CAPITAL DNA
DNA NN repeat
repeat NN sequence
sequence NN variation
variation VBZ is
is JJ low
low IN in
in CD three
three NNS species
species IN of
of VBG burying
burying NNS beetles
beetles IN in
in DT the
the NN genus
genus NN CAPITAL Nicrophorus
Nicrophorus NN (
( NNP CAPITAL Coleoptera
Coleoptera : :
: FW CAPITAL Silphidae
Silphidae NN )

The DT CAPITAL The
The NN importance
importance IN of
of NN patient
patient NN registration
registration CC and
and NN processing

Dose-dependent JJ CAPITAL Dose-dependent
Dose-dependent NNS effects
effects IN of
of JJ recombinant
recombinant JJ human
human NN interleukin-6
interleukin-6 IN on
on NN glucose
glucose NN regulation

Genomic JJ CAPITAL Genomic
Genomic NN sequence
sequence IN of
of DT a
a NN CAPITAL Lyme
Lyme NN disease
disease NN spirochaete
spirochaete , ,
, FW CAPITAL Borrelia
Borrelia FW burgdorferi

Interaction NN CAPITAL Interaction
Interaction IN between
between JJ electronic
electronic NN article
article NN surveillance
surveillance NNS systems
systems CC and
and JJ implantable
implantable NNS defibrillators
defibrillators : :
: NNS insights
insights IN from
from DT a
a JJ fourth
fourth NN generation
generation NN CAPITAL ICD

Human JJ CAPITAL Human
Human JJ bodily
bodily NN health
health CC and
and DT the
the JJ common
common JJ good

Proposals NNS CAPITAL Proposals
Proposals IN for
for NN action
action IN by
by NNS individuals
individuals CC and
and DT the
the NNP CAPITAL Catholic
Catholic NNP CAPITAL Church

Invited VBN CAPITAL Invited
Invited NN commentary
commentary : :
: DT le
le NN mystre
mystre IN de
de CAPITAL Montr
Montr NN (
( NN c
c NN )
) NNP al
al . .

Why WRB CAPITAL Why
Why NNP CAPITAL Oedipus
Oedipus CC and
and RB not
not NNP CAPITAL Christ
Christ . ?
? : :
: DT a
a JJ psychoanalytic
psychoanalytic NN inquiry
inquiry IN into
into NN innocence
innocence , ,
, JJ human
human NN sacrifice
sacrifice , ,
, CC and
and DT the
the JJ sacred
sacred : --
-- NN CAPITAL Part
Part PRP CAPITAL I
I : :
: NN CAPITAL Innocence
Innocence , ,
, NN spirituality
spirituality , ,
, CC and
and JJ human
human NN sacrifice

Equine NN CAPITAL Equine
Equine NN dinucleotide
dinucleotide NN repeat
repeat NNS loci
loci NN CAPITAL LEX049-LEX063

Molecular JJ CAPITAL Molecular
Molecular NNS systematics
systematics IN of
of NNS tanagers
tanagers NN (
( FW CAPITAL Thraupinae
Thraupinae NN )
) : :
: NN evolution
evolution CC and
and NN biogeography
biogeography IN of
of DT a
a JJ diverse
diverse NN radiation
radiation IN of
of JJ neotropical
neotropical NNS birds

Expression NN CAPITAL Expression
Expression IN of
of NN cytokeratin
cytokeratin CD 20
20 IN in
in JJ urinary
urinary NN cytology
cytology IN of
of NNS patients
patients IN with
with NN bladder
bladder NN carcinoma

A DT CAPITAL A
A NN family
family IN of
of RB highly
highly JJ repetitive
repetitive NNS CAPITAL DNAs
DNAs IN from
from `` ``
`` NN ginbuna
ginbuna '' ''
'' NN (
( NNP CAPITAL Carassius
Carassius NN auratus
auratus NN langsdorfi
langsdorfi NN )
) NN genome
genome JJ common
common TO to
to NNP CAPITAL Carassius
Carassius NN auratus
auratus NNS populations

Characterization NN CAPITAL Characterization
Characterization IN of
of NN cDNA
cDNA NNS clones
clones IN in
in JJ size-fractionated
size-fractionated NN cDNA
cDNA NNS libraries
libraries IN from
from JJ human
human NN brain

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Respiratory
Respiratory NN arrest
arrest VBG following
following NN peribulbar
peribulbar NN anesthesia
anesthesia IN for
for NN cataract
cataract NN surgery
surgery : :
: NN case
case NN report
report CC and
and NN review
review IN of
of DT the
the NN literature

Mouse NN CAPITAL Mouse
Mouse NN CAPITAL LIM-kinase
LIM-kinase CD 2
2 NN gene
gene : :
: NN cDNA
cDNA VBG cloning
cloning , ,
, JJ genomic
genomic NN organization
organization , ,
, CC and
and JJ tissue-specific
tissue-specific NN expression
expression IN of
of CD two
two RB alternatively
alternatively VBN initiated
initiated NNS transcripts

A DT CAPITAL A
A JJ gross
gross CC and
and JJ microscopic
microscopic NN study
study IN of
of JJ cerebral
cerebral NNS injuries
injuries VBG accompanying
accompanying JJ maxillofacial
maxillofacial NN high-velocity
high-velocity NN projectile
projectile VBG wounding
wounding IN in
in NNS dogs

Does VBZ CAPITAL Does
Does DT this
this NN patient
patient VB have
have DT a
a NN mole
mole CC or
or DT a
a NN melanoma
melanoma . ?

Methotrexate NNP CAPITAL Methotrexate
Methotrexate CC and
and NN trimethoprim
trimethoprim : :
: DT a
a JJ fatal
fatal NN interaction

Pellagra NNP CAPITAL Pellagra
Pellagra CC and
and DT the
the NN origin
origin IN of
of DT a
a NN myth
myth : :
: NN evidence
evidence IN from
from JJ CAPITAL European
European NN literature
literature CC and
and NN folklore

Absorbable JJ CAPITAL Absorbable
Absorbable NN suture
suture NN technique
technique : :
: NN solution
solution TO to
to DT the
the NN growth
growth NN problem
problem IN in
in JJ pediatric
pediatric NN pacing
pacing IN with
with JJ endocardial
endocardial NNS leads

Undergraduate JJ CAPITAL Undergraduate
Undergraduate NN orthodontic
orthodontic NN education
education : :
: WDT what
what MD should
should PRP we
we VB teach
teach RB rather
rather IN than
than WDT what
what MD can
can PRP we
we VB teach
teach . ?

Genetic JJ CAPITAL Genetic
Genetic NN variation
variation IN in
in DT the
the JJ dimorphic
dimorphic NNS regions
regions IN of
of NN CAPITAL RAP-1
RAP-1 NNS genes
genes CC and
and NN rap-1
rap-1 NNS loci
loci IN of
of NNP CAPITAL Babesia
Babesia NN bigemina

History NN CAPITAL History
History : --
-- DT a
a VBG living
living NN museum

Interview NN CAPITAL Interview
Interview IN by
by NNP CAPITAL Grethe
Grethe NNP CAPITAL Kjaergaard

Gastric JJ CAPITAL Gastric
Gastric NN site
site IN of
of NN epidermoid
epidermoid NN carcinoma

Hypodermic JJ CAPITAL Hypodermic
Hypodermic NNS needles
needles IN in
in DT the
the JJ neuropathic
neuropathic NN foot
foot IN of
of DT a
a NN patient
patient IN with
with NN diabetes

Helicobacter NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori : --
-- RBR more
more NN light
light , ,
, JJR less
less NN heat

A DT CAPITAL A
A JJ national
national NN survey
survey IN of
of JJ physician-assisted
physician-assisted NN suicide
suicide CC and
and NN euthanasia
euthanasia IN in
in DT the
the NNP CAPITAL United
United NNPS CAPITAL States

Death NN CAPITAL Death
Death VBZ is
is DT a
a NN journey
journey TO to
to VB be
be VBN undertaken

Replicated VBN CAPITAL Replicated
Replicated NNS declines
declines IN in
in NN assault
assault NNS rates
rates IN after
after NN implementation
implementation IN of
of DT the
the VBN CAPITAL Assaulted
Assaulted NN CAPITAL Staff
Staff NNP CAPITAL Action
Action NN CAPITAL Program

Positive JJ CAPITAL Positive
Positive NN patch
patch NN test
test TO to
to NN cocamidopropyl
cocamidopropyl NN betaine
betaine IN in
in DT a
a NN hairdresser

Management NN CAPITAL Management
Management IN of
of NN dyslipidemia
dyslipidemia IN in
in NNS adults
adults IN with
with NN diabetes

American NNP CAPITAL American
American NNP CAPITAL Diabetes
Diabetes NNP CAPITAL Association

Acute JJ CAPITAL Acute
Acute NN diverticulitis

Investigation NN CAPITAL Investigation
Investigation IN of
of DT the
the NN yeast
yeast JJ mitochondrial
mitochondrial JJ unselective
unselective NN channel
channel IN in
in JJ intact
intact CC and
and JJ permeabilized
permeabilized NNS spheroplasts

Acute JJ CAPITAL Acute
Acute NN sciatica
sciatica IN with
with DT an
an JJ infective
infective NN cause

An DT CAPITAL An
An JJ ecologic
ecologic NN analysis
analysis IN of
of JJ psychosocial
psychosocial NN stress
stress CC and
and NN heart
heart NN disease
disease IN in
in JJ CAPITAL British
British NNP CAPITAL Columbia

Human JJ CAPITAL Human
Human NN leukocyte
leukocyte NN antigen
antigen NNS frequencies
frequencies IN in
in DT a
a VBN selected
selected NN group
group IN of
of JJ CAPITAL Lebanese
Lebanese JJ CAPITAL Greek
Greek NN CAPITAL Orthodox

Alcohol NN CAPITAL Alcohol
Alcohol CC and
and DT the
the NN heart

Spontaneous JJ CAPITAL Spontaneous
Spontaneous JJ ovarian
ovarian NN hyperstimulation
hyperstimulation NN syndrome
syndrome IN with
with NN pregnancy

Will MD CAPITAL Will
Will DT the
the RB real
real NN plastic
plastic NN surgeon
surgeon VB please
please VB stand
stand RB up
up . ?

Modulation NN CAPITAL Modulation
Modulation IN of
of NN ultraviolet
ultraviolet JJ light-induced
light-induced JJ epidermal
epidermal NN damage
damage : :
: JJ beneficial
beneficial NNS effects
effects IN of
of NN tocopherol

A DT CAPITAL A
A NN survey
survey IN of
of DT the
the NNS attitudes
attitudes IN of
of JJ chronic
chronic JJ psychiatric
psychiatric NNS patients
patients VBG living
living IN in
in DT the
the NN community
community IN toward
toward PRP$ their
their NN medication

Alterations NNS CAPITAL Alterations
Alterations IN in
in DT the
the VBG developing
developing JJ immune
immune NN system
system IN of
of DT the
the NN CAPITAL F344
F344 NN rat
rat IN after
after JJ perinatal
perinatal NN exposure
exposure TO to
to CD 2
2 , ,
, CD 3
3 , ,
, CD 7
7 , ,
, NN 8-tetrachlorodibenzo-p-dioxin
8-tetrachlorodibenzo-p-dioxin : :
: NNP CAPITAL II

Effects NNS CAPITAL Effects
Effects IN on
on DT the
the NN pup
pup CC and
and DT the
the JJ adult

Renal JJ CAPITAL Renal
Renal NN ultrasonography
ultrasonography : :
: DT a
a NN procedure
procedure IN for
for NNS nephrologists

Use NN CAPITAL Use
Use IN of
of NN cisapride
cisapride IN in
in NN treatment
treatment IN of
of NN constipation
constipation IN in
in NNS children

Bilateral JJ CAPITAL Bilateral
Bilateral NN sampling
sampling IN of
of DT the
the JJ internal
internal JJ jugular
jugular NN vein
vein TO to
to VB distinguish
distinguish IN between
between NNS mechanisms
mechanisms IN of
of JJ adrenocorticotropic
adrenocorticotropic JJ hormone-dependent
hormone-dependent NN CAPITAL Cushing
Cushing NN syndrome

The DT CAPITAL The
The NN influence
influence IN of
of NNS patients
patients '' '
' NNS hopes
hopes IN of
of VBG receiving
receiving DT a
a NN prescription
prescription IN on
on NNS doctors
doctors '' '
' NNS perceptions
perceptions CC and
and DT the
the NN decision
decision TO to
to VB prescribe
prescribe : :
: DT a
a NN questionnaire
questionnaire NN survey

Coronary JJ CAPITAL Coronary
Coronary JJ endothelial
endothelial NN dysfunction
dysfunction IN in
in NNS humans
humans VBZ is
is VBN associated
associated IN with
with JJ myocardial
myocardial NN perfusion
perfusion NNS defects

Medical NNP CAPITAL Medical
Medical NNS devices
devices CC and
and DT the
the NN year
year CD 2000
2000 NN problem

Internists NNS CAPITAL Internists
Internists '' '
' CC and
and NNS surgeons
surgeons '' '
' NNS attitudes
attitudes IN toward
toward NNS guns
guns CC and
and NN firearm
firearm NN injury
injury NN prevention

Firearm NN CAPITAL Firearm
Firearm NN injury
injury NN prevention

American NNP CAPITAL American
American NNP CAPITAL College
College IN of
of NNP CAPITAL Physicians

Management NN CAPITAL Management
Management IN of
of JJ vaginal
vaginal NN vault
vault NN prolapse

Death NN CAPITAL Death
Death NNS rates
rates IN of
of NNS characters
characters IN in
in NN soap
soap NNS operas
operas IN on
on JJ CAPITAL British
British NN television
television : :
: VBZ is
is DT a
a NN government
government NN health
health VBG warning
warning VBN required
required . ?

Child NN CAPITAL Child
Child JJ sexual
sexual NN abuse
abuse : :
: WRB when
when DT a
a NN doctor
doctor POS 's
's NN duty
duty TO to
to NN report
report NN abuse
abuse NNS conflicts
conflicts IN with
with DT a
a NN duty
duty IN of
of NN confidentiality
confidentiality TO to
to DT the
the NN victim

Tissue NN CAPITAL Tissue
Tissue NNS adhesives
adhesives : --
-- VBN revisited

Racial JJ CAPITAL Racial
Racial NN discrimination
discrimination IN in
in DT the
the NN allocation
allocation IN of
of NN distinction
distinction NNS awards
awards . ?
? NN CAPITAL Analysis
Analysis IN of
of NN list
list IN of
of NN award
award NNS holders
holders IN by
by NN type
type IN of
of NN award
award , ,
, NN specialty
specialty CC and
and NN region

Multicenter NNP CAPITAL Multicenter
Multicenter NN study
study IN of
of NN surfactant
surfactant NN (
( NN beractant
beractant NN )
) NN use
use IN in
in DT the
the NN treatment
treatment IN of
of NN term
term NNS infants
infants IN with
with JJ severe
severe JJ respiratory
respiratory NN failure

Survanta NN CAPITAL Survanta
Survanta IN in
in NN CAPITAL Term
Term NNS CAPITAL Infants
Infants NN CAPITAL Study
Study NNP CAPITAL Group

Consultation NN CAPITAL Consultation
Consultation NN section

Cataract NN CAPITAL Cataract
Cataract JJ surgical
surgical NN problem

Changing VBG CAPITAL Changing
Changing DT the
the NN law
law IN on
on NN decision
decision VBG making
making IN for
for RB mentally
mentally VBN incapacitated
incapacitated NNS adults

The DT CAPITAL The
The VBG coding
coding NN audit

Providing VBG CAPITAL Providing
Providing JJ primary
primary NN care
care IN in
in DT the
the NN accident
accident CC and
and NN emergency
emergency NN department

Challenges NNS CAPITAL Challenges
Challenges TO to
to JJ CAPITAL Native
Native NNP CAPITAL American
American NN health
health NN care

Federal NNP CAPITAL Federal
Federal NNS programs
programs CC and
and JJ CAPITAL Indian
Indian NN country
country : :
: DT a
a NN time
time IN for
for NN reinvention

Chicago NNP CAPITAL Chicago
Chicago NN report
report NNS profiles

Big NNP CAPITAL Big
Big NN city
city NN health

College-age JJ CAPITAL College-age
College-age NN drinking
drinking NNS problems

Using VBG CAPITAL Using
Using NN CAPITAL YPLL
YPLL IN in
in NN health
health VBG planning

WHO WP CAPITAL WHO
WHO VBZ decides
decides : :
: NN food
food NN irradiation
irradiation JJ safe
safe IN at
at DT any
any NN level

Genetic JJ CAPITAL Genetic
Genetic NN sampling
sampling : :
: JJ big
big NN brother
brother CC or
or JJ big
big NN science
science . ?

Physician NN CAPITAL Physician
Physician NNS assistants
assistants CC and
and NN nurse
nurse NNS practitioners
practitioners IN in
in NN hospital
hospital NN outpatient
outpatient NNS departments
departments , ,
, CD 1993-1994

Laying VBG CAPITAL Laying
Laying DT the
the NN foundation
foundation IN for
for JJ CAPITAL Healthy
Healthy NNS CAPITAL People
People CD 2010

The DT CAPITAL The
The RB first
first NN year
year IN of
of NN consultation

The DT CAPITAL The
The JJ veracious
veracious NN etiology
etiology IN of
of JJ ectopic
ectopic NN pregnancy

Is VBZ CAPITAL Is
Is JJ dietary
dietary NN fat
fat DT a
a JJ major
major NN determinant
determinant IN of
of NN body
body NN fat
fat . ?

Factors NNS CAPITAL Factors
Factors VBN involved
involved IN in
in DT the
the NN rate
rate IN of
of NN fall
fall IN of
of NN thyroid
thyroid VBG stimulating
stimulating NN hormone
hormone IN in
in VBN treated
treated NN hypothyroidism

Case NN CAPITAL Case
Case NN complexity

Imaging NNP CAPITAL Imaging
Imaging JJ pulmonary
pulmonary NN embolism

Early RB CAPITAL Early
Early NN inpatient
inpatient NN rehabilitation
rehabilitation IN after
after JJ elective
elective NN hip
hip CC and
and NN knee
knee NN arthroplasty

Inpatient JJ CAPITAL Inpatient
Inpatient NN rehabilitation
rehabilitation IN after
after NN total
total NN joint
joint NN replacement

Delayed VBN CAPITAL Delayed
Delayed NN healing
healing IN of
of NN rhytidectomy
rhytidectomy NN flap
flap VBD resurfaced
resurfaced IN with
with NN CAPITAL CO2
CO2 NN laser

The DT CAPITAL The
The NNP CAPITAL SAPHO
SAPHO NN syndrome
syndrome : :
: DT an
an VBG evolving
evolving NN concept
concept IN for
for JJ unifying
unifying JJ several
several JJ idiopathic
idiopathic NNS disorders
disorders IN of
of NN bone
bone CC and
and NN skin

Beverage NNP CAPITAL Beverage
Beverage NN use
use CC and
and NN risk
risk IN for
for NN kidney
kidney NNS stones
stones IN in
in NNS women

Use NN CAPITAL Use
Use IN of
of DT a
a NNP CAPITAL Foley
Foley NN catheter
catheter IN in
in DT the
the NN removal
removal IN of
of DT a
a JJ substernal
substernal NN goiter

Early RB CAPITAL Early
Early NN identification
identification IN of
of NN variant
variant NN CAPITAL Creutzfeldt-Jakob
Creutzfeldt-Jakob NN disease

Slater NNP CAPITAL Slater
Slater VBN revisited
revisited : :
: CD 6
6 NN year
year VB follow
follow RB up
up NN study
study IN of
of NNS patients
patients IN with
with RB medically
medically JJ unexplained
unexplained NN motor
motor NNS symptoms

Re NNP CAPITAL Re
Re : :
: NNP CAPITAL Intermediate
Intermediate NN term
term NN assessment
assessment IN of
of DT the
the NN reliability
reliability , ,
, NN function
function CC and
and NN patient
patient NN satisfaction
satisfaction IN with
with DT the
the NN CAPITAL AMS700
AMS700 NN ultrex
ultrex NN penile
penile NN prosthesis

Reduced VBN CAPITAL Reduced
Reduced NN ratio
ratio IN of
of NN male
male TO to
to NN female
female NNS births
births IN in
in JJ several
several JJ industrial
industrial NNS countries
countries : :
: DT a
a NN sentinel
sentinel NN health
health NN indicator
indicator . ?

Should MD CAPITAL Should
Should PRP we
we VB accept
accept NN mediocrity
mediocrity . ?

Resolution NN CAPITAL Resolution
Resolution IN of
of JJ recalcitrant
recalcitrant NN molluscum
molluscum NN contagiosum
contagiosum NN virus
virus NNS lesions
lesions IN in
in JJ human
human NN immunodeficiency
immunodeficiency JJ virus-infected
virus-infected NNS patients
patients VBN treated
treated IN with
with NN cidofovir

Colonoscopic NNP CAPITAL Colonoscopic
Colonoscopic NN removal
removal IN of
of NN chicken
chicken NNS bones
bones VBN impacted
impacted IN in
in DT the
the NN sigmoid
sigmoid IN in
in CD two
two NNS patients

`` `` ``
`` VB CAPITAL Pull
Pull '' ''
'' CC or
or `` ``
`` NN push
push '' ''
'' NN CAPITAL PEG
PEG : :
: DT the
the NN reinsertion
reinsertion IN of
of DT the
the NN gastroscope
gastroscope VBZ is
is RB often
often JJ unnecessary

Clear JJ CAPITAL Clear
Clear NN cell
cell NN papulosis
papulosis : :
: NN case
case NN report
report CC and
and NN literature
literature NN review

Malignant JJ CAPITAL Malignant
Malignant NN melanoma
melanoma IN in
in FW situ
situ : :
: DT an
an NN oxymoron
oxymoron WP$ whose
whose NN time
time VBZ has
has VBN come

External JJ CAPITAL External
External NN beam
beam NN radiation
radiation NN therapy
therapy IN for
for NN choroidal
choroidal NN neovascularization

Somatic JJ CAPITAL Somatic
Somatic NN mesoderm
mesoderm NN differentiation
differentiation CC and
and DT the
the NN development
development IN of
of DT a
a NN subset
subset IN of
of JJ pericardial
pericardial NNS cells
cells VB depend
depend IN on
on DT the
the RB not
not RB enough
enough NNS muscles
muscles NN (
( NN nem
nem NN )
) NN locus
locus , ,
, WDT which
which VBZ contains
contains DT the
the JJ inscuteable
inscuteable NN gene
gene CC and
and DT the
the NN intron
intron JJ located
located NN gene
gene , ,
, NNS skittles

Hemodynamic JJ CAPITAL Hemodynamic
Hemodynamic NNS effects
effects IN of
of JJ acute
acute NN tetrandrine
tetrandrine CC and
and NN terlipressin
terlipressin NN administration
administration IN on
on NN portal
portal JJ hypertensive
hypertensive NNS rats

Nonneoplastic JJ CAPITAL Nonneoplastic
Nonneoplastic NNS disorders
disorders IN of
of DT the
the NN eccrine
eccrine NNS glands

Cerebrospinal JJ CAPITAL Cerebrospinal
Cerebrospinal NN fluid
fluid CC and
and NN plasma
plasma NN insulin
insulin NNS levels
levels IN in
in NN CAPITAL Alzheimer
Alzheimer POS 's
's NN disease
disease : :
: NN relationship
relationship TO to
to NN severity
severity IN of
of NN dementia
dementia CC and
and NN apolipoprotein
apolipoprotein NN CAPITAL E
E NN genotype

Isolated VBN CAPITAL Isolated
Isolated JJ internal
internal NN ophthalmoplegia
ophthalmoplegia VBN associated
associated IN with
with NN CAPITAL IgG
IgG JJ anti-GQ1b
anti-GQ1b NN antibody

Bolus NN CAPITAL Bolus
Bolus JJ thrombolytic
thrombolytic NNS infusions
infusions IN during
during NNP CAPITAL CPR
CPR IN for
for NNS patients
patients IN with
with JJ refractory
refractory NN arrest
arrest NNS rhythms
rhythms : :
: NN outcome
outcome IN of
of DT a
a NN case
case NN series

Enthesopathy NNP CAPITAL Enthesopathy
Enthesopathy IN in
in DT a
a NN case
case IN of
of JJ primary
primary JJ biliary
biliary NN cirrhosis
cirrhosis IN with
with JJ positive
positive NN CAPITAL HLA-B27

Remifentanil NNP CAPITAL Remifentanil
Remifentanil IN in
in DT the
the RB critically
critically RB ill

Hyponatremia NN CAPITAL Hyponatremia
Hyponatremia IN with
with NN venlafaxine
venlafaxine . .

Use NN CAPITAL Use
Use IN of
of DT a
a NN nerve
nerve NN stimulator
stimulator IN for
for JJ phrenic
phrenic NN nerve
nerve NN block
block IN in
in NN treatment
treatment IN of
of NNS hiccups

Anaesthesia NNP CAPITAL Anaesthesia
Anaesthesia IN for
for JJ laparoscopic
laparoscopic NN cholecystectomy
cholecystectomy IN in
in DT a
a NN patient
patient IN with
with NNP CAPITAL Eisenmenger
Eisenmenger POS 's
's NN syndrome

Micronutrients NNS CAPITAL Micronutrients
Micronutrients CC and
and JJ human
human NN cancer
cancer NNS risks
risks : --
-- NNS prospects
prospects IN for
for NN prevention

Joint NNP CAPITAL Joint
Joint NNP CAPITAL International
International NNP CAPITAL Symposium
Symposium IN of
of DT the
the JJ CAPITAL Danish
Danish NN CAPITAL Cancer
Cancer NNP CAPITAL Society
Society , ,
, JJ CAPITAL European
European NN CAPITAL Cancer
Cancer NNP CAPITAL Prevention
Prevention NNP CAPITAL Organization
Organization CC and
and NNP CAPITAL National
National NNP CAPITAL Food
Food NNP CAPITAL Agency
Agency IN of
of NNP CAPITAL Denmark

Aarhus NNP CAPITAL Aarhus
Aarhus , ,
, NNP CAPITAL Denmark
Denmark , ,
, CD 21-24
21-24 NNP CAPITAL May
May CD 1997

Abstracts NNS CAPITAL Abstracts

Vitamin NN CAPITAL Vitamin
Vitamin NN CAPITAL K2
K2 CC and
and NN serum
serum NN cholesterol
cholesterol IN in
in NNS patients
patients IN on
on JJ continuous
continuous JJ ambulatory
ambulatory NN peritoneal
peritoneal NN dialysis

Income NN CAPITAL Income
Income NN inequality
inequality CC and
and NN population
population NN health

Naloxone NN CAPITAL Naloxone
Naloxone JJ -precipitated
-precipitated JJ acute
acute NN opioid
opioid NN withdrawal
withdrawal NN syndrome
syndrome IN after
after JJ epidural
epidural NN morphine

Idiopathic JJ CAPITAL Idiopathic
Idiopathic IN atrial
atrial NN flutter

Munchausen NN CAPITAL Munchausen
Munchausen POS 's
's NN syndrome

Clinical JJ CAPITAL Clinical
Clinical NN evaluation
evaluation IN of
of JJ adjuvant
adjuvant NN chemoradiotherapy
chemoradiotherapy IN with
with NN CAPITAL CDDP
CDDP , ,
, NN 5-FU
5-FU , ,
, CC and
and NN CAPITAL VP-16
VP-16 IN for
for VBN advanced
advanced NN esophageal
esophageal NN cancer

New NNP CAPITAL New
New NN drug
drug NN treatment
treatment IN for
for NN CAPITAL Alzheimer
Alzheimer POS 's
's NN disease
disease : :
: NNS lessons
lessons IN for
for NN healthcare
healthcare NN policy

Development NNP CAPITAL Development
Development IN of
of NN neurosurgery
neurosurgery IN in
in NNP CAPITAL Greece
Greece : :
: IN past
past , ,
, JJ present
present , ,
, CC and
and NN future

Intravascular-catheter-related JJ CAPITAL Intravascular-catheter-related
Intravascular-catheter-related NNS infections

The DT CAPITAL The
The NN effect
effect IN of
of DT a
a JJ social
social NN support
support VBG boosting
boosting NN intervention
intervention IN on
on NN stress
stress , ,
, VBG coping
coping , ,
, CC and
and JJ social
social NN support
support IN in
in NNS caregivers
caregivers IN of
of NNS children
children IN with
with NN CAPITAL HIV/AIDS

Point-counterpoint NN CAPITAL Point-counterpoint

Mass NNP CAPITAL Mass
Mass NN population
population NN skin
skin NN cancer
cancer NN screening
screening VBZ is
is RB not
not JJ worthwhile

Persons NNS CAPITAL Persons
Persons JJ successful
successful IN at
at JJ long-term
long-term NN weight
weight NN loss
loss CC and
and NN maintenance
maintenance VB continue
continue TO to
to VB consume
consume DT a
a JJ low-energy
low-energy , ,
, JJ low-fat
low-fat NN diet

Ultrasound NN CAPITAL Ultrasound
Ultrasound NNS measurements
measurements IN of
of DT the
the JJ newborn
newborn NN hip

Comparison NN CAPITAL Comparison
Comparison IN of
of CD two
two NNS methods
methods IN in
in CD 657
657 NNS newborns

Inferences NNS CAPITAL Inferences
Inferences IN from
from NN symphysiotomy
symphysiotomy NN experience

1995 CD 1995
1995 JJ coronary
coronary NN artery
artery NN bypass
bypass NN risk
risk NN model
model : :
: DT CAPITAL The
The NNP CAPITAL Society
Society IN of
of JJ CAPITAL Thoracic
Thoracic NNS CAPITAL Surgeons
Surgeons NN CAPITAL Adult
Adult JJ CAPITAL Cardiac
Cardiac NNP CAPITAL National
National NN CAPITAL Database

Informed VBN CAPITAL Informed
Informed NN consent
consent : :
: VBG edging
edging RB forwards
forwards NN (
( CC and
and RB backwards
backwards NN )

Online NN CAPITAL Online
Online JJ medical
medical NNS surveys
surveys : :
: VBG using
using DT the
the NN CAPITAL Internet
Internet IN as
as DT a
a NN research
research NN tool

US-guided JJ CAPITAL US-guided
US-guided NN puncture
puncture IN of
of DT the
the JJ internal
internal JJ jugular
jugular NN vein
vein : :
: NNS complications
complications CC and
and JJ anatomic
anatomic NNS considerations

Mouth NN CAPITAL Mouth
Mouth NN care
care CC and
and NN skin
skin NN care
care IN in
in NN palliative
palliative NN medicine

Simple JJ CAPITAL Simple
Simple JJ antiseptic
antiseptic NNS mouthwashes
mouthwashes VBP are
are RB best
best IN for
for NN infection

The DT CAPITAL The
The NN effect
effect IN of
of NN melatonin
melatonin NN administration
administration IN on
on JJ ethanol-induced
ethanol-induced NN lipid
lipid NN peroxidation
peroxidation IN in
in NNS rats

A DT CAPITAL A
A NN comparison
comparison IN of
of NN aspirin
aspirin CC plus
plus NN tirofiban
tirofiban IN with
with NN aspirin
aspirin CC plus
plus NN heparin
heparin IN for
for JJ unstable
unstable NN angina

Platelet NN CAPITAL Platelet
Platelet NN CAPITAL Receptor
Receptor NN CAPITAL Inhibition
Inhibition IN in
in JJ CAPITAL Ischemic
Ischemic NN CAPITAL Syndrome
Syndrome NN CAPITAL Management
Management NN (
( NN CAPITAL PRISM
PRISM NN )
) NN CAPITAL Study
Study NNS CAPITAL Investigators

Mike NNP CAPITAL Mike
Mike NNP CAPITAL Grace
Grace NNS talks
talks TO to
to NNP CAPITAL Mike
Mike NNP CAPITAL Joy

Interview NN CAPITAL Interview
Interview IN by
by NNP CAPITAL Mike
Mike NNP CAPITAL Grace

Multivalent JJ CAPITAL Multivalent
Multivalent NNS cations
cations VB depress
depress NN ligand
ligand NN affinity
affinity IN of
of JJ insulin-like
insulin-like NN growth
growth JJ factor-binding
factor-binding NN proteins-3
proteins-3 CC and
and CD -5
-5 IN on
on JJ human
human NN CAPITAL GM-10
GM-10 NN fibroblast
fibroblast NN cell
cell NNS surfaces

Effect NN CAPITAL Effect
Effect IN of
of JJ continuous
continuous JJ spinal
spinal NN remifentanil
remifentanil NN infusion
infusion IN on
on NN behaviour
behaviour CC and
and JJ spinal
spinal NN glutamate
glutamate NN release
release VBN evoked
evoked IN by
by JJ subcutaneous
subcutaneous NN formalin
formalin IN in
in DT the
the NN rat

How WRB CAPITAL How
How RB long
long MD should
should NN suction
suction VBZ drains
drains NN stay
stay IN in
in IN after
after NN breast
breast NN surgery
surgery IN with
with JJ axillary
axillary NN dissection
dissection . ?

Physicians NNP CAPITAL Physicians
Physicians VBN disciplined
disciplined IN for
for JJ sex-related
sex-related NNS offenses

Something NN CAPITAL Something
Something IN from
from NN nothing
nothing : :
: DT the
the NN evolution
evolution CC and
and NN utility
utility IN of
of NN satellite
satellite NNS repeats

Sudden JJ CAPITAL Sudden
Sudden NN death
death IN in
in JJ young
young NNS athletes
athletes : :
: NN screening
screening IN for
for DT the
the NN needle
needle IN in
in DT a
a NN haystack

Chemotherapy NN CAPITAL Chemotherapy
Chemotherapy RB alone
alone VBN compared
compared IN with
with NN chemotherapy
chemotherapy CC plus
plus NN radiotherapy
radiotherapy IN for
for JJ localized
localized NN intermediate-
intermediate- CC and
and JJ high-grade
high-grade JJ non-Hodgkin
non-Hodgkin POS 's
's NN lymphoma

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNP CAPITAL Prevention
Prevention IN of
of DT a
a RB first
first NN stroke
stroke IN by
by NNS transfusions
transfusions IN in
in NNS children
children IN with
with NN sickle
sickle NN cell
cell NN anemia
anemia CC and
and JJ abnormal
abnormal NNS results
results IN on
on JJ transcranial
transcranial NNP CAPITAL Doppler
Doppler NN ultrasonography

HIV NN CAPITAL HIV
HIV NNS vaccines
vaccines : :
: NNS prospects
prospects CC and
and NNS challenges

Occupation NN CAPITAL Occupation
Occupation : :
: DT the
the NN keystone
keystone IN of
of DT a
a NN curriculum
curriculum IN for
for DT a
a JJ self-defined
self-defined NN profession

Touch NN CAPITAL Touch
Touch NN sensibility
sensibility IN in
in DT the
the NN breast
breast IN after
after JJ subcutaneous
subcutaneous NN mastectomy
mastectomy CC and
and JJ immediate
immediate NN reconstruction
reconstruction IN with
with DT a
a NN prosthesis

Iatrogenic JJ CAPITAL Iatrogenic
Iatrogenic NNS ruptures
ruptures IN of
of DT the
the JJ tracheobronchial
tracheobronchial NN tree

Endoscopic JJ CAPITAL Endoscopic
Endoscopic NN hemostasis
hemostasis IN of
of VBG bleeding
bleeding JJ duodenal
duodenal NN ulcer
ulcer IN in
in DT a
a NN child
child IN with
with NN CAPITAL Henoch-Schnlein
Henoch-Schnlein NN purpura

Classification NN CAPITAL Classification
Classification IN of
of JJ primary
primary JJ gastric
gastric NNS lymphomas
lymphomas VBG according
according TO to
to JJ histologic
histologic NNS features

SCIM NN CAPITAL SCIM
SCIM : --
-- JJ spinal
spinal NN cord
cord NN independence
independence NN measure
measure : :
: DT a
a JJ new
new NN disability
disability NN scale
scale IN for
for NNS patients
patients IN with
with JJ spinal
spinal NN cord
cord NNS lesions

Molecular JJ CAPITAL Molecular
Molecular NN analysis
analysis IN of
of NN cellulose
cellulose NN biosynthesis
biosynthesis IN in
in NNP CAPITAL Arabidopsis

Users NNS CAPITAL Users
Users '' '
' NNS guides
guides TO to
to DT the
the JJ medical
medical NN literature
literature : :
: NNP CAPITAL XIV

How WRB CAPITAL How
How TO to
to VB decide
decide IN on
on DT the
the NN applicability
applicability IN of
of JJ clinical
clinical NN trial
trial NNS results
results TO to
to PRP$ your
your NN patient

Evidence-Based JJ CAPITAL Evidence-Based
Evidence-Based NN CAPITAL Medicine
Medicine VBG CAPITAL Working
Working NNP CAPITAL Group

Hemispheric NNP CAPITAL Hemispheric
Hemispheric NN difference
difference IN in
in JJ human
human NN skin
skin NN color

Limitations NNPS CAPITAL Limitations
Limitations IN of
of JJ diagnostic
diagnostic NNS criteria
criteria CC and
and NN assessment
assessment NNS instruments
instruments IN for
for JJ mental
mental NNS disorders

Implications NNS CAPITAL Implications
Implications IN for
for NN research
research CC and
and NN policy

Causing VBG CAPITAL Causing
Causing NN death
death CC or
or VBG allowing
allowing TO to
to VB die
die . ?
? NNS CAPITAL Developments
Developments IN in
in DT the
the NN law

Albumin NN CAPITAL Albumin
Albumin NN synthesis
synthesis NNS rates
rates VBP are
are RB not
not VBN decreased
decreased IN in
in JJ hypoalbuminemic
hypoalbuminemic NN cachectic
cachectic NN cancer
cancer NNS patients
patients IN with
with DT an
an JJ ongoing
ongoing NN acute-phase
acute-phase NN protein
protein NN response

Brain-gut NN CAPITAL Brain-gut
Brain-gut NN axis
axis IN in
in NN health
health CC and
and NN disease

Pins NNS CAPITAL Pins
Pins CC and
and NNS CAPITAL Rubbers
Rubbers NNP CAPITAL Traction
Traction NNP CAPITAL System

A DT CAPITAL A
A NN specialist
specialist NN nurse
nurse MD can
can VB replace
replace NN pre-registration
pre-registration NN house
house NNS officers
officers IN in
in DT the
the JJ surgical
surgical JJ pre-admission
pre-admission NN clinic

Voluntary JJ CAPITAL Voluntary
Voluntary NN death
death : :
: DT a
a NN comparison
comparison IN of
of JJ terminal
terminal NN dehydration
dehydration CC and
and JJ physician-assisted
physician-assisted NN suicide

Ionized VBN CAPITAL Ionized
Ionized NN magnesium
magnesium IN in
in NN serum
serum CC and
and NN ultrafiltrate
ultrafiltrate : :
: NN pH
pH CC and
and NN bicarbonate
bicarbonate NN effect
effect IN on
on NNS measurements
measurements IN with
with DT the
the NN CAPITAL AVL
AVL CD 988-4
988-4 NN electrolyte
electrolyte NN analyzer

Anterior NNP CAPITAL Anterior
Anterior NN glenohumeral
glenohumeral NNS dislocations
dislocations : :
: WDT what
what TO to
to VB do
do CC and
and WRB how
how TO to
to VB do
do PRP it

Relationship NN CAPITAL Relationship
Relationship IN between
between NN topotecan
topotecan JJ systemic
systemic NN exposure
exposure CC and
and NN tumor
tumor NN response
response IN in
in JJ human
human NN neuroblastoma
neuroblastoma NNS xenografts

Cerebral JJ CAPITAL Cerebral
Cerebral NN infarct
infarct VBG following
following JJ central
central JJ venous
venous NN cannulation

The DT CAPITAL The
The NN CAPITAL Gram
Gram VB stain

Heavy NNP CAPITAL Heavy
Heavy NN caffeine
caffeine NN intake
intake IN in
in NN pregnancy
pregnancy CC and
and JJ sudden
sudden NN infant
infant NN death
death NN syndrome

New NNP CAPITAL New
New NNP CAPITAL Zealand
Zealand NN CAPITAL Cot
Cot NN CAPITAL Death
Death NN CAPITAL Study
Study NNP CAPITAL Group

When WRB CAPITAL When
When MD can
can NNS odds
odds NNS ratios
ratios NN mislead
mislead . ?

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ renal
renal NN failure
failure IN in
in JJ idiopathic
idiopathic JJ membranous
membranous NN nephropathy
nephropathy IN with
with NN azathioprine
azathioprine CC and
and NN prednisolone

Enzyme NN CAPITAL Enzyme
Enzyme NN structure
structure IN with
with CD two
two JJ catalytic
catalytic NNS sites
sites IN for
for JJ double-sieve
double-sieve NN selection
selection IN of
of NN substrate

Role NN CAPITAL Role
Role IN of
of DT the
the JJ ketogenic
ketogenic NN diet
diet IN in
in NNS children
children IN with
with JJ intractable
intractable NNS seizures
seizures . .

Building-associated JJ CAPITAL Building-associated
Building-associated JJ pulmonary
pulmonary NN disease
disease IN from
from NN exposure
exposure TO to
to NNS CAPITAL Stachybotrys
Stachybotrys NN chartarum
chartarum CC and
and NN CAPITAL Aspergillus
Aspergillus NN versicolor

Interleukin-8 NN CAPITAL Interleukin-8
Interleukin-8 VBZ participates
participates IN in
in NN angiogenesis
angiogenesis IN in
in JJ non-small
non-small NN cell
cell , ,
, CC but
but RB not
not JJ small
small NN cell
cell NN carcinoma
carcinoma IN of
of DT the
the NN lung

Antenatal JJ CAPITAL Antenatal
Antenatal NN indomethacin
indomethacin : --
-- JJ adverse
adverse JJ fetal
fetal NNS effects
effects VBN confirmed

Evaluation NN CAPITAL Evaluation
Evaluation IN of
of DT the
the NN microparticle
microparticle NN enzyme
enzyme NN immunoassay
immunoassay NNP CAPITAL Abbott
Abbott NN CAPITAL IMx
IMx NNP CAPITAL Select
Select NN CAPITAL Chlamydia
Chlamydia CC and
and DT the
the NN importance
importance IN of
of NN urethral
urethral NN site
site NN sampling
sampling TO to
to VB detect
detect NN CAPITAL Chlamydia
Chlamydia NN trachomatis
trachomatis IN in
in NNS women

The DT CAPITAL The
The JJ persistent
persistent JJ vegetative
vegetative NN state
state IN after
after VBN closed
closed NN head
head NN injury
injury : :
: JJ clinical
clinical CC and
and JJ magnetic
magnetic NN resonance
resonance NN imaging
imaging NNS findings
findings IN in
in CD 42
42 NNS patients

Wegener NNP CAPITAL Wegener
Wegener POS 's
's NN granulomatosis
granulomatosis IN of
of DT the
the NN head
head CC and
and NN neck

Chromosomal JJ CAPITAL Chromosomal
Chromosomal NNS abnormalities
abnormalities IN of
of DT a
a JJ new
new NN nasopharyngeal
nasopharyngeal NN carcinoma
carcinoma NN cell
cell NN line
line NN (
( NN CAPITAL NPC-BM1
NPC-BM1 NN )
) VBN derived
derived IN from
from DT a
a NN bone
bone NN marrow
marrow JJ metastatic
metastatic NN lesion

Relation NN CAPITAL Relation
Relation IN between
between JJ intellectual
intellectual VBG dysfunctioning
dysfunctioning CC and
and NN mortality
mortality IN in
in NN community-residing
community-residing JJR older
older NNS people

Anxiety NN CAPITAL Anxiety
Anxiety CC and
and JJ autonomic
autonomic NN flexibility
flexibility : :
: DT a
a JJ cardiovascular
cardiovascular NN approach

Cross-reactivity NN CAPITAL Cross-reactivity
Cross-reactivity IN of
of JJ specific
specific NNS antibodies
antibodies VBN directed
directed TO to
to NN heat
heat NN shock
shock NNS proteins
proteins IN from
from JJ periodontopathogenic
periodontopathogenic NNS bacteria
bacteria CC and
and IN of
of JJ human
human NN origin
origin NN (
( VBN corrected
corrected NN )

Immunogenicity NN CAPITAL Immunogenicity
Immunogenicity IN of
of NN hepatitis
hepatitis NN CAPITAL B
B NN vaccine
vaccine IN in
in NN term
term CC and
and NN preterm
preterm NNS infants

Secondary JJ CAPITAL Secondary
Secondary NN prevention
prevention IN for
for NN stroke
stroke IN after
after NNP CAPITAL CAPRIE
CAPRIE CC and
and NN CAPITAL ESPS-2

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL New-onset
New-onset NN angina
angina VBG preceding
preceding JJ acute
acute JJ myocardial
myocardial NN infarction
infarction VBZ is
is VBN associated
associated IN with
with VBN improved
improved NN contractile
contractile NN recovery
recovery IN after
after NN thrombolysis

Magnetic JJ CAPITAL Magnetic
Magnetic NN resonance
resonance NN imaging
imaging IN in
in JJ focal
focal NN myositis

Concomitant JJ CAPITAL Concomitant
Concomitant NN alveolitis
alveolitis CC and
and NN asthma
asthma VBG following
following NN exposure
exposure TO to
to NN triphenylmethane
triphenylmethane NN triisocyanate

Gorlin NNP CAPITAL Gorlin
Gorlin NN syndrome
syndrome : :
: NN identification
identification IN of
of CD 4
4 JJ novel
novel NN germ-line
germ-line NNS mutations
mutations IN of
of DT the
the JJ human
human VBN patched
patched NN (
( NN CAPITAL PTCH
PTCH NN )
) NN gene

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

137 CD 137

Online NN CAPITAL Online

Genetic JJ CAPITAL Genetic
Genetic NNS findings
findings IN in
in JJ congenital
congenital JJ bilateral
bilateral NN aplasia
aplasia IN of
of FW vas
vas NNS deferens
deferens NNS patients
patients CC and
and NN identification
identification IN of
of CD six
six JJ novel
novel NNS mutatations

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

138 CD 138

Online NN CAPITAL Online

A DT CAPITAL A
A JJ novel
novel NN point
point NN mutation
mutation IN in
in DT a
a NN splice
splice NN acceptor
acceptor NN site
site IN of
of NN intron
intron CD 1
1 IN of
of DT the
the JJ human
human JJ low
low NN density
density NN lipoprotein
lipoprotein NN receptor
receptor NN gene
gene WDT which
which NNS causes
causes JJ severe
severe NN hypercholesterolemia
hypercholesterolemia : :
: DT an
an JJ unexpected
unexpected NN absence
absence IN of
of NN exon
exon VBG skipping

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

139 CD 139

Online NN CAPITAL Online

A DT CAPITAL A
A IN de
de FW novo
novo NN missense
missense NN mutation
mutation NN (
( NN CAPITAL R1623Q
R1623Q NN )
) IN of
of DT the
the NN CAPITAL SCN5A
SCN5A NN gene
gene IN in
in DT a
a JJ CAPITAL Japanese
Japanese NN girl
girl IN with
with JJ sporadic
sporadic RB long
long NN CAPITAL QT
QT NN sydrome

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

140 CD 140

Online NN CAPITAL Online

Missense NN CAPITAL Missense
Missense NN mutation
mutation IN in
in NN exon
exon CD 11
11 NN (
( NNP CAPITAL Codon
Codon CD 378
378 NN )
) IN of
of DT the
the NN presenilin-1
presenilin-1 NN gene
gene IN in
in DT a
a JJ CAPITAL French
French NN family
family IN with
with JJ early-onset
early-onset NN CAPITAL Alzheimer
Alzheimer POS 's
's NN disease
disease CC and
and NN transmission
transmission NN study
study IN by
by NN mismatch
mismatch VBN enhanced
enhanced NN allele
allele JJ specific
specific NN amplification

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

141 CD 141

Online NN CAPITAL Online

besancon NN besancon
besancon SYM @
@ NN rockefeller1.univ.lyon1.fr

Mutation NN CAPITAL Mutation
Mutation VBG sharing
sharing , ,
, JJ predominant
predominant NN involvement
involvement IN of
of DT the
the NN CAPITAL MLH1
MLH1 NN gene
gene CC and
and NN description
description IN of
of CD four
four JJ novel
novel NNS mutations
mutations IN in
in JJ hereditary
hereditary NN nonpolyposis
nonpolyposis JJ colorectal
colorectal NN cancer

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

144 CD 144

Online NN CAPITAL Online

A DT CAPITAL A
A JJ new
new JJ informative
informative NN CAPITAL Alw
Alw CD 26
26 PRP CAPITAL I
I NN polymorphism
polymorphism IN in
in NN exon
exon CD 10
10 IN of
of DT the
the JJ human
human JJ low
low NN density
density NN lipoprotein
lipoprotein NN receptor
receptor NN gene

Application NN CAPITAL Application
Application TO to
to JJ prenatal
prenatal NN diagnosis

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

145 CD 145

Online NN CAPITAL Online

Novel JJ CAPITAL Novel
Novel NN acceptor
acceptor NN splice
splice NN site
site NN mutation
mutation IN in
in DT the
the JJ invariant
invariant NNP CAPITAL AG
AG IN of
of NN intron
intron CD 6
6 IN of
of NN alpha-galactosidase
alpha-galactosidase DT CAPITAL A
A NN gene
gene , ,
, VBG causing
causing NN CAPITAL Fabry
Fabry NN disease

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

146 CD 146

Online NN CAPITAL Online

Meta-analysis NN CAPITAL Meta-analysis
Meta-analysis IN of
of NNS trials
trials VBG comparing
comparing NNS antidepressants
antidepressants IN with
with JJ active
active NNS placebos

Evidence-based JJ CAPITAL Evidence-based
Evidence-based NNS guidelines
guidelines IN for
for JJ universal
universal VBG counselling
counselling CC and
and NN offering
offering IN of
of NN CAPITAL HIV
HIV NN testing
testing IN in
in NN pregnancy
pregnancy IN in
in NNP CAPITAL Canada

Chelation NN CAPITAL Chelation
Chelation NN therapy
therapy IN for
for JJ peripheral
peripheral JJ arterial
arterial NN occlusive
occlusive NN disease
disease : :
: DT a
a JJ systematic
systematic NN review

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Sodium
Sodium NN channel
channel NN block
block IN with
with NN mexiletine
mexiletine VBZ is
is JJ effective
effective IN in
in VBG reducing
reducing NN dispersion
dispersion IN of
of NN repolarization
repolarization CC and
and VBG preventing
preventing NN torsade
torsade FW des
des NNS pointes
pointes IN in
in NN CAPITAL LQT2
LQT2 CC and
and NN CAPITAL LQT3
LQT3 NNS models
models IN of
of DT the
the JJ long-QT
long-QT NN syndrome

Simultaneous JJ CAPITAL Simultaneous
Simultaneous JJ microsurgical
microsurgical NN vasal
vasal NN reconstruction
reconstruction CC and
and NN varicocele
varicocele NN ligation
ligation : :
: NN safety
safety NN profile
profile CC and
and NNS outcomes

A DT CAPITAL A
A VBN predetermined
predetermined NN design
design IN for
for JJR easier
easier JJ aesthetic
aesthetic NN abdominoplasty

Significance NN CAPITAL Significance
Significance IN of
of NN revision
revision IN of
of DT the
the JJ occupational
occupational NN illness
illness NN legislation
legislation IN for
for VBG evaluating
evaluating NN intervertebral
intervertebral NN disk
disk NN damage

Serum NN CAPITAL Serum
Serum NN urate
urate IN during
during NNS bouts
bouts IN of
of JJ acute
acute JJ gouty
gouty NN arthritis

Isolated VBN CAPITAL Isolated
Isolated IN axial
axial JJ lateral
lateral NN pulse
pulse IN as
as DT a
a NN sign
sign IN of
of JJ latero-bulbar
latero-bulbar NN ischemia
ischemia : :
: JJ clinical
clinical JJ topographic
topographic NN correlation

Microalbuminuria NNP CAPITAL Microalbuminuria
Microalbuminuria VBZ is
is RB positively
positively VBN associated
associated IN with
with JJ usual
usual JJ dietary
dietary VBN saturated
saturated NN fat
fat NN intake
intake CC and
and RB negatively
negatively VBN associated
associated IN with
with JJ usual
usual JJ dietary
dietary NN protein
protein NN intake
intake IN in
in NNS people
people IN with
with JJ insulin-dependent
insulin-dependent NN diabetes
diabetes NN mellitus

Endoscopic JJ CAPITAL Endoscopic
Endoscopic NN ultrasound
ultrasound JJ miniprobe-guided
miniprobe-guided NN steroid
steroid NN injection
injection IN for
for NN treatment
treatment IN of
of JJ refractory
refractory NN esophageal
esophageal NNS strictures

Purification NN CAPITAL Purification
Purification CC and
and NN characterization
characterization IN of
of DT an
an NN acetyl
acetyl NN xylan
xylan NN esterase
esterase IN from
from NN CAPITAL Bacillus
Bacillus NN pumilus

The DT CAPITAL The
The NN CAPITAL Stresst'er
Stresst'er NN ergometer
ergometer IN as
as DT an
an NN alternative
alternative TO to
to NN treadmill
treadmill NN testing
testing IN in
in NNS patients
patients IN with
with NN claudication

Renal JJ CAPITAL Renal
Renal NN trauma
trauma CC and
and DT the
the NN risk
risk IN of
of JJ long-term
long-term NNS complications
complications IN in
in NN shock
shock NN wave
wave NN lithotripsy

Current JJ CAPITAL Current
Current NN management
management IN of
of NN corneal
corneal NNS abrasions
abrasions : :
: NN evidence
evidence VBN based
based NN practice
practice . ?

Placebo NN CAPITAL Placebo
Placebo IN in
in NN drug
drug JJ clinical
clinical NNS trials

Chromosome NN CAPITAL Chromosome
Chromosome NN 22qII
22qII NNS deletions

An DT CAPITAL An
An JJ under-recognised
under-recognised NN cause
cause IN of
of JJ idiopathic
idiopathic VBG learning
learning NN disability

Serial JJ CAPITAL Serial
Serial JJ magnetic
magnetic NN resonance
resonance NN imaging
imaging NNS findings
findings IN for
for DT a
a RB spontaneously
spontaneously VBG resolving
resolving JJ spinal
spinal JJ subdural
subdural NN hematoma
hematoma : :
: NN case
case NN report

A DT CAPITAL A
A JJ simple
simple NN technique
technique IN for
for NN correction
correction IN of
of JJ mucosal
mucosal NNS irregularities
irregularities IN of
of DT the
the NN lip

Cancer NN CAPITAL Cancer
Cancer NN risk
risk IN in
in DT the
the NN rubber
rubber NN industry
industry : :
: DT a
a NN review
review IN of
of DT the
the JJ recent
recent JJ epidemiological
epidemiological NN evidence

HIV NN CAPITAL HIV
HIV NN treatment
treatment NNS strategies
strategies : :
: VBG planning
planning IN for
for DT the
the RB long
long NN term

The DT CAPITAL The
The NN project
project IN of
of DT a
a JJ national
national NN control
control NN program
program IN for
for NN tuberculosis
tuberculosis IN in
in NNP CAPITAL Spain

Decrease NN CAPITAL Decrease
Decrease IN in
in JJ antibiotic
antibiotic NN susceptibility
susceptibility CC or
or NN increase
increase IN in
in NN resistance
resistance . ?

Helicobacter NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori CC and
and JJ abdominal
abdominal NNS symptoms
symptoms : :
: DT a
a JJ population-based
population-based NN study
study IN among
among JJ preschool
preschool NNS children
children IN in
in JJ southern
southern NNP CAPITAL Germany

Have VBP CAPITAL Have
Have PRP we
we VBN treated
treated NN CAPITAL AIDS
AIDS RB too
too RB well
well . ?
? VBG CAPITAL Rationing
Rationing CC and
and DT the
the NN future
future IN of
of NN CAPITAL AIDS
AIDS NN exceptionalism

Recommendations NNS CAPITAL Recommendations
Recommendations IN on
on JJ antiretroviral
antiretroviral NN treatment

The DT CAPITAL The
The NN CAPITAL AIDS
AIDS NN CAPITAL Study
Study NNP CAPITAL Group
Group IN of
of DT the
the JJ CAPITAL Spanish
Spanish NNP CAPITAL Society
Society IN of
of JJ CAPITAL Infectious
Infectious NNS CAPITAL Diseases
Diseases CC and
and JJ CAPITAL Clinical
Clinical NNP CAPITAL Microbiology

Requirements NNS CAPITAL Requirements
Requirements IN for
for NN training
training TO to
to VB ensure
ensure NN competence
competence IN of
of NNS endoscopists
endoscopists VBG performing
performing JJ invasive
invasive NNS procedures
procedures IN in
in NNS children

Safe NN CAPITAL Safe
Safe NN motherhood
motherhood : :
: MD can
can PRP we
we VB make
make DT a
a NN difference
difference . ?

Lumbar NNP CAPITAL Lumbar
Lumbar NN spine
spine NN stenosis
stenosis : :
: DT a
a JJ common
common NN cause
cause IN of
of RB back
back CC and
and NN leg
leg NN pain

Myoepithelial JJ CAPITAL Myoepithelial
Myoepithelial NN carcinoma
carcinoma IN with
with NN predominance
predominance IN of
of NN plasmacytoid
plasmacytoid NNS cells
cells VBG arising
arising IN in
in DT a
a JJ pleomorphic
pleomorphic NN adenoma
adenoma IN of
of DT the
the NN parotid
parotid NN gland

Lonomia NNP CAPITAL Lonomia
Lonomia NN obliqua
obliqua NN caterpillar
caterpillar NNS spicules
spicules NN trigger
trigger JJ human
human NN blood
blood NN coagulation
coagulation IN via
via NN activation
activation IN of
of NN factor
factor NN CAPITAL X
X CC and
and NN prothrombin

Doing VBG CAPITAL Doing
Doing NN everything

Successful JJ CAPITAL Successful
Successful NN replantation
replantation IN of
of DT an
an VBN amputated
amputated NN tongue

Morbidity NN CAPITAL Morbidity
Morbidity CC and
and NN healthcare
healthcare NN utilisation
utilisation IN of
of NNS children
children IN in
in NNS households
households IN with
with CD one
one JJ adult
adult : :
: JJ comparative
comparative JJ observational
observational NN study

A DT CAPITAL A
A JJ novel
novel NN frameshift
frameshift NN mutation
mutation NN 840delA
840delA CC and
and DT a
a JJ novel
novel NN polymorphism
polymorphism NN CAPITAL D203A
D203A IN in
in DT the
the JJ steroidogenic
steroidogenic JJ acute
acute JJ regulatory
regulatory NN protein
protein NN gene
gene IN in
in DT a
a JJ CAPITAL Japanese
Japanese NN patient
patient IN with
with JJ congenital
congenital NN lipoid
lipoid JJ adrenal
adrenal NN hyperplasia

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

117 CD 117

Online NN CAPITAL Online

Identification NN CAPITAL Identification
Identification IN of
of CD five
five JJ new
new NNS mutations
mutations CC and
and CD three
three JJ novel
novel NNS polymorphisms
polymorphisms IN in
in DT the
the NN muscle
muscle NN chloride
chloride NN channel
channel NN gene
gene NN (
( NN CAPITAL CLCN1
CLCN1 NN )
) IN in
in CD 20
20 JJ CAPITAL Italian
Italian NNS patients
patients IN with
with JJ dominant
dominant CC and
and JJ recessive
recessive NN myotonia
myotonia NN congenita

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

118 CD 118

Online NN CAPITAL Online

Identification NN CAPITAL Identification
Identification IN of
of DT a
a JJ large
large NN insertion
insertion CC and
and CD two
two JJ novel
novel NN point
point NNS mutations
mutations NN (
( NN 3671del8
3671del8 CC and
and NN CAPITAL S1221X
S1221X NN )
) IN in
in JJ tuberous
tuberous NN sclerosis
sclerosis NN complex
complex NN (
( NNP CAPITAL TSC
TSC NN )
) NNS patients

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

119 CD 119

Online NN CAPITAL Online

Mutational JJ CAPITAL Mutational
Mutational NN analysis
analysis IN of
of DT the
the NN cystathionine
cystathionine NN beta-synthase
beta-synthase NN gene
gene : :
: DT a
a NN splicing
splicing NN mutation
mutation , ,
, CD two
two NN missense
missense NNS mutations
mutations CC and
and DT an
an NN insertion
insertion IN in
in NNS patients
patients IN with
with NN homocystinuria

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

120 CD 120

Online NN CAPITAL Online

Analysis NN CAPITAL Analysis
Analysis IN of
of CD five
five NNS mutations
mutations IN in
in CD 20
20 NN mucopolysaccharidois
mucopolysaccharidois NN type
type CD 1
1 NNS patients
patients : :
: JJ high
high NN prevalence
prevalence IN of
of DT the
the NN CAPITAL W402X
W402X NN mutation

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

121 CD 121

Online NN CAPITAL Online

A DT CAPITAL A
A JJ novel
novel NN missense
missense NN mutation
mutation NN CAPITAL Ile538Val
Ile538Val IN in
in DT the
the NN fibroblast
fibroblast NN growth
growth NN factor
factor NN receptor
receptor CD 3
3 IN in
in NN hypochondroplasia

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

122 CD 122

Online NN CAPITAL Online

Detection NN CAPITAL Detection
Detection IN of
of CD four
four JJ novel
novel NNS mutations
mutations IN in
in DT the
the NN iduronate-2-sulfatase
iduronate-2-sulfatase NN gene

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

123 CD 123

Online NN CAPITAL Online

Polymorphisms NNS CAPITAL Polymorphisms
Polymorphisms IN in
in DT the
the VBG coding
coding NNS exons
exons IN of
of DT the
the JJ human
human VBG luteinizing
luteinizing NN hormone
hormone NN receptor
receptor NN gene

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

124 CD 124

Online NN CAPITAL Online

Independent NNP CAPITAL Independent
Independent NN occurrence
occurrence IN of
of DT the
the JJ novel
novel NN CAPITAL Arg2163
Arg2163 TO to
to PRP$ CAPITAL His
His NN mutation
mutation IN in
in DT the
the NN factor
factor CD CAPITAL VIII
VIII NN gene
gene IN in
in CD three
three JJ unrelated
unrelated NNS families
families IN with
with NN haemophila
haemophila DT CAPITAL A
A IN with
with JJ different
different NNS phenotypes

Mutations NNS CAPITAL Mutations
Mutations IN in
in NN brief
brief DT no

126 CD 126

Online NN CAPITAL Online

Are VBP CAPITAL Are
Are JJ CAPITAL Japanese
Japanese NNS researchers
researchers VBG exploiting
exploiting NNP CAPITAL Thai
Thai NN CAPITAL HIV
HIV NNS patients
patients . ?

Underutilization NN CAPITAL Underutilization
Underutilization IN of
of NN aspirin
aspirin IN in
in JJR older
older NNS patients
patients IN with
with RB prior
prior JJ myocardial
myocardial NN infarction
infarction IN at
at DT the
the NN time
time IN of
of NN admission
admission TO to
to DT a
a NN nursing
nursing NN home
home . .

Distinguishing VBG CAPITAL Distinguishing
Distinguishing JJ silent
silent NN lacunar
lacunar NN infarction
infarction IN from
from JJ enlarged
enlarged NNP CAPITAL Virchow-Robin
Virchow-Robin NNS spaces
spaces : :
: DT a
a JJ magnetic
magnetic NN resonance
resonance NN imaging
imaging CC and
and JJ pathological
pathological NN study

Correlation NN CAPITAL Correlation
Correlation VBZ is
is RB not
not NN causation

Inhalation NN CAPITAL Inhalation
Inhalation IN of
of NN ammonium
ammonium VB nitrate
nitrate NN fuel
fuel NN oil
oil NN explosive
explosive NN (
( NNP CAPITAL ANFO
ANFO NN )

Management NN CAPITAL Management
Management IN of
of NN polycythaemia
polycythaemia IN in
in NNS adults
adults IN with
with JJ cyanotic
cyanotic JJ congenital
congenital NN heart
heart NN disease

Bolstering VBG CAPITAL Bolstering
Bolstering NNP CAPITAL Sisyphus

Use NN CAPITAL Use
Use IN of
of NN public
public NN performance
performance NNS reports
reports : :
: DT a
a NN survey
survey IN of
of NNS patients
patients VBG undergoing
undergoing JJ cardiac
cardiac NN surgery

Role NN CAPITAL Role
Role IN of
of DT a
a NN p53
p53 NN polymorphism
polymorphism IN in
in DT the
the NN development
development IN of
of JJ human
human JJ papillomavirus-associated
papillomavirus-associated NN cancer

The DT CAPITAL The
The NN use
use IN of
of NNS nurses
nurses IN in
in NN alternative
alternative NN dispute
dispute NN resolution

Re NNP CAPITAL Re
Re : :
: NNP CAPITAL Friday
Friday NN afternoon
afternoon JJ pulmonary
pulmonary NN arteriography
arteriography NN (
( NN CAPITAL FAPA
FAPA NN )
) : :
: VBP are
are NNS CAPITAL Fridays
Fridays JJ good
good IN for
for PRP$ your
your NN health
health . ?

Hormone NN CAPITAL Hormone
Hormone NN replacement
replacement NN therapy
therapy CC and
and NN breast
breast NN cancer
cancer . .

Physician NN CAPITAL Physician
Physician VB heal
heal IN thyself
thyself : :
: VBP are
are NNS antibiotics
antibiotics DT the
the NN cure
cure CC or
or DT the
the NN disease
disease . ?

Primary JJ CAPITAL Primary
Primary JJ biliary
biliary NN cirrhosis

Polymorphism NN CAPITAL Polymorphism
Polymorphism IN in
in NN promoter
promoter NN region
region IN of
of JJ inducible
inducible JJ nitric
nitric NN oxide
oxide NN synthase
synthase NN gene
gene CC and
and NN protection
protection IN against
against NN malaria

Ventilatory JJ CAPITAL Ventilatory
Ventilatory NNS responses
responses TO to
to JJ acute
acute CC and
and JJ sustained
sustained NN hypoxia
hypoxia IN during
during NN isoflurane
isoflurane NN anesthesia

Leprosy NNP CAPITAL Leprosy
Leprosy NN type
type CD 1
1 NN reaction
reaction IN as
as DT the
the RB first
first NN manifestation
manifestation IN of
of NN borderline
borderline JJ lepromatous
lepromatous NNP leprosy
leprosy IN in
in DT a
a JJ young
young JJ native
native JJ CAPITAL German

A DT CAPITAL A
A JJ systematic
systematic NN review
review IN of
of CD five
five JJ systemic
systemic NNS treatments
treatments IN for
for JJ severe
severe NN psoriasis

Trisomy NNP CAPITAL Trisomy
Trisomy CD 10
10 IN in
in NN leukemia

Receptive JJ CAPITAL Receptive
Receptive NNS properties
properties IN of
of JJ primary
primary JJ afferent
afferent NNS fibres
fibres IN from
from NN rabbit
rabbit NN pleura
pleura , ,
, IN in
in NN vitro

Congenital JJ CAPITAL Congenital
Congenital NNS anomalies
anomalies IN of
of JJ tracheobronchial
tracheobronchial VBG branching
branching NNS patterns
patterns : :
: NN spiral
spiral NN CAPITAL CT
CT NNS aspects
aspects IN in
in NNS adults

American NNP CAPITAL American
American NNP CAPITAL Heart
Heart NNP CAPITAL Association
Association VBZ urges
urges NN caution
caution IN on
on JJ new
new NN diet
diet NN drug

Absence NN CAPITAL Absence
Absence IN of
of JJ renal
renal CC and
and JJ hepatic
hepatic NN toxicity
toxicity IN after
after CD four
four NNS hours
hours IN of
of CD 1.25
1.25 NN minimum
minimum JJ alveolar
alveolar NN anesthetic
anesthetic NN concentration
concentration NN sevoflurane
sevoflurane NN anesthesia
anesthesia IN in
in NNS volunteers

Linear JJ CAPITAL Linear
Linear NN lichen
lichen NN planopilaris
planopilaris IN of
of DT the
the NN face

Electrolyte NN CAPITAL Electrolyte
Electrolyte NNS abnormalities
abnormalities IN in
in NNS patients
patients IN with
with JJ chronic
chronic JJ renal
renal NN failure
failure VBG receiving
receiving JJ parenteral
parenteral NN nutrition

Risk NN CAPITAL Risk
Risk NNS factors
factors IN for
for JJ hemiretinal
hemiretinal NN vein
vein NN occlusion
occlusion : :
: NN comparison
comparison IN with
with NN risk
risk NNS factors
factors IN for
for JJ central
central CC and
and NN branch
branch JJ retinal
retinal NN vein
vein NN occlusion
occlusion : :
: DT the
the NN eye
eye NN disease
disease JJ case-control
case-control NN study

The DT CAPITAL The
The JJ psychological
psychological NNS profiles
profiles IN of
of NNS patients
patients IN with
with JJ whiplash-associated
whiplash-associated NN headache

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Fatal
Fatal JJ spontaneous
spontaneous JJ spinal
spinal JJ epidural
epidural NN hematoma
hematoma VBG following
following NN thrombolysis
thrombolysis IN for
for JJ myocardial
myocardial NN infarction

Bifid NN CAPITAL Bifid
Bifid NN CAPITAL T
T NNS waves
waves VBN induced
induced IN by
by NN isoprenaline
isoprenaline IN in
in DT a
a NN patient
patient IN with
with NNP CAPITAL Brugada
Brugada NN syndrome
syndrome . .

Quo NN CAPITAL Quo
Quo NN vadis
vadis `` ``
`` NN suprema
suprema NN lex
lex '' ''
'' . ?

Death NN CAPITAL Death
Death IN in
in NN springtime

Clinical JJ CAPITAL Clinical
Clinical NN management
management CC and
and NN treatment
treatment NNS outcomes
outcomes IN of
of NNP CAPITAL Merkel
Merkel NN cell
cell NN carcinoma

Relatives NNS CAPITAL Relatives
Relatives IN in
in DT the
the NN resuscitation
resuscitation NN room
room : :
: PRP$ their
their NN point
point IN of
of NN view

Large JJ CAPITAL Large
Large NN airway
airway NN disease
disease VBN associated
associated IN with
with JJ inflammatory
inflammatory NN bowel
bowel NN disease

Autonomy NN CAPITAL Autonomy
Autonomy IN in
in DT the
the NN face
face IN of
of DT a
a VBG devastating
devastating NN diagnosis

Advanced NNP CAPITAL Advanced
Advanced NN practice
practice NN nursing
nursing : :
: VBZ is
is DT the
the NN physician
physician POS 's
's NN assistant
assistant DT an
an NN accident
accident IN of
of NN history
history CC or
or DT a
a NN failure
failure TO to
to NN act
act . ?

Acute JJ CAPITAL Acute
Acute JJ obstructive
obstructive NN hydrocephalus
hydrocephalus VBG complicating
complicating JJ bacterial
bacterial NN meningitis
meningitis IN in
in NN childhood

Subcutaneous NNP CAPITAL Subcutaneous
Subcutaneous JJ autologous
autologous JJ ovarian
ovarian NN transplantation
transplantation IN in
in NNP CAPITAL Wistar
Wistar NNS rats
rats VBZ maintains
maintains NN hormone
hormone NN secretion

Teaching NN CAPITAL Teaching
Teaching JJ irritable
irritable NN bowel
bowel NN syndrome
syndrome NNS patients
patients TO to
to NN care
care IN for
for PRP themselves

Nonanesthetic JJ CAPITAL Nonanesthetic
Nonanesthetic JJ volatile
volatile NNS drugs
drugs VB obey
obey DT the
the NNP CAPITAL Meyer-Overton
Meyer-Overton NN correlation
correlation IN in
in CD two
two JJ molecular
molecular NN protein
protein NN site
site NNS models

Inhaled VBN CAPITAL Inhaled
Inhaled NN sodium
sodium NN cromoglycate
cromoglycate IN in
in JJ young
young NNS children
children IN with
with JJ moderate
moderate NN asthma

Directly RB CAPITAL Directly
Directly VBN observed
observed NN therapy
therapy CC and
and NN treatment
treatment NN completion
completion IN for
for NN tuberculosis
tuberculosis IN in
in DT the
the NNP CAPITAL United
United NNPS CAPITAL States
States : :
: VBZ is
is JJ universal
universal VBN supervised
supervised NN therapy
therapy JJ necessary
necessary . ?

Investigation NN CAPITAL Investigation
Investigation IN of
of JJ antibiotic
antibiotic NN prophylaxis
prophylaxis NN usage
usage IN for
for JJ vascular
vascular CC and
and JJ nonvascular
nonvascular JJ interventional
interventional NNS procedures

Effect NN CAPITAL Effect
Effect IN of
of NN protein
protein NN kinase
kinase NN CAPITAL C
C NNS inhibitors
inhibitors IN on
on NN cardioprotection
cardioprotection IN by
by JJ ischemic
ischemic VBG preconditioning
preconditioning VBZ depends
depends IN on
on DT the
the NN number
number IN of
of VBG preconditioning
preconditioning NNS episodes

How WRB CAPITAL How
How VB do
do PRP you
you NN treat
treat JJ refractory
refractory NN pouchitis
pouchitis CC and
and WRB when
when VB do
do PRP you
you VB decide
decide TO to
to VB remove
remove DT the
the NN pouch
pouch . ?

Filter NNP CAPITAL Filter
Filter NN paper
paper NN blood
blood NN spot
spot NN assay
assay IN of
of JJ human
human JJ insulin-like
insulin-like NN growth
growth NN factor
factor PRP CAPITAL I
I NN (
( NN CAPITAL IGF-I
IGF-I NN )
) CC and
and JJ CAPITAL IGF-binding
IGF-binding NN protein-3
protein-3 CC and
and JJ preliminary
preliminary NN application
application IN in
in DT the
the NN evaluation
evaluation IN of
of NN growth
growth NN hormone
hormone NN status

Effect NN CAPITAL Effect
Effect IN of
of NN iodixanol
iodixanol IN on
on JJ renal
renal NN function
function RB immediately
immediately IN after
after JJ abdominal
abdominal NN angiography
angiography . .

Clinical JJ CAPITAL Clinical
Clinical NN comparison
comparison IN with
with NN iomeprol
iomeprol CC and
and NN ioxaglate

A DT CAPITAL A
A JJ new
new VBN modified
modified NN technique
technique IN for
for NN harvest
harvest IN of
of NN calcaneal
calcaneal NN bone
bone NNS grafts
grafts IN in
in NN surgery
surgery IN on
on DT the
the NN foot
foot CC and
and NN ankle

Is VBZ CAPITAL Is
Is NN prevaccination
prevaccination NN screening
screening IN for
for NN hepatitis
hepatitis NN CAPITAL B
B IN among
among RB sexually
sexually JJ active
active NNS adolescents
adolescents JJ cost-effective
cost-effective . ?

Epilepsy NNP CAPITAL Epilepsy
Epilepsy : --
-- DT a
a NN guide
guide TO to
to JJ medical
medical NN treatment

1 CD 1
1 : :
: JJ CAPITAL Antiepileptic
Antiepileptic NNS drugs

Adolescent JJ CAPITAL Adolescent
Adolescent NN pregnancy
pregnancy CC and
and JJ sexual
sexual NN abuse

Normoxic JJ CAPITAL Normoxic
Normoxic JJ cardiopulmonary
cardiopulmonary NN bypass
bypass VBZ reduces
reduces JJ oxidative
oxidative JJ myocardial
myocardial NN damage
damage CC and
and JJ nitric
nitric NN oxide
oxide IN during
during JJ cardiac
cardiac NNS operations
operations IN in
in DT the
the JJ adult

A DT CAPITAL A
A JJ multidimensional
multidimensional NN study
study IN of
of NN preference
preference NNS judgements
judgements IN for
for NNS excerpts
excerpts IN of
of NN music

Extending VBG CAPITAL Extending
Extending DT the
the NNS benefits
benefits IN of
of NN breast
breast NN cancer
cancer NN screening

Still RB CAPITAL Still
Still RB hard
hard TO to
to VB know
know WRB how
how JJ large
large DT the
the NNS benefits
benefits MD will
will RB really
really VB be

Rhabdomyolysis NNP CAPITAL Rhabdomyolysis
Rhabdomyolysis CC and
and NN carbon
carbon NN monoxide
monoxide NN poisoning

Effect NN CAPITAL Effect
Effect IN of
of JJ dental
dental NN treatment
treatment IN on
on DT the
the NN lung
lung NN function
function IN of
of NNS children
children IN with
with NN asthma
asthma . .

conclusions NNS conclusions
conclusions : :
: IN apc
apc VBZ is
is JJ effective
effective IN for
for DT the
the NN treatment
treatment IN of
of JJ endoluminal
endoluminal NN hemoptysis
hemoptysis CC and
and NN airway
airway NN obstruction

induction NN induction
induction NN chemotherapy
chemotherapy NN (
( NN cisplatin
cisplatin CC +
+ NN vinorelbine
vinorelbine NN )
) VBZ is
is VBN found
found TO to
to VB be
be RB markedly
markedly JJ effective
effective IN for
for JJ squamous
squamous NN cell
cell NN lung
lung NN carcinoma
carcinoma IN with
with NN sarcoidosis
sarcoidosis : --
-- DT a
a NN case
case NN report

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN in
in NN conclusion
conclusion , ,
, NN 3d
3d JJ computer-assisted
computer-assisted NN analysis
analysis IN of
of DT the
the JJ internal
internal NN structure
structure IN of
of JJ small
small JJ pulmonary
pulmonary NNS nodules
nodules VBG using
using JJ contrast-enhanced
contrast-enhanced NN dh-ct
dh-ct VBD was
was VBN found
found TO to
to VB be
be JJ effective
effective IN for
for VBG differentiating
differentiating IN between
between JJ benign
benign CC and
and JJ malignant
malignant NNS nodules

the DT the
the NN patient
patient VBD was
was DT a
a JJ 62-year-old
62-year-old NN man
man IN with
with JJ squamous
squamous NN cell
cell NN lung
lung NN cancer
cancer , ,
, WDT which
which VBD was
was RB first
first RB successfully
successfully VBN treated
treated IN by
by DT a
a NN combination
combination IN of
of NN radiation
radiation NN therapy
therapy CC and
and NN chemotherapy
chemotherapy , ,
, CC but
but VBD showed
showed JJ local
local NN recurrence
recurrence IN after
after CD 8
8 NNS months

the DT the
the NN combination
combination IN of
of NN txt
txt , ,
, NN gem
gem CC and
and NN cddp
cddp MD may
may VB be
be JJ effective
effective IN for
for JJ recurrent
recurrent JJ non-small-cell
non-small-cell NN lung
lung NN carcinoma
carcinoma , ,
, RB even
even IN in
in NNS patients
patients IN that
that VB have
have VBD failed
failed TO to
to NN respond
respond TO to
to RBR more
more IN than
than CD one
one NN chemotherapy
chemotherapy NNS regimen

the DT the
the NN aim
aim IN of
of DT the
the JJ current
current NN study
study VBD was
was TO to
to VB compare
compare DT the
the NN objective
objective NN response
response CC and
and NN survival
survival NNS rates
rates IN of
of NNS patients
patients IN with
with NN mrcc
mrcc VBN treated
treated IN with
with NN il-2
il-2 VBN administered
administered DT either
either RB systemically
systemically NN (
( IN syst
syst , ,
, RB subcutaneously
subcutaneously NN )
) CC or
or IN via
via NN inhalation
inhalation NN (
( NN inh
inh NN )
) , ,
, VBG using
using RB relatively
relatively JJ large
large NN sample
sample NNS sizes
sizes TO to
to VB afford
afford DT a
a RBR more
more JJ meaningful
meaningful NN comparison

conclusion NN conclusion
conclusion : :
: IN as
as VBN expected
expected , ,
, DT the
the NN type
type IN of
of NN chemotherapy
chemotherapy PRP we
we VBN used
used , ,
, TO to
to NN treat
treat JJ non-seminomatous
non-seminomatous NN germ-cell
germ-cell NNS tumors
tumors VBN proved
proved TO to
to VB be
be RB highly
highly JJ effective
effective IN for
for JJ seminomatous
seminomatous NNS types
types , ,
, IN as
as RB well

carboplatin NN carboplatin
carboplatin CC and
and NN ifosfamide
ifosfamide VBN performed
performed RB well
well CC and
and JJ safe
safe , ,
, IN in
in DT the
the NN treatment
treatment IN of
of JJ non-bulky
non-bulky JJ metastatic
metastatic NN seminoma

these DT these
these NNS results
results VBN suggested
suggested IN that
that DT the
the NN sp1
sp1 NN decoy
decoy NN strategy
strategy MD would
would VB be
be JJ effective
effective IN for
for VBG regulating
regulating NN tumor
tumor NN growth
growth IN by
by RB simultaneously
simultaneously VBG reducing
reducing NN cancer
cancer NN cell
cell NN (
( DT a
a NN )
) JJ angiogenic
angiogenic NN growth
growth NN factor
factor NN expression
expression , ,
, NN (
( NN b
b NN )
) NN proliferation
proliferation , ,
, CC and
and NN (
( NN c
c NN )
) NN invasiveness

considering VBG considering
considering IN that
that NNS hamsters
hamsters VBD had
had DT a
a NN lung
lung NN metastasis
metastasis NN rate
rate IN of
of CD 50
50 NN %
% IN before
before NNS mdp-lys
mdp-lys NN treatment
treatment , ,
, JJ liposomal
liposomal NNS mdp-lys
mdp-lys VBN given
given IN at
at DT a
a NN dose
dose IN of
of CD 20
20 NN microg
microg NN twice/week
twice/week VBD was
was JJ effective
effective IN for
for VBG inhibiting
inhibiting NN lung
lung NN metastasis
metastasis IN at
at DT a
a RB far
far JJR lower
lower NN dose
dose IN of
of NNS mdp-lys
mdp-lys IN than
than IN that
that VBN given
given IN as
as DT a
a NN solution
solution NN (
( CD 40
40 NN microg
microg CC vs.
vs. CD 350
350 NN microg
microg IN per
per NN week
week NN )

we PRP we
we VB have
have VBN documented
documented RB previously
previously IN that
that JJ adenovirus-mediated
adenovirus-mediated NN interleukin
interleukin CD 12
12 NN (
( NN il-12
il-12 NN )
) NN gene
gene NN therapy
therapy VBZ is
is JJ effective
effective IN for
for JJ orthotopic
orthotopic NN tumor
tumor NN control
control CC and
and NN suppression
suppression IN of
of JJ pre-established
pre-established NNS metastases
metastases IN in
in DT a
a JJ preclinical
preclinical NN prostate
prostate NN cancer
cancer NN model
model NN (
( IN y.
y. NN nasu
nasu FW et
et NNP al
al . .
. , ,
, NN gene
gene IN ther

we PRP we
we RB further
further VBN developed
developed DT a
a NN vaccine
vaccine NN model
model VBN based
based IN on
on NN s.c.injection
s.c.injection IN of
of JJ infected
infected , ,
, JJ irradiated
irradiated NN rm-9
rm-9 NNS cells
cells CC and
and VBN found
found IN that
that DT both
both NN admil-12
admil-12 CC and
and NN admil-12/b7
admil-12/b7 VBP are
are JJ effective
effective IN at
at VBG suppressing
suppressing DT the
the NN development
development CC and
and NN growth
growth IN of
of NN challenge
challenge JJ orthotopic
orthotopic NNS tumors
tumors VBG using
using DT this
this NN protocol

despite IN despite
despite DT the
the JJ marked
marked NN toxicity
toxicity IN of
of DT the
the JJ initial
initial JJ intensive
intensive NN chemotherapy
chemotherapy , ,
, DT the
the NNS treatments
treatments VBP are
are JJ tolerable
tolerable CC and
and JJ effective
effective IN in
in DT the
the NN control
control IN of
of JJ extra-thoracic
extra-thoracic NNS micrometastases
micrometastases , ,
, IN whereas
whereas PRP they
they VBP are
are JJR less
less JJ effective
effective IN for
for JJ thoracic
thoracic JJ primary
primary NN tumor

radiotherapy NN radiotherapy
radiotherapy VBZ is
is JJ effective
effective IN for
for NN palliation
palliation IN of
of NNS symptoms
symptoms VBN associated
associated IN with
with NN sblc

clinically RB clinically
clinically , ,
, JJ oral
oral NN administration
administration IN of
of NN uft
uft VBZ has
has VBN proved
proved TO to
to VB be
be JJ effective
effective IN as
as DT an
an JJ adjuvant
adjuvant NN therapy
therapy IN after
after NN surgery
surgery IN for
for DT some
some JJ malignant
malignant NNS tumors
tumors JJ such
such IN as
as JJ non-small
non-small NN cell
cell NN lung
lung NN cancer

moreover RB moreover
moreover , ,
, NN uft
uft VBZ has
has VBN proved
proved TO to
to VB be
be JJ effective
effective IN for
for JJ inoperable
inoperable VBN advanced
advanced NNS malignancies
malignancies JJ such
such IN as
as JJ colorectal
colorectal NN cancer
cancer , ,
, RB especially
especially IN in
in NN combination
combination IN with
with NN leucovorin
leucovorin CC or
or NN cisplatin

a DT a
a NN phase
phase LS ii
ii NN study
study IN of
of VBN fractionated
fractionated NN administration
administration IN of
of NN irinotecan
irinotecan NN (
( NN cpt-11
cpt-11 NN )
) CC and
and NN cisplatin
cisplatin NN (
( NN cddp
cddp NN )
) IN in
in NNS patients
patients IN with
with JJ non-small-cell
non-small-cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )
) VBD was
was VBN conducted

in IN in
in NN conclusion
conclusion , ,
, VBN fractionated
fractionated NN administration
administration IN of
of NN cpt-11
cpt-11 CC and
and NN cddp
cddp VBD was
was RB highly
highly JJ effective
effective IN for
for VBN advanced
advanced NN nsclc
nsclc IN with
with JJ manageable
manageable NNS toxicities

we PRP we
we NN report
report DT the
the NN use
use IN of
of NN paclitaxel
paclitaxel IN in
in DT the
the JJ successful
successful NN treatment
treatment IN of
of DT a
a NN patient
patient IN with
with JJ recurrent
recurrent NN adenocarcinoma
adenocarcinoma IN of
of DT the
the NN cervix

weekly RB weekly
weekly NN paclitaxel
paclitaxel VBD was
was RB very
very RB well
well VBN tolerated
tolerated , ,
, RB yet
yet VBD was
was JJ effective
effective IN for
for JJ recurrent
recurrent JJ cervical
cervical NN adenocarcinoma

conclusion NN conclusion
conclusion : :
: PRP$ our
our NNS results
results VB suggest
suggest IN that
that NN pseudoephedrine
pseudoephedrine CC plus
plus NN acetaminophen
acetaminophen VBZ is
is JJ effective
effective IN for
for NN relief
relief IN of
of NNS symptoms
symptoms JJ attributable
attributable TO to
to DT the
the NN paranasal
paranasal NNS sinuses
sinuses IN that
that MD may
may VB develop
develop RB early
early IN in
in DT the
the NN course
course IN of
of DT a
a JJ cold

reviewer NN reviewer
reviewer POS 's
's NNS conclusions
conclusions : :
: DT a
a JJ single
single NN dose
dose IN of
of JJ nasal
nasal NN decongestant
decongestant IN in
in DT the
the JJ common
common JJ cold
cold VBZ is
is RB moderately
moderately JJ effective
effective IN for
for DT the
the RB short
short NN term
term NN relief
relief IN of
of NN congestion
congestion IN in
in NNS adults
adults , ,
, IN while
while RB there
there VBZ is
is DT no
no NN evidence
evidence JJ available
available TO to
to NN show
show NN benefit
benefit IN after
after VBN repeated
repeated NN use
use IN over
over JJ several
several NNS days

conclusions NNS conclusions
conclusions : :
: NNS members
members IN of
of DT an
an RB ethnically
ethnically JJ diverse
diverse NN community
community VB believe
believe NNS antibiotics
antibiotics VBP are
are JJ effective
effective IN for
for NNS colds
colds , ,
, VBP are
are RB very
very RB likely
likely TO to
to VB seek
seek NN care
care IN for
for NNS colds
colds , ,
, CC and
and RB often
often VB obtain
obtain NNS antibiotics
antibiotics IN without
without DT a
a NN prescription

the DT the
the JJ available
available VBN inactivated
inactivated NN vaccine
vaccine VBZ is
is JJ effective
effective IN for
for VBG preventing
preventing NN influenza
influenza CC and
and DT the
the JJ serious
serious NN disease
disease CC and
and NN death
death IN that
that MD can
can VB accompany
accompany PRP it

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN amantadine
amantadine , ,
, NN rimantadine
rimantadine , ,
, CC and
and DT the
the RB newly
newly JJ available
available NNS drugs
drugs NN zanamivir
zanamivir CC and
and NN oseltamivir
oseltamivir VBP are
are JJ effective
effective IN for
for NN influenza
influenza NN prevention
prevention CC and
and NN treatment
treatment NN (
( DT the
the JJ former
former CD two
two IN for
for NN influenza
influenza DT a
a RB only
only NN )

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> DT the
the NN availability
availability IN of
of CD four
four JJ antiviral
antiviral NNS agents
agents IN that
that RB effectively
effectively VB prevent
prevent CC and
and NN treat
treat NN influenza
influenza VBZ provides
provides DT the
the NN physician
physician IN with
with JJ considerable
considerable NN flexibility
flexibility IN for
for PRP$ their
their NN use
use IN in
in NN influenza
influenza NN control

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> RB thus
thus NN influenza
influenza NN vaccination
vaccination VBZ is
is JJ effective
effective IN for
for VBG preventing
preventing NN influenza
influenza NN disease
disease IN in
in NNS persons
persons JJ aged
aged CD 65
65 NNS years
years CC and
and IN over
over , ,
, CC and
and MD should
should VB be
be DT an
an JJ integral
integral NN part
part IN of
of DT the
the NN care
care IN of
of DT this
this NN population
population VBG residing
residing IN in
in NN nursing
nursing NNS homes

intravenous JJ intravenous
intravenous NN injection
injection IN of
of NNS pb2-as
pb2-as , ,
, IN as
as DT a
a NN complex
complex IN with
with NN dmrie-c
dmrie-c , ,
, DT a
a NN cationic
cationic NN liposome
liposome , ,
, VBD was
was RBS most
most JJ effective
effective IN for
for VBG prolonging
prolonging DT the
the VB mean
mean NN survival
survival NN time
time IN in
in NNS days
days NN (
( NNS msds
msds NN )
) CC and
and VBG increasing
increasing DT the
the NN survival
survival NNS rates
rates IN of
of NNS mice
mice JJ infected
infected IN with
with DT the
the NN influenza
influenza DT a
a NN virus

background NN background
background CC and
and NNS objectives
objectives : :
: JJ thoracic
thoracic NN paravertebral
paravertebral NN block
block NN (
( NN tpvb
tpvb NN )
) VBZ is
is DT a
a JJ unilateral
unilateral JJ analgesic
analgesic NN technique
technique IN that
that VBZ has
has VBN been
been VBN advocated
advocated IN in
in DT both
both JJ acute
acute CC and
and JJ chronic
chronic JJ thoracic
thoracic CC and
and JJ abdominal
abdominal NN pain

other JJ other
other NNS blocks
blocks JJ such
such IN as
as JJ interpleural
interpleural CC and
and JJ epidural
epidural MD can
can VB be
be RB effectively
effectively VBN used
used IN in
in JJ pleuritic
pleuritic NN pain

this DT this
this NN report
report VBZ illustrates
illustrates IN that
that NN tpvb
tpvb MD could
could RB also
also VB be
be JJ effective
effective IN for
for DT this
this NN kind
kind IN of
of NN pain

conclusions NNS conclusions
conclusions : :
: DT this
this NN case
case NN report
report NNS supports
supports DT the
the NN notion
notion IN that
that , ,
, IN in
in NN practice
practice , ,
, DT the
the NN paravertebral
paravertebral NN block
block MD could
could VB be
be DT an
an JJ effective
effective CC and
and JJ safe
safe NN alternative
alternative TO to
to NN relief
relief IN of
of JJ pleuritic
pleuritic NN pain

conclusion NN conclusion
conclusion : :
: JJ mr-guided
mr-guided NN rfa
rfa VBG using
using JJ single
single VBN cooled
cooled NN tip
tip NNS electrodes
electrodes VBZ is
is JJ safe
safe CC and
and RB technically
technically JJ effective
effective IN for
for NN treatment
treatment IN of
of JJ hepatic
hepatic NNS neoplasms
neoplasms RB up
up TO to
to CD 3
3 NN cm
cm IN in
in NN size
size , ,
, RB however
however RB further
further NNS improvements
improvements VBP are
are JJ necessary

a DT a
a JJ 68-year-old
68-year-old NN man
man VBD underwent
underwent JJ curative
curative NN pancreaticoduodenectomy
pancreaticoduodenectomy IN for
for NN bile
bile NN duct
duct NN cancer

one CD one
one NN course
course IN of
of NN chronochemotherapy
chronochemotherapy VBD was
was JJ effective
effective IN for
for NN lymph
lymph NN node
node CC and
and NN peritoneum
peritoneum NNS metastases

the DT the
the RB only
only JJ specific
specific NN antidote
antidote IN for
for JJ dosage-dependent
dosage-dependent NN hepatotoxicity
hepatotoxicity VBZ is
is NN n-acetylcysteine
n-acetylcysteine NN (
( CC and
and DT some
some JJ other
other NN sulfhydryl
sulfhydryl NNS donors
donors NN )
) , ,
, WDT which
which VBZ is
is RB highly
highly JJ effective
effective IN for
for DT the
the NN prevention
prevention IN of
of JJ significant
significant NN hepatotoxicity
hepatotoxicity IN after
after NN acetaminophen
acetaminophen NN overdose

corticosteroids NNS corticosteroids
corticosteroids MD can
can VB be
be VBN considered
considered IN for
for NNS cases
cases IN of
of JJ drug-induced
drug-induced NN hepatitis
hepatitis , ,
, RB especially
especially DT those
those IN with
with NN evidence
evidence IN of
of JJ immune
immune NN hypersensitivity
hypersensitivity , ,
, IN if
if DT no
no NN improvement
improvement VBZ is
is VBN seen
seen IN in
in CD 8
8 TO to
to CD 12
12 NNS weeks

our PRP$ our
our NN conclusion
conclusion VBD was
was IN that
that DT the
the NNS covered-ems
covered-ems MD can
can VB be
be JJ effective
effective IN for
for DT the
the NN palliation
palliation IN of
of JJ esophagorespiratory
esophagorespiratory NNS fistulas

the DT the
the NN food
food CC and
and NN drug
drug NN administration
administration NN (
( NN fda
fda NN )
) RB recently
recently VBN approved
approved DT the
the RB first
first JJ protein-polysaccharide
protein-polysaccharide NN conjugate
conjugate NN vaccine
vaccine TO to
to VB prevent
prevent JJ invasive
invasive JJ pneumococcal
pneumococcal NNS diseases
diseases IN in
in NNS infants
infants CC and
and NNS toddlers
toddlers JJR <
< CD 2
2 NNS years
years IN of
of NN age

this DT this
this VBN conjugated
conjugated NN vaccine
vaccine IN against
against NN pneumococcus
pneumococcus NNS uses
uses DT the
the JJ same
same NN technology
technology IN as
as DT the
the JJ successful
successful NN vaccine
vaccine IN against
against NN haemophilus
haemophilus NNS influenzae
influenzae NN type
type NN b

the DT the
the RBS most
most JJ recent
recent NN study
study , ,
, VBG involving
involving IN over
over CD 37
37 , ,
, CD 000
000 JJ young
young NNS children
children , ,
, RB also
also VBN evaluated
evaluated DT the
the NN vaccine
vaccine POS 's
's NN efficacy
efficacy , ,
, CC and
and VBN reported
reported IN that
that DT the
the NN vaccine
vaccine VBZ is
is RB highly
highly JJ effective
effective IN in
in VBG preventing
preventing JJ invasive
invasive NN disease
disease CC and
and VBZ has
has VBD had
had DT an
an NN impact
impact IN on
on NN otitis
otitis NNS media

conclusions NNS conclusions
conclusions : :
: DT the
the NN heptavalent
heptavalent JJ pneumococcal
pneumococcal NN conjugate
conjugate NN vaccine
vaccine VBZ is
is JJ safe
safe CC and
and RB highly
highly JJ effective
effective IN in
in VBG preventing
preventing JJ pneumococcal
pneumococcal NN meningitis
meningitis CC and
and JJ bacteremic
bacteremic NN pneumonia
pneumonia IN in
in JJ young
young NNS children
children JJR <
< CD 2
2 NNS years
years IN of
of NN age
age : ;
; PRP it
it VBZ is
is JJR less
less JJ effective
effective IN in
in VBG preventing
preventing NN otitis
otitis NNS media

based VBN based
based IN on
on DT the
the NNS results
results IN of
of CD three
three JJ well-designed
well-designed NNS studies
studies VBG demonstrating
demonstrating DT the
the NN vaccine
vaccine POS 's
's NN safety
safety , ,
, NN immunogenicity
immunogenicity , ,
, CC and
and NN efficacy
efficacy , ,
, DT the
the NN vaccine
vaccine VBZ is
is JJ safe
safe CC and
and JJ effective
effective IN for
for JJ active
active NN immunization
immunization IN of
of NNS children
children JJR <
< CD 2
2 NNS years
years IN of
of NN age
age IN against
against JJ invasive
invasive NN disease
disease VBN caused
caused IN by
by CD seven
seven NN streptococcus
streptococcus FW pneumoniae
pneumoniae NNS serotypes
serotypes VBN included
included IN in
in DT the
the NN vaccine

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> LS i
i VBD concluded
concluded IN that
that JJ 6-month
6-month NNS regimen
regimen VBG containing
containing NN pyrazinamide
pyrazinamide VBD was
was JJ effective
effective IN for
for DT the
the NNS patients
patients IN with
with NN isoniazid-rifampicin
isoniazid-rifampicin JJ susceptible
susceptible NN tuberculosis
tuberculosis NNS patients
patients IN except
except DT the
the NNS patients
patients VBN complicated
complicated IN with
with NN diabetes
diabetes NN mellitus

only RB only
only DT the
the NN combination
combination IN of
of DT a
a NN cell
cell JJ wall-active
wall-active JJ antibiotic
antibiotic TO to
to WDT which
which DT the
the NN enterococcus
enterococcus VBZ is
is JJ susceptible
susceptible NN (
( FW ie
ie , ,
, JJ certain
certain NNS beta-lactams
beta-lactams CC or
or NN vancomycin
vancomycin NN )
) CC plus
plus DT an
an IN aminoglycoside
aminoglycoside NN (
( FW ie
ie , ,
, NN gentamicin
gentamicin CC or
or NN streptomycin
streptomycin NN )
) VBZ is
is JJ bactericidal
bactericidal , ,
, CC and
and VBZ is
is VBN required
required IN for
for NN cure
cure IN of
of NN endocarditis
endocarditis , ,
, NN meningitis
meningitis CC and
and RB probably
probably NN infection
infection IN in
in NN neutropenic
neutropenic NNS patients
patients : ;
; JJ bacteriostatic
bacteriostatic NN activity
activity VBZ is
is JJ sufficient
sufficient TO to
to NN treat
treat RBS most
most JJ other
other NNS infections

two CD two
two NN triazole
triazole JJ antifungal
antifungal NNS agents
agents , ,
, NN fluconazole
fluconazole CC and
and NN itraconazole
itraconazole , ,
, VBD were
were VBN introduced
introduced IN over
over DT a
a NN decade
decade IN ago
ago CC and
and IN since
since RB then
then VB have
have VBN been
been VBN used
used RB extensively
extensively IN for
for DT the
the NN prophylaxis
prophylaxis CC and
and NN treatment
treatment IN of
of DT a
a NN variety
variety IN of
of JJ fungal
fungal NNS infections

the DT the
the NN use
use IN of
of JJ topical
topical NNS corticosteroids
corticosteroids VBZ has
has VBN revolutionised
revolutionised DT the
the NN treatment
treatment IN of
of JJ inflammatory
inflammatory NN skin
skin NNS diseases

in IN in
in JJ particular
particular , ,
, NN tacrolimus
tacrolimus CC and
and NN ascomycin
ascomycin NNS derivatives
derivatives VB have
have VBN been
been VBN shown
shown TO to
to VB be
be JJ effective
effective IN for
for VBG treating
treating JJ atopic
atopic NN dermatitism
dermatitism IN with
with DT a
a JJ surprising
surprising NN lack
lack IN of
of NN side
side NNS effects

cyclophosphamide NN cyclophosphamide
cyclophosphamide NN therapy
therapy VBZ is
is JJ effective
effective IN for
for NN bronchiolitis
bronchiolitis NNS obliterans
obliterans VBG occurring
occurring IN as
as DT a
a RB late
late NN manifestation
manifestation IN of
of NN lupus
lupus NN erythematosus
erythematosus NN (
( NN letter
letter NN )

in IN in
in NN summary
summary , ,
, NN gemifloxacin
gemifloxacin VBD was
was VBN found
found TO to
to VB be
be RB well
well VBN tolerated
tolerated CC and
and JJ effective
effective IN for
for DT the
the NN treatment
treatment IN of
of IN aecb
aecb , ,
, VBG suggesting
suggesting PRP it
it VBZ is
is RB well
well VBN suited
suited IN for
for JJ empirical
empirical NN treatment
treatment IN of
of DT this
this JJ common
common JJ respiratory
respiratory NN condition
condition IN in
in DT the
the JJ current
current JJ clinical
clinical NN environment

d-penicillamine NN d-penicillamine
d-penicillamine NN (
( JJ 2-amino-3-mercapto-3-methylbutanoic
2-amino-3-mercapto-3-methylbutanoic NN acid
acid NN )
) , ,
, DT a
a JJ well-known
well-known JJ heavy
heavy NN metal
metal NN chelator
chelator , ,
, VBZ is
is DT the
the NN drug
drug IN of
of NN choice
choice IN in
in DT the
the NN treatment
treatment IN of
of NN wilson
wilson POS 's
's NN disease
disease CC and
and VBZ is
is RB also
also JJ effective
effective IN for
for DT the
the NN treatment
treatment IN of
of JJ several
several NNS disorders
disorders VBG including
including JJ rheumatoid
rheumatoid NN arthritis
arthritis , ,
, JJ primary
primary JJ biliary
biliary NN cirrhosis
cirrhosis , ,
, NN scleroderma
scleroderma , ,
, JJ fibrotic
fibrotic NN lung
lung NNS diseases
diseases CC and
and JJ progressive
progressive JJ systemic
systemic NN sclerosis

stages NNS stages
stages IN of
of JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )
) IN that
that VBP are
are NN potential
potential NNS candidates
candidates IN for
for JJ surgical
surgical NN resection
resection VB have
have VBN been
been VBN treated
treated IN in
in JJ several
several NNS ways
ways : :
: NN surgery
surgery RB alone
alone VBZ is
is JJ curative
curative IN in
in RB only
only NNS two-thirds
two-thirds IN of
of NNS cases
cases CC and
and JJ post-operative
post-operative NN radiotherapy
radiotherapy NN (
( NN rt
rt NN )
) VBZ provides
provides RB only
only JJ weak
weak NN control
control IN of
of NN advanced-stage
advanced-stage NN disease

among IN among
among DT these
these , ,
, DT the
the NN gemcitabine/cisplatin
gemcitabine/cisplatin NN study
study NN protocol
protocol NN (
( NN gc
gc NN )
) , ,
, NN set
set RB up
up IN in
in DT a
a NN phase
phase LS ii
ii NN study
study IN for
for NNS patients
patients IN with
with NN stage
stage NN iiia
iiia NN n2
n2 NN nsclc
nsclc , ,
, VBD was
was RB very
very JJ effective
effective NN (
( NN objective
objective NN response
response NN (
( CC or
or NN )
) : :
: CD 70.2
70.2 NN %
% : ;
; NN median
median NN survival
survival : :
: CD 19
19 NNS months
months NN )
) CC and
and MD should
should VB be
be VBG promising
promising IN for
for NNS stages
stages NN ib
ib CC and
and LS ii

several JJ several
several NNS studies
studies VB have
have VBN suggested
suggested IN that
that JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )
) NNS patients
patients WP$ whose
whose NNS tumors
tumors VB have
have NN neuroendocrine
neuroendocrine NN (
( NN ne
ne NN )
) NNS features
features MD may
may VB be
be RBR more
more JJ responsive
responsive TO to
to NN chemotherapy
chemotherapy IN in
in NN addition
addition , ,
, VBN increased
increased NN expression
expression IN of
of NN p53
p53 CC and
and NN her2
her2 MD may
may VB confer
confer JJ relative
relative NN chemotherapy
chemotherapy NN resistance
resistance CC and
and VBD shortened
shortened NN survival

the DT the
the NN cancer
cancer CC and
and NN leukemia
leukemia NN group
group NN b
b VBN performed
performed DT a
a NN series
series IN of
of NNS studies
studies VBG involving
involving JJ sequential
sequential NN chemotherapy
chemotherapy VBN followed
followed IN by
by NN radiation
radiation IN for
for NNS patients
patients IN with
with JJ unresectable
unresectable NN stage
stage LS iii
iii NN nsclc

this DT this
this NN london
london NN lung
lung NN cancer
cancer NN group
group NN trial
trial IN of
of NN gemcitabine/carboplatin
gemcitabine/carboplatin MD may
may VB define
define DT an
an JJ active
active , ,
, JJ safe
safe , ,
, CC and
and JJ acceptable
acceptable NN treatment
treatment IN for
for NNS patients
patients IN with
with NN extensive-stage
extensive-stage CC and
and NN poor-prognosis
poor-prognosis JJ small
small NN cell
cell NN lung
lung NN cancer

gemcitabine NN gemcitabine
gemcitabine CC and
and NN carboplatin
carboplatin IN for
for NNS patients
patients IN with
with VBN advanced
advanced JJ non-small
non-small NN cell
cell NN lung
lung NN cancer

an DT an
an JJ aggressive
aggressive JJ surgical
surgical NN approach
approach VBZ is
is JJ justified
justified IN in
in NNS patients
patients IN with
with NN mplc
mplc CC and
and NNS offers
offers DT the
the JJS greatest
greatest NN chance
chance IN for
for JJ long-term
long-term NN survival
survival RB even
even IN in
in DT the
the NN case
case IN of
of JJ limited
limited NN resection

methods NNS methods
methods CC and
and NNS materials
materials : :
: NNS eleven
eleven NNS patients
patients IN with
with JJ small
small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN sclc
sclc NN )
) , ,
, WP who
who VBD had
had VBN presented
presented JJ complete
complete NN response
response IN of
of NN disease
disease IN after
after NN chemotherapy
chemotherapy CC and
and NN radical
radical NN radiotherapy
radiotherapy IN in
in DT the
the NN lung
lung , ,
, VBD were
were VBN prescribed
prescribed TO to
to VB receive
receive DT a
a VBG prophylacting
prophylacting JJ cranial
cranial NN irradiation
irradiation NN (
( NN pci
pci NN )
) IN with
with DT a
a CD 6
6 NN mev
mev JJ linear
linear NN accelerator

only RB only
only CD 22
22 NNS patients
patients NN (
( CD 10
10 NN %
% NN )
) VBD were
were JJ alive
alive IN at
at CD five
five NNS years
years : :
: CD 19
19 NNS patients
patients IN with
with NN nsclc
nsclc WP who
who VBD had
had VBD got
got JJ surgical
surgical NN treatment
treatment , ,
, CD one
one NN patient
patient IN with
with NN nsclc
nsclc NN (
( NN stage
stage NN iiib
iiib NN )
) WP who
who VBD had
had VBN recieved
recieved NN radiotherapy
radiotherapy , ,
, CC and
and CD two
two NNS patients
patients IN with
with NN sclc
sclc , ,
, JJ limited
limited NN disease
disease , ,
, VBN treated
treated IN with
with JJ chemo-
chemo- CC and
and NN radiotherapy

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> DT the
the NN standard
standard NN care
care IN for
for NNS patients
patients IN with
with JJ non-small-cell
non-small-cell NN lung
lung NN cancer
cancer VBZ is
is NN chemotherapy
chemotherapy IN of
of JJ supportive
supportive NN care
care , ,
, IN with
with NN surgery
surgery VBG being
being VBN reserved
reserved IN for
for NN palliation
palliation IN of
of NNS symptoms
symptoms : ;
; RB however
however , ,
, RB there
there VBZ is
is DT a
a JJ small
small NN group
group IN of
of NNS patients
patients IN with
with DT a
a JJ finite
finite NN number
number IN of
of JJ extrathoracic
extrathoracic NNS metastases
metastases NN (
( NNS oligometastases
oligometastases NN )
) WP who
who MD may
may NN experience
experience VBN improved
improved NN survival
survival IN by
by NN resection
resection IN of
of PRP$ their
their NNS metastases
metastases CC and
and DT the
the JJ primary
primary NN site
site , ,
, IN with
with CC or
or IN without
without JJ systemic
systemic NN treatment

five CD five
five JJ new
new NNS agents
agents , ,
, NN paclitaxel
paclitaxel , ,
, NN docetaxel
docetaxel , ,
, NN vinorelbine
vinorelbine , ,
, NN gemcitabine
gemcitabine CC and
and NN irinotecan
irinotecan , ,
, VB have
have VBN been
been VBN introduced
introduced IN for
for DT the
the NN treatment
treatment IN of
of NN nsclc
nsclc CC and
and VBN investigated
investigated RB extensively
extensively DT both
both RB preclinically
preclinically CC and
and RB clinically

whether IN whether
whether DT the
the NN era
era IN of
of JJ platinum-based
platinum-based NN chemotherapy
chemotherapy IN in
in DT the
the NN treatment
treatment IN of
of NN nsclc
nsclc MD should
should VB continue
continue CC or
or RB not
not MD must
must VB be
be VBN determined
determined IN by
by NN phase
phase LS iii
iii NNS trials
trials , ,
, VBG evaluating
evaluating DT the
the NN use
use IN of
of DT a
a NN platinum
platinum NN agent
agent IN with
with CD one
one IN of
of DT the
the JJ new
new NN agent
agent NNS combinations

these DT these
these JJ aggressive
aggressive JJ chemotherapeutic
chemotherapeutic NNS combinations
combinations MD will
will RB hopefully
hopefully VB improve
improve NN survival
survival CC and
and NN quality
quality IN of
of NN life
life IN for
for NNS patients
patients IN with
with VBN advanced
advanced NN nsclc

results NNS results
results : :
: PRP we
we VB have
have VBN performed
performed CD 60
60 JJ carinal
carinal NNS resections
resections IN for
for JJ bronchogenic
bronchogenic NN carcinoma
carcinoma : :
: CD 18
18 VBN isolated
isolated JJ carinal
carinal NNS resections
resections IN for
for NN tumor
tumor VBN confined
confined TO to
to DT the
the JJ carinal
carinal CC or
or JJ proximal
proximal JJ main
main NN stem
stem NNS bronchus
bronchus : ;
; CD 35
35 JJ carinal
carinal NNS pneumonectomies
pneumonectomies : ;
; CD 5
5 JJ carinal
carinal CC plus
plus NN lobar
lobar NNS resections
resections , ,
, CC and
and CD 2
2 JJ carinal
carinal NNS resections
resections IN for
for NN stump
stump NN recurrence
recurrence IN after
after RB prior
prior NN pneumonectomy

conclusions NNS conclusions
conclusions : :
: DT this
this VBZ constitutes
constitutes CD one
one IN of
of DT the
the JJS largest
largest NN single-institution
single-institution NNS reports
reports IN on
on JJ carinal
carinal NN resection
resection IN for
for JJ bronchogenic
bronchogenic NN carcinoma
carcinoma VBG involving
involving DT the
the NN carina

extracorporeal JJ extracorporeal
extracorporeal NN photopheresis
photopheresis VBZ has
has VBD evolved
evolved IN as
as DT a
a JJ possible
possible NN therapy
therapy IN for
for NNS patients
patients IN with
with JJ acute
acute NN nd
nd JJ chronic
chronic NN lung
lung NN allograft
allograft NN rejection

methods NNS methods
methods : :
: PRP we
we RB retrospectively
retrospectively VBN reviewed
reviewed CD 14
14 NNS patients
patients VBN diagnosed
diagnosed IN with
with NNS bos
bos WP who
who VBD underwent
underwent NN therapy
therapy IN with
with JJ extracorporeal
extracorporeal NN photopheresis

in IN in
in CD three
three NNS patients
patients IN with
with NNS bos
bos CC and
and JJ concurrent
concurrent JJ acute
acute NN rejection
rejection , ,
, NN therapy
therapy IN with
with JJ extracorporeal
extracorporeal NN photopheresis
photopheresis VBN led
led TO to
to DT the
the NN resolution
resolution IN of
of DT the
the JJ acute
acute NN rejection
rejection NN episode

conclusion NN conclusion
conclusion : :
: JJ extracorporeal
extracorporeal NN photopheresis
photopheresis VBZ appears
appears TO to
to VB be
be DT a
a VBG promising
promising NN therapy
therapy IN for
for NNS patients
patients IN with
with RB early
early NNS bos

purpose NN purpose
purpose : :
: JJ many
many NNS patients
patients IN with
with RB locally
locally VBN advanced
advanced JJ non-small-cell
non-small-cell NN lung
lung NN cancer
cancer NN (
( NN la-nsclc
la-nsclc NN )
) VBP are
are NN eligible
eligible IN for
for NN combined-modality
combined-modality NN therapy
therapy NN (
( NN cmt
cmt : ;
; NN chemotherapy
chemotherapy CC and
and NN radiotherapy
radiotherapy NN )

over IN over
over DT the
the IN past
past CD twenty
twenty NNS years
years NN combination
combination NN chemotherapy
chemotherapy VBZ has
has VBN continued
continued TO to
to VB produce
produce JJ small
small NN survival
survival NNS gains
gains IN for
for NNS patients
patients IN with
with NN sclc

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN purpose
purpose : :
: DT the
the NN benefit
benefit IN of
of JJ whole-lung
whole-lung NN irradiation
irradiation NN (
( NNS wli
wli NN )
) IN for
for NNS patients
patients WP who
who VB have
have JJ pulmonary
pulmonary NNS metastases
metastases NN (
( NN pm
pm NN )
) IN of
of VBG ewing
ewing NN sarcoma
sarcoma NN family
family NNS tumors
tumors NN (
( NN esft
esft NN )
) VBZ is
is JJ unclear

extent NN extent
extent IN of
of JJ pulmonary
pulmonary NN involvement
involvement IN at
at NN diagnosis
diagnosis , ,
, NN response
response IN of
of NN pm
pm IN after
after NN induction
induction NN chemotherapy
chemotherapy , ,
, JJ local
local NN treatment
treatment IN of
of NN pm
pm RB thereafter
thereafter , ,
, CC and
and JJ clinical
clinical NN outcome
outcome VBD were
were VBN recorded

conclusions NNS conclusions
conclusions : :
: DT the
the JJ comparable
comparable NN survival
survival IN of
of NNS patients
patients IN with
with JJ poor
poor CC and
and JJ good
good NN response
response IN of
of NN pm
pm TO to
to NN induction
induction NN chemotherapy
chemotherapy VBZ suggests
suggests IN that
that NNS wli
wli MD may
may NN benefit
benefit JJ poor
poor NNS responders

objective NN objective
objective : :
: TO to
to NN report
report DT the
the NN use
use IN of
of NN heparin
heparin CC and
and NN enoxaparin
enoxaparin IN for
for JJ radiation-induced
radiation-induced NN myelopathy

therefore RB therefore
therefore , ,
, NNS patients
patients IN with
with JJ radiation-induced
radiation-induced JJ spinal
spinal NN cord
cord NN injury
injury MD may
may NN benefit
benefit IN from
from NN anticoagulant
anticoagulant NN therapy

conclusions NNS conclusions
conclusions : :
: NN heparin
heparin CC and/or
and/or NN enoxaparin
enoxaparin MD may
may VB be
be VBN considered
considered IN as
as NN potential
potential NNS treatments
treatments IN for
for NNS patients
patients IN with
with JJ radiation-induced
radiation-induced NN myelopathy

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN tracheal
tracheal NN stent
stent NN insertion
insertion VBZ is
is DT a
a JJ useful
useful NN method
method IN for
for NNS patients
patients IN with
with JJ malignant
malignant NN tracheal
tracheal NN stenosis

expandable JJ expandable
expandable NN metal
metal NNS stents
stents VBD were
were VBN inserted
inserted IN in
in CD two
two NNS patients
patients IN with
with JJ severe
severe NN dyspnea
dyspnea JJ due
due TO to
to NN tracheal
tracheal NN stenosis
stenosis VBN caused
caused IN by
by NN lung
lung NN cancer
cancer CC and
and NN esophageal
esophageal NN cancer

thus RB thus
thus , ,
, PRP we
we MD should
should VB recognize
recognize DT this
this JJ immanent
immanent NN risk
risk CC and
and VB perform
perform JJ peri-
peri- CC and
and JJ postoperative
postoperative NN management
management IN for
for NNS patients
patients IN with
with JJ gh-producing
gh-producing NNS tumors

background NN background
background : :
: IN at
at JJ present
present DT the
the NN addition
addition IN of
of JJ thoracic
thoracic NN irradiation
irradiation TO to
to NN combination
combination NN chemotherapy
chemotherapy VBZ is
is DT a
a NN standard
standard NN treatment
treatment IN for
for JJ limited
limited VBD staged
staged JJ small
small NN cell
cell NN lung
lung NN cancer

we PRP we
we VBN conducted
conducted DT a
a NN phase
phase LS ii
ii NN study
study IN of
of NN etoposide
etoposide NN (
( NN vp-16
vp-16 NN )
) NN -ifosfamide-cisplatin
-ifosfamide-cisplatin NN (
( NN vip
vip NN )
) NN combination
combination NN chemotherapy
chemotherapy CC plus
plus RB early
early JJ concurrent
concurrent JJ thoracic
thoracic NN irradiation
irradiation IN for
for DT the
the NNS patients
patients IN with
with RB previously
previously JJ untreated
untreated JJ limited
limited JJ small
small NN cell
cell NN lung
lung NN cancer
cancer IN in
in NN order
order TO to
to VB assess
assess IN if
if DT the
the NN treatment
treatment NN modality
modality MD could
could VB improve
improve DT the
the NN response
response NN rate
rate CC and
and DT the
the NN toxicity

methods NNS methods
methods : :
: CD forty-four
forty-four NNS patients
patients IN with
with JJ limited
limited JJ small
small NN cell
cell NN lung
lung NN cancer
cancer VBD were
were VBN treated
treated IN with
with NN etoposide-ifosfamide-cisplatin
etoposide-ifosfamide-cisplatin CC and
and JJ concurrent
concurrent JJ thoracic
thoracic NN irradiation

conclusion NN conclusion
conclusion : :
: NN vip
vip NN combination
combination NN chemotherapy
chemotherapy CC and
and RB early
early JJ concurrent
concurrent JJ thoracic
thoracic NN irradiation
irradiation IN for
for NNS patients
patients IN with
with JJ limited
limited NN stage
stage JJ small
small NN cell
cell NN lung
lung NN cancer
cancer VBD revealed
revealed JJ excellent
excellent NN antitumor
antitumor NN response
response IN with
with JJ tolerable
tolerable NN toxicity

in IN in
in DT this
this NN study
study PRP we
we VBN analyzed
analyzed CD 33
33 NNS cases
cases WDT which
which VBD underwent
underwent JJ complete
complete JJ surgical
surgical NN resection
resection TO to
to VB assess
assess DT the
the NN role
role IN of
of NN surgery
surgery IN in
in DT the
the NN treatment
treatment IN of
of NNS patients
patients IN with
with NN n
n CD 2
2 NN nsclc

we PRP we
we RB thereby
thereby VB recommend
recommend IN that
that NN surgery
surgery MD should
should RB only
only VB be
be VBN performed
performed IN for
for DT those
those NN n
n CD 2
2 NN nsclc
nsclc NNS patients
patients VBN diagnosed
diagnosed IN as
as NN t
t CD 1
1 CC or
or NN t
t CD 2
2 IN with
with DT a
a NN classification
classification IN of
of NN p1
p1 CC or
or JJR less

inhaled VBN inhaled
inhaled NN corticosteroid
corticosteroid NN therapy
therapy VBZ is
is VBN recommended
recommended IN for
for NNS patients
patients IN with
with JJ persistent
persistent NN disease
disease , ,
, CC and
and JJ careful
careful NN instruction
instruction IN in
in DT the
the NN use
use IN of
of JJ metered-dose
metered-dose NNS inhalers
inhalers VBZ is
is RB particularly
particularly JJ important
important IN for
for DT the
the JJ elderly

background NN background
background : :
: DT the
the NN role
role IN of
of JJ surgical
surgical NN staging
staging IN of
of NNS patients
patients IN with
with JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )
) VBZ continues
continues TO to
to VB evolve

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> DT this
this NN report
report VBZ describes
describes PRP$ our
our NNS findings
findings VBG utilizing
utilizing JJ routine
routine JJ cervical
cervical NN mediastinoscopy
mediastinoscopy IN in
in DT the
the NN evaluation
evaluation IN of
of JJ peripheral
peripheral NN t1
t1 NN (
( JJR <
< CD 3
3 NN cm
cm NN )
) NN lung
lung NNS tumors

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN mediastinoscopy
mediastinoscopy NNS facilitates
facilitates NN identification
identification IN of
of NNS patients
patients IN with
with RB regionally
regionally VBN advanced
advanced NN disease
disease RB prior
prior TO to
to NN resection
resection , ,
, VBG allowing
allowing NN neoadjuvant
neoadjuvant NN therapy
therapy CC and
and VBG avoiding
avoiding JJ unnecessary
unnecessary NNS resections

purpose NN purpose
purpose : :
: VBN given
given DT the
the JJ cisplatin-related
cisplatin-related NN myelotoxicity
myelotoxicity CC and
and JJ nonhematologic
nonhematologic NNS toxicities
toxicities , ,
, PRP we
we VBD were
were VBD prompted
prompted TO to
to VB undertake
undertake DT a
a NN study
study IN of
of DT the
the NN noncisplatin
noncisplatin NN combination
combination IN of
of NN paclitaxel
paclitaxel CC plus
plus NN gemcitabine
gemcitabine TO to
to VB evaluate
evaluate DT the
the NN efficacy
efficacy , ,
, NN tolerance
tolerance , ,
, CC and
and NN survival
survival IN of
of DT this
this NN combination
combination IN in
in NNS patients
patients IN with
with RB locally
locally VBN advanced
advanced CC and
and JJ metastatic
metastatic JJ non-small-cell
non-small-cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )

we PRP we
we VBN evaluated
evaluated DT the
the NN role
role IN of
of JJ systemic
systemic NN chemotherapy
chemotherapy IN for
for NNS patients
patients IN with
with JJ malignant
malignant JJ pleural
pleural NNS effusions
effusions IN from
from NN nsclc

methods NNS methods
methods : :
: PRP we
we VBN analyzed
analyzed CD 34
34 NNS patients
patients WP who
who VBD were
were VBN found
found TO to
to VB have
have JJ malignant
malignant JJ pleural
pleural NNS effusions
effusions IN in
in DT the
the NN course
course IN of
of NN diagnosis
diagnosis IN of
of CD 118
118 NNS patients
patients VBN enrolled
enrolled IN in
in CD three
three JJ consecutive
consecutive JJ clinical
clinical NNS trials
trials IN on
on VBN advanced
advanced NN nsclc
nsclc VBG assessing
assessing NN combination
combination NN chemotherapy
chemotherapy IN of
of NN cisplatin
cisplatin , ,
, NN ifosfamide
ifosfamide , ,
, CC and
and NN irinotecan
irinotecan IN with
with JJ recombinant
recombinant JJ human
human NN granulocyte
granulocyte JJ colony-stimulating
colony-stimulating NN factor
factor NN support

conclusions NNS conclusions
conclusions : :
: DT both
both DT the
the NN response
response NN rate
rate CC and
and NN survival
survival NNS data
data IN in
in DT this
this NN retrospective
retrospective NN study
study VB suggest
suggest DT a
a JJ high
high NN degree
degree IN of
of NN activity
activity IN of
of DT this
this NN combination
combination NN chemotherapy
chemotherapy IN in
in NNS patients
patients IN with
with JJ malignant
malignant JJ pleural
pleural NNS effusions
effusions IN from
from NN nsclc

in IN in
in NN contrast
contrast , ,
, DT the
the NN introduction
introduction CC and
and NN improvement
improvement IN of
of NN chemotherapy
chemotherapy IN since
since DT the
the NNS 1970s
1970s VBD gave
gave NN rise
rise TO to
to DT an
an NN improvement
improvement IN in
in : -
- RB only
only JJ short-term
short-term NN (
( JJR <
< CD 2
2 NNS years
years NN )
) : -
- NN survival
survival IN for
for NNS patients
patients IN with
with NN small-cell
small-cell NN lung
lung NN cancer

between IN between
between NNP july
july CD 1992
1992 CC and
and NNP december
december CD 1997
1997 , ,
, CD 1799
1799 NNS patients
patients VBD were
were VBN diagnosed
diagnosed IN as
as VBG having
having NN lung
lung NN cancer
cancer IN in
in PRP$ our
our NN hospital
hospital CC and
and CD 926
926 NNS patients
patients VBN received
received NN chemotherapy
chemotherapy CC and/or
and/or JJ thoracic
thoracic NN radiotherapy

the DT the
the NN administration
administration IN of
of NN mitomycin
mitomycin NN c
c IN in
in NN addition
addition TO to
to JJ cisplatin-based
cisplatin-based NNS regimens
regimens IN for
for NNS patients
patients IN with
with NN lung
lung NN cancer
cancer MD should
should VB be
be RB carefully
carefully VBN considered

570 CD 570
570 NNS patients
patients IN with
with NN osteosarcoma
osteosarcoma IN of
of DT the
the NNS extremities
extremities VBD were
were VBN treated
treated IN with
with CD five
five JJ different
different NNS protocols
protocols IN of
of NN neoadjuvant
neoadjuvant NN chemotherapy
chemotherapy IN at
at NNS rizzoli
rizzoli NN institute
institute IN between
between CD 1983
1983 CC and
and CD 1995

we PRP we
we VBP conclude
conclude IN that
that IN for
for NNS patients
patients IN with
with NN osteosarcoma
osteosarcoma IN of
of DT the
the NNS extremities
extremities VBN treated
treated IN with
with NN neoadjuvant
neoadjuvant NN chemotherapy
chemotherapy : :
: NN (
( DT a
a NN )
) DT the
the NN pattern
pattern IN of
of JJ systemic
systemic NN relapse
relapse NNS changes
changes VBG according
according TO to
to DT the
the NN efficacy
efficacy IN of
of DT the
the NN protocol
protocol IN of
of NN chemotherapy
chemotherapy VBN used

the DT the
the NN degree
degree IN of
of NN healing
healing CC and
and NN damage
damage IN of
of DT the
the JJ bronchial
bronchial NN wall
wall IN after
after JJ photodynamic
photodynamic NN therapy
therapy , ,
, NN nd-yag
nd-yag NN laser
laser CC and
and NN electrocautery
electrocautery IN for
for JJ intraluminal
intraluminal JJ early-stage
early-stage NN cancer
cancer VB have
have VBN been
been VBN analysed

to TO to
to VB examine
examine IN whether
whether NN efficacy
efficacy IN of
of JJ postoperative
postoperative JJ oral
oral NN administration
administration IN of
of NN uft
uft , ,
, DT a
a NN 5-fluorouracil
5-fluorouracil NN derivative
derivative JJ chemotherapeutic
chemotherapeutic NN agent
agent , ,
, MD may
may VB be
be VBN influenced
influenced IN by
by NN incidence
incidence IN of
of NN apoptosis
apoptosis NN (
( NN apoptosis
apoptosis NN index
index NN )
) CC or
or JJ apoptosis-related
apoptosis-related NN gene
gene NN status
status NN (
( NN p53
p53 CC and
and NN bcl-2
bcl-2 NN )
) IN of
of DT the
the NN tumour
tumour , ,
, DT a
a NN total
total IN of
of CD 162
162 NNS patients
patients IN with
with JJ pathologic
pathologic NN stage
stage LS i
i JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer VBD were
were RB retrospectively
retrospectively VBN reviewed

objectives NNS objectives
objectives : :
: DT the
the NN purpose
purpose IN of
of DT this
this NN study
study VBZ is
is TO to
to NN review
review PRP$ our
our NN experience
experience IN with
with DT the
the NN spectrum
spectrum IN of
of NN neuroendocrine
neuroendocrine NNS neoplasms
neoplasms IN of
of DT the
the NN lung
lung IN with
with NN emphasis
emphasis IN on
on DT the
the JJ histopathologic
histopathologic NN classification
classification CC and
and JJ surgical
surgical NN therapy
therapy IN of
of DT each
each NN class
class IN of
of NN neoplasm

patients NNS patients
patients : :
: IN during
during DT this
this NN period
period , ,
, DT a
a NN total
total IN of
of CD 77
77 NNS patients
patients VBD underwent
underwent NN lung
lung NN resection
resection IN for
for DT the
the VBG following
following NN neuroendocrine
neuroendocrine NNS neoplasms
neoplasms : :
: JJ typical
typical NN carcinoid
carcinoid NN (
( NN tc
tc NN )
) , ,
, CD 50
50 NNS patients
patients : ;
; JJ atypical
atypical NN carcinoid
carcinoid NN (
( NN ac
ac NN )
) , ,
, CD 5
5 NNS patients
patients : ;
; JJ large
large NN cell
cell NN neuroendocrine
neuroendocrine NN carcinoma
carcinoma NN (
( NN lcnec
lcnec NN )
) , ,
, CD 9
9 NNS patients
patients : ;
; JJ mixed
mixed NN large-small
large-small NN cell
cell NN neuroendocrine
neuroendocrine NN carcinoma
carcinoma NN (
( NN lsnec
lsnec NN )
) , ,
, CD 4
4 NNS patients
patients : ;
; CC or
or JJ small
small NN cell
cell NN neuroendocrine
neuroendocrine NN carcinoma
carcinoma NN (
( NN scc
scc NN )
) , ,
, CD 9
9 NNS patients

despite IN despite
despite DT the
the JJ poor
poor RB overall
overall NN prognosis
prognosis IN in
in JJ high-grade
high-grade NN neuroendocrine
neuroendocrine NNS tumors
tumors IN of
of DT the
the NN lung
lung , ,
, NN surgery
surgery NNS remains
remains DT a
a JJ viable
viable NN adjunct
adjunct IN in
in DT the
the RB early
early NNS stages
stages IN of
of DT this
this NN disease

urpose NN urpose
urpose : :
: TO to
to VB assess
assess NNS results
results IN with
with JJ twice-daily
twice-daily JJ high-dose
high-dose NN radiotherapy
radiotherapy NN (
( NN rt
rt NN )
) IN for
for JJ non-small-cell
non-small-cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )

is VBZ is
is JJ prolonged
prolonged NN survival
survival JJ possible
possible IN for
for NNS patients
patients IN with
with JJ supraclavicular
supraclavicular NN node
node NNS metastases
metastases IN in
in NN nsclc
nsclc VBN treated
treated IN with
with NN chemoradiotherapy
chemoradiotherapy . ?
? NN ijrobp
ijrobp CD 1999
1999 : ;
; CD 44
44 NN (
( CD 4
4 NN )
) : :
: CD 847-853

we PRP we
we VBN aimed
aimed TO to
to VB investigate
investigate IN whether
whether JJ biological
biological NNS factors
factors JJ related
related TO to
to NN radiosensitivity
radiosensitivity CC and
and NN chemosensitivity
chemosensitivity VB have
have JJ prognostic
prognostic NN significance
significance IN in
in JJ non-small-cell-lung-cancer
non-small-cell-lung-cancer NN (
( NN nsclc
nsclc NN )
) NNS patients
patients VBN treated
treated IN with
with RB daily
daily JJ low
low NNS doses
doses IN of
of NN cisplatin
cisplatin CC and
and NN radiotherapy

we PRP we
we VBN treated
treated CD 27
27 NN nsclcm
nsclcm NNS patients
patients IN with
with JJ concomitant
concomitant RB daily
daily JJ low-dose
low-dose NN cisplatin
cisplatin CC and
and NN radiotherapy
radiotherapy IN between
between CD 1993
1993 CC and
and CD 1995

background NN background
background : :
: PRP we
we VBN examined
examined DT the
the NNS complications
complications CC and
and NNS outcomes
outcomes IN of
of VBG placing
placing NNS stents
stents IN for
for DT both
both NN esophageal
esophageal CC and
and JJ tracheobronchial
tracheobronchial NNS stenoses

methods NNS methods
methods : :
: PRP we
we VBN placed
placed NNS stents
stents IN for
for DT both
both NN esophageal
esophageal CC and
and JJ tracheobronchial
tracheobronchial NNS stenoses
stenoses IN in
in CD 8
8 NNS patients
patients NN (
( CD 7
7 IN with
with NN esophageal
esophageal NN cancer
cancer CC and
and CD 1
1 IN with
with NN lung
lung NN cancer
cancer NN )

covered VBN covered
covered CC or
or JJ noncovered
noncovered JJ metallic
metallic NNS stents
stents VBD were
were VBN used
used IN for
for DT the
the NN esophageal
esophageal NNS stenoses
stenoses , ,
, IN except
except IN in
in CD 1
1 NN patient
patient VBN treated
treated IN with
with DT a
a NN silicone
silicone NN stent

silicone NN silicone
silicone NNS stents
stents VBD were
were VBN used
used IN for
for DT the
the JJ tracheobronchial
tracheobronchial NNS stenoses

results NNS results
results : :
: DT all
all NNS patients
patients JJ experienced
experienced NN improvement
improvement IN of
of NNS grades
grades IN of
of DT both
both NN dysphagia
dysphagia CC and
and JJ respiratory
respiratory NNS symptoms
symptoms IN after
after NN stent
stent NN therapy

conclusions NNS conclusions
conclusions : :
: IN for
for NNS patients
patients IN with
with DT both
both NN esophageal
esophageal CC and
and JJ tracheobronchial
tracheobronchial NNS stenoses
stenoses , ,
, DT a
a NN stent
stent MD should
should VB be
be VBN introduced
introduced IN into
into DT the
the NN tracheobronchus
tracheobronchus RB first

because IN because
because NN placement
placement IN of
of NNS stents
stents IN in
in DT both
both DT the
the NN esophagus
esophagus CC and
and NN tracheobronchus
tracheobronchus VBZ has
has DT a
a JJ high
high NN risk
risk IN of
of NN enlargement
enlargement IN of
of DT the
the NN fistula
fistula , ,
, DT a
a VBN covered
covered JJ metallic
metallic NN stent
stent VBZ is
is JJ preferable
preferable IN for
for NN esophageal
esophageal NN cancer
cancer VBG involving
involving DT the
the NN tracheobronchus

a DT a
a NN retrospective
retrospective JJ immunohistochemical
immunohistochemical NN study
study VBD was
was VBN performed
performed IN on
on NN material
material IN from
from NNS patients
patients WP who
who VBD were
were RB newly
newly VBN diagnosed
diagnosed IN with
with JJ osteogenic
osteogenic NN sarcoma
sarcoma WP who
who VBD were
were VBN treated
treated VBG according
according TO to
to DT the
the NN t12
t12 NN protocol
protocol IN from
from DT the
the NNS authors
authors '' '
' NN institution
institution IN between
between CD 1986
1986 TO to
to CD 1993

these DT these
these NNS data
data VB suggest
suggest IN that
that NN her2/erbb-2
her2/erbb-2 MD should
should VB be
be VBN evaluated
evaluated RB prospectively
prospectively IN as
as DT a
a JJ prognostic
prognostic NN indicator
indicator CC and
and JJ clinical
clinical NNS trials
trials VBG using
using NNS antibodies
antibodies IN that
that NN target
target DT this
this NN receptor
receptor MD should
should VB be
be VBN considered
considered IN for
for DT the
the NN treatment
treatment IN of
of NNS patients
patients IN with
with JJ osteogenic
osteogenic NN sarcoma

objective NN objective
objective : :
: TO to
to VB examine
examine DT the
the NN effectiveness
effectiveness IN of
of NN ninjin
ninjin NN yoei
yoei TO to
to NN (
( NN nyt
nyt : ;
; NN ren-shen-yang-rong-tang
ren-shen-yang-rong-tang IN in
in JJ chinese
chinese NN medicine
medicine : ;
; NN kotaro
kotaro JJ pharmaceutical
pharmaceutical IN co.
co. , ,
, IN ltd.
ltd. , ,
, NN osaka
osaka , ,
, NN japan
japan NN )
) , ,
, CD one
one IN of
of DT the
the JJ traditional
traditional JJ herbal
herbal NNS medicines
medicines , ,
, IN against
against NN lung
lung NN carcinoma

setting VBG setting
setting : :
: DT the
the NN nursing
nursing NN center
center NNS himawari
himawari NN design
design , ,
, NN patient
patient , ,
, CC and
and NN preparation
preparation : :
: DT the
the JJ regular
regular NN dosage
dosage IN of
of NN nyt
nyt NN (
( CD 15
15 NN g/d
g/d NN )
) VBD was
was VBN prescribed
prescribed IN for
for CD 7
7 NNS weeks
weeks TO to
to CD one
one JJ elderly
elderly NN patient
patient IN with
with NN lung
lung NN carcinoma

conclusion NN conclusion
conclusion : :
: NN nyt
nyt VBZ has
has DT a
a JJ positive
positive NN effect
effect IN on
on NN life
life NN expectancy
expectancy IN for
for NNS patients
patients IN with
with NN malignancy

background NN background
background : :
: DT the
the NNS costs
costs IN of
of JJ videothoracoscopic
videothoracoscopic NNS procedures
procedures IN for
for NNS patients
patients IN with
with NN lung
lung NN carcinoma
carcinoma VBD were
were VBN compared
compared IN with
with DT those
those IN of
of NNS patients
patients WP who
who VBD underwent
underwent JJ open
open NN thoracotomy
thoracotomy IN in
in NN japan

methods NNS methods
methods : :
: DT the
the NN cost
cost IN of
of JJ surgical
surgical NN treatment
treatment IN in
in CD 1997
1997 CC and
and CD 1998
1998 IN for
for NNS patients
patients IN with
with JJ resectable
resectable JJ primary
primary CC or
or JJ metastatic
metastatic NN lung
lung NN carcinoma
carcinoma VBD was
was VBN analyzed
analyzed IN from
from VBN itemized
itemized NNS statements
statements IN of
of NN hospital
hospital NNS charges

for IN for
for NNS patients
patients IN with
with NN lung
lung NN carcinoma
carcinoma WP who
who VBP are
are IN in
in RB relatively
relatively JJ poor
poor NN health
health , ,
, DT the
the NNS authors
authors VBD chose
chose JJ videothoracoscopic
videothoracoscopic NN lobectomy
lobectomy CC or
or JJ partial
partial NN resection
resection IN of
of DT the
the NN lung
lung RB instead
instead IN of
of DT an
an JJ open
open NN thoracotomy

for IN for
for NNS patients
patients IN with
with JJ solitary
solitary JJ pulmonary
pulmonary NN metastasis
metastasis , ,
, DT the
the NNS authors
authors RB routinely
routinely VBN performed
performed JJ thoracoscopic
thoracoscopic JJ partial
partial NN resection
resection IN of
of DT the
the NN lung

background NN background
background : :
: JJ curative
curative NN therapy
therapy VBZ is
is JJ available
available IN for
for NNS patients
patients IN with
with NN stage
stage CD 0
0 NN lung
lung NN carcinoma
carcinoma , ,
, IN with
with DT a
a JJR >
> CD 90
90 NN %
% JJ 5-year
5-year NN survival
survival NN rate

promising VBG promising
promising JJ chemopreventive
chemopreventive NNS agents
agents RB also
also VBP are
are IN under
under NN investigation
investigation RB currently
currently TO to
to VB reduce
reduce DT the
the NN risk
risk IN of
of NN lung
lung NN carcinoma
carcinoma IN in
in JJ high
high NN risk
risk NNS populations

object NN object
object : :
: DT the
the NN purpose
purpose IN of
of DT this
this NN retrospective
retrospective NN study
study VBD was
was TO to
to VB compare
compare DT the
the NN effectiveness
effectiveness IN of
of NN gamma
gamma NN knife
knife NN radiosurgery
radiosurgery NN (
( NNS gks
gks NN )
) IN for
for JJ multiple
multiple JJ cerebral
cerebral NNS metastases
metastases IN with
with IN that
that IN of
of NN whole-brain
whole-brain NN radiation
radiation NN therapy
therapy NN (
( NN wbrt
wbrt NN )

in IN in
in DT the
the NNS gks
gks NN group
group , ,
, JJ large
large NNS lesions
lesions NN (
( JJR >
> CD 30
30 NN mm
mm NN )
) VBD were
were VBN removed
removed RB surgically
surgically CC and
and DT all
all JJ other
other JJ small
small NNS lesions
lesions NN (
( JJR <
< CC or
or JJ =
= CD 30
30 NN mm
mm NN )
) VBD were
were VBN treated
treated IN by
by NNS gks

new JJ new
new JJ distant
distant NNS lesions
lesions VBD were
were VBN treated
treated IN by
by VBN repeated
repeated NNS gks
gks IN without
without NN prophylactic
prophylactic NN wbrt

conclusions NNS conclusions
conclusions : :
: NN gamma
gamma NN knife
knife NN radiosurgery
radiosurgery IN without
without NN prophylactic
prophylactic NN wbrt
wbrt MD could
could VB be
be DT a
a JJ primary
primary NN choice
choice IN of
of NN treatment
treatment IN for
for NNS patients
patients IN with
with IN as
as JJ many
many IN as
as CD 10
10 JJ cerebral
cerebral NNS metastases
metastases IN from
from NN nonsmall
nonsmall NN cell
cell NN cancer

the DT the
the JJ notable
notable NN exception
exception VBZ has
has VBN been
been NN docetaxel
docetaxel , ,
, WDT which
which VBZ has
has VBN been
been RB extensively
extensively VBN studied
studied IN as
as DT a
a NN second-line
second-line NN therapy
therapy IN for
for NN nsclc

object NN object
object : :
: DT the
the NN purpose
purpose IN of
of DT this
this NN retrospective
retrospective NN study
study VBD was
was TO to
to VB compare
compare DT the
the NN effectiveness
effectiveness IN of
of NN gamma
gamma NN knife
knife NN radiosurgery
radiosurgery NN (
( NNS gks
gks NN )
) IN for
for JJ multiple
multiple JJ cerebral
cerebral NNS metastases
metastases IN with
with IN that
that IN of
of NN whole-brain
whole-brain NN radiation
radiation NN therapy
therapy NN (
( NN wbrt
wbrt NN )

patients NNS patients
patients IN with
with DT a
a JJ single
single JJ non-sclc
non-sclc , ,
, NN breast
breast , ,
, NN melanoma
melanoma , ,
, JJ renal
renal NN cell
cell , ,
, CC and
and JJ ovarian
ovarian NN carcinoma
carcinoma NN brain
brain NN metastasis
metastasis VB have
have DT the
the RB best
best NN chance
chance IN for
for JJ long-term
long-term NN survival
survival IN if
if VBN treated
treated IN with
with JJ surgical
surgical NN resection
resection CC and
and NN wbrt

objective NN objective
objective : :
: JJ careful
careful NN patient
patient NN selection
selection VBZ is
is JJ vital
vital WRB when
when JJ video-assisted
video-assisted JJ thoracoscopic
thoracoscopic JJ surgical
surgical NN (
( NNS vats
vats NN )
) JJ therapeutic
therapeutic JJ pulmonary
pulmonary NN metastasectomy
metastasectomy IN of
of JJ colorectal
colorectal NN carcinoma
carcinoma VBZ is
is VBN considered

we PRP we
we VBN reviewed
reviewed PRP$ our
our NNS vats
vats NN experience
experience IN for
for JJ therapeutic
therapeutic NN metastasectomy
metastasectomy IN of
of JJ peripheral
peripheral JJ colorectal
colorectal JJ pulmonary
pulmonary NNS metastases

methods NNS methods
methods : :
: IN over
over CD 90
90 NNS months
months , ,
, JJ therapeutic
therapeutic NNS vats
vats NN metastasectomy
metastasectomy VBD was
was VBN accomplished
accomplished IN upon
upon CD 80
80 NNS patients
patients IN with
with JJ colorectal
colorectal NNS metastases

conclusions NNS conclusions
conclusions : :
: JJ therapeutic
therapeutic NNS vats
vats NN resection
resection IN of
of JJ colorectal
colorectal NNS metastases
metastases VBZ appears
appears JJ efficacious

objectives NNS objectives
objectives : :
: TO to
to NN review
review DT the
the NN spectrum
spectrum IN of
of NN presentation
presentation CC and
and DT the
the JJ surgical
surgical NN management
management IN of
of JJ non
non JJ small
small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )
) CC and
and DT the
the NN role
role IN of
of JJ various
various JJ diagnostic
diagnostic NNS modalities
modalities IN in
in VBG predicting
predicting DT the
the JJ post-operative
post-operative NN stage
stage CC and
and DT the
the NN correlation
correlation IN of
of DT the
the JJ post-operative
post-operative NN stage
stage IN with
with DT the
the NNS chances
chances IN of
of NN recurrence

patients NNS patients
patients IN with
with NN limited-stage
limited-stage NN small-cell
small-cell NN carcinoma
carcinoma IN of
of DT the
the NN lung
lung VBP are
are VBN treated
treated IN with
with NN combined-modality
combined-modality NN therapy
therapy IN with
with DT the
the NN intent
intent TO to
to NN cure

in IN in
in DT the
the IN past
past JJ several
several NNS years
years , ,
, JJ new
new JJ chemotherapeutic
chemotherapeutic NNS agents
agents , ,
, VBG including
including DT the
the NNS taxanes
taxanes CC and
and DT the
the NN topoisomerase
topoisomerase LS i
i NNS inhibitors
inhibitors , ,
, VB have
have VBN demonstrated
demonstrated JJ substantial
substantial NN activity
activity IN against
against NN small-cell
small-cell NN carcinoma

we PRP we
we VBN evaluated
evaluated DT the
the NN role
role IN of
of NN chemotherapy
chemotherapy IN for
for NNS patients
patients IN with
with NN brain
brain NNS metastases
metastases IN from
from NN nsclc

methods NNS methods
methods : :
: PRP we
we VBN analyzed
analyzed CD 30
30 NNS patients
patients WP who
who VBD were
were VBN discovered
discovered TO to
to VB have
have NN brain
brain NNS metastases
metastases IN during
during DT the
the NN diagnosis
diagnosis IN of
of CD 121
121 NNS patients
patients VBN enrolled
enrolled IN in
in CD three
three JJ consecutive
consecutive JJ clinical
clinical NNS trials
trials IN on
on VBN advanced
advanced NN nsclc
nsclc VBG assessing
assessing NN combination
combination NN chemotherapy
chemotherapy IN of
of NN cisplatin
cisplatin , ,
, NN ifosfamide
ifosfamide CC and
and NN irinotecan
irinotecan IN with
with NN rhg-csf
rhg-csf NN support

conclusions NNS conclusions
conclusions : :
: DT both
both DT the
the NN response
response NN rate
rate CC and
and NN survival
survival NNS data
data IN in
in DT this
this NN retrospective
retrospective NN study
study VB suggest
suggest DT a
a JJ high
high NN degree
degree IN of
of NN activity
activity IN of
of DT this
this NN combination
combination NN chemotherapy
chemotherapy IN in
in NNS patients
patients IN with
with NN brain
brain NNS metastases
metastases IN from
from NN nsclc

the DT the
the NN aim
aim IN of
of DT this
this NN study
study VBD was
was DT the
the NN evaluation
evaluation IN of
of DT both
both DT the
the NN antitumour
antitumour NN activity
activity CC and
and NN toxicity
toxicity IN of
of DT an
an JJ immunochemotherapeutic
immunochemotherapeutic NNS regimen
regimen VBG consisting
consisting IN of
of NN interferon-alpha2b
interferon-alpha2b CC and
and NN interleukin-2
interleukin-2 IN in
in NN combination
combination IN with
with NN fotemustine
fotemustine IN for
for NNS patients
patients IN with
with JJ metastatic
metastatic NN melanoma

to TO to
to VB explore
explore DT the
the NN induction
induction IN of
of NN chemotherapy
chemotherapy NN (
( NN ct
ct NN )
) NN dna
dna NN damage
damage CC and
and PRP$ its
its NN correlation
correlation IN with
with NN tumor
tumor NN response
response CC and
and NN patient
patient NN survival
survival , ,
, PRP we
we VBD undertook
undertook DT the
the JJ present
present NN study
study IN in
in CD 20
20 JJ small
small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN sclc
sclc NN )
) NNS patients

in IN in
in NNS patients
patients IN with
with JJ metastatic
metastatic JJ colorectal
colorectal NN cancer
cancer , ,
, JJ intravenous
intravenous NN oxaliplatin
oxaliplatin VBZ has
has VBN been
been VBN trialled
trialled IN as
as DT a
a NN monotherapy
monotherapy CC and
and IN in
in NN combination
combination IN with
with JJ other
other NNS agents

neoadjuvant NN neoadjuvant
neoadjuvant NN therapy
therapy IN with
with JJ oxaliplatin/fluorouracil/folinic
oxaliplatin/fluorouracil/folinic NN acid
acid VBZ has
has VBN proven
proven JJ beneficial
beneficial IN in
in VBG enabling
enabling JJ surgical
surgical NN removal
removal IN of
of RB previously
previously JJ unresectable
unresectable NN liver
liver NNS metastases

in IN in
in CD 2
2 NNS studies
studies , ,
, NN surgery
surgery IN with
with JJ curative
curative NN intent
intent VBD was
was VBN performed
performed IN in
in CD 16
16 CC and
and CD 51
51 NN %
% IN of
of NNS patients
patients IN with
with RB initially
initially JJ unresectable
unresectable NN liver
liver NNS metastases
metastases VBG following
following JJ oxaliplatin/fluorouracil/folinic
oxaliplatin/fluorouracil/folinic NN acid
acid NN therapy
therapy : ;
; DT the
the JJ 5-year
5-year NN survival
survival NNS rates
rates VBD were
were CD 40
40 CC and
and CD 50
50 NN %
% , ,
, RB respectively

in IN in
in NNS patients
patients IN with
with VBN advanced
advanced JJ ovarian
ovarian NN cancer
cancer , ,
, NN first-line
first-line NN therapy
therapy IN with
with NN oxaliplatin/cyclophosphamide
oxaliplatin/cyclophosphamide VBN achieved
achieved DT an
an NN objective
objective NN response
response NN rate
rate WDT which
which VBD did
did RB not
not VB differ
differ RB significantly
significantly IN from
from IN that
that IN of
of NN cisplatin/cyclophosphamide
cisplatin/cyclophosphamide NN (
( CD 33
33 CC vs
vs CD 42
42 NN %
% NN )

in IN in
in NN addition
addition , ,
, NN oxaliplatin
oxaliplatin VBZ has
has VBN shown
shown NN efficacy
efficacy IN in
in NNS patients
patients IN with
with JJ platinum-pretreated
platinum-pretreated JJ ovarian
ovarian NN cancer
cancer CC and
and VBN achieved
achieved NN objective
objective NN response
response NNS rates
rates JJ similar
similar TO to
to NN paclitaxel
paclitaxel IN in
in DT this
this VBG setting
setting NN (
( CD 16
16 CC vs
vs CD 17
17 NN %
% NN )

promising VBG promising
promising NNS results
results VB have
have RB also
also VBN been
been VBN found
found IN with
with NN oxaliplatin
oxaliplatin IN in
in NNS patients
patients IN with
with JJ non-hodgkin
non-hodgkin POS 's
's NN lymphoma
lymphoma , ,
, NN breast
breast NN cancer
cancer , ,
, NN mesothelioma
mesothelioma CC and
and JJ non-small
non-small NN cell
cell NN lung
lung NN cancer

conclusion NN conclusion
conclusion : :
: NN oxaliplatin
oxaliplatin IN in
in NN combination
combination IN with
with JJ fluorouracil/folinic
fluorouracil/folinic NN acid
acid VBZ is
is DT an
an JJ effective
effective NN treatment
treatment NN option
option IN for
for NNS patients
patients IN with
with JJ metastatic
metastatic JJ colorectal
colorectal NN cancer
cancer , ,
, DT both
both IN as
as DT a
a NN first-line
first-line NN therapy
therapy CC and
and IN in
in NNS patients
patients JJ refractory
refractory TO to
to JJ previous
previous NN chemotherapy

additional JJ additional
additional JJ clinical
clinical NN investigation
investigation IN of
of NN oxaliplatin
oxaliplatin IN in
in NNS patients
patients IN with
with JJ other
other NNS cancers
cancers VBZ is
is VBN warranted
warranted VBN given
given DT the
the VBG promising
promising NNS results
results VBN achieved
achieved IN in
in RB early
early NNS trials
trials , ,
, RBS most
most RB notably
notably IN in
in NNS patients
patients IN with
with JJ platinum-pretreated
platinum-pretreated JJ ovarian
ovarian NN cancer

combined VBN combined
combined NN modality
modality NN treatment
treatment VBZ has
has NN 'come
'come IN out
out IN of
of NN age
age '' '
' CC and
and RB increasingly
increasingly VBZ represents
represents NN standard
standard IN of
of NN care
care IN for
for DT a
a RB rapidly
rapidly VBG growing
growing NN number
number IN of
of NNS patients
patients IN in
in RB locally
locally VBN advanced
advanced NNS stages
stages IN of
of NN nsclc

the DT the
the JJ current
current NN study
study VBD was
was VBN designed
designed TO to
to VB assess
assess DT the
the JJ prognostic
prognostic NN value
value IN of
of JJ immunomorphologic
immunomorphologic NNS changes
changes IN in
in JJ locoregional
locoregional NN lymph
lymph NNS nodes
nodes CC and
and JJ lymphocytic
lymphocytic NN infiltration
infiltration IN of
of JJ primary
primary NN tumor
tumor NN (
( NN li
li NN )
) IN in
in NNS patients
patients WP who
who VB undergo
undergo NN resection
resection IN for
for JJ bronchogenic
bronchogenic NN carcinoma

conclusions NNS conclusions
conclusions : :
: NN lymph
lymph NN node
node NN immunoreactivity
immunoreactivity CC and
and NN li
li RB significantly
significantly NN influence
influence RB long
long NN term
term NN survival
survival IN after
after JJ curative
curative NN surgery
surgery IN for
for NNS patients
patients IN with
with NN carcinoma
carcinoma IN of
of DT the
the NN lung
lung CC and
and MD may
may VB be
be JJ useful
useful IN in
in VBG stratifying
stratifying NNS patients
patients IN for
for JJ prospective
prospective NNS trials
trials IN of
of JJ adjuvant
adjuvant NN treatment
treatment , ,
, VBG including
including NN immunotherapy

the DT the
the NN drug
drug VBZ is
is RB currently
currently IN in
in NN phase
phase LS iii
iii JJ clinical
clinical NNS trials
trials IN for
for NNS patients
patients IN with
with JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer IN in
in NN combination
combination IN with
with NN paclitaxel
paclitaxel CC and
and NN carboplatin
carboplatin , ,
, IN as
as RB well
well IN as
as IN in
in VBN advanced
advanced NN hormone
hormone JJ refractory
refractory NN prostate
prostate NN cancer
cancer IN in
in NN combination
combination IN with
with NN mitoxantrone

standard NN standard
standard NN treatment
treatment IN of
of NN sclc
sclc VBZ consists
consists IN of
of JJ platinum-based
platinum-based NN combination
combination NN chemotherapy
chemotherapy , ,
, IN with
with JJ thoracic
thoracic NN irradiation
irradiation VBN added
added IN for
for NNS patients
patients IN with
with NN limited-stage
limited-stage NN disease

several JJ several
several JJR newer
newer JJ chemotherapeutic
chemotherapeutic NNS drugs
drugs VB have
have RB recently
recently VBN been
been VBN shown
shown TO to
to VB have
have JJ significant
significant NN activity
activity IN in
in NNS patients
patients IN with
with JJ untreated
untreated CC or
or VBD relapsed
relapsed NN sclc

we PRP we
we RB recently
recently VBN performed
performed NN completion
completion NN pneumonectomy
pneumonectomy IN of
of DT the
the RB left
left NN lung
lung IN in
in DT a
a JJ 70-year-old
70-year-old NN man
man IN with
with NN hemophilia
hemophilia DT a
a , ,
, IN for
for JJ squamous
squamous NN cell
cell NN carcinoma
carcinoma IN in
in DT the
the JJ residual
residual RB left
left NN lung

objective NN objective
objective : :
: JJ several
several NNS reports
reports VB emphasize
emphasize DT the
the NN importance
importance IN of
of NN en-bloc
en-bloc NN resection
resection IN as
as DT the
the JJ optimal
optimal JJ surgical
surgical NN treatment
treatment IN of
of NN lung
lung NN cancer
cancer IN with
with NN chest
chest NN wall
wall NN invasion

methods NNS methods
methods : :
: IN between
between CD 1981
1981 CC and
and CD 1998
1998 , ,
, CD 100
100 NNS patients
patients NN (
( CD 90
90 NN male
male : ;
; CD ten
ten NN female
female NN )
) , ,
, IN with
with DT a
a NN median
median NN age
age IN of
of CD 60
60 NNS years
years NN (
( NN 36-84
36-84 NN )
) , ,
, VBD underwent
underwent NN radical
radical NN en-bloc
en-bloc NN resection
resection IN of
of JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )
) IN with
with NN chest
chest NN wall
wall NN involvement

over IN over
over DT the
the IN past
past CD 17
17 NNS years
years NN (
( CD 1981
1981 TO to
to CD 1997
1997 NN )
) , ,
, CD 29
29 NNS patients
patients VBD underwent
underwent JJ complete
complete JJ pulmonary
pulmonary NN resection
resection IN for
for JJ primary
primary NN lung
lung NN cancer
cancer VBN accompanied
accompanied IN by
by NN satellite
satellite NNS nodules
nodules IN in
in DT the
the JJ same
same NN lobe
lobe IN as
as DT the
the JJ primary

of IN of
of CD 1
1 , ,
, CD 042
042 NNS patients
patients IN with
with JJ primary
primary NN lung
lung NN cancer
cancer WP who
who VBD underwent
underwent NN resection
resection IN from
from CD 1982
1982 TO to
to CD 1995
1995 , ,
, CD 549
549 NNS patients
patients IN with
with NN adenocarcinoma
adenocarcinoma NN (
( NN ad
ad NN )
) CC and
and CD 363
363 IN with
with JJ squamous
squamous NN cell
cell NN carcinoma
carcinoma NN (
( NN sq
sq NN )
) VBD were
were VBN included
included IN in
in DT this
this NN study

for IN for
for JJ small
small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN sclc
sclc NN )
) , ,
, WDT which
which NNS accounts
accounts IN for
for RB approximately
approximately CD 20
20 NN %
% IN of
of NNS cases
cases IN of
of NN lung
lung NN cancer
cancer , ,
, DT the
the JJ primary
primary NN treatment
treatment VBZ is
is NN chemotherapy
chemotherapy CC and
and IN in
in DT the
the NN majority
majority IN of
of NNS cases
cases DT the
the JJ primary
primary NN aim
aim VBZ is
is TO to
to NN control
control DT the
the NN disease
disease WDT which
which RB generally
generally MD would
would VB have
have NN spread
spread IN beyond
beyond DT the
the NNS lungs
lungs IN at
at DT the
the NN time
time IN of
of NN presentation

a DT a
a VBG growing
growing NN body
body IN of
of NN evidence
evidence VBZ suggests
suggests IN that
that JJ postoperative
postoperative NN irradiation
irradiation IN for
for JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer MD may
may NN cause
cause JJ life-threatening
life-threatening NN toxicity
toxicity CC and
and , ,
, WRB when
when DT the
the NN risk
risk IN of
of JJ local-regional
local-regional NN recurrence
recurrence VBZ is
is JJ low
low , ,
, DT the
the NN toxicity
toxicity IN of
of NN irradiation
irradiation MD may
may VB outweight
outweight DT the
the NN benefit

as IN as
as DT a
a JJ best-case
best-case NN scenario
scenario , ,
, JJ postoperative
postoperative NN irradiation
irradiation MD may
may VB improve
improve DT the
the NN chance
chance IN for
for JJ long-term
long-term NN survival
survival IN in
in NNS patients
patients IN with
with NN n2
n2 NNS tumors

for IN for
for NNS patients
patients IN with
with NN stage
stage LS i
i CC or
or LS ii
ii JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN nsclc
nsclc NN )
) , ,
, JJ surgical
surgical NN resection
resection VBZ is
is VBN considered
considered DT the
the NN standard
standard IN of
of NN care

efforts NNS efforts
efforts IN at
at VBG improving
improving NN survival
survival IN for
for JJ early-stage
early-stage NN nsclc
nsclc NNS patients
patients VB have
have VBN focused
focused IN on
on DT the
the NN use
use IN of
of NN chemotherapy
chemotherapy VBN administered
administered RB postoperatively
postoperatively NN (
( JJ adjuvant
adjuvant NN )
) CC or
or RB preoperatively
preoperatively NN (
( NN neoadjuvant
neoadjuvant CC or
or NN induction
induction NN )
) TO to
to VB eradicate
eradicate JJ micrometastatic
micrometastatic NN disease

chemotherapy NN chemotherapy
chemotherapy VBN administered
administered IN before
before NN surgery
surgery CC or
or JJ definitive
definitive NN irradiation
irradiation VBZ has
has VBN improved
improved NN survival
survival NNS rates
rates IN in
in NNS patients
patients IN with
with NN stage
stage LS iii
iii NN nsclc

patients NNS patients
patients : :
: NNS patients
patients IN with
with DT a
a JJ single
single NN (
( NN n
n JJ =
= CD 2
2 , ,
, CD 764
764 NN )
) CC and
and JJ synchronous
synchronous NN nsclc
nsclc NN (
( NN n
n JJ =
= CD 85
85 NN )
) WP who
who VBD underwent
underwent JJ pulmonary
pulmonary NN resection

background NN background
background : :
: NN prophylactic
prophylactic JJ cranial
cranial NN irradiation
irradiation NNS halves
halves DT the
the NN rate
rate IN of
of NN brain
brain NNS metastases
metastases IN in
in NNS patients
patients IN with
with JJ small
small NN cell
cell NN lung
lung NN cancer

objectives NNS objectives
objectives : :
: DT this
this NN study
study NNS aims
aims TO to
to NN test
test IN whether
whether NN prophylactic
prophylactic JJ cranial
cranial NN irradiation
irradiation VBZ prolongs
prolongs NN survival
survival IN of
of NNS patients
patients IN with
with JJ small
small NN cell
cell NN lung
lung NN cancer
cancer IN in
in JJ complete
complete NN remission

reviewer NN reviewer
reviewer POS 's
's NNS conclusions
conclusions : :
: NN prophylactic
prophylactic JJ cranial
cranial NN irradiation
irradiation RB significantly
significantly VBZ improves
improves NN survival
survival CC and
and JJ disease-free
disease-free NN survival
survival IN for
for NNS patients
patients IN with
with JJ small
small NN cell
cell NN lung
lung NN cancer
cancer IN in
in JJ complete
complete NN remission

methods NNS methods
methods : :
: JJ non-small
non-small NN cell
cell NN lung
lung NN cancer
cancer NNS cells
cells VBD were
were VBN treated
treated IN with
with NN gemcitabine
gemcitabine , ,
, VBN harvested
harvested , ,
, CC and
and JJ nuclear
nuclear NNS extracts
extracts VBN analyzed
analyzed IN for
for JJ nf-kappab
nf-kappab NN dna
dna NN binding
binding IN by
by JJ electrophoretic
electrophoretic NN mobility
mobility NN shift
shift NNS assays

novel JJ novel
novel NN treatment
treatment NNS strategies
strategies IN for
for NNS patients
patients IN with
with VBN advanced
advanced NN nsclc
nsclc MD may
may VB involve
involve NN chemotherapy
chemotherapy VBN combined
combined IN with
with NN inhibition
inhibition IN of
of JJ nf-kappab-dependent
nf-kappab-dependent JJ cell-survival
cell-survival NNS pathways

combination NN combination
combination NN chemotherapy
chemotherapy VBZ is
is DT the
the NN cornerstone
cornerstone IN of
of NN treatment
treatment IN that
that VBZ confers
confers DT a
a JJ meaningful
meaningful NN survival
survival NN benefit
benefit IN for
for NNS patients
patients IN with
with NN small-cell
small-cell NN lung
lung NN cancer

in IN in
in JJ single-agent
single-agent NN phase
phase LS ii
ii NNS studies
studies , ,
, NN irinotecan
irinotecan VBD yielded
yielded NN response
response NNS rates
rates IN between
between CD 16
16 NN %
% CC and
and CD 47
47 NN %
% IN in
in NNS patients
patients IN with
with RB previously
previously VBN treated
treated NN small-cell
small-cell NN lung
lung NN cancer

a DT a
a NN phase
phase LS ii
ii NN study
study IN of
of NN irinotecan
irinotecan IN in
in NN combination
combination IN with
with NN cisplatin
cisplatin NN (
( NN platinol
platinol NN )
) VBD resulted
resulted IN in
in DT a
a NN response
response NN rate
rate IN of
of CD 86
86 NN %
% CC and
and DT a
a NN median
median NN survival
survival IN of
of CD 13.0
13.0 NNS months
months IN in
in NNS patients
patients IN with
with NN extensive-disease
extensive-disease NN small-cell
small-cell NN lung
lung NN cancer

based VBN based
based IN on
on DT these
these NNS results
results , ,
, DT the
the NN irinotecan
irinotecan CC and
and NN cisplatin
cisplatin NN combination
combination VBZ is
is DT a
a JJ new
new NN standard
standard NNS regimen
regimen IN in
in DT the
the NN treatment
treatment IN of
of NN extensive-disease
extensive-disease NN small-cell
small-cell NN lung
lung NN cancer

background NN background
background : :
: DT both
both NN gemcitabine
gemcitabine CC and
and NN etoposide
etoposide VBP are
are JJ active
active IN in
in DT the
the NN treatment
treatment IN of
of NN small-cell
small-cell NN lung
lung NN cancer
cancer NN (
( NN sclc
sclc NN )
) , ,
, CC and
and VBP are
are VBN characterised
characterised IN by
by JJ mild
mild NN toxicity
toxicity NNS profiles

patients NNS patients
patients CC and
and NNS methods
methods : :
: CD forty-two
forty-two JJ chemo-naive
chemo-naive JJ extensive
extensive NN disease
disease NN sclc
sclc NNS patients
patients VBD were
were VBN enrolled
enrolled TO to
to VB receive
receive NN gemcitabine
gemcitabine CD 1000
1000 NN mg/m2
mg/m2 , ,
, NNS days
days CD 1
1 , ,
, CD 8
8 CC and
and CD 15
15 , ,
, CC and
and NN etoposide
etoposide CD 80
80 NN mg/m2
mg/m2 , ,
, NNS days
days CD 8
8 , ,
, CD 9
9 CC and
and CD 10
10 IN of
of DT a
a JJ 28-day
28-day NN cycle

background NN background
background : :
: TO to
to VB find
find DT the
the NN maximum
maximum VBN tolerated
tolerated NN dose
dose IN for
for NN ifosfamide
ifosfamide IN in
in NN combination
combination IN with
with NN paclitaxel
paclitaxel CC and
and NN carboplatin
carboplatin IN in
in NN small-cell
small-cell NN lung
lung NN cancer
cancer NNS patients
patients NN (
( NN sclc
sclc NN )
) , ,
, WP who
who VBP are
are JJ resistant
resistant TO to
to NN cyclophosphamide
cyclophosphamide , ,
, NN doxorubicin
doxorubicin CC and
and NN etoposide
etoposide NN (
( NN cde
cde NN )

conclusions NNS conclusions
conclusions : :
: DT the
the NN maximum
maximum VBN tolerated
tolerated NN dose
dose IN of
of DT this
this NN combination
combination IN for
for NNS patients
patients IN with
with JJ resistant
resistant NN sclc
sclc VBZ is
is NN ifosfamide
ifosfamide CD 2000
2000 NN mg/m2
mg/m2 IN in
in NN combination
combination IN with
with NN paclitaxel
paclitaxel CD 175
175 NN mg/m2
mg/m2 CC and
and NN carboplatin
carboplatin NN auc
auc CD 6
6 NN mg/ml
mg/ml NN min
min VBN administered
administered IN on
on DT the
the RB first
first NN day
day IN of
of DT a
a JJ 21-day
21-day NN cycle

many JJ many
many JJ endobronchial
endobronchial NN treatment
treatment NNS modalities
modalities VBP are
are JJ available
available TO to
to NN supplement
supplement JJ traditional
traditional NNS therapies
therapies IN for
for VBN advanced
advanced NN lung
lung NN cancer

methods NNS methods
methods : :
: DT the
the NN author
author NNS reviews
reviews DT the
the NN use
use IN of
of JJ several
several JJ endobronchial
endobronchial NN treatment
treatment NNS modalities
modalities IN that
that MD can
can VBP augment
augment NN standard
standard NN antitumor
antitumor NNS therapies
therapies IN for
for VBN advanced
advanced NN lung
lung NN cancer
cancer , ,
, VBG including
including JJ rigid
rigid CC and
and JJ flexible
flexible NN bronchoscopy
bronchoscopy , ,
, NN laser
laser NN therapy
therapy , ,
, JJ endobronchial
endobronchial NN prosthesis
prosthesis , ,
, CC and
and JJ photodynamic
photodynamic NN therapy

conclusions NNS conclusions
conclusions : :
: JJ endobronchial
endobronchial NNS interventions
interventions VBP are
are JJ important
important NNS adjuncts
adjuncts IN in
in DT the
the NN multimodality
multimodality NN management
management IN of
of NN lung
lung NN cancer
cancer CC and
and MD should
should VB become
become NN standard
standard NNS considerations
considerations IN in
in DT the
the NN management
management IN of
of NNS patients
patients IN with
with VBN advanced
advanced NN lung
lung NN cancer

standard NN standard
standard NNS operations
operations IN for
for NN lung
lung NN cancer
cancer NNS patients
patients VBP are
are RB generally
generally VBN accepted
accepted IN as
as VBG performing
performing NN lobectomy
lobectomy CC or
or NN pneumonectomy
pneumonectomy IN on
on DT the
the NN tumor
tumor VBG baring
baring NN lung
lung CC and
and JJ ipsilateral
ipsilateral JJ hilar
hilar CC and
and JJ mediastinal
mediastinal NN lymphadenectomy
lymphadenectomy VBG including
including JJ subcarinal
subcarinal NN lymph
lymph NNS nodes

small JJ small
small NN cell
cell NN lung
lung NN cancer
cancer VBZ is
is DT a
a RB frequently
frequently VBG relapsing
relapsing NN tumor
tumor IN despite
despite DT a
a JJ high
high NN rate
rate IN of
of NN response
response IN after
after NN first-line
first-line NN chemotherapy

for IN for
for JJ symptomatic
symptomatic NNS metastases
metastases IN in
in NN bone
bone CC or
or NN brain
brain , ,
, NN radiotherapy
radiotherapy RB usually
usually VBZ gives
gives JJ temporary
temporary NN palliation

for IN for
for JJ intrathoracic
intrathoracic NN relapse
relapse CC and
and JJ severe
severe NN obstruction
obstruction IN of
of JJ main
main NNS bronchus
bronchus CC and/or
and/or JJ superior
superior NN caval
caval NN vein
vein , ,
, NN radiotherapy
radiotherapy VBZ is
is DT a
a NN possibility
possibility IN if
if RB not
not VBN given
given IN as
as NN part
part IN of
of NN first-line
first-line NN treatment

tumor NN tumor
tumor NNS vaccines
vaccines IN against
against NNS gangliosides
gangliosides IN that
that VBP are
are VBN expressed
expressed IN on
on RB almost
almost DT all
all JJ human
human NN sclc
sclc NNS cells
cells VB have
have VBN been
been RB recently
recently VBN developed

an DT an
an JJ anti-idiotypic
anti-idiotypic JJ monoclonal
monoclonal NN antibody
antibody IN against
against DT the
the NN gd3
gd3 NN ganglioside
ganglioside , ,
, NN bec-2
bec-2 , ,
, VBZ is
is VBG being
being VBN evaluated
evaluated IN after
after NN chemotherapy
chemotherapy IN in
in NN sclc
sclc NNS patients
patients IN in
in DT a
a NN european
european NN study

the DT the
the NN matrix
matrix NN metalloproteinase
metalloproteinase NNS inhibitors
inhibitors NN marimastat
marimastat CC and
and NN bms-275291
bms-275291 VBP are
are IN under
under NN evaluation
evaluation IN in
in NN sclc

we PRP we
we VBN attempted
attempted DT a
a JJ new
new NNS regimen
regimen IN of
of JJ intermittent
intermittent NN administration
administration IN of
of NN 5-fu
5-fu CC and
and JJ low-dose
low-dose NN isovorin
isovorin NN (
( NNS f.i
f.i NN )
) TO to
to CD four
four NNS patients
patients IN with
with VBN advanced
advanced CC and
and JJ recurrent
recurrent NN colon
colon NN cancer

purpose/objectives NNS purpose/objectives
purpose/objectives : :
: TO to
to VBP describe
describe DT the
the NN relationship
relationship IN between
between NN fatigue
fatigue CC and
and JJ nutritional
nutritional NN status
status IN in
in NNS patients
patients VBG receiving
receiving NN radiation
radiation NN therapy
therapy IN for
for NN lung
lung NN cancer

sample NN sample
sample : :
: CD 45
45 NNS adults
adults IN with
with JJ primary
primary NN cancer
cancer IN of
of DT the
the NN lung
lung VBG receiving
receiving JJR <
< NN outpatient
outpatient JJ primary
primary CC or
or JJ adjuvant
adjuvant NN radiation
radiation NN therapy

we PRP we
we JJ present
present DT the
the NN case
case IN of
of DT a
a NN patient
patient IN with
with JJ metastatic
metastatic JJ transitional
transitional NN cell
cell NN carcinoma
carcinoma IN of
of DT the
the NN bladder
bladder CC and
and JJ renal
renal NN failure
failure WP who
who VBD underwent
underwent JJ successful
successful JJ systemic
systemic NN chemotherapy
chemotherapy IN with
with NN paclitaxel
paclitaxel CC and
and NN carboplatin

background NN background
background : :
: DT the
the NN objective
objective IN of
of DT this
this NN phase
phase LS ii
ii NN study
study VBD was
was TO to
to VB evaluate
evaluate DT the
the NN concept
concept IN of
of JJ sequential
sequential NN chemotherapy
chemotherapy IN in
in DT the
the NN treatment
treatment IN of
of NNS patients
patients IN with
with VBN advanced
advanced NN nonsmall
nonsmall NN cell
cell NN lung
lung NN carcinoma
carcinoma NN (
( NN nsclc
nsclc NN )
) IN by
by DT the
the NN administration
administration IN of
of NN carboplatin
carboplatin CC plus
plus NN gemcitabine
gemcitabine VBN followed
followed IN by
by IN of
of NN paclitaxel

conclusions NNS conclusions
conclusions : :
: DT this
this NN study
study VBZ is
is DT the
the RB first
first TO to
to VB evaluate
evaluate VBN planned
planned JJ sequential
sequential NN chemotherapy
chemotherapy IN in
in NNS patients
patients IN with
with NN nsclc

patients NNS patients
patients WP who
who NN benefit
benefit IN from
from DT a
a JJ surgical
surgical NN resection
resection IN for
for JJ non-small-cell
non-small-cell NN lung
lung NN cancer
cancer IN with
with NN aneuploid
aneuploid NN dna
dna NN content
content VB prove
prove TO to
to VB have
have DT a
a JJR higher
higher NN risk
risk IN of
of NN death

purpose NN purpose
purpose : :
: DT this
this VBN randomized
randomized NN trial
trial VBD was
was VBN designed
designed TO to
to VB determine
determine IN whether
whether NN paclitaxel
paclitaxel CC plus
plus NN carboplatin
carboplatin NN (
( NN pc
pc NN )
) VBN offered
offered DT a
a NN survival
survival NN advantage
advantage IN over
over NN vinorelbine
vinorelbine CC plus
plus NN cisplatin
cisplatin NN (
( NN vc
vc NN )
) IN for
for NNS patients
patients IN with
with VBN advanced
advanced JJ non
non : --
-- NN small-cell
small-cell NN lung
lung NN cancer

conclusion NN conclusion
conclusion : :
: NN pc
pc VBZ is
is RB equally
equally JJ efficacious
efficacious IN as
as NN vc
vc IN for
for DT the
the NN treatment
treatment IN of
of VBN advanced
advanced JJ non
non : --
-- NN small-cell
small-cell NN lung
lung NN cancer

purpose NN purpose
purpose : :
: DT a
a JJ prospective
prospective VBN randomized
randomized NN trial
trial IN in
in NN small-cell
small-cell NN lung
lung NN cancer
cancer NN (
( NN sclc
sclc NN )
) VBD was
was VBN performed
performed TO to
to VB determine
determine IN if
if NN intensification
intensification IN of
of DT the
the NN platinum
platinum NN dose
dose IN by
by VBG giving
giving NN cisplatin
cisplatin CC and
and NN carboplatin
carboplatin IN in
in NN combination
combination TO to
to NNS patients
patients IN with
with NN sclc
sclc NNS yields
yields JJR higher
higher NN response
response NNS rates
rates CC and
and NN survival
survival , ,
, IN than
than NN carboplatin
carboplatin RB alone
alone IN in
in DT a
a NN combination
combination NN chemotherapy
chemotherapy NNS regimen

conclusions NNS conclusions
conclusions : :
: DT the
the NN intensification
intensification IN of
of NN platinum
platinum NN dose
dose NN (
( NN cisplatin
cisplatin CC plus
plus NN carboplatin
carboplatin NN )
) IN in
in NN combination
combination NN chemotherapy
chemotherapy RB significantly
significantly VBN increased
increased DT the
the JJ complete
complete NN response
response NN rate
rate , ,
, RB overall
overall NN survival
survival CC and
and NN number
number IN of
of JJ two-year
two-year NNS survivors
survivors IN among
among NN sclc
sclc NNS patients
patients IN with
with JJ limited
limited NN disease
disease VBN compared
compared TO to
to NN combination
combination NN therapy
therapy IN with
with NN carboplatin
carboplatin RB alone
alone , ,
, VBG suggesting
suggesting IN that
that DT a
a RBR more
more JJ aggressive
aggressive NN treatment
treatment TO to
to DT this
this NN category
category IN of
of NNS patients
patients VBZ is
is JJ worthwhile
worthwhile , ,
, IN while
while DT no
no NN difference
difference IN in
in NN treatment
treatment NN outcome
outcome VBD was
was VBN observed
observed IN for
for NNS patients
patients IN with
with JJ extensive
extensive NN disease

the DT the
the NN aim
aim IN of
of DT this
this NN study
study VBD was
was TO to
to VB investigate
investigate DT the
the NNS relationships
relationships IN among
among NN technetium-99m
technetium-99m NN tetrofosmin
tetrofosmin NN (
( NN tc-tf
tc-tf NN )
) NN accumulation
accumulation IN in
in JJ untreated
untreated JJ small
small NN cell
cell NN lung
lung NN cancer
cancer NN (
( NN sclc
sclc NN )
) , ,
, DT the
the NN expression
expression IN of
of NN p-glycoprotein
p-glycoprotein NN (
( NN pgp
pgp NN )
) CC and
and JJ multidrug
multidrug NN resistance
resistance JJ related
related NN protein-1
protein-1 NN (
( NN mrp1
mrp1 NN )
) , ,
, CC and
and DT the
the NN response
response TO to
to NN chemotherapy
chemotherapy IN in
in NNS patients
patients IN with
with JJ untreated
untreated NN sclc

tc-tf NN tc-tf
tc-tf NN chest
chest NN scintigraphy
scintigraphy VBD correlated
correlated RB well
well IN with
with NN pgp
pgp CC or
or NN mrp1
mrp1 NN expression
expression CC and
and RB accurately
accurately VBN predicted
predicted DT the
the NN response
response TO to
to NN chemotherapy
chemotherapy IN in
in NNS patients
patients IN with
with NN sclc

exploratory NN exploratory
exploratory NNS interventions
interventions , ,
, JJ partial
partial NN tumor
tumor NNS resections
resections CC and
and NN lung
lung NNS resections
resections IN for
for NN metastasis
metastasis VBD were
were RBR more
more RB frequently
frequently VBN performed
performed IN in
in JJ young
young NNS patients
patients IN than
than IN in
in JJR older
older NNS patients

in IN in
in DT the
the JJ present
present NN report
report , ,
, PRP we
we VBN reviewed
reviewed NNS articles
articles IN on
on JJ pulmonary
pulmonary NN angiography
angiography IN for
for NNS patients
patients IN with
with JJ pulmonary
pulmonary NN hypertension

prophylactic NN prophylactic
prophylactic JJ cranial
cranial NN irradiation
irradiation NN (
( NN pci
pci NN )
) VBZ has
has VBN been
been VBN demonstrated
demonstrated TO to
to RB significantly
significantly VB reduce
reduce DT the
the NN incidence
incidence IN of
of NN brain
brain NN relapse
relapse IN from
from JJ limited
limited NN disease
disease NN small-cell
small-cell NN lung
lung NN cancer
cancer NN (
( NN ld
ld NN sclc
sclc NN )
) , ,
, CC but
but NNS concerns
concerns IN about
about JJ neurologic
neurologic NN toxicity
toxicity VB remain

thus RB thus
thus , ,
, JJ twice-daily
twice-daily NN pci
pci MD should
should VB be
be VBN considered
considered IN for
for NNS patients
patients IN with
with NN ld
ld NN sclc
sclc WP who
who VB achieve
achieve DT a
a JJ complete
complete NN response
response TO to
to NN chemoirradiation

animal NN animal
animal NNS studies
studies VB suggest
suggest IN that
that DT the
the NN kidney
kidney VBZ is
is VBN involved
involved IN in
in DT the
the NN elimination
elimination IN of
of JJ recombinant
recombinant JJ human
human NN granulocyte
granulocyte JJ colony-stimulating
colony-stimulating NN factor
factor NN (
( NN rhg-csf
rhg-csf NN )
) , ,
, WDT which
which VBZ is
is VBN used
used IN for
for NNS patients
patients IN with
with NN neutropenia
neutropenia IN during
during NN cancer
cancer NN chemotherapy

amifostine NN amifostine
amifostine NN (
( NN wr-2721
wr-2721 NN )
) VBZ is
is DT a
a JJ cytoprotective
cytoprotective NN agent
agent IN that
that VBZ protects
protects DT a
a JJ broad
broad NN range
range IN of
of JJ normal
normal NNS tissues
tissues IN from
from DT the
the JJ toxic
toxic NNS effects
effects IN of
of NN chemotherapy
chemotherapy CC and
and NN radiotherapy
radiotherapy IN without
without VBG attenuating
attenuating NN tumour
tumour NN response

in IN in
in DT a
a JJ pivotal
pivotal NN phase
phase LS iii
iii NN trial
trial , ,
, CD 242
242 NNS patients
patients IN with
with VBN advanced
advanced JJ ovarian
ovarian NN cancer
cancer VBD were
were VBN randomised
randomised TO to
to VB receive
receive NN treatment
treatment IN with
with NN cisplatin
cisplatin CD 100
100 NN mg/m2
mg/m2 CC and
and NN cyclophosphamide
cyclophosphamide CD 1000
1000 NN mg/m2
mg/m2 DT every
every CD 3
3 NNS weeks
weeks IN with
with CC or
or IN without
without NN pretreatment
pretreatment IN with
with JJ intravenous
intravenous NN amifostine
amifostine CD 910
910 NN mg/m2

over IN over
over CD 6
6 NNS cycles
cycles IN of
of NN therapy
therapy , ,
, NN amifostine
amifostine RB significantly
significantly VBN reduced
reduced JJ haematological
haematological , ,
, JJ renal
renal CC and
and JJ neurological
neurological NNS toxicities
toxicities : :
: NN treatment
treatment NNS delays
delays , ,
, NN treatment
treatment NN discontinuation
discontinuation CC and
and NNS days
days IN in
in NN hospital
hospital JJ related
related TO to
to DT these
these JJ adverse
adverse NNS events
events VBD were
were RB also
also RB significantly
significantly VBN reduced
reduced IN in
in NNS patients
patients VBG receiving
receiving NN amifostine
amifostine CC versus
versus NNS patients
patients VBG receiving
receiving NN chemotherapy
chemotherapy RB alone

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN in
in DT another
another VBN randomised
randomised NN phase
phase LS iii
iii NN trial
trial IN in
in CD 303
303 NNS patients
patients IN with
with NN head
head CC and
and NN neck
neck NN cancer
cancer VBG undergoing
undergoing NN irradiation
irradiation NN therapy
therapy NN (
( NN total
total NN dose
dose CD 50
50 TO to
to JJ 70gy
70gy NN )
) , ,
, NN pretreatment
pretreatment IN with
with JJ intravenous
intravenous NN amifostine
amifostine CD 200
200 NN mg/m2
mg/m2 RB significantly
significantly VBN reduced
reduced DT the
the NN incidence
incidence IN of
of JJ acute
acute CC and
and RB late
late NN grade
grade JJR >
> CC or
or NN =2
=2 NN xerostomia

amifostine NN amifostine
amifostine NN (
( CD 340
340 NN mg/m2
mg/m2 NN )
) RB also
also VBN provided
provided JJ significant
significant NN protection
protection IN against
against NN pneumonitis
pneumonitis CC and
and NN oesophagitis
oesophagitis IN in
in NNS patients
patients IN with
with NN lung
lung NN cancer
cancer VBG receiving
receiving JJ thoracic
thoracic NN irradiation
irradiation IN in
in DT a
a JJ preliminary
preliminary NN report
report IN from
from DT a
a NN phase
phase LS iii
iii NN trial
trial NN (
( NN n
n JJ =
= CD 144
144 NN )

amifostine NN amifostine
amifostine VBZ has
has RB also
also VBN been
been VBN shown
shown TO to
to VB stimulate
stimulate JJ haematopoietic
haematopoietic NN stem
stem NNS cells
cells CC and
and VBZ has
has VBN been
been VBN investigated
investigated IN as
as DT a
a NN therapy
therapy IN for
for NNS patients
patients IN with
with JJ myelodysplastic
myelodysplastic NN syndrome
syndrome IN in
in NN number
number IN of
of JJ small
small JJ preliminary
preliminary NNS studies

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN conclusion
conclusion : :
: DT the
the NNS results
results IN of
of NN phase
phase LS iii
iii NNS trials
trials VB have
have VBN confirmed
confirmed DT the
the NN safety
safety CC and
and NN efficacy
efficacy IN of
of NN amifostine
amifostine IN as
as DT a
a NN cytoprotectant
cytoprotectant TO to
to VB ameliorate
ameliorate JJ cisplatin-induced
cisplatin-induced JJ cumulative
cumulative JJ renal
renal NN toxicity
toxicity , ,
, IN for
for WDT which
which PRP it
it VBZ is
is DT the
the RB only
only NN agent
agent VBN proven
proven TO to
to VB be
be JJ effective
effective , ,
, CC and
and NN neutropenia
neutropenia IN in
in NNS patients
patients IN with
with VBN advanced
advanced JJ ovarian
ovarian NN cancer
cancer , ,
, CC and
and TO to
to VB reduce
reduce NN xerostomia
xerostomia IN in
in NNS patients
patients IN with
with NN head
head CC and
and NN neck
neck NN cancer
cancer VBG receiving
receiving NN irradiation
irradiation NN therapy

depending VBG depending
depending IN on
on DT the
the NN outcome
outcome IN of
of JJ numerous
numerous JJ ongoing
ongoing JJ clinical
clinical NNS trials
trials , ,
, NN amifostine
amifostine MD may
may RB eventually
eventually VB find
find JJR broader
broader JJ clinical
clinical NNS applications
applications , ,
, DT both
both IN as
as DT a
a NN cytoprotectant
cytoprotectant CC and
and IN as
as DT a
a NN potential
potential NN therapy
therapy IN in
in JJ myelodysplastic
myelodysplastic NN syndrome

to TO to
to VB perform
perform DT a
a JJ curative
curative NN operation
operation IN for
for DT the
the NN lung
lung NN cancer
cancer IN without
without JJ myocardial
myocardial NN infarction
infarction , ,
, RB minimally
minimally JJ invasive
invasive JJ direct
direct JJ coronary
coronary NN artery
artery NN bypass
bypass CC and
and RB left
left JJR lower
lower NN lobectomy
lobectomy IN with
with JJ video-endoscopic
video-endoscopic NN assistance
assistance VBD were
were VBN performed
performed RB simultaneously

A DT CAPITAL A
A NN review
review IN of
of DT the
the JJ fetal-maternal
fetal-maternal NN carboxyhemoglobin
carboxyhemoglobin NNS relationships
relationships CC and
and DT the
the NNS differences
differences IN in
in JJ fetal
fetal NN oxyhemoglobin
oxyhemoglobin NN physiology
physiology VBP are
are VBN used
used TO to
to VB explain
explain DT the
the NN recommendation
recommendation IN that
that JJ pregnant
pregnant NNS women
women IN with
with NN carbon
carbon NN monoxide
monoxide NN poisoning
poisoning MD should
should VB receive
receive CD 100
100 NN %
% NN oxygen
oxygen NN therapy
therapy IN for
for RB up
up TO to
to CD five
five NNS times
times RB longer
longer IN than
than VBZ is
is RB otherwise
otherwise JJ necessary

The DT CAPITAL The
The NNS authors
authors VBP describe
describe DT the
the NN case
case IN of
of DT a
a NN child
child IN with
with NN status
status NN epilepticus
epilepticus IN in
in WP whom
whom NN phenytoin
phenytoin VBD was
was VBN administered
administered IN via
via DT the
the JJ intraosseous
intraosseous NN route
route , ,
, CC and
and NN seizure
seizure NN resolution
resolution CC and
and JJ therapeutic
therapeutic NN serum
serum NNS levels
levels VBD were
were VBN achieved

A DT CAPITAL A
A NN patient
patient VBG suffering
suffering NN baclofen
baclofen NN overdose
overdose RB successfully
successfully VBN treated
treated IN with
with NN atropine
atropine VBZ is
is VBN reported

Atropine NNP CAPITAL Atropine
Atropine VBZ appears
appears TO to
to VB be
be JJ useful
useful IN in
in VBG treating
treating NNS cases
cases IN of
of NN baclofen
baclofen NN overdose
overdose VBN complicated
complicated IN by
by NN bradycardia
bradycardia CC and
and NN hypotension

Therapeutic JJ CAPITAL Therapeutic
Therapeutic NN effect
effect IN of
of DT a
a RB left
left JJ ventricular
ventricular VB assist
assist NN device
device IN on
on JJ acute
acute JJ myocardial
myocardial NN infarction
infarction VBN evaluated
evaluated IN by
by JJ magnetic
magnetic NN resonance
resonance NN imaging

Continuous JJ CAPITAL Continuous
Continuous JJ arteriovenous
arteriovenous NN hemofiltration
hemofiltration IN for
for DT the
the NN treatment
treatment IN of
of NN anasarca
anasarca CC and
and JJ acute
acute JJ renal
renal NN failure
failure IN in
in RB severely
severely VBN burned
burned NNS patients

Continuous JJ CAPITAL Continuous
Continuous JJ renal
renal NN replacement
replacement NN therapy
therapy IN in
in NNS patients
patients IN with
with JJ acute
acute JJ renal
renal NN dysfunction
dysfunction VBG undergoing
undergoing JJ intraaortic
intraaortic NN balloon
balloon NN pump
pump CC and/or
and/or RB left
left JJ ventricular
ventricular NN device
device NN support

Continuous JJ CAPITAL Continuous
Continuous JJ arterio-venous
arterio-venous NN hemofiltration
hemofiltration IN in
in DT a
a JJ wearable
wearable NN device
device TO to
to NN treat
treat NN end-stage
end-stage JJ renal
renal NN disease

The DT CAPITAL The
The NN effectiveness
effectiveness IN of
of NN neostigmine
neostigmine CD 0.07
0.07 NN mg
mg NN kg-1
kg-1 CC and
and NN edrophonium
edrophonium CD 0.8
0.8 NN mg
mg NN kg-1
kg-1 IN as
as NNS antagonists
antagonists IN of
of JJ profound
profound JJ neuromuscular
neuromuscular NN blockade
blockade VBN induced
induced IN by
by NN vecuronium
vecuronium CD 0.1
0.1 NN mg
mg NN kg-1
kg-1 CC or
or NN atracurium
atracurium CD 0.5
0.5 NN mg
mg NN kg-1
kg-1 VBD was
was VBN studied
studied IN in
in CD 59
59 JJ healthy
healthy NNS patients

Antagonism NN CAPITAL Antagonism
Antagonism IN of
of JJ atracurium-induced
atracurium-induced JJ neuromuscular
neuromuscular NN blockade
blockade IN by
by NN neostigmine
neostigmine CC or
or NN edrophonium
edrophonium VBZ has
has VBN been
been VBN studied
studied VBG using
using DT the
the JJ tetanic
tetanic NN (
( CD 50
50 NN CAPITAL Hz
Hz NN )
) CC and
and NN train-of-four
train-of-four NN (
( CD 2
2 NN CAPITAL Hz
Hz NN )
) CC or
or JJ single
single VB twitch
twitch NNS responses
responses IN of
of DT the
the NN adductor
adductor NN pollicis
pollicis NN muscle
muscle IN in
in CD 22
22 VBN anaesthetized
anaesthetized NNS patients

Active JJ CAPITAL Active
Active NNS forms
forms IN of
of NN vitamin
vitamin NN CAPITAL D3
D3 , ,
, CD 1
1 NN alpha-hydroxyvitamin
alpha-hydroxyvitamin NN CAPITAL D3
D3 CC and
and CD 1
1 NN alpha
alpha , ,
, NN 25-dihydroxyvitamin
25-dihydroxyvitamin NN CAPITAL D3
D3 , ,
, VBD were
were VBN administered
administered IN in
in DT an
an JJ open-design
open-design NN study
study TO to
to CD 40
40 NNS patients
patients IN with
with NN psoriasis
psoriasis NN vulgaris
vulgaris IN in
in CD three
three NNS ways
ways : :
: TO to
to CD 17
17 NNS patients
patients CD 1
1 NN alpha-hydroxyvitamin
alpha-hydroxyvitamin NN CAPITAL D3
D3 VBD was
was VBN given
given RB orally
orally IN at
at DT a
a NN dose
dose IN of
of CD 1.0
1.0 NN micrograms/day
micrograms/day IN for
for CD 6
6 NNS months
months , ,
, TO to
to CD four
four NNS patients
patients CD 1
1 NN alpha
alpha , ,
, NN 25-dihydroxyvitamin
25-dihydroxyvitamin NN CAPITAL D3
D3 VBD was
was VBN given
given RB orally
orally IN at
at DT a
a NN dose
dose IN of
of CD 0.5
0.5 NNS microgram/day
microgram/day IN for
for CD 6
6 NNS months
months , ,
, CC and
and CD 19
19 NNS patients
patients VBD were
were VBN given
given CD 1
1 NN alpha
alpha , ,
, NN 25-dihydroxyvitamin
25-dihydroxyvitamin NN CAPITAL D3
D3 VBN applied
applied RB topically
topically IN at
at NN concentration
concentration IN of
of CD 0.5
0.5 NN microgram/g
microgram/g IN of
of NN base
base IN for
for CD 8
8 NNS weeks

These DT CAPITAL These
These NNS data
data VB suggest
suggest IN that
that NN psoriasis
psoriasis MD may
may NN respond
respond TO to
to JJ active
active NNS metabolites
metabolites IN of
of NN vitamin
vitamin NN CAPITAL D3
D3 CC and
and IN that
that NNS abnormalities
abnormalities IN in
in NN vitamin
vitamin NN CAPITAL D
D NN metabolism
metabolism CC or
or IN in
in NN responsiveness
responsiveness IN of
of DT the
the NN skin
skin NNS cells
cells TO to
to JJ active
active NNS metabolites
metabolites IN of
of NN vitamin
vitamin NN CAPITAL D
D MD may
may VB be
be VBN involved
involved IN in
in DT the
the NN pathogenesis
pathogenesis IN of
of DT this
this NN skin
skin NN disease

Successful JJ CAPITAL Successful
Successful NN treatment
treatment IN of
of NN psoriasis
psoriasis IN with
with JJ topical
topical NN application
application IN of
of JJ active
active NN vitamin
vitamin NN CAPITAL D3
D3 NN analogue
analogue , ,
, CD 1
1 NN alpha
alpha , ,
, JJ 24-dihydroxycholecalciferol

We PRP CAPITAL We
We VB suggest
suggest IN that
that CD 1
1 NN alpha
alpha , ,
, CD 24
24 NN (
( NN CAPITAL OH
OH NN )
) NN 2D3
2D3 NNS merits
merits RB further
further NN investigation
investigation IN as
as DT a
a RB potentially
potentially JJ useful
useful JJ topical
topical NN therapy
therapy IN for
for NN psoriasis

When WRB CAPITAL When
When NN indomethacin
indomethacin VBD was
was VBN applied
applied RB immediately
immediately IN after
after NN irradiation
irradiation , ,
, NN CAPITAL UVR
UVR NN (
( NN ultraviolet
ultraviolet NN radiation
radiation NN )
) JJ dose-dependent
dose-dependent NN suppression
suppression IN of
of NN erythema
erythema VBD was
was VBN demonstrated
demonstrated IN for
for DT both
both NNS wavelengths
wavelengths IN until
until CD 36
36 NN h
h IN after
after NN irradiation
irradiation WRB when
when DT both
both NN indomethacin
indomethacin CC and
and NN control
control NN gel
gel JJ base-treated
base-treated NNS sites
sites VBD were
were RB equally
equally JJ erythematous

Suppression NN CAPITAL Suppression
Suppression IN of
of NN erythema
erythema RB also
also VBD occurred
occurred WRB when
when NN application
application IN of
of NN indomethacin
indomethacin VBD was
was VBN delayed
delayed IN until
until CD 24
24 NN h
h IN after
after NN irradiation
irradiation , ,
, VBG showing
showing IN that
that IN for
for DT both
both NNS wavelengths
wavelengths NN prostaglandin
prostaglandin NN synthesis
synthesis NNS remains
remains VBN increased
increased IN throughout
throughout DT this
this NN period

There EX CAPITAL There
There VBD was
was CD one
one JJ retinal
retinal NN dialysis
dialysis , ,
, CC and
and CD one
one NN lens
lens NN dislocation
dislocation VBG requiring
requiring NN extraction

Rates NNS CAPITAL Rates
Rates IN of
of NN superoxide
superoxide NN (
( NNP CAPITAL SA
SA NN )
) NN generation
generation IN by
by NN blood
blood NNS monocytes
monocytes VBN stimulated
stimulated FW ex
ex FW vivo
vivo VBD were
were VBN studied
studied IN before
before CC and
and IN during
during NN corticosteroid
corticosteroid NN treatment
treatment IN of
of JJ rheumatoid
rheumatoid NN arthritis
arthritis NN (
( NN CAPITAL RA
RA NN )
) NNS patients
patients , ,
, IN in
in NN control
control NNS patients
patients CC and
and IN in
in JJ healthy
healthy NNS controls

Significant JJ CAPITAL Significant
Significant NN inhibition
inhibition IN of
of NN monocyte
monocyte NNP CAPITAL SA
SA NN output
output VBN stimulated
stimulated IN with
with JJ CAPITAL IgG-treated
IgG-treated NN zymosan
zymosan NN (
( NN CAPITAL ITZ
ITZ NN )
) CC and
and NN fluoride
fluoride NN ion
ion NN (
( NN CAPITAL F
F NN )
) , ,
, CC but
but RB not
not JJ serum-treated
serum-treated NN zymosan
zymosan NN (
( NN CAPITAL STZ
STZ NN )
) VBD was
was VBN demonstrated
demonstrated VBG following
following NN steroid
steroid NN therapy
therapy IN in
in NN CAPITAL RA

Methotrexate NNP CAPITAL Methotrexate
Methotrexate NN (
( NN CAPITAL MTX
MTX NN )
) VBZ appears
appears TO to
to VB be
be JJ useful
useful IN in
in NNS patients
patients IN with
with JJ rheumatoid
rheumatoid NN arthritis
arthritis NN (
( NN CAPITAL RA
RA NN )
) JJ refractory
refractory TO to
to JJ other
other NNS drugs
drugs CC but
but PRP$ its
its JJ long-term
long-term NN toxicity
toxicity CC and
and NN efficacy
efficacy VBP are
are JJ uncertain

MTX NN CAPITAL MTX
MTX IN in
in DT a
a JJ low-dose
low-dose NNS regimen
regimen VBZ is
is JJ useful
useful IN in
in JJ refractory
refractory NN CAPITAL RA
RA CC and
and JJ superior
superior TO to
to JJ low-dose
low-dose NN purine
purine NNS analogues

Twelve CD CAPITAL Twelve
Twelve NNS patients
patients IN with
with JJ intractable
intractable JJ rheumatoid
rheumatoid NN arthritis
arthritis VBD were
were VBN treated
treated IN with
with NN antilymphocyte
antilymphocyte NN globulin
globulin NN (
( NN CAPITAL ALG
ALG NN )
) , ,
, NN prednisolone
prednisolone CC and
and DT a
a JJ cytotoxic
cytotoxic NN agent
agent , ,
, RB usually
usually NN azathioprine
azathioprine , ,
, CC and
and VBD were
were VBN followed
followed IN for
for CD 1
1 NN year

Rigid JJ CAPITAL Rigid
Rigid NN ureteroscopy
ureteroscopy IN for
for DT the
the NN treatment
treatment IN of
of JJ ureteric
ureteric NNS calculi
calculi : :
: NN experience
experience IN in
in CD 120
120 NNS cases

Over IN CAPITAL Over
Over DT a
a JJ 1-year
1-year NN period
period , ,
, JJ rigid
rigid NN ureteroscopy
ureteroscopy VBZ has
has VBN been
been VBN used
used TO to
to VB retrieve
retrieve JJ ureteric
ureteric NNS calculi
calculi IN in
in CD 120
120 NNS patients

Eleven CD CAPITAL Eleven
Eleven NNS patients
patients IN with
with JJ vesicoureteric
vesicoureteric NN reflux
reflux JJ secondary
secondary TO to
to JJ neuropathic
neuropathic NN bladder
bladder VBD were
were VBN treated
treated IN by
by JJ endoscopic
endoscopic NN injection
injection IN of
of VBN pyrolised
pyrolised NN polytetrafluoroethylene
polytetrafluoroethylene NN (
( NN CAPITAL Polytef
Polytef NN )
) VB paste

Two CD CAPITAL Two
Two CD hundred
hundred CC and
and CD seventy-seven
seventy-seven NNS patients
patients IN with
with VBN advanced
advanced JJ prostatic
prostatic NN cancer
cancer VBD were
were VBN treated
treated IN by
by DT either
either NN orchiectomy
orchiectomy CC or
or NN oestrogen

Use NN CAPITAL Use
Use IN of
of VBN scarred
scarred NNS flaps
flaps CC and
and JJ secondary
secondary NNS flaps
flaps IN for
for NN reconstructive
reconstructive NN surgery
surgery IN of
of JJ extensive
extensive NNS burns

A DT CAPITAL A
A NN patient
patient IN with
with DT a
a JJ vesico-enteric
vesico-enteric NN fistula
fistula VBD was
was RB successfully
successfully VBN treated
treated IN with
with NN resection
resection IN of
of DT the
the JJ small
small NN intestine
intestine CC and
and NN dome
dome IN of
of DT the
the NN bladder
bladder CC and
and NN drainage
drainage IN of
of DT the
the VBG intervening
intervening NN abscess

Supramaximal JJ CAPITAL Supramaximal
Supramaximal JJ horizontal
horizontal NN rectus
rectus NN surgery
surgery IN in
in DT the
the NN management
management IN of
of JJ third
third CC and
and JJ sixth
sixth NN nerve
nerve NN palsy

Supramaximal JJ CAPITAL Supramaximal
Supramaximal JJ medial
medial CC and
and JJ lateral
lateral NN rectus
rectus NN surgery
surgery VBD was
was VBN performed
performed TO to
to JJ correct
correct JJ horizontal
horizontal NNS deviations
deviations IN in
in CD seven
seven NNS cases
cases IN of
of JJ sixth
sixth NN nerve
nerve NN palsy
palsy CC and
and CD three
three NNS cases
cases IN of
of JJ third
third NN nerve
nerve NN palsy
palsy , ,
, IN with
with JJ satisfactory
satisfactory NNS results
results IN in
in RBS most
most NNS cases

Steroid NN CAPITAL Steroid
Steroid NN therapy
therapy VBD was
was RB also
also VBN used
used IN in
in CD two
two NNS patients
patients IN with
with JJ CAPITAL NSAID-induced
NSAID-induced NN proteinuria

Recombinant JJ CAPITAL Recombinant
Recombinant NN leukocyte
leukocyte DT CAPITAL A
A NN interferon
interferon NN (
( NN rIFN-alpha
rIFN-alpha DT CAPITAL A
A NN )
) IN in
in DT the
the NN treatment
treatment IN of
of VBN disseminated
disseminated JJ malignant
malignant NN melanoma

Ninety-six CD CAPITAL Ninety-six
Ninety-six NNS patients
patients IN with
with VBN disseminated
disseminated JJ malignant
malignant NN melanoma
melanoma VBN received
received NN thrice
thrice RB weekly
weekly JJ intramuscular
intramuscular NNS injections
injections IN of
of NN leukocyte
leukocyte DT CAPITAL A
A JJ recombinant
recombinant NN interferon
interferon NN (
( NN rIFN-alpha
rIFN-alpha DT CAPITAL A
A , ,
, NN CAPITAL Roferon-A
Roferon-A , ,
, NNP CAPITAL Hoffmann
Hoffmann NNP CAPITAL La
La NNP CAPITAL Roche
Roche NN )
) IN at
at NNS doses
doses IN of
of CD 12
12 NN CAPITAL X
X CD 10
10 NN (
( CD 6
6 NN )
) NN CAPITAL U/m2
U/m2 CC or
or CD 50
50 NN CAPITAL X
X CD 10
10 NN (
( CD 6
6 NN )
) NN CAPITAL U/m2
U/m2 IN with
with CC or
or IN without
without NN cimetidine
cimetidine IN as
as DT an
an JJ immunorestorative
immunorestorative NN agent

As IN CAPITAL As
As VBN noted
noted RB previously
previously , ,
, VBG using
using NN chemotherapy
chemotherapy , ,
, DT a
a JJ small
small NN proportion
proportion IN of
of NNS patients
patients IN with
with VBN advanced
advanced JJ malignant
malignant NN melanoma
melanoma , ,
, IN despite
despite RB prior
prior NN therapy
therapy , ,
, MD may
may VB achieve
achieve JJ prolonged
prolonged NN objective
objective NN regression
regression IN with
with NN rIFN-alpha
rIFN-alpha DT CAPITAL A

Clinical JJ CAPITAL Clinical
Clinical NN course
course IN of
of NN breast
breast NN cancer
cancer NNS patients
patients IN with
with JJ osseous
osseous NN metastasis
metastasis VBN treated
treated IN with
with NN combination
combination NN chemotherapy

Between IN CAPITAL Between
Between NNP CAPITAL July
July CD 1973
1973 CC and
and NNP CAPITAL December
December CD 1979
1979 , ,
, CD 1171
1171 NNS patients
patients IN with
with JJ metastatic
metastatic NN breast
breast NN cancer
cancer VBD were
were VBN treated
treated IN with
with JJ doxorubicin-containing
doxorubicin-containing NN chemotherapy

Two CD CAPITAL Two
Two NNS patients
patients IN with
with JJ metastatic
metastatic NN dysgerminoma
dysgerminoma IN of
of DT the
the NN ovary
ovary VBD were
were VBN treated
treated IN with
with DT a
a NN combination
combination IN of
of NN etoposide
etoposide , ,
, NN bleomycin
bleomycin , ,
, CC and
and NN cisplatin
cisplatin IN at
at DT CAPITAL The
The NNP CAPITAL University
University IN of
of NNP CAPITAL Texas
Texas NN CAPITAL M.D

Chemotherapy NN CAPITAL Chemotherapy
Chemotherapy MD may
may VB be
be DT an
an NN alternative
alternative TO to
to NN radiotherapy
radiotherapy IN for
for DT the
the NN treatment
treatment IN of
of JJ metastatic
metastatic NN dysgerminoma
dysgerminoma CC and
and MD should
should RB also
also VB be
be VBN considered
considered IN for
for VBN selected
selected NNS patients
patients IN with
with NN CAPITAL Stage
Stage PRP CAPITAL I
I NN disease

Long-term JJ CAPITAL Long-term
Long-term NN survival
survival CC and
and NN morbidity
morbidity IN in
in NNS patients
patients IN with
with JJ metastatic
metastatic JJ malignant
malignant NN germ
germ NN cell
cell NNS tumors
tumors VBN treated
treated IN with
with JJ cisplatin-based
cisplatin-based NN combination
combination NN chemotherapy

Treatment NN CAPITAL Treatment
Treatment IN of
of VBN advanced
advanced NN stage
stage NN mycosis
mycosis NNS fungoides
fungoides IN with
with NN bleomycin
bleomycin , ,
, NN doxorubicin
doxorubicin , ,
, CC and
and NN methotrexate
methotrexate IN with
with JJ topical
topical NN nitrogen
nitrogen NN mustard
mustard NN (
( NN CAPITAL BAM-M
BAM-M NN )

Ten CD CAPITAL Ten
Ten NNS patients
patients IN with
with VBN advanced
advanced NN stage
stage NN (
( NN CAPITAL TNM
TNM NN CAPITAL IIB-IVB
IIB-IVB NN )
) NN mycosis
mycosis NNS fungoides
fungoides VBD were
were VBN treated
treated IN with
with DT a
a NN combination
combination NN chemotherapy
chemotherapy NN program
program VBG consisting
consisting IN of
of NN bleomycin
bleomycin CC and
and NN methotrexate
methotrexate RB weekly
weekly , ,
, NN doxorubicin
doxorubicin DT every
every CD 3
3 NNS weeks
weeks , ,
, CC and
and JJ topical
topical NN nitrogen
nitrogen NN mustard
mustard RB daily
daily NN (
( NN CAPITAL BAM-M
BAM-M NN )

Three CD CAPITAL Three
Three NNS patients
patients IN in
in WP whom
whom NN splenomegaly
splenomegaly VBD was
was VBN detected
detected IN during
during PRP$ their
their NN staging
staging NN evaluation
evaluation VBD underwent
underwent NN splenectomy

This DT CAPITAL This
This NN study
study VBZ indicates
indicates IN that
that NN CAPITAL BAM-M
BAM-M VBZ is
is JJ effective
effective NN therapy
therapy IN for
for VBN advanced
advanced NN stage
stage NN mycosis
mycosis NNS fungoides
fungoides CC and
and VBZ suggests
suggests IN that
that DT the
the JJ therapeutic
therapeutic NN role
role IN of
of NN splenectomy
splenectomy MD should
should VB be
be VBN evaluated
evaluated RB further

Only RB CAPITAL Only
Only NNS patients
patients WP$ whose
whose JJ primary
primary NN head
head CC and
and NN neck
neck NN tumor
tumor NNS shows
shows DT a
a NN response
response TO to
to JJ systemic
systemic NN therapy
therapy VB undergo
undergo NNP CAPITAL Ommaya
Ommaya NN placement

Additional JJ CAPITAL Additional
Additional NN chemotherapy
chemotherapy MD may
may RB thus
thus VB have
have VBN eradicated
eradicated DT these
these NNS micrometastases
micrometastases IN in
in DT the
the JJR older
older NNS children
children , ,
, IN since
since DT the
the NN age
age NN influence
influence IN on
on NN CAPITAL Stage
Stage NNP CAPITAL II
II NN disease
disease VBD disappeared
disappeared WRB when
when JJ multimodal
multimodal NN treatment
treatment VBD was
was VBN given
given IN in
in DT this
this NN study

Traditional JJ CAPITAL Traditional
Traditional NN therapy
therapy IN for
for JJ malignant
malignant JJ pleural
pleural NNS effusions
effusions VBZ includes
includes NN thoracentesis
thoracentesis CC or
or NN tube
tube NN drainage
drainage IN with
with NN instillation
instillation IN of
of NNS irritants
irritants TO to
to VB achieve
achieve NN pleurodesis

We PRP CAPITAL We
We VB feel
feel IN that
that NN pleuroperitoneal
pleuroperitoneal VBG shunting
shunting VBZ is
is DT a
a JJ valid
valid JJ new
new NN method
method IN for
for NN treatment
treatment IN of
of JJ malignant
malignant JJ pleural
pleural NNS effusions
effusions WDT which
which MD can
can RB effectively
effectively VB palliate
palliate JJ respiratory
respiratory NNS symptoms
symptoms IN with
with JJ low
low NN morbidity

When WRB CAPITAL When
When RB right
right JJ ventricular
ventricular NN failure
failure VBZ prohibits
prohibits NN separation
separation IN from
from JJ cardiopulmonary
cardiopulmonary NN bypass
bypass , ,
, NN standard
standard NNS methods
methods IN of
of VBG increasing
increasing JJ pulmonary
pulmonary NN blood
blood NN flow
flow MD should
should VB be
be VBN employed
employed , ,
, VBG including
including NN correction
correction IN of
of NN hypoxia
hypoxia CC and
and NN acidosis
acidosis , ,
, NN volume
volume VBG loading
loading , ,
, CC and
and JJ inotropic
inotropic NN support
support IN of
of DT the
the RB right
right NN ventricle

For IN CAPITAL For
For JJ refractory
refractory RB right
right JJ ventricular
ventricular NN failure
failure VBG following
following DT the
the JJ surgical
surgical NN repair
repair IN of
of JJ congenital
congenital JJ cardiac
cardiac NNS defects
defects IN in
in WDT which
which DT the
the NN placement
placement IN of
of RB right
right IN atrial
atrial CC and
and JJ pulmonary
pulmonary NN artery
artery FW cannulae
cannulae VBZ is
is RB not
not RB technically
technically JJ feasible
feasible , ,
, NN use
use IN of
of VB high-frequency
high-frequency JJ high-volume
high-volume NN ventilation
ventilation VBZ appears
appears TO to
to VB be
be RB quite
quite VBG promising

Current JJ CAPITAL Current
Current NNS results
results VB suggest
suggest IN that
that NN CAPITAL RHBP
RHBP NNS remains
remains DT the
the NN gold
gold NN standard
standard IN for
for JJ severe
severe NN CAPITAL RV
RV NN failure
failure , ,
, CC but
but RB further
further JJ clinical
clinical NN experience
experience IN with
with NN CAPITAL PABC
PABC MD may
may RBR more
more RB clearly
clearly VB define
define PRP$ its
its NN role
role IN in
in DT the
the NN management
management IN of
of NN CAPITAL RV
RV NN failure

Guiding VBG CAPITAL Guiding
Guiding JJ surgical
surgical NN therapy
therapy IN of
of JJ ventricular
ventricular NN tachycardia
tachycardia IN by
by JJ preoperative
preoperative JJ endocardial
endocardial NN catheter
catheter NN mapping
mapping VBZ necessitates
necessitates NN improvement
improvement IN of
of DT the
the NN accuracy
accuracy IN of
of NN localization
localization IN of
of DT the
the JJ arrhythmogenic
arrhythmogenic NN site

However RB CAPITAL However
However , ,
, DT the
the NNS results
results IN of
of DT this
this NN study
study VBP indicate
indicate IN that
that NN procainamide
procainamide MD may
may VB be
be JJ effective
effective IN in
in VBG suppressing
suppressing DT the
the NN induction
induction IN of
of JJ sustained
sustained JJ ventricular
ventricular NN tachycardia
tachycardia IN at
at DT a
a RB relatively
relatively JJ low
low NN plasma
plasma NN concentration
concentration , ,
, CC but
but RB not
not IN at
at DT a
a JJR higher
higher NN plasma
plasma NN concentration

Coronary JJ CAPITAL Coronary
Coronary NN angioplasty
angioplasty IN for
for RB early
early NN postinfarction
postinfarction JJ unstable
unstable NN angina

Coronary JJ CAPITAL Coronary
Coronary NN angioplasty
angioplasty VBD was
was VBN performed
performed IN in
in CD 53
53 NNS patients
patients IN in
in WP whom
whom JJ unstable
unstable NN angina
angina VBD had
had VBD reoccurred
reoccurred IN after
after CD 48
48 NN hr
hr CC and
and IN within
within CD 30
30 NNS days
days IN after
after JJ sustained
sustained JJ myocardial
myocardial NN infarction

At IN CAPITAL At
At CD 6
6 NNS months
months NN follow-up
follow-up CD 26
26 NN %
% NN (
( CD 14/53
14/53 NN )
) IN of
of DT all
all DT the
the NNS patients
patients WP who
who VBD underwent
underwent NN angioplasty
angioplasty VBD had
had NN recurrence
recurrence IN of
of NN angina
angina , ,
, WDT which
which VBD was
was RB successfully
successfully VBN treated
treated IN with
with NN repeat
repeat NN angioplasty
angioplasty , ,
, NN bypass
bypass NN surgery
surgery , ,
, CC or
or JJ medical
medical NN therapy

Coronary JJ CAPITAL Coronary
Coronary NN dissection
dissection CC and
and NN total
total JJ coronary
coronary NN occlusion
occlusion VBG leading
leading TO to
to NN emergency
emergency JJ coronary
coronary NN surgery
surgery VBP are
are DT the
the RBS most
most JJ frequent
frequent NNS complications
complications IN of
of JJ percutaneous
percutaneous JJ transluminal
transluminal JJ coronary
coronary NN angioplasty
angioplasty NN (
( NN CAPITAL PTCA
PTCA NN )
) CC and
and PRP$ their
their NN occurrence
occurrence RB usually
usually VBZ is
is JJ unpredictable

Effect NN CAPITAL Effect
Effect IN of
of NN zanamivir
zanamivir IN on
on NN duration
duration CC and
and NN resolution
resolution IN of
of NN influenza
influenza NNS symptoms

A DT CAPITAL A
A NN comparison
comparison IN of
of DT a
a JJ five-day
five-day NNS regimen
regimen IN of
of NN cefdinir
cefdinir IN with
with DT a
a JJ seven-day
seven-day NNS regimen
regimen IN of
of NN loracarbef
loracarbef IN for
for DT the
the NN treatment
treatment IN of
of JJ acute
acute NNS exacerbations
exacerbations IN of
of JJ chronic
chronic NN bronchitis

Initial JJ CAPITAL Initial
Initial JJ empiric
empiric NN therapy
therapy IN for
for JJ community-acquired
community-acquired JJ bacterial
bacterial NN meningitis
meningitis MD should
should VB be
be VBN based
based IN on
on DT the
the NN possibility
possibility IN that
that JJ penicillin-resistant
penicillin-resistant NNS pneumococci
pneumococci MD may
may VB be
be DT the
the JJ etiologic
etiologic NNS organisms
organisms CC and
and , ,
, RB hence
hence , ,
, MD should
should VB include
include DT a
a NN combination
combination IN of
of NN third-generation
third-generation NN cephalosporin
cephalosporin NN (
( NN cefotaxime
cefotaxime CC or
or NN ceftriaxone
ceftriaxone NN )
) CC and
and NN vancomycin

Ampicillin NNP CAPITAL Ampicillin
Ampicillin MD should
should VB be
be VBN included
included IN if
if DT the
the NN patient
patient VBZ has
has VBG predisposing
predisposing NNS factors
factors IN that
that VBP are
are VBN associated
associated IN with
with DT a
a NN risk
risk IN for
for NN infection
infection IN with
with NN CAPITAL Listeria
Listeria NNS monocytogenes

Results NNS CAPITAL Results
Results IN of
of JJ clinical
clinical NNS trials
trials CC and
and NN meta-analysis
meta-analysis VB suggest
suggest IN that
that NN dexamethasone
dexamethasone NN therapy
therapy VBZ improves
improves DT the
the NN outcome
outcome IN for
for NNS patients
patients IN with
with JJ bacterial
bacterial NN meningitis

Placebo-controlled JJ CAPITAL Placebo-controlled
Placebo-controlled NNS trials
trials VB have
have VBN shown
shown IN that
that NN vitamin
vitamin NN CAPITAL C
C NN supplementation
supplementation NNS decreases
decreases DT the
the NN duration
duration CC and
and NN severity
severity IN of
of JJ common
common JJ cold
cold NNS infections

Since IN CAPITAL Since
Since JJ few
few NNS trials
trials VB have
have VBN examined
examined DT the
the NNS effects
effects IN of
of JJ therapeutic
therapeutic NN supplementation
supplementation CC and
and PRP$ their
their NNS results
results VB have
have VBN been
been JJ variable
variable , ,
, RB further
further JJ therapeutic
therapeutic NNS trials
trials VBP are
are VBN required
required TO to
to VB examine
examine DT the
the NN role
role IN of
of NN vitamin
vitamin NN CAPITAL C
C IN in
in DT the
the NN treatment
treatment IN of
of NNS colds

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Progressive
Progressive JJ multifocal
multifocal NN leukoencephalopathy
leukoencephalopathy VBG following
following JJ oral
oral NN fludarabine
fludarabine NN treatment
treatment IN of
of JJ chronic
chronic JJ lymphocytic
lymphocytic NN leukemia

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL PURPOSE
PURPOSE : :
: TO CAPITAL To
To NN review
review VBN reported
reported JJ inflammatory
inflammatory NNS reactions
reactions VBG occurring
occurring IN after
after NN initiation
initiation IN of
of RB highly
highly JJ active
active JJ antiretroviral
antiretroviral NN therapy
therapy NN (
( NNP CAPITAL HAART
HAART NN )
) IN in
in NNS persons
persons JJ infected
infected IN with
with NN CAPITAL HIV-1
HIV-1 CC and
and TO to
to VB explore
explore DT the
the NNS mechanisms
mechanisms VBG leading
leading TO to
to DT these
these NNS reactions

Levofloxacin NN CAPITAL Levofloxacin
Levofloxacin CC versus
versus JJ intravenous
intravenous NN ceftriaxone
ceftriaxone CC and
and NN amoxicillin/clavulanate
amoxicillin/clavulanate IN in
in DT the
the NN treatment
treatment IN of
of JJ community-acquired
community-acquired NN pneumonia
pneumonia IN that
that VB require
require NN hospitalization

Overall RB CAPITAL Overall
Overall CD 1
1 NN year
year NN survival
survival NN (
( NN operative
operative NNS deaths
deaths VBN excluded
excluded NN )
) VBD was
was CD 68
68 NN %
% IN after
after NN tumor
tumor NN resection
resection VBN compared
compared TO to
to CD 31
31 NN %
% IN after
after NN palliative
palliative NN surgery
surgery NN (
( NN CAPITAL P
P JJR <
< CD 0.001
0.001 NN )

The DT CAPITAL The
The NNS results
results IN of
of DT this
this NN study
study NN show
show IN that
that NN resection
resection IN of
of JJ extrahepatic
extrahepatic NN bile
bile NN duct
duct NNS carcinomas
carcinomas , ,
, RB particularly
particularly IN in
in DT an
an NN upper-third
upper-third NN localization
localization , ,
, VBZ is
is RB often
often VBN associated
associated IN with
with JJ worthwhile
worthwhile JJ long-term
long-term NN survival

Background NN CAPITAL Background
Background : :
: NN CAPITAL N-acetylcysteine
N-acetylcysteine NN (
( NN CAPITAL NAC
NAC NN )
) CC and
and NN ambroxol
ambroxol NN (
( NNP CAPITAL AMB
AMB NN )
) VB have
have RB recently
recently VBN been
been VBN proposed
proposed IN as
as JJ possible
possible JJ therapeutic
therapeutic NNS agents
agents IN in
in DT the
the NN treatment
treatment IN of
of JJ pulmonary
pulmonary NNS disorders

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Postoperative
Postoperative NN alkaline
alkaline NN reflux
reflux IN after
after NN total
total NN gastrectomy
gastrectomy IN for
for NN stomach
stomach NN cancer

Antimicrobial JJ CAPITAL Antimicrobial
Antimicrobial NN therapy
therapy IN for
for JJ respiratory
respiratory NN disease

Corticosteroids NNS CAPITAL Corticosteroids
Corticosteroids IN for
for DT the
the NN treatment
treatment IN of
of NN croup

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL BACKGROUND
BACKGROUND : :
: IN CAPITAL In
In DT the
the JJ present
present NN study
study PRP we
we VBN investigated
investigated DT the
the NN efficacy
efficacy CC and
and NN tolerability
tolerability IN of
of NN i.m
i.m . .
. NN octreotide
octreotide NN acetate
acetate NN (
( NN octreotide
octreotide NN CAPITAL LAR
LAR NN )
) IN in
in NNS patients
patients IN with
with JJ metastatic
metastatic NN neuroendocrine
neuroendocrine NNS tumors
tumors NN (
( NNS CAPITAL NETs
NETs NN )
) RB previously
previously VBN treated
treated CC and
and VBD failed
failed IN on
on NN i.m
i.m . .
. NN lanreotide

The DT CAPITAL The
The NN CAPITAL PR
PR VBD was
was VBN observed
observed IN in
in CD one
one NN patient
patient IN with
with JJ non-functioning
non-functioning NN endocrine
endocrine JJ pancreatic
pancreatic NN tumor
tumor IN with
with JJ progressive
progressive NN liver
liver CC and
and NN lymph
lymph NN node
node NNS metastases
metastases IN after
after CD 16
16 NNS months
months IN of
of NN i.m
i.m . .
. NN lanreotide
lanreotide NN therapy

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NN CAPITAL Octreotide
Octreotide NN CAPITAL LAR
LAR CD 20
20 NN mg
mg NNS shows
shows JJ significant
significant NN efficacy
efficacy IN in
in NNS terms
terms IN of
of NN objective
objective NN response
response NN rate
rate NN (
( NN CAPITAL PR
PR CC +
+ NN CAPITAL SD
SD NN )
) , ,
, JJ biochemical
biochemical CC and
and JJ symptomatic
symptomatic NN control
control IN in
in NNS patients
patients IN with
with JJ metastatic
metastatic NNS CAPITAL NETs
NETs IN of
of DT the
the NN CAPITAL GEP
GEP NN system
system JJ pretreated
pretreated CC and
and VBG progressing
progressing IN on
on JJ slow
slow NN release
release NN lanreotide

Inchinko-to JJ CAPITAL Inchinko-to
Inchinko-to NN (
( NN CAPITAL TJ-135
TJ-135 NN )
) VBZ is
is DT a
a JJ herbal
herbal NN medicine
medicine VBG consisting
consisting IN of
of CD three
three NNS kinds
kinds IN of
of NN crude
crude NNS drugs
drugs , ,
, CC and
and IN in
in NNP CAPITAL Japan
Japan PRP it
it VBZ is
is VBN administered
administered RB mainly
mainly TO to
to NNS patients
patients IN with
with NN cholestasis

The DT CAPITAL The
The JJ present
present NN study
study VBN evaluated
evaluated DT the
the NNS effects
effects IN of
of NN CAPITAL TJ-135
TJ-135 IN on
on NN concanavalin
concanavalin DT CAPITAL A
A NN (
( RB con
con DT CAPITAL A
A NN )
) JJ -induced
-induced NN hepatitis
hepatitis IN in
in NNS mice
mice IN in
in FW vivo
vivo CC and
and RB con
con JJ CAPITAL A-induced
A-induced NN cytokine
cytokine NN production
production IN in
in NN vitro

These DT CAPITAL These
These NNS results
results VB suggest
suggest IN that
that RB con
con JJ CAPITAL A-induced
A-induced NN hepatitis
hepatitis VBD was
was VBN ameliorated
ameliorated IN by
by NN pretreatment
pretreatment IN with
with NN CAPITAL TJ-135

Therefore RB CAPITAL Therefore
Therefore NN administration
administration IN of
of NN CAPITAL TJ-135
TJ-135 MD may
may VB be
be JJ useful
useful IN in
in NNS patients
patients IN with
with JJ severe
severe JJ acute
acute NN hepatitis
hepatitis VBG accompanying
accompanying NN cholestasis
cholestasis CC or
or IN in
in DT those
those IN with
with JJ autoimmune
autoimmune NN hepatitis

Zinc NN CAPITAL Zinc
Zinc NNS lozenges
lozenges : --
-- DT a
a NN cure
cure IN for
for JJ common
common NNS colds
colds . ?

T-helper NN CAPITAL T-helper
T-helper NN type
type CD 2
2 JJ cell-directed
cell-directed NN therapy
therapy IN for
for NN asthma

Effects NNS CAPITAL Effects
Effects IN of
of DT the
the JJ CAPITAL Japanese
Japanese JJ herbal
herbal NN medicine
medicine NN 'Inchinko-to
'Inchinko-to '' '
' NN (
( NN CAPITAL TJ-135
TJ-135 NN )
) IN on
on NN concanavalin
concanavalin JJ CAPITAL A-induced
A-induced NN hepatitis
hepatitis IN in
in NNS mice

Presumed VBN CAPITAL Presumed
Presumed NNS cavernomas
cavernomas VB have
have VBN been
been VBN documented
documented VBG following
following NN radiation
radiation IN for
for NN malignancy
malignancy NN (
( CD 5-6
5-6 NN )
) , ,
, CC and
and JJ sterotactic
sterotactic JJ cerebral
cerebral NN biopsy
biopsy NN (
( CD 7
7 NN )

Surgical NNP CAPITAL Surgical
Surgical NN management
management IN of
of NN syringomyelia
syringomyelia VBN associated
associated IN with
with JJ spinal
spinal JJ adhesive
adhesive NN arachnoiditis

Discontinuation NN CAPITAL Discontinuation
Discontinuation IN of
of JJ secondary
secondary NN prophylaxis
prophylaxis IN for
for JJ cryptococcal
cryptococcal NN meningitis
meningitis IN in
in JJ CAPITAL HIV-infected
HIV-infected NNS patients
patients VBG responding
responding TO to
to RB highly
highly JJ active
active JJ antiretroviral
antiretroviral NN therapy

Hepatectomy NNP CAPITAL Hepatectomy
Hepatectomy IN for
for NN cholangiocarcinoma
cholangiocarcinoma VBN complicated
complicated IN with
with RB right
right JJ umbilical
umbilical NN portion
portion : :
: JJ anomalous
anomalous NN configuration
configuration IN of
of DT the
the JJ intrahepatic
intrahepatic JJ biliary
biliary NN tree

Traditionally RB CAPITAL Traditionally
Traditionally , ,
, DT the
the NN therapy
therapy IN of
of JJ symptomatic
symptomatic NN bronchiectasis
bronchiectasis VBZ is
is VBN based
based IN on
on NNS antibiotics
antibiotics , ,
, JJ antibronchoobstructive
antibronchoobstructive NN medication
medication , ,
, CC and
and NN chest
chest JJ physical
physical NN therapy

Bilateral JJ CAPITAL Bilateral
Bilateral NN lung
lung NN transplantation
transplantation MD should
should VB be
be VBN considered
considered IN in
in JJR younger
younger NNS patients
patients IN with
with JJ severe
severe , ,
, VBN generalized
generalized NN bronchiectasis
bronchiectasis CC and
and JJ respiratory
respiratory NN failure

Prospective JJ CAPITAL Prospective
Prospective , ,
, VBN randomized
randomized , ,
, JJ largescale
largescale NNS trials
trials VBG supporting
supporting DT any
any IN of
of DT the
the JJ different
different NN treatment
treatment NNS strategies
strategies VBP are
are RB not
not JJ available
available , ,
, CC but
but NNS antibiotics
antibiotics CC and
and NN surgery
surgery RB probably
probably VB have
have VBN improved
improved DT the
the JJ long-term
long-term NN outcome
outcome IN of
of JJ many
many NNS patients
patients IN with
with NN bronchiectasis

OBJECTIVES NNS CAPITAL OBJECTIVES
OBJECTIVES : :
: NN CAPITAL Interest
Interest IN in
in NN zinc
zinc IN as
as DT a
a NN treatment
treatment IN for
for DT the
the JJ common
common JJ cold
cold VBZ has
has VBN grown
grown VBG following
following DT the
the JJ recent
recent NN publication
publication IN of
of JJ several
several VBN controlled
controlled NNS trials

The DT CAPITAL The
The NN objective
objective IN of
of DT this
this NN review
review VBD was
was TO to
to VB assess
assess DT the
the NNS effects
effects IN of
of NN zinc
zinc NNS lozenges
lozenges IN for
for JJ cold
cold NNS symptoms

Results NNS CAPITAL Results
Results IN from
from CD two
two NNS trials
trials NN (
( NN 04
04 : -
- NNP CAPITAL Mossad
Mossad : ;
; CD 08
08 : -
- NNP CAPITAL Smith
Smith NN )
) VBN suggested
suggested NN zinc
zinc NNS lozenges
lozenges VBN reduced
reduced DT the
the NN severity
severity CC and
and NN duration
duration IN of
of JJ cold
cold NNS symptoms

Given VBN CAPITAL Given
Given DT the
the NN potential
potential IN for
for NN treatment
treatment TO to
to VB produce
produce NN side
side NNS effects
effects , ,
, DT the
the NN use
use IN of
of NN zinc
zinc NNS lozenges
lozenges TO to
to NN treat
treat JJ cold
cold NNS symptoms
symptoms VBZ deserves
deserves RB further
further NN study

Randomized VBN CAPITAL Randomized
Randomized NN trial
trial IN of
of NN interferon-alpha
interferon-alpha CC plus
plus JJ ursodeoxycholic
ursodeoxycholic NN acid
acid CC versus
versus NN interferon
interferon CC plus
plus NN placebo
placebo IN in
in NNS patients
patients IN with
with JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL C
C JJ resistant
resistant TO to
to NN interferon

We PRP CAPITAL We
We VBP describe
describe DT a
a JJ rare
rare NN case
case IN of
of JJ spontaneous
spontaneous NN rupture
rupture IN of
of DT a
a JJ hepatic
hepatic NN metastasis
metastasis IN from
from JJ renal
renal NN cell
cell NN carcinoma
carcinoma IN that
that VBD was
was VBN treated
treated RB successfully
successfully IN by
by JJ hepatic
hepatic JJ arterial
arterial NN embolization

A DT CAPITAL A
A JJ 65-year-old
65-year-old NN woman
woman , ,
, WP who
who VBD had
had VBN been
been VBG undergoing
undergoing NN immunotherapy
immunotherapy IN for
for RB inoperably
inoperably VBN disseminated
disseminated JJ renal
renal NN carcinoma
carcinoma CC and
and NN lung
lung NNS metastases
metastases , ,
, VBN presented
presented IN with
with JJ severe
severe JJ abdominal
abdominal NN pain
pain IN in
in DT a
a NN state
state IN of
of JJ hypovolemic
hypovolemic NN shock

Although IN CAPITAL Although
Although JJ hepatic
hepatic NN rupture
rupture JJ due
due TO to
to JJ metastatic
metastatic NN cancer
cancer VBZ is
is RB extremely
extremely JJ rare
rare , ,
, NN transcatheter
transcatheter JJ arterial
arterial NN embolization
embolization NN (
( NNP CAPITAL TAE
TAE NN )
) VBZ is
is DT an
an JJ appropriate
appropriate CC and
and JJ useful
useful NN treatment
treatment IN for
for JJ massive
massive NN hemorrhage
hemorrhage VBN caused
caused IN by
by JJ spontaneous
spontaneous NN rupture
rupture IN of
of NN liver
liver NN metastasis

Patients NNS CAPITAL Patients
Patients IN with
with JJ classical
classical NNS symptoms
symptoms JJ such
such IN as
as NN heartburn
heartburn CC and
and NN regurgitation
regurgitation MD may
may VB be
be VBN treated
treated RB pharmaceutically
pharmaceutically VBN combined
combined IN with
with NN life
life NN style
style VBG counselling

Surgical NNP CAPITAL Surgical
Surgical NN treatment
treatment VBZ is
is DT a
a JJ good
good NN alternative
alternative IN for
for NNS patients
patients IN with
with JJ persistent
persistent JJ severe
severe NN regurgitation
regurgitation IN during
during JJ medical
medical NN therapy
therapy CC and
and IN for
for JJ young
young NNS patients
patients WP who
who VBP prefer
prefer NN surgery
surgery TO to
to JJ lifelong
lifelong NN medication

The DT CAPITAL The
The JJ surgical
surgical NN treatment
treatment IN of
of NN lung
lung NNS lacerations
lacerations CC and
and JJ major
major JJ bronchial
bronchial NNS disruptions
disruptions VBN caused
caused IN by
by JJ blunt
blunt JJ thoracic
thoracic NN trauma

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: DT CAPITAL An
An VBG increasing
increasing NN number
number IN of
of NNS reports
reports VBP indicate
indicate JJ symptomatic
symptomatic NN relief
relief IN of
of JJ biliary
biliary JJ colic
colic NNS symptoms
symptoms IN after
after NN cholecystectomy
cholecystectomy IN for
for JJ biliary
biliary NN dyskinesia

Despite IN CAPITAL Despite
Despite DT this
this , ,
, NN cholecystectomy
cholecystectomy IN as
as DT a
a NN treatment
treatment IN for
for JJ biliary
biliary NN dyskinesia
dyskinesia NNS remains
remains JJ controversial

Our PRP$ CAPITAL Our
Our NN aim
aim VBD was
was TO to
to VB determine
determine NN efficacy
efficacy IN of
of NN cholecystectomy
cholecystectomy IN in
in VBG alleviating
alleviating JJ biliary
biliary NN dyskinesia
dyskinesia NNS symptoms
symptoms CC and
and DT the
the NN correlation
correlation IN with
with JJ histologic
histologic NNS findings

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: JJ CAPITAL Biliary
Biliary NN dyskinesia
dyskinesia NNS patients
patients WP who
who VBD underwent
underwent NN cholecystectomy
cholecystectomy VBD had
had RB significantly
significantly JJR greater
greater NN symptom
symptom NN improvement
improvement VBN compared
compared IN with
with JJ nonsurgical
nonsurgical NNS patients

Cholecystectomy NN CAPITAL Cholecystectomy
Cholecystectomy MD should
should VB be
be DT a
a NN first-line
first-line NN therapy
therapy IN for
for JJ biliary
biliary NN dyskinesia
dyskinesia NNS patients

Transbronchial JJ CAPITAL Transbronchial
Transbronchial NN biopsy
biopsy VBD revealed
revealed JJ inflammatory
inflammatory JJ nonspecific
nonspecific JJ alveolar
alveolar NNS lesions
lesions JJ suggestive
suggestive IN of
of NN bronchiolitis
bronchiolitis NNS obliterans
obliterans VBG organizing
organizing NN pneumonia
pneumonia , ,
, WDT which
which VBD responded
responded RB well
well RB clinically
clinically CC and
and RB radiologically
radiologically TO to
to JJ oral
oral NNS corticosteroids

Novel JJ CAPITAL Novel
Novel NN treatment
treatment NNS strategies
strategies IN for
for NNS patients
patients IN with
with VBN advanced
advanced NN CAPITAL NSCLC
NSCLC MD may
may VB involve
involve NN chemotherapy
chemotherapy VBN combined
combined IN with
with NN inhibition
inhibition IN of
of JJ CAPITAL NF-kappaB-dependent
NF-kappaB-dependent JJ cell-survival
cell-survival NNS pathways

Effectiveness NN CAPITAL Effectiveness
Effectiveness IN of
of NN pseudoephedrine
pseudoephedrine CC plus
plus NN acetaminophen
acetaminophen IN for
for NN treatment
treatment IN of
of NNS symptoms
symptoms VBN attributed
attributed TO to
to DT the
the NN paranasal
paranasal NNS sinuses
sinuses VBN associated
associated IN with
with DT the
the JJ common
common JJ cold

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: DT CAPITAL This
This NN retrospective
retrospective NN study
study VBD was
was VBN designed
designed TO to
to VB confirm
confirm IN that
that JJ aggressive
aggressive JJ pulmonary
pulmonary NN resection
resection MD can
can VB provide
provide JJ effective
effective JJ long-term
long-term NN palliation
palliation IN of
of NN disease
disease IN for
for NNS patients
patients IN with
with JJ pulmonary
pulmonary NN aspergilloma

METHODS NNS CAPITAL METHODS
METHODS CC CAPITAL AND
AND NNS CAPITAL RESULTS
RESULTS : :
: IN CAPITAL From
From CD 1959
1959 TO to
to CD 1998
1998 , ,
, CD 84
84 NNS patients
patients VBD underwent
underwent DT a
a NN total
total IN of
of CD 90
90 NNS operations
operations IN for
for NN treatment
treatment IN of
of JJ pulmonary
pulmonary NN aspergilloma
aspergilloma IN in
in DT the
the NNP CAPITAL Marie-Lannelongue
Marie-Lannelongue NN CAPITAL Hospital

The DT CAPITAL The
The NN lesion
lesion VBD was
was JJ resected
resected IN by
by JJ video-assisted
video-assisted JJ thoracoscopic
thoracoscopic NN surgery
surgery IN because
because PRP it
it VBD was
was VBN suspected
suspected IN of
of VBG being
being DT a
a NN lung
lung NN abscess
abscess IN that
that VBD had
had VBN caused
caused VBN repeated
repeated NNS episodes
episodes IN of
of NN inflammation

In IN CAPITAL In
In DT this
this NN study
study , ,
, PRP we
we VBN investigated
investigated DT the
the NN expression
expression CC and
and JJ therapeutic
therapeutic NN potential
potential IN of
of NN CAPITAL TRAIL
TRAIL IN in
in NN cholangiocarcinoma
cholangiocarcinoma , ,
, CD one
one IN of
of DT the
the RBS most
most VBG devastating
devastating JJ human
human JJ hepatic
hepatic NNS malignancies

Finally RB CAPITAL Finally
Finally , ,
, IN in
in FW vivo
vivo NN administration
administration IN of
of JJ recombinant
recombinant NN CAPITAL TRAIL
TRAIL RB substantially
substantially VBD inhibited
inhibited JJ subcutaneous
subcutaneous NN tumor
tumor NN growth
growth IN of
of JJ human
human NN cholangiocarcinoma
cholangiocarcinoma NNS cells

Induction NN CAPITAL Induction
Induction IN of
of NN apoptosis
apoptosis IN in
in NN tumor
tumor NNS cells
cells VBZ is
is JJ possible
possible IN with
with DT a
a RB biologically
biologically JJ active
active NN CAPITAL TRAIL
TRAIL , ,
, CC and
and VBZ suggests
suggests IN that
that DT this
this NN cytokine
cytokine VBZ is
is DT a
a VBG promising
promising NN antitumor
antitumor NN agent
agent IN against
against JJ human
human NN cholangiocarcinoma

Interferon NN CAPITAL Interferon
Interferon NNS plays
plays DT a
a JJ critical
critical NN role
role IN in
in DT the
the NN host
host POS 's
's JJ natural
natural NN defense
defense IN against
against JJ viral
viral NNS infections
infections CC and
and IN in
in PRP$ their
their NN treatment

This DT CAPITAL This
This NN study
study VBN investigated
investigated IN whether
whether JJ intensive
intensive NN chemotherapy
chemotherapy MD might
might VB have
have DT a
a JJ positive
positive NN effect
effect IN on
on NN asthma
asthma IN in
in DT these
these JJ special
special NNS cases
cases CC and
and IN whether
whether NN asthma
asthma RB generally
generally NNS relapses
relapses IN after
after NN completion
completion IN of
of NN chemotherapy

The DT CAPITAL The
The NNS authors
authors VBN monitored
monitored JJ clinical
clinical NN outcome
outcome CC and
and NN lung
lung NN function
function IN of
of CD 43
43 NNS children
children IN with
with JJ acute
acute JJ lymphoblastic
lymphoblastic NN leukemia
leukemia CC and
and JJ non-Hodgkin
non-Hodgkin NN lymphoma
lymphoma WP who
who VBN received
received NN chemotherapy
chemotherapy IN at
at DT the
the NNP CAPITAL University
University NNS CAPITAL Children
Children POS 's
's NN CAPITAL Hospital
Hospital IN of
of NNP CAPITAL Greifswald
Greifswald IN between
between CD 1993
1993 CC and
and CD 1998

She PRP CAPITAL She
She VBD was
was VBN diagnosed
diagnosed IN as
as JJ miliary
miliary NN tuberculosis
tuberculosis CC and
and VBN treated
treated IN with
with JJ antituberculous
antituberculous NNS drugs

The DT CAPITAL The
The NN hemorrhage
hemorrhage VBD was
was RB successfully
successfully VBD stopped
stopped IN by
by NN microcoil
microcoil NN embolization

Immunomodulatory JJ CAPITAL Immunomodulatory
Immunomodulatory NNS effects
effects IN of
of NN acupuncture
acupuncture IN in
in DT the
the NN treatment
treatment IN of
of JJ allergic
allergic NN asthma
asthma : :
: DT a
a VBN randomized
randomized VBN controlled
controlled NN study

An DT CAPITAL An
An JJ open-label
open-label NN study
study IN of
of NN lamivudine
lamivudine IN for
for JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL B
B IN in
in CD six
six NNS patients
patients IN with
with JJ chronic
chronic JJ renal
renal NN failure
failure IN before
before CC and
and IN after
after NN kidney
kidney NN transplantation

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: DT CAPITAL The
The NN CAPITAL WDTA
WDTA VBZ is
is DT an
an RB intrinsically
intrinsically VBG motivating
motivating JJ educational
educational NN program
program IN that
that VBZ has
has DT the
the NN ability
ability TO to
to NN effect
effect NNS determinants
determinants IN of
of NN asthma
asthma NN self-management
self-management NN behavior
behavior IN in
in CD 9-
9- TO to
to JJ 13-year-old
13-year-old NNS children
children IN with
with NN asthma

Usefulness NN CAPITAL Usefulness
Usefulness IN of
of JJ percutaneous
percutaneous JJ transhepatic
transhepatic JJ biliary
biliary NN drainage
drainage IN in
in NNS patients
patients IN with
with JJ surgical
surgical NN jaundice
jaundice : --
-- DT a
a JJ prospective
prospective VBN randomised
randomised NN study

Neutralization NN CAPITAL Neutralization
Neutralization IN of
of NN hepatitis
hepatitis DT CAPITAL A
A NN virus
virus NN (
( NN CAPITAL HAV
HAV NN )
) IN by
by DT an
an NN immunoadhesin
immunoadhesin VBG containing
containing DT the
the JJ cysteine-rich
cysteine-rich NN region
region IN of
of NN CAPITAL HAV
HAV JJ cellular
cellular NN receptor-1

To TO CAPITAL To
To VB ascertain
ascertain DT the
the NNS results
results IN of
of NN standard
standard NN CAPITAL ABVD
ABVD NN chemotherapy
chemotherapy NN (
( NN doxorubicin
doxorubicin , ,
, NN bleomycin
bleomycin , ,
, NN vinblastine
vinblastine , ,
, NN dacarbazine
dacarbazine NN )
) IN in
in JJ CAPITAL HIV-infected
HIV-infected NNS patients
patients IN with
with RB newly
newly VBN diagnosed
diagnosed NN CAPITAL Hodgkin
Hodgkin POS 's
's NN disease
disease NN (
( NN CAPITAL HD
HD NN )
) , ,
, DT a
a JJ nonrandomized
nonrandomized , ,
, JJ prospective
prospective , ,
, JJ multiinstitutional
multiinstitutional JJ clinical
clinical NN trial
trial VBD was
was VBN conducted
conducted IN by
by DT the
the NN CAPITAL AIDS
AIDS JJ CAPITAL Clinical
Clinical NNS CAPITAL Trials
Trials NNP CAPITAL Group
Group NN (
( NN CAPITAL ACTG
ACTG NN )
) , ,
, IN in
in JJ CAPITAL HIV-infected
HIV-infected NNS patients
patients IN with
with NN CAPITAL Hodgkin
Hodgkin POS 's
's NN disease

The DT CAPITAL The
The NN effectiveness
effectiveness IN of
of NNS glucocorticoids
glucocorticoids IN in
in VBG treating
treating NN croup
croup : :
: NN meta-analysis
meta-analysis NN (
( VB see
see NNS comments
comments NN )

PURPOSE NN CAPITAL PURPOSE
PURPOSE : :
: VBN CAPITAL Inhaled
Inhaled NNS corticosteroids
corticosteroids VB have
have JJ beneficial
beneficial NNS effects
effects IN on
on JJ pulmonary
pulmonary NN function
function CC and
and NN inflammation
inflammation IN in
in NNS patients
patients IN with
with NN asthma
asthma , ,
, CC but
but PRP they
they RB also
also NN cause
cause JJ systemic
systemic JJ adverse
adverse NNS effects
effects , ,
, JJ such
such IN as
as JJ adrenal
adrenal NN suppression

Second JJ CAPITAL Second
Second , ,
, NNS children
children IN in
in DT the
the RB first
first NN year
year IN of
of NN life
life VBP are
are IN at
at JJS highest
highest NN risk
risk IN of
of NN progression
progression CC and
and MD should
should VB be
be VBN treated
treated IN with
with NN trimethoprim-sulfamethoxazole
trimethoprim-sulfamethoxazole TO to
to VB prevent
prevent NN CAPITAL Pneumocystis
Pneumocystis NN carinii
carinii NN pneumonia
pneumonia , ,
, CC and
and VBN targeted
targeted IN for
for VBG receiving
receiving NNS antiretrovirals

Effectiveness NN CAPITAL Effectiveness
Effectiveness IN of
of NN casein
casein NN hydrolysate
hydrolysate NNS feedings
feedings IN in
in NNS infants
infants IN with
with JJ colic
colic NN (
( VB see
see NNS comments
comments NN )

We PRP CAPITAL We
We VBP conclude
conclude IN that
that NN antimicrobial/
antimicrobial/ JJ antituberculous
antituberculous NNS agents
agents VB have
have RB only
only DT a
a JJ minor
minor JJ short-term
short-term NN effect
effect IN in
in JJ long-lasting
long-lasting NNP CAPITAL CGM
CGM IN of
of JJ undetermined
undetermined NN cause

The DT CAPITAL The
The NN patient
patient VBD had
had RB previously
previously VBN been
been VBN immunized
immunized IN with
with CD two
two NNS doses
doses IN of
of NN CAPITAL Hib
Hib NN conjugate
conjugate NN vaccine
vaccine NN (
( NN CAPITAL PRP-T
PRP-T NN )

Thus RB CAPITAL Thus
Thus , ,
, NN s-ECP
s-ECP VBZ appears
appears TO to
to VB be
be DT a
a JJ useful
useful NN marker
marker IN for
for VBG determining
determining WRB when
when DT a
a JJ step-down
step-down IN in
in NN iBDP
iBDP NN therapy
therapy VBZ is
is VBD indicated
indicated , ,
, CC and
and RB thus
thus MD may
may VB contribute
contribute TO to
to JJ successful
successful JJ long-term
long-term NN management
management IN of
of JJ chronic
chronic NN asthma

Twinrix NNP CAPITAL Twinrix
Twinrix NN (
( NNP CAPITAL SmithKline
SmithKline NNP CAPITAL Beecham
Beecham NNS CAPITAL Biologicals
Biologicals NN )
) VBZ is
is DT a
a VBN combined
combined NN hepatitis
hepatitis DT CAPITAL A
A CC and
and NN CAPITAL B
B NN vaccine
vaccine JJ licensed
licensed IN with
with DT a
a JJ three-dose
three-dose NN schedule

A DT CAPITAL A
A JJ two-dose
two-dose VBN combined
combined NN hepatitis
hepatitis DT CAPITAL A
A CC and
and NN CAPITAL B
B NN vaccine
vaccine MD would
would VB facilitate
facilitate NN immunisation
immunisation NNS programs

Therefore RB CAPITAL Therefore
Therefore , ,
, PRP it
it MD can
can VB be
be VBD concluded
concluded IN that
that IN with
with CD two
two NNS injections
injections IN of
of DT the
the JJ high-dose
high-dose NN hepatitis
hepatitis DT CAPITAL A
A CC and
and NN CAPITAL B
B NN vaccine
vaccine , ,
, CD 6
6 NNS months
months RB apart
apart , ,
, DT a
a JJ similar
similar JJ immune
immune NN response
response MD can
can VB be
be VBN obtained
obtained IN as
as VBN induced
induced IN with
with CD three
three NNS doses
doses IN of
of NNP CAPITAL Twinrix
Twinrix IN at
at NNS months
months CD 0
0 , ,
, CD 1
1 CC and
and CD 6

AIM NN CAPITAL AIM
AIM : :
: TO CAPITAL To
To VB assess
assess DT the
the NN impact
impact IN on
on JJ community-based
community-based NNS pediatricians
pediatricians IN of
of DT the
the NNS conclusions
conclusions IN of
of DT the
the JJ 10th
10th NN CAPITAL Conference
Conference IN de
de NN CAPITAL Consensus
Consensus IN en
en NN CAPITAL Therapeutique
Therapeutique NNP CAPITAL Anti-Infectieuse
Anti-Infectieuse NN (
( NN CAPITAL CCTAI
CCTAI NN )
) IN on
on DT the
the JJ antibiotic
antibiotic NN treatment
treatment IN in
in JJ acute
acute NN nasopharyngitis
nasopharyngitis NN (
( NN CAPITAL ANP
ANP NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL These
These NNS data
data , ,
, DT the
the RB first
first NN evidence
evidence IN that
that JJ chronic
chronic NN stress
stress MD can
can VB inhibit
inhibit DT the
the NN stability
stability IN of
of DT the
the NN CAPITAL IgG
IgG NN antibody
antibody NN response
response TO to
to DT a
a JJ bacterial
bacterial NN vaccine
vaccine IN for
for NN pneumonia
pneumonia , ,
, VB provide
provide JJ additional
additional NN evidence
evidence IN of
of NN health
health NNS risks
risks VBN associated
associated IN with
with NN dementia
dementia NN caregiving

We PRP CAPITAL We
We VBN assessed
assessed DT the
the NN prevalence
prevalence IN of
of NN head
head NN louse
louse NN infestation
infestation CC and
and DT the
the NN effectiveness
effectiveness IN of
of CD 1
1 NN %
% NN permethrin
permethrin IN against
against NN head
head NN lice
lice IN in
in NNP CAPITAL Kosovar
Kosovar NNS refugees

Refugees NNS CAPITAL Refugees
Refugees IN with
with VBG crawling
crawling NN lice
lice VBD were
were VBN treated
treated IN with
with DT a
a NN pediculicide
pediculicide VBG containing
containing CD 1
1 NN %
% NN permethrin

We PRP CAPITAL We
We VBP conclude
conclude IN that
that CD 1
1 NN %
% NN permethrin
permethrin NN treatment
treatment VBD was
was JJ effective
effective IN in
in NN louse
louse NN control
control IN in
in DT this
this NN refugee
refugee NN population

Antibiotics NNS CAPITAL Antibiotics
Antibiotics IN for
for FW CAPITAL Salmonella
Salmonella NN meningitis
meningitis IN in
in NNS children

Four CD CAPITAL Four
Four NNS patients
patients VBN developed
developed JJ mild
mild NN pancreatitis
pancreatitis , ,
, CD one
one VBD had
had JJ moderate
moderate NN pancreatitis
pancreatitis CC and
and CD one
one VBD had
had NN leak
leak IN of
of NN contrast
contrast , ,
, WDT which
which VBD was
was VBN treated
treated IN by
by NN administration
administration IN of
of JJ clear
clear NNS fluids
fluids RB orally
orally IN for
for CD one
one NN day

We PRP CAPITAL We
We VBN treated
treated CD two
two NNS children
children IN with
with JJ influenza-associated
influenza-associated JJ acute
acute NN encephalopathy
encephalopathy IN by
by DT a
a NN combination
combination IN of
of JJ mild
mild NN hypothermia
hypothermia CC and
and NN steroid
steroid NN pulse
pulse NN therapy

Successful JJ CAPITAL Successful
Successful NN treatment
treatment IN of
of JJ anaerobic
anaerobic JJ pleuropulmonary
pleuropulmonary NNS infections
infections VBZ requires
requires DT a
a NN combination
combination IN of
of JJ antibiotic
antibiotic NN therapy
therapy CC and
and JJ surgical
surgical NNS interventions

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ spontaneous
spontaneous JJ carotid-cavernous
carotid-cavernous NN fistula
fistula IN in
in NNP CAPITAL Ehlers-Danlos
Ehlers-Danlos NN syndrome
syndrome IN by
by JJ transvenous
transvenous NN occlusion
occlusion IN with
with NNP CAPITAL Guglielmi
Guglielmi JJ detachable
detachable NNS coils

PURPOSE NN CAPITAL PURPOSE
PURPOSE : :
: NN CAPITAL Macrolide
Macrolide NNS antibiotics
antibiotics VBP are
are RB frequently
frequently VBN prescribed
prescribed TO to
to NNS patients
patients IN with
with NNS symptoms
symptoms IN of
of DT a
a JJ common
common JJ cold

Because IN CAPITAL Because
Because DT the
the NNS symptoms
symptoms IN of
of NN rhinovirus
rhinovirus NNS colds
colds VBP are
are VBN attributed
attributed TO to
to DT the
the JJ inflammatory
inflammatory NN response
response TO to
to NN infection
infection , ,
, PRP we
we VBN studied
studied DT the
the NNS effects
effects IN of
of NN treatment
treatment IN with
with NN clarithromycin
clarithromycin IN on
on DT the
the JJ symptomatic
symptomatic CC and
and JJ inflammatory
inflammatory NN response
response TO to
to JJ nasal
nasal NN inoculation
inoculation IN with
with NN rhinovirus

Therapeutic JJ CAPITAL Therapeutic
Therapeutic NN pneumothorax
pneumothorax NN (
( NN CAPITAL TP
TP NN )
) VBN proved
proved PRP$ its
its NN efficacy
efficacy IN in
in JJ pre-antibiotic
pre-antibiotic NN era
era , ,
, RB so
so CD one
one MD can
can VB assume
assume IN that
that PRP it
it MD can
can VB be
be VBN applied
applied IN with
with DT the
the JJ same
same NN success
success IN in
in JJ multidrug
multidrug JJ resistant
resistant NN CAPITAL TB

In IN CAPITAL In
In NN conclusion
conclusion , ,
, IN in
in DT some
some NNS cases
cases IN of
of NN CAPITAL MDR
MDR NN CAPITAL TB
TB , ,
, DT the
the NN CAPITAL TP
TP NN (
( IN if
if RB there
there VBP are
are DT no
no JJ pleural
pleural NNS adherences
adherences NN )
) MD may
may NN lead
lead TO to
to JJ good
good NNS results

Acupuncture NN CAPITAL Acupuncture
Acupuncture NN treatment
treatment IN of
of JJ common
common JJ cold

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL These
These NNS data
data , ,
, DT the
the RB first
first NN evidence
evidence IN that
that JJ chronic
chronic NN stress
stress MD can
can VB inhibit
inhibit DT the
the NN stability
stability IN of
of DT the
the NN CAPITAL IgG
IgG NN antibody
antibody NN response
response TO to
to DT a
a JJ bacterial
bacterial NN vaccine
vaccine IN for
for NN pneumonia
pneumonia , ,
, VB provide
provide JJ additional
additional NN evidence
evidence IN of
of NN health
health NNS risks
risks VBN associated
associated IN with
with NN dementia
dementia NN caregiving

When WRB CAPITAL When
When VBG bleeding
bleeding VBZ is
is VBD stopped
stopped IN via
via JJ surgical
surgical CC or
or JJ radiological
radiological NNS methods
methods , ,
, DT the
the JJ clinical
clinical NN course
course IN of
of JJ hemobilia-associated
hemobilia-associated NN pancreatitis
pancreatitis VBZ appears
appears TO to
to VB be
be JJ benign

A DT CAPITAL A
A NN case
case IN of
of JJ biliary
biliary NN stenosis
stenosis IN in
in JJ polycystic
polycystic NN liver
liver VBN improved
improved IN by
by NN injection
injection IN of
of NN minocycline
minocycline NN hydrochloride
hydrochloride TO to
to DT a
a JJ hepatic
hepatic NN cyst

The DT CAPITAL The
The VBN ruptured
ruptured NN horn
horn VBD was
was VBN excised
excised IN by
by NN laparotomy

Therapy NN CAPITAL Therapy
Therapy VBN designed
designed TO to
to NN control
control DT the
the NN efferent
efferent NN phase
phase IN of
of VBN established
established NN asthma
asthma IN by
by VBG augmenting
augmenting JJ down-regulatory
down-regulatory NN CAPITAL Th1
Th1 VBG counterbalancing
counterbalancing NNS mechanisms
mechanisms MD should
should VB be
be JJ effective

All DT CAPITAL All
All NNS children
children IN with
with NN croup
croup NNS symptoms
symptoms WP who
who VB demonstrate
demonstrate VBN increased
increased NN work
work IN of
of NN breathing
breathing IN in
in DT the
the NNS clinics
clinics CC or
or NN emergency
emergency NNS departments
departments MD should
should VB be
be VBN treated
treated IN with
with NNS glucocorticoids

Increasing VBG CAPITAL Increasing
Increasing NN resistance
resistance IN among
among DT the
the JJ common
common JJ respiratory
respiratory NNS pathogens
pathogens VBZ has
has JJ encouraged
encouraged NN assessment
assessment IN of
of NN alternative
alternative NNS agents
agents , ,
, IN for
for NN example
example , ,
, NN levofloxacin

Unlike IN CAPITAL Unlike
Unlike RB earlier
earlier NNS quinolones
quinolones , ,
, NN levofloxacin
levofloxacin VBZ has
has JJ excellent
excellent NN activity
activity IN against
against NN CAPITAL Streptococcus
Streptococcus FW pneumoniae
pneumoniae , ,
, VBG including
including NNS strains
strains JJ resistant
resistant TO to
to NN penicillin

Clinical JJ CAPITAL Clinical
Clinical NNS trials
trials NN show
show NN levofloxacin
levofloxacin TO to
to VB be
be IN as
as JJ effective
effective IN as
as NNS cephalosporins
cephalosporins IN in
in JJ acute
acute NN exacerbation
exacerbation IN of
of JJ chronic
chronic NN bronchitis
bronchitis CC and
and IN as
as JJ effective
effective IN as
as NN co-amoxiclav
co-amoxiclav , ,
, NNS cephalosporins
cephalosporins CC or
or NN amoxycillin
amoxycillin IN in
in JJ community-acquired
community-acquired NN pneumonia

Additionally RB CAPITAL Additionally
Additionally , ,
, JJ epidemiologic
epidemiologic NN evidence
evidence IN of
of DT a
a JJ marked
marked NN decline
decline IN in
in JJ new
new NN CAPITAL KS
KS IN since
since DT the
the JJ widespread
widespread NN use
use IN of
of RB highly
highly JJ active
active JJ antiretroviral
antiretroviral NN therapy
therapy NN (
( NNP CAPITAL HAART
HAART NN )
) NNS advocates
advocates PRP$ its
its NN use

A DT CAPITAL A
A NN field
field NN study
study VBD was
was VBD carried
carried IN out
out TO to
to VB evaluate
evaluate DT the
the NN effect
effect IN of
of NN vaccination
vaccination IN against
against NNS swine
swine JJ enzootic
enzootic NN pneumonia
pneumonia IN in
in JJ different
different NN production
production NNS systems
systems NN (
( VBN closed
closed CC or
or JJ one-site
one-site , ,
, CC and
and JJ open
open , ,
, CD two-
two- CC or
or JJ three-site
three-site , ,
, NNS systems
systems NN )

Humoral JJ CAPITAL Humoral
Humoral JJ immune
immune NN response
response IN after
after NN vaccination
vaccination IN against
against NN influenza
influenza IN in
in NNS patients
patients IN with
with NN breast
breast NN cancer

Gingyo-san JJ CAPITAL Gingyo-san
Gingyo-san CC and
and PRP$ its
its NNS components
components VBD were
were VBN administered
administered RB orally
orally TO to
to NNS mice
mice CD 1
1 NN day
day IN before
before , ,
, RB then
then CD 1
1 CC and
and CD 4
4 NNS days
days IN after
after DT the
the NN inhalation
inhalation IN of
of DT a
a JJ mouse-adopted
mouse-adopted NN strain
strain IN of
of NN influenza
influenza NN CAPITAL A2
A2 NN (
( NN CAPITAL H2N2
H2N2 NN )
) NN virus

From IN CAPITAL From
From DT these
these NNS results
results JJ CAPITAL Gingyo-san
Gingyo-san VBD was
was VBN shown
shown TO to
to VB be
be DT an
an JJ antiviral
antiviral NN agent
agent IN in
in NNS mice
mice JJ infected
infected IN with
with DT a
a JJ lethal
lethal NN amount
amount IN of
of DT a
a JJ mouse-adopted
mouse-adopted NN strain
strain IN of
of NN influenza
influenza NN CAPITAL A2
A2 NN virus

The DT CAPITAL The
The NN purpose
purpose IN of
of DT the
the JJ present
present NN study
study VBD was
was TO to
to VB analyze
analyze DT the
the NN association
association IN of
of JJ recurrent
recurrent JJ abdominal
abdominal NN pain
pain CC and
and NNP CAPITAL H.
H. NN pylori
pylori NN infection
infection IN in
in NNS children
children CC and
and TO to
to VB evaluate
evaluate DT the
the NN efficacy
efficacy IN of
of JJ antimicrobial
antimicrobial NN treatment
treatment IN in
in NNS patients
patients IN with
with NN evidence
evidence IN of
of NN infection

Patients NNS CAPITAL Patients
Patients IN with
with NN evidence
evidence IN of
of NN infection
infection IN with
with NNP CAPITAL H.
H. NN pylori
pylori VBD were
were VBN treated
treated IN with
with DT a
a NN combination
combination IN of
of NN omeprazole
omeprazole , ,
, NNP amoxicillin
amoxicillin , ,
, CC and
and NN clarithromycin

Treatment NN CAPITAL Treatment
Treatment IN with
with NN omeprazole
omeprazole , ,
, NNP amoxicillin
amoxicillin , ,
, CC and
and NN clarithromycin
clarithromycin VBD resulted
resulted IN in
in NN eradication
eradication IN of
of DT the
the NN infection
infection IN in
in DT all
all CC and
and IN in
in NN resolution
resolution IN of
of DT the
the JJ clinical
clinical NNS symptoms
symptoms IN in
in CD 15
15 NN (
( CD 80
80 NN %
% NN )
) IN of
of CD 19
19 NNS patients
patients WP who
who VBD had
had DT a
a NN follow-up
follow-up NN examination

A DT CAPITAL A
A VBN combined
combined NN therapy
therapy NNS results
results IN in
in NN eradication
eradication IN of
of DT the
the NN bacterium
bacterium CC and
and IN in
in NN improvement
improvement IN of
of DT the
the JJ clinical
clinical NNS symptoms
symptoms IN in
in DT a
a JJ significant
significant NN majority
majority IN of
of DT the
the NNS patients

In IN CAPITAL In
In JJ certain
certain JJ clinical
clinical NNS settings
settings , ,
, JJ interventional
interventional JJ radiologic
radiologic NNS procedures
procedures VB have
have VB become
become DT an
an JJ important
important NN alternative
alternative TO to
to NN surgery
surgery IN in
in DT the
the NN treatment
treatment IN of
of NNS gallstones
gallstones CC and
and PRP$ their
their NNS complications
complications : ;
; NNS techniques
techniques VB include
include JJ percutaneous
percutaneous NN cholecystostomy
cholecystostomy CC and
and NN gallstone
gallstone NN removal

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: DT CAPITAL The
The NN administration
administration IN of
of NN salbutamol
salbutamol VBZ is
is VBN permitted
permitted RB only
only IN by
by NN inhalation
inhalation IN by
by DT the
the NNP CAPITAL International
International NNP CAPITAL Olympic
Olympic NNP CAPITAL Committee
Committee NN (
( NNP CAPITAL IOC
IOC NN )
) IN for
for DT the
the NN management
management IN of
of NN asthma
asthma CC and
and JJ exercise-induced
exercise-induced NN asthma
asthma IN in
in NNS athletes

Urine NN CAPITAL Urine
Urine VBD was
was RB also
also VBN obtained
obtained IN from
from NNS subjects
subjects WP who
who VBD had
had VBN received
received DT the
the NN maximum
maximum NN dosage
dosage IN of
of VBN inhaled
inhaled NN salbutamol
salbutamol JJ advisable
advisable IN for
for VBG competing
competing NNS athletes
athletes TO to
to VB provide
provide NN protection
protection IN from
from JJ exercise-induced
exercise-induced NN asthma
asthma CC and
and NN treatment
treatment IN of
of NN asthma
asthma NN (
( CD 1600
1600 NN microg
microg IN in
in CD 24
24 NN h
h , ,
, CD 800
800 NN microg
microg VBG being
being IN in
in DT the
the JJ last
last CD 4
4 NN h
h NN )

Antimicrobials NNS CAPITAL Antimicrobials
Antimicrobials VBD were
were VBN prescribed
prescribed TO to
to CD 175
175 NN (
( CD 83.73
83.73 IN per
per NN cent
cent NN )
) NNS patients
patients IN with
with JJ common
common JJ cold
cold CC and
and CD 78
78 NN (
( NN 82.11
82.11 IN per
per NN cent
cent NN )
) NNS patients
patients IN with
with NN diarrhea

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO to
to VB evaluate
evaluate DT the
the JJ possible
possible NN existence
existence IN of
of DT the
the JJ so-called
so-called JJR <
< NN CAPITAL Roux-en-Y
Roux-en-Y NN syndrome
syndrome JJR >
> IN in
in DT a
a NN group
group IN of
of CD 21
21 NNS patients
patients WP who
who VBD underwent
underwent NN surgery
surgery TO to
to JJ correct
correct JJ postoperative
postoperative NN alkaline
alkaline NN reflux
reflux NN gastritis

All DT CAPITAL All
All VBD had
had VBN undergone
undergone NNP CAPITAL Billroth
Billroth NNP CAPITAL II
II JJ subtotal
subtotal NN gastrectomy
gastrectomy NN (
( CD 20
20 IN for
for NN ulcer
ulcer CC and
and CD 1
1 IN for
for JJ gastric
gastric NN cancer
cancer NN )

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: PRP we
we VBN found
found DT no
no NN evidence
evidence IN of
of NNS disturbances
disturbances IN in
in JJ gastric
gastric NN remnant
remnant VBG emptying
emptying IN after
after NN CAPITAL Roux-en-Y
Roux-en-Y NN gastrojejunostomy
gastrojejunostomy TO to
to NN treat
treat JJ postoperative
postoperative NN alkaline
alkaline JJ gastric
gastric NN reflux

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: NN CAPITAL Drainage
Drainage NNS methods
methods IN for
for DT the
the JJ gastric
gastric NN conduit
conduit IN after
after NN esophagectomy
esophagectomy IN for
for NN carcinoma
carcinoma VB have
have VBN been
been JJ controversial

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: DT CAPITAL This
This NN study
study VBZ indicates
indicates IN that
that DT the
the NN use
use IN of
of DT a
a NN computerized
computerized NN physician
physician NN reminder
reminder CC and
and DT a
a VBN mailed
mailed NN patient
patient NN reminder
reminder VBD had
had DT a
a JJ positive
positive NN impact
impact IN on
on NN influenza
influenza NNS immunizations
immunizations IN for
for JJR older
older NNS adults
adults IN in
in DT a
a JJ large
large NN family
family NN practice
practice NN office

Contemporary NNP CAPITAL Contemporary
Contemporary NN asthma
asthma NN management
management NNS guidelines
guidelines NN list
list VBN inhaled
inhaled NNS corticosteroids
corticosteroids IN as
as DT the
the VBN preferred
preferred NN controller
controller NN medication
medication IN for
for NNS patients
patients IN with
with JJ persistent
persistent NN asthma

Fluticasone NN CAPITAL Fluticasone
Fluticasone NN propionate
propionate VBZ is
is CD one
one IN of
of JJ several
several VBN inhaled
inhaled NNS corticosteroids
corticosteroids VBN used
used IN for
for DT the
the NN treatment
treatment IN of
of NN asthma

A DT CAPITAL A
A NN series
series IN of
of JJ comparative
comparative NNS analyses
analyses NN show
show IN that
that VBN inhaled
inhaled NN fluticasone
fluticasone NN propionate
propionate VBZ is
is RBR more
more NN cost
cost JJ effective
effective IN than
than JJ oral
oral NN zafirlukast
zafirlukast CC and
and NN triamcinolone
triamcinolone NN acetonide
acetonide CC and
and RB slightly
slightly RBR more
more NN cost
cost JJ effective
effective IN than
than NN flunisolide
flunisolide IN in
in JJ adult
adult NNS patients
patients IN with
with NN asthma

Quality-of-life NN CAPITAL Quality-of-life
Quality-of-life NNS assessments
assessments IN in
in NNS patients
patients IN with
with JJ mild
mild TO to
to JJ moderate
moderate NN disease
disease NN show
show IN that
that VBN inhaled
inhaled NN fluticasone
fluticasone NN propionate
propionate VBN achieved
achieved NNS improvements
improvements WDT which
which VBD were
were VBN deemed
deemed TO to
to VB be
be RB clinically
clinically JJ meaningful
meaningful IN in
in NNS patients
patients IN with
with JJ mild
mild TO to
to JJ moderate
moderate NN asthma
asthma : ;
; DT these
these NNS changes
changes VBD were
were RB significantly
significantly JJR greater
greater IN than
than DT those
those VBN achieved
achieved IN with
with JJ oral
oral NN zafirlukast
zafirlukast , ,
, VBN inhaled
inhaled NN triamcinolone
triamcinolone NN acetonide
acetonide CC or
or NN placebo

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: IN CAPITAL In
In NN addition
addition TO to
to DT the
the JJ considerable
considerable NN body
body IN of
of JJ clinical
clinical NN evidence
evidence VBG supporting
supporting DT the
the NN use
use IN of
of VBN inhaled
inhaled NN fluticasone
fluticasone NN propionate
propionate IN in
in NNS patients
patients IN with
with NN asthma
asthma , ,
, VBG accumulating
accumulating RB short
short NN term
term NN cost-effectiveness
cost-effectiveness NNS data
data RB also
also VB suggest
suggest IN that
that DT this
this NN agent
agent MD can
can VB be
be VBN administered
administered IN for
for DT a
a JJ similar
similar CC or
or JJR lower
lower NN cost
cost IN per
per NN outcome
outcome IN than
than JJ other
other VBN inhaled
inhaled NNS corticosteroids
corticosteroids CC or
or JJ oral
oral NN zafirlukast

Importantly RB CAPITAL Importantly
Importantly , ,
, DT the
the JJ clinical
clinical NNS benefits
benefits VBN offered
offered IN by
by NN fluticasone
fluticasone NN propionate
propionate IN in
in NNS patients
patients IN with
with JJ persistent
persistent NN asthma
asthma VBP are
are VBN accompanied
accompanied IN by
by RB clinically
clinically JJ significant
significant NNS improvements
improvements IN in
in NN quality
quality IN of
of NN life

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VBP describe
describe DT the
the NN effect
effect IN of
of NN influenza
influenza NN vaccination
vaccination IN on
on JJ long-term
long-term NN change
change IN in
in NN CAPITAL CD4
CD4 NN count
count CC and
and NN CAPITAL HIV
HIV NN CAPITAL RNA
RNA NN level
level , ,
, CC and
and IN on
on NN progression
progression TO to
to NN CAPITAL AIDS
AIDS CC or
or NN death

Combination NN CAPITAL Combination
Combination NN therapy
therapy IN with
with NN interferon-alpha
interferon-alpha NN (
( NN CAPITAL IFN
IFN NN alpha
alpha NN )
) CC plus
plus NNP CAPITAL Ribavirin
Ribavirin VBZ has
has VBN been
been VBN shown
shown TO to
to VB improve
improve DT the
the NN response
response NN rate
rate IN in
in NNS patients
patients IN with
with JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL C
C IN as
as VBN compared
compared TO to
to NN CAPITAL IFN
IFN NN alpha
alpha RB alone

To TO CAPITAL To
To VB prove
prove , ,
, IN whether
whether NNP CAPITAL Ribavirin
Ribavirin VBZ has
has DT any
any JJ additional
additional NN effect
effect IN on
on DT the
the NN decline
decline IN of
of NN hepatitis
hepatitis NN CAPITAL C
C NN viremia
viremia IN during
during DT the
the RB first
first NNS weeks
weeks IN of
of NN treatment
treatment NNS patients
patients IN with
with CC and
and IN without
without NN combination
combination NN therapy
therapy VBD were
were VBN compared

In IN CAPITAL In
In NNS patients
patients IN with
with NN combination
combination NN therapy
therapy , ,
, DT a
a RB further
further NN reduction
reduction IN of
of NN viremia
viremia NN level
level MD could
could VB be
be VBN observed
observed , ,
, IN whereas
whereas NN viremia
viremia NNS levels
levels IN in
in NNS patients
patients IN with
with NN CAPITAL IFN
IFN NN alpha
alpha RB alone
alone RB slightly
slightly VBN increased

Ribavirin NNP CAPITAL Ribavirin
Ribavirin IN in
in NN combination
combination IN with
with NN CAPITAL IFN
IFN NN alpha
alpha VBZ exerts
exerts DT an
an JJ additional
additional JJ anti-viral/immunmodulatory
anti-viral/immunmodulatory NN effect
effect WDT which
which VBZ manifests
manifests PRP itself
itself IN in
in NN phase
phase CD 2
2 IN of
of NN hepatitis
hepatitis NN CAPITAL C
C NN viremia
viremia NN decline

Surgical NNP CAPITAL Surgical
Surgical NN clearance
clearance IN of
of NN CAPITAL CBD
CBD NNS stones
stones VBD was
was VBN achieved
achieved IN in
in CD 58
58 NNS patients
patients NN (
( CD 93.5
93.5 NN %
% : ;
; NN group
group NN CAPITAL Ia
Ia NN )

Use NN CAPITAL Use
Use IN of
of NN CAPITAL ES
ES TO to
to NN treat
treat NN CAPITAL CBD
CBD NNS stones
stones IN on
on DT a
a JJ routine
routine NN basis
basis VBD was
was RB therefore
therefore RB not
not VBN found
found TO to
to VB be
be DT any
any RB better
better IN than
than JJ one-time
one-time JJ surgical
surgical NN exploration

Effect NN CAPITAL Effect
Effect IN of
of NN cholecystectomy
cholecystectomy IN on
on NN gastroesophageal
gastroesophageal CC and
and JJ duodenogastric
duodenogastric NN reflux

It PRP CAPITAL It
It VBZ is
is VBN suggested
suggested IN that
that VBN damaged
damaged JJ mucosal
mucosal NNS tissues
tissues IN with
with NN CAPITAL AHF
AHF MD can
can VB be
be RB effectively
effectively VBN compensated
compensated IN by
by VBN enhanced
enhanced NN regeneration
regeneration NN response
response JJ due
due TO to
to DT an
an RB adequately
adequately JJ high
high NN dose
dose NN intensity
intensity , ,
, VBG suggesting
suggesting DT a
a JJ possible
possible NN tolerability
tolerability NN advantage
advantage IN for
for NN CAPITAL AHF

Minimally RB CAPITAL Minimally
Minimally JJ invasive
invasive NN treatment
treatment IN of
of NNS abscesses
abscesses IN by
by JJ CAPITAL CT-controlled
CT-controlled NN drainage
drainage IN with
with DT a
a NN basket
basket NN catheter
catheter NN system

PL NN CAPITAL PL
PL NN granule
granule VBZ is
is CD one
one IN of
of DT the
the RBS most
most JJ common
common NNS forms
forms IN of
of JJ composite
composite NN medicine
medicine IN for
for NNS colds
colds IN in
in NNP CAPITAL Japan
Japan , ,
, VBG including
including NN acetaminophen

A DT CAPITAL A
A JJ 72-year
72-year JJ old
old NN man
man WP who
who VBD had
had VBN been
been VBN prescribed
prescribed NN amiodarone
amiodarone IN for
for RBR more
more IN than
than CD one
one NN year
year IN before
before IN for
for JJ arrhythmogenic
arrhythmogenic RB right
right JJ ventricular
ventricular NN dystrophy
dystrophy , ,
, RB repeatedly
repeatedly VBD took
took NN CAPITAL PL
PL NNS granules
granules IN at
at JJ one-week
one-week NNS intervals
intervals IN because
because IN of
of VBG sneezing
sneezing CC and
and NN fever

He PRP CAPITAL He
He VBN needed
needed JJ mechanical
mechanical NN ventilation
ventilation IN for
for JJ severe
severe NN hypoxemia
hypoxemia , ,
, CC but
but VBN recovered
recovered IN with
with NN glucocorticoid
glucocorticoid NN pulse
pulse NN therapy

In IN CAPITAL In
In DT a
a NN follow-up
follow-up NN study
study NN operative
operative NN risk
risk , ,
, JJ postoperative
postoperative JJ functional
functional NNS disorders
disorders CC and
and NN incidence
incidence IN of
of JJ anastomotic
anastomotic NN (
( JJ recurrent
recurrent NN )
) NN ulcer
ulcer IN after
after JJ partial
partial NN gastrectomy
gastrectomy IN with
with NN CAPITAL Roux-en-Y
Roux-en-Y NN gastrojejunostomy
gastrojejunostomy IN for
for NN gastroduodenal
gastroduodenal NN ulcer
ulcer VBD were
were VBN evaluated
evaluated IN in
in CD 52
52 NNS patients

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL With
With NN regard
regard TO to
to DT the
the JJ high
high NN rate
rate IN of
of JJ recurrent
recurrent NN ulcer
ulcer NN CAPITAL Roux-en-Y
Roux-en-Y NN reconstruction
reconstruction IN after
after JJ partial
partial NN gastrectomy
gastrectomy IN for
for JJ primary
primary NN ulcer
ulcer NN surgery
surgery MD should
should VB be
be VBN avoided
avoided CC and
and NN reconstruction
reconstruction NNS procedures
procedures VBN preferred
preferred , ,
, WDT which
which NN guarantee
guarantee JJ duodenogastric
duodenogastric NN reflux

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: DT CAPITAL The
The NN aim
aim IN of
of DT these
these NNS studies
studies VBD was
was TO to
to VB compare
compare DT the
the NNS pharmacokinetics
pharmacokinetics IN of
of VBN inhaled
inhaled NN fluticasone
fluticasone NN propionate
propionate NN (
( NN CAPITAL FP
FP NN )
) IN after
after VBN repeated
repeated NN administration
administration IN via
via DT the
the NNP CAPITAL Diskus
Diskus CC or
or NNP CAPITAL Diskhaler
Diskhaler JJ dry
dry NN powder
powder NNS inhalers
inhalers NN (
( NNS CAPITAL DPIs
DPIs NN )
) TO to
to NNS patients
patients IN with
with JJ mild-to-moderate
mild-to-moderate NN asthma

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: IN CAPITAL In
In NNS patients
patients IN with
with NN asthma
asthma VBG receiving
receiving VBN repeated
repeated VBN inhaled
inhaled NNS doses
doses IN of
of NN CAPITAL FP
FP , ,
, DT the
the JJ systemic
systemic NN exposure
exposure NN (
( NN CAPITAL AUC
AUC NN )
) IN after
after NN inhalation
inhalation IN from
from DT the
the NNP CAPITAL Diskus
Diskus VBD was
was JJ similar
similar TO to
to IN that
that IN from
from DT the
the NNP CAPITAL Diskhaler
Diskhaler , ,
, IN with
with DT no
no NN difference
difference IN between
between DT the
the NNS CAPITAL DPIs
DPIs IN in
in DT the
the NNS effects
effects IN on
on NN cortisol
cortisol NN suppression

DATA NNP CAPITAL DATA
DATA NN CAPITAL SYNTHESIS
SYNTHESIS : :
: RB CAPITAL Recently
Recently , ,
, DT an
an NN expert
expert NN panel
panel IN of
of DT the
the NNPS CAPITAL Centers
Centers IN for
for NN CAPITAL Disease
Disease NN CAPITAL Control
Control CC and
and NNP CAPITAL Prevention
Prevention VBN recommended
recommended NN use
use IN of
of RB only
only CD three
three IN of
of CD 16
16 JJ systemic
systemic NNS antibiotics
antibiotics VBN approved
approved IN by
by DT the
the NNP CAPITAL Food
Food CC and
and NN CAPITAL Drug
Drug NN CAPITAL Administration
Administration IN for
for NN treatment
treatment IN of
of NNP CAPITAL AOM
AOM : :
: NNP amoxicillin
amoxicillin , ,
, NN cefuroxime
cefuroxime NN axetil
axetil , ,
, CC and
and NN ceftriaxone

A DT CAPITAL A
A JJ three-step
three-step NN treatment
treatment NN algorithm
algorithm IN for
for JJ refractory
refractory NNP CAPITAL AOM
AOM IN that
that VBZ employs
employs NNP amoxicillin
amoxicillin , ,
, NN trimethoprim/sulfamethoxazole
trimethoprim/sulfamethoxazole NN (
( NN CAPITAL TMP/SMX
TMP/SMX NN )
) , ,
, CC or
or JJ high-dose
high-dose NN amoxicillin/clavulanate
amoxicillin/clavulanate NN (
( VBG depending
depending IN on
on DT the
the RB prior
prior NN dose
dose IN of
of CC and
and NN adherence
adherence TO to
to NNP amoxicillin
amoxicillin NN therapy
therapy NN )
) , ,
, CC and
and NN ceftriaxone
ceftriaxone CC or
or NN tympanocentesis
tympanocentesis IN at
at NNS steps
steps CD 1
1 , ,
, CD 2
2 , ,
, CC and
and CD 3
3 , ,
, RB respectively
respectively , ,
, VBZ appears
appears JJ rational
rational CC and
and JJ cost-effective

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NNP CAPITAL Amoxicillin
Amoxicillin NNS remains
remains DT the
the JJ antibiotic
antibiotic IN of
of NN choice
choice IN for
for JJ initial
initial JJ empiric
empiric NN treatment
treatment IN of
of NNP CAPITAL AOM
AOM , ,
, IN although
although DT the
the JJ traditional
traditional NN dosage
dosage MD should
should VB be
be VBN increased
increased IN in
in NNS patients
patients IN at
at NN risk
risk IN for
for JJ drug-resistant
drug-resistant NNP CAPITAL S.
S. FW pneumoniae

We PRP CAPITAL We
We NN support
support DT the
the NN use
use IN of
of NN conjugate
conjugate JJ pneumococcal
pneumococcal NN vaccine
vaccine IN per
per NNS guidelines
guidelines IN for
for NN prevention
prevention IN of
of NN CAPITAL Raom
Raom IN from
from DT the
the NNP CAPITAL Advisory
Advisory NNP CAPITAL Committee
Committee IN on
on NN CAPITAL Immunization
Immunization NN CAPITAL Practice
Practice IN of
of DT the
the NNPS CAPITAL Centers
Centers IN for
for NN CAPITAL Disease
Disease NN CAPITAL Control
Control CC and
and NNP CAPITAL Prevention
Prevention , ,
, IN with
with NN consideration
consideration VBN given
given TO to
to NN influenza
influenza NN vaccine
vaccine IN for
for NNS cases
cases IN of
of NN rAOM
rAOM IN that
that RB historically
historically VB worsen
worsen IN during
during DT the
the NN flu
flu NN season

This DT CAPITAL This
This NN model
model MD can
can VB be
be VBN used
used TO to
to NN test
test DT the
the NN safety
safety CC and
and NN efficacy
efficacy IN of
of NN liver-assist
liver-assist NNS devices
devices VBN aimed
aimed IN at
at VBG temporizing
temporizing DT the
the NN detoxification
detoxification NNS functions
functions IN of
of DT the
the VBG failing
failing NN liver

Recent JJ CAPITAL Recent
Recent JJ major
major JJ epidemiologic
epidemiologic NNS trends
trends IN in
in JJ bacterial
bacterial NN meningitis
meningitis VB include
include DT a
a JJ dramatic
dramatic NN decline
decline IN in
in DT the
the NN incidence
incidence IN of
of NN CAPITAL Haemophilus
Haemophilus NNS influenzae
influenzae NN meningitis
meningitis IN since
since DT the
the NN introduction
introduction IN of
of DT the
the JJ protein-conjugated
protein-conjugated NNP CAPITAL H.
H. NNS influenzae
influenzae NNS vaccines
vaccines , ,
, CC and
and DT a
a RB worldwide
worldwide NN increase
increase IN in
in NNS infections
infections IN with
with JJ antibiotic-resistant
antibiotic-resistant NNS strains
strains IN of
of JJ bacterial
bacterial NNS pathogens

dverse NN dverse
dverse NNS outcomes
outcomes CC and
and NN opioid
opioid JJ analgesic
analgesic NN administration
administration IN in
in JJ acute
acute JJ abdominal
abdominal NN pain

We PRP CAPITAL We
We VBN examined
examined DT the
the NN remnant
remnant NN stomach
stomach IN for
for NNP CAPITAL H.
H. NN pylori
pylori NN infection
infection IN after
after NN gastrectomy
gastrectomy IN for
for JJ gastric
gastric NN cancer
cancer CC or
or JJ peptic
peptic NN ulcer
ulcer IN between
between NNP CAPITAL October
October CD 1992
1992 CC and
and NNP CAPITAL July
July CD 1997

The DT CAPITAL The
The JJ recent
recent NN introduction
introduction IN of
of NNP ribavirin
ribavirin , ,
, VBN given
given IN in
in NN combination
combination , ,
, VBZ has
has VBN led
led TO to
to DT a
a NN re-appraisal
re-appraisal IN of
of DT the
the NN management
management IN of
of JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL C

The DT CAPITAL The
The JJ current
current NN report
report VBZ considers
considers DT the
the JJ additional
additional NN benefit
benefit IN of
of NN combination
combination NN therapy
therapy NN (
( NN interferon
interferon IN alfa
alfa CC and
and NNP ribavirin
ribavirin NN )
) VBN compared
compared IN with
with NN monotherapy
monotherapy NN (
( NN interferon
interferon IN alfa
alfa RB alone
alone NN )
) IN for
for DT the
the NN treatment
treatment IN of
of NNS patients
patients IN with
with JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL C

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To NN review
review DT the
the JJ clinical
clinical NN effectiveness
effectiveness CC and
and NN cost-effectiveness
cost-effectiveness IN of
of NN combination
combination NN therapy
therapy IN with
with NN interferon
interferon IN alfa
alfa CC and
and NNP ribavirin
ribavirin IN in
in NNS patients
patients IN with
with JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL C

Sida NNP CAPITAL Sida
Sida NN cordifolia
cordifolia NNP CAPITAL L.
L. NN (
( FW CAPITAL Malvaceae
Malvaceae NN )
) VBZ is
is VBN used
used IN in
in NN folk
folk NN medicine
medicine IN for
for DT the
the NN treatment
treatment IN of
of NN inflammation
inflammation IN of
of DT the
the JJ oral
oral NN mucosa
mucosa , ,
, NN blenorrhea
blenorrhea , ,
, JJ asthmatic
asthmatic NN bronchitis
bronchitis CC and
and JJ nasal
nasal NN congestion

Double-blind JJ CAPITAL Double-blind
Double-blind JJ placebo-controlled
placebo-controlled NN trial
trial IN of
of NN CAPITAL Mycobacterium
Mycobacterium NN vaccae
vaccae NN immunotherapy
immunotherapy IN for
for NN tuberculosis
tuberculosis IN in
in NNP CAPITAL KwaZulu
KwaZulu , ,
, NNP CAPITAL South
South NNP CAPITAL Africa
Africa , ,
, CD 1991-97

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To VB evaluate
evaluate DT the
the NN efficacy
efficacy IN of
of JJ oral
oral NN tacrolimus
tacrolimus IN as
as DT an
an NN induction
induction NN agent
agent IN in
in JJ steroid-refractory
steroid-refractory JJ severe
severe NN colitis
colitis NN .Study
.Study NN design
design : :
: JJ CAPITAL Open-label
Open-label , ,
, NN multicenter
multicenter NN trial
trial IN of
of JJ oral
oral NN tacrolimus
tacrolimus IN in
in NNS patients
patients IN with
with JJ severe
severe NN colitis

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: IN CAPITAL Although
Although NN tacrolimus
tacrolimus VBZ is
is JJ effective
effective NN induction
induction NN therapy
therapy IN for
for JJ severe
severe JJ ulcerative
ulcerative CC or
or NN CAPITAL Crohn
Crohn POS 's
's NN colitis
colitis , ,
, JJR fewer
fewer IN than
than CD 50
50 NN %
% IN of
of NNS patients
patients VBN treated
treated MD will
will RB successfully
successfully VB achieve
achieve DT a
a JJ long-term
long-term NN remission

Cytomegalovirus NN CAPITAL Cytomegalovirus
Cytomegalovirus NN (
( NN CAPITAL CMV
CMV NN )
) NN infection
infection VBD was
was CD one
one IN of
of DT the
the RBS most
most JJ common
common JJ opportunistic
opportunistic NNS infections
infections IN in
in NN CAPITAL AIDS
AIDS NNS patients
patients , ,
, VBG leading
leading TO to
to NN blindness
blindness CC or
or JJ life-threatening
life-threatening NN disease
disease IN in
in IN about
about CD 40
40 NN %
% IN of
of NNS patients
patients IN in
in DT the
the RB later
later NNS stages
stages IN of
of NN CAPITAL AIDS
AIDS IN before
before RB highly
highly JJ active
active JJ antiretroviral
antiretroviral NN therapy
therapy NN (
( NNP CAPITAL HAART
HAART NN )

New NNP CAPITAL New
New NNS vaccines
vaccines VBP are
are IN under
under NN study
study TO to
to RB further
further NN control
control JJ bacterial
bacterial NN meningitis

The DT CAPITAL The
The NN study
study VBN involved
involved CD 117
117 NNS infants
infants NN (
( VB mean
mean NN age
age CD 2.6
2.6 NNS months
months NN )
) , ,
, WP who
who VBN needed
needed NN hospital
hospital NN treatment
treatment IN because
because IN of
of NN CAPITAL RSV
RSV NN bronchiolitis

According VBG CAPITAL According
According TO to
to DT the
the JJ present
present NN study
study PRP it
it VBZ seems
seems IN that
that VBN inhaled
inhaled NN corticosteroid
corticosteroid NN treatment
treatment IN during
during CC and
and IN after
after DT the
the JJ acute
acute NN phase
phase IN of
of NN infant
infant NN CAPITAL RSV
RSV NN bronchiolitis
bronchiolitis MD may
may VB have
have DT a
a JJ beneficial
beneficial NN effect
effect IN on
on JJ subsequent
subsequent JJ bronchial
bronchial VBG wheezing
wheezing NN tendency

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: DT CAPITAL This
This NN study
study VBD was
was VBN designed
designed TO to
to VB evaluate
evaluate DT the
the NN safety
safety CC and
and NN estimate
estimate DT the
the NN efficacy
efficacy IN of
of JJ oral
oral NN budesonide
budesonide IN in
in NNS patients
patients IN with
with JJ primary
primary VBG sclerosing
sclerosing NN cholangitis
cholangitis NN (
( NN CAPITAL PSC
PSC NN )

Combined VBN CAPITAL Combined
Combined NN interferon
interferon CC and
and NN lamivudine
lamivudine NN therapy
therapy : :
: VBZ is
is DT this
this DT the
the NN treatment
treatment IN of
of NN choice
choice IN for
for NNS patients
patients IN with
with JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL B
B NN virus
virus NN infection
infection . ?

She PRP CAPITAL She
She VBD had
had VBN been
been VBG taking
taking NNP amitriptyline
amitriptyline CD 75
75 NN mg
mg IN at
at NN night
night IN for
for NN depression
depression IN for
for CD four
four NNS months
months IN before
before PRP$ her
her NN admission

Side NN CAPITAL Side
Side NNS effects
effects IN from
from NN influenza
influenza NN vaccination
vaccination : :
: NNS differences
differences IN between
between VBN returned
returned CC and
and JJ random
random NNS surveys

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: TO CAPITAL To
To NN study
study DT the
the NN relationship
relationship IN between
between NN interleukin-2
interleukin-2 NN (
( NN CAPITAL IL-2
IL-2 NN )
) , ,
, JJ soluble
soluble NN interleukin-2
interleukin-2 NN receptor
receptor NN (
( NN sIL-2R
sIL-2R NN )
) CC and
and DT the
the JJ non-and-hypo-responsiveness
non-and-hypo-responsiveness TO to
to NN hepatitis
hepatitis NN CAPITAL B
B NN vaccine

We PRP CAPITAL We
We VBN assessed
assessed DT the
the NNS effects
effects IN of
of RB early
early NN replacement
replacement NN therapy
therapy IN with
with JJ protein-C
protein-C NN concentrate
concentrate RB together
together IN with
with JJ continuous
continuous JJ veno-venous
veno-venous NN haemodiafiltration
haemodiafiltration CC and
and JJ conventional
conventional NN treatment
treatment IN in
in NN meningococcaemia

The DT CAPITAL The
The NN purpose
purpose IN of
of DT this
this NN study
study VBD was
was TO to
to VB determine
determine IN if
if JJ topical
topical NN CAPITAL DL-alpha-tocopherol
DL-alpha-tocopherol NN (
( NN vitamin
vitamin NN CAPITAL E
E NN )
) MD could
could VB reduce
reduce JJ ultraviolet-induced
ultraviolet-induced NN damage
damage TO to
to DT the
the NN epidermis

We PRP CAPITAL We
We VBN observed
observed DT the
the NNS effects
effects IN of
of NN cisapride
cisapride IN in
in DT the
the NN management
management IN of
of JJ idiopathic
idiopathic NN constipation
constipation IN in
in NNS children

METHODS NNS CAPITAL METHODS
METHODS : :
: CD CAPITAL Thirty-seven
Thirty-seven NNS children
children IN with
with DT a
a NN history
history IN of
of NN constipation
constipation NN (
( NN i.e
i.e . .
. , ,
, NN pain
pain CC and
and NN difficulty
difficulty CC or
or NN delay
delay IN in
in NN defecation
defecation IN for
for JJR >
> CD 3
3 NNS months
months NN )
) VBD were
were VBN recruited
recruited CC and
and RB randomly
randomly VBN assigned
assigned TO to
to CD 8
8 NNS weeks
weeks IN of
of NN treatment
treatment IN with
with DT either
either NN cisapride
cisapride , ,
, CD 0.2
0.2 NN mg/kg
mg/kg CD three
three NNS times
times RB daily
daily , ,
, CC or
or VBG matching
matching NN placebo
placebo IN after
after DT a
a JJ 2-week
2-week NN run-in
run-in NN period
period IN in
in DT a
a JJ double-blind
double-blind , ,
, NN parallel-group
parallel-group NN study
study NN design

Patient NN CAPITAL Patient
Patient CD 1
1 VBN demonstrated
demonstrated JJ dramatic
dramatic NN clearing
clearing IN of
of PRP$ his
his NN CAPITAL MCV
MCV NNS lesions
lesions WRB when
when JJ intravenous
intravenous NN cidofovir
cidofovir NN therapy
therapy VBD was
was VBD started
started IN for
for PRP$ his
his JJ treatment-resistant
treatment-resistant JJ bilateral
bilateral NN CAPITAL CMV
CMV NN retinitis
retinitis CC and
and IN because
because IN of
of NN cidofovir
cidofovir POS 's
's JJ possible
possible NN activity
activity IN against
against NN CAPITAL MCV

In IN CAPITAL In
In NN case
case CD 2
2 , ,
, NN cidofovir
cidofovir VBD was
was VBN compounded
compounded IN as
as DT a
a CD 3
3 NN %
% NN cream
cream IN in
in DT a
a NN combination
combination NN vehicle
vehicle NN (
( JJ CAPITAL Dermovan
Dermovan NN )
) IN for
for JJ extensive
extensive JJ facial
facial NN involvement
involvement , ,
, CC and
and JJ complete
complete NN resolution
resolution IN of
of NN CAPITAL MCV
MCV VBD was
was VBN seen
seen IN after
after CD 1
1 NN month
month IN of
of NN therapy

In IN CAPITAL In
In NN case
case CD 3
3 , ,
, JJ intravenous
intravenous NN cidofovir
cidofovir NN therapy
therapy VBD was
was VBD started
started DT both
both IN for
for NN CAPITAL CMV
CMV NN retinitis
retinitis CC and
and IN in
in DT an
an NN attempt
attempt TO to
to JJ clear
clear CD 90
90 NN %
% JJ facial
facial NN CAPITAL MCV
MCV NN involvement
involvement : ;
; IN after
after CD 1
1 NN month
month IN of
of NN treatment
treatment , ,
, DT all
all JJ clinical
clinical NN evidence
evidence IN of
of NN CAPITAL MCV
MCV VBD had
had VBN resolved

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: NNP CAPITAL Cidofovir
Cidofovir , ,
, DT a
a NN nucleotide
nucleotide NN analog
analog IN of
of NN deoxycytidine
deoxycytidine NN monophosphate
monophosphate , ,
, VBZ appears
appears TO to
to VB have
have VBD contributed
contributed TO to
to NN clearing
clearing IN of
of VBN advanced
advanced NN CAPITAL MCV
MCV NNS lesions
lesions IN in
in DT these
these CD 3
3 NNS patients
patients , ,
, RB thus
thus VBG providing
providing JJ suggestive
suggestive NN evidence
evidence IN of
of JJ clinical
clinical NN activity
activity IN against
against NN CAPITAL MCV

Controlled VBN CAPITAL Controlled
Controlled NNS trials
trials IN of
of NN cidofovir
cidofovir NN therapy
therapy IN for
for NN CAPITAL MCV
MCV IN in
in NNS persons
persons JJ infected
infected IN with
with JJ human
human NN immunodeficiency
immunodeficiency NN virus
virus VBP are
are VBN warranted

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: DT CAPITAL This
This NN study
study VBN aimed
aimed TO to
to VB determine
determine DT the
the NN effect
effect IN of
of JJ external
external NN beam
beam NN radiation
radiation NN therapy
therapy IN on
on NN choroidal
choroidal NN neovascularization
neovascularization NN (
( NN CAPITAL CNV
CNV NN )
) JJ secondary
secondary TO to
to JJ age-related
age-related JJ macular
macular NN degeneration
degeneration NN (
( NNP CAPITAL AMD
AMD NN )

Thrombolytic JJ CAPITAL Thrombolytic
Thrombolytic NN therapy
therapy VBZ has
has VBN been
been VBN accepted
accepted IN in
in DT the
the NN treatment
treatment IN of
of JJ acute
acute JJ myocardial
myocardial NN infarction

A DT CAPITAL A
A NN bolus
bolus NN infusion
infusion IN of
of NN tissue
tissue NN plasminogen
plasminogen NN activator
activator VBD was
was VBN administered
administered IN during
during NNP CAPITAL CPR
CPR IN in
in JJ refractory
refractory JJ ventricular
ventricular NN fibrillation
fibrillation NN (
( CD two
two NNS cases
cases NN )
) CC and
and JJ pulseless
pulseless JJ ventricular
ventricular NN tachycardia
tachycardia NN (
( CD one
one NN case
case NN )

We PRP CAPITAL We
We VBP conclude
conclude IN that
that NN bolus
bolus JJ thrombolytic
thrombolytic NNS infusions
infusions IN during
during NNP CAPITAL CPR
CPR MD may
may VB facilitate
facilitate JJ spontaneous
spontaneous NN return
return IN of
of NN circulation
circulation IN in
in JJ select
select NNS patients
patients IN with
with VBN confirmed
confirmed JJ acute
acute JJ myocardial
myocardial NN infarction
infarction , ,
, VBN witnessed
witnessed JJ cardiac
cardiac NN arrest
arrest IN in
in DT the
the NNP CAPITAL ED
ED , ,
, CC and
and JJ refractory
refractory JJ ventricular
ventricular NN fibrillation
fibrillation CC or
or NN tachycardia

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL CASE
CASE NN CAPITAL SUMMARY
SUMMARY : :
: DT CAPITAL A
A JJ 92-year
92-year JJ old
old JJ white
white NN woman
woman WP who
who VBD was
was VBG receiving
receiving NN venlafaxine
venlafaxine IN for
for NN management
management IN of
of NN depression
depression VBD was
was VBN found
found TO to
to VB have
have NN hyponatremia

Touch NN CAPITAL Touch
Touch NN sensibility
sensibility VBD was
was VBN assessed
assessed IN with
with NN von
von NNP CAPITAL Frey
Frey POS 's
's NNS monofilaments
monofilaments IN in
in DT the
the NNS breasts
breasts IN of
of CD 10
10 JJ healthy
healthy NNS women
women NN (
( NNS controls
controls NN )
) CC and
and IN of
of CD 80
80 NNS women
women IN with
with NN breast
breast NN cancer
cancer WP who
who IN at
at JJS least
least CD 1
1 NN year
year RB previously
previously VBD had
had VBN undergone
undergone JJ subcutaneous
subcutaneous NN mastectomy
mastectomy CC and
and JJ immediate
immediate NN reconstruction
reconstruction IN with
with DT a
a NN prosthesis

Although IN CAPITAL Although
Although VBN improved
improved JJ glycemic
glycemic NN control
control , ,
, NN maintenance
maintenance IN of
of JJ normal
normal NN blood
blood NN pressure
pressure , ,
, CC and
and NN use
use IN of
of JJ angiotensin-converting
angiotensin-converting NN enzyme
enzyme NNS inhibitors
inhibitors VBP are
are JJ important
important NNS strategies
strategies TO to
to VB avoid
avoid VBG developing
developing NN microalbuminuria
microalbuminuria , ,
, JJ dietary
dietary NN macronutrient
macronutrient NN intake
intake MD may
may RB also
also NN play
play DT a
a NN role

Local JJ CAPITAL Local
Local NN injection
injection IN of
of NNS corticosteroids
corticosteroids IN into
into JJ refractory
refractory NN esophageal
esophageal NNS strictures
strictures TO to
to NN decrease
decrease DT the
the NN restenosis
restenosis NN rate
rate VBZ has
has VBN been
been VBN reported

We PRP CAPITAL We
We RB systematically
systematically VBN reviewed
reviewed DT the
the NN evidence
evidence VBG concerning
concerning DT the
the NN ability
ability IN of
of CD five
five JJ systemic
systemic NNS treatments
treatments TO to
to VB induce
induce NN remission
remission IN in
in NNS patients
patients IN with
with JJ severe
severe NN psoriasis
psoriasis : :
: NN ultraviolet
ultraviolet NN CAPITAL B
B NN (
( NN CAPITAL UVB
UVB NN )
) , ,
, NN photochemotherapy
photochemotherapy NN (
( NN CAPITAL PUVA
PUVA NN )
) , ,
, NN methotrexate
methotrexate NN (
( NN CAPITAL MTX
MTX NN )
) , ,
, NNS retinoids
retinoids NN (
( NNP CAPITAL RET
RET NN )
) CC and
and NN cyclosporin
cyclosporin DT CAPITAL A
A NN (
( NNP CAPITAL CYA
CYA NN )

Consequently RB CAPITAL Consequently
Consequently , ,
, JJ parenteral
parenteral NN nutrition
nutrition NN (
( NN CAPITAL PN
PN NN )
) NNS solutions
solutions VBN used
used TO to
to NN treat
treat VBN malnourished
malnourished NNS patients
patients IN with
with JJ chronic
chronic JJ renal
renal NN failure
failure RB usually
usually VBP are
are JJ prepared
prepared IN with
with RB little
little NN supplementation
supplementation IN of
of DT these
these NNS cations

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: VBN CAPITAL Malnourished
Malnourished NNS patients
patients IN with
with JJ chronic
chronic JJ renal
renal NN failure
failure VBG receiving
receiving NN CAPITAL PN
PN VBP are
are IN at
at NN risk
risk IN of
of VBG developing
developing NN electrolyte
electrolyte NNS abnormalities
abnormalities , ,
, RB particularly
particularly NN hypophosphatemia

PURPOSE NN CAPITAL PURPOSE
PURPOSE : :
: PRP CAPITAL We
We NN report
report DT a
a NN multicenter
multicenter NN experience
experience VBG using
using VBN tubularized
tubularized VBN incised
incised NN plate
plate NN urethroplastym
urethroplastym IN for
for JJ proximal
proximal NNS hypospadias

MATERIALS NNS CAPITAL MATERIALS
MATERIALS CC CAPITAL AND
AND NNS CAPITAL METHODS
METHODS : :
: IN CAPITAL From
From NNP CAPITAL August
August CD 1993
1993 TO to
to NNP CAPITAL December
December CD 1996
1996 VBN tubularized
tubularized VBN incised
incised NN plate
plate NN urethroplasty
urethroplasty VBD was
was VBN performed
performed IN in
in CD 27
27 NNS boys
boys CD 6
6 NNS months
months TO to
to CD 3
3 NNS years
years JJ old
old IN with
with JJ mid
mid NN shaft
shaft CC and
and JJ penoscrotal
penoscrotal NNS hypospadias

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: VBN CAPITAL Tubularized
Tubularized VBN incised
incised NN plate
plate NN surgery
surgery VBN created
created DT a
a JJ functional
functional NN neourethra
neourethra RB even
even IN in
in JJ penoscrotal
penoscrotal NNS hypospadias

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: VBN CAPITAL Tubularized
Tubularized VBN incised
incised NN plate
plate NN urethroplasty
urethroplasty VBZ is
is DT a
a JJ versatile
versatile NN operation
operation IN that
that VBZ corrects
corrects JJ proximal
proximal NNS hypospadias
hypospadias NNS defects
defects IN with
with JJ few
few NNS complications
complications CC and
and JJ superior
superior NN cosmetic
cosmetic NNS results

Aortocoronary NNP CAPITAL Aortocoronary
Aortocoronary NN bypass
bypass VBG grafting
grafting VBZ is
is DT an
an VBN accepted
accepted NN procedure
procedure IN for
for JJ ischemic
ischemic NN heart
heart NN disease

Immunotherapy NN CAPITAL Immunotherapy
Immunotherapy IN of
of NNS mice
mice IN with
with VBG preexisting
preexisting NNS cancers
cancers IN with
with NN heat
heat NN shock
shock NN protein
protein NNS preparations
preparations VBN derived
derived IN from
from JJ autologous
autologous NN cancer
cancer VBD resulted
resulted IN in
in VBN retarded
retarded NN progression
progression IN of
of DT the
the JJ primary
primary NN cancer
cancer , ,
, DT a
a VBN reduced
reduced JJ metastatic
metastatic NN load
load , ,
, CC and
and NN prolongation
prolongation IN of
of NN life-span

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Intrapleural
Intrapleural NN injection
injection IN of
of JJ irradiated
irradiated NN CAPITAL LLC-IL2
LLC-IL2 VBN cured
cured JJ pre-existing
pre-existing NN lung
lung NN CAPITAL LLC
LLC NNS tumors
tumors CC and
and VBN extended
extended DT the
the NN survival
survival IN of
of DT the
the NNS mice
mice CC but
but VBD did
did RB not
not VB affect
affect NN survival
survival IN of
of NNS mice
mice IN with
with JJ pre-existing
pre-existing NN peritoneal
peritoneal NNS tumors
tumors CC nor
nor VBD did
did PRP it
it VB affect
affect DT the
the NN growth
growth IN of
of NN s.c.
s.c. NNS tumors

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Intraperitoneal
Intraperitoneal NN injection
injection IN of
of JJ irradiated
irradiated NN CAPITAL LLC-IL2
LLC-IL2 VBN cured
cured JJ pre-existing
pre-existing NN CAPITAL LLC
LLC NN peritoneal
peritoneal NNS tumors
tumors CC and
and VBN extended
extended DT the
the NN survival
survival IN of
of DT the
the NNS mice
mice CC but
but VBD did
did RB not
not VB affect
affect NN survival
survival IN of
of NNS mice
mice VBG bearing
bearing NN lung
lung NNS tumors
tumors CC nor
nor VBD did
did PRP it
it VB affect
affect DT the
the NN growth
growth IN of
of NN s.c.
s.c. NNS tumors

Subcutaneous NNP CAPITAL Subcutaneous
Subcutaneous NN injection
injection IN of
of JJ irradiated
irradiated NN CAPITAL LLC-IL2
LLC-IL2 VBD did
did RB not
not VB affect
affect DT the
the NN growth
growth IN of
of VBG preexisting
preexisting NN s.c.
s.c. NNS tumors
tumors CC and
and RB also
also VBD did
did RB not
not VB improve
improve NN survival
survival IN of
of NNS mice
mice VBG bearing
bearing DT the
the NN lung
lung CC or
or NN peritoneal
peritoneal NNS tumors

We PRP CAPITAL We
We VBP describe
describe JJ such
such DT an
an NN event
event IN in
in DT a
a NN man
man WP who
who VBD underwent
underwent JJ allogeneic
allogeneic NN CAPITAL BMT
BMT IN for
for NN CAPITAL APL
APL IN in
in JJ second
second NN relapse
relapse CC and
and CD 4
4 NNS years
years RB later
later VBN presented
presented IN with
with JJ testicular
testicular NN relapse

Olanzapine NN CAPITAL Olanzapine
Olanzapine VBZ is
is DT an
an JJ atypical
atypical JJ antipsychotic
antipsychotic JJ effective
effective IN in
in DT the
the NN treatment
treatment IN of
of JJ schizophrenic
schizophrenic NNS patients

After IN CAPITAL After
After DT a
a CD 2-
2- TO to
to JJ 9-day
9-day NN placebo
placebo NN lead-in
lead-in , ,
, CD 79
79 NNS inpatients
inpatients IN with
with NN schizophrenia
schizophrenia VBG according
according TO to
to NN CAPITAL DSM-III-R
DSM-III-R NNS criteria
criteria VBD were
were VBN placed
placed IN on
on DT an
an NN olanzapine
olanzapine NN dosage
dosage IN of
of CD 10
10 NN mg/day
mg/day CC or
or CD 1
1 NN mg/day
mg/day IN for
for RB up
up TO to
to CD 6
6 NNS weeks

Fludarabine NN CAPITAL Fludarabine
Fludarabine CC and
and NN ara-C
ara-C RB successfully
successfully VBN eradicated
eradicated NN bone
bone NN marrow
marrow NN disease
disease IN in
in CD 16
16 IN of
of CD 27
27 NNS patients
patients NN (
( CD 59
59 NN %
% NN )
) , ,
, CD 23
23 NNS patients
patients IN of
of WDT which
which VBD had
had VBN been
been VBN treated
treated RB previously
previously IN with
with JJ high-dose
high-dose NN ara-C

These DT CAPITAL These
These NNS results
results VBN verified
verified DT the
the JJ synergistic
synergistic NN effect
effect NN fludarabine
fludarabine VBD exhibited
exhibited IN in
in VBG augmenting
augmenting NN ara-CTP
ara-CTP NNS concentrations
concentrations IN in
in NNS patients
patients '' '
' JJ leukemic
leukemic NNS blasts
blasts , ,
, RB thus
thus VBG improving
improving DT the
the JJ clinical
clinical NN response
response IN in
in VBD relapsed
relapsed JJ pediatric
pediatric NNS leukemias

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: DT CAPITAL The
The VBG growing
growing NN use
use IN of
of NN heparin
heparin IN in
in JJ acute
acute JJ thrombotic
thrombotic NNS disorders
disorders , ,
, VBN coupled
coupled IN with
with DT the
the NN availability
availability IN of
of JJ many
many JJ new
new JJ antithrombotic
antithrombotic NNS agents
agents , ,
, VBZ emphasizes
emphasizes DT the
the NN need
need IN for
for JJ adequate
adequate NN characterization
characterization IN of
of DT the
the NN platelet
platelet NNS effects
effects IN of
of DT the
the JJ various
various NNS anticoagulants

METHODS NNS CAPITAL METHODS
METHODS CC CAPITAL AND
AND NNS CAPITAL RESULTS
RESULTS : :
: NN CAPITAL Platelet
Platelet NN CAPITAL P-selectin
P-selectin NN (
( NN CAPITAL CD62
CD62 NN )
) CC and
and VBN activated
activated NN CAPITAL GP
GP NN CAPITAL IIb/IIIa
IIb/IIIa NN (
( NN CAPITAL PAC-1
PAC-1 NN )
) NN expression
expression IN on
on NN platelet
platelet NN membrane
membrane VBD was
was VBN quantified
quantified IN in
in JJ whole
whole NN blood
blood IN as
as RB well
well IN as
as NN platelet
platelet NN aggregation
aggregation IN in
in JJ platelet-rich
platelet-rich NN plasma
plasma IN in
in CD 43
43 NNS patients
patients IN with
with JJ unstable
unstable NN angina
angina IN before
before CC and
and IN during
during NN treatment
treatment IN with
with NN CAPITAL UFH
UFH CC or
or NN enoxaparin

PURPOSE NN CAPITAL PURPOSE
PURPOSE : :
: PRP CAPITAL We
We NN review
review PRP$ our
our JJ initial
initial NN experience
experience IN with
with JJ direct
direct JJ percutaneous
percutaneous JJ transluminal
transluminal NN angioplasty
angioplasty NN (
( NNP CAPITAL PTA
PTA NN )
) IN as
as DT a
a NN reperfusion
reperfusion NN treatment
treatment IN for
for JJ acute
acute NN occlusion
occlusion IN of
of DT the
the JJ middle
middle JJ cerebral
cerebral NN artery

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL CONCLUSION
CONCLUSION : :
: JJ CAPITAL Direct
Direct NNP CAPITAL PTA
PTA MD may
may VB be
be VBN performed
performed RB safely
safely IN as
as DT an
an NN alternative
alternative TO to
to JJ thrombolytic
thrombolytic NN therapy
therapy IN in
in NNS patients
patients IN with
with JJ acute
acute NN occlusion
occlusion IN of
of DT the
the JJ middle
middle JJ cerebral
cerebral NN artery
artery WRB when
when RB early
early NN CAPITAL CT
CT NNS findings
findings CC and/or
and/or NN lenticulostriate
lenticulostriate NN artery
artery NN involvement
involvement VBP are
are JJ present
present CC or
or WRB when
when JJ superselective
superselective JJ local
local NN angiography
angiography NNS shows
shows DT the
the NN presence
presence IN of
of DT a
a JJ large
large NN embolus
embolus CC or
or JJ high-grade
high-grade NN stenosis

Women NNS CAPITAL Women
Women VBN randomised
randomised TO to
to NN screen-and-treat
screen-and-treat VBN received
received JJ appropriate
appropriate NNS antibiotics
antibiotics RB only
only IN if
if NN screening
screening VBN proved
proved JJ positive
positive IN for
for CD one
one CC or
or RBR more
more NN infection

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> DT CAPITAL A
A JJ 71-year-old
71-year-old NN woman
woman IN with
with JJ autoimmune
autoimmune JJ hemolytic
hemolytic NN anemia
anemia VBD underwent
underwent DT an
an NN emergency
emergency JJ endocardial
endocardial NN patch
patch NN repair
repair IN for
for JJ ventricular
ventricular JJ septal
septal NN perforation
perforation IN after
after JJ acute
acute JJ myocardial
myocardial NN infarction

Use NN CAPITAL Use
Use IN of
of VBN washed
washed JJ red
red NN blood
blood NNS cells
cells VBD was
was JJ effective
effective IN in
in VBG averting
averting JJ hemolytic
hemolytic NN crisis
crisis IN throughout
throughout NN perioperative
perioperative NN period

Therefore RB CAPITAL Therefore
Therefore , ,
, JJ prudent
prudent NN management
management CC and
and NN use
use IN of
of VBN washed
washed JJ red
red NN blood
blood NNS cells
cells NN transfusion
transfusion MD would
would VB prevent
prevent JJ hemolytic
hemolytic NN aggravation
aggravation RB even
even IN in
in JJ open
open NN heart
heart NN surgery

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> PRP CAPITAL We
We NN report
report DT a
a NN case
case IN of
of DT a
a JJ 29-year-old
29-year-old NN male
male JJ chronic
chronic NN CAPITAL HBV
HBV NN carrier
carrier WP who
who VBN developed
developed JJ fulminant
fulminant VBN reactivated
reactivated NN CAPITAL HBV
HBV NN infection
infection VBG following
following JJ intensive
intensive NN chemotherapy
chemotherapy IN for
for NN stage
stage NN CAPITAL IVB
IVB JJ large
large NN cell
cell NN CAPITAL B-cell
B-cell JJ non-Hodgkin
non-Hodgkin POS 's
's NN lymphoma
lymphoma VBN associated
associated IN with
with JJ extensive
extensive JJ central
central JJ nervous
nervous NN system
system CC and
and NN bone
bone NN marrow
marrow NN involvement

We PRP CAPITAL We
We VB advise
advise IN that
that NN lamivudine
lamivudine MD should
should VB be
be VBN considered
considered IN during
during JJ intensive
intensive NN chemotherapy
chemotherapy NN treatment
treatment IN of
of JJ chronic
chronic NNS carriers
carriers IN of
of NN CAPITAL HBV

OBJECTIVES NNS CAPITAL OBJECTIVES
OBJECTIVES : :
: DT CAPITAL The
The NN purpose
purpose IN of
of DT this
this NN analysis
analysis VBD was
was TO to
to VB determine
determine DT the
the NN influence
influence IN of
of DT an
an JJ additional
additional NN treatment
treatment NN delay
delay JJ inherent
inherent IN in
in NN transfer
transfer TO to
to DT an
an NN angioplasty
angioplasty NN center
center IN for
for JJ primary
primary NN angioplasty
angioplasty IN of
of NNS patients
patients IN with
with JJ acute
acute JJ myocardial
myocardial NN infarction
infarction WP who
who VBP are
are RB first
first VBN admitted
admitted TO to
to NNS hospitals
hospitals IN without
without NN angioplasty
angioplasty NNS facilities

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: JJ CAPITAL Several
Several VBN randomized
randomized NNS trials
trials VB have
have VBN demonstrated
demonstrated DT the
the NNS benefits
benefits IN of
of JJ primary
primary NN angioplasty
angioplasty IN in
in JJ acute
acute JJ myocardial
myocardial NN infarction

We PRP CAPITAL We
We NN report
report DT the
the RB first
first NN case
case NN (
( TO to
to PRP$ our
our NN knowledge
knowledge NN )
) IN of
of DT an
an JJ endoscopic
endoscopic NN removal
removal IN of
of DT a
a NN forehead
forehead JJ soft
soft NN tissue
tissue NN mass

As IN CAPITAL As
As DT the
the NN overview
overview NNS shows
shows , ,
, DT both
both NNS groups
groups IN of
of NNS substances
substances VBP are
are JJ useful
useful IN for
for VBN individualized
individualized NN treatment
treatment IN of
of JJ benign
benign JJ prostatic
prostatic NN hyperplasia
hyperplasia NN (
( NNP CAPITAL BPH
BPH NN )
) , ,
, VBN provided
provided IN that
that JJ conservative
conservative JJ pharmacological
pharmacological NN treatment
treatment IN of
of NNP CAPITAL BPH
BPH VBZ is
is RB basically
basically VBN accepted
accepted CC and
and IN that
that DT the
the NNS patients
patients '' '
' NN quality
quality IN of
of NN life
life VBZ is
is RB also
also VBN considered

The DT CAPITAL The
The NNS results
results IN of
of JJ several
several JJ clinical
clinical NNS investigations
investigations VBD showed
showed DT the
the NN efficacy
efficacy CC and
and NN safety
safety IN of
of NN artichoke
artichoke NNS extracts
extracts NN (
( NNP CAPITAL Cynara
Cynara NN scolymus
scolymus NNP CAPITAL L.
L. NN )
) IN in
in DT the
the NN treatment
treatment IN of
of JJ hepato-biliary
hepato-biliary NN dysfunction
dysfunction CC and
and JJ digestive
digestive NNS complaints
complaints , ,
, JJ such
such IN as
as NN sensation
sensation IN of
of NN fullness
fullness , ,
, NN loss
loss IN of
of NN appetite
appetite , ,
, NN nausea
nausea CC and
and JJ abdominal
abdominal NN pain

Besides IN CAPITAL Besides
Besides DT the
the JJ well-known
well-known JJ nonsteroidal
nonsteroidal JJ antiinflammatory
antiinflammatory NNS drugs
drugs NN (
( NN CAPITAL NSAID
NSAID NN )
) IN for
for DT the
the NN treatment
treatment IN of
of JJ rheumatic
rheumatic NN pain
pain JJ herbal
herbal NN medicine
medicine MD can
can RB also
also VB be
be VBN applied
applied RB successfully

Extracts NNS CAPITAL Extracts
Extracts IN of
of DT the
the JJ secondary
secondary NNS tubers
tubers IN of
of NNP CAPITAL Devil
Devil POS 's
's VB CAPITAL Claw
Claw NN (
( NN CAPITAL Harpagophytum
Harpagophytum NNS procumbens
procumbens NN )
) VBP are
are VBN recommended
recommended IN for
for DT the
the JJ supportive
supportive NN treatment
treatment IN of
of JJ degenerative
degenerative JJ painful
painful NN rheumatism

High-dose JJ CAPITAL High-dose
High-dose JJ intravenous
intravenous NN immunoglobulin
immunoglobulin NN (
( NN hdIVIg
hdIVIg NN )
) VBZ is
is RB increasingly
increasingly VBN used
used TO to
to NN treat
treat DT a
a NN range
range IN of
of JJ inflammatory
inflammatory CC and
and JJ autoimmune
autoimmune NNS diseases

The DT CAPITAL The
The JJ current
current JJ dermatological
dermatological NNS uses
uses IN of
of NN hdIVIg
hdIVIg VB include
include DT the
the NN treatment
treatment IN of
of NN dermatomyositis
dermatomyositis CC and
and DT the
the JJ autoimmune
autoimmune JJ bullous
bullous NNS disorders
disorders , ,
, NN epidermolysis
epidermolysis NN bullosa
bullosa NN acquisita
acquisita , ,
, NN pemphigoid
pemphigoid , ,
, CC and
and NN pemphigus

Unfortunately RB CAPITAL Unfortunately
Unfortunately , ,
, JJ current
current JJ dermatological
dermatological NNS uses
uses IN of
of NN hdIVIg
hdIVIg VB have
have VBN been
been JJ limited
limited TO to
to DT either
either JJ uncontrolled
uncontrolled NNS trials
trials CC or
or JJ anecdotal
anecdotal NN case
case NNS reports
reports , ,
, IN except
except IN for
for DT a
a JJ single
single VBN controlled
controlled NN trial
trial IN of
of NN hdIVIg
hdIVIg IN as
as JJ adjunctive
adjunctive NN therapy
therapy IN in
in NNS patients
patients IN with
with NN dermatomyositis
dermatomyositis , ,
, WDT which
which VBN documented
documented DT a
a JJ significant
significant NN benefit

We PRP CAPITAL We
We VBP describe
describe DT a
a NN technique
technique IN that
that VBZ enables
enables DT the
the JJ autologous
autologous NN repair
repair IN of
of JJ large
large NN midline
midline JJ incisional
incisional NNS hernias
hernias IN by
by VBG restoring
restoring DT the
the JJ functional
functional JJ musculoaponeurotic
musculoaponeurotic NN support
support IN of
of DT the
the JJ abdominal
abdominal NN wall

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE CC CAPITAL AND
AND NN CAPITAL IMPORTANCE
IMPORTANCE : :
: DT CAPITAL The
The NN use
use IN of
of JJ chronic
chronic JJ intrathecal
intrathecal NN morphine
morphine IN for
for DT the
the NN treatment
treatment IN of
of JJ intractable
intractable , ,
, JJ nonmalignant
nonmalignant NN pain
pain VBZ is
is VBG becoming
becoming RBR more
more JJ prevalent

METHODS NNS CAPITAL METHODS
METHODS : :
: IN CAPITAL During
During DT a
a JJ 19-month
19-month NN period
period , ,
, CD seven
seven NNS children
children IN with
with NN empyema
empyema VBD underwent
underwent NN thoracoscopy

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> PRP CAPITAL We
We VBP describe
describe DT a
a NN patient
patient IN with
with RB left
left JJ cardiac
cardiac NN herniation
herniation VBG presenting
presenting IN after
after JJ intrapericardial
intrapericardial NN pulmonectomy
pulmonectomy IN for
for JJ primary
primary NN lung
lung NN cancer

The DT CAPITAL The
The VBG growing
growing NN use
use IN of
of VBN automated
automated JJ night-time
night-time NN dialysis
dialysis NN (
( NN CAPITAL APD
APD NN )
) IN in
in NN peritoneal
peritoneal NN dialysis
dialysis IN over
over DT the
the JJ last
last JJ few
few NNS years
years NNS shows
shows IN that
that DT this
this NN method
method VBZ represents
represents DT a
a JJ valid
valid NN alternative
alternative TO to
to JJ continuous
continuous JJ ambulatory
ambulatory NN peritoneal
peritoneal NN dialysis
dialysis NN (
( NN CAPITAL CAPD
CAPD NN )

La NNP CAPITAL La
La NNP CAPITAL Serna
Serna FW et
et NNP al
al . .
. NN (
( NNP CAPITAL Lancet
Lancet CD 1987
1987 : ;
; CD 26
26 : :
: CD 1517
1517 NN )
) VBD were
were DT the
the RB first
first TO to
to NN treat
treat NNS adults
adults IN with
with JJ recurrent
recurrent NN pericarditis
pericarditis IN with
with NN colchicine
colchicine , ,
, CC and
and VBD were
were VBN followed
followed IN by
by JJ other
other NNS authors

While IN CAPITAL While
While DT these
these NNS findings
findings VBP are
are VBN observed
observed IN for
for DT all
all NNS classes
classes IN of
of JJ oral
oral NNS drugs
drugs , ,
, DT the
the NN issue
issue VBZ is
is RB especially
especially JJ critical
critical IN for
for NN cancer
cancer NN chemotherapy
chemotherapy , ,
, IN in
in WDT which
which DT a
a JJ narrow
narrow JJ therapeutic
therapeutic NN index
index VBZ is
is RB frequently
frequently VBN observed

Treatment NN CAPITAL Treatment
Treatment IN for
for JJ low-grade
low-grade NN CAPITAL NHL
NHL IN during
during DT the
the IN past
past CD 30
30 NN yr
yr VBZ has
has VBD consisted
consisted IN of
of JJ high-dose
high-dose NN radiation
radiation CC and
and JJ cytotoxic
cytotoxic NNS agents
agents , ,
, VBN administered
administered RB alone
alone CC or
or IN in
in NN combination
combination , ,
, CC and
and JJ high-dose
high-dose NN therapy
therapy IN with
with NN stem
stem NN cell
cell NN transplant

However RB CAPITAL However
However , ,
, JJ recent
recent JJ clinical
clinical NN use
use IN of
of JJ monoclonal
monoclonal NNS antibodies
antibodies NN (
( NNS mAbs
mAbs NN )
) IN in
in NNS patients
patients IN with
with JJ low-grade
low-grade CC or
or VBN transformed
transformed JJ low-grade
low-grade NN CAPITAL NHL
NHL VBZ has
has VBD resulted
resulted IN in
in JJR less
less NN toxicity
toxicity IN than
than JJ conventional
conventional NNS treatments
treatments , ,
, IN as
as RB well
well IN as
as NN response
response NNS rates
rates IN that
that VBP are
are JJ comparable
comparable CC or
or JJ superior
superior TO to
to DT those
those VBN achieved
achieved IN with
with NN chemotherapy

Therefore RB CAPITAL Therefore
Therefore , ,
, NN interest
interest VBZ is
is VBG growing
growing IN in
in NNS mAbs
mAbs IN as
as JJ therapeutic
therapeutic NNS alternatives
alternatives IN for
for NNS patients
patients IN with
with JJ low-grade
low-grade NN CAPITAL NHL
NHL CC and
and DT those
those IN with
with VBN transformed
transformed NN histology

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: DT CAPITAL The
The NN treatment
treatment NN paradigm
paradigm IN for
for NN CAPITAL NHL
NHL VBZ is
is VBN expected
expected TO to
to NN change
change IN over
over DT the
the IN next
next JJ few
few NNS years
years TO to
to VB include
include VBN radiolabeled
radiolabeled NNS mAbs
mAbs , ,
, VBN administered
administered RB alone
alone CC or
or IN in
in NN combination
combination IN with
with JJ cytotoxic
cytotoxic NNS agents

RESULTS NNS CAPITAL RESULTS
RESULTS : :
: JJ CAPITAL Clinical
Clinical NNS trials
trials IN of
of NNP CAPITAL UFT
UFT VBN published
published IN in
in DT the
the NNP CAPITAL Western
Western NN world
world VB have
have VBN included
included CD 581
581 NNS patients
patients IN with
with JJ colorectal
colorectal NN cancer

The DT CAPITAL The
The NN activity
activity IN of
of JJ oral
oral NNP CAPITAL UFT
UFT IN in
in JJ large-bowel
large-bowel NN cancer
cancer WRB when
when VBN administered
administered IN with
with JJ oral
oral NN CAPITAL LV
LV NN (
( RB approximately
approximately CD 50
50 NN mg/dose
mg/dose NN )
) VBZ has
has VBD resulted
resulted IN in
in NN objective
objective NN response
response NNS rates
rates IN of
of RB approximately
approximately CD 40
40 NN %

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: NNP CAPITAL UFT
UFT VBZ is
is DT a
a NN fluoropyrimidine
fluoropyrimidine JJ active
active IN in
in JJ colorectal
colorectal NN cancer

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: NN CAPITAL Adrenalectomy
Adrenalectomy VBZ is
is DT the
the JJ current
current NN treatment
treatment IN for
for NN phaeochromocytoma

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: NN CAPITAL Adrenal-sparing
Adrenal-sparing NN surgery
surgery VBZ is
is JJ safe
safe CC and
and JJ effective
effective , ,
, CC and
and MD may
may VB become
become DT the
the NN treatment
treatment IN of
of NN choice
choice IN in
in NNS patients
patients IN with
with JJ hereditary
hereditary NN phaeochromocytoma

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL PURPOSE
PURPOSE : :
: DT CAPITAL The
The NNS purposes
purposes IN of
of DT this
this JJ descriptive
descriptive , ,
, JJ longitudinal
longitudinal NN study
study VBD were
were TO to
to VB evaluate
evaluate DT the
the NNS CAPITAL MacDibbs
MacDibbs NN CAPITAL Mouth
Mouth NNP CAPITAL Assessment
Assessment NN instrument
instrument IN for
for DT the
the NN assessment
assessment IN of
of NN mucositis
mucositis IN in
in DT the
the NN radiation
radiation NN therapy
therapy NN patient
patient VBG being
being VBN treated
treated IN for
for NN head
head CC and
and NN neck
neck NN cancer
cancer CC and
and TO to
to VBP describe
describe DT the
the NN course
course IN of
of JJ radiation-induced
radiation-induced NN mucositis
mucositis IN in
in DT these
these NNS patients

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL As
As JJ concomitant
concomitant NN thrombocytosis
thrombocytosis VBD persisted
persisted IN despite
despite NN treatment
treatment IN with
with NN hydroxyurea
hydroxyurea , ,
, DT the
the JJ new
new NN megakaryocyte
megakaryocyte NN inhibitor
inhibitor NN anagrelide
anagrelide NN (
( NN CAPITAL Agrelin
Agrelin NN )
) VBD was
was VBN administered
administered CC and
and VBN led
led TO to
to NN normalization
normalization IN of
of DT the
the NN platelet
platelet NN count
count IN within
within CD 11
11 NNS days

Background NN CAPITAL Background
Background : :
: NN CAPITAL Troglitazone
Troglitazone VBZ is
is DT a
a JJ new
new NN drug
drug IN for
for DT the
the NN treatment
treatment IN of
of NN type
type CD 2
2 NN diabetes

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL For
For DT a
a NN subset
subset IN of
of NNS patients
patients IN with
with NN CAPITAL Kaposi
Kaposi POS 's
's NN sarcoma
sarcoma WP who
who VBD were
were VBN treated
treated IN with
with JJ recombinant
recombinant NN interferon
interferon NN alfa-2a
alfa-2a , ,
, DT the
the NN disease
disease VBZ is
is IN in
in JJ complete
complete NN remission
remission , ,
, IN without
without JJ opportunistic
opportunistic NN infection
infection , ,
, CC and
and PRP they
they VB appear
appear TO to
to VB be
be JJ culture-negative
culture-negative IN for
for DT the
the JJ etiologic
etiologic NN retrovirus
retrovirus IN that
that NNS causes
causes PRP$ their
their JJ immune
immune NN deficiency

Interferon NN CAPITAL Interferon
Interferon NN alfa-2a
alfa-2a VBZ appears
appears TO to
to VB have
have JJ antineoplastic
antineoplastic NN efficacy
efficacy , ,
, NN (
( CC and
and MD may
may VB have
have JJ antiretroviral
antiretroviral NN efficacy
efficacy IN as
as RB well
well NN )
) IN in
in DT this
this JJ epidemic
epidemic NN neoplasm

In IN CAPITAL In
In CD three
three JJ consecutive
consecutive NN CAPITAL Phase
Phase NNP CAPITAL II
II NNS trials
trials IN of
of JJ recombinant
recombinant NN interferon
interferon NN alfa-2a
alfa-2a NN (
( NN rIFN
rIFN NN alfa-2a
alfa-2a : ;
; NN CAPITAL Roferon-A
Roferon-A NNP CAPITAL Hoffmann-La
Hoffmann-La NNP CAPITAL Roche
Roche , ,
, NNP CAPITAL Nutley
Nutley , ,
, NNP CAPITAL NJ
NJ NN )
) VBG involving
involving CD 96
96 NNS patients
patients IN with
with VBN advanced
advanced JJ malignant
malignant NN melanoma
melanoma , ,
, DT an
an RB overall
overall NN response
response NN rate
rate IN of
of CD 22
22 NN %
% VBD was
was VBN observed

As IN CAPITAL As
As JJ single
single NN agent
agent NN therapy
therapy IN in
in JJ malignant
malignant NN melanoma
melanoma , ,
, NN interferon
interferon NN alfa-2a
alfa-2a VBD was
was RB only
only RB marginally
marginally JJ useful
useful IN in
in RBS most
most NNS patients

Studies NNS CAPITAL Studies
Studies IN with
with JJ various
various NN interferon
interferon NN alpha
alpha NNS preparations
preparations , ,
, VBG including
including NNS interferons
interferons VBN induced
induced IN in
in JJ human
human NNS leukocytes
leukocytes , ,
, NN interferon
interferon NN alfa-N1
alfa-N1 , ,
, NN interferon
interferon NN alfa-2a
alfa-2a , ,
, CC and
and NN interferon
interferon NN alfa-2b
alfa-2b , ,
, VB have
have DT all
all VBN provided
provided NN evidence
evidence IN for
for JJ modest
modest CC but
but JJ reproducible
reproducible NN antitumor
antitumor NN activity
activity IN in
in VBN advanced
advanced JJ renal
renal NN cell
cell NN carcinoma

Preliminary JJ CAPITAL Preliminary
Preliminary NN evidence
evidence VBZ suggests
suggests IN that
that NNS interferons
interferons NN beta
beta CC and
and NN gamma
gamma MD may
may RB also
also VB induce
induce NN regression
regression IN of
of JJ metastatic
metastatic JJ renal
renal NN cell
cell NN carcinoma

The DT CAPITAL The
The NN rationale
rationale IN for
for JJ antileukemic
antileukemic NN therapy
therapy IN in
in JJ hairy
hairy NN cell
cell NN leukemia
leukemia VBZ is
is TO to
to VB reduce
reduce DT the
the JJ significant
significant NN risk
risk IN of
of NN infection
infection CC and
and JJ other
other NN potential
potential JJ serious
serious NNS complications

Splenectomy NNP CAPITAL Splenectomy
Splenectomy RB presumably
presumably VBZ alleviates
alleviates DT the
the JJ pancytopenic
pancytopenic NN effect
effect IN of
of NN hypersplenism
hypersplenism IN by
by VBG removing
removing DT the
the VBN preferred
preferred NN site
site IN of
of JJ leukemic
leukemic NN cell
cell NN proliferation

Recombinant JJ CAPITAL Recombinant
Recombinant CC and
and JJ natural
natural NNS forms
forms IN of
of NN interferon
interferon NN alpha
alpha VB have
have VBN been
been VBN shown
shown TO to
to VB bring
bring IN about
about NN tumor
tumor NNS regressions
regressions IN in
in NNS patients
patients IN with
with JJ low-grade
low-grade JJ non-Hodgkin
non-Hodgkin POS 's
's NN lymphoma

Current JJ CAPITAL Current
Current NNS studies
studies VBG using
using NN interferon
interferon IN in
in NNS patients
patients IN with
with JJ low-grade
low-grade JJ non-Hodgkin
non-Hodgkin POS 's
's NNS lymphomas
lymphomas VBP are
are VBG evaluating
evaluating JJR lower
lower , ,
, CC and
and RB perhaps
perhaps RB better
better VBN tolerated
tolerated NNS doses
doses IN of
of NN interferon

This DT CAPITAL This
This NN approach
approach VBZ is
is VBG being
being VBN extended
extended TO to
to DT the
the NN clinic
clinic , ,
, CC and
and NNS trials
trials VBP are
are RB now
now NN underway
underway VBG evaluating
evaluating NNS combinations
combinations IN of
of NN interferon
interferon CC and
and JJ various
various JJ cytotoxic
cytotoxic NNS drugs
drugs VBN known
known IN from
from JJ previous
previous NNS studies
studies TO to
to VB be
be JJ active
active IN in
in NNS patients
patients IN with
with JJ low-grade
low-grade JJ non-Hodgkin
non-Hodgkin POS 's
's NNS lymphomas

While IN CAPITAL While
While DT the
the VBN demonstrated
demonstrated JJ antiviral
antiviral , ,
, JJ antiproliferative
antiproliferative , ,
, CC and
and JJ immunomodulatory
immunomodulatory NNS properties
properties IN of
of NNS interferons
interferons VB have
have VBN led
led TO to
to DT a
a NN number
number IN of
of NNS theories
theories VBG regarding
regarding PRP$ their
their NN potential
potential NN use
use IN in
in VBG treating
treating NNS individuals
individuals IN with
with JJ chronic
chronic JJ myelogenous
myelogenous NN leukemia
leukemia NN (
( NN CAPITAL CML
CML NN )
) , ,
, PRP$ their
their JJ limited
limited NN availability
availability VBZ has
has VBD prevented
prevented JJ thorough
thorough JJ clinical
clinical NN investigation

The DT CAPITAL The
The NNS data
data VBG resulting
resulting IN from
from DT these
these JJ clinical
clinical NNS trials
trials VBP indicate
indicate IN that
that NN interferon
interferon NN alfa-2a
alfa-2a VBZ is
is JJ effective
effective IN in
in VBG inducing
inducing JJ hematologic
hematologic NNS remissions
remissions IN in
in DT the
the NN majority
majority IN of
of RB minimally
minimally VBN treated
treated , ,
, NN benign-phase
benign-phase NN CAPITAL CML
CML , ,
, JJ CAPITAL Ph1-positive
Ph1-positive NNS patients

More RBR CAPITAL More
More IN than
than CD 1600
1600 NNS patients
patients IN with
with JJ neoplastic
neoplastic NNS disorders
disorders VB have
have VBN received
received JJ recombinant
recombinant JJ human
human NN interferon
interferon NN alfa-2a
alfa-2a NN (
( NN CAPITAL Roferon-A
Roferon-A , ,
, NNP CAPITAL Hoffmann-La
Hoffmann-La NNP CAPITAL Roche
Roche , ,
, NNP CAPITAL Nutley
Nutley , ,
, NNP CAPITAL NJ
NJ NN )
) IN as
as NN part
part IN of
of JJ ongoing
ongoing CC or
or VBN completed
completed JJ clinical
clinical NNS trials

PURPOSE NN CAPITAL PURPOSE
PURPOSE : :
: DT CAPITAL A
A NN phase
phase CD CAPITAL I/II
I/II NN trial
trial IN of
of NN docetaxel
docetaxel , ,
, NN cisplatin
cisplatin , ,
, NN fluorouracil
fluorouracil NN (
( NN 5-FU
5-FU NN )
) , ,
, CC and
and NN leucovorin
leucovorin NN (
( NN CAPITAL TPFL5
TPFL5 NN )
) NN induction
induction NN chemotherapy
chemotherapy IN for
for NNS patients
patients IN with
with RB locally
locally VBN advanced
advanced JJ squamous
squamous NN cell
cell NN carcinoma
carcinoma IN of
of DT the
the NN head
head CC and
and NN neck
neck NN (
( NN CAPITAL SCCHN
SCCHN NN )

PATIENTS NNS CAPITAL PATIENTS
PATIENTS CC CAPITAL AND
AND NNS CAPITAL METHODS
METHODS : :
: CD CAPITAL Twenty-three
Twenty-three RB previously
previously JJ untreated
untreated NNS patients
patients IN with
with NN stage
stage NNP CAPITAL III
III CC or
or CD CAPITAL IV
IV NN CAPITAL SCCHN
SCCHN CC and
and NNP CAPITAL Eastern
Eastern NNP CAPITAL Cooperative
Cooperative NNP CAPITAL Oncology
Oncology NNP CAPITAL Group
Group JJ functional
functional NN status
status JJR less
less IN than
than CC or
or JJ equal
equal TO to
to CD 2
2 VBD were
were VBN treated
treated IN with
with NN CAPITAL TPFL5

Intrathecal JJ CAPITAL Intrathecal
Intrathecal NN sufentanil
sufentanil VBZ provides
provides RB approximately
approximately CD 2
2 NN h
h IN of
of JJ excellent
excellent NN labor
labor NN analgesia
analgesia IN with
with JJ minimal
minimal NN motor
motor NN blockade

OBJECTIVE NN CAPITAL OBJECTIVE
OBJECTIVE : :
: PRP CAPITAL We
We NN report
report DT the
the NNS results
results IN of
of DT a
a JJ double-blind
double-blind , ,
, JJ double-dummy
double-dummy , ,
, NN active-control
active-control NN study
study VBN designed
designed TO to
to VB evaluate
evaluate DT the
the NN efficacy
efficacy CC and
and NN safety
safety IN of
of NN lamotrigine
lamotrigine NN (
( NN CAPITAL LTG
LTG NN )
) VBN administered
administered IN as
as NN monotherapy
monotherapy TO to
to JJ adult
adult NNS outpatients
outpatients IN with
with JJ partial
partial NNS seizures

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: DT CAPITAL The
The NN effectiveness
effectiveness IN of
of NN CAPITAL LTG
LTG IN as
as JJ add-on
add-on NN therapy
therapy IN for
for JJ partial
partial NNS seizures
seizures IN in
in NNS adults
adults VBZ has
has RB previously
previously VBN been
been VBN established

CONCLUSIONS NNS CAPITAL CONCLUSIONS
CONCLUSIONS : :
: PRP CAPITAL We
We VBP conclude
conclude IN that
that NN CAPITAL LTG
LTG VBZ is
is JJ effective
effective CC and
and RB well
well VBN tolerated
tolerated WRB when
when VBN administered
administered IN as
as NN monotherapy
monotherapy IN in
in JJ adult
adult NNS patients
patients IN with
with JJ partial
partial NNS seizures

BACKGROUND NN CAPITAL BACKGROUND
BACKGROUND : :
: NN CAPITAL Omega3
Omega3 NN fatty
fatty NNS acids
acids MD may
may VB inhibit
inhibit JJ neuronal
neuronal NN signal
signal NN transduction
transduction NNS pathways
pathways IN in
in DT a
a NN manner
manner JJ similar
similar TO to
to IN that
that IN of
of NN lithium
lithium NN carbonate
carbonate CC and
and NN valproate
valproate , ,
, CD 2
2 JJ effective
effective NNS treatments
treatments IN for
for JJ bipolar
bipolar NN disorder

The DT CAPITAL The
The JJ present
present NN study
study VBD was
was VBN performed
performed TO to
to VB examine
examine IN whether
whether NN omega3
omega3 NN fatty
fatty NNS acids
acids RB also
also NN exhibit
exhibit JJ mood-stabilizing
mood-stabilizing NNS properties
properties IN in
in JJ bipolar
bipolar NN disorder

CONCLUSION NN CAPITAL CONCLUSION
CONCLUSION : :
: NN CAPITAL Omega3
Omega3 NN fatty
fatty NNS acids
acids VBD were
were RB well
well VBN tolerated
tolerated CC and
and VBN improved
improved DT the
the JJ short-term
short-term NN course
course IN of
of NN illness
illness IN in
in DT this
this JJ preliminary
preliminary NN study
study IN of
of NNS patients
patients IN with
with JJ bipolar
bipolar NN disorder

Several JJ CAPITAL Several
Several JJ large-scale
large-scale NNS trials
trials VB have
have RB firmly
firmly VBN established
established DT the
the NN effectiveness
effectiveness IN of
of JJ thrombolytic
thrombolytic NN therapy
therapy , ,
, NN beta
beta NNS blockers
blockers , ,
, CC and
and NN aspirin
aspirin IN in
in DT the
the NN treatment
treatment IN of
of NNP CAPITAL AMI

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL While
While JJ diastolic
diastolic RB left
left JJ ventricular
ventricular NN (
( NN CAPITAL LV
LV NN )
) NN dysfunction
dysfunction VBZ is
is JJ frequent
frequent CC and
and VBN associated
associated IN with
with JJ cardiovascular
cardiovascular NNS complications
complications IN in
in NN end-stage
end-stage JJ renal
renal NN disease
disease VBN treated
treated IN with
with NN dialysis
dialysis , ,
, JJ controversial
controversial NN information
information VBZ exists
exists IN on
on JJ diastolic
diastolic NN CAPITAL LV
LV NN function
function IN after
after JJ renal
renal NN transplantation

METHODS NNS CAPITAL METHODS
METHODS : :
: NN CAPITAL Fluvastatin
Fluvastatin CD 40
40 NN mg
mg RB daily
daily VBD was
was VBN administered
administered TO to
to CD 25
25 NNS patients
patients IN with
with NN hypercholesterolaemia
hypercholesterolaemia IN for
for RB up
up TO to
to CD 24
24 NNS weeks

The DT CAPITAL The
The JJ inhibitory
inhibitory NN effect
effect IN of
of NN n-3
n-3 JJ polyunsaturated
polyunsaturated NN fatty
fatty NNS acids
acids IN on
on JJ human
human JJ colorectal
colorectal NN cancer
cancer VBZ has
has VBN been
been VBD speculated
speculated IN on
on IN from
from JJ epidemiological
epidemiological NNS data
data CC and
and NN animal
animal NNS studies

We PRP CAPITAL We
We VBN conducted
conducted DT a
a JJ long-term
long-term NN trial
trial IN of
of JJ docosahexanoic
docosahexanoic NN acid
acid NN (
( NN CAPITAL DHA
DHA NN )
) JJ -concentrated
-concentrated NN fish
fish NN oil
oil NNS capsules
capsules IN for
for NNS patients
patients IN in
in DT a
a JJ high-risk
high-risk NN group
group IN for
for JJ colorectal
colorectal NN cancer

Three CD CAPITAL Three
Three NNS patients
patients IN with
with NN CAPITAL FAP
FAP CC and
and CD two
two NNS patients
patients IN with
with JJ multiple
multiple NN (
( RBR more
more IN than
than CD 30
30 NN )
) JJ colorectal
colorectal NNS polyps
polyps VBD were
were VBN administered
administered JJ CAPITAL DHA-concentrated
DHA-concentrated NN fish
fish NN oil
oil NN capsules_Hlk427554600
capsules_Hlk427554600 NN (
( CD 2.2
2.2 NN g
g IN of
of NN CAPITAL DHA
DHA CC and
and CD 0.6
0.6 NN g
g IN of
of JJ eicosapentanoic
eicosapentanoic NN acid
acid NN (
( NNP CAPITAL EPA
EPA NN )
) IN per
per NN day
day NN )
) IN for
for CD one
one CC or
or CD two
two NNS years

This DT CAPITAL This
This NN article
article NNS reviews
reviews JJ current
current NNS trends
trends IN in
in NN management
management IN of
of NN esophageal
esophageal NN achalasia
achalasia , ,
, VBG highlighting
highlighting JJ short-term
short-term NN outcome
outcome CC and
and NN cost
cost NNS comparisons
comparisons IN of
of CD three
three NNS treatments
treatments : :
: NN botulinum
botulinum NN toxin
toxin NN injection
injection , ,
, JJ pneumatic
pneumatic NN dilation
dilation , ,
, CC and
and JJ laparoscopic
laparoscopic NN myotomy

The DT CAPITAL The
The JJ clinical
clinical NN application
application IN of
of JJ therapeutic
therapeutic NN hysteroscopy
hysteroscopy , ,
, RB mainly
mainly IN in
in DT the
the NN field
field IN of
of DT the
the NN treatment
treatment IN of
of JJ abnormal
abnormal NN uterine
uterine VBG bleeding
bleeding , ,
, VBD started
started IN in
in DT the
the NNS 1980s

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> IN CAPITAL In
In DT this
this NN article
article , ,
, NN evidence
evidence IN of
of NN effectiveness
effectiveness CC and
and NN cost-effectiveness
cost-effectiveness IN of
of DT the
the VBG following
following NNS procedures
procedures VBZ is
is VBN reviewed
reviewed : :
: NN (
( CD 1
1 NN )
) NN laser
laser NN treatment
treatment IN of
of NN bladder
bladder NNS tumors
tumors : ;
; NN (
( CD 2
2 NN )
) JJ extracorporeal
extracorporeal NN shock-wave
shock-wave NN lithotripsy
lithotripsy CC and
and JJ percutaneous
percutaneous NN nephrolithotomy
nephrolithotomy : ;
; NN (
( CD 3
3 NN )
) JJ laparoscopic
laparoscopic NN treatment
treatment IN of
of NN endometriosis
endometriosis : ;
; NN (
( CD 4
4 NN )
) JJ laparoscopic
laparoscopic NN removal
removal IN of
of JJ ovarian
ovarian NNS cysts
cysts : ;
; NN (
( CD 5
5 NN )
) JJ laparoscopic
laparoscopic NN cholecystectomy
cholecystectomy : ;
; NN (
( CD 6
6 NN )
) JJ laparoscopic
laparoscopic NN appendectomy
appendectomy : ;
; NN (
( CD 7
7 NN )
) NN catheter
catheter NN treatment
treatment IN of
of JJ coronary
coronary NN artery
artery NN disease
disease : ;
; NN (
( CD 8
8 NN )
) NN palliation
palliation IN of
of NN colon
colon NN cancer
cancer IN by
by JJ endoscopic
endoscopic NN intervention
intervention : ;
; NN (
( CD 9
9 NN )
) NN treatment
treatment IN of
of JJ upper
upper JJ gastrointestinal
gastrointestinal NN (
( NNP CAPITAL UGI
UGI NN )
) VBG bleeding
bleeding IN by
by JJ endoscopic
endoscopic NN intervention
intervention : ;
; CC and
and NN (
( CD 10
10 NN )
) NN arthroscopic
arthroscopic NN knee
knee NN surgery

Gene NN CAPITAL Gene
Gene NN therapy
therapy IN of
of JJ malignant
malignant NN brain
brain NNS tumors

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ irritable
irritable NN bowel
bowel NN syndrome
syndrome IN with
with JJ CAPITAL Chinese
Chinese JJ herbal
herbal NN medicine
medicine : :
: DT a
a VBN randomized
randomized VBN controlled
controlled NN trial

Randomised VBN CAPITAL Randomised
Randomised NN trial
trial IN of
of NN interferon
interferon NN alpha2b
alpha2b CC plus
plus NNP ribavirin
ribavirin IN for
for CD 48
48 NNS weeks
weeks CC or
or IN for
for CD 24
24 NNS weeks
weeks CC versus
versus NN interferon
interferon NN alpha2b
alpha2b CC plus
plus NN placebo
placebo IN for
for CD 48
48 NNS weeks
weeks IN for
for NN treatment
treatment IN of
of JJ chronic
chronic NN infection
infection IN with
with NN hepatitis
hepatitis NN CAPITAL C
C NN virus

Low-molecular-weight JJ CAPITAL Low-molecular-weight
Low-molecular-weight NN heparin
heparin IN for
for JJ immediate
immediate NN management
management IN of
of NN thromboembolic
thromboembolic NN disease
disease IN in
in NN pregnancy

Tubularized VBN CAPITAL Tubularized
Tubularized VBN incised
incised NN plate
plate NNS hypospadias
hypospadias NN repair
repair IN for
for JJ proximal
proximal NNS hypospadias

Comparison NN CAPITAL Comparison
Comparison IN of
of NN radical
radical NN prostatectomy
prostatectomy CC and
and NN iodine
iodine CD 125
125 JJ interstitial
interstitial NN radiotherapy
radiotherapy IN for
for DT the
the NN treatment
treatment IN of
of RB clinically
clinically JJ localized
localized NN prostate
prostate NN cancer
cancer : :
: DT a
a JJ 7-year
7-year JJ biochemical
biochemical NN (
( NN CAPITAL PSA
PSA NN )
) NN progression
progression NN analysis

The DT CAPITAL The
The NN effectiveness
effectiveness IN of
of NN acupuncture
acupuncture IN in
in VBG treating
treating JJ acute
acute JJ dental
dental NN pain
pain : :
: DT a
a JJ systematic
systematic NN review

Correction NN CAPITAL Correction
Correction IN of
of JJ cardiac
cardiac NNS defects
defects IN through
through DT a
a RB right
right NN thoracotomy
thoracotomy IN in
in NNS children

New NNP CAPITAL New
New NN technique
technique IN for
for NN mesh
mesh NN repair
repair IN of
of NN paracolostomy
paracolostomy NNS hernias

Immunotherapy NN CAPITAL Immunotherapy
Immunotherapy IN of
of NNS tumors
tumors IN with
with JJ autologous
autologous JJ tumor-derived
tumor-derived NN heat
heat NN shock
shock NN protein
protein NNS preparations

Comprehensive NNP CAPITAL Comprehensive
Comprehensive VBN modified
modified NN diet
diet VBZ simplifies
simplifies NN nutrition
nutrition NN management
management IN of
of NNS adults
adults IN with
with NN short-bowel
short-bowel NN syndrome

Extended VBN CAPITAL Extended
Extended NN use
use IN of
of NN glatiramer
glatiramer NN acetate
acetate NN (
( NN CAPITAL Copaxone
Copaxone NN )
) VBZ is
is RB well
well VBN tolerated
tolerated CC and
and VBZ maintains
maintains PRP$ its
its JJ clinical
clinical NN effect
effect IN on
on JJ multiple
multiple NN sclerosis
sclerosis NN relapse
relapse NN rate
rate CC and
and NN degree
degree IN of
of NN disability

European JJ CAPITAL European
European NN register
register IN of
of NNS patients
patients IN with
with NN sickle
sickle NN cell
cell NN disease
disease VBN treated
treated IN with
with NN hydroxyurea
hydroxyurea VBZ is
is VBG being
being NN set
set RB up

Understanding VBG CAPITAL Understanding
Understanding DT the
the NN culture
culture IN of
of VBG prescribing
prescribing : :
: JJ qualitative
qualitative NN study
study IN of
of JJ general
general NNS practitioners
practitioners '' '
' CC and
and NNS patients
patients '' '
' NNS perceptions
perceptions IN of
of NNS antibiotics
antibiotics IN for
for JJ sore
sore NNS throats

Steroid NN CAPITAL Steroid
Steroid NN delivery
delivery IN in
in NN croup

Haematoma NN CAPITAL Haematoma
Haematoma NN block
block CC versus
versus JJ intravenous
intravenous JJ regional
regional NN anaesthesia
anaesthesia IN in
in NNP CAPITAL Colles
Colles '' '
' NNS fractures

Direct JJ CAPITAL Direct
Direct JJ percutaneous
percutaneous JJ transluminal
transluminal NN angioplasty
angioplasty IN for
for JJ acute
acute JJ middle
middle JJ cerebral
cerebral NN artery
artery NN occlusion

Magnesium NN CAPITAL Magnesium
Magnesium NN sulphate
sulphate IN for
for DT the
the NN control
control IN of
of NNS spasms
spasms IN in
in JJ severe
severe NN tetanus

Protective JJ CAPITAL Protective
Protective NN effect
effect IN of
of NN pralidoxime
pralidoxime IN on
on NN muscle
muscle NN fiber
fiber NN necrosis
necrosis VBN induced
induced IN by
by NN organophosphate
organophosphate NNS compounds

Assessment NNP CAPITAL Assessment
Assessment IN of
of JJ atrioventricular
atrioventricular NN junction
junction NN ablation
ablation CC and
and NN CAPITAL VVIR
VVIR NN pacemaker
pacemaker CC versus
versus JJ pharmacological
pharmacological NN treatment
treatment IN in
in NNS patients
patients IN with
with NN heart
heart NN failure
failure CC and
and JJ chronic
chronic IN atrial
atrial NN fibrillation
fibrillation : :
: DT a
a VBN randomized
randomized , ,
, VBN controlled
controlled NN study

Statins NNS CAPITAL Statins
Statins IN for
for NN prevention
prevention IN of
of NN stroke

Repair NN CAPITAL Repair
Repair IN of
of JJ ventral
ventral NNS hernias
hernias IN with
with VBN expanded
expanded NN polytetrafluoroethylene
polytetrafluoroethylene NN patch

Spinal JJ CAPITAL Spinal
Spinal NN manipulation
manipulation IN in
in DT the
the NN treatment
treatment IN of
of JJ episodic
episodic JJ tension-type
tension-type NN headache
headache : :
: DT a
a VBN randomized
randomized VBN controlled
controlled NN trial

Successful JJ CAPITAL Successful
Successful NN treatment
treatment IN with
with NN lamivudine
lamivudine IN for
for JJ fulminant
fulminant VBN reactivated
reactivated NN hepatitis
hepatitis NN CAPITAL B
B NN infectioN
infectioN VBG following
following JJ intensive
intensive NN therapy
therapy IN for
for JJ high-grade
high-grade JJ non-Hodgkin
non-Hodgkin POS 's
's NN lymphoma

Influence NN CAPITAL Influence
Influence IN of
of NN treatment
treatment NN delay
delay IN on
on NN infarct
infarct NN size
size CC and
and JJ clinical
clinical NN outcome
outcome IN in
in NNS patients
patients IN with
with JJ acute
acute JJ myocardial
myocardial NN infarction
infarction VBN treated
treated IN with
with JJ primary
primary NN angioplasty

Should MD CAPITAL Should
Should NNS patients
patients IN with
with VBN advanced
advanced NNS sarcomas
sarcomas VB be
be VBN treated
treated IN with
with NN chemotherapy
chemotherapy . ?

Plasma NN CAPITAL Plasma
Plasma NN exchange
exchange CC and
and JJ tacrolimus-mycophenolate
tacrolimus-mycophenolate NN rescue
rescue IN for
for JJ acute
acute JJ humoral
humoral NN rejection
rejection IN in
in NN kidney
kidney NN transplantation

Hyperbaric JJ CAPITAL Hyperbaric
Hyperbaric NN oxygen
oxygen NN therapy
therapy IN for
for NNS children
children IN with
with JJ cerebral
cerebral NN palsy

Endoscopic JJ CAPITAL Endoscopic
Endoscopic NN excision
excision IN of
of DT a
a NN forehead
forehead NN mass

Effect NN CAPITAL Effect
Effect IN of
of JJ photodynamic
photodynamic NN therapy
therapy IN in
in NN combination
combination IN with
with NN mitomycin
mitomycin NN CAPITAL C
C IN on
on DT a
a JJ mitomycin-resistant
mitomycin-resistant NN bladder
bladder NN cancer
cancer NN cell
cell NN line

Is VBZ CAPITAL Is
Is JJ conservative
conservative NN surgery
surgery IN for
for JJ tubal
tubal NN pregnancy
pregnancy JJ preferable
preferable TO to
to NN salpingectomy
salpingectomy . ?
? DT CAPITAL An
An JJ economic
economic NN analysis

Laparoscopic JJ CAPITAL Laparoscopic
Laparoscopic NN cornuostomy
cornuostomy IN in
in DT the
the NN treatment
treatment IN of
of JJ interstitial
interstitial NN pregnancy
pregnancy IN with
with JJ subsequent
subsequent NN hysterosalpingography

Experimental JJ CAPITAL Experimental
Experimental NN evaluation
evaluation IN of
of DT the
the NN use
use IN of
of JJ recombinant
recombinant NN prourokinase
prourokinase CC and
and PRP$ its
its VBN immobilized
immobilized NNS forms
forms IN in
in DT the
the NN treatment
treatment IN of
of JJ postoperative
postoperative NN fibrinoid
fibrinoid NN syndrome
syndrome IN in
in NN ophthalmology

In IN CAPITAL In
In NN vitro
vitro CC and
and IN in
in FW vivo
vivo NN comparison
comparison IN between
between DT the
the NNS effects
effects IN of
of NN treatment
treatment IN with
with NN adenosine
adenosine NN triphosphate
triphosphate CC and
and NN treatment
treatment IN with
with NN buthionine
buthionine NN sulfoximine
sulfoximine IN on
on NN chemosensitization
chemosensitization CC and
and NN tumour
tumour NN growth
growth IN of
of NN CAPITAL B16
B16 NN melanoma

Effects NNS CAPITAL Effects
Effects IN of
of JJ transpupillary
transpupillary NN thermotherapy
thermotherapy IN on
on JJ immunological
immunological NNS parameters
parameters CC and
and NN apoptosis
apoptosis IN in
in DT a
a NN case
case IN of
of JJ primary
primary NN uveal
uveal NN melanoma

Is VBZ CAPITAL Is
Is RB there
there DT a
a JJ rational
rational NN therapy
therapy IN for
for JJ symptomatic
symptomatic NN treatment
treatment IN of
of JJ benign
benign JJ prostatic
prostatic NN hyperplasia
hyperplasia IN with
with JJ phytogenic
phytogenic NNS drugs
drugs . ?
? NNP CAPITAL Illustrated
Illustrated IN with
with DT the
the NN example
example IN of
of DT the
the NN prostate
prostate NN agent
agent IN from
from NNP CAPITAL Serenoa
Serenoa NNS repens
repens NN (
( NNP CAPITAL Sabal
Sabal NN fructus
fructus NN )

Pharmacological JJ CAPITAL Pharmacological
Pharmacological CC and
and JJ clinical
clinical NN effectiveness
effectiveness IN of
of DT a
a VBN fixed
fixed JJ phytogenic
phytogenic NN combination
combination VBG trembling
trembling NN poplar
poplar NN (
( NN CAPITAL Populus
Populus NN tremula
tremula NN )
) , ,
, JJ true
true NN goldenrod
goldenrod NN (
( NNP CAPITAL Solidago
Solidago NN virgaurea
virgaurea NN )
) CC and
and JJ ash
ash NN (
( NN CAPITAL Fraxinus
Fraxinus NN excelsior
excelsior NN )
) IN in
in JJ mild
mild TO to
to JJ moderate
moderate JJ rheumatic
rheumatic NNS complaints

Therapy NN CAPITAL Therapy
Therapy IN of
of JJ degenerative
degenerative NNS diseases
diseases IN of
of DT the
the JJ musculoskeletal
musculoskeletal NN system
system IN with
with NNP CAPITAL South
South NNP CAPITAL African
African NNP devil
devil POS 's
's VB claw
claw NN (
( NN CAPITAL Harpagophytum
Harpagophytum NNS procumbens
procumbens NN CAPITAL DC
DC NN )

Treatment NN CAPITAL Treatment
Treatment NN strategy
strategy IN for
for JJ mucin-producing
mucin-producing JJ intrahepatic
intrahepatic NN cholangiocarcinoma
cholangiocarcinoma : :
: NN value
value IN of
of JJ percutaneous
percutaneous JJ transhepatic
transhepatic JJ biliary
biliary NN drainage
drainage CC and
and NN cholangioscopy

Strategy NN CAPITAL Strategy
Strategy IN for
for JJ surgical
surgical NN management
management IN of
of JJ ileocolonic
ileocolonic JJ anastomotic
anastomotic NN recurrence
recurrence IN in
in NN CAPITAL Crohn
Crohn POS 's
's NN disease

Nerve-sparing JJ CAPITAL Nerve-sparing
Nerve-sparing NN surgery
surgery IN for
for VBN advanced
advanced JJ rectal
rectal NN cancer
cancer NNS patients
patients : :
: JJ special
special NN reference
reference TO to
to NNP CAPITAL Dukes
Dukes NN CAPITAL C
C NNS patients

Prognostic JJ CAPITAL Prognostic
Prognostic NNS factors
factors IN in
in NNS patients
patients IN with
with RB locally
locally VBN advanced
advanced JJ rectal
rectal NN adenocarcinoma
adenocarcinoma VBN treated
treated IN with
with JJ preoperative
preoperative NN radiotherapy
radiotherapy CC and
and NN surgery

Current JJ CAPITAL Current
Current JJ surgical
surgical NN therapy
therapy IN for
for NN bronchiectasis

Thoracic JJ CAPITAL Thoracic
Thoracic NN surgery
surgery IN for
for NN hydatid
hydatid NN disease

Surgical NNP CAPITAL Surgical
Surgical NN treatment
treatment IN of
of JJ postpneumonic
postpneumonic NN empyema

Thoracoscopic NNP CAPITAL Thoracoscopic
Thoracoscopic NN surgery
surgery IN for
for JJ pulmonary
pulmonary NN tuberculosis

Thoracoscopic NNP CAPITAL Thoracoscopic
Thoracoscopic NN surgery
surgery IN for
for JJ spontaneous
spontaneous NN pneumothorax

Surgery NN CAPITAL Surgery
Surgery IN for
for JJ chronic
chronic NN thromboembolic
thromboembolic JJ pulmonary
pulmonary NN hypertension

Transabdominal JJ CAPITAL Transabdominal
Transabdominal JJ extensive
extensive JJ esophagogastric
esophagogastric NN devascularization
devascularization IN with
with NN gastroesophageal
gastroesophageal VBG stapling
stapling IN for
for NN management
management IN of
of JJ noncirrhotic
noncirrhotic NN portal
portal NN hypertension
hypertension : :
: JJ long-term
long-term NNS results

Surgical NNP CAPITAL Surgical
Surgical NN treatment
treatment IN for
for NN lung
lung NN hydatid
hydatid NN disease

Sliding VBG CAPITAL Sliding
Sliding NN door
door NN technique
technique IN for
for DT the
the NN repair
repair IN of
of NN midline
midline JJ incisional
incisional NNS hernias

One-lung JJ CAPITAL One-lung
One-lung NN ventilation
ventilation IN in
in NNS patients
patients IN with
with JJ difficult
difficult NNS airways

Thoracoscopy NNP CAPITAL Thoracoscopy
Thoracoscopy IN for
for NN empyema
empyema IN in
in NNS children

Sex NN CAPITAL Sex
Sex NNS differences
differences IN in
in DT the
the NN use
use IN of
of NN asthma
asthma NNS drugs
drugs : :
: NN cross
cross JJ sectional
sectional NN study

Conventional JJ CAPITAL Conventional
Conventional NNS treatments
treatments IN for
for JJ non-Hodgkin
non-Hodgkin POS 's
's NN lymphoma
lymphoma : :
: DT the
the NN need
need IN for
for JJ new
new NNS therapies

Adrenal-sparing NN CAPITAL Adrenal-sparing
Adrenal-sparing NN surgery
surgery IN for
for NN phaeochromocytoma

Antiplatelet JJ CAPITAL Antiplatelet
Antiplatelet NN therapy
therapy IN in
in JJ acute
acute JJ cerebral
cerebral NN ischemia

Laugier-Hunziker NNP CAPITAL Laugier-Hunziker
Laugier-Hunziker NN syndrome
syndrome : :
: NN case
case NN report
report CC and
and NN treatment
treatment IN with
with DT the
the JJ CAPITAL Q-switched
Q-switched NN CAPITAL Nd-Yag
Nd-Yag NN laser

Thoracoscopic NNP CAPITAL Thoracoscopic
Thoracoscopic NN operation
operation IN for
for JJ secondary
secondary NN pneumothorax
pneumothorax IN under
under JJ local
local CC and
and JJ epidural
epidural NN anesthesia
anesthesia IN in
in JJ high-risk
high-risk NNS patients

Troglitazone-induced JJ CAPITAL Troglitazone-induced
Troglitazone-induced JJ hepatic
hepatic NN failure
failure VBG leading
leading TO to
to NN liver
liver NN transplantation

A DT CAPITAL A
A VBN modified
modified NN technique
technique IN of
of JJ tubeless
tubeless NN anaesthesia
anaesthesia IN for
for NN microlaryngoscopy
microlaryngoscopy CC and
and NN bronchoscopy
bronchoscopy IN in
in JJ young
young NNS children
children IN with
with NN stridor

A DT CAPITAL A
A VBN randomized
randomized NN trial
trial IN of
of NN CAPITAL Lactobacillus
Lactobacillus NN acidophilus
acidophilus NN CAPITAL BG2FO4
BG2FO4 TO to
to NN treat
treat NN lactose
lactose NN intolerance

Treatment NN CAPITAL Treatment
Treatment IN of
of JJ idiopathic
idiopathic JJ thrombopenic
thrombopenic NN purpura
purpura IN in
in NNS adolescents
adolescents IN by
by JJ intravenous
intravenous NN immunoglobulin

Azithromycin NN CAPITAL Azithromycin
Azithromycin NN therapy
therapy IN for
for NN scrub
scrub NN typhus
typhus IN during
during NN pregnancy

Excimer NNP CAPITAL Excimer
Excimer NN laser
laser VBN assisted
assisted IN in
in FW situ
situ NN keratomileusis
keratomileusis IN for
for NN hyperopia

Three CD CAPITAL Three
Three JJ consecutive
consecutive NN phase
phase NNP CAPITAL II
II NNS studies
studies IN of
of JJ recombinant
recombinant NN interferon
interferon NN alfa-2a
alfa-2a IN in
in VBN advanced
advanced JJ malignant
malignant NN melanoma

Interferon NN CAPITAL Interferon
Interferon NN treatment
treatment IN of
of JJ renal
renal NN cell
cell NN carcinoma

Current JJ CAPITAL Current
Current CC and
and NN future
future NNS uses
uses IN of
of JJ recombinant
recombinant NN interferon
interferon NN alpha
alpha IN in
in DT the
the NN treatment
treatment IN of
of JJ low-grade
low-grade JJ non-Hodgkin
non-Hodgkin POS 's
's NN lymphoma

Antimicrobial JJ CAPITAL Antimicrobial
Antimicrobial NN treatment
treatment NNS options
options IN in
in DT the
the NN management
management IN of
of JJ odontogenic
odontogenic NNS infections

Recombinant JJ CAPITAL Recombinant
Recombinant NN glycoprotein
glycoprotein NN vaccine
vaccine IN for
for DT the
the NN prevention
prevention IN of
of JJ genital
genital NN CAPITAL HSV-2
HSV-2 NN infection
infection : :
: CD two
two VBN randomized
randomized VBN controlled
controlled NNS trials

Induction NN CAPITAL Induction
Induction NN chemotherapy
chemotherapy IN with
with NN docetaxel
docetaxel , ,
, NN cisplatin
cisplatin , ,
, NN fluorouracil
fluorouracil , ,
, CC and
and NN leucovorin
leucovorin IN for
for JJ squamous
squamous NN cell
cell NN carcinoma
carcinoma IN of
of DT the
the NN head
head CC and
and NN neck
neck : :
: DT a
a NN phase
phase CD CAPITAL I/II
I/II NN trial

Low-dose JJ CAPITAL Low-dose
Low-dose NNS steroids
steroids VB reduce
reduce JJ flu-like
flu-like NNS symptoms
symptoms IN at
at DT the
the NN initiation
initiation IN of
of NN CAPITAL IFNbeta-1b
IFNbeta-1b IN in
in JJ relapsing-remitting
relapsing-remitting NN CAPITAL MS

Study NN CAPITAL Study
Study IN of
of CD three
three JJ different
different NNS doses
doses IN of
of JJ epidural
epidural NN neostigmine
neostigmine VBN coadministered
coadministered IN with
with NN lidocaine
lidocaine IN for
for JJ postoperative
postoperative NN analgesia

An DT CAPITAL An
An NN active-control
active-control NN trial
trial IN of
of NN lamotrigine
lamotrigine NN monotherapy
monotherapy IN for
for JJ partial
partial NNS seizures

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Safety
Safety IN of
of JJ intrathecal
intrathecal NN sodium
sodium NN nitroprusside
nitroprusside IN for
for DT the
the NN treatment
treatment CC and
and NN prevention
prevention IN of
of JJ refractory
refractory JJ cerebral
cerebral NN vasospasm
vasospasm CC and
and NN ischemia
ischemia IN in
in NNS humans

The DT CAPITAL The
The NN effect
effect IN of
of NN heliox
heliox IN in
in JJ acute
acute JJ severe
severe NN asthma
asthma : :
: DT a
a VBN randomized
randomized VBN controlled
controlled NN trial
trial . .

Long-term JJ CAPITAL Long-term
Long-term NN survival
survival IN of
of NNS patients
patients IN with
with JJ unresectable
unresectable JJ colorectal
colorectal NN cancer
cancer NN liver
liver NNS metastases
metastases VBG following
following NN infusional
infusional NN chemotherapy
chemotherapy IN with
with NN 5-fluorouracil
5-fluorouracil , ,
, NN leucovorin
leucovorin , ,
, NN oxaliplatin
oxaliplatin CC and
and NN surgery

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Fatal
Fatal JJ acute
acute NN haemolysis
haemolysis IN in
in DT an
an NN CAPITAL AIDS
AIDS NN patient
patient VBN treated
treated IN with
with NN lindinavir

A DT CAPITAL A
A VBN simplified
simplified JJ laparoscopic
laparoscopic NN technique
technique IN for
for NN mesh
mesh NN placement
placement IN in
in JJ ventral
ventral NN hernia
hernia NN repair

Pharmacological JJ CAPITAL Pharmacological
Pharmacological NN management
management IN of
of JJ acute
acute JJ myocardial
myocardial NN infarction

Mesenteric JJ CAPITAL Mesenteric
Mesenteric JJ venous
venous NN thrombosis
thrombosis : :
: JJ successful
successful NN treatment
treatment IN by
by JJ intraarterial
intraarterial JJ lytic
lytic NN therapy

Gene NN CAPITAL Gene
Gene NN therapy
therapy IN for
for JJ myocardial
myocardial NN angiogenesis

Dipyridamole NNP CAPITAL Dipyridamole
Dipyridamole CC plus
plus NN aspirin
aspirin IN in
in JJ cerebrovascular
cerebrovascular NN disease

What WDT CAPITAL What
What VBZ is
is DT the
the RB real
real NN role
role IN of
of NN CAPITAL CD40
CD40 IN in
in NN cancer
cancer NN immunotherapy
immunotherapy . ?

The DT CAPITAL The
The NNS effects
effects IN of
of JJ oral
oral NN liarozole
liarozole IN on
on JJ epidermal
epidermal NN proliferation
proliferation CC and
and NN differentiation
differentiation IN in
in JJ severe
severe NN plaque
plaque NN psoriasis
psoriasis VBP are
are JJ comparable
comparable IN with
with DT those
those IN of
of NN acitretin
acitretin . .

Safety NN CAPITAL Safety
Safety CC and
and NN potential
potential NN effectiveness
effectiveness IN of
of JJ daunorubicin-containing
daunorubicin-containing NNS liposomes
liposomes IN in
in NNS patients
patients IN with
with VBN advanced
advanced JJ recurrent
recurrent JJ malignant
malignant NNS CAPITAL CNS
CNS NNS tumors

An DT CAPITAL An
An JJ experimental
experimental NN application
application IN of
of NN gene
gene NN therapy
therapy IN for
for JJ human
human NN retinoblastoma

Acid NN CAPITAL Acid
Acid NN suppression
suppression NN therapy
therapy IN in
in NNP CAPITAL Barrett
Barrett POS 's
's NN esophagus
esophagus : :
: DT the
the NN importance
importance IN of
of NN pH
pH VBG monitoring

Surgical NNP CAPITAL Surgical
Surgical NNS approaches
approaches TO to
to JJ pediatric
pediatric JJ defecatory
defecatory NNS disorders

Lutein NN CAPITAL Lutein
Lutein VBZ improves
improves JJ visual
visual NN function
function IN in
in DT some
some NNS patients
patients IN with
with JJ retinal
retinal NN degeneration
degeneration : :
: DT a
a NN pilot
pilot NN study
study IN via
via DT the
the NN CAPITAL Internet

Drug NN CAPITAL Drug
Drug NN information
information NNS questions
questions CC and
and NNS answers
answers : :
: JJ new
new IN for
for NN psoriasis
psoriasis : :
: NN colchicine

IPPB NN CAPITAL IPPB
IPPB IN in
in JJ severe
severe JJ pulmonary
pulmonary NN emphysema
emphysema : :
: JJ limited
limited NNS applications

Long-term JJ CAPITAL Long-term
Long-term NN mortality
mortality IN in
in NNS patients
patients IN after
after DT a
a JJ CAPITAL British
British NN trial
trial IN of
of NNS anticoagulants
anticoagulants IN in
in JJ acute
acute JJ myocardial
myocardial NN infarction

Our PRP$ CAPITAL Our
Our NNS results
results IN in
in DT the
the JJ surgical
surgical NN treatment
treatment IN of
of JJ habitual
habitual NN shoulder
shoulder NN dislocation
dislocation IN with
with JJ special
special NN reference
reference TO to
to JJ occupational
occupational NN disability

Alkaline NN CAPITAL Alkaline
Alkaline NN phosphatase
phosphatase IN in
in NN neutrophil
neutrophil NNS leukocytes
leukocytes IN of
of NNS patients
patients IN with
with JJ infectious
infectious NN mononucleosis
mononucleosis CC and
and DT the
the NN effect
effect IN of
of NN corticosteroid
corticosteroid NN therapy

Surgical NNP CAPITAL Surgical
Surgical NN treatment
treatment IN of
of NN uterine
uterine NN cervix
cervix NN insufficiency
insufficiency IN during
during DT the
the NN 2d
2d NN trimester
trimester IN of
of NN pregnancy

Physiologic JJ CAPITAL Physiologic
Physiologic NN treatment
treatment IN of
of JJ depressive
depressive NNS reactions
reactions : :
: DT a
a NN pilot
pilot NN study

The DT CAPITAL The
The NN use
use IN of
of NN quinidine
quinidine NN sulphate
sulphate IN for
for DT the
the NN treatment
treatment IN of
of IN atrial
atrial NN fibrillation
fibrillation IN in
in CD twelve
twelve NNS horses

Synergism NN CAPITAL Synergism
Synergism IN in
in DT the
the NN chemotherapy
chemotherapy IN of
of NNP CAPITAL Eimeria
Eimeria NNS infections
infections IN of
of NNS chicks

Treatment NN CAPITAL Treatment
Treatment IN of
of NN hydrocele
hydrocele CC and
and NNS cysts
cysts IN of
of DT the
the NN epididymis
epididymis IN with
with VBG sclerosing
sclerosing NNS injections
injections IN of
of NN quinine
quinine CC and
and NN urea
urea NN chlorhydrolactate
chlorhydrolactate IN in
in DT a
a CD 30
30 IN per
per NN cent
cent NN solution

The DT CAPITAL The
The JJ single-place
single-place NN caisson
caisson IN in
in DT the
the NN treatment
treatment IN of
of NN decompression
decompression NNS accidents

Blood NN CAPITAL Blood
Blood NN volume
volume NNS measurements
measurements IN in
in VBP burn
burn NN therapy

Phenylbutazone NN CAPITAL Phenylbutazone
Phenylbutazone CC and
and JJ acute
acute NN leukemia
leukemia . .

The DT CAPITAL The
The NN place
place IN of
of NN surgery
surgery IN in
in JJ hypertrophic
hypertrophic JJ obstructive
obstructive NN cardiomyopathy
cardiomyopathy NN (
( JJ idiopathic
idiopathic JJ hypertrophic
hypertrophic JJ subaortic
subaortic NN stenosis
stenosis NN )

The DT CAPITAL The
The NN treatment
treatment IN of
of JJ autoimmune
autoimmune JJ hemolytic
hemolytic NN anemia
anemia IN with
with NN heparin

Effects NNS CAPITAL Effects
Effects IN of
of NN clomiphene
clomiphene NN citrate
citrate IN on
on JJ endometrial
endometrial NN hyperplasia
hyperplasia IN in
in DT the
the JJ premenopausal
premenopausal NN female

Prolonged JJ CAPITAL Prolonged
Prolonged NN use
use IN of
of NN methyldopa
methyldopa IN in
in JJ severe
severe NN hypertension
hypertension IN in
in NN pregnancy

The DT CAPITAL The
The NNS effects
effects IN of
of JJ social
social NN class
class CC and
and NNS friends
friends '' '
' NNS expectations
expectations IN on
on JJ oral
oral NNP polio
polio NN vaccination
vaccination NN participation

Glutathione NN CAPITAL Glutathione
Glutathione NN CAPITAL S-transferase
S-transferase NN activity
activity IN in
in JJ epithelial
epithelial JJ ovarian
ovarian NN cancer
cancer : :
: NN association
association IN with
with NN response
response TO to
to NN chemotherapy
chemotherapy CC and
and NN disease
disease NN outcome

Interferon-alpha-2b NN CAPITAL Interferon-alpha-2b
Interferon-alpha-2b IN in
in DT the
the NN management
management IN of
of NNS patients
patients IN with
with VBD relapsed
relapsed CC and/or
and/or JJ refractory
refractory NN CAPITAL Hodgkin
Hodgkin POS 's
's NN disease

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Frontal
Frontal NN dysfunction
dysfunction NNS blocks
blocks DT the
the JJ therapeutic
therapeutic NN effect
effect IN of
of NN CAPITAL THA
THA IN on
on NN attention
attention IN in
in NN CAPITAL Alzheimer
Alzheimer POS 's
's NN disease

Effects NNS CAPITAL Effects
Effects IN of
of NN clomipramine
clomipramine IN on
on NN plasma
plasma NN amino
amino NNS acids
acids CC and
and JJ serotonergic
serotonergic NNS parameters
parameters IN in
in NN panic
panic NN disorder
disorder CC and
and NN depression
depression . .

Thalidomide NNP CAPITAL Thalidomide
Thalidomide IN for
for JJ aphthous
aphthous NNS ulcers
ulcers IN in
in NN CAPITAL HIV
HIV NN infection

Aspirin NN CAPITAL Aspirin
Aspirin NN therapy
therapy IN in
in NN diabetes
diabetes NN mellitus

Combined VBN CAPITAL Combined
Combined NN pancreas-/kidney
pancreas-/kidney NN transplantation
transplantation IN as
as DT a
a NN standard
standard NN procedure
procedure IN in
in NN therapy
therapy IN of
of NN kidney
kidney NN failure
failure IN in
in NN type
type PRP CAPITAL I
I JJ diabetic
diabetic NNS patients

Corticosteroid NN CAPITAL Corticosteroid
Corticosteroid NNS injections
injections IN for
for NN sciatica

Flutamide NN CAPITAL Flutamide
Flutamide CC plus
plus NN castration
castration IN in
in NNS patients
patients IN with
with RB previously
previously JJ untreated
untreated NN prostate
prostate NN cancer

The DT CAPITAL The
The JJ immediate
immediate NN effectiveness
effectiveness IN of
of JJ electrical
electrical NN nerve
nerve NN stimulation
stimulation CC and
and JJ electrical
electrical NN muscle
muscle NN stimulation
stimulation IN on
on JJ myofascial
myofascial NN trigger
trigger NNS points

In IN CAPITAL In
In NN vitro
vitro JJ radiation-induced
radiation-induced NN apoptosis
apoptosis CC and
and NN tumour
tumour NN response
response TO to
to NN radiotherapy
radiotherapy : :
: DT a
a JJ prospective
prospective NN study
study IN in
in NNS patients
patients IN with
with JJ non-Hodgkin
non-Hodgkin NNS lymphomas
lymphomas VBN treated
treated IN by
by JJ low-dose
low-dose NN irradiation

Drug NN CAPITAL Drug
Drug NN therapy
therapy IN for
for JJ coronary
coronary NN heart
heart NN disease
disease : :
: DT the
the NNP CAPITAL Sheffield
Sheffield NN table

Percutaneous JJ CAPITAL Percutaneous
Percutaneous NN drainage
drainage IN of
of NN hydatid
hydatid NNS cysts

Surgery NN CAPITAL Surgery
Surgery IN for
for NN ectopia
ectopia NN lentis

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Antiplatelet
Antiplatelet NN therapy
therapy TO to
to VB prevent
prevent NN stroke
stroke : :
: NN risk
risk IN of
of NN brain
brain NN hemorrhage
hemorrhage CC and
and NN efficacy
efficacy IN in
in IN atrial
atrial NN fibrillation

High-dose JJ CAPITAL High-dose
High-dose NN chemotherapy
chemotherapy IN with
with JJ autologous
autologous JJ hematopoietic
hematopoietic NN stem-cell
stem-cell NN support
support IN for
for NN breast
breast NN cancer
cancer IN in
in NNP CAPITAL North
North NNP CAPITAL America

Is VBZ CAPITAL Is
Is JJ concomitant
concomitant NN radiotherapy
radiotherapy CC and
and NN chemotherapy
chemotherapy JJ superior
superior TO to
to JJ optimal
optimal NN radiotherapy
radiotherapy RB alone
alone IN in
in JJ anal
anal NN cancer
cancer . ?

Standard NNP CAPITAL Standard
Standard CC versus
versus JJ high-dose
high-dose NN therapy
therapy IN in
in CD 10+
10+ NN breast
breast NN cancer

Anal JJ CAPITAL Anal
Anal NN continence
continence IN after
after NN surgery
surgery IN for
for JJ rectal
rectal NN prolapse

Aspirin NN CAPITAL Aspirin
Aspirin NN therapy
therapy IN for
for JJ cardiovascular
cardiovascular NN disease

Dosing NN CAPITAL Dosing
Dosing IN of
of NN amoxicillin/clavulanate
amoxicillin/clavulanate IN for
for NN treatment
treatment IN of
of JJR lower
lower JJ respiratory
respiratory NN tract
tract NN infection

Pharmacoeconomic JJ CAPITAL Pharmacoeconomic
Pharmacoeconomic NN analysis
analysis IN of
of NN ampicillin-sulbactam
ampicillin-sulbactam CC versus
versus NN cefoxitin
cefoxitin IN in
in DT the
the NN treatment
treatment IN of
of JJ intraabdominal
intraabdominal NNS infections

New NNP CAPITAL New
New NNS therapies
therapies IN for
for JJ severe
severe JJ meningococcal
meningococcal NN disease

Another DT CAPITAL Another
Another NN potential
potential NN use
use IN of
of NN troglitazone
troglitazone IN in
in JJ noninsulin-dependent
noninsulin-dependent NN diabetes
diabetes NN mellitus

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Jaw
Jaw VBG clenching
clenching VBG following
following NN CAPITAL Gamma
Gamma NNP CAPITAL Knife
Knife NN treatment
treatment IN for
for JJ trigeminal
trigeminal NN neuralgia

The DT CAPITAL The
The JJ protective
protective NN effect
effect IN of
of NNS condoms
condoms CC and
and NN nonoxynol-9
nonoxynol-9 IN against
against NN CAPITAL HIV
HIV NN infection

Evaluation NN CAPITAL Evaluation
Evaluation IN of
of JJ adjuvant
adjuvant JJ psychological
psychological NN therapy
therapy IN in
in NNS patients
patients IN with
with JJ testicular
testicular NN cancer
cancer : :
: VBN randomised
randomised VBN controlled
controlled NN trial

The DT CAPITAL The
The NN effect
effect IN of
of DT an
an NN endothelin-receptor
endothelin-receptor NN antagonist
antagonist , ,
, NN bosentan
bosentan , ,
, IN on
on NN blood
blood NN pressure
pressure IN in
in NNS patients
patients IN with
with JJ essential
essential NN hypertension
hypertension . .

Guidelines NNS CAPITAL Guidelines
Guidelines IN for
for DT the
the NN use
use IN of
of JJ antiretroviral
antiretroviral NNS agents
agents IN in
in NN CAPITAL HIV
HIV JJ -infected
-infected NNS adults
adults CC and
and NNS adolescents

Long-term JJ CAPITAL Long-term
Long-term NN therapy
therapy IN with
with JJ long-acting
long-acting NN octreotide
octreotide NN (
( NN CAPITAL Sandostatin-LAR
Sandostatin-LAR NN )
) IN for
for DT the
the NN management
management IN of
of RB acromegaly

Are VBP CAPITAL Are
Are NN CAPITAL ABVD
ABVD CC and
and NN CAPITAL MOPP/ABV
MOPP/ABV RB truly
truly JJ equivalent
equivalent IN for
for VBG treating
treating NN CAPITAL Hodgkin
Hodgkin POS 's
's NN disease
disease IN at
at VBN advanced
advanced NNS stages
stages . ?

Paclitaxel NN CAPITAL Paclitaxel
Paclitaxel IN for
for DT the
the NN treatment
treatment IN of
of NN lymphoma

Montelukast NN CAPITAL Montelukast
Montelukast , ,
, DT a
a NN leukotriene-receptor
leukotriene-receptor NN antagonist
antagonist , ,
, IN for
for DT the
the NN treatment
treatment IN of
of JJ mild
mild NN asthma
asthma CC and
and JJ exercise-induced
exercise-induced NN bronchoconstriction

Atypical JJ CAPITAL Atypical
Atypical JJ antipsychotic
antipsychotic NNS agents
agents IN in
in DT the
the NN treatment
treatment IN of
of NNP CAPITAL Schizophrenia
Schizophrenia CC and
and JJ other
other JJ psychiatric
psychiatric NNS disorders

Percutaneous JJ CAPITAL Percutaneous
Percutaneous JJ transluminal
transluminal NN angioplasty
angioplasty IN in
in DT the
the NN treatment
treatment IN of
of JJ renovascular
renovascular NN hypertension
hypertension : :
: JJ sequential
sequential JJ prospective
prospective NN study

Esophageal NN CAPITAL Esophageal
Esophageal NN intubation
intubation IN for
for NN palliative
palliative NN treatment
treatment IN in
in VBN advanced
advanced NN carcinoma
carcinoma IN of
of DT the
the NN esophagus
esophagus CC and
and NN cardia

Pathological JJ CAPITAL Pathological
Pathological NN staging
staging CC and
and JJ biochemical
biochemical NN recurrence
recurrence IN after
after NN neoadjuvant
neoadjuvant NN androgen
androgen NN deprivation
deprivation NN therapy
therapy IN in
in NN combination
combination IN with
with NN radical
radical NN prostatectomy
prostatectomy IN in
in RB clinically
clinically JJ localized
localized NN prostate
prostate NN cancer

How WRB CAPITAL How
How RB often
often VBZ does
does NN surgery
surgery IN for
for JJ peptic
peptic NN ulceration
ulceration VB eradicate
eradicate NNP CAPITAL Helicobacter
Helicobacter NN pylori
pylori . ?
? JJ CAPITAL Systematic
Systematic NN review
review IN of
of CD 36
36 NNS studies

A DT CAPITAL A
A NN comparison
comparison IN of
of JJ noninvasive
noninvasive NN positive-pressure
positive-pressure NN ventilation
ventilation CC and
and JJ conventional
conventional JJ mechanical
mechanical NN ventilation
ventilation IN in
in NNS patients
patients IN with
with JJ acute
acute JJ respiratory
respiratory NN failure

Long-term JJ CAPITAL Long-term
Long-term NN safety
safety CC and
and NN effectiveness
effectiveness IN of
of NN iron-chelation
iron-chelation NN therapy
therapy IN with
with NN deferiprone
deferiprone IN for
for NN thalassemia
thalassemia JJ major

Positron NNP CAPITAL Positron
Positron NN emission
emission NN tomography
tomography IN in
in VBG assessing
assessing NN response
response TO to
to NN neoadjuvant
neoadjuvant NN chemotherapy
chemotherapy IN for
for JJ non-small-cell
non-small-cell NN lung
lung NN cancer

Reconstruction NN CAPITAL Reconstruction
Reconstruction IN of
of JJ thoracic
thoracic NN wall
wall NNS defects
defects IN after
after NN tumor
tumor NN resection
resection VBG using
using DT a
a NN polytetrafluoroethylene
polytetrafluoroethylene JJ soft
soft NN tissue
tissue NN (
( NNP CAPITAL Gore-Tex
Gore-Tex NN )
) NN patch

A DT CAPITAL A
A NN comparison
comparison IN of
of JJ rectal
rectal NN diazepam
diazepam NN gel
gel CC and
and NN placebo
placebo IN for
for JJ acute
acute JJ repetitive
repetitive NNS seizures

Effect NN CAPITAL Effect
Effect IN of
of JJ long-term
long-term NN salmeterol
salmeterol NN treatment
treatment IN on
on JJ exercise-induced
exercise-induced NN asthma

Randomized VBN CAPITAL Randomized
Randomized NN trial
trial IN of
of JJ intensive
intensive NN cyclophosphamide
cyclophosphamide , ,
, NN epirubicin
epirubicin , ,
, CC and
and NN fluorouracil
fluorouracil NN chemotherapy
chemotherapy VBN compared
compared IN with
with NN cyclophosphamide
cyclophosphamide , ,
, NN methotrexate
methotrexate , ,
, CC and
and NN fluorouracil
fluorouracil IN in
in JJ premenopausal
premenopausal NNS women
women IN with
with JJ node-positive
node-positive NN breast
breast NN cancer

Acute JJ CAPITAL Acute
Acute NN effect
effect IN of
of NN lorazepam
lorazepam IN on
on JJ respiratory
respiratory NNS muscles
muscles IN in
in NNS patients
patients IN with
with JJ chronic
chronic JJ obstructive
obstructive JJ pulmonary
pulmonary NN disease

Low-molecular-weight JJ CAPITAL Low-molecular-weight
Low-molecular-weight NNS heparins
heparins IN in
in DT the
the NN treatment
treatment IN of
of JJ venous
venous NN thromboembolism

5-year JJ 5-year
5-year NN outcome
outcome IN of
of JJ surgical
surgical NN resection
resection CC and
and JJ watchful
watchful VBG waiting
waiting IN for
for NNS men
men IN with
with RB moderately
moderately JJ symptomatic
symptomatic JJ benign
benign JJ prostatic
prostatic NN hyperplasia
hyperplasia : :
: DT a
a NNP CAPITAL Department
Department IN of
of NNS CAPITAL Veterans
Veterans NNPS CAPITAL Affairs
Affairs JJ cooperative
cooperative NN study

For IN CAPITAL For
For WRB how
how RB long
long MD should
should JJ antipsychotic
antipsychotic NN medication
medication VB be
be VBN continued
continued IN after
after DT the
the RB first
first JJ psychotic
psychotic NN episode
episode IN in
in NNS schizophrenics
schizophrenics . ?

IDA-FLAG NN CAPITAL IDA-FLAG
IDA-FLAG NN (
( NN idarubicin
idarubicin , ,
, NN fludarabine
fludarabine , ,
, NN cytarabine
cytarabine , ,
, NN CAPITAL G-CSF
G-CSF NN )
) , ,
, DT an
an JJ effective
effective NN remission-induction
remission-induction NN therapy
therapy IN for
for NN poor-prognosis
poor-prognosis NN CAPITAL AML
AML IN of
of NN childhood
childhood RB prior
prior TO to
to JJ allogeneic
allogeneic CC or
or JJ autologous
autologous NN bone
bone NN marrow
marrow NN transplantation
transplantation : :
: NNS experiences
experiences IN of
of DT a
a NN phase
phase NNP CAPITAL II
II NN trial

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NNS CAPITAL Effects
Effects IN of
of JJ anal
anal JJ invasive
invasive NN treatment
treatment CC and
and NN incontinence
incontinence IN on
on JJ mental
mental NN health
health CC and
and JJ psychosocial
psychosocial VBG functioning
functioning IN of
of NNS adolescents
adolescents IN with
with NNP CAPITAL Hirshsprung
Hirshsprung POS 's
's NN disease
disease CC and
and JJ low
low JJ anorectal
anorectal NNS anomalies

Single JJ CAPITAL Single
Single CC or
or RB double
double NN lung
lung NN transplantation
transplantation IN for
for JJ pulmonary
pulmonary NN hypertension

Interferon NN CAPITAL Interferon
Interferon NN beta
beta NN treatment
treatment IN for
for JJ multiple
multiple NN sclerosis

Ten-year JJ CAPITAL Ten-year
Ten-year NN disease
disease JJ free
free NN survival
survival IN after
after NN transperineal
transperineal JJ sonography-guided
sonography-guided NN iodine-125
iodine-125 NN brachytherapy
brachytherapy IN with
with CC or
or IN without
without NN 45-Gray
45-Gray JJ external
external NN beam
beam NN irradiation
irradiation IN in
in DT the
the NN treatment
treatment IN of
of NNS patients
patients IN with
with RB clinically
clinically JJ localized
localized , ,
, JJ low
low TO to
to JJ high
high NN CAPITAL Gleason
Gleason NN grade
grade NN prostate
prostate NN carcinoma

Partial JJ CAPITAL Partial
Partial CC or
or IN near
near NN total
total NN pancreatectomy
pancreatectomy IN for
for JJ persistent
persistent JJ neonatal
neonatal JJ hyperinsulinaemic
hyperinsulinaemic NN hypoglycaemia
hypoglycaemia : :
: DT the
the NN pathologist
pathologist POS 's
's NN role

Radical NNP CAPITAL Radical
Radical NN prostatectomy
prostatectomy IN for
for NN prostate
prostate NN cancer
cancer : :
: DT the
the NN perineal
perineal NN approach
approach NNS increases
increases DT the
the NN risk
risk IN of
of RB surgically
surgically VBN induced
induced JJ positive
positive NNS margins
margins CC and
and JJ capsular
capsular NNS incisions

Open VB CAPITAL Open
Open NN capsulorrhaphy
capsulorrhaphy IN with
with NN suture
suture NNS anchors
anchors IN for
for JJ recurrent
recurrent JJ anterior
anterior NN dislocation
dislocation IN of
of DT the
the NN shoulder

Intravenous JJ CAPITAL Intravenous
Intravenous NN immunoglobulin
immunoglobulin NN treatment
treatment IN in
in JJ multiple
multiple NN sclerosis

Randomised VBN CAPITAL Randomised
Randomised NN trial
trial IN of
of NN irinotecan
irinotecan CC versus
versus NN fluorouracil
fluorouracil IN by
by JJ continuous
continuous NN infusion
infusion IN after
after NN fluorouracil
fluorouracil NN failure
failure IN in
in NNS patients
patients IN with
with JJ metastatic
metastatic JJ colorectal
colorectal NN cancer

The DT CAPITAL The
The NN effectiveness
effectiveness IN of
of JJ intraocular
intraocular NN pressure
pressure NN reduction
reduction IN in
in DT the
the NN treatment
treatment IN of
of NN normal-tension
normal-tension NN glaucoma

Perceived VBN CAPITAL Perceived
Perceived NNS contraindications
contraindications TO to
to JJ thrombolytic
thrombolytic NN treatment
treatment IN in
in JJ acute
acute JJ myocardial
myocardial NN infarction

Lignocaine NN CAPITAL Lignocaine
Lignocaine CC or
or NN bupivacaine
bupivacaine IN for
for JJ digital
digital NN ring
ring NN block

Steroids NNS CAPITAL Steroids
Steroids IN in
in JJ lateral
lateral NN epicondylitis

Steroids NNS CAPITAL Steroids
Steroids IN in
in NNP CAPITAL De
De NNP CAPITAL Quervain
Quervain POS 's
's NN tenosynovitis

Antibiotics NNS CAPITAL Antibiotics
Antibiotics IN after
after NN dog
dog VB bite

Immobilisation NN CAPITAL Immobilisation
Immobilisation IN after
after RB first
first JJ anterior
anterior NN shoulder
shoulder NN dislocation

Stereotactic NN CAPITAL Stereotactic
Stereotactic NN radiosurgery
radiosurgery IN for
for JJ acoustic
acoustic NN neuroma
neuroma : :
: DT a
a JJ CAPITAL Canadian
Canadian NN perspective

Anticytokine NN CAPITAL Anticytokine
Anticytokine NN therapy
therapy : --
-- DT a
a JJ new
new NN era
era IN in
in DT the
the NN treatment
treatment IN of
of JJ rheumatoid
rheumatoid NN arthritis
arthritis . ?

Control NN CAPITAL Control
Control IN of
of DT the
the JJ malignant
malignant JJ hyperpyrexic
hyperpyrexic NN syndrome
syndrome IN in
in NN CAPITAL MHS
MHS NNS swine
swine IN by
by NN dantrolene
dantrolene NN sodium

Hematopoietic JJ CAPITAL Hematopoietic
Hematopoietic NN stem-cell
stem-cell NN transplantation
transplantation IN for
for DT the
the NN treatment
treatment IN of
of JJ severe
severe VBN combined
combined NN immunodeficiency

Low-dose JJ CAPITAL Low-dose
Low-dose NN clozapine
clozapine IN for
for DT the
the NN treatment
treatment IN of
of JJ drug-induced
drug-induced NN psychosis
psychosis IN in
in NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease

Comparing VBG CAPITAL Comparing
Comparing DT the
the NN efficacy
efficacy CC and
and NN safety
safety IN of
of NN fluoxetine
fluoxetine CC and
and NN venlafaxine
venlafaxine IN in
in NN outpatient
outpatient NN depression

Cost-effectiveness NN CAPITAL Cost-effectiveness
Cost-effectiveness IN of
of NN interferon
interferon NN treatment
treatment IN for
for NN hepatitis
hepatitis NN CAPITAL C

Hyperbaric JJ CAPITAL Hyperbaric
Hyperbaric NN oxygen
oxygen NN therapy
therapy IN for
for NNS children
children IN with
with JJ cerebral
cerebral NN palsy

Peripheral JJ CAPITAL Peripheral
Peripheral JJ retinal
retinal NN cryotherapy
cryotherapy IN for
for NN postvitrectomy
postvitrectomy JJ diabetic
diabetic JJ vitreous
vitreous NN hemorrhage
hemorrhage IN in
in JJ phakic
phakic NNS patients

Hyperbaric JJ CAPITAL Hyperbaric
Hyperbaric CC or
or JJ normobaric
normobaric NN oxygen
oxygen IN for
for JJ acute
acute NN carbon
carbon NN monoxide
monoxide NN poisoning
poisoning : :
: DT a
a VBN randomised
randomised VBN controlled
controlled JJ clinical
clinical NN trial

Multicentre NNP CAPITAL Multicentre
Multicentre JJ clinical
clinical NN evaluation
evaluation IN of
of NN vigabatrin
vigabatrin NN (
( NNP CAPITAL Sabril
Sabril NN )
) IN in
in JJ mild
mild TO to
to JJ moderate
moderate JJ partial
partial NNS epilepsies

Matrix NNP CAPITAL Matrix
Matrix NN metalloproteinase
metalloproteinase NNS inhibitors
inhibitors IN in
in DT the
the NN treatment
treatment IN of
of NN cancer

High JJ CAPITAL High
High NN dose
dose NN cyclophosphamide
cyclophosphamide IN with
with NN carboplatin
carboplatin : :
: DT a
a JJ tolerable
tolerable NNS regimen
regimen JJ suitable
suitable IN for
for NN dose
dose NN intensification
intensification IN in
in NNS children
children IN with
with JJ solid
solid NNS tumors

Microsurgical JJ CAPITAL Microsurgical
Microsurgical NN treatment
treatment IN of
of JJ supratentorial
supratentorial JJ cavernous
cavernous NNS malformations

Microsurgical JJ CAPITAL Microsurgical
Microsurgical NN treatment
treatment IN of
of NN infratentorial
infratentorial NNS malformations

Stereotactic NN CAPITAL Stereotactic
Stereotactic NN radiosurgery
radiosurgery IN for
for NN management
management IN of
of RB deep
deep NN brain
brain JJ cavernous
cavernous NNS malformations

Interferon-antibodies NNS CAPITAL Interferon-antibodies
Interferon-antibodies CC and
and DT the
the NN breakthrough
breakthrough NN phenomenon
phenomenon IN during
during NN ribavirin/interferon-alpha
ribavirin/interferon-alpha NN combination
combination NN therapy
therapy CC and
and NN interferon-alpha
interferon-alpha NN monotherapy
monotherapy IN of
of NNS patients
patients IN with
with JJ chronic
chronic NN hepatitis
hepatitis NN CAPITAL C

Treatment NN CAPITAL Treatment
Treatment IN of
of NNP CAPITAL Barrett
Barrett NN esophagus
esophagus IN with
with NNP argon
argon NN plasma
plasma NN coagulation
coagulation IN with
with NN acid
acid NN suppression
suppression : --
-- DT a
a JJ prospective
prospective NN study

Meta-analysis NN CAPITAL Meta-analysis
Meta-analysis IN of
of NN typhoid
typhoid NN vaccine
vaccine NN efficacy
efficacy NNS trials
trials VBD showed
showed IN that
that JJ whole
whole NN cell
cell NNS vaccines
vaccines VBP are
are RBR more
more JJ effective
effective IN than
than DT either
either DT the
the JJ oral
oral , ,
, VBN attenuated
attenuated NN vaccine
vaccine CC or
or DT the
the NNP CAPITAL Vi
Vi NN polysaccharide
polysaccharide NN vaccine

Experimental JJ CAPITAL Experimental
Experimental NN vaccination
vaccination IN against
against NN CAPITAL Mycoplasma
Mycoplasma NN agalactiae
agalactiae VBG using
using JJ different
different VBN inactivated
inactivated NNS vaccines

A DT CAPITAL A
A VBN randomized
randomized , ,
, VBN controlled
controlled NN study
study IN in
in NNS adults
adults IN of
of DT the
the NN immunogenicity
immunogenicity IN of
of DT a
a JJ novel
novel NN hepatitis
hepatitis NN CAPITAL B
B NN vaccine
vaccine VBG containing
containing NN CAPITAL MF59
MF59 JJ adjuvant

Immunogenicity NN CAPITAL Immunogenicity
Immunogenicity IN of
of CD three
three NN CAPITAL Haemophilus
Haemophilus NNS influenzae
influenzae NN type
type NN b
b NN protein
protein NN conjugate
conjugate NNS vaccines
vaccines IN in
in NN CAPITAL HIV
HIV JJ seropositive
seropositive NNS adults
adults CC and
and NN analysis
analysis IN of
of NNS predictors
predictors IN of
of NN vaccine
vaccine NN response

Vaccination NN CAPITAL Vaccination
Vaccination IN against
against NN CAPITAL Schistosoma
Schistosoma NNS mansoni
mansoni NN infection
infection VBG using
using CD 74
74 NN kDa
kDa NN CAPITAL Schistosoma
Schistosoma NN protein
protein NN antigen

Phase NN CAPITAL Phase
Phase CD 1
1 NN safety
safety CC and
and JJ immune
immune NN response
response NNS studies
studies IN of
of DT a
a NN CAPITAL DNA
DNA NN vaccine
vaccine VBG encoding
encoding NN hepatitis
hepatitis NN CAPITAL B
B NN surface
surface NN antigen
antigen VBN delivered
delivered IN by
by DT a
a NN gene
gene NN delivery
delivery NN device

Protection NN CAPITAL Protection
Protection IN of
of NNS swine
swine IN from
from NN foot-and-mouth
foot-and-mouth NN disease
disease IN with
with CD one
one NN dose
dose IN of
of DT an
an JJ all-D
all-D NN retro
retro NN peptide

Intranasal JJ CAPITAL Intranasal
Intranasal NN immunization
immunization IN with
with NN CAPITAL Chlamydia
Chlamydia NN trachomatis
trachomatis , ,
, NN serovar
serovar NN CAPITAL E
E , ,
, VBZ protects
protects IN from
from DT a
a JJ subsequent
subsequent JJ vaginal
vaginal NN challenge
challenge IN with
with DT the
the JJ homologous
homologous NN serovar

Mutants NNS CAPITAL Mutants
Mutants IN of
of NN cholera
cholera NN toxin
toxin IN as
as DT an
an JJ effective
effective CC and
and JJ safe
safe JJ adjuvant
adjuvant IN for
for JJ nasal
nasal NN influenza
influenza NN vaccine

Field NN CAPITAL Field
Field NN evaluation
evaluation IN of
of DT the
the JJ clinical
clinical NN effectiveness
effectiveness IN of
of NNS vaccines
vaccines IN against
against NN pertussis
pertussis , ,
, NNS measles
measles , ,
, NN rubella
rubella CC and
and NNS mumps
mumps : :
: NNS comments

Transmural JJ CAPITAL Transmural
Transmural NN drainage
drainage IN of
of JJ pancreatic
pancreatic NN fluid
fluid NNS collections
collections IN without
without NN electrocautery
electrocautery VBG using
using DT the
the NNP CAPITAL Seldinger
Seldinger NN technique

Echocardiography-guided JJ CAPITAL Echocardiography-guided
Echocardiography-guided NN ethanol
ethanol JJ septal
septal NN reduction
reduction IN for
for JJ hypertrophic
hypertrophic JJ obstructive
obstructive NN cardiomyopathy

Alterations NNS CAPITAL Alterations
Alterations IN of
of NN monocyte
monocyte NN function
function IN in
in NNS patients
patients IN with
with NN growth
growth NN hormone
hormone NN (
( NN CAPITAL GH
GH NN )
) NN deficiency
deficiency : :
: NN effect
effect IN of
of JJ substitutive
substitutive NN CAPITAL GH
GH NN therapy

Comparison NN CAPITAL Comparison
Comparison IN of
of DT the
the NNS effects
effects IN of
of NN salmeterol
salmeterol CC and
and NN ipratropium
ipratropium NN bromide
bromide IN on
on NN exercise
exercise NN performance
performance CC and
and NN breathlessness
breathlessness IN in
in NNS patients
patients IN with
with JJ stable
stable JJ chronic
chronic JJ obstructive
obstructive JJ pulmonary
pulmonary NN disease
disease . .

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Safety
Safety NN trial
trial IN with
with DT the
the NN 5HT1B/1D
5HT1B/1D NN agonist
agonist NN avitriptan
avitriptan NN (
( NN CAPITAL BMS-180048
BMS-180048 NN )
) IN in
in NNS patients
patients IN with
with NN migraine
migraine WP who
who VB have
have JJ experienced
experienced NN pressure
pressure , ,
, NN tightness
tightness , ,
, CC and/or
and/or NN pain
pain IN in
in DT the
the NN chest
chest , ,
, NN neck
neck , ,
, CC and/or
and/or NN throat
throat VBG following
following NN sumatriptan

Double JJ CAPITAL Double
Double JJ blind
blind , ,
, NN cluster
cluster VBN randomised
randomised NN trial
trial IN of
of JJ low
low NN dose
dose NN supplementation
supplementation IN with
with NN vitamin
vitamin DT CAPITAL A
A CC or
or NN beta
beta NN carotene
carotene IN on
on NN mortality
mortality JJ related
related TO to
to NN pregnancy
pregnancy IN in
in NNP CAPITAL Nepal
Nepal . .

Medical NNP CAPITAL Medical
Medical NNS treatments
treatments IN for
for VBG balding
balding IN in
in NNS men

Carbon NNP CAPITAL Carbon
Carbon NN monoxide
monoxide NN poisoning
poisoning VBN treated
treated IN with
with JJ hyperbaric
hyperbaric NN oxygen
oxygen : :
: JJ metabolic
metabolic NN acidosis
acidosis IN as
as DT a
a NN predictor
predictor IN of
of NN treatment
treatment NNS requirements

Medication NN CAPITAL Medication
Medication VBN received
received IN by
by NNS patients
patients IN with
with NN depression
depression VBG following
following DT the
the JJ acute
acute NN episode
episode : :
: NN adequacy
adequacy CC and
and NN relation
relation TO to
to NN outcome

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> VBN CAPITAL Reduced
Reduced NN bone
bone NN density
density IN at
at NN completion
completion IN of
of NN chemotherapy
chemotherapy IN for
for DT a
a NN malignancy

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Surgical-site
Surgical-site NNS complications
complications VBN associated
associated IN with
with DT a
a NN morphine
morphine NN nerve
nerve VB paste
paste VBN used
used IN for
for JJ postoperative
postoperative NN pain
pain NN control
control IN after
after NN laminectomy

Splenectomy NNP CAPITAL Splenectomy
Splenectomy IN during
during NN pregnancy
pregnancy : :
: DT an
an NN option
option IN in
in DT the
the NN treatment
treatment IN of
of JJ autoimmune
autoimmune JJ thrombocytopenic
thrombocytopenic NN purpura

Melatonin NN CAPITAL Melatonin
Melatonin NN treatment
treatment IN of
of NN sleep-wake
sleep-wake NN cycle
cycle NNS disorders
disorders IN in
in NNS children
children CC and
and NNS adolescents

Randomized VBN CAPITAL Randomized
Randomized NN phase
phase NNP CAPITAL II
II NN study
study IN of
of DT the
the NN neurokinin
neurokinin CD 1
1 NN receptor
receptor NN antagonist
antagonist NN CAPITAL CJ-11
CJ-11 , ,
, CD 974
974 IN in
in DT the
the NN control
control IN of
of JJ cisplatin-induced
cisplatin-induced NN emesis

Cataract NN CAPITAL Cataract
Cataract NN surgery
surgery CC and
and PRP$ its
its NN effect
effect IN on
on JJ intraocular
intraocular NN pressure

The DT CAPITAL The
The NN outcome
outcome IN of
of NN arthroscopic
arthroscopic NN treatment
treatment IN of
of JJ temporomandibular
temporomandibular NN joint
joint NN arthropathy

Neostigmine NN CAPITAL Neostigmine
Neostigmine IN for
for JJ acute
acute JJ colonic
colonic NN pseudo-obstruction

New NNP CAPITAL New
New NN vaccine
vaccine NNS targets
targets NN childhood
childhood NN pneumonia

A DT CAPITAL A
A NN comparison
comparison IN of
of NN botulinum
botulinum NN toxin
toxin CC and
and NN nitroglycerin
nitroglycerin NN ointment
ointment IN for
for JJ chronic
chronic JJ anal
anal NN fissure

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> DT CAPITAL The
The NN effect
effect IN of
of NN bisoprolol
bisoprolol IN on
on NN perioperative
perioperative NN mortality
mortality CC and
and JJ myocardial
myocardial NN infarction
infarction IN in
in JJ high-risk
high-risk NNS patients
patients VBG undergoing
undergoing JJ vascular
vascular NN surgery

Surgical NNP CAPITAL Surgical
Surgical NN management
management IN of
of JJ severe
severe JJ secondary
secondary NN peritonitis

Early RB CAPITAL Early
Early JJ surgical
surgical NN treatment
treatment IN for
for JJ supratentorial
supratentorial JJ intracerebral
intracerebral NN hemorrhage
hemorrhage : :
: DT a
a VBN randomized
randomized NN feasibility
feasibility NN study

Evaluation NN CAPITAL Evaluation
Evaluation IN of
of NN clomipramine
clomipramine IN as
as DT an
an NN adjunct
adjunct TO to
to NN behavioural
behavioural NN therapy
therapy IN in
in DT the
the NN treatment
treatment IN of
of JJ separation-related
separation-related NNS problems
problems IN in
in NNS dogs

NICE JJ CAPITAL NICE
NICE TO to
to NN rule
rule IN on
on NN influenza
influenza NN flu
flu NN drug
drug NN zanamivir

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> JJ CAPITAL Longitudinal
Longitudinal NN melanonychia
melanonychia VBN associated
associated IN with
with NN hydroxyurea
hydroxyurea NN therapy
therapy IN in
in DT a
a NN patient
patient IN with
with JJ essential
essential NN thrombocytosis

Biologic JJ CAPITAL Biologic
Biologic NNS markers
markers IN as
as NNS predictors
predictors IN of
of JJ clinical
clinical NN outcome
outcome IN from
from JJ systemic
systemic NN therapy
therapy IN for
for JJ primary
primary JJ operable
operable NN breast
breast NN cancer

Treatment NN CAPITAL Treatment
Treatment IN of
of NN hypertension
hypertension IN with
with JJ ascorbic
ascorbic NN acid

Postoperative JJ CAPITAL Postoperative
Postoperative NN peritonitis
peritonitis VBG originating
originating IN from
from DT the
the NN duodenum
duodenum : :
: NN operative
operative NN management
management IN by
by NN intubation
intubation CC and
and JJ continuous
continuous JJ intraluminal
intraluminal NN irrigation

Efficacy NN CAPITAL Efficacy
Efficacy IN of
of JJ open-bite
open-bite NN treatment
treatment IN with
with DT the
the NN CAPITAL Thera-spoon

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Pompholyx
Pompholyx NN (
( JJ vesicular
vesicular NN eczema
eczema NN )
) IN after
after NN i.v
i.v . .
. NN immunoglobulin
immunoglobulin NN therapy
therapy IN for
for JJ neurologic
neurologic NN disease

Mitomycin NN CAPITAL Mitomycin
Mitomycin , ,
, NN ifosfamide
ifosfamide , ,
, CC and
and NN cisplatin
cisplatin IN in
in JJ unresectable
unresectable JJ non-small-cell
non-small-cell NN lung
lung NN cancer
cancer : :
: NNS effects
effects IN on
on NN survival
survival CC and
and NN quality
quality IN of
of NN life
life . .

Hepatic JJ CAPITAL Hepatic
Hepatic JJ arterial
arterial NN infusion
infusion IN of
of NN chemotherapy
chemotherapy IN after
after NN resection
resection IN of
of JJ hepatic
hepatic NNS metastases
metastases IN from
from JJ colorectal
colorectal NN cancer

Waiting VBG CAPITAL Waiting
Waiting IN for
for DT the
the JJ definitive
definitive NN trial
trial IN of
of JJ hepatic
hepatic JJ arterial
arterial NN chemotherapy
chemotherapy IN for
for JJ colorectal
colorectal NN cancer

Phase NN CAPITAL Phase
Phase NNP CAPITAL III
III VBN randomized
randomized NN study
study IN of
of NN cisplatin
cisplatin CC versus
versus NN paclitaxel
paclitaxel CC versus
versus NN cisplatin
cisplatin CC and
and NN paclitaxel
paclitaxel IN in
in NNS patients
patients IN with
with JJ suboptimal
suboptimal NN stage
stage NNP CAPITAL III
III CC or
or CD CAPITAL IV
IV JJ ovarian
ovarian NN cancer
cancer : :
: DT a
a JJ gynecologic
gynecologic NN oncology
oncology NN group
group NN study

Evidence NN CAPITAL Evidence
Evidence IN for
for RB double
double NN resistance
resistance TO to
to NN permethrin
permethrin CC and
and NN malathion
malathion IN in
in NN head
head NN lice

Urgent JJ CAPITAL Urgent
Urgent NN colonoscopy
colonoscopy IN for
for DT the
the NN diagnosis
diagnosis CC and
and NN treatment
treatment IN of
of JJ severe
severe JJ diverticular
diverticular NN hemorrhage

Treatment NN CAPITAL Treatment
Treatment IN of
of NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease
disease MD should
should VB begin
begin IN with
with DT a
a NN dopamine
dopamine NN agonist

< JJR <
< NN CAPITAL TO_SEE
TO_SEE JJR >
> NN CAPITAL Ulceration
Ulceration IN in
in DT an
an JJ ileocolic
ileocolic NN anastomosis
anastomosis VBN treated
treated IN with
with NN ranitidin

Low-molecular-weight JJ CAPITAL Low-molecular-weight
Low-molecular-weight NN heparin
heparin CC vs
vs NN heparin
heparin IN in
in DT the
the NN treatment
treatment IN of
of NNS patients
patients IN with
with JJ pulmonary
pulmonary NN embolism

Radiotherapy NN CAPITAL Radiotherapy
Radiotherapy IN in
in JJ breast-conserving
breast-conserving NN treatment
treatment IN for
for JJ ductal
ductal NN carcinoma
carcinoma IN in
in FW situ
situ : :
: RB first
first NNS results
results IN of
of DT the
the NN CAPITAL EORTC
EORTC VBN randomised
randomised NN phase
phase NNP CAPITAL III
III NN trial
trial CD 10853

Methadone NNP CAPITAL Methadone
Methadone NN maintenance
maintenance CC vs
vs JJ 180-day
180-day RB psychosocially
psychosocially JJ enriched
enriched NN detoxification
detoxification IN for
for NN treatment
treatment IN of
of NN opioid
opioid NN dependence
dependence : :
: DT a
a VBN randomized
randomized VBN controlled
controlled NN trial

Cryogen NN CAPITAL Cryogen
Cryogen NN spray
spray VBG cooling
cooling IN during
during NN CAPITAL Nd
Nd : :
: NN CAPITAL YAG
YAG NN laser
laser NN treatment
treatment IN of
of NNS hemangiomas

Effects NNS CAPITAL Effects
Effects IN of
of NN tolcapone
tolcapone , ,
, DT a
a NN catechol-O-methyltransferase
catechol-O-methyltransferase NN inhibitor
inhibitor , ,
, IN on
on NN motor
motor NNS symptoms
symptoms CC and
and NNS pharmacokinetics
pharmacokinetics IN of
of NN levodopa
levodopa IN in
in NNS patients
patients IN with
with NNP CAPITAL Parkinson
Parkinson POS 's
's NN disease
disease . .

Gene NN CAPITAL Gene
Gene NN therapy
therapy IN for
for NN cancer

Therapeutic JJ CAPITAL Therapeutic
Therapeutic NNS effects
effects IN of
of NN CAPITAL LDL
LDL NN apheresis
apheresis IN in
in DT the
the NN prevention
prevention IN of
of NN atherosclerosis

Dry NNP CAPITAL Dry
Dry JJ powdered
powdered NN formoterol
formoterol , ,
, RB twice
twice DT a
a NN day
day CC versus
versus VBN aerosolized
aerosolized NN salbutamol
salbutamol , ,
, CD four
four NNS times
times DT a
a NN day
day , ,
, IN in
in NNS patients
patients IN with
with JJ stable
stable NN asthma

Cell-based JJ CAPITAL Cell-based
Cell-based NN vaccination
vaccination IN against
against NN melanoma
melanoma : --
-- NN background
background , ,
, JJ preliminary
preliminary NNS results
results , ,
, CC and
and NN perspective

Celecoxib NNP CAPITAL Celecoxib
Celecoxib IN for
for NN arthritis

Poliomyelitis NN CAPITAL Poliomyelitis
Poliomyelitis NN prevention
prevention : :
: VBN revised
revised NNS recommendations
recommendations IN for
for NN use
use IN of
of VBN inactivated
inactivated CC and
and VB live
live JJ oral
oral NN poliovirus
poliovirus NNS vaccines

Mesh NN CAPITAL Mesh
Mesh NN plug
plug NN repair
repair CC and
and NN groin
groin NN hernia
hernia NN surgery

Brimonidine NN CAPITAL Brimonidine
Brimonidine JJ tartrate
tartrate CD 0.2
0.2 NN %
% RB twice
twice RB daily
daily CC vs
vs NN timolol
timolol CD 0.5
0.5 NN %
% RB twice
twice RB daily
daily : :
: JJ 1-year
1-year NNS results
results IN in
in NN glaucoma
glaucoma NNS patients

Ticarcillin/clavulanate NN CAPITAL Ticarcillin/clavulanate
Ticarcillin/clavulanate CC versus
versus NN imipenem/cilistatin
imipenem/cilistatin IN for
for DT the
the NN treatment
treatment IN of
of NNS infections
infections VBN associated
associated IN with
with JJ gangrenous
gangrenous CC and
and JJ perforated
perforated NN appendicitis

Is VBZ CAPITAL Is
Is CD zero
zero NN dose
dose JJ oral
oral NNP polio
polio NN vaccine
vaccine JJ effective
effective IN in
in NN preterm
preterm NNS babies
babies . ?

An DT CAPITAL An
An JJ economic
economic NN analysis
analysis IN of
of JJ different
different NNS strategies
strategies IN of
of NN immunization
immunization IN against
against NN hepatitis
hepatitis DT CAPITAL A
A NN virus
virus IN in
in VBN developed
developed NNS countries

Issues NNS CAPITAL Issues
Issues CC and
and NNS challenges
challenges IN with
with JJ antithrombotic
antithrombotic NN therapy
therapy IN in
in JJ diabetic
diabetic NNS patients
patients IN with
with JJ acute
acute JJ coronary
coronary NNS syndromes

Global JJ CAPITAL Global
Global NN risk
risk NN assessment
assessment IN for
for NN lipid
lipid NN therapy
therapy TO to
to VB prevent
prevent JJ coronary
coronary NN heart
heart NN disease

The DT CAPITAL The
The NN role
role IN of
of JJ fibric
fibric NN acid
acid NNS derivatives
derivatives IN in
in DT the
the JJ secondary
secondary NN prevention
prevention IN of
of JJ coronary
coronary NN heart
heart NN disease

Epoetin NN CAPITAL Epoetin
Epoetin : :
: DT a
a JJ pharmacoeconomic
pharmacoeconomic NN review
review IN of
of PRP$ its
its NN use
use IN in
in JJ chronic
chronic JJ renal
renal NN failure
failure CC and
and PRP$ its
its NNS effects
effects IN on
on NN quality
quality IN of
of NN life

Rationale NN CAPITAL Rationale
Rationale IN for
for DT the
the NN use
use IN of
of JJ antiplatelet
antiplatelet NNS drugs
drugs IN in
in NNS patients
patients IN with
with JJ peripheral
peripheral JJ vascular
vascular NN disease

The DT CAPITAL The
The NNS fluoroquinolones
fluoroquinolones IN for
for JJ urinary
urinary NN tract
tract NNS infections
infections : :
: DT a
a NN review

Reduction NN CAPITAL Reduction
Reduction IN of
of NN vasoreactivity
vasoreactivity CC and
and NN thrombogenicity
thrombogenicity IN with
with JJ laser-thermal
laser-thermal NN angioplasty
angioplasty : :
: NN comparison
comparison IN with
with NN balloon
balloon NN angioplasty

Effects NNS CAPITAL Effects
Effects IN of
of NN ultrasound
ultrasound NN energy
energy IN on
on NN total
total JJ peripheral
peripheral NN artery
artery NNS occlusions
occlusions : :
: JJ initial
initial JJ angiographic
angiographic CC and
and JJ angioscopic
angioscopic NNS results
results . .

High-dose JJ CAPITAL High-dose
High-dose NN chemotherapy
chemotherapy IN with
with JJ autologous
autologous NN stem-cell
stem-cell NN support
support IN for
for JJ epithelial
epithelial JJ ovarian
ovarian NN cancer

Pelvic JJ CAPITAL Pelvic
Pelvic NN floor
floor NN stimulation
stimulation IN in
in DT the
the NN treatment
treatment IN of
of JJ adult
adult JJ urinary
urinary NN incontinence

Chronic JJ CAPITAL Chronic
Chronic NN vagus
vagus NN nerve
nerve NN stimulation
stimulation IN for
for NN treatment
treatment IN of
of NNS seizures

`` `` ``
`` NNP CAPITAL Tandem
Tandem '' ''
'' JJ high-dose
high-dose NN chemoradiotherapy
chemoradiotherapy IN with
with JJ autologous
autologous NN stem-cell
stem-cell NN support
support IN in
in DT the
the NN treatment
treatment IN of
of RB newly
newly VBN diagnosed
diagnosed CC or
or JJ responsive
responsive JJ multiple
multiple NN myeloma

Special JJ CAPITAL Special
Special NN report
report : :
: JJ comparative
comparative NN efficacy
efficacy IN of
of JJ different
different NNS types
types IN of
of JJ pneumatic
pneumatic NN compression
compression NNS pumps
pumps IN for
for DT the
the NN treatment
treatment IN of
of NN lymphedema

Special JJ CAPITAL Special
Special NN report
report : :
: VBG pressure-reducing
pressure-reducing NN support
support NNS surfaces
surfaces IN in
in DT the
the NN prevention
prevention CC and
and NN treatment
treatment IN of
of NN pressure
pressure NNS ulcers
ulcers : :
: NN group
group CD 1
1 NNS technologies

Intravenous JJ CAPITAL Intravenous
Intravenous JJ immune
immune NN globulin
globulin IN for
for JJ recurrent
recurrent JJ spontaneous
spontaneous NN abortion

External JJ CAPITAL External
External NN counterpulsation
counterpulsation IN for
for NN treatment
treatment IN of
of JJ chronic
chronic JJ stable
stable NN angina
angina NN pectoris

Intra-articular JJ CAPITAL Intra-articular
Intra-articular NN hyaluronan
hyaluronan NNS injections
injections IN for
for NN treatment
treatment IN of
of NN osteoarthritis
osteoarthritis IN of
of DT the
the NN knee

Pneumococcal JJ CAPITAL Pneumococcal
Pneumococcal NN vaccine
vaccine : :
: DT a
a JJ second
second NN look

